,query,baseMean,log2FoldChange,lfcSE,pvalue,padj,Heatmap_Label,blast_hit,evalue,ProteinNames,BiologicalProcess,GeneOntologyIDs
1,Pocillopora_acuta_HIv2___RNAseq.g6351.t1,1780.062309,-6.556175924,0.68064185,2.77E-24,4.00E-20,Skeletal aspartic acid-rich protein 2,B3EWY8,8.79E-09,Skeletal aspartic acid-rich protein 2,,GO:0016020
2,Pocillopora_acuta_HIv2___RNAseq.g28575.t1a,2844.390541,17.55255033,3.972464118,4.35E-20,3.15E-16,Chitin synthase chs-2,G5EBQ8,7.13E-107,Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2),cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063],GO:0004100; GO:0005886; GO:0006031; GO:0006038; GO:0030428; GO:0061063; GO:0071944
3,Pocillopora_acuta_HIv2___RNAseq.g27038.t1,1882.714119,16.79642631,3.766802945,1.67E-19,8.04E-16,Protein Wnt-7a,P24383,4.23E-13,Protein Wnt-7a,"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cell-cell signaling [GO:0007267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; establishment of blood-brain barrier [GO:0060856]; establishment of cell polarity [GO:0030010]; limb development [GO:0060173]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; non-canonical Wnt signaling pathway [GO:0035567]; oviduct development [GO:0060066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axon diameter [GO:0031133]; regulation of axonogenesis [GO:0050770]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; signal transduction [GO:0007165]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; uterus development [GO:0060065]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]",GO:0000578; GO:0001502; GO:0001525; GO:0002062; GO:0005102; GO:0005109; GO:0005125; GO:0005615; GO:0005788; GO:0006915; GO:0007165; GO:0007267; GO:0007269; GO:0007416; GO:0008284; GO:0009887; GO:0009953; GO:0009986; GO:0010595; GO:0010628; GO:0014719; GO:0014834; GO:0016055; GO:0021707; GO:0021846; GO:0022009; GO:0030010; GO:0030182; GO:0030326; GO:0031012; GO:0031133; GO:0032355; GO:0035019; GO:0035115; GO:0035116; GO:0035313; GO:0035567; GO:0042127; GO:0042733; GO:0043066; GO:0043627; GO:0045165; GO:0045167; GO:0045893; GO:0045944; GO:0046330; GO:0048103; GO:0048864; GO:0050678; GO:0050768; GO:0050770; GO:0050808; GO:0051216; GO:0051247; GO:0051965; GO:0060054; GO:0060065; GO:0060066; GO:0060070; GO:0060071; GO:0060173; GO:0060856; GO:0060997; GO:0061038; GO:0062009; GO:0071560; GO:0098685; GO:0098793; GO:0098978; GO:0099175; GO:1904891; GO:1905606; GO:2000300; GO:2000463
4,Pocillopora_acuta_HIv2___RNAseq.g2165.t1,1608.739183,16.56883409,3.75190702,3.91E-19,1.22E-15,DBH-like monooxygenase protein 1,Q9CXI3,9.57E-14,DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X),dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421
5,Pocillopora_acuta_HIv2___TS.g18104.t1,1967.609007,16.81376385,3.796365681,4.22E-19,1.22E-15,Protein Wnt-8b,P51029,7.78E-22,Protein Wnt-8b,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055],GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679
6,Pocillopora_acuta_HIv2___RNAseq.g14330.t3,2168.321015,-16.51747983,3.925592816,6.66E-19,1.61E-15,CUB and peptidase domain-containing protein 1,B8V7S0,6.57E-97,CUB and peptidase domain-containing protein 1,acrosome reaction [GO:0007340]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007340
7,Pocillopora_acuta_HIv2___RNAseq.g14090.t1,2027.223581,-16.43607797,3.922086418,1.10E-18,2.11E-15,ZP domain-containing protein,G8HTB6,3.49E-20,ZP domain-containing protein,,GO:0016020
8,Pocillopora_acuta_HIv2___RNAseq.g14025.t1,2533.201058,-16.60127272,3.962168216,1.17E-18,2.11E-15,,NA,NA,NA,NA,NA
9,Pocillopora_acuta_HIv2___RNAseq.g3832.t1,4681.362819,12.49231009,2.348006761,5.40E-18,8.28E-15,Diencephalon mesencephalon homeobox,Q566X8,1.47E-36,Diencephalon/mesencephalon homeobox protein 1-B,midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041],GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074
10,Pocillopora_acuta_HIv2___RNAseq.g8006.t1,1858.293681,-16.16560272,3.919681603,5.74E-18,8.28E-15,,NA,NA,NA,NA,NA
11,Pocillopora_acuta_HIv2___RNAseq.g10378.t1,1200.093234,16.15800829,3.732752662,6.30E-18,8.28E-15,Macrophage mannose receptor 1,P22897,1.35E-39,Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206),cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898],GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353
12,Pocillopora_acuta_HIv2___RNAseq.g14253.t1,1084.626109,15.94498062,3.726002152,1.44E-17,1.73E-14,Hemicentin-1,Q96RW7,2.16E-33,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711
13,Pocillopora_acuta_HIv2___RNAseq.g25431.t1,3378.810077,-11.73493804,1.977329734,1.70E-17,1.81E-14,,NA,NA,NA,NA,NA
14,Pocillopora_acuta_HIv2___RNAseq.11056_t,1574.738891,-15.93586513,3.890786298,1.75E-17,1.81E-14,,NA,NA,NA,NA,NA
15,Pocillopora_acuta_HIv2___RNAseq.g9588.t1,10129.88082,13.0019191,2.915902202,2.00E-17,1.93E-14,Homeobox protein otx5-B,Q9PT61,6.33E-42,Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b),anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0000981; GO:0003677; GO:0005634; GO:0009952; GO:0042706; GO:0045944
16,Pocillopora_acuta_HIv2___TS.g30765.t1,1392.703645,16.34475727,3.808687271,2.47E-17,2.24E-14,,NA,NA,NA,NA,NA
17,Pocillopora_acuta_HIv2___RNAseq.g14021.t1,1390.286857,-15.74431424,3.85317969,3.14E-17,2.67E-14,ZP domain-containing protein,G8HTB6,2.38E-12,ZP domain-containing protein,,GO:0016020
18,Pocillopora_acuta_HIv2___RNAseq.g19082.t1,922.1126122,15.73955476,3.705106121,5.04E-17,4.05E-14,,NA,NA,NA,NA,NA
19,Pocillopora_acuta_HIv2___RNAseq.g16202.t1,815.9585478,11.13516615,1.742290286,8.60E-17,6.55E-14,Carbohydrate sulfotransferase 6,Q9GZX3,1.09E-27,Carbohydrate sulfotransferase 6 (Corneal N-acetylglucosamine-6-O-sulfotransferase) (C-GlcNAc6ST) (hCGn6ST) (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta) (GST4-beta) (N-acetylglucosamine 6-O-sulfotransferase 5) (GlcNAc6ST-5) (Gn6st-5),carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790],GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0018146; GO:0045130
20,Pocillopora_acuta_HIv2___TS.g19991.t2,950.2483827,15.73901701,3.723811452,1.16E-16,8.40E-14,Bacterial protein of unknown function (DUF885),NA,NA,NA,NA,NA
21,Pocillopora_acuta_HIv2___RNAseq.g20860.t1,1265.274216,-15.57624478,3.873810053,1.36E-16,9.35E-14,Hemagglutinin/amebocyte aggregation factor,Q01528,3.72E-11,Hemagglutinin/amebocyte aggregation factor (18K-LAF),collagen fibril organization [GO:0030199],GO:0005615; GO:0030199; GO:0031012
22,Pocillopora_acuta_HIv2___RNAseq.g8588.t1,783.1193336,15.47741175,3.693546498,2.19E-16,1.44E-13,Coadhesin,B3EWZ3,3.14E-104,Coadhesin,,GO:0016020
23,Pocillopora_acuta_HIv2___RNAseq.g26604.t1,3789.964873,12.30512265,2.533075308,2.56E-16,1.61E-13,Protein-glutamine gamma-glutamyltransferase K,Q9GLK0,3.70E-171,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),keratinization [GO:0031424]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838],GO:0003810; GO:0010838; GO:0016020; GO:0031424; GO:0045787; GO:0046872
24,Pocillopora_acuta_HIv2___TS.g27642.t1b,1146.751646,-15.38435701,3.83971614,2.74E-16,1.61E-13,"Beta-1,4-galactosyltransferase 1",P15535,1.41E-89,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]",acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; glycoprotein biosynthetic process [GO:0009101]; lactose biosynthetic process [GO:0005989]; lipid metabolic process [GO:0006629]; macrophage migration [GO:1905517]; negative regulation of epithelial cell proliferation [GO:0050680]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of circulating fibrinogen levels [GO:0061755]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046]; wound healing [GO:0042060],GO:0000138; GO:0002064; GO:0002526; GO:0003831; GO:0003945; GO:0004461; GO:0005576; GO:0005794; GO:0005886; GO:0005989; GO:0006012; GO:0006486; GO:0006487; GO:0006629; GO:0007155; GO:0007339; GO:0007341; GO:0008092; GO:0008283; GO:0008378; GO:0009101; GO:0009312; GO:0009897; GO:0009986; GO:0016323; GO:0030057; GO:0030145; GO:0030175; GO:0030198; GO:0031526; GO:0032580; GO:0032991; GO:0042060; GO:0043065; GO:0045136; GO:0050673; GO:0050680; GO:0060046; GO:0060054; GO:0060055; GO:0061755; GO:1905517
25,Pocillopora_acuta_HIv2___TS.g18100.t1,8027.266414,10.61719949,1.876380507,2.79E-16,1.61E-13,Protein Wnt-8b,P51029,2.52E-27,Protein Wnt-8b,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055],GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679
26,Pocillopora_acuta_HIv2___RNAseq.g11588.t1,1254.25173,-15.46993255,3.890239687,3.02E-16,1.68E-13,Mucin-like protein,B3EWY9,3.43E-26,Mucin-like protein,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005615; GO:0007160; GO:0016020
27,Pocillopora_acuta_HIv2___RNAseq.g25327.t1,1008.530477,-11.85498172,1.974474724,3.84E-16,2.06E-13,,Q13887,2.02E-24,Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2),angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816],GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0046872; GO:0060576; GO:0061586; GO:0099156; GO:1902895; GO:1990830; GO:1990837
28,Pocillopora_acuta_HIv2___RNAseq.g12281.t1,740.0609629,15.40194562,3.720971692,4.03E-16,2.08E-13,Receptor-type tyrosine-protein phosphatase F,P10586,7.23E-48,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR),cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560],GO:0004721; GO:0004725; GO:0005001; GO:0005886; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:0099560; GO:1900121
29,Pocillopora_acuta_HIv2___RNAseq.g19284.t1,5809.188723,15.69330246,3.623388622,4.60E-16,2.22E-13,Matrix metalloproteinase-16 ,Q9WTR0,1.41E-46,Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP),bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; protein processing [GO:0016485]; skeletal system development [GO:0001501],GO:0001501; GO:0001503; GO:0001958; GO:0004222; GO:0005615; GO:0005886; GO:0008270; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0060348; GO:0070006; GO:0097094
30,Pocillopora_acuta_HIv2___RNAseq.g19085.t1,6069.902038,11.12626192,2.1020643,4.61E-16,2.22E-13,Halomucin,Q18DN4,2.43E-08,Halomucin,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],GO:0005509; GO:0005576; GO:0007156; GO:0016020; GO:0030246
31,Pocillopora_acuta_HIv2___TS.g11360.t1,727.482935,11.3112024,1.833068833,4.91E-16,2.29E-13,,NA,NA,NA,NA,NA
32,Pocillopora_acuta_HIv2___RNAseq.g7803.t1,953.4798544,-15.18215787,3.812600263,5.72E-16,2.58E-13,Transcription factor sox-2,Q21305,1.37E-40,Transcription factor sox-2,neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0000977; GO:0000978; GO:0001228; GO:0005634; GO:0030182; GO:0045944; GO:0048665
33,Pocillopora_acuta_HIv2___TS.g16008.t2,945.3622318,-15.13568595,3.797291361,6.04E-16,2.65E-13,Allene oxide synthase,Q40778,1.37E-29,Allene oxide synthase (EC 4.2.1.92) (Cytochrome P450 74A2) (Rubber particle protein) (RPP),fatty acid biosynthetic process [GO:0006633]; oxylipin biosynthetic process [GO:0031408],GO:0004497; GO:0005506; GO:0006633; GO:0009978; GO:0016705; GO:0020037; GO:0031408
34,Pocillopora_acuta_HIv2___RNAseq.g22978.t3b,946.2585374,-15.15442485,3.814048965,7.35E-16,3.13E-13,Bacterial protein of unknown function (DUF885),NA,NA,NA,NA,NA
35,Pocillopora_acuta_HIv2___RNAseq.g2406.t1,916.5835252,-15.13063665,3.816061912,8.13E-16,3.36E-13,,NA,NA,NA,NA,NA
36,Pocillopora_acuta_HIv2___RNAseq.g8119.t1,933.904972,-15.18075149,3.835767955,8.57E-16,3.44E-13,,NA,NA,NA,NA,NA
37,Pocillopora_acuta_HIv2___TS.g9414.t1,1170.471344,-15.54088026,3.977648215,9.67E-16,3.78E-13,Follistatin-related protein 5,Q8BFR2,2.36E-58,Follistatin-related protein 5 (Follistatin-like protein 5) (m-D/Bsp120I 1-2),cell differentiation [GO:0030154]; regulation of BMP signaling pathway [GO:0030510],GO:0005509; GO:0005576; GO:0030154; GO:0030510
38,Pocillopora_acuta_HIv2___RNAseq.g21374.t1,755.9813368,-10.20472545,1.620406258,1.63E-15,6.20E-13,,NA,NA,NA,NA,NA
39,Pocillopora_acuta_HIv2___RNAseq.g21000.t1,1227.757083,-15.59450811,3.963123088,1.74E-15,6.46E-13,ZP domain-containing protein,G8HTB6,7.06E-32,ZP domain-containing protein,,GO:0016020
40,Pocillopora_acuta_HIv2___RNAseq.g5252.t1,685.2377292,-11.5318853,1.917036162,1.85E-15,6.68E-13,,Q00168,4.64E-72,Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17),"cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cytokine production [GO:0001818]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]",GO:0001818; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0032226; GO:0043005; GO:0045211; GO:0048786; GO:0051489; GO:0060278; GO:0106310; GO:2001234
41,Pocillopora_acuta_HIv2___RNAseq.g22853.t1,8612.303902,-11.13293951,2.151304119,1.90E-15,6.72E-13,Sporulation-specific protein 15-like,NA,NA,NA,NA,NA
42,Pocillopora_acuta_HIv2___RNAseq.g17117.t1,1037.729781,-15.15783407,3.859082394,2.19E-15,7.54E-13,Nitric oxide synthase 1,O19132,0,"Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1)",nitric oxide biosynthetic process [GO:0006809],GO:0004517; GO:0005516; GO:0006809; GO:0010181; GO:0020037; GO:0042383; GO:0043197; GO:0046872; GO:0050660; GO:0050661
43,Pocillopora_acuta_HIv2___TS.g16802.t1,3444.718376,-10.70297579,1.991838058,2.40E-15,7.89E-13,,NA,NA,NA,NA,NA
44,Pocillopora_acuta_HIv2___RNAseq.g25759.t1,808.988611,-14.89459268,3.793934411,2.40E-15,7.89E-13,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase,Q27128,0,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103],GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779; GO:0050428
45,Pocillopora_acuta_HIv2___RNAseq.30415_t,893.1763575,-15.1484622,3.884391294,3.10E-15,9.89E-13,Synaptotagmin-10,Q6XYQ8,9.54E-39,Synaptotagmin-10 (Synaptotagmin X) (SytX),calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; sensory perception of smell [GO:0007608],GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0017156; GO:0030276; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0098793; GO:0098978
46,Pocillopora_acuta_HIv2___RNAseq.g24120.t1,770.6499447,-14.87497418,3.803616234,3.15E-15,9.89E-13,Uromodulin (Tamm-Horsfall urinary glycoprotein),Q862Z3,4.51E-46,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829]; neutrophil migration [GO:1990266],GO:0000922; GO:0005509; GO:0005615; GO:0005929; GO:0009986; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367; GO:1990266
47,Pocillopora_acuta_HIv2___RNAseq.g14336.t1,765.6225053,-14.85798212,3.796214819,3.98E-15,1.22E-12,CUB and peptidase domain-containing protein 1,B8V7S0,9.84E-94,CUB and peptidase domain-containing protein 1,acrosome reaction [GO:0007340]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007340
48,Pocillopora_acuta_HIv2___RNAseq.g26594.t2,3371.395232,-13.87644253,3.298652264,4.82E-15,1.45E-12,,Q90632,4.11E-37,Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8),monocarboxylic acid transport [GO:0015718],GO:0005886; GO:0008028; GO:0015293; GO:0015718; GO:0016323
49,Pocillopora_acuta_HIv2___TS.g4983.t1,908.8478863,15.66779675,3.870453386,6.21E-15,1.82E-12,F-box/LRR-repeat protein 20,Q9CZV8,7.00E-18,F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like),"behavioral fear response [GO:0001662]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]",GO:0001662; GO:0005737; GO:0019005; GO:0031146; GO:0045202; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300
50,Pocillopora_acuta_HIv2___RNAseq.g19115.t1,990.626313,-10.45205726,1.823677078,6.28E-15,1.82E-12,,Q8NB59,7.09E-20,Synaptotagmin-14 (Synaptotagmin XIV) (SytXIV),,GO:0005543; GO:0016020
51,Pocillopora_acuta_HIv2___RNAseq.g28635.t1,3721.66148,-13.79729644,3.411359124,7.81E-15,2.19E-12,,Q6P832,0,"Glycine amidinotransferase, mitochondrial (EC 2.1.4.1) (L-arginine:glycine amidinotransferase) (Transamidinase)",creatine biosynthetic process [GO:0006601],GO:0005743; GO:0006601; GO:0015068
52,Pocillopora_acuta_HIv2___RNAseq.g25317.t1,2252.954653,-10.96761738,2.314492251,7.98E-15,2.19E-12,Zona_pellucida,Q03146,4.64E-09,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]",GO:0001558; GO:0001952; GO:0005518; GO:0005524; GO:0005886; GO:0005903; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0010976; GO:0014909; GO:0016323; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046872; GO:0051897; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138
53,Pocillopora_acuta_HIv2___RNAseq.g21373.t1,662.8328642,-14.61874836,3.758584628,8.02E-15,2.19E-12,,NA,NA,NA,NA,NA
54,Pocillopora_acuta_HIv2___RNAseq.g7627.t1,764.1899706,-14.75497336,3.807115129,8.44E-15,2.26E-12,Toll-like receptor 2,Q6T752,6.86E-13,Toll-like receptor 2 (CD antigen CD282),cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224],GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0038023; GO:0042497; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727
55,Pocillopora_acuta_HIv2___RNAseq.g9210.t1,701.4326527,-14.51508828,3.774414617,1.71E-14,4.49E-12,,NA,NA,NA,NA,NA
56,Pocillopora_acuta_HIv2___TS.g16384.t1,645.7042187,-14.59740749,3.798769944,1.94E-14,5.00E-12,,NA,NA,NA,NA,NA
57,Pocillopora_acuta_HIv2___RNAseq.g27377.t1,735.3401451,-10.23696118,1.776168374,2.14E-14,5.43E-12,,NA,NA,NA,NA,NA
58,Pocillopora_acuta_HIv2___RNAseq.g13561.t1,640.6244881,-14.58199475,3.800079305,2.26E-14,5.52E-12,,NA,NA,NA,NA,NA
59,Pocillopora_acuta_HIv2___RNAseq.g1102.t1,682.4100912,-14.67567183,3.817131572,2.28E-14,5.52E-12,Neuropeptide FF receptor 2,Q9EQD2,2.11E-45,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408],GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408
60,Pocillopora_acuta_HIv2___RNAseq.g1234.t1,3320.090205,10.01716349,2.07233083,2.33E-14,5.52E-12,,NA,NA,NA,NA,NA
61,Pocillopora_acuta_HIv2___RNAseq.g9631.t1,5786.086673,-14.75597859,3.166304696,2.33E-14,5.52E-12,Repetitive proline-rich cell wall protein 2,Q40375,3.73E-56,Repetitive proline-rich cell wall protein 2,,GO:0005199; GO:0005576
62,Pocillopora_acuta_HIv2___RNAseq.g11659.t1,606.9452841,-14.4456197,3.782207246,2.66E-14,6.20E-12,,NA,NA,NA,NA,NA
63,Pocillopora_acuta_HIv2___TS.g1968.t2,570.1548136,-14.38357031,3.768190159,3.19E-14,7.32E-12,,NA,NA,NA,NA,NA
64,Pocillopora_acuta_HIv2___RNAseq.g1126.t1,3758.539303,14.57747958,3.157201343,3.83E-14,8.66E-12,Coadhesin,B3EWZ3,7.33E-54,Coadhesin,,GO:0016020
65,Pocillopora_acuta_HIv2___TS.g21863.t2,714.4991869,-11.58702318,2.257521543,3.94E-14,8.77E-12,,NA,NA,NA,NA,NA
66,Pocillopora_acuta_HIv2___RNAseq.g14484.t1,670.5620298,-14.65416379,3.855551896,4.67E-14,1.02E-11,Ras-related protein Rab-37,Q9JKM7,4.74E-106,Ras-related protein Rab-37,protein transport [GO:0015031],GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0015031; GO:0030141
67,Pocillopora_acuta_HIv2___RNAseq.g18517.t1,291.8658889,-9.434439383,1.47306217,5.37E-14,1.16E-11,,NA,NA,NA,NA,NA
68,Pocillopora_acuta_HIv2___RNAseq.g27621.t1,1470.664505,12.63878421,2.732789313,6.35E-14,1.35E-11,,NA,NA,NA,NA,NA
69,Pocillopora_acuta_HIv2___RNAseq.22067_t,613.5248233,-14.2404359,3.777746698,6.54E-14,1.37E-11,Protein Wnt-2b,Q98SN7,6.50E-110,Protein Wnt-2b,camera-type eye photoreceptor cell differentiation [GO:0060219]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; cornea development in camera-type eye [GO:0061303]; embryonic camera-type eye formation [GO:0060900]; embryonic forelimb morphogenesis [GO:0035115]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; limb development [GO:0060173]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of neuron differentiation [GO:0045665]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; retina layer formation [GO:0010842]; Wnt signaling pathway [GO:0016055],GO:0002011; GO:0002088; GO:0003407; GO:0005109; GO:0005125; GO:0005615; GO:0008283; GO:0010842; GO:0016055; GO:0030182; GO:0035115; GO:0045165; GO:0045665; GO:0045686; GO:0045743; GO:0060070; GO:0060173; GO:0060219; GO:0060828; GO:0060900; GO:0061072; GO:0061303; GO:0090270; GO:0090271
70,Pocillopora_acuta_HIv2___RNAseq.g27681.t1b,674.1697312,-14.3970677,3.805804456,7.01E-14,1.45E-11,,NA,NA,NA,NA,NA
71,Pocillopora_acuta_HIv2___RNAseq.g28202.t1,2285.158437,-1.33185387,3.131682184,7.84E-14,1.60E-11,,P12391,1.25E-61,Neuronal acetylcholine receptor subunit beta-3,"acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271]",GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0022848; GO:0032991; GO:0035094; GO:0042166; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098691; GO:0098793; GO:0099171
72,Pocillopora_acuta_HIv2___RNAseq.g8732.t1,507.2404636,-14.12872312,3.725763729,8.63E-14,1.73E-11,UPF0462 protein C4orf33 homolog,Q8BGN2,3.01E-48,UPF0462 protein C4orf33 homolog,,
73,Pocillopora_acuta_HIv2___RNAseq.g11810.t1,633.2448664,-14.32907631,3.79401899,1.06E-13,2.11E-11,Spectrin beta chain,P15508,2.41E-37,"Spectrin beta chain, erythrocytic (Beta-I spectrin)",actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; hemopoiesis [GO:0030097]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779],GO:0003779; GO:0005200; GO:0005886; GO:0006779; GO:0007009; GO:0008091; GO:0014731; GO:0016020; GO:0030036; GO:0030054; GO:0030097; GO:0030863; GO:0030864; GO:0042995; GO:0051015; GO:0051693; GO:0098794; GO:0098978
74,Pocillopora_acuta_HIv2___RNAseq.g13.t1,493.1626962,-14.1602003,3.76373525,1.09E-13,2.12E-11,Immunoglobulin superfamily member 10,Q3V1M1,5.17E-10,Immunoglobulin superfamily member 10 (IgSF10),ossification [GO:0001503]; regulation of neuron migration [GO:2001222]; tissue regeneration [GO:0042246],GO:0001503; GO:0005576; GO:0042246; GO:2001222
75,Pocillopora_acuta_HIv2___RNAseq.g5007.t1,484.0235126,-14.10564506,3.73402568,1.13E-13,2.18E-11,,NA,NA,NA,NA,NA
76,Pocillopora_acuta_HIv2___RNAseq.g8062.t1,492.934931,14.72027567,3.757197184,1.17E-13,2.21E-11,Forkhead box protein C2-B (FoxC2-B) ,Q9PVY8,6.30E-66,Forkhead box protein C2-B (FoxC2-B) (FoxC2b) (Fork head domain-related protein 4') (FD-4') (xFD-4') (xFD4 B),mesoderm development [GO:0007498]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355],GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007498; GO:0043565; GO:0045893; GO:0045944; GO:1990841
77,Pocillopora_acuta_HIv2___RNAseq.g13400.t1,533.2237478,-14.25408228,3.784025563,1.18E-13,2.21E-11,Double-stranded RNA-specific editase 1,P51400,0,Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase),adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965],GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049
78,Pocillopora_acuta_HIv2___RNAseq.g7514.t1,496.3624374,-14.05178749,3.720552913,1.30E-13,2.41E-11,,NA,NA,NA,NA,NA
79,Pocillopora_acuta_HIv2___RNAseq.g9231.t1,1272.975523,11.011794,2.786090579,1.36E-13,2.45E-11,,NA,NA,NA,NA,NA
80,Pocillopora_acuta_HIv2___RNAseq.g23883.t2,638.1024364,-11.72502405,2.348464757,1.36E-13,2.45E-11,,Q5VU97,8.26E-146,VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1),,GO:0005245; GO:0005891
81,Pocillopora_acuta_HIv2___RNAseq.g3939.t1,610.3792155,11.77900856,2.429931051,1.37E-13,2.45E-11,Spondin-1,Q9W770,1.17E-71,Spondin-1 (F-spondin),cell adhesion [GO:0007155],GO:0005576; GO:0007155; GO:0031012; GO:0046872
82,Pocillopora_acuta_HIv2___RNAseq.g17085.t1,542.2018904,-14.17977811,3.781989234,1.41E-13,2.49E-11,Peroxidasin homolog pxn-2,G5EG78,2.82E-87,Peroxidasin homolog pxn-2 (EC 1.11.2.-),axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979],GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825
83,Pocillopora_acuta_HIv2___RNAseq.g3222.t1,584.3146714,-14.20094686,3.797125221,1.66E-13,2.88E-11,Epidermal growth factor-related protein 3,P49013,1.81E-28,Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III),,GO:0005509; GO:0005576; GO:0009374
84,Pocillopora_acuta_HIv2___RNAseq.g17946.t1,517.1954591,-14.12202949,3.777628547,1.67E-13,2.88E-11,,NA,NA,NA,NA,NA
85,Pocillopora_acuta_HIv2___RNAseq.g30104.t1,700.2330005,-9.790095713,1.790679888,1.87E-13,3.18E-11,,Q80VF6,3.22E-10,Protein FAM181B,,
86,Pocillopora_acuta_HIv2___TS.g22105.t1,586.4538651,-14.37351881,3.839912425,2.00E-13,3.36E-11,Major facilitator superfamily domain-containing protein 12,F1PZV2,2.55E-32,Major facilitator superfamily domain-containing protein 12,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],GO:0005764; GO:0005765; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:1903712
87,Pocillopora_acuta_HIv2___RNAseq.g21722.t1,389.2193252,-9.917094452,1.697528792,2.02E-13,3.36E-11,,Q8VCR7,7.68E-44,Putative protein-lysine deacylase ABHD14B (EC 2.3.1.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B),positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0005634; GO:0005737; GO:0016787; GO:0045944; GO:0061733
88,Pocillopora_acuta_HIv2___RNAseq.g14933.t1,451.5034563,-13.94665821,3.708899753,2.15E-13,3.54E-11,,Q3UZD5,2.42E-88,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468],GO:0000122; GO:0005634; GO:0010468; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0046872; GO:0051151; GO:0140944
89,Pocillopora_acuta_HIv2___RNAseq.g16988.t1,376.1632002,-11.04593946,2.066339612,2.29E-13,3.72E-11,,NA,NA,NA,NA,NA
90,Pocillopora_acuta_HIv2___RNAseq.g13796.t1,522.0945124,-14.23655347,3.796406168,2.44E-13,3.92E-11,Tubulin-folding cofactor B,Q9D1E6,3.96E-86,Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B),cell differentiation [GO:0030154]; cytoplasmic microtubule organization [GO:0031122]; nervous system development [GO:0007399]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021],GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0007021; GO:0007023; GO:0007399; GO:0030154; GO:0031122; GO:0035371; GO:0043014; GO:0051010
91,Pocillopora_acuta_HIv2___RNAseq.g10163.t1,764.2954366,-10.20542395,2.036319193,2.66E-13,4.23E-11,,NA,NA,NA,NA,NA
92,Pocillopora_acuta_HIv2___RNAseq.g12.t1,573.9059924,-14.12627284,3.798801396,2.92E-13,4.56E-11,Matrix-remodeling-associated protein 5,Q9NR99,8.15E-10,Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican),response to transforming growth factor beta [GO:0071559],GO:0005201; GO:0005576; GO:0062023; GO:0070062; GO:0071559
93,Pocillopora_acuta_HIv2___RNAseq.g18187.t1,361.1329949,-7.556906592,1.184597326,2.93E-13,4.56E-11,,Q6DBY9,1.70E-30,Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST),carbohydrate metabolic process [GO:0005975]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044],GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0042339; GO:0045130
94,Pocillopora_acuta_HIv2___RNAseq.g11522.t1,426.9906927,-9.354693082,1.628967843,2.99E-13,4.61E-11,,NA,NA,NA,NA,NA
95,Pocillopora_acuta_HIv2___RNAseq.g31136.t1,426.9419738,-13.87595165,3.712500471,3.15E-13,4.80E-11,,Q1L8G7,6.83E-50,GATA zinc finger domain-containing protein 1,chromatin organization [GO:0006325]; regulation of DNA-templated transcription [GO:0006355],GO:0005634; GO:0006325; GO:0006355; GO:0031674; GO:0043565; GO:0046872
96,Pocillopora_acuta_HIv2___RNAseq.g7672.t1,429.5964188,-13.82711969,3.69885971,3.26E-13,4.92E-11,,NA,NA,NA,NA,NA
97,Pocillopora_acuta_HIv2___TS.g28528.t1b,5194.877777,9.853665536,2.898462062,3.69E-13,5.50E-11,,P18460,4.35E-37,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2),apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of macromolecule metabolic process [GO:0060255],GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284; GO:0017134; GO:0030154; GO:0043235; GO:0043410; GO:0060255
98,Pocillopora_acuta_HIv2___RNAseq.g2813.t4,1653.408293,-1.174789501,2.372156794,3.83E-13,5.66E-11,,Q3UP38,3.52E-55,EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46),activation of store-operated calcium channel activity [GO:0032237]; adaptive immune response [GO:0002250]; endosomal transport [GO:0016197]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of JNK cascade [GO:0046330]; response to histamine [GO:0034776]; store-operated calcium entry [GO:0002115]; T-helper 1 cell differentiation [GO:0045063],GO:0000139; GO:0001772; GO:0002115; GO:0002250; GO:0003924; GO:0005509; GO:0005525; GO:0005737; GO:0005815; GO:0005886; GO:0016197; GO:0031982; GO:0032237; GO:0032588; GO:0033093; GO:0034776; GO:0045063; GO:0046330; GO:0051928
99,Pocillopora_acuta_HIv2___TS.g10041.t1,413.3937214,-13.78517232,3.696228085,4.16E-13,6.07E-11,,V6CLA2,4.93E-12,E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26),determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028],GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936
100,Pocillopora_acuta_HIv2___RNAseq.g18278.t1,406.8409713,-13.7874891,3.703210166,4.39E-13,6.35E-11,,NA,NA,NA,NA,NA
101,Pocillopora_acuta_HIv2___RNAseq.g13582.t1,398.6022504,-13.77116098,3.696994486,4.68E-13,6.70E-11,,NA,NA,NA,NA,NA
102,Pocillopora_acuta_HIv2___RNAseq.g14640.t1,409.0878564,-13.78812526,3.709408511,5.16E-13,7.32E-11,,Q6V0K7,4.43E-23,Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein),renal system process [GO:0003014],GO:0003014; GO:0005509; GO:0005635
103,Pocillopora_acuta_HIv2___TS.g20007.t1,530.7280956,-14.26353431,3.853795243,5.41E-13,7.60E-11,Thrombospondin-3,P49746,0,Thrombospondin-3,bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023
104,Pocillopora_acuta_HIv2___RNAseq.g30663.t1,487.4351482,-10.66904215,2.096819027,5.89E-13,8.19E-11,,P25035,1.30E-37,Cellular tumor antigen p53 (Tumor suppressor p53),apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein tetramerization [GO:0051262],GO:0000976; GO:0003700; GO:0005634; GO:0005737; GO:0005739; GO:0006915; GO:0006974; GO:0043066; GO:0045944; GO:0046872; GO:0051262; GO:0140693; GO:1990841
105,Pocillopora_acuta_HIv2___RNAseq.g28971.t1a,1603.228128,12.48367241,2.915055179,5.96E-13,8.21E-11,Uromodulin,Q91X17,8.41E-23,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918],GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266
106,Pocillopora_acuta_HIv2___RNAseq.g829.t1,2530.877727,14.32648009,3.301249269,6.46E-13,8.81E-11,Inward rectifier potassium channel 2 ,P63253,6.37E-87,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2)",cardiac muscle cell action potential involved in contraction [GO:0086002]; magnesium ion transport [GO:0015693]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076],GO:0005242; GO:0005546; GO:0005886; GO:0006813; GO:0008076; GO:0014861; GO:0015693; GO:0016020; GO:0034765; GO:0042802; GO:0051289; GO:0055119; GO:0060306; GO:0086002; GO:0086008; GO:0086091; GO:0090076; GO:1990573
107,Pocillopora_acuta_HIv2___TS.g6907.t1,2839.246671,-9.386159854,2.371365279,6.55E-13,8.85E-11,,NA,NA,NA,NA,NA
108,Pocillopora_acuta_HIv2___RNAseq.g2437.t1,2337.698638,-13.24188953,3.003431906,6.96E-13,9.32E-11,,A2R9H9,2.30E-06,Chromatin-remodeling ATPase INO80 (EC 3.6.4.-),CENP-A containing chromatin assembly [GO:0034080]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of TOR signaling [GO:0032006]; subtelomeric heterochromatin formation [GO:0031509]; telomere maintenance via recombination [GO:0000722]; transcription by RNA polymerase II [GO:0006366],GO:0000722; GO:0000781; GO:0003677; GO:0005524; GO:0006281; GO:0006366; GO:0016887; GO:0031011; GO:0031509; GO:0032006; GO:0034080; GO:0043138; GO:0045944; GO:0140658
109,Pocillopora_acuta_HIv2___RNAseq.g19042.t1,916.6214684,-11.47726201,2.530571922,7.41E-13,9.79E-11,,Q6IWH7,0,Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G),calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220],GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0034220; GO:0046983; GO:0061588; GO:0070161; GO:1902476
110,Pocillopora_acuta_HIv2___RNAseq.g2959.t1,461.103526,-11.15076526,2.224586461,7.44E-13,9.79E-11,,NA,NA,NA,NA,NA
111,Pocillopora_acuta_HIv2___RNAseq.g16527.t1,431.570198,-13.81445058,3.742410354,9.16E-13,1.19E-10,,NA,NA,NA,NA,NA
112,Pocillopora_acuta_HIv2___RNAseq.g25686.t1,380.6592587,-10.83842621,2.166890796,9.75E-13,1.26E-10,,Q32PP9,2.30E-38,Transcription factor Sox-14,brain development [GO:0007420]; hypothalamus development [GO:0021854]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0007420; GO:0021854; GO:0030182; GO:0045944
113,Pocillopora_acuta_HIv2___RNAseq.g24911.t1,853.0360986,0.932128539,1.725650405,9.86E-13,1.26E-10,,F1RWC3,1.53E-09,Cubilin (Intrinsic factor-cobalamin receptor),cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031],GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419
114,Pocillopora_acuta_HIv2___TS.g14372.t1b,364.331646,-13.60559572,3.692364715,9.99E-13,1.27E-10,,NA,NA,NA,NA,NA
115,Pocillopora_acuta_HIv2___RNAseq.g26783.t1,361.9066697,-13.59995063,3.701053743,1.19E-12,1.50E-10,,Q0KHY3,1.47E-58,Protein mesh,cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528],GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528
116,Pocillopora_acuta_HIv2___RNAseq.g299.t1,382.0357994,-13.60263718,3.706028551,1.26E-12,1.56E-10,Sacsin,Q9NZJ4,0,Sacsin (DnaJ homolog subfamily C member 29),negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084
117,Pocillopora_acuta_HIv2___RNAseq.g26596.t1,503.3224402,-13.9368776,3.803634536,1.26E-12,1.56E-10,,Q8NDA2,5.33E-26,Hemicentin-2,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808],GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023
118,Pocillopora_acuta_HIv2___RNAseq.g8688.t1,10616.84233,-8.793603702,2.118567231,1.37E-12,1.68E-10,,NA,NA,NA,NA,NA
119,Pocillopora_acuta_HIv2___RNAseq.g24649.t1,769.933879,-14.50272615,3.902189224,1.51E-12,1.83E-10,Sacsin,Q9NZJ4,0,Sacsin (DnaJ homolog subfamily C member 29),negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084
120,Pocillopora_acuta_HIv2___RNAseq.g18982.t1,470.7049008,-13.87798842,3.842947282,1.52E-12,1.83E-10,,NA,NA,NA,NA,NA
121,Pocillopora_acuta_HIv2___RNAseq.g2567.t1,363.9611239,-13.50371755,3.677283554,1.53E-12,1.83E-10,,P0C7M7,9.38E-55,"Acyl-coenzyme A synthetase ACSM4, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 4)",acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633],GO:0004321; GO:0005524; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0046872; GO:0102391
122,Pocillopora_acuta_HIv2___TS.g1253.t1,528.009636,-13.82735973,3.814080513,1.65E-12,1.95E-10,,Q91175,1.60E-45,Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1),adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410],GO:0004937; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0043410; GO:0071880
123,Pocillopora_acuta_HIv2___RNAseq.5883_t,372.2458825,-13.5429823,3.698695544,1.77E-12,2.08E-10,,Q5RCC4,2.53E-65,Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17),cellular response to interferon-beta [GO:0035458]; dendritic spine development [GO:0060996]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of neuron migration [GO:2001222],GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005954; GO:0014069; GO:0035458; GO:0043197; GO:0046427; GO:0046872; GO:0051346; GO:0060996; GO:0106310; GO:1990443; GO:2000124; GO:2001222
124,Pocillopora_acuta_HIv2___RNAseq.g3739.t1,353.3637531,-13.61725473,3.721080027,1.97E-12,2.30E-10,,NA,NA,NA,NA,NA
125,Pocillopora_acuta_HIv2___RNAseq.g15990.t1,372.608312,-13.5994792,3.722205034,1.99E-12,2.30E-10,,NA,NA,NA,NA,NA
126,Pocillopora_acuta_HIv2___RNAseq.g26586.t1,381.2471396,-13.7468056,3.764961479,2.02E-12,2.32E-10,,Q7TM99,4.51E-38,Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9),carnitine transmembrane transport [GO:1902603]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]; urate metabolic process [GO:0046415],GO:0005308; GO:0005886; GO:0008028; GO:0015226; GO:0015718; GO:0015881; GO:0046415; GO:1902603
127,Pocillopora_acuta_HIv2___RNAseq.g13044.t1,735.6712123,-11.562959,2.622490522,2.43E-12,2.77E-10,,Q9UGM3,2.37E-79,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein),defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031],GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062
128,Pocillopora_acuta_HIv2___RNAseq.g30675.t1,961.1430218,9.707373322,2.11231759,2.81E-12,3.15E-10,Fork head domain-containing protein FD5,P32029,5.44E-27,Fork head domain-containing protein FD5,anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154
129,Pocillopora_acuta_HIv2___RNAseq.g10988.t1,1437.017709,-12.33042131,2.887421381,2.82E-12,3.15E-10,,NA,NA,NA,NA,NA
130,Pocillopora_acuta_HIv2___RNAseq.11917_t,416.6462514,-13.60011729,3.78170396,2.83E-12,3.15E-10,,Q805E5,1.13E-45,Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1),carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655],GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655
131,Pocillopora_acuta_HIv2___RNAseq.g10339.t1,392.0494305,-13.61042337,3.768150754,2.97E-12,3.28E-10,,Q32ZE2,1.08E-33,Adenosine receptor A2b,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cGMP-mediated signaling [GO:0019934]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; relaxation of vascular associated smooth muscle [GO:0060087],GO:0001609; GO:0002882; GO:0005886; GO:0007189; GO:0010575; GO:0010753; GO:0019934; GO:0032722; GO:0032755; GO:0043303; GO:0043306; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171
132,Pocillopora_acuta_HIv2___RNAseq.g5003.t1,327.1969847,-13.43115733,3.703871477,3.00E-12,3.29E-10,,NA,NA,NA,NA,NA
133,Pocillopora_acuta_HIv2___RNAseq.g15838.t1,947.2488888,-1.014613252,1.904746861,3.10E-12,3.37E-10,,A0JP86,5.07E-08,Laminin subunit gamma-1,cell adhesion [GO:0007155],GO:0005576; GO:0005604; GO:0007155
134,Pocillopora_acuta_HIv2___RNAseq.g22261.t1,1251.450849,15.92383318,4.191192768,3.16E-12,3.41E-10,Skeletal aspartic acid-rich protein 2,B3EWY8,1.14E-104,Skeletal aspartic acid-rich protein 2,,GO:0016020
135,Pocillopora_acuta_HIv2___TS.g5308.t2,759.0358857,12.43106547,3.012334724,3.18E-12,3.41E-10,fibroblast growth factor-activated receptor activity,Q9VBW3,7.83E-67,Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14),calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060],GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303
136,Pocillopora_acuta_HIv2___RNAseq.g26798.t1,364.9474628,-13.49115433,3.71989483,3.27E-12,3.48E-10,,NA,NA,NA,NA,NA
137,Pocillopora_acuta_HIv2___RNAseq.g29539.t1,4459.140292,-10.18252479,4.405085504,3.35E-12,3.54E-10,,NA,NA,NA,NA,NA
138,Pocillopora_acuta_HIv2___RNAseq.g2220.t1,4540.857745,-8.543743712,2.118420285,3.43E-12,3.60E-10,,NA,NA,NA,NA,NA
139,Pocillopora_acuta_HIv2___RNAseq.g4369.t1,689.3013006,-9.452323085,2.106194253,3.51E-12,3.64E-10,,O75096,0,Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7),amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395
140,Pocillopora_acuta_HIv2___RNAseq.g14366.t1,250.6020684,13.34522164,3.537360436,3.53E-12,3.64E-10,Scavenger receptor class A member 5,Q5RFW0,7.91E-07,Scavenger receptor class A member 5,endocytosis [GO:0006897]; intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207],GO:0005886; GO:0006879; GO:0006897; GO:0034755; GO:0070207; GO:0070287
141,Pocillopora_acuta_HIv2___RNAseq.g14347.t1,3739.229282,9.626104168,2.398242384,3.75E-12,3.85E-10,,A2AX52,3.50E-14,Collagen alpha-4(VI) chain,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023
142,Pocillopora_acuta_HIv2___RNAseq.g2995.t1,1190.368581,-12.39303555,2.907888935,3.86E-12,3.93E-10,,Q90Z12,2.22E-42,Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a),BMP signaling pathway [GO:0030509]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501],GO:0000122; GO:0002088; GO:0005634; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983
143,Pocillopora_acuta_HIv2___RNAseq.g3838.t1,1113.346911,-0.831206594,1.553757495,3.99E-12,4.04E-10,,Q9HD45,0,Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein),protein localization to membrane [GO:0072657],GO:0016020; GO:0072657
144,Pocillopora_acuta_HIv2___RNAseq.g16699.t1,328.7387831,-13.49180769,3.751578744,4.39E-12,4.41E-10,,P19440,5.01E-149,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0019344; GO:0031179; GO:0031638; GO:0036374; GO:0050727; GO:0070062; GO:0103068; GO:1901750
145,Pocillopora_acuta_HIv2___RNAseq.g26267.t1,338.9903675,-13.4165757,3.728813202,4.56E-12,4.55E-10,,Q3MHX6,1.06E-31,Protein OS-9,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; protein retention in ER lumen [GO:0006621]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0005788; GO:0006511; GO:0006621; GO:0030246; GO:0030968; GO:0030970; GO:0034976; GO:0036503
146,Pocillopora_acuta_HIv2___RNAseq.g16486.t1,2676.391456,-13.41458322,3.229278607,4.90E-12,4.85E-10,Mucin-like protein,B3EWY9,3.19E-114,Mucin-like protein,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005615; GO:0007160; GO:0016020
147,Pocillopora_acuta_HIv2___RNAseq.g7678.t1,349.9617105,-13.51614832,3.754079665,5.09E-12,5.00E-10,,Q60631,4.98E-85,Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2),actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770],GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007165; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019899; GO:0019903; GO:0019904; GO:0030036; GO:0030674; GO:0030838; GO:0031623; GO:0032991; GO:0035987; GO:0038133; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0044877; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0051219; GO:0060090; GO:0060670; GO:0070436; GO:0071479; GO:2000379
148,Pocillopora_acuta_HIv2___RNAseq.g13102.t1,1328.680643,12.63650993,3.301259459,5.35E-12,5.23E-10,,NA,NA,NA,NA,NA
149,Pocillopora_acuta_HIv2___RNAseq.g21444.t1,338.5705381,-13.3295976,3.712897807,5.40E-12,5.24E-10,,NA,NA,NA,NA,NA
150,Pocillopora_acuta_HIv2___RNAseq.g14763.t1,411.1490024,-13.56814673,3.791305466,6.56E-12,6.32E-10,,Q90YK3,8.96E-06,L-gulonolactone oxidase (LGO) (EC 1.1.3.8) (L-gulono-gamma-lactone oxidase) (GLO),L-ascorbic acid biosynthetic process [GO:0019853],GO:0003885; GO:0005789; GO:0019853; GO:0050105; GO:0050660; GO:0071949
151,Pocillopora_acuta_HIv2___RNAseq.g28990.t2,1305.915719,-0.848401764,1.576472925,6.62E-12,6.34E-10,,Q02874,2.65E-147,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y),"DNA repair [GO:0006281]; epigenetic regulation of gene expression [GO:0040029]; establishment of protein localization to chromatin [GO:0071169]; heterochromatin formation [GO:0031507]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of lipid metabolic process [GO:0019216]; regulation of NAD metabolic process [GO:1902688]; regulation of oxidative phosphorylation [GO:0002082]; regulation of response to oxidative stress [GO:1902882]; sex-chromosome dosage compensation [GO:0007549]; transcription initiation-coupled chromatin remodeling [GO:0045815]",GO:0000122; GO:0000182; GO:0000228; GO:0000785; GO:0000786; GO:0000793; GO:0000976; GO:0000977; GO:0001740; GO:0002082; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006281; GO:0006334; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0030527; GO:0031490; GO:0031492; GO:0031507; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0071169; GO:0072570; GO:0090734; GO:0160002; GO:1901837; GO:1902688; GO:1902750; GO:1902882; GO:1902883; GO:1902884; GO:1903226; GO:1904815; GO:1990841
152,Pocillopora_acuta_HIv2___RNAseq.g4770.t1,383.9633546,-13.4647953,3.803668638,7.43E-12,7.07E-10,,Q8TE73,0,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729
153,Pocillopora_acuta_HIv2___RNAseq.g17965.t1,339.1455142,-13.18587874,3.695361644,7.52E-12,7.11E-10,,O02824,5.16E-62,Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor),adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117],GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007204; GO:0007512; GO:0010507; GO:0010613; GO:0031965; GO:0043410; GO:0045907; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0071880; GO:0097195; GO:0150099
154,Pocillopora_acuta_HIv2___RNAseq.g21169.t1,384.7261988,-13.52121084,3.782362435,7.57E-12,7.11E-10,,P79218,7.24E-24,Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2),positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472],GO:0005886; GO:0016497; GO:0061827; GO:0070472; GO:0097225; GO:1902093
155,Pocillopora_acuta_HIv2___TS.g1310.t1,377.3342042,-13.44905885,3.753217808,7.70E-12,7.19E-10,,NA,NA,NA,NA,NA
156,Pocillopora_acuta_HIv2___RNAseq.g9466.t1,3868.107379,-8.737792426,5.463500698,7.82E-12,7.25E-10,TRP A1,Q6RI86,1.07E-142,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071244; GO:0071313; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760
157,Pocillopora_acuta_HIv2___RNAseq.g10039.t1,1074.942516,-0.803275827,1.511893751,8.20E-12,7.49E-10,,P25210,2.56E-62,Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB),,GO:0000978; GO:0001228; GO:0016602; GO:0046982
158,Pocillopora_acuta_HIv2___RNAseq.g14817.t1,308.2779303,-13.21822103,3.688391122,8.22E-12,7.49E-10,,E7F6F9,7.72E-39,Kelch-like protein 3,distal tubule morphogenesis [GO:0072156]; monoatomic ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0003779; GO:0005829; GO:0005856; GO:0006511; GO:0016567; GO:0031463; GO:0050801; GO:0070294; GO:0070936; GO:0072156; GO:1990756
159,Pocillopora_acuta_HIv2___RNAseq.g29834.t1,364.4358387,-13.35337662,3.748440044,8.23E-12,7.49E-10,,NA,NA,NA,NA,NA
160,Pocillopora_acuta_HIv2___RNAseq.g17943.t1,393.527068,-13.698765,3.829304167,8.61E-12,7.78E-10,,NA,NA,NA,NA,NA
161,Pocillopora_acuta_HIv2___RNAseq.g14014.t1,1371.247312,-10.19388256,2.606955897,9.43E-12,8.44E-10,ZP domain-containing protein,G8HTB6,1.54E-16,ZP domain-containing protein,,GO:0016020
162,Pocillopora_acuta_HIv2___RNAseq.g15827.t1,2147.214582,-12.89294785,3.17571594,9.46E-12,8.44E-10,,NA,NA,NA,NA,NA
163,Pocillopora_acuta_HIv2___RNAseq.g28815.t1,448.847439,-13.51826178,3.835686384,9.60E-12,8.52E-10,,Q5R4J5,7.65E-31,Synaptotagmin-1 (Synaptotagmin I) (SytI),calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488],GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0019905; GO:0030154; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0042584; GO:0048488; GO:0048791; GO:0071277; GO:1903235
164,Pocillopora_acuta_HIv2___RNAseq.g3653.t1,1313.495232,-12.31797924,3.02749038,1.00E-11,8.86E-10,,P29145,1.58E-161,PC3-like endoprotease variant B (EC 3.4.21.-) (SPC3),proteolysis [GO:0006508],GO:0004252; GO:0006508
165,Pocillopora_acuta_HIv2___RNAseq.g30781.t1,4420.150946,-5.248161146,0.917675547,1.04E-11,9.15E-10,,NA,NA,NA,NA,NA
166,Pocillopora_acuta_HIv2___RNAseq.g22605.t1,3203.60823,-13.6487275,3.38471797,1.05E-11,9.15E-10,ZP domain-containing protein,G8HTB6,6.89E-38,ZP domain-containing protein,,GO:0016020
167,Pocillopora_acuta_HIv2___RNAseq.g1818.t1,865.7296461,-0.942722665,1.747143511,1.09E-11,9.48E-10,,G3MWR8,1.29E-17,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501
168,Pocillopora_acuta_HIv2___RNAseq.g17429.t1,270.9859497,-13.05468144,3.639590444,1.12E-11,9.65E-10,,NA,NA,NA,NA,NA
169,Pocillopora_acuta_HIv2___RNAseq.g20365.t1,286.9989147,-13.11498629,3.66633168,1.13E-11,9.65E-10,,NA,NA,NA,NA,NA
170,Pocillopora_acuta_HIv2___RNAseq.5910_t,434.9041336,-10.97513992,2.462497838,1.16E-11,9.85E-10,ZP domain-containing protein,G8HTB6,3.21E-12,ZP domain-containing protein,,GO:0016020
171,Pocillopora_acuta_HIv2___RNAseq.g7692.t1,381.6100155,-13.33023685,3.775919756,1.18E-11,1.00E-09,Netrin-1,O09118,0,Netrin-1,"animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]",GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0007409; GO:0007411; GO:0008045; GO:0008283; GO:0009887; GO:0009888; GO:0014009; GO:0015629; GO:0016358; GO:0030334; GO:0030517; GO:0030879; GO:0032488; GO:0033564; GO:0042472; GO:0045202; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0062023; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147
172,Pocillopora_acuta_HIv2___RNAseq.g18342.t1,1995.303983,-12.51596846,3.116555904,1.28E-11,1.08E-09,,NA,NA,NA,NA,NA
173,Pocillopora_acuta_HIv2___RNAseq.g31286.t1c,336.709258,-13.25920619,3.768359016,1.32E-11,1.10E-09,,B8VIU6,2.62E-24,Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5),,GO:0005576
174,Pocillopora_acuta_HIv2___TS.g27807.t1,791.7660863,-1.012480862,1.863424378,1.39E-11,1.16E-09,,Q86UK0,0,Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12) (ATP-binding cassette 12),cellular homeostasis [GO:0019725]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; cholesterol efflux [GO:0033344]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129],GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016020; GO:0016887; GO:0019725; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033344; GO:0033700; GO:0034040; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0043231; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010
175,Pocillopora_acuta_HIv2___RNAseq.g21255.t1,942.4351625,11.99777764,4.135313083,1.52E-11,1.26E-09,,NA,NA,NA,NA,NA
176,Pocillopora_acuta_HIv2___RNAseq.g30046.t1,2980.311989,8.581922393,5.697864109,1.71E-11,1.40E-09,,NA,NA,NA,NA,NA
177,Pocillopora_acuta_HIv2___RNAseq.g13339.t1,286.2021901,-13.07520162,3.701805761,1.73E-11,1.42E-09,,P86854,1.96E-20,Perlucin-like protein,,GO:0005576; GO:0030246; GO:0038023
178,Pocillopora_acuta_HIv2___TS.g26248.t1,501.5392286,-14.00011785,3.899444806,1.75E-11,1.42E-09,,NA,NA,NA,NA,NA
179,Pocillopora_acuta_HIv2___TS.g29848.t1,292.5215441,-13.06078212,3.682258641,1.78E-11,1.44E-09,,O77775,5.75E-29,Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (Neutrophil NADPH oxidase factor 2) (p67-phox),phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554],GO:0005737; GO:0006909; GO:0016176; GO:0042554; GO:0043020; GO:0045730
180,Pocillopora_acuta_HIv2___TS.g28126.t1,1512.93781,12.92910981,3.461960809,1.85E-11,1.48E-09,,NA,NA,NA,NA,NA
181,Pocillopora_acuta_HIv2___RNAseq.g11198.t1,3305.390342,-8.711809605,2.914032272,1.85E-11,1.48E-09,,NA,NA,NA,NA,NA
182,Pocillopora_acuta_HIv2___TS.g16172.t3,491.8151981,-10.54177707,2.392379613,2.06E-11,1.64E-09,Sodium channel protein 1 brain,Q05973,0,Sodium channel protein 1 brain (Sodium channel protein I brain),membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228],GO:0001518; GO:0005248; GO:0019228; GO:0086010
183,Pocillopora_acuta_HIv2___TS.7324_t,804.5677932,12.31874617,3.191616682,2.13E-11,1.68E-09,Homeobox protein koza,Q9W7E8,1.48E-11,Homeobox protein koza (Homeodomain transcription factor koza),positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127],GO:0000981; GO:0003677; GO:0005634; GO:0042127; GO:0045944
184,Pocillopora_acuta_HIv2___RNAseq.g25168.t1,347.7309846,-13.51805089,3.815701968,2.28E-11,1.79E-09,,Q9DAJ5,9.74E-37,"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)",microtubule-based movement [GO:0007018],GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505
185,Pocillopora_acuta_HIv2___RNAseq.g16.t1,248.5371598,-12.94118955,3.654892834,2.31E-11,1.81E-09,,Q61006,2.70E-08,"Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)","cell differentiation [GO:0030154]; enzyme-linked receptor protein signaling pathway [GO:0007167]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; motor neuron apoptotic process [GO:0097049]; negative regulation of gene expression [GO:0010629]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; receptor clustering [GO:0043113]; regulation of DNA-templated transcription [GO:0006355]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; response to electrical stimulus [GO:0051602]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]",GO:0001934; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006355; GO:0007167; GO:0007528; GO:0007613; GO:0008582; GO:0009897; GO:0010628; GO:0010629; GO:0010976; GO:0016020; GO:0017147; GO:0019901; GO:0030154; GO:0030165; GO:0031594; GO:0032224; GO:0035022; GO:0042995; GO:0043113; GO:0043235; GO:0045202; GO:0045211; GO:0045887; GO:0046872; GO:0050731; GO:0051602; GO:0051897; GO:0060291; GO:0071340; GO:0097049; GO:1904395; GO:2000541; GO:2000673
186,Pocillopora_acuta_HIv2___RNAseq.g13056.t1,308.2422361,-13.11190545,3.727517132,2.38E-11,1.85E-09,,Q18775,7.71E-07,Dopamine receptor 4,"adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]",GO:0004952; GO:0004993; GO:0005886; GO:0007186; GO:0007187; GO:0007191; GO:0007268; GO:0030425; GO:0030594; GO:0045211
187,Pocillopora_acuta_HIv2___TS.g2428.t1,1117.382519,-0.739267324,1.424175443,2.41E-11,1.86E-09,,Q99JI4,0,26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (p42A),proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005838; GO:0022624; GO:0043161
188,Pocillopora_acuta_HIv2___RNAseq.g27458.t1,269.7611359,-13.14986191,3.725196492,2.46E-11,1.88E-09,,NA,NA,NA,NA,NA
189,Pocillopora_acuta_HIv2___TS.g11189.t1,1096.332071,-0.57499942,1.261979388,2.46E-11,1.88E-09,,Q8IS64,1.23E-145,Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-),proteolysis [GO:0006508],GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270
190,Pocillopora_acuta_HIv2___RNAseq.g24787.t1,282.0874723,-13.17129344,3.74422799,2.66E-11,2.02E-09,,E7FAM5,1.26E-34,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177
191,Pocillopora_acuta_HIv2___RNAseq.g1516.t1,374.0922729,-10.71210355,2.429650501,2.67E-11,2.02E-09,,NA,NA,NA,NA,NA
192,Pocillopora_acuta_HIv2___TS.g12860.t1,867.1138585,12.44030391,3.300363944,2.70E-11,2.04E-09,Collagen alpha-1(VI) chain,Q801S8,1.54E-10,Collagen alpha-1(VI) chain,cell adhesion [GO:0007155],GO:0005576; GO:0005581; GO:0007155; GO:0062023
193,Pocillopora_acuta_HIv2___RNAseq.g10896.t1,275.5870574,-13.05560605,3.709750166,2.80E-11,2.10E-09,,Q6XD76,1.39E-17,Achaete-scute homolog 4 (ASH-4) (hASH4) (Achaete-scute-like protein 4) (Class A basic helix-loop-helix protein 44) (bHLHa44),regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588],GO:0000785; GO:0000977; GO:0000981; GO:0006357; GO:0043588; GO:0046983; GO:0090575
194,Pocillopora_acuta_HIv2___RNAseq.g9054.t1,818.3468613,11.95340814,3.18660284,3.16E-11,2.36E-09,Heparan-alpha-glucosaminide N-acetyltransferase,Q68CP4,2.88E-135,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821
195,Pocillopora_acuta_HIv2___TS.g9777.t1,344.1655675,-13.50567454,3.833071479,3.21E-11,2.37E-09,,Q29RU2,4.18E-35,Oncoprotein-induced transcript 3 protein,,GO:0005509; GO:0005635
196,Pocillopora_acuta_HIv2___RNAseq.g10991.t1,264.6026029,-13.075623,3.717763224,3.23E-11,2.37E-09,,Q9UGM3,6.87E-86,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein),defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031],GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062
197,Pocillopora_acuta_HIv2___RNAseq.g30235.t1,499.6330374,11.68577407,2.857199127,3.24E-11,2.37E-09,Zinc metalloproteinase nas-15,P55115,1.20E-54,Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15),proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008270
198,Pocillopora_acuta_HIv2___RNAseq.g14358.t1,241.294678,13.36597252,3.633756104,3.25E-11,2.37E-09,,NA,NA,NA,NA,NA
199,Pocillopora_acuta_HIv2___RNAseq.g22572.t1,587.1844204,9.227794928,2.462775836,3.33E-11,2.41E-09,,P55115,9.29E-54,Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15),proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008270
200,Pocillopora_acuta_HIv2___RNAseq.g14871.t1,360.8118846,-7.613556231,1.468607221,3.33E-11,2.41E-09,,P48442,1.34E-110,Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR),adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; vasodilation [GO:0042311],GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0014070; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476
201,Pocillopora_acuta_HIv2___RNAseq.g18617.t1,610.4944606,-0.894686109,1.659627274,3.49E-11,2.51E-09,,Q795M8,3.45E-08,Putative potassium channel protein YugO,,GO:0005267; GO:0005886
202,Pocillopora_acuta_HIv2___TS.g902.t1,264.5834913,-12.93221497,3.692514554,3.66E-11,2.62E-09,,NA,NA,NA,NA,NA
203,Pocillopora_acuta_HIv2___RNAseq.g3322.t1,1641.029799,-12.63894559,3.22039852,3.69E-11,2.63E-09,Homeobox protein Dlx4a (DLX-8),Q98879,1.66E-38,Homeobox protein Dlx4a (DLX-8) (Distal-less homeobox protein 4a),cell differentiation [GO:0030154]; chordate embryonic development [GO:0043009]; embryonic morphogenesis [GO:0048598]; negative regulation of transcription by RNA polymerase II [GO:0000122],GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0030154; GO:0043009; GO:0048598
204,Pocillopora_acuta_HIv2___TS.g12050.t1,195.8577158,12.97578442,3.539765456,3.82E-11,2.71E-09,,NA,NA,NA,NA,NA
205,Pocillopora_acuta_HIv2___RNAseq.g14160.t1,880.3952919,-0.639901587,1.318771091,3.84E-11,2.71E-09,,Q2KIU0,1.98E-57,Vesicle transport through interaction with t-SNAREs homolog 1B,"Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]",GO:0000149; GO:0005484; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006891; GO:0006896; GO:0012507; GO:0016236; GO:0031201; GO:0031901; GO:0031902; GO:0042147; GO:0048280; GO:0055038; GO:1903076
206,Pocillopora_acuta_HIv2___RNAseq.g29962.t1,666.2026136,-0.807291526,1.503023015,3.94E-11,2.77E-09,3-hydroxyacyl-CoA dehydrogenase type-2,O02691,4.94E-121,3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-estradiol 17-dehydrogenase) (EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))) (EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase) (EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH),androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; protein homotetramerization [GO:0051289],GO:0000049; GO:0003857; GO:0004303; GO:0005739; GO:0006550; GO:0006631; GO:0006635; GO:0006699; GO:0008207; GO:0008209; GO:0008210; GO:0008709; GO:0030283; GO:0030678; GO:0042645; GO:0044594; GO:0047015; GO:0047035; GO:0047044; GO:0051289; GO:0062173; GO:0070901; GO:0097745; GO:0106281; GO:0106282; GO:0106283; GO:1990180
207,Pocillopora_acuta_HIv2___RNAseq.g14348.t1,242.9894196,-12.9275977,3.700183878,4.03E-11,2.81E-09,,A2AX52,1.61E-13,Collagen alpha-4(VI) chain,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023
208,Pocillopora_acuta_HIv2___RNAseq.g1018.t1,314.6647172,-13.17242244,3.79882851,4.04E-11,2.81E-09,,Q0VA40,2.36E-89,Transcription factor Sp9,,GO:0003677; GO:0005634; GO:0046872
209,Pocillopora_acuta_HIv2___TS.g28528.t1a,661.5724302,11.42790854,2.930746041,4.12E-11,2.85E-09,C-type mannose receptor 2,Q9UBG0,1.20E-39,C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280),collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649],GO:0001649; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0030246; GO:0030574; GO:0038023
210,Pocillopora_acuta_HIv2___RNAseq.g5325.t1,1851.395995,-12.85507738,3.31550966,4.22E-11,2.89E-09,,NA,NA,NA,NA,NA
211,Pocillopora_acuta_HIv2___RNAseq.g6468.t1,936.2426646,-9.407020388,2.813315712,4.23E-11,2.89E-09,,P11617,5.42E-18,Adenosine receptor A2a,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic signaling pathway [GO:0097190]; eating behavior [GO:0042755]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; response to amphetamine [GO:0001975]; response to purine-containing compound [GO:0014074]; synaptic transmission, dopaminergic [GO:0001963]",GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005886; GO:0007189; GO:0007626; GO:0008289; GO:0014074; GO:0019899; GO:0032230; GO:0042755; GO:0042802; GO:0046636; GO:0050728; GO:0060080; GO:0097190; GO:0098794; GO:2001235
212,Pocillopora_acuta_HIv2___RNAseq.g14932.t2,321.1440667,-13.27792036,3.818693792,4.24E-11,2.89E-09,,P0C6Y7,5.95E-49,Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361),chromatin remodeling [GO:0006338]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiosis I [GO:0007127]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0006338; GO:0007127; GO:0007129; GO:0007283; GO:0007292; GO:0008270; GO:0010468; GO:0010844; GO:0010845; GO:0032259; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0045944; GO:0046975; GO:0048232; GO:0060903; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:0140999; GO:1905516; GO:1990918
213,Pocillopora_acuta_HIv2___RNAseq.g3439.t1,237.0352011,-12.777892,3.634428033,4.25E-11,2.89E-09,Zona_pellucida,NA,NA,NA,NA,NA
214,Pocillopora_acuta_HIv2___RNAseq.g23400.t1,225.3815496,-12.77541711,3.637151326,4.41E-11,2.98E-09,,NA,NA,NA,NA,NA
215,Pocillopora_acuta_HIv2___RNAseq.g15331.t1,302.467343,-10.28342881,2.322188369,4.57E-11,3.07E-09,,Q03046,1.06E-18,Isopenicillin N epimerase (EC 5.1.1.17),antibiotic biosynthetic process [GO:0017000],GO:0017000; GO:0045439
216,Pocillopora_acuta_HIv2___RNAseq.g298.t1,988.3566256,-0.63859528,1.30257031,4.60E-11,3.08E-09,Sacsin,Q9NZJ4,0,Sacsin (DnaJ homolog subfamily C member 29),negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084
217,Pocillopora_acuta_HIv2___RNAseq.g7759.t1,254.5203703,-12.96155333,3.709468714,4.81E-11,3.19E-09,,Q9WYX8,2.00E-50,Uncharacterized protein TM_0508,DNA recombination [GO:0006310]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261],GO:0000731; GO:0003677; GO:0005524; GO:0006261; GO:0006310; GO:0008047; GO:0009378; GO:0016887; GO:0017116
218,Pocillopora_acuta_HIv2___TS.g13571.t1,264.7333801,-13.01356903,3.762903485,4.81E-11,3.19E-09,,Q7RTR2,5.88E-31,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)",canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110],GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223
219,Pocillopora_acuta_HIv2___RNAseq.g8685.t1,253.7378246,-12.78506778,3.66046065,4.83E-11,3.19E-09,,NA,NA,NA,NA,NA
220,Pocillopora_acuta_HIv2___RNAseq.g21265.t1,347.296729,-13.0248147,3.782257953,4.91E-11,3.23E-09,,Q9N126,8.65E-67,Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase),estrogen biosynthetic process [GO:0006703]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0042572; GO:0042622; GO:0052650
221,Pocillopora_acuta_HIv2___RNAseq.g28641.t1,1378.322845,-12.28842814,3.252697875,5.10E-11,3.34E-09,,P31851,1.07E-85,Protein TabA,lysine biosynthetic process via diaminopimelate [GO:0009089],GO:0008836; GO:0009089
222,Pocillopora_acuta_HIv2___RNAseq.g26781.t1,215.5556549,-12.69785746,3.609430717,5.21E-11,3.40E-09,,NA,NA,NA,NA,NA
223,Pocillopora_acuta_HIv2___TS.g25577.t1a,635.7136581,-14.42210665,4.02854215,5.43E-11,3.51E-09,,NA,NA,NA,NA,NA
224,Pocillopora_acuta_HIv2___RNAseq.g18273.t1,936.2327221,-11.91925919,2.979449183,5.43E-11,3.51E-09,,Q8IS64,0,Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-),proteolysis [GO:0006508],GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270
225,Pocillopora_acuta_HIv2___RNAseq.g1841.t1,225.0015359,-12.83298536,3.667476547,5.48E-11,3.52E-09,,Q8N3E9,8.21E-102,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3)",angiogenesis [GO:0001525]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; regulation of cell population proliferation [GO:0042127],GO:0001525; GO:0004435; GO:0005654; GO:0005737; GO:0005886; GO:0016042; GO:0032154; GO:0035556; GO:0042127; GO:0046872; GO:0060716
226,Pocillopora_acuta_HIv2___RNAseq.g25839.t1,417.1033487,-13.45985365,3.822879365,5.51E-11,3.53E-09,,Q9UDY8,8.87E-39,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321
227,Pocillopora_acuta_HIv2___RNAseq.g19355.t1,356.0450245,-10.64190362,2.524463571,5.80E-11,3.70E-09,,NA,NA,NA,NA,NA
228,Pocillopora_acuta_HIv2___TS.g22613.t2,886.8383699,-0.605244878,1.287798782,5.99E-11,3.79E-09,,Q9QXG4,0,"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)",acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; long-term memory [GO:0007616]; propionate biosynthetic process [GO:0019542],GO:0003682; GO:0003713; GO:0003987; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006085; GO:0007616; GO:0019413; GO:0019542; GO:0050218
229,Pocillopora_acuta_HIv2___RNAseq.g7975.t1,465.5931533,-9.845045865,2.23316768,6.01E-11,3.79E-09,,NA,NA,NA,NA,NA
230,Pocillopora_acuta_HIv2___RNAseq.g463.t1,969.0046764,-0.60450357,1.271828412,6.03E-11,3.79E-09,,Q9GZY4,3.01E-11,Cytochrome c oxidase assembly factor 1 homolog (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 15 kDa),mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981],GO:0005739; GO:0005743; GO:0005829; GO:0032981; GO:0033617
231,Pocillopora_acuta_HIv2___TS.g12304.t1,114980.2558,5.932170943,1.205425076,6.27E-11,3.93E-09,Carbonic anhydrase 2,P00918,2.04E-48,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0006730; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225
232,Pocillopora_acuta_HIv2___RNAseq.g12018.t1,4250.423879,-3.562466583,0.58519852,6.63E-11,4.12E-09,,NA,NA,NA,NA,NA
233,Pocillopora_acuta_HIv2___RNAseq.g27022.t1,1176.163422,10.20366463,3.2731416,6.64E-11,4.12E-09,,NA,NA,NA,NA,NA
234,Pocillopora_acuta_HIv2___TS.6598_t,238.1948555,-12.84472267,3.681883456,6.74E-11,4.15E-09,,Q6L8S8,2.41E-71,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",chondroitin sulfate biosynthetic process [GO:0030206],GO:0008376; GO:0030206; GO:0032580; GO:0033842; GO:0047238
235,Pocillopora_acuta_HIv2___RNAseq.g9089.t1,319.5651714,-10.09637922,2.120586572,6.75E-11,4.15E-09,Sulfotransferase 1C4,A0A2K5X3B6,1.25E-51,Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1),3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; flavonoid metabolic process [GO:0009812],GO:0004062; GO:0005829; GO:0008146; GO:0009812; GO:0050427
236,Pocillopora_acuta_HIv2___TS.g4109.t3,319.8189714,-9.837347775,2.190872012,6.79E-11,4.16E-09,Pejvakin,Q0ZLH3,8.77E-14,Pejvakin (Autosomal recessive deafness type 59 protein),detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; pexophagy [GO:0000425]; programmed cell death in response to reactive oxygen species [GO:0097468]; regulation of peroxisome organization [GO:1900063]; response to reactive oxygen species [GO:0000302]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045],GO:0000302; GO:0000425; GO:0005737; GO:0005778; GO:0007605; GO:0030864; GO:0035253; GO:0043025; GO:0050910; GO:0097468; GO:0120044; GO:0120045; GO:1900063
237,Pocillopora_acuta_HIv2___RNAseq.g26032.t1,1243.052444,-12.4053793,3.216278458,6.97E-11,4.26E-09,,Q85WU2,2.86E-10,Protein TIC 214 (Translocon at the inner envelope membrane of chloroplasts 214) (AtTIC214),protein transport [GO:0015031],GO:0009706; GO:0015031
238,Pocillopora_acuta_HIv2___TS.g6104.t1,847.6040234,-11.39563038,2.893240849,7.13E-11,4.33E-09,,Q5HY64,3.55E-18,Putative protein FAM47C,,
239,Pocillopora_acuta_HIv2___RNAseq.g29835.t1,632.0366139,-10.80275258,2.722714408,7.30E-11,4.42E-09,,NA,NA,NA,NA,NA
240,Pocillopora_acuta_HIv2___RNAseq.g3837.t1a,978.541972,-12.04592997,3.096524991,7.33E-11,4.42E-09,,Q90268,1.29E-63,Paired box protein Pax-2a (No isthmus protein) (Pax[Zf-b]),anterior/posterior pattern specification [GO:0009952]; anterior/posterior pattern specification involved in pronephros development [GO:0034672]; cell fate specification [GO:0001708]; cerebellum development [GO:0021549]; cerebellum formation [GO:0021588]; cilium assembly [GO:0060271]; closure of optic fissure [GO:0061386]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic pattern specification [GO:0009880]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; kidney development [GO:0001822]; locus ceruleus development [GO:0021703]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; nervous system development [GO:0007399]; otic placode formation [GO:0043049]; peripheral nervous system development [GO:0007422]; pronephric glomerulus morphogenesis [GO:0035775]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; regulation of transcription by RNA polymerase II [GO:0006357]; thyroid gland development [GO:0030878]; vestibular receptor cell development [GO:0060118],GO:0000978; GO:0000981; GO:0001708; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0007422; GO:0009880; GO:0009952; GO:0021549; GO:0021588; GO:0021703; GO:0030878; GO:0030901; GO:0030902; GO:0030917; GO:0034672; GO:0035775; GO:0043049; GO:0043565; GO:0048596; GO:0048793; GO:0060113; GO:0060118; GO:0060271; GO:0061386; GO:0072114
241,Pocillopora_acuta_HIv2___RNAseq.7335_t,1155.231213,11.63670713,3.092223422,7.40E-11,4.43E-09,Nodal-related protein 1,Q91619,1.16E-10,Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1),axial mesoderm development [GO:0048318]; axial mesoderm formation [GO:0048320]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; nodal signaling pathway [GO:0038092]; paraxial mesoderm development [GO:0048339],GO:0003140; GO:0005125; GO:0005576; GO:0005615; GO:0007368; GO:0007507; GO:0008083; GO:0016015; GO:0038092; GO:0048318; GO:0048320; GO:0048339
242,Pocillopora_acuta_HIv2___RNAseq.g14712.t1,259.1632736,-7.36033977,1.406172384,7.41E-11,4.43E-09,,NA,NA,NA,NA,NA
243,Pocillopora_acuta_HIv2___RNAseq.g14576.t1,352.9440138,-13.42059636,3.935349361,7.44E-11,4.43E-09,,P46023,9.55E-52,G-protein coupled receptor GRL101,,GO:0004930; GO:0005886
244,Pocillopora_acuta_HIv2___RNAseq.g23688.t1,747.9221687,-11.10105693,2.908930575,7.58E-11,4.49E-09,,NA,NA,NA,NA,NA
245,Pocillopora_acuta_HIv2___RNAseq.g8579.t1,237.302809,-12.72409197,3.660976528,7.64E-11,4.51E-09,,NA,NA,NA,NA,NA
246,Pocillopora_acuta_HIv2___TS.g15672.t1,261.9831307,-10.19693778,2.326119011,7.95E-11,4.68E-09,Low-density lipoprotein receptor-related protein 5 (LRP-5),Q91VN0,1.90E-41,Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7),adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; osteoblast proliferation [GO:0033687]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033687; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060764; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963
247,Pocillopora_acuta_HIv2___RNAseq.g21915.t1,239.4108559,-12.66087152,3.652064159,7.99E-11,4.68E-09,,Q6IND7,3.85E-110,LRP2-binding protein,,GO:0005737
248,Pocillopora_acuta_HIv2___RNAseq.g18413.t1,302.6387323,11.4020014,2.818086791,8.64E-11,5.04E-09,"Alpha-(1,3)-fucosyltransferase 11",Q8AWC7,4.91E-29,"Alpha-(1,3)-fucosyltransferase 11 (EC 2.4.1.-) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11)",fucosylation [GO:0036065]; protein glycosylation [GO:0006486],GO:0000139; GO:0006486; GO:0032580; GO:0036065; GO:0046920
249,Pocillopora_acuta_HIv2___TS.g23308.t1,433.3368183,-8.163051101,1.810793874,9.04E-11,5.24E-09,,B8EIZ7,1.29E-173,Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148),,GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661
250,Pocillopora_acuta_HIv2___RNAseq.7853_t,1313.273737,-12.55994403,3.277583004,9.06E-11,5.24E-09,,NA,NA,NA,NA,NA
251,Pocillopora_acuta_HIv2___RNAseq.g2416.t1,191.3542812,-8.476488695,1.672560386,9.10E-11,5.24E-09,,NA,NA,NA,NA,NA
252,Pocillopora_acuta_HIv2___RNAseq.g25532.t1,344.3257325,-10.56266221,2.575703008,9.37E-11,5.38E-09,,Q5REJ1,1.31E-61,"Small ribosomal subunit protein uS5m (28S ribosomal protein S5, mitochondrial) (MRP-S5) (S5mt)",translation [GO:0006412],GO:0003723; GO:0003735; GO:0005763; GO:0006412
253,Pocillopora_acuta_HIv2___RNAseq.g26092.t1,435.1198933,-9.046983401,2.072757834,9.41E-11,5.38E-09,,NA,NA,NA,NA,NA
254,Pocillopora_acuta_HIv2___RNAseq.1261_t,305.4291338,-12.98535492,3.766265342,9.49E-11,5.40E-09,,Q58116,2.27E-71,3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34),coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126],GO:0004420; GO:0008299; GO:0015936; GO:0016126
255,Pocillopora_acuta_HIv2___RNAseq.g12660.t1,293.9066121,-12.95324952,3.755283449,1.02E-10,5.79E-09,,NA,NA,NA,NA,NA
256,Pocillopora_acuta_HIv2___RNAseq.g9609.t1,210.6942687,-12.63864494,3.66172669,1.05E-10,5.92E-09,,G8XYX6,3.32E-69,Monocarboxylate transporter 8 (MCT 8) (Solute carrier family 16 member 2),brain development [GO:0007420]; central nervous system development [GO:0007417]; chordate embryonic development [GO:0043009]; locomotion [GO:0040011]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; optomotor response [GO:0071632]; regulation of thyroid hormone generation [GO:2000609]; Schwann cell differentiation [GO:0014037]; spinal cord development [GO:0021510]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; thyroid gland development [GO:0030878]; transmission of nerve impulse [GO:0019226],GO:0007417; GO:0007420; GO:0014037; GO:0015349; GO:0016324; GO:0019226; GO:0021510; GO:0021529; GO:0030182; GO:0030878; GO:0040011; GO:0043009; GO:0048709; GO:0070324; GO:0071632; GO:2000609
257,Pocillopora_acuta_HIv2___TS.g4148.t1b,261.2437446,-12.88451565,3.745857592,1.05E-10,5.92E-09,,NA,NA,NA,NA,NA
258,Pocillopora_acuta_HIv2___RNAseq.6257_t,1225.634106,-12.35236477,3.213345361,1.09E-10,6.13E-09,,A6H584,2.93E-15,Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain),cell adhesion [GO:0007155],GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023
259,Pocillopora_acuta_HIv2___RNAseq.g5054.t1,255.372151,-12.65092305,3.696471109,1.11E-10,6.19E-09,,NA,NA,NA,NA,NA
260,Pocillopora_acuta_HIv2___TS.g4148.t1c,2544.664514,-6.334327881,1.32676146,1.13E-10,6.28E-09,Mucin-5AC,P98088,4.18E-06,"Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM)",,GO:0005201; GO:0005615; GO:0005796; GO:0005886; GO:0031012; GO:0046872; GO:0070062; GO:0070701
261,Pocillopora_acuta_HIv2___TS.g8934.t1,1086.976966,-5.598846445,1.095226452,1.18E-10,6.52E-09,,NA,NA,NA,NA,NA
262,Pocillopora_acuta_HIv2___RNAseq.g13682.t1,211.2683692,-12.67486812,3.674904282,1.27E-10,7.02E-09,,Q1G7G9,1.61E-47,TALPID3 protein,centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; smoothened signaling pathway [GO:0007224],GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0044458; GO:0051642; GO:0060271
263,Pocillopora_acuta_HIv2___TS.g6682.t1,2368.98413,-9.971489156,3.340509007,1.37E-10,7.53E-09,,Q6GM82,2.43E-154,Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2),2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853
264,Pocillopora_acuta_HIv2___TS.g5115.t2,13271.98004,5.767407726,1.177889926,1.40E-10,7.68E-09,,P07898,1.61E-11,Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP),cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; skeletal system development [GO:0001501],GO:0001501; GO:0002052; GO:0005509; GO:0005540; GO:0005615; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0045202; GO:0072534
265,Pocillopora_acuta_HIv2___RNAseq.g19043.t1,733.8610334,-11.23739242,3.10305489,1.43E-10,7.79E-09,,Q14AT5,0,Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G),calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; establishment of localization in cell [GO:0051649],GO:0005254; GO:0005783; GO:0005886; GO:0017128; GO:0046983; GO:0051649; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476
266,Pocillopora_acuta_HIv2___RNAseq.g22818.t1,223.1449817,-12.58805299,3.653364283,1.44E-10,7.83E-09,,NA,NA,NA,NA,NA
267,Pocillopora_acuta_HIv2___RNAseq.g17427.t1,303.3655821,-12.99057211,3.748923412,1.45E-10,7.88E-09,,NA,NA,NA,NA,NA
268,Pocillopora_acuta_HIv2___RNAseq.g19428.t1,952.5465081,-11.87820205,3.078524027,1.56E-10,8.44E-09,,Q8IS64,0,Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-),proteolysis [GO:0006508],GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270
269,Pocillopora_acuta_HIv2___RNAseq.g29795.t1,402.1395045,11.35680655,3.007523613,1.58E-10,8.51E-09,Zonadhesin,O88799,2.25E-08,Zonadhesin,binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; regulation of binding of sperm to zona pellucida [GO:2000359],GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840; GO:2000359
270,Pocillopora_acuta_HIv2___RNAseq.g8849.t1,636.2759717,-11.45656493,2.954054403,1.63E-10,8.71E-09,,Q59I44,6.43E-68,2-haloacrylate reductase (EC 1.3.1.103),halogenated hydrocarbon catabolic process [GO:0042206],GO:0003960; GO:0005829; GO:0016628; GO:0042206; GO:0070402; GO:0102523
271,Pocillopora_acuta_HIv2___RNAseq.g13450.t1,694.2174837,-0.754029798,1.44393464,1.66E-10,8.84E-09,,O17185,3.21E-25,Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38),potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322],GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0030322; GO:0036195; GO:0055120; GO:0071805
272,Pocillopora_acuta_HIv2___TS.g13882.t1c,196.6820041,12.64232704,3.609044876,1.73E-10,9.18E-09,Zinc metalloproteinase nas-13,Q20191,5.77E-07,Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13),proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008270
273,Pocillopora_acuta_HIv2___RNAseq.g7509.t2,1718.620325,7.282941215,4.873156844,1.73E-10,9.19E-09,,Q9Y2G1,2.00E-151,"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]",central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902],GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0042802; GO:0043565; GO:0045893; GO:0048709; GO:0048714
274,Pocillopora_acuta_HIv2___RNAseq.g13583.t1,188.3049647,-12.5028766,3.639062384,1.78E-10,9.39E-09,,NA,NA,NA,NA,NA
275,Pocillopora_acuta_HIv2___RNAseq.g7241.t1,474.3336761,-10.22675593,2.550278361,1.79E-10,9.43E-09,,Q8WU66,1.99E-36,Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR),hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505],GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170
276,Pocillopora_acuta_HIv2___RNAseq.g26552.t1,8991.890502,-9.291470187,2.724680325,1.86E-10,9.77E-09,,Q9U6Y6,3.32E-59,GFP-like fluorescent chromoprotein amFP486,bioluminescence [GO:0008218]; generation of precursor metabolites and energy [GO:0006091],GO:0006091; GO:0008218
277,Pocillopora_acuta_HIv2___TS.g20196.t1,743.7697759,-11.79480432,3.095372289,1.92E-10,1.00E-08,,Q3UZD5,8.48E-95,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468],GO:0000122; GO:0005634; GO:0010468; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0046872; GO:0051151; GO:0140944
278,Pocillopora_acuta_HIv2___RNAseq.g24078.t1,228.1868329,-12.80224087,3.754586463,1.93E-10,1.00E-08,,Q96DX5,2.61E-33,Ankyrin repeat and SOCS box protein 9 (ASB-9),intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005739; GO:0005829; GO:0016567; GO:0031466; GO:0035556; GO:0043161; GO:0045732; GO:1990756
279,Pocillopora_acuta_HIv2___TS.g15797.t1,226.0624817,-12.50335171,3.662915071,1.94E-10,1.00E-08,,NA,NA,NA,NA,NA
280,Pocillopora_acuta_HIv2___RNAseq.g3224.t1,1245.070916,-12.35419627,3.292371662,1.95E-10,1.00E-08,,NA,NA,NA,NA,NA
281,Pocillopora_acuta_HIv2___RNAseq.g20063.t1,1022.351535,-9.857155059,2.777888349,2.00E-10,1.03E-08,,NA,NA,NA,NA,NA
282,Pocillopora_acuta_HIv2___RNAseq.g25934.t1,281.7931368,-12.82415898,3.77703732,2.00E-10,1.03E-08,,Q9TV36,4.47E-17,Fibrillin-1 [Cleaved into: Asprosin],anatomical structure morphogenesis [GO:0009653],GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0008201; GO:0009653; GO:0031012
283,Pocillopora_acuta_HIv2___RNAseq.g28408.t1,303.6618643,-7.214925696,1.544227681,2.03E-10,1.04E-08,,Q9DCR2,9.28E-107,AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a),"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]",GO:0005769; GO:0005802; GO:0006886; GO:0006896; GO:0008089; GO:0016020; GO:0016183; GO:0016192; GO:0030123; GO:0030659; GO:0035654; GO:0036465; GO:0043231; GO:0046907; GO:0048490; GO:0060155; GO:0098793; GO:1903232; GO:1904115
284,Pocillopora_acuta_HIv2___RNAseq.g14872.t1,515.4597687,-0.720710859,1.404969464,2.06E-10,1.05E-08,,O64411,5.51E-16,Polyamine oxidase 1 (EC 1.5.3.14) (EC 1.5.3.15),polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208],GO:0006598; GO:0009505; GO:0016491; GO:0046208; GO:0046592; GO:0048046; GO:0050660; GO:0052893; GO:0052896; GO:0052897; GO:0052900
285,Pocillopora_acuta_HIv2___RNAseq.g28741.t1,193.9796343,-12.52237281,3.651163072,2.10E-10,1.07E-08,,P57695,2.29E-71,Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit),"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; monoatomic ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; response to alcohol [GO:0097305]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]",GO:0001964; GO:0004888; GO:0005886; GO:0006811; GO:0006821; GO:0006936; GO:0007218; GO:0008270; GO:0016594; GO:0016934; GO:0022824; GO:0030425; GO:0030594; GO:0030977; GO:0034707; GO:0043005; GO:0043025; GO:0043204; GO:0043231; GO:0045202; GO:0045211; GO:0051970; GO:0060012; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:1902476; GO:1902495
286,Pocillopora_acuta_HIv2___RNAseq.g14013.t1a,937.5155059,-11.88234555,3.14530941,2.11E-10,1.07E-08,,O42574,1.37E-29,Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR),adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; positive regulation of heart contraction [GO:0045823],GO:0004940; GO:0005769; GO:0005886; GO:0045823; GO:0071880
287,Pocillopora_acuta_HIv2___RNAseq.g8080.t1,735.0176068,-11.56786172,3.18445738,2.16E-10,1.08E-08,,Q9P2E3,0,NFX1-type zinc finger-containing protein 1,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607
288,Pocillopora_acuta_HIv2___RNAseq.g23418.t1,1185.96706,12.56838971,3.666221965,2.16E-10,1.08E-08,,NA,NA,NA,NA,NA
289,Pocillopora_acuta_HIv2___TS.g14387.t1,605.7878287,-0.677235292,1.361888325,2.19E-10,1.10E-08,,Q5XHC1,1.85E-86,Cilia-and flagella-associated protein 96,,GO:0005737; GO:0005813
290,Pocillopora_acuta_HIv2___RNAseq.g26057.t1,470.8706088,8.524006419,2.212791019,2.25E-10,1.12E-08,,Q96P65,6.23E-25,Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870; GO:0042277
291,Pocillopora_acuta_HIv2___RNAseq.g6500.t1,142.0452364,12.44482219,3.487284022,2.43E-10,1.21E-08,,NA,NA,NA,NA,NA
292,Pocillopora_acuta_HIv2___RNAseq.g29823.t1,598.3561429,-9.122071349,2.4774611,2.45E-10,1.21E-08,,NA,NA,NA,NA,NA
293,Pocillopora_acuta_HIv2___TS.g18521.t1b,182.2165253,-12.37598945,3.605302672,2.46E-10,1.22E-08,,NA,NA,NA,NA,NA
294,Pocillopora_acuta_HIv2___RNAseq.g6446.t1,7264.080634,4.273965913,0.764677191,2.49E-10,1.22E-08,Hemicentin (Coadhesin),B3EWZ3,0,Coadhesin,,GO:0016020
295,Pocillopora_acuta_HIv2___TS.g23175.t1,218.4604843,-12.49967519,3.664065728,2.52E-10,1.24E-08,,Q96RW7,3.37E-66,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711
296,Pocillopora_acuta_HIv2___RNAseq.g5386.t1,2718.699758,-1.212795465,2.504334723,2.70E-10,1.32E-08,,NA,NA,NA,NA,NA
297,Pocillopora_acuta_HIv2___RNAseq.g7573.t1,197.5550235,-12.38875191,3.636449816,2.72E-10,1.33E-08,,Q96M20,4.21E-28,Cyclic nucleotide-binding domain-containing protein 2,spermatogenesis [GO:0007283],GO:0005829; GO:0007283; GO:0030552
298,Pocillopora_acuta_HIv2___TS.g19887.t1,525.9971891,11.81419156,3.149951878,2.77E-10,1.35E-08,Carbonic anhydrase,Q92051,2.10E-38,Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase),carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]; regulation of pH [GO:0006885],GO:0004089; GO:0005737; GO:0006730; GO:0006885; GO:0008270; GO:0015670; GO:0042539
299,Pocillopora_acuta_HIv2___TS.g25258.t1,2035.876144,-8.95474672,3.549446968,2.84E-10,1.37E-08,Mucin-like protein,B3EWY9,0,Mucin-like protein,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005615; GO:0007160; GO:0016020
300,Pocillopora_acuta_HIv2___RNAseq.1449_t,2692.516603,-6.514993192,4.903124799,2.87E-10,1.39E-08,,Q58A42,2.65E-67,Protein DD3-3,,GO:0016020
301,Pocillopora_acuta_HIv2___RNAseq.g2734.t1,2074.160256,-1.082068993,2.108025943,2.94E-10,1.41E-08,,NA,NA,NA,NA,NA
302,Pocillopora_acuta_HIv2___RNAseq.g39.t2,624.4185015,11.61327011,3.205818379,2.95E-10,1.41E-08,Kielin/chordin-like protein,Q9IBG7,5.87E-17,Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin),,GO:0005576
303,Pocillopora_acuta_HIv2___RNAseq.g25891.t1,1602.053095,-9.575076997,2.670685614,2.97E-10,1.42E-08,,P48630,1.35E-119,"Omega-6 fatty acid desaturase, endoplasmic reticulum isozyme 1 (EC 1.14.19.-)",unsaturated fatty acid biosynthetic process [GO:0006636],GO:0005789; GO:0006636; GO:0016491
304,Pocillopora_acuta_HIv2___TS.g22690.t1,549.0442426,-0.709409842,1.396010979,2.98E-10,1.42E-08,,NA,NA,NA,NA,NA
305,Pocillopora_acuta_HIv2___RNAseq.g4907.t1,563.906126,-0.687163945,1.371661547,3.07E-10,1.45E-08,,O16025,0,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677
306,Pocillopora_acuta_HIv2___RNAseq.g15526.t1,934.8602622,-11.07839179,3.123587066,3.08E-10,1.45E-08,,O93384,2.14E-162,"S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin)",defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778],GO:0003824; GO:0005739; GO:0005789; GO:0005811; GO:0045087; GO:0046872; GO:0050778; GO:0051539; GO:0051607
307,Pocillopora_acuta_HIv2___RNAseq.g15097.t1,414.0979983,-8.766721005,2.255869058,3.09E-10,1.46E-08,,Q16322,1.70E-08,Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8),action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],GO:0001508; GO:0005221; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016020; GO:0051260; GO:0071805
308,Pocillopora_acuta_HIv2___RNAseq.g6506.t1,185.4193619,-12.28540446,3.604952794,3.22E-10,1.51E-08,,NA,NA,NA,NA,NA
309,Pocillopora_acuta_HIv2___RNAseq.g26602.t1,134.1816471,12.45611282,3.534679021,3.22E-10,1.51E-08,,NA,NA,NA,NA,NA
310,Pocillopora_acuta_HIv2___RNAseq.g30398.t1,1296.999523,-1.565927052,6.163395953,3.31E-10,1.55E-08,,P83858,2.55E-24,Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0032870; GO:0042277; GO:0097730
311,Pocillopora_acuta_HIv2___RNAseq.g20587.t2,299.5617816,-10.13137987,2.538585318,3.34E-10,1.55E-08,Uncharacterized biomineralization protein LOC111345150 ,NA,NA,NA,NA,NA
312,Pocillopora_acuta_HIv2___RNAseq.g710.t1,707.1930895,-11.53497229,3.153348878,3.44E-10,1.59E-08,,Q7TN88,1.00E-49,Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2),detection of mechanical stimulus [GO:0050982],GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982
313,Pocillopora_acuta_HIv2___RNAseq.g14886.t1,967.3716421,-8.457735897,3.442359482,3.88E-10,1.79E-08,,Q9Y2U5,5.86E-73,Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.11.25) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2),cellular response to mechanical stimulus [GO:0071260]; intracellular signal transduction [GO:0035556],GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0019901; GO:0035556; GO:0046872; GO:0071260; GO:0106310
314,Pocillopora_acuta_HIv2___RNAseq.g28870.t1,594.269792,-0.602621309,1.268112048,4.12E-10,1.90E-08,,Q5R991,8.77E-79,Late secretory pathway protein AVL9 homolog,cell migration [GO:0016477],GO:0016020; GO:0016477; GO:0055037
315,Pocillopora_acuta_HIv2___RNAseq.g18767.t1,1916.462485,-1.121314058,2.197581796,4.38E-10,2.01E-08,,P50430,1.07E-114,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),anterior head development [GO:0097065]; autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065
316,Pocillopora_acuta_HIv2___RNAseq.g17186.t1,508.5971984,-0.644709775,1.328546322,4.55E-10,2.08E-08,,NA,NA,NA,NA,NA
317,Pocillopora_acuta_HIv2___RNAseq.g16881.t1,324.1562466,-10.00110626,2.607513039,4.57E-10,2.08E-08,,NA,NA,NA,NA,NA
318,Pocillopora_acuta_HIv2___TS.g18814.t1,407.5392284,-10.36981435,2.784294064,4.83E-10,2.20E-08,,NA,NA,NA,NA,NA
319,Pocillopora_acuta_HIv2___RNAseq.21015_t,2419.080234,3.446252511,0.597369865,4.91E-10,2.22E-08,,Q95ND7,2.89E-40,Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain],blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638],GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0005788; GO:0005796; GO:0006508; GO:0007596; GO:0031638
320,Pocillopora_acuta_HIv2___RNAseq.g11521.t1,253.3662672,-10.21772057,2.552898926,4.91E-10,2.22E-08,,NA,NA,NA,NA,NA
321,Pocillopora_acuta_HIv2___TS.g25259.t2,1914.037843,-12.34003693,4.042508518,4.97E-10,2.24E-08,Mucin-like protein,B3EWY9,0,Mucin-like protein,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005615; GO:0007160; GO:0016020
322,Pocillopora_acuta_HIv2___TS.g2952.t1,159.8580196,-12.21357995,3.597828667,5.04E-10,2.26E-08,,A6QLU6,7.47E-15,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189
323,Pocillopora_acuta_HIv2___RNAseq.g21457.t1,161.1545401,-12.1919261,3.587532705,5.08E-10,2.27E-08,,Q8NFZ0,1.53E-155,F-box DNA helicase 1 (hFBH1) (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18),DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429],GO:0000724; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016853; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042
324,Pocillopora_acuta_HIv2___RNAseq.g14337.t1,183.5551059,-12.43937096,3.7213602,5.13E-10,2.29E-08,,B8V7S0,2.54E-93,CUB and peptidase domain-containing protein 1,acrosome reaction [GO:0007340]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007340
325,Pocillopora_acuta_HIv2___RNAseq.g29115.t1,762.4050217,-8.429056132,2.744270551,5.16E-10,2.30E-08,,P15989,1.08E-10,Collagen alpha-3(VI) chain,cell adhesion [GO:0007155],GO:0004867; GO:0005581; GO:0005615; GO:0007155; GO:0062023
326,Pocillopora_acuta_HIv2___RNAseq.18499_t,910.1937535,-0.531552546,1.211666603,5.23E-10,2.32E-08,,P21576,1.51E-15,Vacuolar protein sorting-associated protein 1,actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell division [GO:0051301]; endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; lipid tube assembly [GO:0060988]; meiotic cell cycle [GO:0051321]; mitochondrial fission [GO:0000266]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; protein localization to phagophore assembly site [GO:0034497]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; vacuolar transport [GO:0007034],GO:0000045; GO:0000266; GO:0000329; GO:0000407; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005770; GO:0005777; GO:0005829; GO:0005874; GO:0006623; GO:0006897; GO:0006914; GO:0007031; GO:0007034; GO:0008017; GO:0016020; GO:0016559; GO:0030036; GO:0030479; GO:0034497; GO:0045053; GO:0048312; GO:0051015; GO:0051017; GO:0051301; GO:0051321; GO:0060988
327,Pocillopora_acuta_HIv2___RNAseq.g6680.t1,408.564768,-0.68938332,1.377422188,5.34E-10,2.36E-08,,NA,NA,NA,NA,NA
328,Pocillopora_acuta_HIv2___RNAseq.g19312.t1,4224.36053,-6.032679496,5.176983843,5.38E-10,2.37E-08,,P33435,6.65E-31,Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13),bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; heart development [GO:0007507]; positive regulation of pancreatic trypsinogen secretion [GO:1904244]; protein catabolic process [GO:0030163]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to hormone [GO:0009725],GO:0001958; GO:0001968; GO:0003417; GO:0004222; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0007507; GO:0008233; GO:0008270; GO:0009725; GO:0019538; GO:0022617; GO:0030163; GO:0030198; GO:0030282; GO:0030574; GO:0031012; GO:0046581; GO:0048306; GO:0050750; GO:0060349; GO:1904244
329,Pocillopora_acuta_HIv2___TS.g6681.t1,1375.402471,-1.271876435,2.772328273,5.66E-10,2.49E-08,,Q6NYL5,2.28E-110,Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2),2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853
330,Pocillopora_acuta_HIv2___RNAseq.g4591.t1,324.2386756,-12.91581941,3.88535564,5.70E-10,2.50E-08,,NA,NA,NA,NA,NA
331,Pocillopora_acuta_HIv2___RNAseq.g13576.t1,169.5487604,-12.26085837,3.666952765,5.82E-10,2.54E-08,,P13608,5.61E-25,Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP),cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; skeletal system development [GO:0001501],GO:0001501; GO:0002052; GO:0005509; GO:0005540; GO:0005576; GO:0005615; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0045202; GO:0072534
332,Pocillopora_acuta_HIv2___RNAseq.g24021.t1,787.0723946,-11.77295512,3.222978902,5.88E-10,2.56E-08,,O88823,5.82E-13,Protein JTB,apoptotic mitochondrial changes [GO:0008637]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; positive regulation of protein kinase activity [GO:0045860]; regulation of cell population proliferation [GO:0042127],GO:0000278; GO:0000281; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0008637; GO:0016020; GO:0019901; GO:0030496; GO:0042127; GO:0045860
333,Pocillopora_acuta_HIv2___TS.g19999.t1,1687.938544,-8.631083456,3.398783933,5.89E-10,2.56E-08,Retinal homeobox protein Rx2,O42357,1.98E-31,Retinal homeobox protein Rx2,camera-type eye photoreceptor cell differentiation [GO:0060219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0045944; GO:0060219
334,Pocillopora_acuta_HIv2___RNAseq.g9825.t1,4116.908241,-6.759426508,2.793282203,5.91E-10,2.56E-08,,B8NHE3,6.07E-10,Methyltransferase flvH (EC 2.1.1.-) (Flavunoidine biosynthesis cluster protein H),methylation [GO:0032259]; terpenoid biosynthetic process [GO:0016114],GO:0008168; GO:0016114; GO:0032259; GO:0046872
335,Pocillopora_acuta_HIv2___RNAseq.g913.t2,828.3244646,-10.7788746,3.103153507,6.36E-10,2.75E-08,,Q0VE29,5.36E-06,Sterile alpha motif domain-containing protein 12 (SAM domain-containing protein 12),cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0007169; GO:0009898
336,Pocillopora_acuta_HIv2___TS.g11181.t1,232.349094,-12.53739475,3.713721861,6.68E-10,2.88E-08,,NA,NA,NA,NA,NA
337,Pocillopora_acuta_HIv2___RNAseq.g3070.t1,186.2317112,-12.37449218,3.695183747,7.04E-10,3.02E-08,,NA,NA,NA,NA,NA
338,Pocillopora_acuta_HIv2___TS.g16486.t1,427.5248151,-10.07990478,2.665696225,7.32E-10,3.13E-08,,NA,NA,NA,NA,NA
339,Pocillopora_acuta_HIv2___RNAseq.g25241.t1,922.2732991,-8.35827484,2.83731333,7.42E-10,3.17E-08,,Q5HZE0,5.80E-99,Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29),acyl carnitine transmembrane transport [GO:1902616]; acyl carnitine transport [GO:0006844]; L-arginine transmembrane transport [GO:1903826]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; organic cation transport [GO:0015695]; ornithine transport [GO:0015822],GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0006844; GO:0015174; GO:0015227; GO:0015695; GO:0015822; GO:0089709; GO:1902616; GO:1903401; GO:1903826; GO:1990575
340,Pocillopora_acuta_HIv2___RNAseq.g18859.t1,155.4516921,-12.16290487,3.608984808,7.48E-10,3.18E-08,,NA,NA,NA,NA,NA
341,Pocillopora_acuta_HIv2___RNAseq.g17495.t1,695.2761049,-11.69058004,3.248052236,7.69E-10,3.26E-08,,Q6AX80,2.12E-90,Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4),blood coagulation [GO:0007596],GO:0005886; GO:0007596; GO:0046872; GO:0047710
342,Pocillopora_acuta_HIv2___RNAseq.g23744.t1,356.7757991,-12.74317121,3.934231059,7.72E-10,3.26E-08,,NA,NA,NA,NA,NA
343,Pocillopora_acuta_HIv2___TS.g29407.t1,343.8080201,-12.94552187,3.95073374,7.88E-10,3.32E-08,,O00339,1.29E-24,Matrilin-2,axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678],GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216
344,Pocillopora_acuta_HIv2___RNAseq.g1847.t1,595.3009027,-11.09765353,3.082748285,8.08E-10,3.40E-08,,NA,NA,NA,NA,NA
345,Pocillopora_acuta_HIv2___TS.g17433.t1,262.8015163,-9.888859764,2.484065351,8.16E-10,3.42E-08,,NA,NA,NA,NA,NA
346,Pocillopora_acuta_HIv2___RNAseq.g21572.t1a,170.4948276,-12.17005356,3.663089651,8.33E-10,3.48E-08,,P63079,2.23E-50,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3),"brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]",GO:0004890; GO:0005216; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0045202; GO:0045211; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1902476; GO:1902495; GO:1902711; GO:1904315; GO:1904862
347,Pocillopora_acuta_HIv2___RNAseq.g8217.t1,745.8732448,-8.570991107,2.450450925,8.54E-10,3.56E-08,,Q16992,7.91E-09,LWamide neuropeptides [Cleaved into: LWamide I; Metamorphosin A (MMA) (LWamide II); LWamide III; LWamide IV; LWamide V; LWamide VI; LWamide VII; LWamide VIII; LWamide IX],extracellular matrix organization [GO:0030198]; neuropeptide signaling pathway [GO:0007218],GO:0005615; GO:0007218; GO:0030020; GO:0030198; GO:0062023
348,Pocillopora_acuta_HIv2___RNAseq.g16129.t1,1785.112439,-6.34676459,4.892606064,8.61E-10,3.58E-08,,A1RYE4,9.57E-58,Glyoxylate reductase (EC 1.1.1.26),,GO:0005829; GO:0016618; GO:0030267; GO:0047964; GO:0051287
349,Pocillopora_acuta_HIv2___RNAseq.g30624.t2b,1458.34038,-8.253206223,4.243448834,8.68E-10,3.60E-08,,Q99NH0,5.34E-66,Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein),blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],GO:0000785; GO:0001673; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246
350,Pocillopora_acuta_HIv2___RNAseq.g9029.t1,538.6354643,-0.566608859,1.258763728,9.09E-10,3.76E-08,,NA,NA,NA,NA,NA
351,Pocillopora_acuta_HIv2___RNAseq.g25446.t1,633.200938,-11.00108794,3.023195098,9.31E-10,3.83E-08,,NA,NA,NA,NA,NA
352,Pocillopora_acuta_HIv2___RNAseq.g619.t1,2642.450719,6.147338405,4.420395264,9.33E-10,3.83E-08,,Q6P1S6,3.47E-18,Myotrophin,,GO:0005634; GO:0048471
353,Pocillopora_acuta_HIv2___RNAseq.g21562.t1,1563.294101,7.694286261,3.507101149,9.58E-10,3.93E-08,CUB and sushi domain-containing protein 1,Q923L3,5.79E-12,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964],GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708
354,Pocillopora_acuta_HIv2___RNAseq.g21375.t1,152.1859478,-12.03478475,3.58294405,9.69E-10,3.96E-08,,NA,NA,NA,NA,NA
355,Pocillopora_acuta_HIv2___RNAseq.g7628.t1,523.5357004,-10.3367111,2.913729013,9.87E-10,4.02E-08,Toll-like receptor 6,Q704V6,2.62E-16,Toll-like receptor 6 (CD antigen CD286),cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224],GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227
356,Pocillopora_acuta_HIv2___RNAseq.g17650.t1,3302.144406,-0.829738089,1.522285174,1.06E-09,4.29E-08,,Q8I030,1.68E-24,Cystatin-B (Stefin-B),,GO:0004869; GO:0005634; GO:0005829
357,Pocillopora_acuta_HIv2___RNAseq.g17781.t1,430.2596795,-10.39321073,2.934501196,1.09E-09,4.39E-08,,NA,NA,NA,NA,NA
358,Pocillopora_acuta_HIv2___RNAseq.g27023.t1,1089.260437,7.969753439,4.845425393,1.09E-09,4.39E-08,,NA,NA,NA,NA,NA
359,Pocillopora_acuta_HIv2___RNAseq.g14642.t1,167.480075,-12.20030407,3.673615528,1.14E-09,4.58E-08,,NA,NA,NA,NA,NA
360,Pocillopora_acuta_HIv2___RNAseq.g3854.t1,848.1659954,-1.319372358,3.030048824,1.15E-09,4.63E-08,,P30974,4.07E-26,Tachykinin-like peptides receptor 86C (NKD),G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217],GO:0002121; GO:0004995; GO:0005886; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016020
361,Pocillopora_acuta_HIv2___RNAseq.g6379.t1,156.4214211,-12.19177603,3.667049692,1.21E-09,4.83E-08,,A6QLU6,8.77E-21,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189
362,Pocillopora_acuta_HIv2___RNAseq.g6505.t1,1954.756221,8.096242617,2.483724357,1.27E-09,5.09E-08,,NA,NA,NA,NA,NA
363,Pocillopora_acuta_HIv2___RNAseq.18284_t,232.5065579,-12.50033968,3.84281429,1.29E-09,5.13E-08,Putative ammonium transporter 3,Q21565,1.40E-128,Putative ammonium transporter 3,ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488],GO:0005886; GO:0008519; GO:0072488; GO:0097272
364,Pocillopora_acuta_HIv2___RNAseq.g25699.t1,362.7112477,-10.2373691,2.805754782,1.32E-09,5.25E-08,,Q90YK3,5.02E-162,L-gulonolactone oxidase (LGO) (EC 1.1.3.8) (L-gulono-gamma-lactone oxidase) (GLO),L-ascorbic acid biosynthetic process [GO:0019853],GO:0003885; GO:0005789; GO:0019853; GO:0050105; GO:0050660; GO:0071949
365,Pocillopora_acuta_HIv2___RNAseq.g19434.t1,1914.296839,-8.273851589,4.083378657,1.33E-09,5.26E-08,,NA,NA,NA,NA,NA
366,Pocillopora_acuta_HIv2___RNAseq.g1877.t1,482.0899622,-10.90519505,3.099348506,1.34E-09,5.29E-08,,NA,NA,NA,NA,NA
367,Pocillopora_acuta_HIv2___RNAseq.g28943.t1,161.3476832,-11.96519123,3.604082188,1.34E-09,5.29E-08,,NA,NA,NA,NA,NA
368,Pocillopora_acuta_HIv2___RNAseq.7765_t,851.6646896,-1.254389215,2.693997233,1.35E-09,5.29E-08,,NA,NA,NA,NA,NA
369,Pocillopora_acuta_HIv2___RNAseq.g29794.t1,381.9851246,-0.69836692,1.383362605,1.35E-09,5.29E-08,,Q03435,1.65E-14,Non-histone protein 10 (High mobility group protein 2),chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; regulation of DNA-templated transcription [GO:0006355]; telomere maintenance via recombination [GO:0000722],GO:0000404; GO:0000722; GO:0005634; GO:0006281; GO:0006302; GO:0006338; GO:0006355; GO:0031011; GO:0045027
370,Pocillopora_acuta_HIv2___TS.g27848.t1,185402.9008,-5.525990783,1.270359105,1.37E-09,5.34E-08,,Q86VQ3,2.61E-13,Thioredoxin domain-containing protein 2 (Spermatid-specific thioredoxin-1) (Sptrx-1),cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283],GO:0004791; GO:0005737; GO:0007283; GO:0030154; GO:0045454
371,Pocillopora_acuta_HIv2___RNAseq.g7644.t1,573.9320305,-11.04823633,3.230943991,1.41E-09,5.48E-08,,Q9BYK8,0,"3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein)",positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194],GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008859; GO:0016020; GO:0016887; GO:0030374; GO:0035194; GO:0043186; GO:0045944; GO:0046872
372,Pocillopora_acuta_HIv2___RNAseq.g29592.t1,139.2362064,-11.98130164,3.593483714,1.45E-09,5.60E-08,,NA,NA,NA,NA,NA
373,Pocillopora_acuta_HIv2___TS.g4312.t1,138.8235759,-11.95925062,3.582702975,1.45E-09,5.60E-08,,O70277,5.42E-20,Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22),negative regulation of translation [GO:0017148]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252],GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252
374,Pocillopora_acuta_HIv2___RNAseq.g17848.t1,501.708782,-0.577145224,1.268923381,1.45E-09,5.60E-08,,Q5F364,0,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908],GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729
375,Pocillopora_acuta_HIv2___RNAseq.g23049.t1,892.3221876,-8.797420951,2.693966079,1.45E-09,5.60E-08,,B3RFR8,7.89E-11,Hydramacin-1 (Hm-1),defense response to bacterium [GO:0042742]; innate immune response [GO:0045087],GO:0005576; GO:0016020; GO:0042742; GO:0044218; GO:0045087
376,Pocillopora_acuta_HIv2___TS.g9570.t1,7006.638041,6.8304631,2.214696328,1.47E-09,5.64E-08,,NA,NA,NA,NA,NA
377,Pocillopora_acuta_HIv2___RNAseq.g3441.t1,148.7449329,-11.99863074,3.608151163,1.49E-09,5.72E-08,Zona_pellucida,NA,NA,NA,NA,NA
378,Pocillopora_acuta_HIv2___RNAseq.g22644.t1,1223.764286,-1.244602266,2.63578701,1.52E-09,5.82E-08,,P31597,1.72E-126,Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1),chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813],GO:0005313; GO:0005314; GO:0005886; GO:0015108; GO:0015501; GO:0015813; GO:0016324; GO:0031901; GO:0031902; GO:0033229; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0055038; GO:0070779; GO:0098712; GO:0140009; GO:1902476
379,Pocillopora_acuta_HIv2___RNAseq.g30427.t1,558.5964587,-0.606499189,1.29208686,1.52E-09,5.82E-08,,Q8TCQ1,8.41E-15,E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING finger protein 171) (RING-type E3 ubiquitin transferase MARCHF1),antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209],GO:0000209; GO:0002495; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0043231; GO:0061630
380,Pocillopora_acuta_HIv2___RNAseq.g5871.t1,975.1563479,8.274141687,3.329689707,1.57E-09,5.96E-08,,Q96JQ5,3.47E-06,Membrane-spanning 4-domains subfamily A member 4A (CD20 antigen-like 1) (Four-span transmembrane protein 1),,GO:0005783; GO:0005794; GO:0005886; GO:0044853
381,Pocillopora_acuta_HIv2___RNAseq.10969_t,147.5445406,-12.01953428,3.629371597,1.58E-09,6.00E-08,Sulfotransferase 1B1,O43704,1.12E-55,Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase),3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923
382,Pocillopora_acuta_HIv2___TS.g25792.t1c,157.403228,-12.19369871,3.686920577,1.61E-09,6.08E-08,,Q8TD84,5.33E-23,Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1),axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],GO:0001709; GO:0005615; GO:0005886; GO:0007156; GO:0007409; GO:0007411; GO:0007417; GO:0007420; GO:0009953; GO:0009986; GO:0030424; GO:0042803; GO:0045202; GO:0048704; GO:0070593; GO:0098632
383,Pocillopora_acuta_HIv2___RNAseq.g385.t1,1369.130963,-7.587624592,2.727581746,1.64E-09,6.21E-08,,NA,NA,NA,NA,NA
384,Pocillopora_acuta_HIv2___RNAseq.g17934.t1,667.7402888,-8.837752959,2.692146523,1.66E-09,6.26E-08,,NA,NA,NA,NA,NA
385,Pocillopora_acuta_HIv2___RNAseq.g23857.t1,185.0422538,-12.31841331,3.750770274,1.67E-09,6.29E-08,,NA,NA,NA,NA,NA
386,Pocillopora_acuta_HIv2___RNAseq.g28227.t1,162.777211,-12.1037795,3.690647679,1.68E-09,6.31E-08,,P10079,4.85E-90,Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1),,GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579
387,Pocillopora_acuta_HIv2___RNAseq.g11840.t1,608.420428,-11.10573812,3.23454596,1.75E-09,6.55E-08,,Q6PEI7,0,CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1),'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; notochord development [GO:0030903]; pyrimidine nucleobase biosynthetic process [GO:0019856],GO:0003883; GO:0005524; GO:0005737; GO:0006241; GO:0006541; GO:0019856; GO:0030903; GO:0042802; GO:0044210; GO:0097268
388,Pocillopora_acuta_HIv2___TS.g16956.t1a,186.3954616,-12.18189578,3.692405609,1.77E-09,6.61E-08,,P51398,3.95E-28,"Small ribosomal subunit protein mS29 (28S ribosomal protein S29, mitochondrial) (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3) (Ionizing radiation resistance conferring protein)",apoptotic signaling pathway [GO:0097190]; mitochondrial translation [GO:0032543],GO:0003723; GO:0003735; GO:0005525; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0097190
389,Pocillopora_acuta_HIv2___RNAseq.g4628.t1,143.3841998,-12.00977785,3.647697351,1.78E-09,6.63E-08,,Q9TU23,8.35E-07,Centrosomal protein of 290 kDa (Cep290) (Nephrocystin-6),camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; protein transport [GO:0015031],GO:0001822; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0031410; GO:0032391; GO:0034451; GO:0035869; GO:0036038; GO:0043010; GO:0045893; GO:0090316; GO:0097711; GO:1905349; GO:1905515
390,Pocillopora_acuta_HIv2___RNAseq.g14914.t1,325.0839779,-12.66203168,3.953714374,1.81E-09,6.72E-08,,Q8N371,2.56E-19,Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.73) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8),circadian regulation of gene expression [GO:0032922]; fibroblast proliferation [GO:0048144]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; regulation of signal transduction by p53 class mediator [GO:1901796],GO:0000086; GO:0001701; GO:0002039; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006508; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0048144; GO:0051864; GO:0106157; GO:1901796
391,Pocillopora_acuta_HIv2___RNAseq.g31026.t1,710.6772209,-9.827196716,2.799560393,1.88E-09,6.96E-08,,NA,NA,NA,NA,NA
392,Pocillopora_acuta_HIv2___RNAseq.g1200.t1,410.4569735,-10.64543757,3.089643207,1.94E-09,7.15E-08,Sodium- and chloride-dependent GABA transporter 2 (GAT-2),P31649,0,Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13),amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734],GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718
393,Pocillopora_acuta_HIv2___TS.g16229.t1,4088.829978,-1.049598155,2.017399014,1.94E-09,7.15E-08,,NA,NA,NA,NA,NA
394,Pocillopora_acuta_HIv2___RNAseq.g25589.t1,156.3758493,-11.87328659,3.607784301,1.96E-09,7.20E-08,,NA,NA,NA,NA,NA
395,Pocillopora_acuta_HIv2___RNAseq.g18390.t1,242.2370102,-9.444151594,2.467131439,1.99E-09,7.30E-08,,NA,NA,NA,NA,NA
396,Pocillopora_acuta_HIv2___RNAseq.g13977.t1,1008.247706,-6.809696099,4.817546651,2.01E-09,7.36E-08,Mucin-like protein,B3EWY9,0,Mucin-like protein,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005615; GO:0007160; GO:0016020
397,Pocillopora_acuta_HIv2___RNAseq.g15652.t1,146.9460155,-11.95188054,3.619971219,2.05E-09,7.46E-08,,Q6P4F7,7.00E-37,Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A),positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056
398,Pocillopora_acuta_HIv2___TS.g20127.t1b,1359.92325,-7.33150203,4.620748538,2.07E-09,7.54E-08,,Q5PQM2,1.52E-10,Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8),microtubule-based movement [GO:0007018],GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894
399,Pocillopora_acuta_HIv2___RNAseq.g344.t1,3346.918445,-1.006364575,1.865601085,2.12E-09,7.70E-08,,Q9LQU4,5.60E-16,Protein PLANT CADMIUM RESISTANCE 2 (AtPCR2),response to oxidative stress [GO:0006979],GO:0005886; GO:0006979
400,Pocillopora_acuta_HIv2___RNAseq.g7250.t1,426.6908856,-0.648821996,1.327322812,2.20E-09,7.96E-08,,Q96PM5,1.41E-28,RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2),error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987; GO:0072344
401,Pocillopora_acuta_HIv2___RNAseq.g10736.t1,176.8599997,-12.37614217,3.742195328,2.21E-09,7.96E-08,,A0A0C2SRU0,1.77E-79,Decarboxylase iboD (EC 4.1.1.-) (Ibotenic acid biosynthesis cluster protein D),phospholipid biosynthetic process [GO:0008654],GO:0004609; GO:0008654
402,Pocillopora_acuta_HIv2___RNAseq.g23421.t1,760.151213,-11.08931297,3.243609137,2.22E-09,8.00E-08,,NA,NA,NA,NA,NA
403,Pocillopora_acuta_HIv2___RNAseq.g26118.t1,743.1981075,-1.207525811,2.489626913,2.27E-09,8.13E-08,,C9D7C2,0,Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein),calcium ion import across plasma membrane [GO:0098703]; chemical synaptic transmission [GO:0007268],GO:0005509; GO:0005891; GO:0007268; GO:0008331; GO:0045202; GO:0098703
404,Pocillopora_acuta_HIv2___RNAseq.g1971.t1,260.72645,-10.24223169,2.875702599,2.35E-09,8.43E-08,Cortactin-binding protein 2 (CARP 8),Q2QLF8,6.66E-13,Cortactin-binding protein 2 (CortBP2),,GO:0005938; GO:0043197; GO:0090443
405,Pocillopora_acuta_HIv2___RNAseq.g25689.t1,180.0958143,-12.01673995,3.682760363,2.38E-09,8.51E-08,,Q61184,3.00E-24,Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor),adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of insulin secretion [GO:0046676],GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043025; GO:0043235; GO:0046676; GO:0097159
406,Pocillopora_acuta_HIv2___RNAseq.g10927.t1,5557.525882,-4.225730464,0.832662897,2.41E-09,8.58E-08,,A0A0B5RUB0,9.02E-112,Trimethylamine transporter (TMA transporter) (TMA-specific transporter),,GO:0005886; GO:0022857
407,Pocillopora_acuta_HIv2___TS.g2153.t1c,432.1926728,-0.642647345,1.32898853,2.42E-09,8.61E-08,,P21266,1.33E-64,Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3),cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178],GO:0004364; GO:0005634; GO:0005737; GO:0005829; GO:0006749; GO:0008065; GO:0018916; GO:0019899; GO:0035686; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043627; GO:0045171; GO:0070062; GO:0070458
408,Pocillopora_acuta_HIv2___RNAseq.g5108.t1b,386.9866228,-10.26639135,3.008810823,2.45E-09,8.67E-08,,NA,NA,NA,NA,NA
409,Pocillopora_acuta_HIv2___RNAseq.g7049.t1,175.1427334,-12.18048348,3.750023201,2.48E-09,8.78E-08,,Q6JZS3,5.00E-83,Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1),,GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0043231; GO:0070330
410,Pocillopora_acuta_HIv2___RNAseq.14721_t,1452.829937,0.73022315,1.406709169,2.53E-09,8.93E-08,,O42412,4.83E-51,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403],GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042446
411,Pocillopora_acuta_HIv2___RNAseq.g24764.t1,547.6418929,-10.24995235,3.183738989,2.58E-09,9.06E-08,,P60899,7.71E-71,DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II subunit I) (RNA polymerase II 14.5 kDa subunit) (RPB14.5),maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II [GO:0001193]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0008270
412,Pocillopora_acuta_HIv2___TS.g12848.t1,975.4100626,7.104587859,4.590934407,2.60E-09,9.14E-08,,Q5RFW0,1.02E-17,Scavenger receptor class A member 5,endocytosis [GO:0006897]; intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207],GO:0005886; GO:0006879; GO:0006897; GO:0034755; GO:0070207; GO:0070287
413,Pocillopora_acuta_HIv2___RNAseq.g993.t1,2110.825452,-4.037129037,5.67440726,2.63E-09,9.20E-08,,P09917,2.26E-47,Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34),arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426],GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301
414,Pocillopora_acuta_HIv2___TS.g17424.t1,236.4114435,-12.38669954,3.804338634,2.68E-09,9.37E-08,,NA,NA,NA,NA,NA
415,Pocillopora_acuta_HIv2___TS.g21128.t1,169.891696,-12.12876368,3.711636378,2.76E-09,9.63E-08,Sodium channel protein type 4 subunit alpha B,Q20JQ7,0,Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b),membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; sodium ion transmembrane transport [GO:0035725],GO:0001518; GO:0005248; GO:0019228; GO:0030424; GO:0035725; GO:0086010
416,Pocillopora_acuta_HIv2___RNAseq.g24003.t1a,287.3278228,-0.737870881,1.43758649,2.87E-09,9.98E-08,,Q58CR4,2.25E-53,Dolichol kinase (EC 2.7.1.108) (Transmembrane protein 15),dolichyl monophosphate biosynthetic process [GO:0043048]; protein mannosylation [GO:0035268],GO:0004168; GO:0005789; GO:0035268; GO:0043048
417,Pocillopora_acuta_HIv2___RNAseq.g23827.t1,422.9916849,-0.664630392,1.350224918,2.94E-09,1.02E-07,,Q5DJU3,2.26E-178,Origin recognition complex subunit 3,DNA replication initiation [GO:0006270],GO:0003688; GO:0005656; GO:0005664; GO:0006270; GO:0031261
418,Pocillopora_acuta_HIv2___RNAseq.g17089.t1,175.0867438,-12.0810073,3.684438619,2.94E-09,1.02E-07,Peroxidasin homolog pxn-2,G5EG78,1.90E-101,Peroxidasin homolog pxn-2 (EC 1.11.2.-),axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979],GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825
419,Pocillopora_acuta_HIv2___RNAseq.g30874.t1,444.9763103,-0.507535004,1.198294421,3.06E-09,1.06E-07,,Q8NCX0,1.55E-116,Coiled-coil domain-containing protein 150,,
420,Pocillopora_acuta_HIv2___RNAseq.g16758.t1,155.6980265,-12.14954629,3.736393006,3.07E-09,1.06E-07,,NA,NA,NA,NA,NA
421,Pocillopora_acuta_HIv2___RNAseq.g1127.t2,394.894998,10.32270881,3.203487697,3.09E-09,1.06E-07,,Q6V0K7,1.63E-26,Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein),renal system process [GO:0003014],GO:0003014; GO:0005509; GO:0005635
422,Pocillopora_acuta_HIv2___RNAseq.g30797.t1,563.4269327,-0.575566773,1.264457886,3.09E-09,1.06E-07,,Q9D7M8,8.62E-78,DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D),transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],GO:0000166; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006366; GO:0006367; GO:0016607; GO:0031369
423,Pocillopora_acuta_HIv2___TS.g22704.t2,475.4466073,-10.35090694,3.116959576,3.11E-09,1.06E-07,,Q5U206,1.45E-52,Calmodulin-like protein 3,,GO:0005509; GO:0005737
424,Pocillopora_acuta_HIv2___RNAseq.g13690.t1,602.0585009,10.58399715,3.828886894,3.13E-09,1.07E-07,,NA,NA,NA,NA,NA
425,Pocillopora_acuta_HIv2___RNAseq.g15408.t1,273.6748164,-9.41091754,2.541646118,3.18E-09,1.08E-07,,NA,NA,NA,NA,NA
426,Pocillopora_acuta_HIv2___RNAseq.g13403.t1,858.5197949,-1.205041256,2.484743707,3.29E-09,1.12E-07,,Q86SS6,1.79E-35,Synaptotagmin-9 (Synaptotagmin IX) (SytIX),calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; regulation of calcium ion-dependent exocytosis [GO:0017158],GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0017156; GO:0017158; GO:0030276; GO:0030669; GO:0030672; GO:0031045; GO:0042802; GO:0070382; GO:0098686; GO:0099502
427,Pocillopora_acuta_HIv2___RNAseq.g175.t1,1221.920435,-6.880124503,5.224990982,3.31E-09,1.12E-07,,NA,NA,NA,NA,NA
428,Pocillopora_acuta_HIv2___RNAseq.g12572.t1,2986.846018,-0.825502257,1.526678057,3.45E-09,1.16E-07,,NA,NA,NA,NA,NA
429,Pocillopora_acuta_HIv2___RNAseq.g29275.t1,140.7752157,-11.90042032,3.642211814,3.45E-09,1.16E-07,,Q09081,1.11E-116,Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2),"neuronal action potential [GO:0019228]; optic nerve structural organization [GO:0021633]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; sensory perception of pain [GO:0019233]",GO:0005249; GO:0005251; GO:0005789; GO:0005886; GO:0008076; GO:0014059; GO:0019228; GO:0019233; GO:0021633; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0042734; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045188; GO:0051260; GO:0071805
430,Pocillopora_acuta_HIv2___RNAseq.g21481.t1,792.0654568,7.245233233,1.811441333,3.49E-09,1.17E-07,,P24821,5.67E-52,Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C),bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611],GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966
431,Pocillopora_acuta_HIv2___RNAseq.g26050.t1,4356.962458,7.80776916,2.372179873,3.51E-09,1.18E-07,Secreted frizzled-related protein 3,Q9IA95,9.55E-45,Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1),canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; epithelial cell development [GO:0002064]; hepatocyte differentiation [GO:0070365]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell differentiation [GO:0014033]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; somite development [GO:0061053],GO:0002064; GO:0005615; GO:0005737; GO:0008285; GO:0010721; GO:0014033; GO:0017147; GO:0030178; GO:0030308; GO:0035567; GO:0043065; GO:0045600; GO:0060029; GO:0060070; GO:0061037; GO:0061053; GO:0070365; GO:0070367; GO:0090090; GO:0090103
432,Pocillopora_acuta_HIv2___RNAseq.g10024.t1,124.9567973,-11.75354287,3.578082694,3.52E-09,1.18E-07,,NA,NA,NA,NA,NA
433,Pocillopora_acuta_HIv2___RNAseq.g15159.t1,303.9692218,-9.727390264,2.755721292,3.55E-09,1.19E-07,,Q7TN88,1.45E-54,Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2),detection of mechanical stimulus [GO:0050982],GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982
434,Pocillopora_acuta_HIv2___RNAseq.g28715.t1,157.2184907,-11.94521062,3.694684459,3.64E-09,1.21E-07,,NA,NA,NA,NA,NA
435,Pocillopora_acuta_HIv2___RNAseq.g6366.t1,214.0772959,-12.25704843,3.756479181,3.67E-09,1.22E-07,,Q7SY09,4.76E-36,Adhesion G protein-coupled receptor L4,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; animal organ development [GO:0048513]; cell surface receptor signaling pathway [GO:0007166],GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007189; GO:0048513
436,Pocillopora_acuta_HIv2___TS.g9752.t3,593.727731,-1.257344455,2.710796792,3.71E-09,1.23E-07,,Q14517,4.66E-21,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754],GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609; GO:1904385; GO:1904754
437,Pocillopora_acuta_HIv2___RNAseq.g2526.t1,131.7777358,-11.78208905,3.597232927,3.82E-09,1.27E-07,,NA,NA,NA,NA,NA
438,Pocillopora_acuta_HIv2___RNAseq.g14951.t1,847.2975927,-8.23821193,2.566514547,3.84E-09,1.27E-07,,B3EWZ3,1.50E-76,Coadhesin,,GO:0016020
439,Pocillopora_acuta_HIv2___RNAseq.g15257.t1,1581.918028,-7.304526798,2.486834491,3.88E-09,1.28E-07,,NA,NA,NA,NA,NA
440,Pocillopora_acuta_HIv2___TS.g5171.t1,295.1982655,-9.495284266,2.643413882,4.02E-09,1.32E-07,Cationic amino acid transporter 2 (CAT-2),P52569,2.27E-146,Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2),amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104],GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352; GO:1903826
441,Pocillopora_acuta_HIv2___TS.g19097.t2,208.317013,-12.35534773,3.852472704,4.29E-09,1.41E-07,,Q94887,1.07E-14,Neurexin-4 (Neurexin IV),"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553]",GO:0003015; GO:0005886; GO:0005919; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105
442,Pocillopora_acuta_HIv2___RNAseq.g24677.t1,367.1371553,-0.584696394,1.276872164,4.36E-09,1.42E-07,,D3ZEH5,4.71E-06,SID1 transmembrane family member 2,cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342],GO:0000902; GO:0003323; GO:0003677; GO:0003725; GO:0005764; GO:0005765; GO:0005886; GO:0006401; GO:0009749; GO:0035612; GO:0035650; GO:0042593; GO:0044342; GO:0050658; GO:0051032; GO:0051033; GO:0061178
443,Pocillopora_acuta_HIv2___RNAseq.g10294.t1,175.4293851,-12.20332576,3.784468513,4.36E-09,1.42E-07,,Q58A42,5.84E-70,Protein DD3-3,,GO:0016020
444,Pocillopora_acuta_HIv2___RNAseq.g12752.t1,1551.674522,-6.727097011,5.180116001,4.43E-09,1.44E-07,,Q9UKP5,3.14E-146,A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-),aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508],GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976
445,Pocillopora_acuta_HIv2___RNAseq.g7553.t1,178.6066108,-12.12362769,3.761472993,4.53E-09,1.47E-07,,Q14517,2.69E-09,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754],GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609; GO:1904385; GO:1904754
446,Pocillopora_acuta_HIv2___RNAseq.g15598.t1,2185.211359,-1.459498837,4.449202266,4.56E-09,1.48E-07,,NA,NA,NA,NA,NA
447,Pocillopora_acuta_HIv2___RNAseq.g10096.t1,187.3510475,-12.17502362,3.766400803,4.58E-09,1.48E-07,,NA,NA,NA,NA,NA
448,Pocillopora_acuta_HIv2___RNAseq.g15137.t1,188.0128888,-12.22824819,3.852038608,4.59E-09,1.48E-07,,Q9Z2E3,0,Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (Ire1-beta) (IRE1b) (mIre1) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],apoptotic chromosome condensation [GO:0030263]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075],GO:0000287; GO:0004521; GO:0004674; GO:0005524; GO:0005829; GO:0006355; GO:0006397; GO:0006468; GO:0016075; GO:0030263; GO:0034976; GO:0036498; GO:0043507; GO:0044322; GO:0045892; GO:0051082; GO:0070059; GO:0106310; GO:1990604
449,Pocillopora_acuta_HIv2___RNAseq.g11039.t1,612.2919241,-8.964767322,2.599315261,4.59E-09,1.48E-07,,NA,NA,NA,NA,NA
450,Pocillopora_acuta_HIv2___RNAseq.g11852.t1,385.001906,-0.555389454,1.247492867,4.60E-09,1.48E-07,TRP A1,Q8BLA8,1.82E-109,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071244; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760
451,Pocillopora_acuta_HIv2___RNAseq.g18882.t1,213.3435042,-9.200468918,2.469955857,4.69E-09,1.50E-07,,NA,NA,NA,NA,NA
452,Pocillopora_acuta_HIv2___RNAseq.g14869.t1,277.2244053,-12.89566767,4.061594835,4.80E-09,1.53E-07,,Q9Y5X5,6.03E-26,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408],GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408
453,Pocillopora_acuta_HIv2___RNAseq.g21834.t1,364.0678933,-0.627865535,1.296310523,4.86E-09,1.55E-07,,Q9HB40,3.35E-125,Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1),blood vessel diameter maintenance [GO:0097746]; negative regulation of blood pressure [GO:0045776]; proteolysis [GO:0006508]; retinoic acid metabolic process [GO:0042573],GO:0004185; GO:0005829; GO:0006508; GO:0042573; GO:0045776; GO:0070062; GO:0097746
454,Pocillopora_acuta_HIv2___RNAseq.g8276.t1,579.7556945,-10.72150909,3.257792885,4.90E-09,1.56E-07,,Q6VAB6,7.67E-45,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265],GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0019722; GO:0031434; GO:0043410; GO:0046872; GO:0106310; GO:0120162
455,Pocillopora_acuta_HIv2___RNAseq.g3492.t1,120.3602595,-11.63182289,3.557971583,5.10E-09,1.62E-07,,NA,NA,NA,NA,NA
456,Pocillopora_acuta_HIv2___RNAseq.g30992.t1,924.6268023,-1.01171178,1.892229867,5.12E-09,1.62E-07,,Q9Z2J0,0,Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3),brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814],GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015143; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837
457,Pocillopora_acuta_HIv2___RNAseq.g16525.t1,160.9601156,-9.442410704,2.486137363,5.14E-09,1.63E-07,,Q6VTH5,1.59E-89,Radial spoke head 1 homolog (Meichroacidin homolog) (Meichroacidin-like sperm-specific axonemal protein) (Testis-specific gene A2-like protein),cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283],GO:0001535; GO:0007283; GO:0030154; GO:0036126; GO:0051321; GO:0097729
458,Pocillopora_acuta_HIv2___RNAseq.673_t,1356.356282,8.273152028,3.513072877,5.24E-09,1.65E-07,LHFPL tetraspan subfamily member 4 protein,Q7TSY2,9.23E-33,LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein),gamma-aminobutyric acid receptor clustering [GO:0097112]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of inhibitory synapse assembly [GO:1905702]; sensory perception of sound [GO:0007605],GO:0005886; GO:0007605; GO:0030425; GO:0045211; GO:0050811; GO:0060077; GO:0097112; GO:0098982; GO:0099572; GO:0099645; GO:1905702
459,Pocillopora_acuta_HIv2___RNAseq.g16193.t1,298.3651247,-10.22846927,3.042889769,5.49E-09,1.73E-07,,Q496Y0,1.46E-90,LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127),,GO:0005737; GO:0046872; GO:0061630
460,Pocillopora_acuta_HIv2___RNAseq.g13533.t1,410.7097562,-10.44283549,3.229172293,5.53E-09,1.74E-07,,Q6V4S5,4.55E-54,Protein sidekick-2,camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219
461,Pocillopora_acuta_HIv2___RNAseq.g20440.t1,389.320524,-0.586084476,1.275412178,5.56E-09,1.74E-07,,Q6IE24,2.19E-120,Ubiquitin carboxyl-terminal hydrolase 54 (EC 3.4.19.12) (Ubiquitin-specific peptidase 54),protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004843; GO:0006508; GO:0016579
462,Pocillopora_acuta_HIv2___TS.g28482.t1,446.3672509,-0.63381517,1.318912827,5.59E-09,1.75E-07,,Q8BP74,7.35E-37,L-seryl-tRNA(Sec) kinase (EC 2.7.1.164) (O-phosphoseryl-tRNA(Sec) kinase),selenocysteine incorporation [GO:0001514],GO:0000049; GO:0001514; GO:0005524; GO:0005739; GO:0005829; GO:0016301; GO:0043915
463,Pocillopora_acuta_HIv2___RNAseq.g16715.t1,164499.2959,3.533732677,0.674689347,5.82E-09,1.82E-07,Late embryogenesis protein,Q9LF88,2.78E-07,Late embryogenesis abundant protein At3g53040 (LEA domain-containing protein At3g53040),floral organ abscission [GO:0010227],GO:0005829; GO:0010227
464,Pocillopora_acuta_HIv2___RNAseq.g18966.t1,158.8194162,-12.04227563,3.770961491,5.83E-09,1.82E-07,,P63142,1.56E-142,Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2),"action potential [GO:0001508]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; neuronal action potential [GO:0019228]; optic nerve development [GO:0021554]; optic nerve structural organization [GO:0021633]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; sensory perception of pain [GO:0019233]",GO:0001508; GO:0005249; GO:0005251; GO:0005768; GO:0005789; GO:0005886; GO:0008076; GO:0014059; GO:0015271; GO:0016020; GO:0019228; GO:0019233; GO:0019894; GO:0021554; GO:0021633; GO:0021987; GO:0022038; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0034705; GO:0042734; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045188; GO:0045211; GO:0051260; GO:0071805; GO:0097623; GO:0098978; GO:0099508; GO:1905030
465,Pocillopora_acuta_HIv2___RNAseq.g2199.t1,169.9626404,-11.90758216,3.71892707,5.92E-09,1.84E-07,,NA,NA,NA,NA,NA
466,Pocillopora_acuta_HIv2___RNAseq.g15988.t1,402.615653,-10.02453944,3.060388029,6.09E-09,1.89E-07,,NA,NA,NA,NA,NA
467,Pocillopora_acuta_HIv2___RNAseq.g2105.t1,318.6471405,-0.570371541,1.263786393,6.11E-09,1.89E-07,,D2XV59,0,GTP-binding protein 1,cytoplasmic translation [GO:0002181]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414],GO:0000049; GO:0000177; GO:0002181; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014; GO:1904678
468,Pocillopora_acuta_HIv2___RNAseq.g3500.t1,395.143573,-9.822751027,2.993862463,6.11E-09,1.89E-07,,NA,NA,NA,NA,NA
469,Pocillopora_acuta_HIv2___RNAseq.g9811.t1,280.1359892,-9.94290072,2.926239416,6.19E-09,1.91E-07,,Q924H0,7.27E-29,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408],GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408
470,Pocillopora_acuta_HIv2___RNAseq.g8523.t1,133.4568976,-11.85123069,3.679836334,6.20E-09,1.91E-07,,B3EWZ3,2.54E-29,Coadhesin,,GO:0016020
471,Pocillopora_acuta_HIv2___TS.g412.t1,3321.11237,-0.797836616,1.467168284,6.50E-09,1.99E-07,,P11533,3.86E-83,Dystrophin,muscle cell development [GO:0055001]; neuron development [GO:0048666]; regulation of muscle system process [GO:0090257]; skeletal muscle tissue development [GO:0007519]; synaptic signaling [GO:0099536],GO:0003779; GO:0005737; GO:0005856; GO:0007519; GO:0008270; GO:0042383; GO:0045211; GO:0048666; GO:0055001; GO:0090257; GO:0099536; GO:0120025
472,Pocillopora_acuta_HIv2___RNAseq.g27399.t1,695.1940866,-9.986687725,3.422891424,6.54E-09,2.01E-07,,O57382,1.05E-16,Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid),cell differentiation [GO:0030154]; proteolysis [GO:0006508],GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154
473,Pocillopora_acuta_HIv2___RNAseq.g19083.t1,2772.764543,7.622828828,2.295820266,6.59E-09,2.02E-07,,P0C6X2,6.74E-08,Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Papain-like proteinase nsp3 (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.-) (Non-structural protein 3) (nsp3) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase nsp5 (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Viral protein genome-linked nsp9 (Non-structural protein 9) (nsp9) (RNA-capping enzyme subunit nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); RNA-directed RNA polymerase nsp12 (Pol) (RdRp) (EC 2.7.7.48) (EC 2.7.7.50) (nsp12) (p100); Helicase nsp13 (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (nsp13) (p67); Guanine-N7 methyltransferase nsp14 (ExoN) (EC 2.1.1.56) (EC 3.1.13.-) (nsp14); Uridylate-specific endoribonuclease nsp15 (EC 4.6.1.-) (NendoU) (nsp15) (p35); 2'-O-methyltransferase nsp16 (EC 2.1.1.57) (nsp16)],DNA-templated transcription [GO:0006351]; induction by virus of host autophagy [GO:0039520]; proteolysis [GO:0006508]; symbiont-mediated degradation of host mRNA [GO:0039595]; symbiont-mediated perturbation of host ubiquitin-like protein modification [GO:0039648]; symbiont-mediated suppression of host ISG15-protein conjugation [GO:0039579]; symbiont-mediated suppression of host NF-kappaB cascade [GO:0085034]; symbiont-mediated suppression of host type I interferon-mediated signaling pathway [GO:0039502]; viral genome replication [GO:0019079]; viral protein processing [GO:0019082]; viral translational frameshifting [GO:0075523]; virus-mediated perturbation of host defense response [GO:0019049],GO:0000175; GO:0003724; GO:0003727; GO:0003968; GO:0004197; GO:0004482; GO:0004483; GO:0004519; GO:0004843; GO:0005524; GO:0006351; GO:0006508; GO:0008242; GO:0008270; GO:0016020; GO:0016829; GO:0016887; GO:0019049; GO:0019079; GO:0019082; GO:0033644; GO:0039502; GO:0039520; GO:0039579; GO:0039595; GO:0039648; GO:0044172; GO:0044220; GO:0075523; GO:0085034
474,Pocillopora_acuta_HIv2___RNAseq.g7626.t1,648.3803869,-7.395155065,3.495355783,6.70E-09,2.05E-07,Toll-like receptor Tollo,Q9V477,6.49E-15,Toll-like receptor Tollo (Toll-like receptor 8),axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165],GO:0003401; GO:0005886; GO:0007165; GO:0016324; GO:0045087; GO:0048018; GO:0048935; GO:0060026; GO:0060049; GO:0061809
475,Pocillopora_acuta_HIv2___RNAseq.g13270.t1,193.2550768,-8.784211964,2.221548832,7.01E-09,2.14E-07,,NA,NA,NA,NA,NA
476,Pocillopora_acuta_HIv2___TS.g19988.t1,141.4069312,-11.5771967,3.631212543,7.12E-09,2.16E-07,,NA,NA,NA,NA,NA
477,Pocillopora_acuta_HIv2___RNAseq.g8086.t1,748.2212442,-10.32783096,3.413256363,7.14E-09,2.17E-07,,Q8R151,1.86E-146,NFX1-type zinc finger-containing protein 1,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607
478,Pocillopora_acuta_HIv2___RNAseq.g26672.t1,145.8887385,-11.75358098,3.65833003,7.22E-09,2.18E-07,,P54131,1.59E-110,Neuronal acetylcholine receptor subunit alpha-7,calcium ion transport [GO:0006816]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165],GO:0001540; GO:0001666; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0032720; GO:0035094; GO:0042166; GO:0042803; GO:0043005; GO:0043410; GO:0045202; GO:0045211; GO:0045766; GO:0050890
479,Pocillopora_acuta_HIv2___TS.g3229.t1,1043.029606,7.887329436,2.697752893,7.27E-09,2.20E-07,,NA,NA,NA,NA,NA
480,Pocillopora_acuta_HIv2___TS.g1516.t1,150.2500774,-9.025542655,2.3823069,7.36E-09,2.22E-07,,A0AUR5,8.27E-124,Ubiquitin carboxyl-terminal hydrolase MINDY-3 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-3) (Protein CARP),apoptotic process [GO:0006915]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508],GO:0004843; GO:0005634; GO:0006508; GO:0006915; GO:0071108; GO:1990380
481,Pocillopora_acuta_HIv2___RNAseq.g15141.t1,178.3823,-12.06880333,3.865994243,7.59E-09,2.28E-07,,Q8L8B8,1.54E-56,Cytokinin riboside 5'-monophosphate phosphoribohydrolase LOG3 (EC 3.2.2.n1) (Protein LONELY GUY 3),cytokinin biosynthetic process [GO:0009691],GO:0005634; GO:0005829; GO:0009691; GO:0016799; GO:0102682
482,Pocillopora_acuta_HIv2___RNAseq.g24018.t1,147.6204036,9.703296541,2.740240581,7.64E-09,2.29E-07,,NA,NA,NA,NA,NA
483,Pocillopora_acuta_HIv2___RNAseq.g27413.t1,680.3737987,-10.80685412,3.413989095,7.87E-09,2.36E-07,,P63079,4.11E-92,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3),"brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]",GO:0004890; GO:0005216; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0045202; GO:0045211; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1902476; GO:1902495; GO:1902711; GO:1904315; GO:1904862
484,Pocillopora_acuta_HIv2___RNAseq.g9381.t1,374.1962291,10.17038163,3.247035478,7.91E-09,2.36E-07,Glutathione hydrolase 1 proenzyme,Q60928,3.76E-122,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006536; GO:0006749; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068
485,Pocillopora_acuta_HIv2___RNAseq.g21627.t1,740.2851964,-6.318541325,4.120388988,7.97E-09,2.38E-07,,Q96N23,0,Cilia- and flagella-associated protein 54,cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316
486,Pocillopora_acuta_HIv2___RNAseq.g21884.t1,182.2254984,-11.89405256,3.749322078,7.99E-09,2.38E-07,,Q9Y227,2.93E-168,Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42),CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256],GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0016020; GO:0017110; GO:0017111; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712
487,Pocillopora_acuta_HIv2___RNAseq.g11054.t1,331.0200306,-0.512075554,1.216538215,8.20E-09,2.44E-07,,NA,NA,NA,NA,NA
488,Pocillopora_acuta_HIv2___RNAseq.g22344.t1,1683.072127,-0.830327132,1.503317527,8.28E-09,2.46E-07,,Q8VHT8,6.11E-76,Transcription factor IIIA (TFIIIA),ribosomal large subunit biogenesis [GO:0042273],GO:0000995; GO:0003677; GO:0005634; GO:0008097; GO:0042273; GO:0046872
489,Pocillopora_acuta_HIv2___RNAseq.5937_t,477.4474801,-0.513301367,1.210765559,8.41E-09,2.49E-07,,P32588,2.47E-07,Nuclear and cytoplasmic polyadenylated RNA-binding protein PUB1 (ARS consensus-binding protein ACBP-60) (Poly uridylate-binding protein) (Poly(U)-binding protein),"cellular response to glucose starvation [GO:0042149]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; stress granule assembly [GO:0034063]; translational termination [GO:0006415]",GO:0000184; GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006415; GO:0008266; GO:0010494; GO:0034063; GO:0042149; GO:0043022; GO:0043488
490,Pocillopora_acuta_HIv2___RNAseq.g7443.t1,443.1722717,-10.40978234,3.240735165,8.54E-09,2.52E-07,,Q32NG4,2.39E-94,Glutamine amidotransferase-like class 1 domain-containing protein 1 (Ferry endosomal RAB5 effector complex subunit 5) (Fy-5) (Parkinson disease 7 domain-containing protein 1),,GO:0005576; GO:0005769
491,Pocillopora_acuta_HIv2___RNAseq.g2173.t1,371.3618821,-10.29669793,3.240669048,8.64E-09,2.55E-07,,Q8N0W5,4.39E-49,IQ domain-containing protein K,,
492,Pocillopora_acuta_HIv2___RNAseq.g994.t1,1097.046855,-5.875486158,4.796164699,8.85E-09,2.60E-07,,P09917,1.46E-46,Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34),arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426],GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301
493,Pocillopora_acuta_HIv2___TS.g12453.t2,884.1998203,4.274685758,6.101937904,8.95E-09,2.62E-07,,O08746,2.22E-19,Matrilin-2,axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678],GO:0001764; GO:0005509; GO:0005604; GO:0005615; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0031175; GO:0048678; GO:0062023; GO:0120216
494,Pocillopora_acuta_HIv2___TS.g1768.t1,504.4776502,-1.485052019,4.484502891,8.96E-09,2.62E-07,,P16621,2.14E-07,Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR),axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124],GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386
495,Pocillopora_acuta_HIv2___TS.g2144.t1,187.4421644,-12.04887355,3.867773875,9.07E-09,2.65E-07,,NA,NA,NA,NA,NA
496,Pocillopora_acuta_HIv2___RNAseq.g13716.t1,1305.778101,-1.093258122,2.041317482,9.25E-09,2.70E-07,,D2IYS2,7.39E-70,Tyrosine-protein kinase receptor torso (EC 2.7.10.1),cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0043235; GO:0046872
497,Pocillopora_acuta_HIv2___TS.g28037.t1,120.1141173,-11.57847131,3.661421076,1.00E-08,2.91E-07,,NA,NA,NA,NA,NA
498,Pocillopora_acuta_HIv2___TS.g16482.t1,595.1027378,-9.748089625,3.517500003,1.03E-08,2.99E-07,Sodium- and chloride-dependent GABA transporter 2,P31649,0,Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13),amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734],GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718
499,Pocillopora_acuta_HIv2___TS.g12260.t1,509.9736492,6.980977232,1.940702032,1.03E-08,3.00E-07,,P55024,3.06E-70,Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase),melanin biosynthetic process [GO:0042438]; pigmentation [GO:0043473]; response to blue light [GO:0009637],GO:0004503; GO:0009637; GO:0033162; GO:0042438; GO:0042470; GO:0043473; GO:0046872
500,Pocillopora_acuta_HIv2___RNAseq.g1125.t1,1202.443085,0.922673435,1.647911096,1.04E-08,3.01E-07,,P12111,1.23E-65,Collagen alpha-3(VI) chain,cell adhesion [GO:0007155]; muscle organ development [GO:0007517]; neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; response to glucose [GO:0009749]; response to UV [GO:0009411],GO:0004867; GO:0005576; GO:0005589; GO:0005615; GO:0005788; GO:0007155; GO:0007517; GO:0009411; GO:0009749; GO:0030020; GO:0031012; GO:0042383; GO:0043491; GO:0051402; GO:0062023; GO:0070062; GO:1903561
501,Pocillopora_acuta_HIv2___RNAseq.g1195.t1,121.8643092,-11.492196,3.599066771,1.04E-08,3.01E-07,,P24668,2.85E-06,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0006622; GO:0006886; GO:0007041; GO:0019904; GO:0033299; GO:0048471; GO:1905394
502,Pocillopora_acuta_HIv2___RNAseq.19049_t,22594.10177,-3.340909669,0.64815032,1.05E-08,3.01E-07,,NA,NA,NA,NA,NA
503,Pocillopora_acuta_HIv2___TS.g1731.t1,516.5552495,-10.41151908,3.253060356,1.05E-08,3.01E-07,,P10079,5.83E-76,Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1),,GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579
504,Pocillopora_acuta_HIv2___RNAseq.g22676.t1,476.6748024,-10.68189623,3.303478015,1.05E-08,3.03E-07,,NA,NA,NA,NA,NA
505,Pocillopora_acuta_HIv2___RNAseq.g1932.t1,163.9735488,-11.93553469,3.823594868,1.06E-08,3.03E-07,,P23999,4.72E-09,Protein S-Myc,apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0006915; GO:0046983
506,Pocillopora_acuta_HIv2___RNAseq.g14868.t1b,329.4653986,-9.922223922,3.011922089,1.11E-08,3.18E-07,,P46825,2.56E-08,Kinesin light chain (KLC),microtubule-based movement [GO:0007018],GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894
507,Pocillopora_acuta_HIv2___RNAseq.g29822.t1,2126.25199,4.460650413,0.962085636,1.12E-08,3.21E-07,,NA,NA,NA,NA,NA
508,Pocillopora_acuta_HIv2___RNAseq.g14726.t1,143.7555753,-11.98001089,3.724871716,1.14E-08,3.24E-07,,NA,NA,NA,NA,NA
509,Pocillopora_acuta_HIv2___RNAseq.g24123.t1,284.0345953,-9.805936899,2.952039086,1.22E-08,3.46E-07,,NA,NA,NA,NA,NA
510,Pocillopora_acuta_HIv2___RNAseq.6942_t,1070.860151,-11.02789051,3.430489029,1.24E-08,3.51E-07,,Q8CBH5,5.47E-52,Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2),adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590],GO:0002250; GO:0005886; GO:0032393; GO:0042288; GO:0042590
511,Pocillopora_acuta_HIv2___RNAseq.g4978.t1,626.0353722,-10.46605072,3.316974451,1.24E-08,3.52E-07,,Q6P1X6,1.81E-68,UPF0598 protein C8orf82,,
512,Pocillopora_acuta_HIv2___RNAseq.g7550.t1,700.3692516,-7.106635578,4.342924401,1.25E-08,3.52E-07,,Q8VI63,1.13E-69,MOB kinase activator 2 (Mob2 homolog) (Mps one binder kinase activator-like 2) (Ovary-specific MOB-like protein),actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165],GO:0001934; GO:0005634; GO:0005737; GO:0007165; GO:0010976; GO:0030036; GO:0030295; GO:0044306; GO:0046872; GO:0048471
513,Pocillopora_acuta_HIv2___RNAseq.g7668.t1,1907.611221,-0.836585506,1.50585743,1.27E-08,3.57E-07,Tenascin-X (Hexabrachion-like protein),P22105,7.80E-78,Tenascin-X (TN-X) (Hexabrachion-like protein),actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; triglyceride metabolic process [GO:0006641],GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0043231; GO:0045595; GO:0048251; GO:0062023; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935
514,Pocillopora_acuta_HIv2___TS.g11075.t2,373.0645621,-9.939841906,3.131782896,1.28E-08,3.60E-07,,P30051,0,Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13),cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; transition between fast and slow fiber [GO:0014883],GO:0000978; GO:0000981; GO:0003143; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007507; GO:0010468; GO:0014883; GO:0030307; GO:0030903; GO:0035329; GO:0042127; GO:0045893; GO:0045944; GO:0048339; GO:0048368; GO:0048568; GO:0071300; GO:0140552; GO:1902459
515,Pocillopora_acuta_HIv2___TS.g5006.t1c,506.2968442,-1.344708015,3.179029006,1.30E-08,3.66E-07,,NA,NA,NA,NA,NA
516,Pocillopora_acuta_HIv2___RNAseq.g10393.t1,270.1355758,-9.577084853,2.939468693,1.33E-08,3.74E-07,,A9UMP7,1.21E-72,Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),glycolytic process [GO:0006096],GO:0000015; GO:0000287; GO:0004634; GO:0006096
517,Pocillopora_acuta_HIv2___RNAseq.g672.t1,528.0128089,-10.36922943,3.252999629,1.34E-08,3.74E-07,,B3EWZ3,2.84E-96,Coadhesin,,GO:0016020
518,Pocillopora_acuta_HIv2___RNAseq.12690_t,645.0848185,-10.15796274,3.332207934,1.37E-08,3.83E-07,,Q9VQX4,0,Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21),NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979],GO:0004516; GO:0005829; GO:0006979; GO:0016740; GO:0034355; GO:0046872
519,Pocillopora_acuta_HIv2___RNAseq.g17655.t1,1450.265133,-0.809536986,1.499120643,1.39E-08,3.86E-07,,Q66HG5,0,Transmembrane 9 superfamily member 2,ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; protein localization to membrane [GO:0072657]; regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010908],GO:0005794; GO:0005815; GO:0006672; GO:0006688; GO:0010008; GO:0010908; GO:0016020; GO:0072657
520,Pocillopora_acuta_HIv2___RNAseq.g29670.t2,209.2192277,-12.21280843,3.94915574,1.39E-08,3.86E-07,,Q16281,1.33E-122,Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3),inorganic cation import across plasma membrane [GO:0098659]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601],GO:0005222; GO:0005223; GO:0005262; GO:0005272; GO:0005886; GO:0006812; GO:0007165; GO:0007601; GO:0015276; GO:0017022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0043194; GO:0043204; GO:0044877; GO:0045296; GO:0051591; GO:0097386; GO:0098655; GO:0098659; GO:1902495
521,Pocillopora_acuta_HIv2___RNAseq.g20653.t1,563.4761905,6.279162789,4.452730341,1.39E-08,3.86E-07,,NA,NA,NA,NA,NA
522,Pocillopora_acuta_HIv2___RNAseq.g7243.t1,147.9108782,-11.7051698,3.749676708,1.39E-08,3.86E-07,,Q8WU66,1.73E-32,Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR),hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505],GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170
523,Pocillopora_acuta_HIv2___RNAseq.g14744.t1,298.3159855,-9.80719068,3.12154787,1.40E-08,3.88E-07,,Q7SC45,1.39E-33,Protein btn-1,L-arginine transmembrane transport [GO:1903826]; lysine transport [GO:0015819]; regulation of intracellular pH [GO:0051453],GO:0000324; GO:0005773; GO:0005774; GO:0015819; GO:0051453; GO:1903826
524,Pocillopora_acuta_HIv2___RNAseq.g8965.t1,348.3760746,-10.03503287,3.25613427,1.50E-08,4.13E-07,,Q640L5,8.02E-105,Coiled-coil domain-containing protein 18,,GO:0005737; GO:0034451
525,Pocillopora_acuta_HIv2___RNAseq.g673.t1,447.0998743,8.762718673,2.830833174,1.57E-08,4.31E-07,,O15460,4.76E-137,"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)",,GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0031418; GO:0043231
526,Pocillopora_acuta_HIv2___RNAseq.g12500.t1,661.2015324,-0.869239142,1.613523902,1.59E-08,4.37E-07,,Q9H4G4,7.79E-27,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374
527,Pocillopora_acuta_HIv2___RNAseq.g7635.t1,6055.093173,3.825899551,0.787517108,1.59E-08,4.37E-07,,C0H690,1.84E-11,Small cysteine-rich protein 1 (Amil-SCRiP1) (SCRiP1),,GO:0005576; GO:0042151; GO:0090729
528,Pocillopora_acuta_HIv2___RNAseq.g21538.t1,130.2092415,-11.73630445,3.694912528,1.63E-08,4.47E-07,Sulfotransferase 1B1,O43704,2.35E-56,Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase),3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923
529,Pocillopora_acuta_HIv2___RNAseq.g3580.t1,975.169963,-1.371699329,3.1327,1.63E-08,4.47E-07,,Q7ZSX3,2.09E-57,Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48),amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; developmental process [GO:0032502]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; neuron development [GO:0048666]; pancreas development [GO:0031016]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888],GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0032502; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048666; GO:0048699
530,Pocillopora_acuta_HIv2___RNAseq.g30417.t1,444.0652909,-7.266433167,3.31709549,1.65E-08,4.50E-07,,NA,NA,NA,NA,NA
531,Pocillopora_acuta_HIv2___RNAseq.g20828.t1,298.1508804,-0.587441478,1.272841806,1.65E-08,4.50E-07,,Q80T11,2.78E-62,pre-mRNA splicing regulator USH1G (Jackson shaker protein) (Scaffold protein containing ankyrin repeats and SAM domain) (Usher syndrome type-1G protein homolog),equilibrioception [GO:0050957]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; photoreceptor cell maintenance [GO:0045494]; regulation of clathrin-dependent endocytosis [GO:2000369]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],GO:0001917; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007605; GO:0015030; GO:0015629; GO:0016020; GO:0016607; GO:0030507; GO:0032391; GO:0036064; GO:0042472; GO:0042802; GO:0045494; GO:0050953; GO:0050957; GO:0060113; GO:0060122; GO:0097546; GO:2000369
532,Pocillopora_acuta_HIv2___TS.g18947.t1,17030.60621,-3.357370456,0.664919768,1.67E-08,4.54E-07,Neuron marker protein (Spectrin beta chain),Q9QWN8,4.06E-57,"Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)",actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cellular response to ethanol [GO:0071361]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of postsynaptic specialization assembly [GO:0099150]; synapse assembly [GO:0007416]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192],GO:0000139; GO:0005200; GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007416; GO:0008021; GO:0008091; GO:0016079; GO:0016081; GO:0016192; GO:0016324; GO:0016363; GO:0017158; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0048471; GO:0051015; GO:0051693; GO:0071361; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099150; GO:0099173; GO:0099186; GO:0099189
533,Pocillopora_acuta_HIv2___RNAseq.g22977.t1,124.3848883,-11.71482823,3.683243847,1.67E-08,4.54E-07,,NA,NA,NA,NA,NA
534,Pocillopora_acuta_HIv2___RNAseq.g18756.t2,130.6296891,-11.56445273,3.711315255,1.68E-08,4.54E-07,,O75382,1.34E-10,Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97),negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008270; GO:0015031; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534
535,Pocillopora_acuta_HIv2___RNAseq.g9165.t1,258.4455659,-10.00200069,3.05394839,1.74E-08,4.69E-07,,NA,NA,NA,NA,NA
536,Pocillopora_acuta_HIv2___RNAseq.g27209.t1,284.5529277,-9.643491352,2.968718636,1.78E-08,4.80E-07,,NA,NA,NA,NA,NA
537,Pocillopora_acuta_HIv2___RNAseq.g18640.t1,150.631665,-11.84395414,3.860318693,1.78E-08,4.81E-07,,D2GXS7,1.03E-40,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0030371; GO:0043161; GO:0043523; GO:0061630
538,Pocillopora_acuta_HIv2___RNAseq.g8521.t2,282.5232996,-8.443271416,2.539037353,1.79E-08,4.81E-07,,P55023,1.56E-19,Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase),melanin biosynthetic process [GO:0042438],GO:0004503; GO:0042438; GO:0046872
539,Pocillopora_acuta_HIv2___TS.g29621.t1,108.0961644,-11.55606014,3.677677408,1.79E-08,4.81E-07,,O75581,0,Low-density lipoprotein receptor-related protein 6 (LRP-6),canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055],GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909
540,Pocillopora_acuta_HIv2___RNAseq.g17953.t1,487.4134254,9.604545928,3.500308773,1.81E-08,4.85E-07,,NA,NA,NA,NA,NA
541,Pocillopora_acuta_HIv2___RNAseq.g14952.t1,100.5047651,-11.38033643,3.589905837,1.84E-08,4.92E-07,,B3EWZ3,5.23E-51,Coadhesin,,GO:0016020
542,Pocillopora_acuta_HIv2___RNAseq.g3741.t1,229.9740318,-9.765649944,2.962104304,1.87E-08,4.99E-07,,Q8R323,0,Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38),DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683],GO:0003677; GO:0003689; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0017116; GO:0031390; GO:0046683; GO:1900264
543,Pocillopora_acuta_HIv2___TS.g9946.t1,302.0027185,-0.53747282,1.232961009,1.90E-08,5.05E-07,,Q947D2,1.43E-67,"PH, RCC1 and FYVE domains-containing protein 1 (Protein Praf4)",,GO:0005085; GO:0035091; GO:0046872; GO:0070300
544,Pocillopora_acuta_HIv2___RNAseq.g21476.t1,97.59121243,-8.839748523,2.257304367,1.90E-08,5.05E-07,,P24821,1.15E-46,Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C),bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611],GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966
545,Pocillopora_acuta_HIv2___RNAseq.g720.t1,1195.835698,-6.831552166,2.763068878,1.95E-08,5.19E-07,,NA,NA,NA,NA,NA
546,Pocillopora_acuta_HIv2___RNAseq.g16404.t1,128.5203352,-7.245272464,1.826732295,2.03E-08,5.39E-07,,NA,NA,NA,NA,NA
547,Pocillopora_acuta_HIv2___RNAseq.g28213.t1,2856.058273,-1.200558294,2.433604577,2.05E-08,5.43E-07,,C3ZQF9,4.07E-23,QRFP-like peptide receptor,cellular response to hormone stimulus [GO:0032870]; cellular response to peptide [GO:1901653]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0032870; GO:0042277; GO:1901653
548,Pocillopora_acuta_HIv2___RNAseq.g8582.t1,396.2007847,-10.37344445,3.304427733,2.08E-08,5.48E-07,,NA,NA,NA,NA,NA
549,Pocillopora_acuta_HIv2___RNAseq.g2780.t1,379.6567343,-1.463122223,4.203972672,2.11E-08,5.55E-07,,Q7YS61,3.27E-112,tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2),tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416],GO:0003723; GO:0005634; GO:0005737; GO:0016428; GO:0030488; GO:0036416
550,Pocillopora_acuta_HIv2___RNAseq.g11785.t1,185.5004635,-12.1556665,3.875964082,2.13E-08,5.59E-07,,P79888,7.01E-51,S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain],spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597],GO:0004014; GO:0006597; GO:0008295
551,Pocillopora_acuta_HIv2___RNAseq.g16070.t1,127.9935637,-11.56824704,3.760816204,2.15E-08,5.65E-07,,NA,NA,NA,NA,NA
552,Pocillopora_acuta_HIv2___TS.g385.t1,2127.13897,-0.925635856,1.671870619,2.28E-08,5.98E-07,,Q8T1E3,1.98E-41,S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain],putrescine biosynthetic process [GO:0009446]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597],GO:0004014; GO:0005829; GO:0006597; GO:0008295; GO:0009446
553,Pocillopora_acuta_HIv2___TS.g18900.t1,320.1544646,-9.627588697,3.17365857,2.29E-08,5.99E-07,,NA,NA,NA,NA,NA
554,Pocillopora_acuta_HIv2___RNAseq.g12573.t1,9305.290958,-5.524130872,1.509268316,2.34E-08,6.11E-07,,NA,NA,NA,NA,NA
555,Pocillopora_acuta_HIv2___RNAseq.g22296.t1,560.5878077,-1.294941184,2.705324689,2.43E-08,6.34E-07,,Q5DTY9,4.90E-43,BTB/POZ domain-containing protein KCTD16,protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],GO:0008277; GO:0042734; GO:0042995; GO:0043235; GO:0045211; GO:0051260
556,Pocillopora_acuta_HIv2___RNAseq.g12548.t1b,125.972938,-11.42878254,3.696373275,2.44E-08,6.34E-07,,Q9DBQ9,9.59E-50,Transcriptional protein SWT1,,GO:0005634
557,Pocillopora_acuta_HIv2___RNAseq.g22394.t1,622.2469477,-10.205304,3.400753924,2.47E-08,6.42E-07,,NA,NA,NA,NA,NA
558,Pocillopora_acuta_HIv2___RNAseq.g15709.t1,395.8646709,-10.28677934,3.279391925,2.59E-08,6.70E-07,,NA,NA,NA,NA,NA
559,Pocillopora_acuta_HIv2___RNAseq.g14899.t1,656.5951072,-0.926304107,1.718189295,2.62E-08,6.77E-07,,A7Z064,0,3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34),cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126],GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0008299; GO:0015936; GO:0016126; GO:0050661
560,Pocillopora_acuta_HIv2___TS.g21030.t2,881.776434,-1.028595979,1.898705521,2.66E-08,6.87E-07,,Q2I327,1.48E-41,Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5),sex differentiation [GO:0007548],GO:0000978; GO:0000981; GO:0005634; GO:0007548; GO:0046872
561,Pocillopora_acuta_HIv2___RNAseq.g1274.t1,255.6426117,-11.94645157,3.985975002,2.67E-08,6.89E-07,,Q6P8B3,1.15E-173,Speckle-type POZ protein,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161
562,Pocillopora_acuta_HIv2___RNAseq.25384_t,433.7243396,-1.329299996,3.073250378,2.74E-08,7.05E-07,,B3TP03,7.71E-126,Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2),L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352],GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015189; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352
563,Pocillopora_acuta_HIv2___TS.g8089.t1,326.1608403,-9.256419876,2.858134929,2.79E-08,7.16E-07,,Q02290,8.03E-07,"Endo-1,4-beta-xylanase B (Xylanase B) (EC 3.2.1.8) (1,4-beta-D-xylan xylanohydrolase B)",xylan catabolic process [GO:0045493],GO:0005576; GO:0030248; GO:0031176; GO:0045493
564,Pocillopora_acuta_HIv2___RNAseq.g18303.t1,1409.336294,0.653557883,1.289562156,2.81E-08,7.19E-07,,NA,NA,NA,NA,NA
565,Pocillopora_acuta_HIv2___RNAseq.g25691.t1,566.0311553,-10.37641632,3.318880775,2.82E-08,7.22E-07,,Q5RC04,5.13E-159,Ras-GEF domain-containing family member 1B,Ras protein signal transduction [GO:0007265],GO:0005085; GO:0005769; GO:0005770; GO:0005886; GO:0007265; GO:0030496
566,Pocillopora_acuta_HIv2___RNAseq.g8220.t1,328.1787629,-10.06450546,3.206189594,2.82E-08,7.22E-07,,NA,NA,NA,NA,NA
567,Pocillopora_acuta_HIv2___RNAseq.g17559.t1,552.611619,-6.622940617,3.773272337,2.92E-08,7.45E-07,,P34410,2.48E-29,TWiK family of potassium channels protein 7,potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322],GO:0005886; GO:0015271; GO:0022841; GO:0030322; GO:0071805
568,Pocillopora_acuta_HIv2___RNAseq.g7643.t1,2319.637719,-0.477707933,1.126871197,3.00E-08,7.64E-07,,Q9BYK8,0,"3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein)",positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194],GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008859; GO:0016020; GO:0016887; GO:0030374; GO:0035194; GO:0043186; GO:0045944; GO:0046872
569,Pocillopora_acuta_HIv2___RNAseq.g24455.t1,302.2938614,-9.574122651,3.222512429,3.05E-08,7.75E-07,,NA,NA,NA,NA,NA
570,Pocillopora_acuta_HIv2___RNAseq.g19116.t1,614.653193,-7.499931816,3.335261335,3.14E-08,7.97E-07,,Q7TN84,2.18E-32,Synaptotagmin-14 (Synaptotagmin XIV) (SytXIV),,GO:0005543; GO:0016020; GO:0042802
571,Pocillopora_acuta_HIv2___RNAseq.g13312.t1,811.7296547,-4.896772346,4.525205756,3.16E-08,7.99E-07,,NA,NA,NA,NA,NA
572,Pocillopora_acuta_HIv2___TS.g6400.t1,246.6674697,-0.566862216,1.260747912,3.20E-08,8.09E-07,,Q60848,0,Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein),apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; DNA methylation-dependent heterochromatin formation [GO:0006346]; heterochromatin formation [GO:0031507]; kidney development [GO:0001822]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin formation [GO:0031508]; urogenital system development [GO:0001655],GO:0000775; GO:0001655; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006338; GO:0006346; GO:0006915; GO:0016787; GO:0030098; GO:0031507; GO:0031508; GO:0043066; GO:0044027; GO:0046651; GO:0051301; GO:0140658; GO:0141119; GO:1990830; GO:2001243
573,Pocillopora_acuta_HIv2___RNAseq.g2083.t1,874.4026284,0.81283896,1.459638206,3.25E-08,8.20E-07,,NA,NA,NA,NA,NA
574,Pocillopora_acuta_HIv2___RNAseq.g1812.t1,9662.949375,3.793190398,0.799071303,3.37E-08,8.49E-07,"Actin, cytoplasmic",P12716,0,"Actin, cytoplasmic (EC 3.6.4.-) [Cleaved into: Actin, cytoplasmic, intermediate form]",,GO:0005524; GO:0005737; GO:0005856; GO:0016787
575,Pocillopora_acuta_HIv2___RNAseq.g33.t1,30447.91021,-2.837110578,0.558014909,3.47E-08,8.73E-07,ZP domain-containing protein,G8HTB6,6.70E-42,ZP domain-containing protein,,GO:0016020
576,Pocillopora_acuta_HIv2___TS.g28592.t1,279.6583683,-0.560268154,1.25078694,3.51E-08,8.81E-07,,NA,NA,NA,NA,NA
577,Pocillopora_acuta_HIv2___RNAseq.6093_tb,123.1507444,-7.916730593,2.197389601,3.51E-08,8.81E-07,,Q8K5B3,2.12E-22,Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein),carboxylic acid metabolic process [GO:0019752]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],GO:0005509; GO:0005576; GO:0005783; GO:0005793; GO:0005794; GO:0015031; GO:0016192; GO:0019752
578,Pocillopora_acuta_HIv2___RNAseq.g25909.t1,129.5040177,-11.53307175,3.811235154,3.57E-08,8.92E-07,,NA,NA,NA,NA,NA
579,Pocillopora_acuta_HIv2___RNAseq.g13552.t1,463.7075492,-10.13089698,3.411843861,3.57E-08,8.92E-07,,P48547,3.35E-106,Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4),action potential [GO:0001508]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636],GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030673; GO:0032590; GO:0032809; GO:0035864; GO:0042734; GO:0043679; GO:0044305; GO:0044325; GO:0045211; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1901381; GO:1990089
580,Pocillopora_acuta_HIv2___RNAseq.g15567.t1,456.8272216,-8.473130541,2.96507723,3.62E-08,9.02E-07,,P54357,2.51E-43,Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain),actin filament-based movement [GO:0030048],GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036
581,Pocillopora_acuta_HIv2___RNAseq.g4482.t1,698.6062517,-6.626265821,4.187381113,3.67E-08,9.12E-07,,NA,NA,NA,NA,NA
582,Pocillopora_acuta_HIv2___RNAseq.g4938.t1,145.7374557,-11.78124478,3.918263915,3.67E-08,9.12E-07,,E7FAM5,1.12E-121,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177
583,Pocillopora_acuta_HIv2___TS.g17158.t1,132.0278357,-5.696062327,1.389916438,3.80E-08,9.42E-07,,NA,NA,NA,NA,NA
584,Pocillopora_acuta_HIv2___RNAseq.g1119.t1,934.2105409,1.848510115,6.732507511,3.83E-08,9.50E-07,,Q8C6K9,5.82E-52,Collagen alpha-6(VI) chain,cell adhesion [GO:0007155],GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023
585,Pocillopora_acuta_HIv2___RNAseq.g28097.t1b,100.5384068,-11.31738092,3.653977078,3.86E-08,9.54E-07,,NA,NA,NA,NA,NA
586,Pocillopora_acuta_HIv2___RNAseq.g19152.t1,364.257946,-9.933598774,3.457327677,3.88E-08,9.58E-07,High affinity cationic amino acid transporter 1 (CAT-1),P30825,7.14E-165,High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter),amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; transport across blood-brain barrier [GO:0150104],GO:0000064; GO:0001618; GO:0005290; GO:0005886; GO:0006865; GO:0009925; GO:0015171; GO:0015174; GO:0015189; GO:0015807; GO:0015819; GO:0015822; GO:0016020; GO:0016323; GO:0016324; GO:0032991; GO:0042102; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1903352; GO:1903810; GO:1903826
587,Pocillopora_acuta_HIv2___RNAseq.g8219.t1,577.0219928,-10.10954694,3.332181612,3.92E-08,9.65E-07,,NA,NA,NA,NA,NA
588,Pocillopora_acuta_HIv2___TS.g21290.t1,463.9815292,7.120654341,4.68081911,3.93E-08,9.67E-07,,NA,NA,NA,NA,NA
589,Pocillopora_acuta_HIv2___RNAseq.g30954.t1,542.3358191,6.470950478,2.44217177,3.99E-08,9.81E-07,,A1KZ92,2.07E-33,Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2),hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],GO:0004519; GO:0004601; GO:0005615; GO:0005783; GO:0005886; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0140825
590,Pocillopora_acuta_HIv2___RNAseq.g474.t1,214.7006076,-0.498060221,1.208668484,4.06E-08,9.94E-07,,Q6DIM3,8.80E-32,Tubulin delta chain (Delta-tubulin),cell projection organization [GO:0030030]; microtubule-based process [GO:0007017]; positive regulation of smoothened signaling pathway [GO:0045880],GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005814; GO:0005874; GO:0005929; GO:0007017; GO:0030030; GO:0045880
591,Pocillopora_acuta_HIv2___RNAseq.g12215.t1,490.3495282,-7.378216851,3.542669109,4.06E-08,9.94E-07,,P08629,3.14E-30,Thioredoxin (Trx),positive regulation of DNA binding [GO:0043388]; response to radiation [GO:0009314],GO:0005576; GO:0005634; GO:0005737; GO:0009314; GO:0015035; GO:0043388
592,Pocillopora_acuta_HIv2___RNAseq.g10760.t1,718.0580401,-0.860859519,1.602362479,4.08E-08,9.98E-07,,B3DK16,3.01E-78,Polycomb group RING finger protein 5-A,regulation of transcription by RNA polymerase II [GO:0006357],GO:0006357; GO:0031519; GO:0035102; GO:0046872
593,Pocillopora_acuta_HIv2___RNAseq.g12796.t1,189.8656875,-12.13576588,3.969336617,4.09E-08,9.99E-07,Protein BTN1,Q4HX89,1.23E-41,Protein BTN1,amino acid transport [GO:0006865],GO:0005774; GO:0006865
594,Pocillopora_acuta_HIv2___TS.g20646.t1,113.5215123,-11.36174199,3.709438197,4.18E-08,1.02E-06,,NA,NA,NA,NA,NA
595,Pocillopora_acuta_HIv2___TS.g2710.t1,25241.70684,-2.77483874,0.5454097,4.18E-08,1.02E-06,ZP domain-containing protein,G8HTB6,2.94E-156,ZP domain-containing protein,,GO:0016020
596,Pocillopora_acuta_HIv2___TS.g16852.t1,9806.125862,-6.052201081,1.467901547,4.21E-08,1.02E-06,,NA,NA,NA,NA,NA
597,Pocillopora_acuta_HIv2___RNAseq.g11333.t1,588.4053096,-0.960184283,1.778154211,4.39E-08,1.06E-06,,Q5ZID0,2.54E-17,NmrA-like family domain-containing protein 1,,GO:0005634; GO:0048471
598,Pocillopora_acuta_HIv2___TS.g10567.t1,1767.881105,-3.828795336,4.894734991,4.45E-08,1.08E-06,,NA,NA,NA,NA,NA
599,Pocillopora_acuta_HIv2___RNAseq.g10683.t1,709.0107265,-1.130973159,2.209671475,4.46E-08,1.08E-06,,Q9VCA2,5.37E-73,Organic cation transporter protein,apoptotic process [GO:0006915]; monoatomic ion transport [GO:0006811],GO:0006811; GO:0006915; GO:0016020; GO:0022857
600,Pocillopora_acuta_HIv2___RNAseq.g22675.t2,2729.830465,-3.760252933,0.811411588,4.52E-08,1.09E-06,,NA,NA,NA,NA,NA
601,Pocillopora_acuta_HIv2___RNAseq.g28451.t1,35500.34211,3.784700472,0.824738734,4.54E-08,1.09E-06,,NA,NA,NA,NA,NA
602,Pocillopora_acuta_HIv2___RNAseq.g367.t1,388.9335505,-9.967840843,3.392184451,4.58E-08,1.10E-06,ZP domain-containing protein,G8HTB6,6.37E-37,ZP domain-containing protein,,GO:0016020
603,Pocillopora_acuta_HIv2___RNAseq.g18214.t1,325.6385438,-9.711534954,3.333338082,4.60E-08,1.10E-06,,A0A1D5NSM8,1.02E-53,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)","cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of complement activation, classical pathway [GO:0045959]",GO:0001945; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0045959; GO:0090136
604,Pocillopora_acuta_HIv2___RNAseq.g7813.t1,1286.330467,-0.570758059,1.245387593,4.60E-08,1.10E-06,,O60268,1.01E-23,Uncharacterized protein KIAA0513,,GO:0005737
605,Pocillopora_acuta_HIv2___RNAseq.g14020.t1,192.0152111,-11.98964057,3.955859209,4.74E-08,1.13E-06,ZP domain-containing protein,G8HTB6,3.10E-10,ZP domain-containing protein,,GO:0016020
606,Pocillopora_acuta_HIv2___RNAseq.g14732.t1,1589.699372,5.535416512,1.490575733,4.76E-08,1.14E-06,,NA,NA,NA,NA,NA
607,Pocillopora_acuta_HIv2___TS.g8259.t1b,611.3733883,5.973731481,4.263895404,4.89E-08,1.16E-06,,P13590,6.63E-23,Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1),homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic membrane adhesion [GO:0099560],GO:0005886; GO:0007156; GO:0099560
608,Pocillopora_acuta_HIv2___RNAseq.g14728.t1,490.6442177,-9.913116132,3.648206882,4.94E-08,1.18E-06,,NA,NA,NA,NA,NA
609,Pocillopora_acuta_HIv2___RNAseq.g679.t1,1182.721089,0.735231787,1.351629887,4.98E-08,1.18E-06,,P07314,2.92E-161,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750
610,Pocillopora_acuta_HIv2___RNAseq.g19648.t1,108.3742128,-11.21734048,3.647547591,5.02E-08,1.19E-06,,Q6GPB9,0,Dynein axonemal intermediate chain 4 (WD repeat-containing protein 78),,GO:0005856; GO:0031514; GO:0120293
611,Pocillopora_acuta_HIv2___RNAseq.g25795.t1,451.0937444,-0.544273505,1.23816442,5.05E-08,1.20E-06,,P97479,0,Unconventional myosin-VIIa,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; auditory receptor cell stereocilium organization [GO:0060088]; cell projection organization [GO:0030030]; cochlea development [GO:0090102]; endocytosis [GO:0006897]; equilibrioception [GO:0050957]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mechanoreceptor differentiation [GO:0042490]; phagocytosis [GO:0006909]; phagolysosome assembly [GO:0001845]; pigment granule localization [GO:0051875]; pigment granule transport [GO:0051904]; protein localization [GO:0008104]; sensory organ development [GO:0007423]; sensory perception [GO:0007600]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],GO:0000146; GO:0001750; GO:0001845; GO:0001917; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005765; GO:0005829; GO:0005902; GO:0005938; GO:0006886; GO:0006897; GO:0006909; GO:0007015; GO:0007040; GO:0007423; GO:0007600; GO:0007601; GO:0007605; GO:0008104; GO:0015629; GO:0016020; GO:0016324; GO:0016459; GO:0019904; GO:0030030; GO:0030048; GO:0030507; GO:0031477; GO:0032391; GO:0032420; GO:0042470; GO:0042472; GO:0042490; GO:0042491; GO:0042802; GO:0043531; GO:0044877; GO:0045202; GO:0048839; GO:0050953; GO:0050957; GO:0051015; GO:0051875; GO:0051904; GO:0060088; GO:0060113; GO:0060122; GO:0090102; GO:0120044; GO:1990435
612,Pocillopora_acuta_HIv2___TS.g8093.t1,595.1651279,-6.043372762,4.969896644,5.06E-08,1.20E-06,,NA,NA,NA,NA,NA
613,Pocillopora_acuta_HIv2___RNAseq.g12580.t1,201.2917646,-0.592286797,1.283802804,5.10E-08,1.20E-06,,P24628,4.32E-14,D(2) dopamine receptor A (D2R-A) (D2R 1),adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; regulation of secretion by cell [GO:1903530],GO:0000139; GO:0004930; GO:0004952; GO:0005886; GO:0007195; GO:0045202; GO:1903530
614,Pocillopora_acuta_HIv2___TS.g9162.t3,596.872708,-0.867428331,1.607859869,5.15E-08,1.21E-06,,P16066,0,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114],GO:0001653; GO:0004016; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620
615,Pocillopora_acuta_HIv2___RNAseq.g12618.t1,235.5425865,-9.273449515,3.082731504,5.20E-08,1.22E-06,,NA,NA,NA,NA,NA
616,Pocillopora_acuta_HIv2___RNAseq.g21369.t1,799.6818202,10.98570129,5.136978128,5.22E-08,1.23E-06,,NA,NA,NA,NA,NA
617,Pocillopora_acuta_HIv2___RNAseq.g25806.t1,191.8777599,-0.518068623,1.220579545,5.23E-08,1.23E-06,,Q9BZM1,1.65E-19,Group XIIA secretory phospholipase A2 (GXII sPLA2) (sPLA2-XII) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 12A),arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],GO:0004623; GO:0005509; GO:0005576; GO:0005737; GO:0006644; GO:0016042; GO:0047498; GO:0050482
618,Pocillopora_acuta_HIv2___RNAseq.g27370.t1,522.2754121,-6.897903461,2.932304388,5.31E-08,1.24E-06,,NA,NA,NA,NA,NA
619,Pocillopora_acuta_HIv2___RNAseq.g21261.t1,254.9755178,-9.346684037,3.126056783,5.34E-08,1.25E-06,,Q00808,4.43E-11,Vegetative incompatibility protein HET-E-1,,GO:0005525
620,Pocillopora_acuta_HIv2___RNAseq.20930_t,12932.76419,4.17802368,0.958496628,5.35E-08,1.25E-06,,B8EIZ7,3.42E-180,Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148),,GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661
621,Pocillopora_acuta_HIv2___TS.g3863.t1,332.1306592,-9.8508725,3.633229165,5.36E-08,1.25E-06,,O88813,0,Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5),cellular response to insulin stimulus [GO:0032869]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to sucrose [GO:0009744],GO:0001676; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0009744; GO:0009749; GO:0010747; GO:0010867; GO:0016020; GO:0032869; GO:0035338; GO:0047676; GO:0070723; GO:0090434
622,Pocillopora_acuta_HIv2___RNAseq.g1187.t1,403.6944743,-10.08472711,3.242668384,5.39E-08,1.25E-06,,NA,NA,NA,NA,NA
623,Pocillopora_acuta_HIv2___RNAseq.g16285.t1,1143.464182,6.332577608,2.078334606,5.42E-08,1.26E-06,,Q01484,3.37E-06,Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin),atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259
624,Pocillopora_acuta_HIv2___RNAseq.g3735.t1,483.8115088,-7.304147972,4.110284282,5.47E-08,1.27E-06,,NA,NA,NA,NA,NA
625,Pocillopora_acuta_HIv2___RNAseq.g29651.t1,2269.009218,-0.568351527,1.200183829,5.48E-08,1.27E-06,,F1DFM9,4.95E-50,Antimicrobial peptide damicornin,defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640],GO:0005576; GO:0010494; GO:0031640; GO:0042742; GO:0045087; GO:0050832
626,Pocillopora_acuta_HIv2___RNAseq.g25257.t1,484.6655857,-0.880239539,1.635361579,5.54E-08,1.28E-06,Adenosine 3'-phospho 5'-phosphosulfate transporter 1,Q91ZN5,1.02E-137,Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (Solute carrier family 35 member B2),3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; chondroitin sulfate biosynthetic process [GO:0030206]; transmembrane transport [GO:0055085],GO:0000139; GO:0005789; GO:0015297; GO:0030206; GO:0046963; GO:0046964; GO:0055085
627,Pocillopora_acuta_HIv2___RNAseq.g22749.t1,578.5947428,-6.068287634,3.72444199,5.56E-08,1.28E-06,,Q6EJB7,7.95E-60,Transcription factor Sox-3,brain development [GO:0007420]; central nervous system development [GO:0007417]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; otic placode development [GO:1905040]; otic placode formation [GO:0043049]; ovarian follicle development [GO:0001541]; peripheral nervous system development [GO:0007422]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000122; GO:0000978; GO:0001228; GO:0001541; GO:0005634; GO:0006357; GO:0007417; GO:0007420; GO:0007422; GO:0030182; GO:0043049; GO:0045944; GO:1905040
628,Pocillopora_acuta_HIv2___TS.g13342.t1,123.6533716,-8.428997191,2.412152113,5.58E-08,1.29E-06,,Q7Z494,1.20E-38,Nephrocystin-3,"atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]",GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095
629,Pocillopora_acuta_HIv2___RNAseq.g28834.t1a,197.4725734,-0.592069586,1.280124109,5.64E-08,1.30E-06,,Q76KP1,5.26E-69,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)",,GO:0008376; GO:0032580; GO:0033842
630,Pocillopora_acuta_HIv2___TS.g3599.t1,1264.50738,-0.687602968,1.31103635,6.00E-08,1.38E-06,,Q2TBA3,1.39E-06,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase),B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; cellular response to lipopolysaccharide [GO:0071222]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005829; GO:0006508; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051168; GO:0051603; GO:0071222; GO:2000321
631,Pocillopora_acuta_HIv2___RNAseq.g16958.t1,416.8428786,-0.948016614,1.75872967,6.08E-08,1.39E-06,,NA,NA,NA,NA,NA
632,Pocillopora_acuta_HIv2___RNAseq.g19392.t1,343.3089857,-1.034471245,1.952205167,6.11E-08,1.40E-06,,A2AP18,8.20E-180,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)",lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209],GO:0004435; GO:0004629; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209
633,Pocillopora_acuta_HIv2___RNAseq.g20232.t1,90.20486697,-11.15967719,3.620854506,6.35E-08,1.45E-06,,Q8TER0,6.47E-56,"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)",cell-matrix adhesion [GO:0007160],GO:0005112; GO:0005509; GO:0005576; GO:0007160; GO:0031012
634,Pocillopora_acuta_HIv2___RNAseq.g18162.t1,227.6518381,-11.55639019,4.048025518,6.40E-08,1.46E-06,,B3DFV0,2.99E-25,LYR motif-containing protein 9,,
635,Pocillopora_acuta_HIv2___RNAseq.g17052.t1,423.7006504,-0.357236201,1.109913577,6.43E-08,1.46E-06,,P63012,8.51E-53,Ras-related protein Rab-3A,acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; calcium-ion regulated exocytosis [GO:0017156]; establishment of localization in cell [GO:0051649]; evoked neurotransmitter secretion [GO:0061670]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; lung development [GO:0030324]; lysosome localization [GO:0032418]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; plasma membrane repair [GO:0001778]; positive regulation of regulated secretory pathway [GO:1903307]; post-embryonic development [GO:0009791]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulated exocytosis [GO:0045055]; regulation of dopamine secretion [GO:0014059]; regulation of exocytosis [GO:0017157]; regulation of plasma membrane repair [GO:1905684]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489],GO:0001669; GO:0001671; GO:0001778; GO:0003016; GO:0003924; GO:0005525; GO:0005764; GO:0005768; GO:0005829; GO:0005886; GO:0006887; GO:0007005; GO:0007274; GO:0007409; GO:0008021; GO:0009306; GO:0009791; GO:0010807; GO:0014059; GO:0016079; GO:0016188; GO:0017156; GO:0017157; GO:0030073; GO:0030141; GO:0030324; GO:0030424; GO:0030672; GO:0030674; GO:0030742; GO:0031489; GO:0031630; GO:0032418; GO:0032482; GO:0032991; GO:0036465; GO:0043195; GO:0045055; GO:0048172; GO:0048471; GO:0048489; GO:0048786; GO:0048790; GO:0050975; GO:0051021; GO:0051117; GO:0051602; GO:0051649; GO:0060478; GO:0061670; GO:0097091; GO:0098793; GO:0098794; GO:0099161; GO:1903307; GO:1905684; GO:2000300
636,Pocillopora_acuta_HIv2___RNAseq.g3013.t1,198.0976219,-8.86519609,3.066963473,6.44E-08,1.46E-06,,NA,NA,NA,NA,NA
637,Pocillopora_acuta_HIv2___TS.g3401.t1,92.69481076,-11.20189773,3.635354967,6.46E-08,1.47E-06,,Q0V8E4,8.22E-94,Asparagine synthetase domain-containing protein 1,asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541],GO:0004066; GO:0006529; GO:0006541
638,Pocillopora_acuta_HIv2___TS.g18522.t1a,495.5558083,-6.657628475,3.068667308,6.71E-08,1.52E-06,,NA,NA,NA,NA,NA
639,Pocillopora_acuta_HIv2___RNAseq.g9900.t1,294.0894316,-9.882672687,3.243968654,6.85E-08,1.55E-06,,NA,NA,NA,NA,NA
640,Pocillopora_acuta_HIv2___RNAseq.g25181.t1,191.698987,-9.439364697,3.102781285,6.88E-08,1.56E-06,,Q9CQ40,1.74E-19,"Large ribosomal subunit protein mL49 (39S ribosomal protein L49, mitochondrial) (L49mt) (MRP-L49)",mitochondrial translation [GO:0032543],GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543
641,Pocillopora_acuta_HIv2___RNAseq.g15830.t1,578.6973883,-3.517612578,0.751763304,6.89E-08,1.56E-06,,NA,NA,NA,NA,NA
642,Pocillopora_acuta_HIv2___RNAseq.g11747.t1,567.2329669,-1.048036388,1.983662691,6.92E-08,1.56E-06,,Q3SYV5,5.43E-80,Tetraspanin-33 (Tspan-33),protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659
643,Pocillopora_acuta_HIv2___RNAseq.g11882.t1,417.3132375,-1.549250937,5.658125691,7.07E-08,1.59E-06,,O00628,7.60E-126,Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7),endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625],GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803
644,Pocillopora_acuta_HIv2___RNAseq.g1504.t1,415.2238475,-6.233857066,3.957460222,7.27E-08,1.63E-06,,Q9WYJ1,2.66E-76,L-threonine ammonia-lyase (EC 4.3.1.19) (L-serine ammonia-lyase) (EC 4.3.1.17) (Threonine dehydratase),isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567],GO:0003941; GO:0004794; GO:0006565; GO:0006567; GO:0009097; GO:0030170
645,Pocillopora_acuta_HIv2___RNAseq.g10518.t1,136.6898375,-11.51608975,3.831445087,7.30E-08,1.64E-06,,A5D8N2,1.26E-75,Protein DPCD,,
646,Pocillopora_acuta_HIv2___RNAseq.g4757.t1,627.1269614,-1.083714181,2.075679181,7.31E-08,1.64E-06,,Q92556,0,Engulfment and cell motility protein 1 (Protein ced-12 homolog),"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]",GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870
647,Pocillopora_acuta_HIv2___RNAseq.g9205.t1,827.3574015,0.937692795,1.655626007,7.35E-08,1.64E-06,,NA,NA,NA,NA,NA
648,Pocillopora_acuta_HIv2___RNAseq.g30591.t1,105.2305816,-11.25837821,3.727178499,7.50E-08,1.67E-06,,NA,NA,NA,NA,NA
649,Pocillopora_acuta_HIv2___TS.g9749.t1,91.57137595,-11.03177635,3.588198402,7.60E-08,1.69E-06,,P10079,2.84E-72,Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1),,GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579
650,Pocillopora_acuta_HIv2___TS.g28200.t1,322.1226759,-0.474099431,1.189187423,7.95E-08,1.77E-06,,Q96I24,4.65E-07,Far upstream element-binding protein 3 (FUSE-binding protein 3),DNA-templated transcription [GO:0006351]; intracellular mRNA localization [GO:0008298]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0006351; GO:0006357; GO:0008298; GO:0010628; GO:0016020; GO:0043025; GO:0043198; GO:0045893; GO:0045944
651,Pocillopora_acuta_HIv2___RNAseq.g16264.t2,160.61478,-0.562590513,1.254941646,8.18E-08,1.82E-06,,Q8IWL3,1.53E-33,"Iron-sulfur cluster co-chaperone protein HscB (DnaJ homolog subfamily C member 20) [Cleaved into: Iron-sulfur cluster co-chaperone protein HscB, cytoplasmic (C-HSC20); Iron-sulfur cluster co-chaperone protein HscB, mitochondrial]",[2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; primitive erythrocyte differentiation [GO:0060319]; primitive hemopoiesis [GO:0060215]; protein complex oligomerization [GO:0051259],GO:0001671; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0016226; GO:0042802; GO:0044571; GO:0046872; GO:0051087; GO:0051259; GO:0060215; GO:0060319
652,Pocillopora_acuta_HIv2___RNAseq.g3974.t1,383.3119811,-1.008082041,1.889448432,8.48E-08,1.88E-06,,Q5XK92,0,Protein CIP2A homolog L,chromosome organization [GO:0051276]; DNA damage response [GO:0006974],GO:0004864; GO:0005694; GO:0005737; GO:0006974; GO:0051276
653,Pocillopora_acuta_HIv2___RNAseq.g1103.t1,548.1038,-9.726817304,3.695687645,8.52E-08,1.89E-06,,Q96EH3,2.75E-24,Mitochondrial assembly of ribosomal large subunit protein 1,negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273],GO:0005739; GO:0005759; GO:0005829; GO:0017148; GO:0042273; GO:0043023; GO:0070130; GO:0090071; GO:0140978
654,Pocillopora_acuta_HIv2___RNAseq.g4250.t1,1645.316965,-0.416757679,1.104862341,8.53E-08,1.89E-06,,Q13443,2.35E-74,Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase),amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to antineoplastic agent [GO:0097327]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to laminar fluid shear stress [GO:0034616]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0004222; GO:0005080; GO:0005178; GO:0005518; GO:0005615; GO:0005886; GO:0005925; GO:0006509; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008237; GO:0009897; GO:0009986; GO:0010042; GO:0016323; GO:0016477; GO:0016485; GO:0017124; GO:0030216; GO:0030335; GO:0031293; GO:0033627; GO:0033630; GO:0033631; GO:0034241; GO:0034612; GO:0034616; GO:0042117; GO:0042542; GO:0042987; GO:0043236; GO:0043406; GO:0046872; GO:0050714; GO:0051044; GO:0051384; GO:0051549; GO:0051592; GO:0070062; GO:0071222; GO:0097327; GO:1902945
655,Pocillopora_acuta_HIv2___RNAseq.g16488.t1,271.9796706,-0.54164114,1.24046229,8.54E-08,1.89E-06,,O08875,7.50E-112,Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Calcium/calmodulin-dependent protein kinase type I-like CPG16) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1),axon extension [GO:0048675]; axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; forebrain development [GO:0030900]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; protein localization to nucleus [GO:0034504]; regulation of postsynapse assembly [GO:0150052]; response to virus [GO:0009615],GO:0001764; GO:0004672; GO:0004674; GO:0005524; GO:0007409; GO:0007420; GO:0009615; GO:0014069; GO:0021952; GO:0030424; GO:0030426; GO:0030900; GO:0034504; GO:0048675; GO:0048812; GO:0048813; GO:0098794; GO:0098978; GO:0106310; GO:0150052; GO:1900181
656,Pocillopora_acuta_HIv2___RNAseq.g20584.t1,1077.438756,5.501162024,1.491025758,8.60E-08,1.90E-06,,NA,NA,NA,NA,NA
657,Pocillopora_acuta_HIv2___RNAseq.g12560.t1,282.3688547,-9.454921723,3.320907772,8.67E-08,1.91E-06,,NA,NA,NA,NA,NA
658,Pocillopora_acuta_HIv2___RNAseq.g14724.t1,1653.606896,-5.150801136,4.238768552,8.70E-08,1.91E-06,,NA,NA,NA,NA,NA
659,Pocillopora_acuta_HIv2___RNAseq.g10475.t1,124.6447488,-11.42869913,3.802698295,8.75E-08,1.92E-06,,Q9NZM1,0,Myoferlin (Fer-1-like protein 3),blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0043231; GO:0046928; GO:0070062
660,Pocillopora_acuta_HIv2___RNAseq.g16722.t1,461.129666,-6.266073595,2.033047159,8.94E-08,1.96E-06,,A6NFN9,3.59E-59,Protein ANKUB1 (Ankyrin repeat and ubiquitin domain-containing 1),,
661,Pocillopora_acuta_HIv2___TS.g23225.t1,174.4416736,-0.600559603,1.290703202,8.98E-08,1.97E-06,,Q8NHH1,8.82E-129,Tubulin polyglutamylase TTLL11 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 11),microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; protein modification process [GO:0036211],GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0036064; GO:0036211; GO:0046872; GO:0051013; GO:0070740
662,Pocillopora_acuta_HIv2___RNAseq.g1926.t1,739.4258781,-0.783806883,1.409437398,9.07E-08,1.98E-06,,NA,NA,NA,NA,NA
663,Pocillopora_acuta_HIv2___RNAseq.g23757.t1,309.6270961,-0.96268188,1.787117328,9.10E-08,1.98E-06,,D4G3R4,1.84E-22,tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA),tRNA decay [GO:0016078],GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0016798; GO:0090729
664,Pocillopora_acuta_HIv2___RNAseq.21393_t,211.272625,-0.477706848,1.193207864,9.16E-08,1.99E-06,,Q9NXG6,1.49E-59,Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4),regulation of erythrocyte differentiation [GO:0045646],GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0031418; GO:0045646; GO:0160082
665,Pocillopora_acuta_HIv2___RNAseq.g26808.t1,339.3086618,-8.460920464,2.76568163,9.20E-08,2.00E-06,,NA,NA,NA,NA,NA
666,Pocillopora_acuta_HIv2___RNAseq.g7107.t1,303.6670436,-9.697285661,3.293521053,9.26E-08,2.01E-06,,O02833,9.97E-24,Insulin-like growth factor-binding protein complex acid labile subunit (ALS),cell adhesion [GO:0007155],GO:0005576; GO:0005886; GO:0007155
667,Pocillopora_acuta_HIv2___TS.g16770.t1,578.6121565,-5.91435577,4.270368313,9.31E-08,2.02E-06,,NA,NA,NA,NA,NA
668,Pocillopora_acuta_HIv2___TS.g3751.t1,624.875212,-0.172902509,1.033610434,9.59E-08,2.08E-06,,Q96QG7,0,Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9),endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],GO:0005737; GO:0005783; GO:0005829; GO:0006897; GO:0010507; GO:0010922; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0046856; GO:0048471; GO:0050821; GO:0060304
669,Pocillopora_acuta_HIv2___RNAseq.g12258.t1,434.161743,4.736042157,5.163604735,9.73E-08,2.10E-06,,F1NWE3,1.64E-24,Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha),negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; peptidyl-tyrosine dephosphorylation [GO:0035335]; synaptic membrane adhesion [GO:0099560],GO:0004725; GO:0005886; GO:0008201; GO:0030424; GO:0030426; GO:0030517; GO:0030672; GO:0035335; GO:0042803; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0098839; GO:0099560
670,Pocillopora_acuta_HIv2___TS.g27307.t1,535.7855145,-4.817640447,5.253661238,1.01E-07,2.17E-06,,Q6B9X6,1.04E-16,Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase),contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288],GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006971; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177; GO:0106310
671,Pocillopora_acuta_HIv2___RNAseq.10010_t,685.3822128,-1.476638131,3.59446244,1.01E-07,2.17E-06,TRP A1,O75762,6.47E-137,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor),calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955],GO:0005262; GO:0005886; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070588; GO:0097604
672,Pocillopora_acuta_HIv2___RNAseq.g18385.t1,410.6370046,8.070812534,2.683334425,1.02E-07,2.19E-06,,O95429,3.10E-07,BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains),cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA modification [GO:0090367]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; ruffle assembly [GO:0097178],GO:0000774; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0010763; GO:0016020; GO:0030838; GO:0031625; GO:0033138; GO:0043066; GO:0044877; GO:0045785; GO:0050821; GO:0051087; GO:0051496; GO:0051897; GO:0071356; GO:0071364; GO:0072659; GO:0090367; GO:0097178; GO:1903215
673,Pocillopora_acuta_HIv2___RNAseq.g22616.t1,148.0278536,-0.504501316,1.213015271,1.04E-07,2.24E-06,,NA,NA,NA,NA,NA
674,Pocillopora_acuta_HIv2___TS.g15329.t1,1897.509894,-0.794666584,1.451756335,1.05E-07,2.25E-06,,D3Z5L6,2.65E-57,MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT),serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296],GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610
675,Pocillopora_acuta_HIv2___RNAseq.g9115.t1,1734.416842,-0.430909872,1.102174567,1.07E-07,2.29E-06,,Q5RC90,1.87E-91,Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog),regulation of neuron projection development [GO:0010975],GO:0005245; GO:0005509; GO:0005794; GO:0005886; GO:0008048; GO:0010975; GO:0014069; GO:0048471
676,Pocillopora_acuta_HIv2___RNAseq.g5826.t1,542.6664538,-7.198112141,3.209264396,1.11E-07,2.38E-06,,Q9BVS4,5.13E-150,Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2),maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274],GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:0106310; GO:2000208; GO:2000234
677,Pocillopora_acuta_HIv2___RNAseq.g6980.t1,361.1853042,-0.935070261,1.734595525,1.12E-07,2.40E-06,,F1PZV2,6.77E-21,Major facilitator superfamily domain-containing protein 12,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],GO:0005764; GO:0005765; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:1903712
678,Pocillopora_acuta_HIv2___RNAseq.g5752.t1,90.48470024,-11.00020455,3.667341673,1.14E-07,2.42E-06,,Q9NX04,5.38E-18,AFG2-interacting ribosome maturation factor (Ribosome biogenesis protein C1orf109),ribosomal large subunit biogenesis [GO:0042273],GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0042273
679,Pocillopora_acuta_HIv2___RNAseq.g28466.t1,431.1314961,-1.08564872,1.942726774,1.15E-07,2.45E-06,,O73874,8.06E-14,Ephrin-B2a,angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039],GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0021654; GO:0035475; GO:0042734; GO:0046875; GO:0048013; GO:0048514; GO:0050920; GO:0098978
680,Pocillopora_acuta_HIv2___TS.g1545.t1b,504.3293579,0.791044971,1.447028049,1.15E-07,2.45E-06,Uncharacterized skeletal organic matrix protein 2,B7WFQ1,1.07E-62,Uncharacterized skeletal organic matrix protein 2 (Uncharacterized SOMP-2),,GO:0016020
681,Pocillopora_acuta_HIv2___RNAseq.g7192.t1,183.0170724,-0.502044012,1.198562091,1.17E-07,2.49E-06,,NA,NA,NA,NA,NA
682,Pocillopora_acuta_HIv2___RNAseq.g29166.t1,1870.312075,-0.882908874,1.575262303,1.18E-07,2.50E-06,,Q9CXI3,3.12E-10,DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X),dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421
683,Pocillopora_acuta_HIv2___RNAseq.g24860.t1,907.6343862,-6.832153972,3.612920258,1.18E-07,2.50E-06,,P55862,0,DNA replication licensing factor mcm5-A (xMCM5-A) (EC 3.6.4.12) (CDC46 homolog A) (xCDC46-A) (CDC46p) (p92),DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; premeiotic DNA replication [GO:0006279]; regulation of DNA-templated DNA replication initiation [GO:0030174],GO:0000785; GO:0003688; GO:0004386; GO:0005524; GO:0006268; GO:0006270; GO:0006279; GO:0016887; GO:0030174; GO:0042555; GO:0071162
684,Pocillopora_acuta_HIv2___RNAseq.g20876.t1,5283.948135,3.147689223,0.669361923,1.18E-07,2.51E-06,,Q9R0R1,1.28E-16,Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228),iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756],GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025
685,Pocillopora_acuta_HIv2___RNAseq.g19040.t1,487.6526483,-9.835060644,3.99671608,1.19E-07,2.52E-06,,O35125,1.38E-111,Leucine-rich repeat-containing protein 23 (Leucine-rich protein B7),flagellated sperm motility [GO:0030317]; radial spoke assembly [GO:0062177],GO:0005737; GO:0005829; GO:0005856; GO:0030317; GO:0036126; GO:0062177
686,Pocillopora_acuta_HIv2___RNAseq.g14615.t1,376.1156344,-6.45942625,3.705563841,1.20E-07,2.53E-06,,Q7Z591,1.40E-16,Microtubule organization protein AKNA (AT-hook-containing transcription factor),delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727],GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234
687,Pocillopora_acuta_HIv2___RNAseq.g21849.t1a,277.4882488,-7.986616478,2.728830473,1.22E-07,2.57E-06,,NA,NA,NA,NA,NA
688,Pocillopora_acuta_HIv2___RNAseq.g5340.t1,196.9194191,-8.455771025,2.75896294,1.29E-07,2.70E-06,,NA,NA,NA,NA,NA
689,Pocillopora_acuta_HIv2___RNAseq.g6079.t1,264.6287933,-9.340746107,3.213861357,1.29E-07,2.71E-06,,Q54468,2.71E-141,Chitobiase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (N-acetyl-beta-glucosaminidase),chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0042597; GO:0102148
690,Pocillopora_acuta_HIv2___RNAseq.g2743.t1,91.72513714,-10.96569871,3.639229807,1.30E-07,2.72E-06,,NA,NA,NA,NA,NA
691,Pocillopora_acuta_HIv2___RNAseq.g18125.t1,6023.760357,3.138607932,0.671064984,1.30E-07,2.72E-06,,Q9R0R1,1.28E-16,Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228),iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756],GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025
692,Pocillopora_acuta_HIv2___RNAseq.2533_t,3992.171005,6.242516178,3.884011457,1.31E-07,2.74E-06,,Q96RW7,4.56E-34,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711
693,Pocillopora_acuta_HIv2___TS.g4671.t2,270.1936723,-1.238068072,2.618465654,1.31E-07,2.74E-06,,P52485,3.94E-98,Ubiquitin-conjugating enzyme E2-24 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209],GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0019915; GO:0061631
694,Pocillopora_acuta_HIv2___RNAseq.g22105.t1,253.5607886,-0.474670867,1.190667771,1.32E-07,2.75E-06,,A6H779,1.10E-11,F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2),negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0005516; GO:0010506; GO:0016020; GO:0016567; GO:0019005; GO:0031146; GO:0050727; GO:0051896; GO:1900226; GO:1990756
695,Pocillopora_acuta_HIv2___RNAseq.g4635.t1,244.5678768,-0.559171868,1.252902377,1.35E-07,2.81E-06,,Q96HA7,0,Tonsoku-like protein (Inhibitor of kappa B-related protein) (I-kappa-B-related protein) (IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2),double-strand break repair via homologous recombination [GO:0000724]; protein localization to chromatin [GO:0071168]; replication fork processing [GO:0031297],GO:0000724; GO:0005654; GO:0005737; GO:0016604; GO:0031297; GO:0035861; GO:0042393; GO:0043596; GO:0071168; GO:0140566
696,Pocillopora_acuta_HIv2___RNAseq.g24441.t1,244.393654,5.463104917,1.492174892,1.40E-07,2.90E-06,,NA,NA,NA,NA,NA
697,Pocillopora_acuta_HIv2___RNAseq.g12987.t1,5067.402038,5.066908808,1.407665621,1.41E-07,2.92E-06,,Q6V0I7,1.97E-109,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609
698,Pocillopora_acuta_HIv2___RNAseq.g4969.t1,364.8253543,-1.115837884,2.154674804,1.41E-07,2.93E-06,,F1NPG5,2.04E-30,Centromere protein T (CENP-T),cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278],GO:0000278; GO:0000776; GO:0003677; GO:0005634; GO:0007059; GO:0046982; GO:0051301; GO:0051382
699,Pocillopora_acuta_HIv2___RNAseq.g10902.t1,169.2344271,-8.931975249,3.10514162,1.42E-07,2.95E-06,,NA,NA,NA,NA,NA
700,Pocillopora_acuta_HIv2___RNAseq.g20846.t1,519.7100419,-8.729080387,3.183865637,1.44E-07,2.97E-06,,Q80ZA4,0,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),sensory perception of sound [GO:0007605],GO:0007605; GO:0016020; GO:0032426; GO:0120234
701,Pocillopora_acuta_HIv2___RNAseq.g2438.t1,1162.876151,-0.694322068,1.320145083,1.44E-07,2.98E-06,,NA,NA,NA,NA,NA
702,Pocillopora_acuta_HIv2___RNAseq.g7881.t1,255.1012549,-9.399287022,3.323036659,1.45E-07,2.98E-06,,Q8IY21,1.62E-32,Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60),defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615],GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246
703,Pocillopora_acuta_HIv2___TS.g28671.t1,813.1910433,-0.263097622,1.070732961,1.47E-07,3.03E-06,,NA,NA,NA,NA,NA
704,Pocillopora_acuta_HIv2___RNAseq.g17622.t1,186.9391598,-9.185863508,3.244260635,1.48E-07,3.04E-06,,P35521,1.81E-42,"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln))","cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; mRNA cis splicing, via spliceosome [GO:0045292]; potassium ion transmembrane transport [GO:0071805]; spliceosomal snRNP assembly [GO:0000387]",GO:0000387; GO:0005229; GO:0005267; GO:0005634; GO:0005681; GO:0005829; GO:0005856; GO:0005886; GO:0006884; GO:0008289; GO:0016020; GO:0032991; GO:0034709; GO:0034715; GO:0036094; GO:0045292; GO:0071805; GO:1902476; GO:1990935
705,Pocillopora_acuta_HIv2___RNAseq.g10343.t1,180.9566911,9.462932202,3.313997578,1.50E-07,3.08E-06,,Q8R508,1.12E-09,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),cell morphogenesis involved in neuron differentiation [GO:0048667]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:0098609; GO:1904936; GO:2000171
706,Pocillopora_acuta_HIv2___RNAseq.g16169.t1,850.9743975,-1.105599208,2.063262688,1.52E-07,3.11E-06,LIM homeobox protein 1,P29674,7.07E-103,LIM/homeobox protein Lhx1 (LIM homeobox protein 1) (Homeobox protein Lim-1) (Xlim1) (x-Lhx1) (xLIM-1),anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; cell migration involved in gastrulation [GO:0042074]; chordate embryonic development [GO:0043009]; muscle organ development [GO:0007517]; nephron tubule development [GO:0072080]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric field specification [GO:0039003]; pronephric nephron tubule development [GO:0039020]; pronephros development [GO:0048793]; regionalization [GO:0003002]; regulation of pronephros size [GO:0035565]; response to retinoic acid [GO:0032526],GO:0000977; GO:0000981; GO:0001221; GO:0003002; GO:0005634; GO:0005667; GO:0007517; GO:0008270; GO:0009798; GO:0009952; GO:0022008; GO:0030182; GO:0030903; GO:0032526; GO:0035565; GO:0039003; GO:0039020; GO:0042074; GO:0043009; GO:0043565; GO:0045893; GO:0045944; GO:0048793; GO:0072080
707,Pocillopora_acuta_HIv2___TS.g10386.t1,510.3316274,-6.122089694,3.181691303,1.54E-07,3.15E-06,,NA,NA,NA,NA,NA
708,Pocillopora_acuta_HIv2___RNAseq.g3211.t1,354.9455636,-0.753937904,1.448944,1.55E-07,3.17E-06,,E1BD52,2.35E-176,Transmembrane protein 245,,GO:0016020
709,Pocillopora_acuta_HIv2___RNAseq.g7879.t1,636.8659311,-0.809047534,1.508914218,1.56E-07,3.18E-06,,Q8IY21,0,Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60),defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615],GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246
710,Pocillopora_acuta_HIv2___RNAseq.g25935.t1,41416.69592,3.66254676,0.839726301,1.56E-07,3.18E-06,Skeletal organic matrix MAM and LDL-receptor 2,B3EWZ6,0,MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2),,GO:0005576; GO:0016020
711,Pocillopora_acuta_HIv2___RNAseq.g15370.t1,233.9245686,-1.306080321,2.938138927,1.57E-07,3.20E-06,,P97259,5.31E-175,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]",positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279],GO:0000139; GO:0004864; GO:0005576; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1904894
712,Pocillopora_acuta_HIv2___RNAseq.g28765.t1,262.8580777,-9.471711605,3.44634562,1.58E-07,3.21E-06,,NA,NA,NA,NA,NA
713,Pocillopora_acuta_HIv2___RNAseq.g3924.t1,149.1579331,8.912316712,3.22644585,1.59E-07,3.22E-06,,NA,NA,NA,NA,NA
714,Pocillopora_acuta_HIv2___RNAseq.g22399.t1,362.0187734,-0.949898347,1.76207353,1.60E-07,3.24E-06,,NA,NA,NA,NA,NA
715,Pocillopora_acuta_HIv2___RNAseq.g6948.t1,113.8929027,-11.23451338,3.762786749,1.61E-07,3.26E-06,,NA,NA,NA,NA,NA
716,Pocillopora_acuta_HIv2___RNAseq.g9093.t1,4489.428479,-0.955066588,1.734873809,1.67E-07,3.36E-06,Sulfotransferase 1C4,O75897,1.15E-54,Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2),3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805],GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923
717,Pocillopora_acuta_HIv2___RNAseq.g6074.t1,332.2656302,-9.394362444,3.484879253,1.69E-07,3.40E-06,,NA,NA,NA,NA,NA
718,Pocillopora_acuta_HIv2___RNAseq.g21964.t1,554.6280069,-1.073845458,2.044104088,1.69E-07,3.40E-06,,NA,NA,NA,NA,NA
719,Pocillopora_acuta_HIv2___RNAseq.g12734.t1,543.6097428,-0.846182256,1.571321979,1.69E-07,3.40E-06,Parafibromin,Q5ZLM0,0,Parafibromin (Cell division cycle protein 73 homolog),endodermal cell fate commitment [GO:0001711]; mRNA 3'-end processing [GO:0031124]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368],GO:0000122; GO:0000993; GO:0001711; GO:0005634; GO:0006368; GO:0008285; GO:0016593; GO:0019827; GO:0030177; GO:0031124; GO:0031442; GO:0032968; GO:0045638; GO:1902808; GO:2000134
720,Pocillopora_acuta_HIv2___RNAseq.g6157.t1,430.7775391,-1.031628578,1.935292695,1.70E-07,3.41E-06,,Q96DC8,5.60E-121,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",fatty acid metabolic process [GO:0006631]; positive regulation of cellular response to insulin stimulus [GO:1900078],GO:0004300; GO:0005739; GO:0006631; GO:0016836; GO:1900078
721,Pocillopora_acuta_HIv2___RNAseq.g11700.t1,324.3769778,-9.689101184,3.985607105,1.71E-07,3.44E-06,,P43247,0,DNA mismatch repair protein Msh2 (MutS protein homolog 2),B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; regulation of cell cycle [GO:0051726]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204],GO:0000287; GO:0000400; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0006974; GO:0007281; GO:0008340; GO:0008584; GO:0008630; GO:0010165; GO:0010224; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0030183; GO:0030983; GO:0031573; GO:0032137; GO:0032142; GO:0032143; GO:0032181; GO:0032301; GO:0032302; GO:0032357; GO:0032405; GO:0042771; GO:0042803; GO:0043524; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051726; GO:0071168; GO:0140664
722,Pocillopora_acuta_HIv2___RNAseq.g1270.t1,360.1642418,0.293463327,1.079875505,1.74E-07,3.48E-06,,Q5RA50,4.16E-23,Protein FAM124A,,
723,Pocillopora_acuta_HIv2___RNAseq.g14867.t1,236.3248614,-9.429087965,3.224358789,1.74E-07,3.49E-06,,Q5PQM2,1.36E-07,Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8),microtubule-based movement [GO:0007018],GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894
724,Pocillopora_acuta_HIv2___RNAseq.g8478.t3,748.4317709,-0.798936798,1.449441759,1.78E-07,3.55E-06,Integrator complex subunit 1,Q6P4S8,0,Integrator complex subunit 1 (Int1),blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; U2 snRNA 3'-end processing [GO:0034474],GO:0001832; GO:0001833; GO:0005634; GO:0007566; GO:0031965; GO:0032039; GO:0034474; GO:0043066
725,Pocillopora_acuta_HIv2___TS.g17626.t1,1265.917444,-0.614403321,1.232602812,1.81E-07,3.61E-06,,P00518,1.51E-144,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1, EC 2.7.11.26)",glycogen metabolic process [GO:0005977],GO:0004689; GO:0005516; GO:0005524; GO:0005964; GO:0005977; GO:0050321; GO:0098723; GO:0106310
726,Pocillopora_acuta_HIv2___RNAseq.g3467.t1,168.26934,-0.552184467,1.234141605,1.83E-07,3.65E-06,,NA,NA,NA,NA,NA
727,Pocillopora_acuta_HIv2___RNAseq.g4213.t1,315.8469194,-0.903381315,1.677026692,1.85E-07,3.68E-06,,Q8CBH5,2.63E-25,Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2),adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590],GO:0002250; GO:0005886; GO:0032393; GO:0042288; GO:0042590
728,Pocillopora_acuta_HIv2___RNAseq.g8316.t1,245.1161875,-1.204544202,2.469799931,1.87E-07,3.71E-06,,Q9Z160,0,Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1) (Low density lipoprotein receptor defect B-complementing protein),"glycosylation [GO:0070085]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",GO:0000139; GO:0000301; GO:0005794; GO:0007030; GO:0015031; GO:0017119; GO:0070085
729,Pocillopora_acuta_HIv2___RNAseq.g8669.t1a,913.5954366,-0.68576773,1.301454881,1.87E-07,3.71E-06,,P02752,1.07E-52,"Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form]",negative regulation of sensory perception of bitter taste [GO:1904661]; negative regulation of sensory perception of sweet taste [GO:1904657]; riboflavin transport [GO:0032218],GO:0009897; GO:0032217; GO:0032218; GO:0038023; GO:1902444; GO:1904657; GO:1904661
730,Pocillopora_acuta_HIv2___RNAseq.g28909.t1,374.1671796,-7.01061233,3.14503778,1.88E-07,3.73E-06,,Q3UHX0,2.26E-46,Nucleolar protein 8,cellular response to leukemia inhibitory factor [GO:1990830]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364],GO:0003723; GO:0005730; GO:0006364; GO:1902570; GO:1990830
731,Pocillopora_acuta_HIv2___RNAseq.g7452.t1,80.684992,-10.74665401,3.581117758,1.97E-07,3.89E-06,,P0CI65,3.08E-32,Nephrocystin-3,cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055],GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546
732,Pocillopora_acuta_HIv2___RNAseq.g8864.t1,28998.80495,-4.39943875,1.138790915,1.97E-07,3.89E-06,,NA,NA,NA,NA,NA
733,Pocillopora_acuta_HIv2___TS.g29166.t1,302.3432485,-5.617158543,3.549216537,1.98E-07,3.91E-06,,Q13163,0,Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5),cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; MAPK cascade [GO:0000165]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165],GO:0000122; GO:0000165; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005819; GO:0007165; GO:0007507; GO:0030307; GO:0032088; GO:0032717; GO:0034115; GO:0034392; GO:0043154; GO:0043406; GO:0045944; GO:0046872; GO:0048009; GO:0050679; GO:0051247; GO:0060761; GO:0070375; GO:0071363; GO:0071499; GO:0090051; GO:0106310; GO:2000342; GO:2001240
734,Pocillopora_acuta_HIv2___RNAseq.g12898.t1,423.4784652,-1.002167179,1.864570329,2.03E-07,3.99E-06,,Q8NFF2,1.74E-134,Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4),amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; monoatomic ion transport [GO:0006811]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725],GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834
735,Pocillopora_acuta_HIv2___RNAseq.g18059.t1,326.7681822,-1.341906443,3.132529721,2.04E-07,4.01E-06,,Q9NHW7,1.68E-63,Aquaporin AQPAe.a,,GO:0015267; GO:0016020
736,Pocillopora_acuta_HIv2___TS.g20776.t1,672.3228348,-0.264453298,1.071253903,2.04E-07,4.02E-06,,Q3T9Z9,6.06E-87,Zinc finger-containing ubiquitin peptidase 1 (EC 3.4.19.12) (Lys-63-specific deubiquitinase ZUFSP) (DUB) (Zinc finger with UFM1-specific peptidase domain protein),,GO:0004843; GO:0005654; GO:0005829; GO:0046872
737,Pocillopora_acuta_HIv2___RNAseq.g20540.t1,517.3412582,0.620548593,1.248105447,2.06E-07,4.04E-06,,NA,NA,NA,NA,NA
738,Pocillopora_acuta_HIv2___RNAseq.g4732.t1,8464.825365,-4.181033976,1.09059114,2.06E-07,4.04E-06,,O97341,2.12E-38,Calmodulin (CaM),,GO:0005509; GO:0030234
739,Pocillopora_acuta_HIv2___TS.g11111.t2,5024.116277,2.936779683,0.631607752,2.06E-07,4.04E-06,,Q13228,0,Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1),protein transport [GO:0015031],GO:0001650; GO:0005615; GO:0005730; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549; GO:0070062
740,Pocillopora_acuta_HIv2___RNAseq.g17047.t1,87.49373015,-8.606108709,2.714783114,2.08E-07,4.07E-06,,P32456,2.12E-09,Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2),activation of innate immune response [GO:0002218]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cytolysis in another organism [GO:0051715]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response [GO:0006955]; positive regulation of AIM2 inflammasome complex assembly [GO:0140973]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to nucleus [GO:0034504],GO:0000139; GO:0002218; GO:0003924; GO:0004866; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0030659; GO:0031410; GO:0034504; GO:0042742; GO:0042802; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0051607; GO:0051715; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0140639; GO:0140678; GO:0140973
741,Pocillopora_acuta_HIv2___RNAseq.g584.t3a,436.6002261,-9.513982315,4.145216846,2.10E-07,4.10E-06,,Q28295,4.27E-97,von Willebrand factor (vWF),blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; platelet activation [GO:0030168],GO:0002020; GO:0005178; GO:0005518; GO:0005576; GO:0005615; GO:0005783; GO:0007155; GO:0007596; GO:0007599; GO:0019865; GO:0030168; GO:0031012; GO:0031589; GO:0033093; GO:0042802; GO:0051087; GO:0062023
742,Pocillopora_acuta_HIv2___RNAseq.g9085.t1,7563.81026,3.022068755,0.653308722,2.11E-07,4.10E-06,,Q96PZ7,8.15E-53,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964],GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708
743,Pocillopora_acuta_HIv2___RNAseq.g28502.t1,2555.165468,6.589889351,2.466911172,2.11E-07,4.10E-06,Mucin-like protein,B3EWY9,4.64E-28,Mucin-like protein,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005615; GO:0007160; GO:0016020
744,Pocillopora_acuta_HIv2___RNAseq.g28742.t1,119.7864516,-11.44705465,3.939166812,2.20E-07,4.27E-06,,Q25060,2.23E-22,LWamide neuropeptides [Cleaved into: LWamide I; LWamide II; LWS],neuropeptide signaling pathway [GO:0007218],GO:0005576; GO:0007218
745,Pocillopora_acuta_HIv2___RNAseq.g7998.t1,122.3760974,-10.90583039,3.785538515,2.21E-07,4.29E-06,,Q6H601,1.44E-23,DEAD-box ATP-dependent RNA helicase 22 (EC 3.6.4.13),,GO:0003724; GO:0003729; GO:0005524; GO:0009507; GO:0016887
746,Pocillopora_acuta_HIv2___RNAseq.g28991.t1,292.5332003,-9.157112402,3.442892231,2.23E-07,4.33E-06,,Q8C4M7,1.03E-13,Centromere protein U (CENP-U) (MLF1-interacting protein),chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059],GO:0000939; GO:0005634; GO:0005654; GO:0005737; GO:0007059; GO:0034451; GO:0043009
747,Pocillopora_acuta_HIv2___RNAseq.25137_t,407.5584521,0.690988228,1.362016917,2.24E-07,4.33E-06,,C5JHY1,5.00E-07,Neutral protease 2 homolog BDBG_02110 (EC 3.4.24.39) (Deuterolysin BDBG_02110),proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0046872
748,Pocillopora_acuta_HIv2___RNAseq.g8737.t1,655.0528002,-0.794812914,1.450974727,2.24E-07,4.33E-06,,NA,NA,NA,NA,NA
749,Pocillopora_acuta_HIv2___RNAseq.g26058.t1,292.9352886,-7.747849108,2.647181542,2.25E-07,4.35E-06,Rhodopsin,O15973,1.70E-18,"Rhodopsin, GQ-coupled (GQ-rhodopsin)",cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; visual perception [GO:0007601],GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0071482
750,Pocillopora_acuta_HIv2___RNAseq.g30929.t1,215.7609836,-1.202716911,2.471969481,2.29E-07,4.41E-06,,Q53FA7,2.68E-124,Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein),NADP metabolic process [GO:0006739],GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0048038; GO:0070402
751,Pocillopora_acuta_HIv2___RNAseq.g11868.t1,321.4538929,-9.214501307,3.774474226,2.33E-07,4.49E-06,,Q8IYF3,1.80E-155,Testis-expressed protein 11 (Protein ZIP4 homolog) (ZIP4H),apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130],GO:0000712; GO:0000801; GO:0005694; GO:0006311; GO:0006915; GO:0007060; GO:0007130; GO:0007131; GO:0008584; GO:0009566; GO:0035234; GO:0043066; GO:0051026; GO:0051093; GO:2000242
752,Pocillopora_acuta_HIv2___RNAseq.g18291.t1,2018.597461,-0.431880694,1.153812565,2.35E-07,4.51E-06,,NA,NA,NA,NA,NA
753,Pocillopora_acuta_HIv2___RNAseq.g10276.t2,244.6558607,-0.501316274,1.208331414,2.37E-07,4.55E-06,,Q5TFE4,4.99E-83,5'-nucleotidase domain-containing protein 1 (EC 3.1.3.-),,GO:0008253; GO:0046872
754,Pocillopora_acuta_HIv2___RNAseq.g13936.t1,415.0176724,-1.027227568,1.884988109,2.42E-07,4.65E-06,,NA,NA,NA,NA,NA
755,Pocillopora_acuta_HIv2___TS.g1848.t2,1040.627069,-0.67298835,1.283182022,2.44E-07,4.67E-06,,Q00168,0,Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17),"cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cytokine production [GO:0001818]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]",GO:0001818; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0032226; GO:0043005; GO:0045211; GO:0048786; GO:0051489; GO:0060278; GO:0106310; GO:2001234
756,Pocillopora_acuta_HIv2___TS.g25579.t1,144.1526612,-8.38608764,2.802305587,2.46E-07,4.71E-06,,NA,NA,NA,NA,NA
757,Pocillopora_acuta_HIv2___RNAseq.g21527.t1,228.3352928,-1.092324527,2.102326288,2.49E-07,4.76E-06,,Q6BZW3,8.15E-41,Protein BTN1,L-arginine transmembrane transport [GO:1903826]; lysine transport [GO:0015819]; regulation of intracellular pH [GO:0051453],GO:0000324; GO:0005773; GO:0005774; GO:0015819; GO:0022857; GO:0051453; GO:1903826
758,Pocillopora_acuta_HIv2___RNAseq.g29870.t1,86.71064216,-10.78887206,3.647105195,2.50E-07,4.76E-06,,NA,NA,NA,NA,NA
759,Pocillopora_acuta_HIv2___RNAseq.g12115.t1,238.6158842,-8.288006737,3.586316226,2.58E-07,4.92E-06,,O14495,2.17E-48,Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP),"Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid catabolic process [GO:0030149]; sphingosine metabolic process [GO:0006670]; wound healing [GO:0042060]",GO:0000139; GO:0001568; GO:0001702; GO:0001933; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005912; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007165; GO:0007229; GO:0008195; GO:0010595; GO:0016020; GO:0016323; GO:0022409; GO:0030111; GO:0030149; GO:0033116; GO:0033631; GO:0034109; GO:0042060; GO:0042392; GO:0045121; GO:0046839; GO:0050731; GO:0050821; GO:0051091; GO:0060020; GO:0070971; GO:0098609; GO:0106235; GO:1902068
760,Pocillopora_acuta_HIv2___RNAseq.g15950.t1,144.1451238,8.17608818,2.852170499,2.64E-07,5.02E-06,,NA,NA,NA,NA,NA
761,Pocillopora_acuta_HIv2___RNAseq.g8821.t1,15967.80052,3.004199747,0.657281251,2.66E-07,5.06E-06,Complement C3,P01026,2.73E-170,Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2],"amyloid-beta clearance [GO:0097242]; chemotaxis [GO:0006935]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement receptor mediated signaling pathway [GO:0002430]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of developmental growth [GO:0048639]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of lipid storage [GO:0010884]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; tolerance induction [GO:0002507]; vascular associated smooth muscle cell differentiation [GO:0035886]; vertebrate eye-specific patterning [GO:0150064]",GO:0001798; GO:0001934; GO:0001970; GO:0002430; GO:0002507; GO:0004866; GO:0005576; GO:0005615; GO:0006631; GO:0006935; GO:0006954; GO:0006956; GO:0006957; GO:0006958; GO:0008289; GO:0009410; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0031715; GO:0032026; GO:0032355; GO:0032570; GO:0032991; GO:0035846; GO:0035886; GO:0043627; GO:0045745; GO:0045766; GO:0048260; GO:0048639; GO:0050766; GO:0051384; GO:0060041; GO:0060100; GO:0070374; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:2000427
762,Pocillopora_acuta_HIv2___TS.g13216.t1,258.4262596,-0.506950692,1.211217299,2.67E-07,5.06E-06,,F1NY98,8.96E-21,Cell adhesion molecule DSCAM (Down syndrome cell adhesion molecule homolog),axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],GO:0005886; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:1990782; GO:1990890
763,Pocillopora_acuta_HIv2___RNAseq.g14373.t1,969.0639181,10.74909352,8.486160346,2.67E-07,5.06E-06,Collagen alpha-1(VI) chain,Q801S8,2.99E-16,Collagen alpha-1(VI) chain,cell adhesion [GO:0007155],GO:0005576; GO:0005581; GO:0007155; GO:0062023
764,Pocillopora_acuta_HIv2___RNAseq.g3723.t1,703.7847208,-0.990196335,1.788156423,2.67E-07,5.06E-06,,A6QLU6,3.82E-31,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189
765,Pocillopora_acuta_HIv2___RNAseq.g24923.t1,212.8549132,-9.12736843,3.497878184,2.70E-07,5.10E-06,,Q96IY1,7.53E-11,Kinetochore-associated protein NSL1 homolog,attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070],GO:0000070; GO:0000444; GO:0000776; GO:0000922; GO:0000940; GO:0005634; GO:0005829; GO:0008608; GO:0016607; GO:0051301
766,Pocillopora_acuta_HIv2___RNAseq.g21689.t1,619.2507166,0.921628298,1.651179241,2.71E-07,5.11E-06,Uncharacterized skeletal organic matrix protein 8,B3EWZ2,4.08E-13,Uncharacterized skeletal organic matrix protein 8 (Uncharacterized SOMP-8),,GO:0005576
767,Pocillopora_acuta_HIv2___TS.g169.t1,836.295547,-0.701300969,1.337656206,2.72E-07,5.12E-06,,Q6P9I7,0,Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (xSMC6),cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722],GO:0000722; GO:0000781; GO:0005524; GO:0006281; GO:0016605; GO:0030915; GO:0090398
768,Pocillopora_acuta_HIv2___RNAseq.g3911.t1,242.5243642,-1.124015073,2.195580721,2.74E-07,5.16E-06,,Q6DGQ8,1.38E-96,Nucleoside diphosphate kinase homolog 5 (3'-5' exonuclease NME5) (EC 3.1.-.-),cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; UTP biosynthetic process [GO:0006228],GO:0003341; GO:0004550; GO:0005929; GO:0006183; GO:0006228; GO:0006241; GO:0008408; GO:1902176
769,Pocillopora_acuta_HIv2___RNAseq.g7100.t1,313.9623344,-5.111128899,4.420940965,2.75E-07,5.17E-06,,Q9DBN1,1.28E-72,Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2),establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939],GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939
770,Pocillopora_acuta_HIv2___RNAseq.g7217.t1,250.8248488,-9.109856523,3.475495045,2.85E-07,5.36E-06,,Q3U481,1.02E-29,Major facilitator superfamily domain-containing protein 12 (Protein grizzled),carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712
771,Pocillopora_acuta_HIv2___RNAseq.g15551.t1,74.32717763,-8.250158131,2.471982364,2.86E-07,5.37E-06,,NA,NA,NA,NA,NA
772,Pocillopora_acuta_HIv2___RNAseq.g25869.t1,286.4201352,-9.436775063,3.510964077,2.93E-07,5.50E-06,,Q5RJA1,1.33E-153,DNA-binding protein RFX6 (Regulatory factor X 6),endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309],GO:0000976; GO:0000978; GO:0000981; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104
773,Pocillopora_acuta_HIv2___RNAseq.g24020.t1,1035.191868,-0.61599627,1.243927809,2.95E-07,5.53E-06,,Q9Z2G9,5.89E-33,Oxidoreductase HTATIP2 (EC 1.1.1.-),angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765],GO:0001525; GO:0004674; GO:0005635; GO:0005737; GO:0006915; GO:0016620; GO:0030154; GO:0043068; GO:0045765; GO:0045944; GO:0051170; GO:0051287
774,Pocillopora_acuta_HIv2___RNAseq.g5360.t1,214.9210941,-9.162609889,3.815452228,2.97E-07,5.55E-06,,E2RYF8,6.49E-74,Targeting protein for Xklp2 homolog (TPX2 homolog) (Microtubule-associated protein TPX2 homolog),regulation of mitotic spindle organization [GO:0060236],GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0060236
775,Pocillopora_acuta_HIv2___RNAseq.g15816.t1,245.604657,-8.986930028,3.473051584,2.98E-07,5.55E-06,,Q9XWN7,2.18E-51,Nucleoside hydrolase (EC 3.2.2.-) (EC 3.2.2.1) (EC 3.2.2.2) (EC 3.2.2.3) (EC 3.2.2.7) (EC 3.2.2.8),nucleobase-containing compound metabolic process [GO:0006139],GO:0006139; GO:0016799; GO:0046872
776,Pocillopora_acuta_HIv2___TS.g22016.t1,313.331385,-6.516875002,2.420838971,2.98E-07,5.55E-06,,A2TLM1,3.30E-97,Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase),"D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]",GO:0004751; GO:0005737; GO:0006014; GO:0009052
777,Pocillopora_acuta_HIv2___RNAseq.g16225.t1,373.4061486,-0.736604738,1.429502067,2.98E-07,5.55E-06,,Q99MS0,3.37E-121,SEC14-like protein 2 (Alpha-tocopherol-associated protein) (TAP) (Squalene transfer protein) (Supernatant protein factor) (SPF),positive regulation of cholesterol biosynthetic process [GO:0045542],GO:0005634; GO:0005737; GO:0005829; GO:0008047; GO:0008289; GO:0016765; GO:0045542
778,Pocillopora_acuta_HIv2___RNAseq.g29830.t1,1424.65924,-0.874843815,1.543748277,2.99E-07,5.55E-06,,J7GQ11,1.41E-76,L-tyrosine decarboxylase (TDC) (EC 4.1.1.25),carboxylic acid metabolic process [GO:0019752],GO:0004837; GO:0019752; GO:0030170; GO:0036468
779,Pocillopora_acuta_HIv2___RNAseq.g439.t1,278.048121,-1.066572049,2.027084858,3.00E-07,5.57E-06,,O08760,5.68E-103,N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)],"base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair [GO:0006289]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]",GO:0000702; GO:0000978; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006285; GO:0006289; GO:0006355; GO:0006974; GO:0006979; GO:0008017; GO:0008534; GO:0009314; GO:0009410; GO:0009416; GO:0016363; GO:0016607; GO:0019104; GO:0019899; GO:0032355; GO:0032357; GO:0032991; GO:0034039; GO:0034614; GO:0043066; GO:0044029; GO:0045471; GO:0045944; GO:0051593; GO:0071276; GO:0140078; GO:1901291
780,Pocillopora_acuta_HIv2___TS.g14315.t1b,424.8447631,-1.227218911,2.552961031,3.09E-07,5.73E-06,,Q6A4L1,0,Solute carrier family 12 member 8,potassium ion transport [GO:0006813],GO:0006813; GO:0015377; GO:0016020
781,Pocillopora_acuta_HIv2___RNAseq.g17557.t1,571.2094616,-0.684777291,1.289936619,3.11E-07,5.76E-06,,P14629,4.96E-92,DNA excision repair protein ERCC-5 homolog (EC 3.1.-.-) (DNA repair protein complementing XP-G cells homolog) (Xeroderma pigmentosum group G-complementing protein homolog),nucleotide-excision repair [GO:0006289],GO:0003697; GO:0004519; GO:0005634; GO:0005694; GO:0006289; GO:0046872
782,Pocillopora_acuta_HIv2___TS.g13410.t1,150.9588004,8.999496214,3.507479152,3.12E-07,5.76E-06,,NA,NA,NA,NA,NA
783,Pocillopora_acuta_HIv2___RNAseq.g20865.t1,1016.041194,-0.668214654,1.350665294,3.15E-07,5.82E-06,,O88427,0,Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2),aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; sodium ion transmembrane transport [GO:0035725],GO:0001518; GO:0005244; GO:0005886; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0019228; GO:0030425; GO:0032342; GO:0034651; GO:0035725; GO:0042383; GO:0043005; GO:0043204; GO:0045211; GO:0045956; GO:0046872; GO:0048787; GO:0070509; GO:0086010; GO:0098662; GO:0098978; GO:0106134
784,Pocillopora_acuta_HIv2___RNAseq.g3485.t1,73.3054284,-10.73460159,3.618009291,3.16E-07,5.83E-06,,V6CLA2,7.35E-23,E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26),determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028],GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936
785,Pocillopora_acuta_HIv2___RNAseq.g15504.t1,1244.650048,-0.420138935,1.11419906,3.23E-07,5.95E-06,,Q90ZK6,1.30E-98,Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (Type I TGF B receptor),activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell fate commitment [GO:0060923]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion formation [GO:0003272]; endocardial cushion fusion [GO:0003274]; endothelial cell activation [GO:0042118]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412],GO:0000082; GO:0001569; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003181; GO:0003183; GO:0003272; GO:0003274; GO:0003289; GO:0004672; GO:0004674; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007369; GO:0007498; GO:0007507; GO:0009953; GO:0009968; GO:0010694; GO:0010718; GO:0016020; GO:0016361; GO:0016477; GO:0018107; GO:0019838; GO:0030278; GO:0030335; GO:0030501; GO:0030509; GO:0030513; GO:0032924; GO:0032926; GO:0035556; GO:0042118; GO:0042803; GO:0045177; GO:0045669; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0051145; GO:0060037; GO:0060317; GO:0060412; GO:0060923; GO:0061445; GO:0062043; GO:0070724; GO:0071363; GO:0071773; GO:2000017; GO:2001237
786,Pocillopora_acuta_HIv2___RNAseq.g26160.t1,613.4936995,-0.932472775,1.622638194,3.24E-07,5.96E-06,,NA,NA,NA,NA,NA
787,Pocillopora_acuta_HIv2___RNAseq.g18062.t1,303.7008282,8.910942489,3.532890984,3.27E-07,6.01E-06,,NA,NA,NA,NA,NA
788,Pocillopora_acuta_HIv2___RNAseq.g5488.t1,115.4041139,-11.3812288,3.915877546,3.27E-07,6.01E-06,,Q5KQT7,1.69E-101,Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694],GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0020037; GO:0030544; GO:0042572; GO:0043231; GO:0051879; GO:0070330; GO:0101020; GO:0101021; GO:0106256
789,Pocillopora_acuta_HIv2___RNAseq.g25912.t1,515.7681518,-9.724252943,5.020526701,3.31E-07,6.06E-06,,NA,NA,NA,NA,NA
790,Pocillopora_acuta_HIv2___RNAseq.g6743.t1,631.4646522,-5.015220186,3.668037329,3.31E-07,6.06E-06,,B2GUB3,2.27E-180,Tubulin tyrosine ligase 3 (EC 6.3.2.-) (Tubulin--tyrosine ligase protein 3),protein polyglycylation [GO:0018094],GO:0005524; GO:0005737; GO:0005874; GO:0018094; GO:0031514; GO:0046872; GO:0070736
791,Pocillopora_acuta_HIv2___RNAseq.g20199.t1,729.0586724,-0.859120566,1.506737226,3.36E-07,6.14E-06,,Q96PM5,2.20E-28,RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2),error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987; GO:0072344
792,Pocillopora_acuta_HIv2___RNAseq.g6350.t1,1498.340171,-5.952948589,2.168955665,3.37E-07,6.15E-06,,B3EWY8,8.13E-08,Skeletal aspartic acid-rich protein 2,,GO:0016020
793,Pocillopora_acuta_HIv2___RNAseq.g26790.t1,144.9217785,-9.00969562,3.310091879,3.45E-07,6.29E-06,,NA,NA,NA,NA,NA
794,Pocillopora_acuta_HIv2___RNAseq.g15172.t1,11660.50749,3.649089546,0.887734804,3.52E-07,6.41E-06,,P86982,1.98E-27,Insoluble matrix shell protein 1 (IMSP1),,GO:0005576
795,Pocillopora_acuta_HIv2___RNAseq.g30609.t1,72.72826462,-10.64607758,3.624927218,3.57E-07,6.50E-06,,NA,NA,NA,NA,NA
796,Pocillopora_acuta_HIv2___RNAseq.g24800.t1,329.3394425,-5.788675788,1.932938745,3.65E-07,6.63E-06,,E7FAM5,1.82E-11,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177
797,Pocillopora_acuta_HIv2___TS.g28493.t1,653.6281865,-1.30332457,2.319980413,3.67E-07,6.66E-06,,NA,NA,NA,NA,NA
798,Pocillopora_acuta_HIv2___TS.g28865.t1,587.150538,-0.946850761,1.737055306,3.77E-07,6.84E-06,,Q6NRH3,4.96E-55,Coiled-coil domain-containing protein 149,,
799,Pocillopora_acuta_HIv2___RNAseq.g21637.t1,81.12761234,-7.971435564,2.378171304,3.83E-07,6.93E-06,Cysteine-rich transmembrane BMP regulator 1,A0A1D5PUP4,1.11E-24,Reversion-inducing cysteine-rich protein with Kazal motifs,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040],GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005615; GO:0005886; GO:0008191; GO:0015026; GO:0030198; GO:0045765; GO:0060070; GO:0090210; GO:0098552; GO:1904684; GO:1990909
800,Pocillopora_acuta_HIv2___RNAseq.g25095.t1,716.9962736,-0.252151463,1.066439774,3.93E-07,7.11E-06,,NA,NA,NA,NA,NA
801,Pocillopora_acuta_HIv2___RNAseq.g13386.t1,817.3435198,-0.564319892,1.195519282,3.98E-07,7.19E-06,,A9JRX0,2.14E-19,Male-specific lethal 1-like 1 (MSL1-like 1) (Male-specific lethal-1 homolog 1) (MSL-1),chromatin remodeling [GO:0006338],GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0016607; GO:0072487
802,Pocillopora_acuta_HIv2___RNAseq.g20556.t1,154.6521897,-8.692431476,3.275708192,4.01E-07,7.23E-06,,Q9HB75,6.98E-08,p53-induced death domain-containing protein 1 (EC 3.4.21.-) (Leucine-rich repeat and death domain-containing protein) [Cleaved into: PIDD-N; PIDD-C; PIDD-CC],"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoprocessing [GO:0016540]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]",GO:0004175; GO:0005123; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0007165; GO:0008625; GO:0016540; GO:0043065; GO:0043066; GO:0043122; GO:0051092; GO:1905369
803,Pocillopora_acuta_HIv2___RNAseq.g13103.t1,2431.046116,6.29919006,2.594947605,4.05E-07,7.30E-06,,NA,NA,NA,NA,NA
804,Pocillopora_acuta_HIv2___TS.g1897.t1,90.63788952,-11.07230523,3.797745235,4.08E-07,7.34E-06,,NA,NA,NA,NA,NA
805,Pocillopora_acuta_HIv2___RNAseq.g22559.t1,3596.942628,3.247941742,0.750637868,4.09E-07,7.34E-06,,Q9GLP1,6.04E-27,Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain],blood circulation [GO:0008015]; blood coagulation [GO:0007596],GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091
806,Pocillopora_acuta_HIv2___RNAseq.g3923.t2,874.2247386,0.943362718,1.653735319,4.12E-07,7.40E-06,,O00468,1.47E-08,Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)],clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808],GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007213; GO:0007528; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062
807,Pocillopora_acuta_HIv2___TS.g20880.t1,77.22180404,-10.73307212,3.640420701,4.14E-07,7.42E-06,,Q8R1U2,2.51E-08,Cell growth regulator with EF hand domain protein 1 (Cell growth regulatory gene 11 protein) (Hydrophobestin),cell adhesion [GO:0007155]; negative regulation of cell growth [GO:0030308]; regulation of cell cycle [GO:0051726],GO:0005509; GO:0005576; GO:0007155; GO:0030308; GO:0051726
808,Pocillopora_acuta_HIv2___RNAseq.g15875.t1,280.674466,-0.985256881,1.835400564,4.19E-07,7.49E-06,,Q8R016,0,Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40),homocysteine catabolic process [GO:0043418]; proteolysis [GO:0006508]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410],GO:0004177; GO:0004197; GO:0005737; GO:0006508; GO:0008233; GO:0008234; GO:0009410; GO:0009636; GO:0042802; GO:0043418; GO:0070005
809,Pocillopora_acuta_HIv2___RNAseq.g18038.t3b,735.2809918,-0.504672319,1.187439888,4.25E-07,7.59E-06,,P91685,0,Metabotropic glutamate receptor (DmGluRA),"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]",GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553
810,Pocillopora_acuta_HIv2___RNAseq.g19299.t1,266.1474358,1.667466696,4.170640317,4.27E-07,7.62E-06,,NA,NA,NA,NA,NA
811,Pocillopora_acuta_HIv2___RNAseq.g26161.t1,508.6250141,-9.11912443,4.167873779,4.27E-07,7.62E-06,,Q9Y711,2.01E-82,"Alternative oxidase, mitochondrial (EC 1.-.-.-)",alternative respiration [GO:0010230],GO:0005743; GO:0009916; GO:0010230; GO:0046872; GO:0070469
812,Pocillopora_acuta_HIv2___RNAseq.g16184.t1,669.9911666,0.416945589,1.099716183,4.29E-07,7.64E-06,,Q6DDL7,2.17E-149,Protein unc-93 homolog A (Unc-93A),,GO:0016020
813,Pocillopora_acuta_HIv2___RNAseq.18888_t,258.9599517,-0.497011988,1.2044637,4.30E-07,7.65E-06,,Q6PAM0,3.09E-79,5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2),cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; positive regulation of cold-induced thermogenesis [GO:0120162]; signal transduction [GO:0007165],GO:0004679; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005952; GO:0006633; GO:0007165; GO:0016324; GO:0019899; GO:0019901; GO:0031588; GO:0031669; GO:0120162
814,Pocillopora_acuta_HIv2___RNAseq.g11580.t1,148.0961717,-11.29406321,4.145908914,4.35E-07,7.73E-06,,Q96RW7,9.94E-21,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711
815,Pocillopora_acuta_HIv2___TS.g19499.t2,256.054527,-1.14489126,2.254762238,4.36E-07,7.73E-06,,P49013,5.45E-61,Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III),,GO:0005509; GO:0005576; GO:0009374
816,Pocillopora_acuta_HIv2___RNAseq.g3720.t1,380.4506505,-0.828675878,1.553910555,4.37E-07,7.74E-06,,Q9NQM4,1.55E-42,Dynein axonemal assembly factor 6 (PIH1 domain-containing protein 3) (Sarcoma antigen NY-SAR-97),axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158],GO:0003341; GO:0005737; GO:0005802; GO:0030317; GO:0036158; GO:0036159; GO:0045505; GO:0051087; GO:0070286
817,Pocillopora_acuta_HIv2___TS.g14578.t2,278.536602,-0.96144946,1.778518303,4.39E-07,7.77E-06,,NA,NA,NA,NA,NA
818,Pocillopora_acuta_HIv2___RNAseq.4782_t,303.0999937,-4.561686501,4.739014128,4.40E-07,7.78E-06,,NA,NA,NA,NA,NA
819,Pocillopora_acuta_HIv2___RNAseq.g20859.t1,501.0472031,-0.22822517,1.054011431,4.41E-07,7.79E-06,,Q8VIG2,1.59E-154,Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1),double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468],GO:0003723; GO:0004540; GO:0005737; GO:0005777; GO:0006302; GO:0007143; GO:0010468; GO:0048477; GO:1905762
820,Pocillopora_acuta_HIv2___RNAseq.g6140.t1,1120.146492,-0.439949659,1.101314252,4.51E-07,7.95E-06,,Q9VPD3,4.82E-148,Phosphatidylserine synthase (EC 2.7.8.29),phosphatidylserine biosynthetic process [GO:0006659],GO:0005789; GO:0006659; GO:0012505; GO:0016780; GO:0106245; GO:0106258
821,Pocillopora_acuta_HIv2___RNAseq.g24760.t1,205.983533,-8.955262384,3.508227798,4.53E-07,7.98E-06,,Q9TT38,0,Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)],arachidonic acid metabolic process [GO:0019369]; glycerol metabolic process [GO:0006071]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; prostaglandin biosynthetic process [GO:0001516],GO:0000139; GO:0001516; GO:0004622; GO:0005509; GO:0005544; GO:0005635; GO:0005737; GO:0005783; GO:0005829; GO:0006071; GO:0006640; GO:0008374; GO:0010314; GO:0019369; GO:0019370; GO:0032266; GO:0034478; GO:0034638; GO:0047498; GO:0047499; GO:0070273; GO:1902387
822,Pocillopora_acuta_HIv2___RNAseq.g26341.t1,452.7416737,-7.11865229,3.164688021,4.54E-07,7.98E-06,,Q8LAD0,4.32E-57,Probable pyridoxal 5'-phosphate synthase subunit PDX2 (AtPDX2) (EC 4.3.3.6) (Protein EMBRYO DEFECTIVE 2407) (Pyridoxal 5'-phosphate synthase glutaminase subunit) (EC 3.5.1.2),glutamine metabolic process [GO:0006541]; pyridoxal phosphate biosynthetic process [GO:0042823]; vitamin B6 biosynthetic process [GO:0042819],GO:0004359; GO:0005829; GO:0006541; GO:0036381; GO:0042819; GO:0042823; GO:0046982
823,Pocillopora_acuta_HIv2___RNAseq.g4498.t1,118.2210395,-10.80238406,3.82474737,4.55E-07,8.00E-06,,NA,NA,NA,NA,NA
824,Pocillopora_acuta_HIv2___RNAseq.g15195.t1,817.638369,-0.463845873,1.109753681,4.60E-07,8.07E-06,,NA,NA,NA,NA,NA
825,Pocillopora_acuta_HIv2___RNAseq.g12282.t1,327.0684306,0.815831751,1.448577457,4.68E-07,8.20E-06,,F1NWE3,9.76E-150,Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha),negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; peptidyl-tyrosine dephosphorylation [GO:0035335]; synaptic membrane adhesion [GO:0099560],GO:0004725; GO:0005886; GO:0008201; GO:0030424; GO:0030426; GO:0030517; GO:0030672; GO:0035335; GO:0042803; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0098839; GO:0099560
826,Pocillopora_acuta_HIv2___RNAseq.g2904.t1,649.5485993,-0.840843335,1.477340668,4.74E-07,8.29E-06,,P49746,1.13E-160,Thrombospondin-3,bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023
827,Pocillopora_acuta_HIv2___TS.g17854.t1,2083.020897,-1.458361712,3.432698154,4.74E-07,8.29E-06,,NA,NA,NA,NA,NA
828,Pocillopora_acuta_HIv2___RNAseq.g4704.t1b,888.3955291,-0.419280849,1.083907685,4.86E-07,8.48E-06,,NA,NA,NA,NA,NA
829,Pocillopora_acuta_HIv2___TS.g14960.t2,557.9252993,-1.131373085,2.10352352,4.86E-07,8.48E-06,,Q91755,4.95E-80,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6)",detection of cold stimulus involved in thermoception [GO:0120169],GO:0004970; GO:0005234; GO:0005886; GO:0015277; GO:0022849; GO:0045211; GO:0120169
830,Pocillopora_acuta_HIv2___RNAseq.g4214.t1,70.41729623,-10.53797757,3.629006012,4.95E-07,8.62E-06,,A1DWM3,1.17E-29,Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog),antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590],GO:0005886; GO:0042590
831,Pocillopora_acuta_HIv2___RNAseq.g24299.t1,517.0077177,4.329648916,1.186994018,4.95E-07,8.62E-06,,NA,NA,NA,NA,NA
832,Pocillopora_acuta_HIv2___TS.g6578.t1,358.6634279,-1.446672959,3.046567252,4.98E-07,8.65E-06,,B8V7Q1,0,Protocadherin-like protein,adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0016339; GO:0016342; GO:0034332; GO:0044331; GO:0045296
833,Pocillopora_acuta_HIv2___RNAseq.g4886.t1,175.2102107,-8.679761468,3.287709791,5.05E-07,8.76E-06,,Q19673,3.30E-10,Putative tyrosinase-like protein tyr-3,,GO:0004497; GO:0046872
834,Pocillopora_acuta_HIv2___RNAseq.g2939.t1,632.2049799,-0.257776999,1.068589784,5.05E-07,8.76E-06,,Q3KRF3,3.56E-10,Uncharacterized protein C1orf131 homolog,ribosomal small subunit biogenesis [GO:0042274],GO:0005694; GO:0005730; GO:0032040; GO:0042274
835,Pocillopora_acuta_HIv2___RNAseq.g15196.t1,310.3822721,5.789280325,3.663445663,5.10E-07,8.83E-06,,Q55DA0,1.11E-53,ABC transporter G family member 22 (ABC transporter ABCG.22),aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085],GO:0005524; GO:0016020; GO:0016887; GO:0031152; GO:0031288; GO:0042626; GO:0048870; GO:0055085; GO:0140359
836,Pocillopora_acuta_HIv2___RNAseq.g17183.t1,721.3770469,0.27560192,1.048205541,5.16E-07,8.93E-06,,NA,NA,NA,NA,NA
837,Pocillopora_acuta_HIv2___RNAseq.g28226.t2,750.9034284,5.605063171,4.581170504,5.17E-07,8.93E-06,von Willebrand factor D and EGF domain-containing,P07207,5.94E-69,Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein],"actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]",GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048
838,Pocillopora_acuta_HIv2___RNAseq.g1013.t1,224.5398736,-8.935352937,3.939432943,5.20E-07,8.98E-06,,NA,NA,NA,NA,NA
839,Pocillopora_acuta_HIv2___RNAseq.g1000.t1,555.2550133,-4.950693786,4.492611871,5.23E-07,9.01E-06,,NA,NA,NA,NA,NA
840,Pocillopora_acuta_HIv2___RNAseq.g11281.t1,186.5935729,-0.506970305,1.214256455,5.28E-07,9.10E-06,,Q3TC46,4.62E-62,Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b),deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962],GO:0000290; GO:0000932; GO:0002151; GO:0003723; GO:0005737; GO:0005829; GO:0008266; GO:0016605; GO:0016607; GO:0017148; GO:0030014; GO:0030371; GO:0033962; GO:0034046
841,Pocillopora_acuta_HIv2___RNAseq.g26344.t1,785.2667331,-0.352319531,1.063012593,5.37E-07,9.23E-06,,Q92047,3.20E-96,Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase),protein methylation [GO:0006479]; regulation of calcium-mediated signaling [GO:0050848],GO:0004719; GO:0005737; GO:0005829; GO:0006479; GO:0050848
842,Pocillopora_acuta_HIv2___TS.g11473.t1,316.8363953,-1.69263223,22.36703619,5.37E-07,9.23E-06,,NA,NA,NA,NA,NA
843,Pocillopora_acuta_HIv2___RNAseq.g12826.t1,311.173602,-0.702587595,1.391099808,5.39E-07,9.24E-06,,H2FLJ1,1.45E-144,Stomatin-like protein stl-1,mitochondrion organization [GO:0007005],GO:0005739; GO:0007005; GO:0045121
844,Pocillopora_acuta_HIv2___RNAseq.g219.t1,168.3161319,-5.088301352,1.318602058,5.45E-07,9.34E-06,,A4IF63,8.41E-25,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630
845,Pocillopora_acuta_HIv2___RNAseq.g22487.t1,856.4185691,-0.701681178,1.310931546,5.59E-07,9.56E-06,,Q9NY47,1.81E-138,Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2],muscle cell development [GO:0055001]; neuromuscular junction development [GO:0007528]; organ growth [GO:0035265]; positive regulation of organ growth [GO:0046622]; regulation of multicellular organism growth [GO:0040014]; rhythmic synaptic transmission [GO:0060024],GO:0005245; GO:0005886; GO:0005891; GO:0007528; GO:0035265; GO:0040014; GO:0046622; GO:0046872; GO:0055001; GO:0060024
846,Pocillopora_acuta_HIv2___RNAseq.g11917.t1,1622.611923,-0.280579995,1.046006731,5.62E-07,9.61E-06,,P54131,4.97E-82,Neuronal acetylcholine receptor subunit alpha-7,calcium ion transport [GO:0006816]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165],GO:0001540; GO:0001666; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0032720; GO:0035094; GO:0042166; GO:0042803; GO:0043005; GO:0043410; GO:0045202; GO:0045211; GO:0045766; GO:0050890
847,Pocillopora_acuta_HIv2___RNAseq.g17090.t1,5915.601729,-5.741044487,2.902218192,5.63E-07,9.62E-06,Peroxidasin,G5EG78,7.00E-92,Peroxidasin homolog pxn-2 (EC 1.11.2.-),axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979],GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825
848,Pocillopora_acuta_HIv2___RNAseq.g709.t1,15945.58608,3.314656415,0.790318861,5.65E-07,9.63E-06,,NA,NA,NA,NA,NA
849,Pocillopora_acuta_HIv2___RNAseq.g11876.t1,195.788641,9.031963634,3.698408461,5.66E-07,9.65E-06,Mucin-like protein,B3EWY9,4.02E-13,Mucin-like protein,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005615; GO:0007160; GO:0016020
850,Pocillopora_acuta_HIv2___RNAseq.g4469.t1,556.8144352,-5.216628668,3.640355698,5.68E-07,9.67E-06,,Q5ZKY0,3.80E-54,Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175),lysosomal lumen pH elevation [GO:0035752]; neuron cellular homeostasis [GO:0070050]; phagosome-lysosome fusion [GO:0090385]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of lysosomal lumen pH [GO:0035751],GO:0005267; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0015252; GO:0022841; GO:0035751; GO:0035752; GO:0050544; GO:0070050; GO:0071805; GO:0090385; GO:1902600
851,Pocillopora_acuta_HIv2___RNAseq.6265_t,510.0970513,0.809003629,1.425839382,5.70E-07,9.69E-06,,NA,NA,NA,NA,NA
852,Pocillopora_acuta_HIv2___RNAseq.g29560.t1,4031.650161,-5.117923695,1.900422329,5.73E-07,9.73E-06,,Q8T882,9.23E-164,Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase),,GO:0050325
853,Pocillopora_acuta_HIv2___RNAseq.g19258.t1,102.9784824,-8.101175527,2.814948437,5.77E-07,9.79E-06,,Q7VWH8,3.50E-21,Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase),organic phosphonate catabolic process [GO:0019700],GO:0000287; GO:0019700; GO:0050194
854,Pocillopora_acuta_HIv2___RNAseq.g22691.t1,536.9241453,5.861121497,2.003409242,5.79E-07,9.81E-06,,E9PUQ8,0,Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107),diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031],GO:0004143; GO:0005524; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007205; GO:0015031; GO:0019900; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046834; GO:0046872; GO:0046982; GO:0090038; GO:2000370
855,Pocillopora_acuta_HIv2___RNAseq.g4785.t1,1227.378618,3.097153883,0.713572306,5.92E-07,1.00E-05,,P12263,1.54E-09,Coagulation factor VIII (Procoagulant component),"acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597]",GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491
856,Pocillopora_acuta_HIv2___RNAseq.g19322.t1,220.3761025,0.305310511,1.08747072,5.92E-07,1.00E-05,,P43646,7.46E-48,Caltractin (Centrin),cell division [GO:0051301]; mitotic cell cycle [GO:0000278],GO:0000278; GO:0005509; GO:0005814; GO:0051301
857,Pocillopora_acuta_HIv2___RNAseq.g19216.t1,1710.437988,-0.338937219,1.048641354,6.04E-07,1.02E-05,,Q9YHT2,4.59E-160,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip) (Malate dehydrogenase [quinone] iron-sulfur subunit) (EC 1.1.5.-)",aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099],GO:0005743; GO:0006099; GO:0008177; GO:0009055; GO:0009060; GO:0022904; GO:0031966; GO:0045273; GO:0046872; GO:0048039; GO:0051537; GO:0051538; GO:0051539
858,Pocillopora_acuta_HIv2___TS.g28596.t2,335.5018448,-1.62815894,3.743055905,6.07E-07,1.02E-05,,NA,NA,NA,NA,NA
859,Pocillopora_acuta_HIv2___RNAseq.g29297.t1,197.7428233,0.304912056,1.085019385,6.08E-07,1.02E-05,,Q2YDN1,2.28E-38,G protein-coupled receptor 161,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621],GO:0004930; GO:0005886; GO:0005929; GO:0007186; GO:0007189; GO:0055037; GO:0060170; GO:1901621
860,Pocillopora_acuta_HIv2___RNAseq.g9622.t1,767.4234518,-0.833182374,1.499846062,6.19E-07,1.04E-05,,NA,NA,NA,NA,NA
861,Pocillopora_acuta_HIv2___RNAseq.g28364.t1,794.5605386,-0.418749662,1.089610483,6.30E-07,1.06E-05,,Q9CQY2,1.81E-06,RNA guanine-N7 methyltransferase activating subunit (Protein FAM103A1) (RNA guanine-7 methyltransferase activating subunit) (RNMT-activating mRNA cap methylating subunit) (RNMT-activating mRNA cap methyltransferase subunit) (RNMT-activating mini protein) (RAM),7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; RNA 5'-cap (guanine-N7)-methylation [GO:0106005],GO:0003723; GO:0005634; GO:0006370; GO:0008047; GO:0031533; GO:0032259; GO:0106005; GO:0160130
862,Pocillopora_acuta_HIv2___RNAseq.g15552.t1,171.7677779,-8.604674718,3.334492244,6.30E-07,1.06E-05,,NA,NA,NA,NA,NA
863,Pocillopora_acuta_HIv2___RNAseq.g2983.t1,110.9379256,-8.321782267,3.034643139,6.34E-07,1.06E-05,,NA,NA,NA,NA,NA
864,Pocillopora_acuta_HIv2___RNAseq.g25003.t1,714.9100704,-5.764367093,2.723953943,6.39E-07,1.07E-05,Mucin-like protein,B3EWY9,0,Mucin-like protein,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005615; GO:0007160; GO:0016020
865,Pocillopora_acuta_HIv2___RNAseq.g29861.t1,105.9324768,-7.920287455,2.71989012,6.41E-07,1.07E-05,,Q6ZV65,5.43E-38,Protein FAM47E,protein localization to chromatin [GO:0071168]; transcription initiation-coupled chromatin remodeling [GO:0045815],GO:0000785; GO:0005634; GO:0005737; GO:0008047; GO:0045815; GO:0071168
866,Pocillopora_acuta_HIv2___RNAseq.g11547.t1,85.20667148,-10.78624387,3.81540836,6.42E-07,1.07E-05,,Q96P65,8.58E-28,Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870; GO:0042277
867,Pocillopora_acuta_HIv2___RNAseq.g20058.t1,93.92826994,-10.67830093,3.784237687,6.46E-07,1.08E-05,,NA,NA,NA,NA,NA
868,Pocillopora_acuta_HIv2___RNAseq.g4915.t1,266.8155412,-0.839049648,1.57796381,6.50E-07,1.08E-05,,Q9CR96,1.47E-49,Transmembrane protein 208,autophagy [GO:0006914]; vacuolar protein processing [GO:0006624],GO:0005773; GO:0005789; GO:0006624; GO:0006914
869,Pocillopora_acuta_HIv2___RNAseq.g4080.t1,2298.648977,4.297491992,1.231880988,6.54E-07,1.09E-05,,NA,NA,NA,NA,NA
870,Pocillopora_acuta_HIv2___RNAseq.g8005.t1,263.6455644,-0.815817319,1.516147962,6.61E-07,1.10E-05,,NA,NA,NA,NA,NA
871,Pocillopora_acuta_HIv2___RNAseq.g30772.t1,345.1363929,-1.012343231,1.954841409,6.61E-07,1.10E-05,,NA,NA,NA,NA,NA
872,Pocillopora_acuta_HIv2___RNAseq.g29595.t1,364.6385878,-5.959876095,3.626274895,6.69E-07,1.11E-05,,Q8R197,7.75E-59,"S-acyl fatty acid synthase thioesterase, medium chain (EC 3.1.2.14) (Oleoyl-ACP hydrolase) (Thioesterase II) (Thioesterase domain-containing protein 1)",lipid biosynthetic process [GO:0008610]; medium-chain fatty acid biosynthetic process [GO:0051792],GO:0005829; GO:0008610; GO:0016297; GO:0051792
873,Pocillopora_acuta_HIv2___RNAseq.22108_t,185.231842,-0.932400155,1.734101541,6.71E-07,1.11E-05,,P26652,8.21E-22,Metalloproteinase inhibitor 3 (21 kDa protein of extracellular matrix) (Tissue inhibitor of metalloproteinases 3) (TIMP-3),negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; response to cytokine [GO:0034097]; response to hormone [GO:0009725],GO:0002020; GO:0005604; GO:0005615; GO:0008191; GO:0008270; GO:0009725; GO:0031012; GO:0034097; GO:0051045
874,Pocillopora_acuta_HIv2___RNAseq.g7498.t1,335.7711193,-1.006949633,1.881894551,6.74E-07,1.11E-05,,A7SLW1,0,Branched-chain-amino-acid aminotransferase (EC 2.6.1.42),L-leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099],GO:0004084; GO:0005739; GO:0009098; GO:0009099; GO:0050048; GO:0052654; GO:0052655; GO:0052656
875,Pocillopora_acuta_HIv2___RNAseq.g20766.t1,128.2882805,-8.553982189,3.199636083,6.74E-07,1.11E-05,,P16157,9.43E-08,Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin),cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014
876,Pocillopora_acuta_HIv2___RNAseq.g25161.t1,299.2172014,-8.643907283,3.726748874,6.87E-07,1.13E-05,,Q9Y3B7,8.69E-55,"Large ribosomal subunit protein uL11m (39S ribosomal protein L11, mitochondrial) (L11mt) (MRP-L11)",mitochondrial translation [GO:0032543]; translation [GO:0006412],GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543; GO:0070180
877,Pocillopora_acuta_HIv2___RNAseq.g8212.t1,303.1512975,-0.27987374,1.077553319,6.94E-07,1.14E-05,,NA,NA,NA,NA,NA
878,Pocillopora_acuta_HIv2___RNAseq.g14060.t1,664.0419195,-1.074906966,1.896387765,6.98E-07,1.15E-05,,A7UKY7,9.87E-67,Insulinoma-associated protein 1 (Zinc finger protein IA-1),endocrine pancreas development [GO:0031018]; endodermal cell differentiation [GO:0035987]; gland development [GO:0048732]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; pancreatic A cell differentiation [GO:0003310]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309],GO:0000122; GO:0000978; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0007399; GO:0017053; GO:0031018; GO:0031490; GO:0035987; GO:0046872; GO:0048732; GO:0060290
879,Pocillopora_acuta_HIv2___RNAseq.g23879.t1,310.5662239,-4.440620493,4.336921706,6.99E-07,1.15E-05,,Q60HG9,0,"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)",carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid metabolic process [GO:0001676],GO:0001676; GO:0004095; GO:0005743; GO:0006635; GO:0008458; GO:0009437; GO:0016746
880,Pocillopora_acuta_HIv2___RNAseq.g11350.t1,1365.527027,-0.431064242,1.106591234,7.08E-07,1.16E-05,,Q28107,3.53E-28,Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain],blood circulation [GO:0008015]; blood coagulation [GO:0007596],GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091
881,Pocillopora_acuta_HIv2___RNAseq.g9824.t1,3467.23763,-5.548040667,2.631315363,7.17E-07,1.18E-05,,B8NHE3,6.70E-11,Methyltransferase flvH (EC 2.1.1.-) (Flavunoidine biosynthesis cluster protein H),methylation [GO:0032259]; terpenoid biosynthetic process [GO:0016114],GO:0008168; GO:0016114; GO:0032259; GO:0046872
882,Pocillopora_acuta_HIv2___TS.g805.t1a,1602.313043,-1.337449988,2.563348863,7.21E-07,1.18E-05,,P19623,1.01E-149,Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase),cellular response to leukemia inhibitory factor [GO:1990830]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295],GO:0004766; GO:0005829; GO:0006595; GO:0008295; GO:0042802; GO:0042803; GO:1990830
883,Pocillopora_acuta_HIv2___RNAseq.g13784.t1,113.997873,8.556905721,3.447764114,7.23E-07,1.18E-05,,Q04604,7.19E-103,Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase),melanin biosynthetic process from tyrosine [GO:0006583],GO:0004503; GO:0005507; GO:0006583; GO:0033162; GO:0042470
884,Pocillopora_acuta_HIv2___TS.g4831.t1,300.736941,-0.281943379,1.078509504,7.25E-07,1.19E-05,,Q0EEE2,3.71E-69,Patched domain-containing protein 3 (RND-type protein RNDEu-3),,GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0097225
885,Pocillopora_acuta_HIv2___RNAseq.g15253.t1,246.4093577,-0.840395459,1.573292912,7.28E-07,1.19E-05,Peptidyl-prolyl cis-trans isomerase FKBP14,Q5R941,7.85E-32,Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (FK506-binding protein 14) (FKBP-14) (Rotamase),,GO:0003755; GO:0005509; GO:0005788
886,Pocillopora_acuta_HIv2___RNAseq.g19394.t1,195.1191253,-0.780301809,1.489476873,7.30E-07,1.19E-05,,A2AP18,0,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)",lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209],GO:0004435; GO:0004629; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209
887,Pocillopora_acuta_HIv2___RNAseq.g1859.t1,252.2723765,-0.809750287,1.529280883,7.31E-07,1.19E-05,,Q07068,7.84E-19,"Tropomyosin, smooth muscle/fibroblast CTM1",actin filament organization [GO:0007015]; muscle contraction [GO:0006936],GO:0005884; GO:0006936; GO:0007015; GO:0051015
888,Pocillopora_acuta_HIv2___RNAseq.g9723.t1,149.2702724,-1.290568697,2.847326324,7.39E-07,1.20E-05,,P29241,1.20E-48,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase),positive regulation of B cell proliferation [GO:0030890]; single fertilization [GO:0007338],GO:0003953; GO:0005886; GO:0007338; GO:0016740; GO:0016849; GO:0030890; GO:0031410; GO:0061809
889,Pocillopora_acuta_HIv2___TS.g17699.t2,262.8894612,-1.154381042,2.27398439,7.45E-07,1.21E-05,,Q3UVD5,3.11E-27,Leucine-rich repeat-containing G-protein coupled receptor 6,bone regeneration [GO:1990523]; cell population proliferation [GO:0008283]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; tissue regeneration [GO:0042246]; Wnt signaling pathway [GO:0016055],GO:0004930; GO:0005615; GO:0005886; GO:0008283; GO:0016055; GO:0016500; GO:0030177; GO:0030335; GO:0031012; GO:0031982; GO:0042246; GO:1990523
890,Pocillopora_acuta_HIv2___RNAseq.g8906.t1,577.5787537,-0.826759838,1.482069738,7.57E-07,1.23E-05,,Q19863,4.60E-08,Transcription factor aptf-4,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0042127; GO:0043565; GO:0045944
891,Pocillopora_acuta_HIv2___RNAseq.g8913.t1,760.9217892,-3.005043348,0.695729433,7.58E-07,1.23E-05,,P10079,3.51E-11,Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1),,GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579
892,Pocillopora_acuta_HIv2___RNAseq.g6559.t1,684.897711,5.856144782,2.292454619,8.04E-07,1.30E-05,,A7RX26,0,Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog),L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557],GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480
893,Pocillopora_acuta_HIv2___RNAseq.g3895.t2,610.7753302,-0.429812828,1.099515484,8.06E-07,1.31E-05,,A5PK21,5.07E-10,Cytoskeleton-associated protein 2-like (Radial fiber and mitotic spindle protein) (Radmis),,GO:0000922; GO:0005813; GO:0005829; GO:0072686
894,Pocillopora_acuta_HIv2___RNAseq.g23181.t1,528.6248516,-8.880213462,4.688201663,8.07E-07,1.31E-05,,Q17LW0,7.15E-107,Myosin-VIIa (Protein crinkled),actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605],GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0032027; GO:0035317; GO:0048800; GO:0071944; GO:0120025
895,Pocillopora_acuta_HIv2___RNAseq.g18987.t1,818.302649,-0.530515774,1.162983165,8.11E-07,1.31E-05,,NA,NA,NA,NA,NA
896,Pocillopora_acuta_HIv2___RNAseq.g15157.t1,751.1940975,-0.491158231,1.139034173,8.16E-07,1.32E-05,,NA,NA,NA,NA,NA
897,Pocillopora_acuta_HIv2___RNAseq.g9090.t1,169.7101424,-7.190833925,2.685563747,8.21E-07,1.32E-05,,Q9WUW9,7.37E-52,Sulfotransferase 1C2A (ST1C2A) (rSULT1C2A) (EC 2.8.2.1) (Sulfotransferase K2),sulfation [GO:0051923],GO:0004062; GO:0005737; GO:0005764; GO:0008146; GO:0051923
898,Pocillopora_acuta_HIv2___RNAseq.g25049.t1,154.397161,0.308115851,1.088997213,8.21E-07,1.32E-05,,NA,NA,NA,NA,NA
899,Pocillopora_acuta_HIv2___RNAseq.g12806.t1,1124.084402,-0.607320292,1.216216777,8.23E-07,1.32E-05,,P00636,7.08E-155,"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)","cellular response to magnesium ion [GO:0071286]; cellular response to xenobiotic stimulus [GO:0071466]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]",GO:0005737; GO:0005829; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0030388; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286; GO:0071466
900,Pocillopora_acuta_HIv2___RNAseq.g3509.t1,137.2352664,5.677470552,3.238419966,8.25E-07,1.33E-05,,V6CLA2,7.25E-18,E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26),determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028],GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936
901,Pocillopora_acuta_HIv2___RNAseq.g5915.t1,199.2443551,0.295256067,1.080523322,8.27E-07,1.33E-05,,P98160,5.66E-25,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide],angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of endothelial cell proliferation [GO:0001938]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224],GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031100; GO:0043202; GO:0050750; GO:0062023; GO:0070052; GO:0070062; GO:0072359; GO:0098797
902,Pocillopora_acuta_HIv2___RNAseq.g30904.t1,207.36685,-8.810176604,3.374738342,8.29E-07,1.33E-05,,P27163,4.14E-15,Calmodulin-2 (CaM-2),,GO:0005509; GO:0030234
903,Pocillopora_acuta_HIv2___RNAseq.g30143.t1,319.4344765,-0.894963629,1.565944612,8.39E-07,1.34E-05,,P62597,1.41E-43,Protection of telomeres protein 1 (cPot1) (POT1-like telomere end-binding protein),regulation of telomere maintenance via telomerase [GO:0032210]; telomere capping [GO:0016233]; telomere maintenance via telomerase [GO:0007004],GO:0000781; GO:0000783; GO:0005654; GO:0007004; GO:0010521; GO:0016233; GO:0032210; GO:0042162; GO:0043047; GO:0098505
904,Pocillopora_acuta_HIv2___RNAseq.26328_t,293.9525672,-6.39606933,2.772385104,8.44E-07,1.35E-05,,NA,NA,NA,NA,NA
905,Pocillopora_acuta_HIv2___TS.g28908.t1,330.8921299,-5.637318706,1.947977911,8.50E-07,1.36E-05,,Q0IIL7,7.88E-06,Complexin-1,regulation of neurotransmitter secretion [GO:0046928]; synaptic vesicle exocytosis [GO:0016079],GO:0000149; GO:0005829; GO:0016079; GO:0019905; GO:0031201; GO:0043195; GO:0043204; GO:0046928
906,Pocillopora_acuta_HIv2___RNAseq.17790_t,8086.664987,3.393848381,0.841610664,8.53E-07,1.36E-05,,NA,NA,NA,NA,NA
907,Pocillopora_acuta_HIv2___RNAseq.26321_t,275.9571161,-1.442695041,6.502434336,8.69E-07,1.38E-05,,Q5U374,3.26E-111,Kelch-like protein 12,anterior/posterior pattern specification [GO:0009952]; convergent extension involved in axis elongation [GO:0060028]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055],GO:0006513; GO:0006888; GO:0009952; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0048208; GO:0060028
908,Pocillopora_acuta_HIv2___TS.g17564.t1,121.6142443,-8.594674402,3.393060961,8.70E-07,1.38E-05,,O15254,0,Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase),fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088],GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949
909,Pocillopora_acuta_HIv2___RNAseq.g12259.t1,477.0798018,0.601154593,1.236385296,8.70E-07,1.38E-05,,P18052,3.33E-63,Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28),insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of focal adhesion assembly [GO:0051893],GO:0004725; GO:0005925; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0051893; GO:0097060; GO:0098685
910,Pocillopora_acuta_HIv2___TS.g29618.t1,80.54444545,-8.121818924,2.856622338,9.03E-07,1.43E-05,,O75581,0,Low-density lipoprotein receptor-related protein 6 (LRP-6),canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055],GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909
911,Pocillopora_acuta_HIv2___RNAseq.g11117.t1,313.3169317,-0.805325287,1.521689944,9.03E-07,1.43E-05,,Q9NJ15,3.03E-11,Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase PC6-like) (aPC6),proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0005886; GO:0006508
912,Pocillopora_acuta_HIv2___RNAseq.g28986.t1,400.5260227,-5.923747322,3.749151447,9.05E-07,1.43E-05,,NA,NA,NA,NA,NA
913,Pocillopora_acuta_HIv2___RNAseq.g15149.t1,1373.295935,-1.461513415,2.950167768,9.39E-07,1.49E-05,,NA,NA,NA,NA,NA
914,Pocillopora_acuta_HIv2___RNAseq.g17695.t1,183.2278146,-5.625565836,1.979326672,9.40E-07,1.49E-05,,Q7RTR2,4.30E-74,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)",canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110],GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223
915,Pocillopora_acuta_HIv2___TS.g23073.t1,71.57223729,-10.30786908,3.631597112,9.43E-07,1.49E-05,,NA,NA,NA,NA,NA
916,Pocillopora_acuta_HIv2___RNAseq.g17236.t1,86.74274422,-6.367665545,2.051250551,9.58E-07,1.51E-05,,NA,NA,NA,NA,NA
917,Pocillopora_acuta_HIv2___RNAseq.g30859.t1,544.5333173,-0.566543972,1.181142278,9.60E-07,1.51E-05,,NA,NA,NA,NA,NA
918,Pocillopora_acuta_HIv2___RNAseq.g15158.t1,771.3079524,-0.423426823,1.104546668,9.66E-07,1.52E-05,,Q6P1R4,3.67E-13,tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (EC 1.3.1.88) (tRNA-dihydrouridine synthase 1-like),tRNA dihydrouridine synthesis [GO:0002943],GO:0002943; GO:0017150; GO:0050660; GO:0102262; GO:0102263
919,Pocillopora_acuta_HIv2___RNAseq.g13970.t2,372.9059218,-8.561605058,3.825803847,9.81E-07,1.54E-05,,Q8TAM2,0,Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein),axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; fat cell differentiation [GO:0045444]; inner ear receptor cell stereocilium organization [GO:0060122]; multi-ciliated epithelial cell differentiation [GO:1903251]; multicellular organism growth [GO:0035264]; non-motile cilium assembly [GO:1905515]; olfactory bulb development [GO:0021772]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]; regulation of stress fiber assembly [GO:0051492]; renal tubule development [GO:0061326]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893],GO:0001736; GO:0005813; GO:0005829; GO:0005929; GO:0007411; GO:0007608; GO:0015031; GO:0021772; GO:0032391; GO:0032880; GO:0034451; GO:0034464; GO:0035264; GO:0036064; GO:0045198; GO:0045444; GO:0048560; GO:0050893; GO:0051492; GO:0060122; GO:0060170; GO:0060219; GO:0060271; GO:0061326; GO:0061629; GO:0072659; GO:0097730; GO:1903251; GO:1905515
920,Pocillopora_acuta_HIv2___RNAseq.g2384.t1,386.9496752,-1.409289261,2.741352343,9.91E-07,1.56E-05,,P02597,2.19E-39,"Calmodulin, striated muscle",,GO:0005509; GO:0005737
921,Pocillopora_acuta_HIv2___RNAseq.g22613.t1,1739.823186,-0.417132543,1.093793541,1.01E-06,1.58E-05,,Q9UHV9,3.17E-46,Prefoldin subunit 2,chaperone-mediated protein folding [GO:0061077]; negative regulation of amyloid fibril formation [GO:1905907]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]; protein stabilization [GO:0050821],GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0050821; GO:0051082; GO:0051495; GO:0061077; GO:0101031; GO:1905907; GO:1990062
922,Pocillopora_acuta_HIv2___RNAseq.g17162.t1,189.7601376,-8.530040169,3.48925103,1.01E-06,1.58E-05,,Q76KP1,1.37E-82,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)",,GO:0008376; GO:0032580; GO:0033842
923,Pocillopora_acuta_HIv2___TS.g29536.t1,347.7467807,-0.997135818,1.818443559,1.01E-06,1.58E-05,,Q3USF0,2.96E-17,"Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.147) (Core 3 synthase) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) (BGnT-6) (Beta-1,3-Gn-T6) (Beta-1,3-N-acetylglucosaminyltransferase 6) (Beta3Gn-T6)",poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein O-linked glycosylation [GO:0006493],GO:0000139; GO:0006493; GO:0008194; GO:0008378; GO:0030311; GO:0047224
924,Pocillopora_acuta_HIv2___RNAseq.g12530.t1,1103.722321,-0.352771659,1.068586554,1.02E-06,1.60E-05,,Q8NE28,5.58E-60,Serine/threonine kinase-like domain-containing protein STKLD1 (Serine/threonine kinase-like domain-containing protein 1) (Sugen kinase 071),,GO:0004674; GO:0005524
925,Pocillopora_acuta_HIv2___RNAseq.g12801.t1b,184.466244,-8.480437624,3.361972918,1.05E-06,1.63E-05,,Q56A36,1.50E-22,Hematopoietic SH2 domain-containing protein homolog,signal transduction [GO:0007165],GO:0005737; GO:0007165
926,Pocillopora_acuta_HIv2___RNAseq.g14159.t1,1025.157519,-0.280315131,1.03720956,1.05E-06,1.64E-05,,P61023,1.04E-78,Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22),cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005886; GO:0006469; GO:0006611; GO:0006903; GO:0006906; GO:0008017; GO:0010923; GO:0015385; GO:0015630; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0045121; GO:0048306; GO:0050821; GO:0051222; GO:0051259; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070885; GO:0071073; GO:0071468; GO:0090314; GO:1990351
927,Pocillopora_acuta_HIv2___TS.g21317.t2,279.5341503,-7.901832934,3.166725523,1.05E-06,1.64E-05,,Q9D3U0,2.30E-125,tRNA pseudouridine synthase Pus10 (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase),primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119],GO:0005634; GO:0005737; GO:0005739; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029; GO:0160148
928,Pocillopora_acuta_HIv2___RNAseq.g16538.t1,726.1458706,-0.682246393,1.309705548,1.06E-06,1.65E-05,Cnidocyte marker protein (leucine-rich),NA,NA,NA,NA,NA
929,Pocillopora_acuta_HIv2___RNAseq.g5341.t1,2339.320557,4.953471165,3.002418833,1.08E-06,1.68E-05,,NA,NA,NA,NA,NA
930,Pocillopora_acuta_HIv2___TS.g19623.t2,269.4022347,-0.73958564,1.427873222,1.10E-06,1.71E-05,,A6H603,5.93E-111,NACHT domain- and WD repeat-containing protein 1,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088
931,Pocillopora_acuta_HIv2___RNAseq.g22542.t1,953.0773589,-0.465379329,1.113821296,1.10E-06,1.71E-05,,Q9H2A2,1.65E-115,2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase 12) (Aldehyde dehydrogenase family 8 member A1),9-cis-retinoic acid biosynthetic process [GO:0042904]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573],GO:0001758; GO:0005829; GO:0042573; GO:0042574; GO:0042904; GO:0047102; GO:0070062; GO:0097053
932,Pocillopora_acuta_HIv2___RNAseq.18718_t,265.1327384,-8.634970523,3.449243434,1.11E-06,1.72E-05,,NA,NA,NA,NA,NA
933,Pocillopora_acuta_HIv2___RNAseq.g16747.t1,634.2613523,0.485386168,1.139811674,1.11E-06,1.73E-05,,NA,NA,NA,NA,NA
934,Pocillopora_acuta_HIv2___TS.g28111.t1,363.6774109,-3.863360219,5.284056447,1.11E-06,1.73E-05,,Q7TPD1,0,F-box only protein 11,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756
935,Pocillopora_acuta_HIv2___TS.g31246.t1a,144.1968879,-0.500327217,1.208184536,1.12E-06,1.73E-05,,Q04962,2.96E-09,Coagulation factor XII (EC 3.4.21.38) (Hageman factor) (HAF) [Cleaved into: Coagulation factor XIIa heavy chain; Coagulation factor XIIa light chain],blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; zymogen activation [GO:0031638],GO:0004252; GO:0005509; GO:0005615; GO:0005791; GO:0007596; GO:0031638; GO:0042730
936,Pocillopora_acuta_HIv2___RNAseq.g26862.t1,335.4894185,-1.374749996,2.677981184,1.13E-06,1.74E-05,,NA,NA,NA,NA,NA
937,Pocillopora_acuta_HIv2___TS.g25964.t2,241.9306907,-0.817173802,1.537956378,1.14E-06,1.77E-05,,Q9NXZ2,0,Probable ATP-dependent RNA helicase DDX43 (EC 3.6.4.13) (Cancer/testis antigen 13) (CT13) (DEAD box protein 43) (DEAD box protein HAGE) (Helical antigen),,GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0016887
938,Pocillopora_acuta_HIv2___TS.g31203.t1,318.1040222,-0.417706199,1.140800273,1.15E-06,1.78E-05,,A0JMW2,0,Dynein axonemal assembly factor 5 (HEAT repeat-containing protein 2),cell projection organization [GO:0030030],GO:0030030; GO:0120293
939,Pocillopora_acuta_HIv2___RNAseq.g31382.t1,534.4072773,-0.434595777,1.097086601,1.16E-06,1.78E-05,,Q5E9B2,1.15E-16,PCNA-associated factor (PCNA-associated factor of 15 kDa) (PAF15) (p15PAF) (PCNA-clamp-associated factor),centrosome cycle [GO:0007098]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985],GO:0003682; GO:0005634; GO:0006260; GO:0006974; GO:0007098; GO:0009411; GO:0019985; GO:0048471; GO:0051726
940,Pocillopora_acuta_HIv2___TS.g21601.t1,154.9192828,-6.15751461,1.943330776,1.16E-06,1.78E-05,,NA,NA,NA,NA,NA
941,Pocillopora_acuta_HIv2___RNAseq.g6042.t1,481.7227105,-0.653416609,1.274863506,1.16E-06,1.79E-05,,Q8BX94,4.46E-155,Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2),intracellular cholesterol transport [GO:0032367]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509],GO:0005546; GO:0005811; GO:0005829; GO:0005886; GO:0007009; GO:0008526; GO:0009898; GO:0015485; GO:0032367; GO:0051289; GO:0097038; GO:0098831; GO:0098978; GO:0099509; GO:0120020
942,Pocillopora_acuta_HIv2___TS.g24340.t1,158.7618019,-0.503685931,1.208487556,1.17E-06,1.80E-05,,Q8CG09,0,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),astrocyte differentiation [GO:0048708]; carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin transport [GO:0015889]; cyclic nucleotide transport [GO:0070729]; export across plasma membrane [GO:0140115]; glial cell differentiation [GO:0010001]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; regulation of cellular response to drug [GO:2001038]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962],GO:0005324; GO:0005524; GO:0005886; GO:0006979; GO:0008559; GO:0009410; GO:0009925; GO:0010001; GO:0015420; GO:0015431; GO:0015562; GO:0015889; GO:0015911; GO:0016323; GO:0016324; GO:0016328; GO:0016491; GO:0016887; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042887; GO:0042908; GO:0042910; GO:0045332; GO:0046943; GO:0048708; GO:0050729; GO:0055085; GO:0060326; GO:0070633; GO:0070729; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1904646; GO:1905039; GO:1990961; GO:1990962; GO:2001038
943,Pocillopora_acuta_HIv2___RNAseq.g5807.t1,9139.316417,4.455411762,1.40923497,1.18E-06,1.81E-05,Spore wall protein 2,Q8I335,2.76E-08,"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)",positive regulation of translation [GO:0045727]; translation [GO:0006412],GO:0003924; GO:0005525; GO:0005743; GO:0006412; GO:0043022; GO:0045727
944,Pocillopora_acuta_HIv2___RNAseq.g4097.t1,64440.91906,-4.718750479,1.419492757,1.19E-06,1.82E-05,,NA,NA,NA,NA,NA
945,Pocillopora_acuta_HIv2___RNAseq.g7215.t1,116.6683532,-7.997164069,3.018932903,1.19E-06,1.82E-05,,Q3U481,4.13E-30,Major facilitator superfamily domain-containing protein 12 (Protein grizzled),carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712
946,Pocillopora_acuta_HIv2___RNAseq.g25207.t1,281.7356491,-1.486648605,3.056859699,1.19E-06,1.82E-05,,NA,NA,NA,NA,NA
947,Pocillopora_acuta_HIv2___RNAseq.g31067.t1,208.1178229,-7.470509266,3.353314126,1.20E-06,1.83E-05,,NA,NA,NA,NA,NA
948,Pocillopora_acuta_HIv2___RNAseq.g22547.t1,104.9326581,-0.486907119,1.19920194,1.20E-06,1.84E-05,,Q9D0E5,5.45E-31,EF-hand calcium-binding domain-containing protein 11,,GO:0005509
949,Pocillopora_acuta_HIv2___TS.g13296.t1,219.6944055,-0.847800592,1.591153219,1.22E-06,1.87E-05,,A7RTB3,1.37E-13,SOSS complex subunit C homolog,DNA repair [GO:0006281],GO:0005654; GO:0006281; GO:0070876
950,Pocillopora_acuta_HIv2___RNAseq.g3870.t1,361.2489385,-0.899452157,1.678186344,1.23E-06,1.87E-05,,Q5SSI6,9.69E-131,U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50),ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],GO:0005654; GO:0006364; GO:0031965; GO:0032040; GO:0034388; GO:0042274
951,Pocillopora_acuta_HIv2___RNAseq.10655_t,235.6240633,-0.305528155,1.088194231,1.23E-06,1.88E-05,,Q5XI46,9.03E-14,ATPase PAAT (EC 3.6.1.-) (Protein associated with ABC transporters) (PAAT),,GO:0005737; GO:0005739; GO:0016887; GO:0042802
952,Pocillopora_acuta_HIv2___RNAseq.g9293.t1,214.074367,-1.242143497,2.688754122,1.25E-06,1.90E-05,,Q9CR50,1.88E-50,RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363),positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0051865; GO:0061630; GO:0072344
953,Pocillopora_acuta_HIv2___RNAseq.g2436.t1,3002.387332,-3.022643838,0.734034152,1.27E-06,1.93E-05,,NA,NA,NA,NA,NA
954,Pocillopora_acuta_HIv2___RNAseq.g1071.t1,1265.957132,0.506870058,1.135749731,1.28E-06,1.95E-05,,NA,NA,NA,NA,NA
955,Pocillopora_acuta_HIv2___RNAseq.g1255.t1,1051.120277,-0.419640013,1.096316477,1.29E-06,1.95E-05,,A5GFY8,2.15E-158,D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399) (Malate dehydrogenase) (EC 1.1.1.37),L-serine biosynthetic process [GO:0006564],GO:0004617; GO:0006564; GO:0030060; GO:0051287
956,Pocillopora_acuta_HIv2___RNAseq.g11854.t1,118.9664114,-0.493134179,1.202303527,1.29E-06,1.95E-05,,NA,NA,NA,NA,NA
957,Pocillopora_acuta_HIv2___RNAseq.g22622.t1,692.8745057,-0.551166896,1.200034742,1.30E-06,1.97E-05,,Q63665,2.81E-16,Upstream stimulatory factor 2 (Major late transcription factor 2) (Upstream transcription factor 2),lactation [GO:0007595]; lipid homeostasis [GO:0055088]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000432; GO:0000978; GO:0000981; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0006357; GO:0007595; GO:0042802; GO:0042803; GO:0043425; GO:0043565; GO:0044877; GO:0045893; GO:0045944; GO:0046982; GO:0055088; GO:1990837
958,Pocillopora_acuta_HIv2___TS.g1929.t1,672.7947601,-0.377939299,1.07158268,1.31E-06,1.98E-05,,A8CEP3,6.04E-38,Calmodulin (CaM),,GO:0005509; GO:0016460
959,Pocillopora_acuta_HIv2___RNAseq.g24329.t1,231.6006081,-0.896419257,1.660703445,1.37E-06,2.07E-05,,G7H7V7,2.12E-09,Protein TOPAZ1 (Testis- and ovary-specific PAZ domain-containing protein 1),cell differentiation [GO:0030154]; spermatocyte division [GO:0048137],GO:0005829; GO:0030154; GO:0048137
960,Pocillopora_acuta_HIv2___RNAseq.g1508.t1,634.7088915,-4.704057301,4.742385372,1.39E-06,2.09E-05,Tachylectin-2,Q27084,1.79E-76,Tachylectin-2 (Lectin L10c),innate immune response [GO:0045087],GO:0005576; GO:0030246; GO:0045087
961,Pocillopora_acuta_HIv2___RNAseq.g31.t1,1891.438373,-1.047358709,1.793106156,1.40E-06,2.11E-05,ZP domain-containing protein,G8HTB6,3.14E-49,ZP domain-containing protein,,GO:0016020
962,Pocillopora_acuta_HIv2___RNAseq.g832.t1,245.1776694,-6.568789446,2.450367096,1.43E-06,2.15E-05,,A0A2B4RNI3,6.97E-23,Cyclic GMP-AMP synthase-like receptor 2 (Sp-cGLR2) (EC 2.7.7.86),innate immune response [GO:0045087],GO:0005524; GO:0005525; GO:0045087; GO:0046872; GO:0061501
963,Pocillopora_acuta_HIv2___RNAseq.g21099.t1,185.4648002,-0.863399041,1.612505145,1.44E-06,2.17E-05,,NA,NA,NA,NA,NA
964,Pocillopora_acuta_HIv2___RNAseq.g17733.t1,183.613079,-0.925567859,1.716660817,1.45E-06,2.18E-05,,Q7RTR2,5.85E-80,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)",canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110],GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223
965,Pocillopora_acuta_HIv2___RNAseq.g24795.t1,675.4367917,-0.605747012,1.220579481,1.45E-06,2.18E-05,,A0A1X7TVA9,5.30E-16,Death domain-containing ATP nucleosidase (DDAN) (EC 3.5.99.-),nucleoside metabolic process [GO:0009116],GO:0009116; GO:0016787
966,Pocillopora_acuta_HIv2___TS.g11923.t1,113.2625353,-0.46288449,1.18147588,1.46E-06,2.18E-05,,Q9H6E4,6.55E-41,Coiled-coil domain-containing protein 134,angiogenesis [GO:0001525]; embryonic hemopoiesis [GO:0035162]; embryonic liver development [GO:1990402]; placenta development [GO:0001890]; regulation of ossification [GO:0030278]; ventricular system development [GO:0021591],GO:0001525; GO:0001890; GO:0005576; GO:0005634; GO:0005783; GO:0005829; GO:0016020; GO:0021591; GO:0030278; GO:0035162; GO:0043231; GO:1990402
967,Pocillopora_acuta_HIv2___RNAseq.g15454.t1,1988.134738,-5.634531541,2.647519745,1.46E-06,2.19E-05,,NA,NA,NA,NA,NA
968,Pocillopora_acuta_HIv2___RNAseq.g17024.t1,544.4742553,-0.599239666,1.212231611,1.47E-06,2.20E-05,,A7STV9,2.63E-92,Structure-specific endonuclease subunit SLX1 homolog (EC 3.1.-.-),double-strand break repair via homologous recombination [GO:0000724],GO:0000724; GO:0008821; GO:0017108; GO:0033557; GO:0046872
969,Pocillopora_acuta_HIv2___RNAseq.2466_t,596.6488904,5.697708489,2.542285409,1.49E-06,2.22E-05,,NA,NA,NA,NA,NA
970,Pocillopora_acuta_HIv2___RNAseq.g19327.t1,462.8404557,-1.134543671,1.995208,1.51E-06,2.25E-05,,NA,NA,NA,NA,NA
971,Pocillopora_acuta_HIv2___RNAseq.g10841.t1,155.6965004,-0.480884268,1.180485232,1.51E-06,2.26E-05,,Q8CIB6,1.09E-42,Transmembrane protein 230,synaptic vesicle transport [GO:0048489],GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005802; GO:0008021; GO:0012505; GO:0016020; GO:0048489; GO:0055037
972,Pocillopora_acuta_HIv2___TS.g16956.t1b,407.5863814,-0.369914598,1.070257797,1.52E-06,2.27E-05,,Q9I8C7,2.09E-93,Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10),,GO:0004888; GO:0005262; GO:0005886; GO:0022848; GO:0043005; GO:0045202; GO:0045211; GO:1902495
973,Pocillopora_acuta_HIv2___RNAseq.g19593.t1,552.3904763,-0.569839794,1.210415656,1.53E-06,2.27E-05,,Q6P8Y1,1.48E-61,Calcyphosin-like protein,,GO:0005509; GO:0005737
974,Pocillopora_acuta_HIv2___TS.g21980.t1,267.0825529,-7.803111522,3.335045154,1.54E-06,2.29E-05,Chloroquine resistance transporter paralog 1,Q9GSB0,3.83E-10,Crt homolog 1 (Chloroquine resistance transporter paralog 1) (DdCRTp1),amino acid transport [GO:0006865],GO:0005774; GO:0006865; GO:0012506; GO:0042910
975,Pocillopora_acuta_HIv2___RNAseq.g28425.t1,213.8831445,-1.325622603,2.860706425,1.55E-06,2.30E-05,,O60678,2.98E-171,Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3),chromatin remodeling [GO:0006338]; methylation [GO:0032259]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053],GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0008168; GO:0016274; GO:0031397; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0043022; GO:0046872; GO:1900053
976,Pocillopora_acuta_HIv2___RNAseq.g4406.t1,490.2981655,-0.574511591,1.205895767,1.56E-06,2.30E-05,,H3BNL1,2.91E-10,Uncharacterized protein C3orf84,,
977,Pocillopora_acuta_HIv2___RNAseq.g7175.t1,230.2552778,-0.317147799,1.075704683,1.56E-06,2.30E-05,,Q0IJ33,1.52E-153,E3 ubiquitin-protein ligase TM129 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TM129),protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986],GO:0005789; GO:0006986; GO:0016567; GO:0046872; GO:0061630
978,Pocillopora_acuta_HIv2___RNAseq.g3025.t1,345.3040505,-1.005905365,1.862640931,1.57E-06,2.33E-05,,Q9QXV3,1.25E-69,Inhibitor of growth protein 1,negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; protein import into nucleus [GO:0006606]; regulation of programmed cell death [GO:0043067],GO:0000122; GO:0005634; GO:0006606; GO:0030336; GO:0030512; GO:0035064; GO:0043067; GO:0045893; GO:0046872; GO:0070822; GO:1902455; GO:1902459
979,Pocillopora_acuta_HIv2___RNAseq.g898.t1b,482.1629632,-0.991920552,1.817069098,1.58E-06,2.34E-05,,Q9WUA6,0,RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma),brain morphogenesis [GO:0048854]; cellular response to insulin stimulus [GO:0032869]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular signal transduction [GO:0035556]; mitochondrial genome maintenance [GO:0000002]; negative regulation of cellular senescence [GO:2000773]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564],GO:0000002; GO:0004672; GO:0004674; GO:0005080; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0010765; GO:0032008; GO:0032869; GO:0035556; GO:0045766; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:0106310; GO:1905564; GO:1905653; GO:2000773
980,Pocillopora_acuta_HIv2___RNAseq.g11463.t1,741.7927357,0.534245711,1.225235213,1.59E-06,2.35E-05,,Q14192,1.72E-73,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],GO:0000122; GO:0001649; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885
981,Pocillopora_acuta_HIv2___RNAseq.g24853.t1,677.424504,-0.52709751,1.147879799,1.59E-06,2.35E-05,,Q9BX10,0,GTP-binding protein 2,translational elongation [GO:0006414],GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802; GO:1904678
982,Pocillopora_acuta_HIv2___RNAseq.g3268.t1,1102.635772,-0.411498511,1.091736152,1.59E-06,2.35E-05,,P24045,7.55E-97,Gamma-aminobutyric acid receptor subunit beta-4 (GABA(A) receptor subunit beta-4),chloride transmembrane transport [GO:1902476],GO:0004890; GO:0005230; GO:0005254; GO:0005886; GO:0030594; GO:0034707; GO:0043005; GO:0045202; GO:0045211; GO:1902476; GO:1902495; GO:1902711
983,Pocillopora_acuta_HIv2___RNAseq.g17476.t1,168.4636137,-8.221788124,3.56636245,1.60E-06,2.35E-05,,A5PJF4,7.28E-10,Transmembrane protein 218,,GO:0005929; GO:0016020
984,Pocillopora_acuta_HIv2___RNAseq.g28690.t1,536.3454483,-0.686461798,1.326832591,1.64E-06,2.41E-05,,Q9HBI5,5.15E-06,Centrosomal protein 15 (Centrosomal protein 15 kDa),,GO:0005929
985,Pocillopora_acuta_HIv2___RNAseq.g14133.t1,310.4447101,-0.754347056,1.44707937,1.66E-06,2.43E-05,,Q941Q2,1.28E-14,Anaerobic nitrite reductase HB2 (EC 1.7.2.-) (BRAna GLB2) (Hb2) (Non-symbiotic hemoglobin 2),,GO:0005634; GO:0005737; GO:0016491; GO:0019825; GO:0020037; GO:0046872
986,Pocillopora_acuta_HIv2___RNAseq.g15279.t1,1874.325372,5.715430996,2.586062878,1.67E-06,2.45E-05,,O95236,1.64E-12,Apolipoprotein L3 (Apolipoprotein L-III) (ApoL-III) (TNF-inducible protein CG12-1) (CG12_1),inflammatory response [GO:0006954]; lipoprotein metabolic process [GO:0042157]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],GO:0005319; GO:0005576; GO:0005737; GO:0006954; GO:0008289; GO:0016020; GO:0042157; GO:0043123
987,Pocillopora_acuta_HIv2___RNAseq.g7625.t1,56.76601906,-10.18933523,3.640653048,1.67E-06,2.45E-05,Toll-like receptor 1,Q15399,3.37E-10,Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281),cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224],GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0032755; GO:0032757; GO:0032760; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0042116; GO:0042495; GO:0042802; GO:0043235; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071727
988,Pocillopora_acuta_HIv2___RNAseq.g29984.t1,336.5688856,-8.195834555,3.724380927,1.68E-06,2.46E-05,Protein Wnt-2b-A,P87387,1.57E-100,Protein Wnt-2b-A (Wnt-2b) (XWnt-2b) (XWnt-2),system development [GO:0048731]; Wnt signaling pathway [GO:0016055],GO:0005102; GO:0005576; GO:0016055; GO:0048731
989,Pocillopora_acuta_HIv2___RNAseq.g10069.t1,218.4524321,3.09329346,0.755303531,1.71E-06,2.50E-05,,NA,NA,NA,NA,NA
990,Pocillopora_acuta_HIv2___RNAseq.g29124.t1,396.7444248,-3.874534297,4.055081011,1.73E-06,2.52E-05,,Q6NX31,0,DNA replication licensing factor mcm7 (EC 3.6.4.12) (CDC47 homolog) (Minichromosome maintenance protein 7),DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-templated DNA replication initiation [GO:0030174],GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0006268; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0046872; GO:0071162
991,Pocillopora_acuta_HIv2___RNAseq.g12287.t1,160.9396599,-6.299516377,3.099062281,1.74E-06,2.54E-05,,P16621,3.33E-16,Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR),axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124],GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386
992,Pocillopora_acuta_HIv2___RNAseq.g26393.t1,555.4094429,-3.618324804,0.981397586,1.75E-06,2.56E-05,,Q2HJ86,0,Tubulin alpha-1D chain (EC 3.6.5.-) [Cleaved into: Detyrosinated tubulin alpha-1D chain],microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278],GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0016787; GO:0046872
993,Pocillopora_acuta_HIv2___RNAseq.g31325.t2,212.7969236,0.595394245,1.277826506,1.76E-06,2.56E-05,,Q3MV19,2.85E-50,TNF receptor-associated factor 6-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6-A),activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122],GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005938; GO:0007250; GO:0008270; GO:0042981; GO:0043122; GO:0070534
994,Pocillopora_acuta_HIv2___TS.g19040.t1,79.63900163,-10.68415374,3.898093261,1.76E-06,2.56E-05,,Q9UIJ7,1.38E-58,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)",ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051],GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899
995,Pocillopora_acuta_HIv2___RNAseq.g22509.t1,1219.75159,5.770329556,2.570473151,1.78E-06,2.59E-05,,Q95JR6,1.75E-25,Cyclic nucleotide-binding domain-containing protein 2,spermatogenesis [GO:0007283],GO:0005829; GO:0007283; GO:0030552
996,Pocillopora_acuta_HIv2___TS.g28813.t2,278.9929711,-0.851024043,1.580679062,1.79E-06,2.61E-05,,Q80UM7,0,Mannosyl-oligosaccharide glucosidase (EC 3.2.1.106) (Endoplasmic reticulum alpha-glucosidase I) (ER glu I) (Glucosidase 1) (Glycoprotein-processing glucosidase I),oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487],GO:0004573; GO:0005789; GO:0006487; GO:0009311
997,Pocillopora_acuta_HIv2___RNAseq.g11548.t1,128.4927108,-8.061113984,3.277119528,1.82E-06,2.63E-05,,Q96P65,1.17E-28,Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870; GO:0042277
998,Pocillopora_acuta_HIv2___RNAseq.g20660.t1,345.1790861,-0.852272734,1.553408892,1.82E-06,2.64E-05,,O18598,2.16E-31,Glutathione S-transferase (EC 2.5.1.18) (GST class-sigma) (Major allergen Bla g 5) (allergen Bla g 5),,GO:0004364
999,Pocillopora_acuta_HIv2___RNAseq.g28453.t1,326.2093142,-0.221352242,1.052281335,1.84E-06,2.66E-05,,Q12923,1.42E-56,Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1),cellular response to toxic substance [GO:0097237]; negative regulation of excitatory synapse assembly [GO:1904890]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],GO:0001650; GO:0001933; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0030027; GO:0035335; GO:0036312; GO:0044297; GO:0051896; GO:0070062; GO:0097237; GO:1904890
1000,Pocillopora_acuta_HIv2___RNAseq.g612.t1,391.8290462,-0.699590136,1.311813862,1.85E-06,2.68E-05,,Q54TM7,2.45E-23,Probable serine/threonine-protein kinase drkD (EC 2.7.11.1) (Receptor-like kinase D),defense response to Gram-negative bacterium [GO:0050829]; negative regulation of cell motility [GO:2000146]; negative regulation of phagocytosis [GO:0050765]; peptidyl-serine autophosphorylation [GO:0036289]; response to folic acid [GO:0051593],GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0036289; GO:0050765; GO:0050829; GO:0051593; GO:0106310; GO:2000146
1001,Pocillopora_acuta_HIv2___RNAseq.g28846.t1,635.0789592,-0.505511939,1.146147436,1.86E-06,2.68E-05,,E2RFJ3,3.13E-92,Ferroportin (Solute carrier family 40 protein member 1),iron ion export across plasma membrane [GO:1903988],GO:0005381; GO:0016323; GO:0017046; GO:0046872; GO:1903988
1002,Pocillopora_acuta_HIv2___TS.g23115.t1,82.01846733,-10.48704274,3.927626746,1.87E-06,2.70E-05,,P10079,8.89E-84,Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1),,GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579
1003,Pocillopora_acuta_HIv2___RNAseq.g25411.t1,226.3981095,-0.281438139,1.078218751,1.88E-06,2.71E-05,,Q24UI6,1.53E-09,Translation initiation factor IF-2,,GO:0003743; GO:0003924; GO:0005525; GO:0005737
1004,Pocillopora_acuta_HIv2___RNAseq.g936.t1,2339.963113,-3.076111295,0.767498253,1.88E-06,2.71E-05,,Q86TI4,2.51E-93,WD repeat-containing protein 86,,
1005,Pocillopora_acuta_HIv2___RNAseq.g14987.t1,487.8394937,-0.553902444,1.186375879,1.88E-06,2.71E-05,,P48509,5.07E-18,CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151),"cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]",GO:0005178; GO:0005604; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0009986; GO:0016020; GO:0016477; GO:0030335; GO:0042098; GO:0044319; GO:0045807
1006,Pocillopora_acuta_HIv2___TS.g9513.t1,11530.17861,-3.742421497,3.733002371,1.89E-06,2.72E-05,,Q9VIK2,1.18E-56,Carcinine transporter,carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601],GO:0001504; GO:0005326; GO:0005886; GO:0007601; GO:0043679; GO:0046956; GO:0050908; GO:1905130; GO:1905131
1007,Pocillopora_acuta_HIv2___RNAseq.g11877.t2b,2944.036552,3.662839935,1.015017138,1.91E-06,2.74E-05,,Q8IUL8,7.39E-55,Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2],,GO:0005615; GO:0070062
1008,Pocillopora_acuta_HIv2___RNAseq.g17483.t1,186.4957473,-0.852812063,1.59275407,1.94E-06,2.78E-05,,P09884,6.29E-161,DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180),"DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of type I interferon production [GO:0032479]",GO:0000166; GO:0000731; GO:0000785; GO:0003677; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006281; GO:0006303; GO:0008270; GO:0016363; GO:0019901; GO:0032479; GO:1902975
1009,Pocillopora_acuta_HIv2___RNAseq.g30426.t1,140.0765868,-0.460618449,1.178459593,1.96E-06,2.81E-05,,A0A1L8FZ98,9.46E-76,Peroxisome biogenesis factor 2 (EC 2.3.2.27) (EC 2.3.2.36) (Peroxin-2),"pexophagy [GO:0000425]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein ubiquitination [GO:0016567]; response to amino acid starvation [GO:1990928]",GO:0000425; GO:0005778; GO:0008270; GO:0016562; GO:0016567; GO:0061630; GO:1990928
1010,Pocillopora_acuta_HIv2___TS.g22566.t1,419.9066045,0.855087171,1.498063116,1.96E-06,2.81E-05,,NA,NA,NA,NA,NA
1011,Pocillopora_acuta_HIv2___RNAseq.g4064.t1,355.061998,-0.507124401,1.138621171,2.00E-06,2.86E-05,,Q3ZBH0,0,T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta),protein folding [GO:0006457],GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082; GO:0140662
1012,Pocillopora_acuta_HIv2___RNAseq.g24372.t1,749.5539639,-0.670241691,1.281151142,2.01E-06,2.87E-05,,Q9D0T2,1.30E-79,Dual specificity protein phosphatase 12 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase T-DSP4) (Dual specificity phosphatase VH1),dephosphorylation [GO:0016311],GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0008270; GO:0016311; GO:0017018; GO:0019900
1013,Pocillopora_acuta_HIv2___RNAseq.g7892.t1,259.9367147,-0.657155185,1.329655794,2.03E-06,2.90E-05,,A3KG59,1.31E-115,Xaa-Arg dipeptidase (EC 3.4.13.4),proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246
1014,Pocillopora_acuta_HIv2___RNAseq.g701.t1,129.2228777,-8.267885945,3.517509967,2.05E-06,2.92E-05,,H2LRU7,3.96E-27,Polycystin-2 (Polycystic kidney disease 2 protein homolog),calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055],GO:0003127; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005789; GO:0005886; GO:0005929; GO:0007166; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662
1015,Pocillopora_acuta_HIv2___TS.g25420.t1,749.7607382,-0.497170151,1.125421543,2.05E-06,2.92E-05,,NA,NA,NA,NA,NA
1016,Pocillopora_acuta_HIv2___RNAseq.g4030.t1,142.2684729,-7.967409592,3.394278407,2.05E-06,2.92E-05,,Q6DCV0,5.29E-164,WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45),autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786],GO:0000045; GO:0000407; GO:0009267; GO:0032266; GO:1901981; GO:2000786
1017,Pocillopora_acuta_HIv2___RNAseq.g702.t1,58.20862203,-10.11213927,3.667626181,2.06E-06,2.93E-05,,Q26627,2.92E-39,Sperm receptor for egg jelly (suREJ),detection of mechanical stimulus [GO:0050982],GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0030246; GO:0050982
1018,Pocillopora_acuta_HIv2___RNAseq.g22863.t1,681.0974966,-0.655767724,1.290059849,2.06E-06,2.93E-05,,Q6PHN7,7.14E-72,Transmembrane protein 164 (Arachidonoyl ether phospholipid synthase),positive regulation of ferroptosis [GO:0160020],GO:0016020; GO:0160020
1019,Pocillopora_acuta_HIv2___TS.g25599.t1,10009.48628,6.386912128,2.578251211,2.07E-06,2.94E-05,,NA,NA,NA,NA,NA
1020,Pocillopora_acuta_HIv2___RNAseq.g29841.t1,816.0022374,-5.135190425,2.019022383,2.08E-06,2.94E-05,,O00339,8.25E-51,Matrilin-2,axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678],GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216
1021,Pocillopora_acuta_HIv2___RNAseq.g14156.t1,1140.608868,-0.825724665,1.465859211,2.09E-06,2.96E-05,,Q8HXY4,0,"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha)",branched-chain amino acid catabolic process [GO:0009083],GO:0003863; GO:0005759; GO:0009083; GO:0046872; GO:0160157
1022,Pocillopora_acuta_HIv2___RNAseq.g18958.t1,1870.13484,3.771264162,1.092393351,2.11E-06,2.99E-05,,NA,NA,NA,NA,NA
1023,Pocillopora_acuta_HIv2___RNAseq.g3018.t1,984.3846811,-0.316751097,1.056422866,2.15E-06,3.04E-05,,O43264,0,Centromere/kinetochore protein zw10 homolog,"cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",GO:0000070; GO:0000132; GO:0000776; GO:0000922; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0005828; GO:0005829; GO:0006888; GO:0006890; GO:0007030; GO:0007080; GO:0007094; GO:0007096; GO:0015031; GO:0016020; GO:0019237; GO:0034501; GO:0051301; GO:0051321; GO:0051988; GO:0065003; GO:0070939; GO:1990423
1024,Pocillopora_acuta_HIv2___RNAseq.g17580.t1,634.0076611,-0.462990311,1.176537242,2.15E-06,3.04E-05,,Q01484,2.35E-25,Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin),atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259
1025,Pocillopora_acuta_HIv2___RNAseq.g4383.t1,634.5903647,-4.966090449,4.05746923,2.16E-06,3.04E-05,,D2GXS7,1.41E-15,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0030371; GO:0043161; GO:0043523; GO:0061630
1026,Pocillopora_acuta_HIv2___RNAseq.g28456.t1,404.0988497,-0.830859444,1.516430453,2.18E-06,3.07E-05,,O57478,0,"Ferrochelatase, mitochondrial (EC 4.98.1.1) (Heme synthase) (Protoheme ferro-lyase)",heme biosynthetic process [GO:0006783],GO:0004325; GO:0005743; GO:0006783; GO:0046872; GO:0051537
1027,Pocillopora_acuta_HIv2___RNAseq.g17464.t1,349.1807242,-0.782547771,1.477864862,2.19E-06,3.08E-05,,NA,NA,NA,NA,NA
1028,Pocillopora_acuta_HIv2___TS.g15563.t1b,488.3779493,-0.826556507,1.480409582,2.20E-06,3.10E-05,,Q2TBV5,9.54E-169,General transcription factor IIH subunit 2 (General transcription factor IIH polypeptide 2),nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],GO:0000438; GO:0005634; GO:0005675; GO:0006289; GO:0006357; GO:0006366; GO:0008270
1029,Pocillopora_acuta_HIv2___RNAseq.g9603.t1,749.2971249,-5.046523763,1.958734863,2.25E-06,3.16E-05,,P36514,2.08E-91,UDP-glucuronosyltransferase 2C1 (UDPGT 2C1) (EC 2.4.1.17),lipid metabolic process [GO:0006629],GO:0005789; GO:0006629; GO:0015020
1030,Pocillopora_acuta_HIv2___RNAseq.g26782.t1,73.09334745,-10.40217184,3.837850315,2.28E-06,3.19E-05,,Q9DER7,2.57E-97,Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid),cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485],GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154
1031,Pocillopora_acuta_HIv2___RNAseq.g9150.t1,479.9130539,4.96546075,1.849291246,2.32E-06,3.25E-05,,NA,NA,NA,NA,NA
1032,Pocillopora_acuta_HIv2___RNAseq.g28149.t1,307.4598373,-0.726884161,1.424018891,2.35E-06,3.29E-05,,NA,NA,NA,NA,NA
1033,Pocillopora_acuta_HIv2___RNAseq.g30517.t1,497.9379877,-0.461540817,1.122724324,2.39E-06,3.35E-05,,NA,NA,NA,NA,NA
1034,Pocillopora_acuta_HIv2___RNAseq.g12597.t1,804.9392331,-0.44158156,1.099080989,2.40E-06,3.35E-05,,Q3TXU5,0,Deoxyhypusine synthase (DHS) (EC 2.5.1.46),glucose homeostasis [GO:0042593]; positive regulation of T cell proliferation [GO:0042102]; spermidine catabolic process [GO:0046203],GO:0005737; GO:0034038; GO:0042102; GO:0042593; GO:0042802; GO:0046203
1035,Pocillopora_acuta_HIv2___RNAseq.g25708.t1,635.8756021,-1.205273176,2.17279875,2.40E-06,3.36E-05,,Q8IVV2,0,Lipoxygenase homology domain-containing protein 1,sensory perception of sound [GO:0007605],GO:0007605; GO:0032420
1036,Pocillopora_acuta_HIv2___RNAseq.g28169.t1,119.663113,-5.396747311,1.515719037,2.42E-06,3.38E-05,,F6QEU4,1.29E-49,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177
1037,Pocillopora_acuta_HIv2___RNAseq.g28450.t1,209.3304923,3.296300135,0.850025452,2.43E-06,3.39E-05,,P35033,1.19E-62,Trypsin-3 (EC 3.4.21.4) (Trypsin III),digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872
1038,Pocillopora_acuta_HIv2___RNAseq.g9863.t1,107.3310673,-7.772159927,3.085392393,2.44E-06,3.39E-05,,NA,NA,NA,NA,NA
1039,Pocillopora_acuta_HIv2___RNAseq.g1109.t2,242.5782531,-0.884431352,1.613900321,2.44E-06,3.40E-05,,Q6QNK2,3.35E-09,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607
1040,Pocillopora_acuta_HIv2___RNAseq.g22820.t1,440.2014966,-0.612099804,1.239061987,2.46E-06,3.42E-05,,P0CB05,1.28E-57,Centrosomal protein of 63 kDa (Cep63),cell division [GO:0051301]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; DNA damage checkpoint signaling [GO:0000077]; signal transduction in response to DNA damage [GO:0042770]; spindle assembly [GO:0051225],GO:0000077; GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0042770; GO:0051225; GO:0051301; GO:0098535
1041,Pocillopora_acuta_HIv2___RNAseq.5685_t,266.6537656,-5.184493898,3.488473677,2.46E-06,3.42E-05,,NA,NA,NA,NA,NA
1042,Pocillopora_acuta_HIv2___RNAseq.g9743.t1,177.7938081,-0.395514932,1.137107779,2.47E-06,3.43E-05,,Q9Z321,0,DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1),chromosome segregation [GO:0007059]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA topological change [GO:0006265],GO:0000793; GO:0003677; GO:0003917; GO:0005634; GO:0006265; GO:0006281; GO:0006310; GO:0007059; GO:0140225
1043,Pocillopora_acuta_HIv2___TS.g24185.t1,681.1960544,-1.462643164,2.640095173,2.52E-06,3.49E-05,,NA,NA,NA,NA,NA
1044,Pocillopora_acuta_HIv2___RNAseq.g18951.t1,944.6810778,-5.234595381,3.325640993,2.53E-06,3.50E-05,,Q3SYV5,2.73E-65,Tetraspanin-33 (Tspan-33),protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659
1045,Pocillopora_acuta_HIv2___RNAseq.g26134.t1,1184.88041,-0.72461326,1.296578588,2.53E-06,3.50E-05,,O13076,8.40E-17,Adenosine receptor A2b (Adenosine receptor 2b),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cGMP-mediated signaling [GO:0019934]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; relaxation of vascular associated smooth muscle [GO:0060087]; vasodilation [GO:0042311],GO:0001609; GO:0002882; GO:0004930; GO:0005886; GO:0007189; GO:0010575; GO:0010753; GO:0019934; GO:0032722; GO:0032755; GO:0042311; GO:0043303; GO:0043306; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171
1046,Pocillopora_acuta_HIv2___RNAseq.g19787.t1,104.2718553,-6.748859367,2.136798776,2.54E-06,3.51E-05,,NA,NA,NA,NA,NA
1047,Pocillopora_acuta_HIv2___TS.g23179.t1,1052.766906,0.236416222,1.042738492,2.58E-06,3.57E-05,,P43903,3.95E-67,Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase),,GO:0003960; GO:0005829; GO:0008270; GO:0035925; GO:0070402
1048,Pocillopora_acuta_HIv2___TS.g4502.t1,763.5846846,0.262679421,1.05533165,2.62E-06,3.61E-05,Homeobox protein Nkx-2.4,Q9EQM3,2.51E-24,Homeobox protein Nkx-2.4 (Homeobox protein NK-2 homolog D),cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030154
1049,Pocillopora_acuta_HIv2___RNAseq.7292_t,196.4960409,-1.070040295,1.949280836,2.65E-06,3.66E-05,,Q99PW8,0,Kinesin-like protein KIF17 (MmKIF17),anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098794; GO:0098971; GO:1990075
1050,Pocillopora_acuta_HIv2___RNAseq.g17311.t1,2064.858451,3.513629051,0.984625316,2.66E-06,3.67E-05,,A6QLN9,1.27E-13,von Willebrand factor A domain-containing protein 1,translation [GO:0006412],GO:0003735; GO:0005576; GO:0005604; GO:0005840; GO:0006412; GO:0062023
1051,Pocillopora_acuta_HIv2___RNAseq.g13486.t1,447.3839158,-0.77188515,1.435361075,2.70E-06,3.71E-05,,Q921L8,3.94E-17,Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11),cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593],GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0006493; GO:0007220; GO:0007368; GO:0008593; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314
1052,Pocillopora_acuta_HIv2___RNAseq.g16987.t1,378.318812,-0.800734268,1.516489569,2.70E-06,3.72E-05,,Q02447,5.20E-43,Transcription factor Sp3 (SPR-2),B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; myeloid progenitor cell differentiation [GO:0002318]; natural killer cell differentiation [GO:0001779]; negative regulation of DNA-templated transcription [GO:0045892]; ossification [GO:0001503]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829],GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001779; GO:0001829; GO:0001889; GO:0001892; GO:0002318; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0032993; GO:0043353; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048596; GO:0048706; GO:0060136; GO:0060216; GO:0061629; GO:1990837
1053,Pocillopora_acuta_HIv2___RNAseq.g26093.t1,292.7048938,-1.264668748,2.252577152,2.72E-06,3.73E-05,,NA,NA,NA,NA,NA
1054,Pocillopora_acuta_HIv2___RNAseq.g9208.t1,98.29619374,0.331473635,1.097714719,2.73E-06,3.74E-05,,NA,NA,NA,NA,NA
1055,Pocillopora_acuta_HIv2___RNAseq.25954_t,318.1680526,-0.739782204,1.331570239,2.73E-06,3.74E-05,,Q3SJU1,2.09E-49,Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase),protein repair [GO:0030091]; response to oxidative stress [GO:0006979],GO:0005737; GO:0006979; GO:0008270; GO:0030091; GO:0033743
1056,Pocillopora_acuta_HIv2___RNAseq.g11768.t1,182.5473536,-8.064978079,3.899677965,2.74E-06,3.74E-05,,NA,NA,NA,NA,NA
1057,Pocillopora_acuta_HIv2___RNAseq.g25817.t1,377.8201344,0.363114321,1.098184096,2.74E-06,3.74E-05,,NA,NA,NA,NA,NA
1058,Pocillopora_acuta_HIv2___TS.g10198.t2,278.9680722,-1.304146387,2.387097129,2.76E-06,3.77E-05,,Q9UMZ3,1.08E-40,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48),regulation of fat cell differentiation [GO:0045598],GO:0004725; GO:0009925; GO:0016324; GO:0043235; GO:0045598; GO:0120044
1059,Pocillopora_acuta_HIv2___RNAseq.g218.t1,550.9508798,-0.253316751,1.066214105,2.77E-06,3.79E-05,,NA,NA,NA,NA,NA
1060,Pocillopora_acuta_HIv2___RNAseq.g25885.t1,338.2784717,6.119491572,2.906366733,2.78E-06,3.79E-05,Solute carrier family 22 member 15,Q8IZD6,8.86E-61,Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1),amino acid transport [GO:0006865]; monoatomic ion transport [GO:0006811],GO:0005886; GO:0006811; GO:0006865; GO:0015199
1061,Pocillopora_acuta_HIv2___TS.g16682.t1,358.978191,-0.736055773,1.335116281,2.78E-06,3.79E-05,,Q642F4,8.10E-76,Vesicle-trafficking protein SEC22a (SEC22 vesicle-trafficking protein homolog A) (SEC22 vesicle-trafficking protein-like 2) (rSec22a),endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031],GO:0005789; GO:0006888; GO:0015031
1062,Pocillopora_acuta_HIv2___RNAseq.g12339.t1,344.8161696,-0.977245367,1.667678707,2.79E-06,3.80E-05,,Q08DP0,0,Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1),carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006],GO:0000287; GO:0004614; GO:0005829; GO:0005975; GO:0006006
1063,Pocillopora_acuta_HIv2___RNAseq.g13940.t1,129.6960316,-7.716155771,3.303800903,2.79E-06,3.80E-05,,NA,NA,NA,NA,NA
1064,Pocillopora_acuta_HIv2___RNAseq.g1217.t1,278.8045561,-4.532388033,5.847872513,2.82E-06,3.83E-05,,P29274,2.79E-14,Adenosine receptor A2a,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of calcium ion transport [GO:0051924]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]",GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005882; GO:0005886; GO:0006355; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007188; GO:0007189; GO:0007205; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0008289; GO:0009410; GO:0014049; GO:0014057; GO:0014061; GO:0014074; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0042311; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0097190; GO:0098978; GO:0099171; GO:1900273; GO:2001235
1065,Pocillopora_acuta_HIv2___RNAseq.g1030.t1,175.9717395,-7.792808103,3.447959811,2.83E-06,3.84E-05,,Q90X67,3.13E-30,Suppressor of cytokine signaling 3 (SOCS-3),intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein ubiquitination [GO:0016567],GO:0005942; GO:0009968; GO:0016567; GO:0035556; GO:0046854; GO:0046935
1066,Pocillopora_acuta_HIv2___RNAseq.g26099.t1,397.6383297,-0.691538634,1.292070546,2.84E-06,3.85E-05,,Q9UIG0,5.57E-80,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2),chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; negative regulation of mitotic chromosome condensation [GO:1905213]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; post-translational protein modification [GO:0043687]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000793; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006338; GO:0006357; GO:0006974; GO:0008270; GO:0035173; GO:0042393; GO:0043687; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0110016; GO:0140801; GO:1905213
1067,Pocillopora_acuta_HIv2___RNAseq.g25805.t1,213.1158709,-1.133907759,2.331283997,2.85E-06,3.86E-05,,O74549,2.16E-27,NEDD8-conjugating enzyme ubc12 (EC 2.3.2.34) (RUB1-conjugating enzyme) (Ubiquitin carrier protein 12),protein neddylation [GO:0045116],GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654
1068,Pocillopora_acuta_HIv2___RNAseq.g30774.t1,358.1837848,-7.936891718,3.77005125,2.86E-06,3.87E-05,,NA,NA,NA,NA,NA
1069,Pocillopora_acuta_HIv2___RNAseq.g22370.t1,314.560571,0.772695223,1.41925433,2.91E-06,3.94E-05,,P23780,0,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),galactose catabolic process [GO:0019388]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005773; GO:0005794; GO:0016787; GO:0016936; GO:0019388; GO:0042803; GO:0051413; GO:1904016
1070,Pocillopora_acuta_HIv2___RNAseq.g20371.t1,870.5811899,-0.387934896,1.066992845,2.93E-06,3.95E-05,,Q95L74,0,Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (Neutrophil cytochrome b 91 kDa polypeptide) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome),inflammatory response [GO:0006954]; innate immune response [GO:0045087]; monoatomic ion transmembrane transport [GO:0034220]; superoxide metabolic process [GO:0006801],GO:0006801; GO:0006954; GO:0016491; GO:0034220; GO:0034702; GO:0043020; GO:0045087; GO:0046872
1071,Pocillopora_acuta_HIv2___RNAseq.g10498.t1,139.4811852,-0.98754019,1.83195123,2.94E-06,3.97E-05,,NA,NA,NA,NA,NA
1072,Pocillopora_acuta_HIv2___TS.g11855.t2,102.7948138,-8.008896093,3.474159988,2.96E-06,4.00E-05,,NA,NA,NA,NA,NA
1073,Pocillopora_acuta_HIv2___RNAseq.g7683.t1,792.4209627,-4.342462821,3.957106301,2.97E-06,4.00E-05,,Q9ULH7,2.01E-40,Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2),muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145],GO:0003713; GO:0005634; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145; GO:1902895
1074,Pocillopora_acuta_HIv2___TS.g4466.t2,150.3453326,-7.897919825,3.803178758,2.97E-06,4.00E-05,,Q1RLY6,9.20E-175,Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase),'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; podocyte development [GO:0072015]; quinolinate biosynthetic process [GO:0019805]; response to yeast [GO:0001878]; tryptophan catabolic process [GO:0006569],GO:0001878; GO:0004502; GO:0005741; GO:0006569; GO:0019674; GO:0019805; GO:0034354; GO:0043420; GO:0070189; GO:0071949; GO:0072015
1075,Pocillopora_acuta_HIv2___RNAseq.21243_t,439.9684804,-0.629967974,1.238931768,2.98E-06,4.01E-05,,Q8WYR4,1.92E-56,Radial spoke head 1 homolog (Cancer/testis antigen 79) (CT79) (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],GO:0000794; GO:0001520; GO:0001535; GO:0005634; GO:0005829; GO:0007286; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0120336; GO:0120338
1076,Pocillopora_acuta_HIv2___RNAseq.g12120.t1,238.6081856,-0.271706814,1.074122134,2.99E-06,4.02E-05,,Q2KIL7,6.47E-29,R3H domain-containing protein 4,,GO:0003676; GO:0005634
1077,Pocillopora_acuta_HIv2___RNAseq.g23801.t1a,542.5633106,-0.684377792,1.30696222,3.06E-06,4.11E-05,,Q5K6N0,4.62E-28,Transmembrane protein 232 (Testis-specific protein 13),cell projection organization [GO:0030030]; flagellated sperm motility [GO:0030317]; maintenance of protein complex location [GO:0098544]; spermatid cytoplasm removal during spermiation of flagellated sperm [GO:0160087]; spermatogenesis [GO:0007283],GO:0001520; GO:0007283; GO:0016020; GO:0030030; GO:0030317; GO:0098544; GO:0160087
1078,Pocillopora_acuta_HIv2___RNAseq.g1468.t1,992.6011043,-0.437983406,1.140886704,3.10E-06,4.16E-05,,Q8CHU3,7.06E-112,Epsin-2 (EPS-15-interacting protein 2) (Intersectin-EH-binding protein 2) (Ibp2),embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; Notch signaling pathway [GO:0007219]; regulation of endocytosis [GO:0030100],GO:0001701; GO:0005543; GO:0005768; GO:0005886; GO:0006897; GO:0007219; GO:0030100; GO:0030125; GO:0030128; GO:0030276; GO:0048568
1079,Pocillopora_acuta_HIv2___RNAseq.g2235.t1,168.4973125,-0.650306898,1.338072235,3.17E-06,4.25E-05,,NA,NA,NA,NA,NA
1080,Pocillopora_acuta_HIv2___RNAseq.g7777.t1,419.929982,-0.377209857,1.078531297,3.20E-06,4.28E-05,,O75521,1.24E-134,"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)",fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062],GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0009062; GO:0016020; GO:0043231
1081,Pocillopora_acuta_HIv2___RNAseq.g13196.t1,183.1673774,3.626207435,1.019173406,3.21E-06,4.29E-05,,NA,NA,NA,NA,NA
1082,Pocillopora_acuta_HIv2___RNAseq.g20464.t1,1103.579572,-0.230676392,1.023421806,3.21E-06,4.29E-05,,Q8R034,6.28E-17,Anaphase-promoting complex subunit 13 (APC13) (Cyclosome subunit 13),anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936],GO:0005680; GO:0031145; GO:0051301; GO:0070936; GO:0070979; GO:0141198
1083,Pocillopora_acuta_HIv2___TS.g15668.t1,900.8172677,-4.805920324,1.7344234,3.29E-06,4.40E-05,,A2TF48,3.83E-07,Myeloid differentiation primary response protein MyD88,defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 8 signaling pathway [GO:0034158],GO:0002755; GO:0005634; GO:0005737; GO:0005886; GO:0006954; GO:0008063; GO:0032731; GO:0034142; GO:0034158; GO:0035325; GO:0043123; GO:0045087; GO:0050830; GO:0051607; GO:0070976; GO:1900227
1084,Pocillopora_acuta_HIv2___RNAseq.g2214.t1c,148.0123528,-7.602069732,3.269020345,3.30E-06,4.40E-05,,NA,NA,NA,NA,NA
1085,Pocillopora_acuta_HIv2___RNAseq.g25256.t1,327.8517864,-0.257944767,1.068606579,3.36E-06,4.48E-05,,F1QCP6,4.26E-87,Tafazzin (Taz) (EC 2.3.1.-),cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin metabolic process [GO:0032048]; heart development [GO:0007507]; heart looping [GO:0001947]; inner mitochondrial membrane organization [GO:0007007]; mitophagy [GO:0000423]; positive regulation of heart contraction [GO:0045823],GO:0000423; GO:0001947; GO:0005739; GO:0005741; GO:0005743; GO:0007007; GO:0007507; GO:0031966; GO:0032048; GO:0035965; GO:0045823; GO:0047184
1086,Pocillopora_acuta_HIv2___RNAseq.g26111.t1,107.4325089,-0.481296344,1.191935876,3.39E-06,4.52E-05,,NA,NA,NA,NA,NA
1087,Pocillopora_acuta_HIv2___RNAseq.g5063.t1,132.0085368,-7.753257057,3.667803166,3.39E-06,4.52E-05,,Q8GYB1,4.56E-37,"Nudix hydrolase 15, mitochondrial (AtNUDT15) (EC 3.6.1.-) (Coenzyme A diphosphatase NUDT15)",coenzyme A biosynthetic process [GO:0015937]; nucleoside phosphate metabolic process [GO:0006753]; succinyl-CoA metabolic process [GO:0006104],GO:0005739; GO:0006104; GO:0006753; GO:0008893; GO:0010945; GO:0015937; GO:0046872
1088,Pocillopora_acuta_HIv2___RNAseq.g30215.t1,4238.852934,2.927176352,0.75005068,3.42E-06,4.55E-05,,Q9GLP1,1.48E-30,Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain],blood circulation [GO:0008015]; blood coagulation [GO:0007596],GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091
1089,Pocillopora_acuta_HIv2___RNAseq.g28714.t1,191.2222257,-0.701273422,1.394702839,3.44E-06,4.56E-05,,A5D8W1,0,Cilia- and flagella-associated protein 69,flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288],GO:0005737; GO:0007288; GO:0007608; GO:0030317; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834
1090,Pocillopora_acuta_HIv2___RNAseq.g22111.t1,698.0687659,0.463218214,1.18392102,3.48E-06,4.62E-05,,Q7LGC8,1.55E-29,Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (EC 2.8.2.21) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (C6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0),carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]; T cell homeostasis [GO:0043029],GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0030206; GO:0043029; GO:0050698
1091,Pocillopora_acuta_HIv2___RNAseq.g28911.t1,5629.059053,2.94566463,0.757052094,3.50E-06,4.64E-05,,Q75N90,7.52E-85,Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide],anatomical structure morphogenesis [GO:0009653],GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0031012
1092,Pocillopora_acuta_HIv2___RNAseq.g26553.t1,96.45026925,-10.46597437,4.06711464,3.51E-06,4.64E-05,,NA,NA,NA,NA,NA
1093,Pocillopora_acuta_HIv2___RNAseq.g7060.t1,630.0431366,0.39130567,1.110001457,3.51E-06,4.64E-05,,Q2PC93,5.31E-13,SCO-spondin,cell adhesion [GO:0007155],GO:0005615; GO:0007155; GO:0031012
1094,Pocillopora_acuta_HIv2___RNAseq.g14801.t1,617.3523136,-0.246369417,1.063752151,3.52E-06,4.66E-05,,P70414,5.51E-118,Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1),calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to reactive oxygen species [GO:0034614]; embryonic heart tube development [GO:0035050]; embryonic placenta development [GO:0001892]; heart morphogenesis [GO:0003007]; intracellular calcium ion homeostasis [GO:0006874]; muscle cell development [GO:0055001]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; post-embryonic development [GO:0009791]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to hypoxia [GO:0001666]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; vascular associated smooth muscle contraction [GO:0014829],GO:0001666; GO:0001892; GO:0002026; GO:0002027; GO:0002028; GO:0003007; GO:0005432; GO:0005509; GO:0005516; GO:0005874; GO:0005886; GO:0006814; GO:0006816; GO:0006874; GO:0007204; GO:0009791; GO:0010468; GO:0010763; GO:0010881; GO:0014069; GO:0014704; GO:0014829; GO:0016020; GO:0016323; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030506; GO:0033198; GO:0034614; GO:0035050; GO:0035725; GO:0036376; GO:0042383; GO:0042995; GO:0043025; GO:0043197; GO:0043198; GO:0043679; GO:0044325; GO:0044557; GO:0045202; GO:0045211; GO:0051481; GO:0051924; GO:0055001; GO:0055013; GO:0055074; GO:0060048; GO:0060402; GO:0070509; GO:0070588; GO:0071313; GO:0071320; GO:0071901; GO:0086036; GO:0086064; GO:0098703; GO:0098719; GO:0098794; GO:0099580; GO:1901660; GO:1905060
1095,Pocillopora_acuta_HIv2___RNAseq.g3479.t1,531.9365077,-0.491687814,1.152181511,3.54E-06,4.68E-05,,Q7T3E6,7.48E-62,Polycomb complex protein BMI-1-B (Polycomb group RING finger protein 4-B),"cerebellum development [GO:0021549]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]",GO:0000122; GO:0021549; GO:0031519; GO:0035102; GO:0045814; GO:0046872; GO:1990841
1096,Pocillopora_acuta_HIv2___RNAseq.g17608.t1,478.1899961,-0.609231923,1.270136916,3.55E-06,4.68E-05,,NA,NA,NA,NA,NA
1097,Pocillopora_acuta_HIv2___RNAseq.g7741.t1,144.532541,-7.795399112,3.61582584,3.58E-06,4.72E-05,,Q8BH95,1.32E-42,"Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH)",fatty acid beta-oxidation [GO:0006635],GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092
1098,Pocillopora_acuta_HIv2___RNAseq.g24509.t1,416.3012992,-0.611914731,1.272605537,3.60E-06,4.74E-05,,Q4R495,7.33E-142,UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11),,GO:0016020
1099,Pocillopora_acuta_HIv2___RNAseq.g14758.t1,416.487588,-0.496931665,1.129998633,3.64E-06,4.78E-05,,Q6PEC0,1.04E-49,"Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] (EC 3.6.1.17) (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase) (Ap4A hydrolase) (Ap4Aase) (Diadenosine tetraphosphatase) (Nucleoside diphosphate-linked moiety X motif 2) (Nudix motif 2)",AMP biosynthetic process [GO:0006167]; ATP biosynthetic process [GO:0006754],GO:0004081; GO:0005525; GO:0006167; GO:0006754; GO:0016787
1100,Pocillopora_acuta_HIv2___RNAseq.g9598.t1,793.5975128,-0.677474765,1.296241043,3.64E-06,4.78E-05,,Q803R5,0,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (EC 2.1.1.57) (Cap methyltransferase 1) (Cap1 2'O-ribose methyltransferase 1) (MTr1) (FtsJ methyltransferase domain-containing protein 2),7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; mRNA processing [GO:0006397],GO:0003676; GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0006397; GO:0032259
1101,Pocillopora_acuta_HIv2___RNAseq.g12558.t2,785.7565307,-0.366502666,1.063040348,3.64E-06,4.78E-05,,NA,NA,NA,NA,NA
1102,Pocillopora_acuta_HIv2___TS.g5257.t1,364.5354688,-0.846374543,1.586510989,3.72E-06,4.88E-05,,Q4V8C3,2.49E-160,Echinoderm microtubule-associated protein-like 1 (EMAP-1),brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405],GO:0000226; GO:0002244; GO:0005829; GO:0005874; GO:0007052; GO:0007405; GO:0007420; GO:0008017; GO:0015630; GO:0015631; GO:0048471; GO:0097431; GO:1990023
1103,Pocillopora_acuta_HIv2___RNAseq.g5402.t1,841.0291496,-0.320473775,1.062111917,3.76E-06,4.93E-05,,Q5RF83,2.87E-12,Cold-inducible RNA-binding protein (Glycine-rich RNA-binding protein CIRP),mRNA stabilization [GO:0048255]; positive regulation of translation [GO:0045727]; response to UV [GO:0009411]; stress granule assembly [GO:0034063],GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0009411; GO:0010494; GO:0030371; GO:0034063; GO:0045727; GO:0048255; GO:0070181
1104,Pocillopora_acuta_HIv2___RNAseq.g8901.t1,506.7483512,0.305927156,1.05177659,3.78E-06,4.95E-05,,D3YXG0,0,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711
1105,Pocillopora_acuta_HIv2___TS.g563.t1,169.2969882,-0.79145726,1.495213142,3.78E-06,4.95E-05,,NA,NA,NA,NA,NA
1106,Pocillopora_acuta_HIv2___RNAseq.g16654.t1,451.5570199,-0.354797126,1.062197398,3.82E-06,4.99E-05,,O75339,2.59E-88,Cartilage intermediate layer protein 1 (CILP-1) (Cartilage intermediate-layer protein) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2],negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],GO:0005615; GO:0010629; GO:0030512; GO:0043569; GO:0060392; GO:0062023; GO:0070062
1107,Pocillopora_acuta_HIv2___RNAseq.g23813.t1,318.5666889,-0.50495989,1.130719877,3.87E-06,5.05E-05,,Q9R022,4.25E-31,DnaJ homolog subfamily C member 12 (J domain-containing protein 1),,GO:0005737
1108,Pocillopora_acuta_HIv2___RNAseq.g703.t1,1021.555208,3.864193561,1.277280039,3.87E-06,5.06E-05,,NA,NA,NA,NA,NA
1109,Pocillopora_acuta_HIv2___RNAseq.g1031.t1,260.4760339,-0.829059183,1.440503729,3.89E-06,5.07E-05,,Q5EAB6,0,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)",O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],GO:0000139; GO:0006493; GO:0008375; GO:0016020; GO:0016266; GO:0030145; GO:0030246; GO:0047223
1110,Pocillopora_acuta_HIv2___RNAseq.g9784.t1,584.3289265,-0.431486655,1.092275175,3.92E-06,5.11E-05,,A0AVT1,0,Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2),amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004792; GO:0004839; GO:0005524; GO:0005737; GO:0005829; GO:0006511; GO:0007612; GO:0007626; GO:0016567; GO:0016779; GO:0019780; GO:0021764; GO:0021766; GO:0060996
1111,Pocillopora_acuta_HIv2___TS.g5618.t1,10064.38118,5.385801583,1.85864476,3.92E-06,5.11E-05,,Q9UGM3,3.42E-55,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein),defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031],GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062
1112,Pocillopora_acuta_HIv2___TS.g26020.t2,54.29418163,-9.879438157,3.6398443,3.97E-06,5.17E-05,,NA,NA,NA,NA,NA
1113,Pocillopora_acuta_HIv2___RNAseq.g27846.t1,186.3382237,-5.56734555,3.09024336,3.98E-06,5.17E-05,,Q17RP2,6.86E-62,Tigger transposable element-derived protein 6,,GO:0003677; GO:0005634
1114,Pocillopora_acuta_HIv2___RNAseq.g14608.t1,320.7416776,-4.567420484,1.656824534,4.00E-06,5.19E-05,,NA,NA,NA,NA,NA
1115,Pocillopora_acuta_HIv2___RNAseq.g28639.t1,192.2716807,-5.388562977,3.969281721,4.00E-06,5.19E-05,,A0A1L8H0H2,2.61E-37,DNA-binding protein RFX7 (Regulatory factor X 7),positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0000979; GO:0003700; GO:0005634; GO:0045944
1116,Pocillopora_acuta_HIv2___RNAseq.g6432.t1,156.4344684,-0.28582085,1.080070549,4.02E-06,5.21E-05,,Q9NVH0,3.09E-96,Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2),DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid metabolic process [GO:0090304]; replication fork processing [GO:0031297],GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090304; GO:0090734
1117,Pocillopora_acuta_HIv2___RNAseq.10171_t,13842.45472,3.978360483,1.376459918,4.07E-06,5.27E-05,,Q95218,1.53E-53,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin),cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031],GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830
1118,Pocillopora_acuta_HIv2___RNAseq.g20831.t1,377.100848,-0.98462102,1.816684572,4.09E-06,5.29E-05,,Q9UBH6,2.13E-104,Solute carrier family 53 member 1 (Phosphate exporter SLC53A1) (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor) (Xenotropic and polytropic retrovirus receptor 1),cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615],GO:0000822; GO:0001618; GO:0005315; GO:0005737; GO:0005794; GO:0005886; GO:0006817; GO:0009615; GO:0015562; GO:0016036; GO:0030643; GO:0035435
1119,Pocillopora_acuta_HIv2___RNAseq.g11742.t1,239.4444735,-0.935386418,1.731966073,4.11E-06,5.31E-05,,NA,NA,NA,NA,NA
1120,Pocillopora_acuta_HIv2___RNAseq.g2735.t1,1136.209393,-0.502813908,1.191134361,4.12E-06,5.32E-05,,NA,NA,NA,NA,NA
1121,Pocillopora_acuta_HIv2___TS.g27662.t3a,628.3872898,-0.981863425,1.687632257,4.13E-06,5.33E-05,,Q5NVD0,0,U4/U6 small nuclear ribonucleoprotein Prp4 (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4),"mRNA splicing, via spliceosome [GO:0000398]",GO:0000398; GO:0005681; GO:0016607; GO:0017070; GO:0030621; GO:0046540; GO:0071001; GO:0097525
1122,Pocillopora_acuta_HIv2___RNAseq.g12162.t1,533.7666663,0.519596065,1.207380409,4.14E-06,5.34E-05,,O15118,7.79E-58,NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein),adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; cyclodextrin metabolic process [GO:2000900]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intestinal cholesterol absorption [GO:0030299]; intracellular cholesterol transport [GO:0032367]; intracellular lipid transport [GO:0032365]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; macroautophagy [GO:0016236]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TORC1 signaling [GO:1904262]; neurogenesis [GO:0022008]; programmed cell death [GO:0012501]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; symbiont entry into host cell [GO:0046718],GO:0001618; GO:0001889; GO:0004888; GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0010878; GO:0012501; GO:0015485; GO:0016020; GO:0016236; GO:0016242; GO:0022008; GO:0030299; GO:0030301; GO:0031579; GO:0031902; GO:0032365; GO:0032367; GO:0033344; GO:0038023; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1904036; GO:1904262; GO:2000900
1123,Pocillopora_acuta_HIv2___RNAseq.g16613.t1,410.5312359,-0.523655721,1.147586378,4.16E-06,5.36E-05,,NA,NA,NA,NA,NA
1124,Pocillopora_acuta_HIv2___TS.g8082.t1,184.9306619,-5.758449609,2.411447918,4.23E-06,5.44E-05,,Q60855,5.97E-07,Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1),amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA processing [GO:1903800]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; regulation of reactive oxygen species metabolic process [GO:2000377]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0001934; GO:0004672; GO:0004674; GO:0004706; GO:0005123; GO:0005524; GO:0005739; GO:0006915; GO:0006954; GO:0008625; GO:0030163; GO:0031264; GO:0031625; GO:0032757; GO:0032760; GO:0032991; GO:0033209; GO:0035591; GO:0036289; GO:0042327; GO:0042803; GO:0043065; GO:0043066; GO:0043123; GO:0043124; GO:0043235; GO:0043410; GO:0043525; GO:0044877; GO:0045651; GO:0045944; GO:0046330; GO:0046777; GO:0050729; GO:0051092; GO:0060545; GO:0060546; GO:0070105; GO:0070231; GO:0070266; GO:0070301; GO:0070513; GO:0071356; GO:0071363; GO:0097300; GO:0097342; GO:0097343; GO:0097527; GO:0106310; GO:1900119; GO:1901026; GO:1901224; GO:1903265; GO:1903800; GO:1990000; GO:2000377; GO:2001237; GO:2001238; GO:2001240
1125,Pocillopora_acuta_HIv2___TS.g16611.t1,68.50210105,-10.16436116,3.90860232,4.24E-06,5.46E-05,,Q8N972,1.61E-170,Zinc finger protein 709,regulation of transcription by RNA polymerase II [GO:0006357],GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872
1126,Pocillopora_acuta_HIv2___RNAseq.g6071.t1,129.6611784,-7.682398202,3.628224248,4.32E-06,5.55E-05,,NA,NA,NA,NA,NA
1127,Pocillopora_acuta_HIv2___TS.g3927.t1,500.1706428,-0.380161787,1.076988057,4.36E-06,5.59E-05,,Q9DE14,0,Serine/threonine-protein kinase atr (Xatr) (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein),DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105],GO:0000077; GO:0003677; GO:0004674; GO:0005524; GO:0005635; GO:0006281; GO:0016605; GO:0018105; GO:0035979; GO:0046982; GO:0051081; GO:0090734; GO:0106310
1128,Pocillopora_acuta_HIv2___TS.g21616.t3a,735.6050539,-3.705623532,1.145270012,4.37E-06,5.60E-05,,Q6R520,2.51E-51,Calmodulin (CaM),,GO:0005509; GO:0030234
1129,Pocillopora_acuta_HIv2___RNAseq.g334.t1,1218.883364,-3.337007253,0.948944398,4.37E-06,5.60E-05,,F8WLE0,0,Kinesin-like protein KIF28P (Kinesin-like protein 6),cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0030705; GO:0031966; GO:0072384
1130,Pocillopora_acuta_HIv2___RNAseq.g29856.t1,135.7503406,-0.294608871,1.083795942,4.40E-06,5.64E-05,,Q07263,2.25E-78,Neuronal acetylcholine receptor subunit alpha-3,"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; nervous system development [GO:0007399]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]",GO:0005794; GO:0005886; GO:0005892; GO:0007165; GO:0007271; GO:0007399; GO:0015464; GO:0022848; GO:0035094; GO:0035095; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0060084; GO:0095500
1131,Pocillopora_acuta_HIv2___RNAseq.g25834.t1,1000.34255,-0.40921184,1.082784353,4.41E-06,5.64E-05,,Q9BXB4,0,Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11),fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890],GO:0005654; GO:0005794; GO:0005829; GO:0006869; GO:0010890; GO:0016020; GO:0031902; GO:0032934; GO:0045444
1132,Pocillopora_acuta_HIv2___TS.g19896.t2,437.4645589,-0.710243867,1.309983949,4.45E-06,5.68E-05,,NA,NA,NA,NA,NA
1133,Pocillopora_acuta_HIv2___RNAseq.665_t,411.692399,-1.012463113,1.773340331,4.46E-06,5.69E-05,,Q15319,1.61E-90,"POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C)",axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601],GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007601; GO:0007605; GO:0021562; GO:0031290; GO:0042472; GO:0042491; GO:0045944; GO:0048675; GO:0050885; GO:0051402; GO:1990837
1134,Pocillopora_acuta_HIv2___RNAseq.g29941.t1,26708.53418,3.10382736,0.8302242,4.49E-06,5.73E-05,,NA,NA,NA,NA,NA
1135,Pocillopora_acuta_HIv2___RNAseq.g5717.t1,255.3794251,-0.64639911,1.33250324,4.56E-06,5.81E-05,,NA,NA,NA,NA,NA
1136,Pocillopora_acuta_HIv2___RNAseq.g18126.t1,202.7518178,0.920013047,1.581225396,4.56E-06,5.81E-05,,Q924H0,2.29E-43,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408],GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408
1137,Pocillopora_acuta_HIv2___RNAseq.g30923.t1,582.3196426,-0.24459363,1.063515029,4.59E-06,5.84E-05,,Q5U315,3.85E-47,Poly(A) RNA polymerase GLD2 (EC 2.7.7.19) (PAP-associated domain-containing protein 4) (Terminal nucleotidyltransferase 2),dark adaptation [GO:1990603]; hematopoietic progenitor cell differentiation [GO:0002244]; hippocampus development [GO:0021766]; histone mRNA catabolic process [GO:0071044]; mRNA 3'-end processing [GO:0031124]; negative regulation of miRNA catabolic process [GO:2000626]; neuron differentiation [GO:0030182]; positive regulation of protein targeting to membrane [GO:0090314]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of translation at postsynapse [GO:0140245]; retina development in camera-type eye [GO:0060041]; RNA polyadenylation at postsynapse [GO:0140235],GO:0002244; GO:0005524; GO:0005634; GO:0005737; GO:0021766; GO:0030182; GO:0031124; GO:0046872; GO:0060041; GO:0071044; GO:0090314; GO:0098794; GO:0098978; GO:0099170; GO:0140235; GO:0140240; GO:0140245; GO:1990603; GO:1990817; GO:2000626
1138,Pocillopora_acuta_HIv2___TS.g18458.t1,221.5046448,-0.725988213,1.418558001,4.61E-06,5.86E-05,,A2R7P5,6.75E-06,Stress response protein nst1,,GO:0005737
1139,Pocillopora_acuta_HIv2___RNAseq.g9374.t1,382.0909403,8.51683517,4.05643159,4.64E-06,5.89E-05,,Q6NXR0,6.95E-58,Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1),positive regulation of flagellated sperm motility [GO:1902093],GO:0003924; GO:0005525; GO:0005811; GO:0016020; GO:0036126; GO:0097226; GO:1902093
1140,Pocillopora_acuta_HIv2___RNAseq.g2625.t1,267.7244181,-0.699789987,1.384556851,4.71E-06,5.97E-05,,NA,NA,NA,NA,NA
1141,Pocillopora_acuta_HIv2___RNAseq.g26722.t1,873.9172588,-2.635779587,0.661197894,4.72E-06,5.98E-05,,NA,NA,NA,NA,NA
1142,Pocillopora_acuta_HIv2___RNAseq.g30590.t1,495.6295641,-0.358327708,1.073772845,4.76E-06,6.03E-05,,NA,NA,NA,NA,NA
1143,Pocillopora_acuta_HIv2___RNAseq.g6726.t2,404.3367148,0.927026819,1.598126727,4.79E-06,6.05E-05,,Q91035,1.55E-97,Sonic hedgehog protein (SHH) (EC 3.1.-.-) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) [Cleaved into: Sonic hedgehog protein N-product (ShhN) (Shh N-terminal processed signaling domains) (ShhNp)],anterior/posterior pattern specification [GO:0009952]; apoptotic signaling pathway [GO:0097190]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell fate specification involved in pattern specification [GO:0060573]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; commissural neuron axon guidance [GO:0071679]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; fibroblast growth factor production [GO:0090269]; floor plate formation [GO:0021508]; growth plate cartilage chondrocyte growth [GO:0003430]; homeostasis of number of retina cells [GO:0048877]; intein-mediated protein splicing [GO:0016539]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; oligodendrocyte differentiation [GO:0048709]; optic cup formation involved in camera-type eye development [GO:0003408]; optic nerve morphogenesis [GO:0021631]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; positive regulation of gene expression [GO:0010628]; positive regulation of neural retina development [GO:0061075]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of cell differentiation involved in tissue homeostasis [GO:0060786]; regulation of gene expression [GO:0010468]; regulation of neural precursor cell proliferation [GO:2000177]; response to retinoic acid [GO:0032526]; retina homeostasis [GO:0001895]; retinal pigment epithelium development [GO:0003406]; self proteolysis [GO:0097264]; signaling [GO:0023052]; smoothened signaling pathway [GO:0007224]; spinal cord dorsal/ventral patterning [GO:0021513]; tissue development [GO:0009888],GO:0000139; GO:0001708; GO:0001709; GO:0001895; GO:0003406; GO:0003408; GO:0003430; GO:0005113; GO:0005509; GO:0005576; GO:0005615; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0008270; GO:0009880; GO:0009888; GO:0009949; GO:0009951; GO:0009952; GO:0010468; GO:0010628; GO:0016015; GO:0016539; GO:0016540; GO:0021508; GO:0021513; GO:0021631; GO:0023052; GO:0030326; GO:0030514; GO:0032526; GO:0042733; GO:0043066; GO:0045880; GO:0048709; GO:0048877; GO:0060059; GO:0060573; GO:0060591; GO:0060785; GO:0060786; GO:0061075; GO:0071679; GO:0090269; GO:0097190; GO:0097264; GO:0140853; GO:2000177
1144,Pocillopora_acuta_HIv2___RNAseq.g2158.t1,348.1275627,-0.976821776,1.732215236,4.79E-06,6.05E-05,,Q6P255,4.30E-24,Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11),regulation of transcription by RNA polymerase II [GO:0006357],GO:0003712; GO:0006357; GO:0016592
1145,Pocillopora_acuta_HIv2___RNAseq.g8285.t1,847.1625805,-0.207311475,1.027982032,4.79E-06,6.05E-05,,A6NJI9,3.05E-48,Leucine-rich repeat-containing protein 72,,
1146,Pocillopora_acuta_HIv2___TS.g25396.t1,342.6692998,-0.253306267,1.066789956,4.79E-06,6.05E-05,,NA,NA,NA,NA,NA
1147,Pocillopora_acuta_HIv2___TS.g5158.t1,876.2136103,-0.432184344,1.104331264,4.81E-06,6.06E-05,,Q5F464,5.10E-78,Lipoma-preferred partner homolog,cell-cell adhesion [GO:0098609],GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609
1148,Pocillopora_acuta_HIv2___RNAseq.g11209.t1,483.391751,-0.470393578,1.115948851,4.88E-06,6.15E-05,,Q29496,3.17E-107,Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24),oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202],GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0020037; GO:0050649; GO:0070330; GO:0070989
1149,Pocillopora_acuta_HIv2___TS.g19253.t1,100.1454072,-7.03313702,3.481330758,4.88E-06,6.15E-05,,P54886,0,Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)],citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]; response to temperature stimulus [GO:0009266],GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0006536; GO:0006561; GO:0006592; GO:0009266; GO:0019240; GO:0042802; GO:0055129
1150,Pocillopora_acuta_HIv2___TS.g19435.t1,970.0516562,5.128109638,2.355041501,4.99E-06,6.27E-05,,Q70AG8,2.82E-26,"Alpha-(1,3)-fucosyltransferase 11 (EC 2.4.1.-) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11)",protein glycosylation [GO:0006486],GO:0000139; GO:0006486; GO:0032580; GO:0046920
1151,Pocillopora_acuta_HIv2___RNAseq.g20518.t1,3244.629041,4.610043878,1.429559329,5.01E-06,6.30E-05,,NA,NA,NA,NA,NA
1152,Pocillopora_acuta_HIv2___RNAseq.g26711.t1,1640.37593,-2.515537145,0.624286456,5.03E-06,6.32E-05,,NA,NA,NA,NA,NA
1153,Pocillopora_acuta_HIv2___RNAseq.g8736.t1,714.2567791,-1.12121575,1.81802357,5.07E-06,6.36E-05,,NA,NA,NA,NA,NA
1154,Pocillopora_acuta_HIv2___TS.g18997.t1b,182.2586089,-0.613335986,1.321862338,5.11E-06,6.40E-05,,NA,NA,NA,NA,NA
1155,Pocillopora_acuta_HIv2___RNAseq.g10278.t1,303.5441861,-1.139528103,2.240681529,5.13E-06,6.42E-05,,Q3KR73,3.51E-165,KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog),chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitochondrial transcription [GO:1903108],GO:0000123; GO:0005634; GO:0005739; GO:0006325; GO:0044545; GO:0045944; GO:1903108
1156,Pocillopora_acuta_HIv2___TS.g900.t1,308.1977764,-0.947698642,1.618625562,5.14E-06,6.43E-05,,NA,NA,NA,NA,NA
1157,Pocillopora_acuta_HIv2___RNAseq.g5117.t2,620.2613443,-0.32316819,1.058555772,5.14E-06,6.43E-05,,Q8TEP8,5.34E-160,Centrosomal protein of 192 kDa (Cep192) (Cep192/SPD-2),centriole replication [GO:0007099]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617],GO:0000242; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0009617; GO:0019901; GO:0019902; GO:0071539; GO:0090222; GO:0090307; GO:0120098; GO:0120099
1158,Pocillopora_acuta_HIv2___RNAseq.g11881.t1,421.7121413,-0.635015778,1.231012394,5.19E-06,6.48E-05,,Q8BGC0,2.02E-103,17S U2 SnRNP complex component HTATSF1 (HIV Tat-specific factor 1 homolog),"double-strand break repair via homologous recombination [GO:0000724]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to site of double-strand break [GO:1990166]; U2-type prespliceosome assembly [GO:1903241]",GO:0000398; GO:0000724; GO:0003723; GO:0005654; GO:0005684; GO:0005686; GO:0035861; GO:0140463; GO:0160004; GO:1903241; GO:1990166
1159,Pocillopora_acuta_HIv2___RNAseq.g16397.t1,78.59723909,-0.429992113,1.14836649,5.26E-06,6.56E-05,,Q8AYC9,0,Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Checkpoint kinase-1),"chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of mitotic nuclear division [GO:0045839]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mitotic centrosome separation [GO:0046602]; signal transduction in response to DNA damage [GO:0042770]",GO:0000077; GO:0000785; GO:0000794; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006281; GO:0006338; GO:0006974; GO:0007095; GO:0010569; GO:0018107; GO:0035402; GO:0042770; GO:0045814; GO:0045839; GO:0046602; GO:0106310
1160,Pocillopora_acuta_HIv2___RNAseq.g1870.t1,473.6497086,-0.494480654,1.134127431,5.29E-06,6.59E-05,,Q5HZT0,6.45E-98,Decapping and exoribonuclease protein (DXO) (EC 3.6.1.-) (5'-3' exoribonuclease DXO) (EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO) (DeNADding enzyme DXO) (EC 3.6.1.-),mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nucleic acid metabolic process [GO:0090304]; RNA destabilization [GO:0050779],GO:0000166; GO:0000287; GO:0003729; GO:0005634; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090304; GO:0110152; GO:0110155
1161,Pocillopora_acuta_HIv2___RNAseq.g3987.t1,515.6645618,-0.503081515,1.163172913,5.36E-06,6.67E-05,,NA,NA,NA,NA,NA
1162,Pocillopora_acuta_HIv2___TS.g25939.t3,116.8848783,-0.302713467,1.087542282,5.37E-06,6.69E-05,,Q7Z569,0,BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63),MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265],GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630
1163,Pocillopora_acuta_HIv2___RNAseq.g13060.t1,7815.936782,-5.149616249,2.072383926,5.43E-06,6.76E-05,,O88572,1.08E-113,Low-density lipoprotein receptor-related protein 6 (LRP-6),anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of developmental process [GO:0051093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of morphogenesis of an epithelium [GO:1905331]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of anatomical structure morphogenesis [GO:0022603]; regulation of cell development [GO:0060284]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0022603; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045893; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051091; GO:0051093; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1905331; GO:1990963; GO:2000051; GO:2000149; GO:2000151; GO:2000164; GO:2000166; GO:2000168; GO:2000648
1164,Pocillopora_acuta_HIv2___RNAseq.g7918.t1,662.2582535,-0.462655658,1.119873211,5.55E-06,6.90E-05,,Q9JJ94,4.43E-47,Microtubule nucleation factor SSNA1 (Sjoegren syndrome nuclear autoantigen 1 homolog),axon arborization [GO:0140060]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell division [GO:0051301]; intraciliary transport [GO:0042073]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; receptor clustering [GO:0043113],GO:0000226; GO:0005634; GO:0005813; GO:0005814; GO:0005886; GO:0005930; GO:0007020; GO:0007409; GO:0008017; GO:0030424; GO:0030496; GO:0031514; GO:0036064; GO:0042073; GO:0042802; GO:0043113; GO:0048675; GO:0051301; GO:0099512; GO:0140060
1165,Pocillopora_acuta_HIv2___RNAseq.g29920.t1,319.8570203,-0.80505251,1.492384236,5.59E-06,6.94E-05,,Q9Y673,6.22E-140,Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog),determination of left/right symmetry [GO:0007368]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],GO:0004581; GO:0005789; GO:0006487; GO:0006488; GO:0007368; GO:0016020; GO:0018279; GO:0098556
1166,Pocillopora_acuta_HIv2___RNAseq.g15935.t1,237.6733978,6.084465237,2.682847031,5.59E-06,6.94E-05,,NA,NA,NA,NA,NA
1167,Pocillopora_acuta_HIv2___RNAseq.g17443.t1,120.9609005,-7.359099877,3.322328828,5.61E-06,6.95E-05,,Q5REY7,7.09E-132,UBX domain-containing protein 7,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005654; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629
1168,Pocillopora_acuta_HIv2___RNAseq.g4682.t1,270.9403245,-1.003197804,1.845175672,5.61E-06,6.95E-05,,NA,NA,NA,NA,NA
1169,Pocillopora_acuta_HIv2___TS.g18914.t1,483.8296831,-0.46295406,1.112905709,5.64E-06,6.98E-05,,Q8N357,6.77E-70,Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog),negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284],GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016020; GO:0022857; GO:0043231; GO:0070062; GO:1901029
1170,Pocillopora_acuta_HIv2___RNAseq.g26035.t1,2844.02786,3.466916926,1.040665978,5.68E-06,7.02E-05,CUB domain-containing protein,B3EWZ7,2.34E-11,Threonine-rich protein,,GO:0005576
1171,Pocillopora_acuta_HIv2___RNAseq.g23901.t1,751.5798294,0.275318128,1.061679279,5.69E-06,7.02E-05,,NA,NA,NA,NA,NA
1172,Pocillopora_acuta_HIv2___RNAseq.g14043.t1,765.4709013,-0.504217272,1.137448314,5.84E-06,7.20E-05,,P62489,1.88E-115,DNA-directed RNA polymerase II subunit RPB7 (RNA polymerase II subunit B7) (DNA-directed RNA polymerase II subunit G),nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],GO:0000932; GO:0000956; GO:0003697; GO:0003727; GO:0005634; GO:0005665; GO:0006366; GO:0006367; GO:0031369; GO:0045948; GO:0060213
1173,Pocillopora_acuta_HIv2___RNAseq.g7479.t3a,601.1573051,-0.397271025,1.100777023,5.90E-06,7.28E-05,,Q5ZIE8,1.26E-18,Activating transcription factor 7-interacting protein 1 (MBD1-containing chromatin-associated factor 1),positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein stability [GO:0031647],GO:0003712; GO:0005634; GO:0005667; GO:0006355; GO:0031647; GO:0050821; GO:0090309
1174,Pocillopora_acuta_HIv2___RNAseq.g261.t1,436.5220156,-0.859197401,1.510444734,5.95E-06,7.33E-05,,NA,NA,NA,NA,NA
1175,Pocillopora_acuta_HIv2___RNAseq.g23499.t1,45.60325501,-9.818365755,3.641141305,6.01E-06,7.38E-05,,NA,NA,NA,NA,NA
1176,Pocillopora_acuta_HIv2___RNAseq.g707.t1,116.3085812,-0.901964211,1.679134271,6.01E-06,7.38E-05,,Q9U1S7,1.42E-12,Polycystin-2 (CePc2) (Polycystic kidney disease 2 protein homolog),calcium ion transport [GO:0006816]; detection of mechanical stimulus [GO:0050982]; male mating behavior [GO:0060179]; mating behavior [GO:0007617]; neuronal signal transduction [GO:0023041]; regulation of male mating behavior [GO:1902435]; response to hermaphrodite contact [GO:0034606]; vulval location [GO:0034608],GO:0005262; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0005929; GO:0006816; GO:0007617; GO:0016020; GO:0023041; GO:0030424; GO:0030425; GO:0031090; GO:0034606; GO:0034608; GO:0043025; GO:0043204; GO:0048471; GO:0050982; GO:0060170; GO:0060179; GO:0071683; GO:0097730; GO:1902435
1177,Pocillopora_acuta_HIv2___RNAseq.g15978.t1,102.583809,-0.936991655,1.737844845,6.01E-06,7.38E-05,,NA,NA,NA,NA,NA
1178,Pocillopora_acuta_HIv2___RNAseq.g3358.t1,374.9609439,-0.522048898,1.150829672,6.02E-06,7.38E-05,,NA,NA,NA,NA,NA
1179,Pocillopora_acuta_HIv2___RNAseq.g26270.t1a,2780.754389,4.816520454,1.584544491,6.02E-06,7.38E-05,Solute carrier family 12 member 2,P55012,0,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1),ammonium transmembrane transport [GO:0072488]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to potassium ion [GO:0035865]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; intracellular chloride ion homeostasis [GO:0030644]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of blood-brain barrier [GO:0035633]; mammary duct terminal end bud growth [GO:0060763]; multicellular organism growth [GO:0035264]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; T cell chemotaxis [GO:0010818],GO:0006813; GO:0006814; GO:0006821; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0008511; GO:0008519; GO:0010818; GO:0015079; GO:0016323; GO:0016324; GO:0030007; GO:0030644; GO:0035264; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043025; GO:0044297; GO:0045795; GO:0050910; GO:0055064; GO:0055075; GO:0055078; GO:0060444; GO:0060763; GO:0061044; GO:0071222; GO:0071944; GO:0072488; GO:0098658; GO:0098719; GO:0150003; GO:1902476; GO:1904450; GO:1904464; GO:1990573; GO:1990869
1180,Pocillopora_acuta_HIv2___RNAseq.g23145.t1,640.2514459,-0.703137247,1.306113062,6.04E-06,7.41E-05,,Q8BG30,5.44E-99,Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 homolog) (mWHSC2),negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of protein modification process [GO:0031401]; positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0003682; GO:0005634; GO:0005829; GO:0016604; GO:0031401; GO:0032021; GO:0034244; GO:0045944; GO:0060090
1181,Pocillopora_acuta_HIv2___RNAseq.g25184.t1,1197.802176,4.611436103,3.965636116,6.05E-06,7.42E-05,,P70191,5.24E-44,TNF receptor-associated factor 5,apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0005164; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0048255; GO:0051092; GO:0070534; GO:0097400
1182,Pocillopora_acuta_HIv2___RNAseq.g938.t1,1031.719691,0.470439474,1.164267456,6.09E-06,7.46E-05,Homeobox protein Nkx-2.2,P42586,4.58E-40,Homeobox protein Nkx-2.2 (Homeobox protein NK-2 homolog B),astrocyte differentiation [GO:0048708]; cell development [GO:0048468]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; endocrine pancreas development [GO:0031018]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; optic nerve development [GO:0021554]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell differentiation [GO:0003309]; type B pancreatic cell fate commitment [GO:0003327]; ventral spinal cord interneuron fate determination [GO:0060580],GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003309; GO:0003323; GO:0003326; GO:0003327; GO:0003329; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007224; GO:0007399; GO:0009749; GO:0010628; GO:0014003; GO:0021522; GO:0021529; GO:0021530; GO:0021554; GO:0030154; GO:0030182; GO:0030858; GO:0031018; GO:0032570; GO:0043565; GO:0045665; GO:0045666; GO:0045944; GO:0048468; GO:0048565; GO:0048665; GO:0048708; GO:0048709; GO:0048714; GO:0060580; GO:0061101
1183,Pocillopora_acuta_HIv2___RNAseq.g30624.t2a,46.91991988,-9.840285992,3.671568769,6.13E-06,7.49E-05,,NA,NA,NA,NA,NA
1184,Pocillopora_acuta_HIv2___RNAseq.g5712.t1,748.8652791,-0.316824609,1.048245787,6.17E-06,7.53E-05,,Q5TJE1,2.93E-36,Death domain-associated protein 6 (Daxx),apoptotic process [GO:0006915]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to heat [GO:0034605]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; nucleosome assembly [GO:0006334]; regulation of apoptotic process [GO:0042981]; regulation of protein ubiquitination [GO:0031396],GO:0000775; GO:0003713; GO:0003714; GO:0005634; GO:0005730; GO:0005829; GO:0006334; GO:0006915; GO:0010629; GO:0016605; GO:0031396; GO:0034605; GO:0034620; GO:0042393; GO:0042803; GO:0042981; GO:0045892; GO:0050681; GO:0061629; GO:0071276; GO:0071280; GO:0072738; GO:1903936
1185,Pocillopora_acuta_HIv2___TS.g4055.t1,42.8677633,-6.125494104,2.14674041,6.17E-06,7.53E-05,,NA,NA,NA,NA,NA
1186,Pocillopora_acuta_HIv2___RNAseq.g8968.t1,127.1741029,-0.303264881,1.087524933,6.25E-06,7.62E-05,,Q28C91,7.38E-85,Ethylmalonyl-CoA decarboxylase (EC 4.1.1.94) (Enoyl-CoA hydratase domain-containing protein 1) (Methylmalonyl-CoA decarboxylase) (MMCD),,GO:0004492; GO:0005829; GO:0016831
1187,Pocillopora_acuta_HIv2___TS.g8258.t1,75.73227443,7.175383862,3.331601062,6.26E-06,7.63E-05,,Q8NDA2,9.73E-30,Hemicentin-2,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808],GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023
1188,Pocillopora_acuta_HIv2___RNAseq.g11916.t1,585.8524037,-1.213856525,2.18748583,6.27E-06,7.63E-05,,Q9I8C7,6.31E-78,Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10),,GO:0004888; GO:0005262; GO:0005886; GO:0022848; GO:0043005; GO:0045202; GO:0045211; GO:1902495
1189,Pocillopora_acuta_HIv2___RNAseq.g17573.t1,2170.589159,2.458608743,0.613632668,6.40E-06,7.78E-05,Homeobox protein Hox-D1,Q28IU6,4.07E-11,Homeobox protein Hox-D1,,GO:0000981; GO:0005634; GO:0043565
1190,Pocillopora_acuta_HIv2___RNAseq.9584_t,582.7247818,-0.333832499,1.047797597,6.41E-06,7.80E-05,,Q9UGM6,3.95E-119,"Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS)",mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; positive regulation of angiogenesis [GO:0045766]; tRNA aminoacylation for protein translation [GO:0006418]; vasculogenesis [GO:0001570],GO:0001570; GO:0004830; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0006418; GO:0045766; GO:0070183
1191,Pocillopora_acuta_HIv2___RNAseq.g10358.t1,208.2902611,-0.644018808,1.326644719,6.55E-06,7.95E-05,,P16455,1.08E-33,Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase),DNA alkylation repair [GO:0006307]; DNA ligation [GO:0006266]; DNA repair [GO:0006281]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of double-strand break repair [GO:2000781],GO:0003677; GO:0003908; GO:0005634; GO:0005654; GO:0006266; GO:0006281; GO:0006307; GO:0008168; GO:0009008; GO:0016020; GO:0032259; GO:0043066; GO:0046872; GO:2000781
1192,Pocillopora_acuta_HIv2___RNAseq.g24040.t1,1807.458929,4.568379012,2.083979427,6.55E-06,7.95E-05,,Q9BQG1,1.04E-25,Synaptotagmin-3 (Synaptotagmin III) (SytIII),calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; positive regulation of dendrite extension [GO:1903861],GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005768; GO:0005886; GO:0017156; GO:0030154; GO:0030276; GO:0030658; GO:0070382; GO:1903861
1193,Pocillopora_acuta_HIv2___RNAseq.g24656.t1,233.4325312,-0.595877113,1.239080145,6.56E-06,7.95E-05,,Q5FWL3,9.42E-22,E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1),extrinsic apoptotic signaling pathway [GO:0097191]; protein polyubiquitination [GO:0000209],GO:0000209; GO:0004842; GO:0046872; GO:0061630; GO:0071782; GO:0097191
1194,Pocillopora_acuta_HIv2___RNAseq.g3212.t1,425.6605364,-0.522510278,1.178303098,6.60E-06,7.99E-05,,A0A3Q1MT14,2.90E-07,Sperm microtubule inner protein 11 (Testis-expressed protein 49),,GO:0160111
1195,Pocillopora_acuta_HIv2___RNAseq.g14896.t1,449.5363467,-0.488958037,1.122047026,6.75E-06,8.16E-05,,Q9CPX9,3.68E-45,Anaphase-promoting complex subunit 11 (APC11) (Cyclosome subunit 11),anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005654; GO:0005680; GO:0005730; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031145; GO:0034450; GO:0045842; GO:0051301; GO:0061630; GO:0070936; GO:0070979; GO:0097602; GO:0141198
1196,Pocillopora_acuta_HIv2___RNAseq.g26958.t1,765.3177389,-1.220222283,2.048922431,6.75E-06,8.16E-05,,A7RZS0,1.42E-48,Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC-1 subunit 2),endosomal transport [GO:0016197]; lysosome localization [GO:0032418],GO:0000930; GO:0005765; GO:0005813; GO:0016197; GO:0031083; GO:0032418; GO:0043015; GO:0099078
1197,Pocillopora_acuta_HIv2___RNAseq.g21218.t1,209.3047579,-0.733385794,1.421506143,6.76E-06,8.16E-05,,O57460,7.82E-36,Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein),blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; protein processing [GO:0016485]; proteolysis [GO:0006508],GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264
1198,Pocillopora_acuta_HIv2___RNAseq.g2345.t1,169.8324327,-0.88086519,1.620740771,6.76E-06,8.16E-05,,NA,NA,NA,NA,NA
1199,Pocillopora_acuta_HIv2___TS.g27239.t2,5362.681321,2.779089354,0.730872463,6.81E-06,8.21E-05,,Q08D11,1.95E-166,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),phosphatidylserine biosynthetic process [GO:0006659],GO:0005789; GO:0006659; GO:0106245
1200,Pocillopora_acuta_HIv2___TS.g9835.t1,367.2440976,-0.636596867,1.272231935,6.82E-06,8.22E-05,,A6H791,6.72E-108,tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (EC 2.1.1.220) (mRNA methyladenosine-N(1)-methyltransferase catalytic subunit TRMT61A) (EC 2.1.1.-) (tRNA(m1A58)-methyltransferase subunit TRMT61A) (tRNA(m1A58)MTase subunit TRMT61A),mRNA processing [GO:0006397]; tRNA methylation [GO:0030488],GO:0005634; GO:0006397; GO:0030488; GO:0031515; GO:0061953; GO:0160107
1201,Pocillopora_acuta_HIv2___RNAseq.g2263.t1b,1355.993282,-5.014814907,2.486629277,6.89E-06,8.30E-05,,P42893,6.72E-148,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492],GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005886; GO:0007411; GO:0007507; GO:0008217; GO:0008270; GO:0009410; GO:0009897; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0035994; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0046686; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287
1202,Pocillopora_acuta_HIv2___RNAseq.g4521.t1,469.2053401,-0.559585096,1.174920733,6.94E-06,8.35E-05,,Q6GLA2,6.49E-92,Mitochondrial S-adenosylmethionine carrier protein (SAM carrier) (Solute carrier family 25 member 26),mitochondrial S-adenosyl-L-methionine transmembrane transport [GO:1990543]; S-adenosyl-L-methionine transport [GO:0015805],GO:0000095; GO:0005743; GO:0015805; GO:0180003; GO:1990543
1203,Pocillopora_acuta_HIv2___TS.g17461.t1,354.1007296,-0.565806879,1.177859174,6.97E-06,8.38E-05,,Q8NE09,4.20E-109,Regulator of G-protein signaling 22 (RGS22),negative regulation of signal transduction [GO:0009968],GO:0001650; GO:0001965; GO:0005634; GO:0005737; GO:0005829; GO:0009968; GO:0015629
1204,Pocillopora_acuta_HIv2___RNAseq.g6094.t2,191.3722729,-0.945019535,1.745647208,6.98E-06,8.38E-05,,Q12791,0,"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo)",intracellular potassium ion homeostasis [GO:0030007]; micturition [GO:0060073]; negative regulation of cell volume [GO:0045794]; positive regulation of apoptotic process [GO:0043065]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391]; response to calcium ion [GO:0051592]; response to carbon monoxide [GO:0034465]; response to hypoxia [GO:0001666]; response to osmotic stress [GO:0006970]; smooth muscle contraction involved in micturition [GO:0060083]; vasodilation [GO:0042311],GO:0001666; GO:0003779; GO:0005249; GO:0005886; GO:0005901; GO:0006813; GO:0006970; GO:0008076; GO:0015269; GO:0016020; GO:0016324; GO:0030007; GO:0034465; GO:0042311; GO:0042391; GO:0042802; GO:0043065; GO:0045211; GO:0045794; GO:0046872; GO:0051592; GO:0060072; GO:0060073; GO:0060083; GO:0071805
1205,Pocillopora_acuta_HIv2___TS.g19918.t1,278.8409615,-0.50205968,1.145918692,7.06E-06,8.48E-05,,NA,NA,NA,NA,NA
1206,Pocillopora_acuta_HIv2___RNAseq.g8226.t1,346.2667968,-0.255019882,1.067364912,7.14E-06,8.56E-05,,NA,NA,NA,NA,NA
1207,Pocillopora_acuta_HIv2___RNAseq.g16001.t1,226.5800398,-5.062665945,3.484345937,7.15E-06,8.57E-05,,Q9VX98,2.13E-61,Density-regulated protein homolog,formation of translation preinitiation complex [GO:0001731]; positive regulation of ecdysone receptor signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; translation reinitiation [GO:0002188],GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0032991; GO:0046628; GO:0048027; GO:0120142
1208,Pocillopora_acuta_HIv2___RNAseq.g23403.t1,152.4818164,-0.266543905,1.070903361,7.18E-06,8.59E-05,,NA,NA,NA,NA,NA
1209,Pocillopora_acuta_HIv2___RNAseq.g21827.t1a,526.5457019,-0.456656997,1.107296358,7.19E-06,8.59E-05,Homeobox protein not2 (Xnot-2),Q91770,1.13E-20,Homeobox protein not2 (Xnot-2) (Xnot2),negative regulation of DNA-templated transcription [GO:0045892]; notochord formation [GO:0014028],GO:0000981; GO:0003677; GO:0005634; GO:0014028; GO:0045892
1210,Pocillopora_acuta_HIv2___TS.g11286.t1,2158.521136,4.913062747,1.831814197,7.19E-06,8.59E-05,,B3EWZ3,3.60E-28,Coadhesin,,GO:0016020
1211,Pocillopora_acuta_HIv2___RNAseq.g5445.t1,128.8659406,-1.665758556,8.499596794,7.26E-06,8.67E-05,,Q96DM1,1.11E-69,PiggyBac transposable element-derived protein 4,,
1212,Pocillopora_acuta_HIv2___RNAseq.g11283.t1,289.2142096,0.379257798,1.123369759,7.34E-06,8.76E-05,,NA,NA,NA,NA,NA
1213,Pocillopora_acuta_HIv2___RNAseq.g16905.t1,276.1795213,-5.999666793,2.704295192,7.37E-06,8.79E-05,,E7FAM5,1.96E-63,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177
1214,Pocillopora_acuta_HIv2___RNAseq.g18282.t1,392.6106021,-0.778326961,1.381596726,7.41E-06,8.83E-05,,P30043,1.87E-19,Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.-) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR) (S-nitroso-CoA-assisted nitrosyltransferase) (SNO-CoA-assisted nitrosyltransferase) (EC 2.6.99.-),heme catabolic process [GO:0042167]; megakaryocyte differentiation [GO:0030219]; negative regulation of insulin receptor signaling pathway [GO:0046627],GO:0004074; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0008752; GO:0030219; GO:0035605; GO:0042167; GO:0042602; GO:0043231; GO:0046627; GO:0052873; GO:0052874; GO:0070062; GO:0106276; GO:0106277
1215,Pocillopora_acuta_HIv2___RNAseq.g3661.t1,266.7200519,-0.584317401,1.281124218,7.42E-06,8.83E-05,,Q8C7H1,1.01E-148,"Methylmalonic aciduria type A homolog, mitochondrial (EC 3.6.-.-)",cobalamin metabolic process [GO:0009235],GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0009235; GO:0016887; GO:0042802; GO:0042803
1216,Pocillopora_acuta_HIv2___RNAseq.g19660.t1,464.3048743,-0.338714921,1.105404647,7.43E-06,8.84E-05,,A2VDD2,1.68E-21,Dynein light chain Tctex-type 5-B (Tctex1 domain-containing protein 1-B),,
1217,Pocillopora_acuta_HIv2___RNAseq.g28584.t1a,143.8508949,-0.280991787,1.077979731,7.44E-06,8.85E-05,Rho-associated protein kinase 1,P70335,4.25E-105,"Rho-associated protein kinase 1 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)",actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; bleb assembly [GO:0032060]; blood vessel diameter maintenance [GO:0097746]; canonical NF-kappaB signal transduction [GO:0007249]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; motor neuron apoptotic process [GO:0097049]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of phosphorylation [GO:0042326]; neuron projection arborization [GO:0140058]; podocyte cell migration [GO:0090521]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of synapse maturation [GO:0090128]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266],GO:0000139; GO:0000281; GO:0001726; GO:0001837; GO:0003383; GO:0004674; GO:0005524; GO:0005737; GO:0005814; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0007249; GO:0007266; GO:0010494; GO:0010508; GO:0010613; GO:0010628; GO:0016525; GO:0019828; GO:0022614; GO:0030027; GO:0030036; GO:0030334; GO:0030866; GO:0031032; GO:0031267; GO:0032059; GO:0032060; GO:0032956; GO:0032970; GO:0035306; GO:0042326; GO:0043410; GO:0045616; GO:0045664; GO:0046872; GO:0048598; GO:0050901; GO:0051451; GO:0051894; GO:0061157; GO:0070507; GO:0071559; GO:0072518; GO:0072659; GO:0090128; GO:0090521; GO:0097049; GO:0097746; GO:0098685; GO:0106003; GO:0106310; GO:0110061; GO:0140058; GO:1900223; GO:1900242; GO:1901888; GO:1902430; GO:1903140; GO:1903347; GO:1905205; GO:1990776; GO:2000672
1218,Pocillopora_acuta_HIv2___RNAseq.18068_t,158.6742408,-0.761371663,1.458067384,7.56E-06,8.98E-05,,Q5I597,4.53E-160,Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5),amino-acid betaine catabolic process [GO:0006579]; L-methionine salvage [GO:0071267]; methylation [GO:0032259],GO:0005634; GO:0005829; GO:0006579; GO:0008270; GO:0032259; GO:0047150; GO:0071267
1219,Pocillopora_acuta_HIv2___TS.g7110.t1,221.3145852,-0.826242793,1.546073026,7.62E-06,9.04E-05,,NA,NA,NA,NA,NA
1220,Pocillopora_acuta_HIv2___TS.g568.t1,575.6121945,4.982425952,2.301875936,7.64E-06,9.05E-05,,P28741,7.63E-61,Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A),anterior/posterior pattern specification [GO:0009952]; anterograde axonal transport [GO:0008089]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dentate gyrus development [GO:0021542]; determination of left/right symmetry [GO:0007368]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inner ear receptor cell stereocilium organization [GO:0060122]; keratinocyte proliferation [GO:0043616]; kidney development [GO:0001822]; microtubule anchoring at centrosome [GO:0034454]; motile cilium assembly [GO:0044458]; neural precursor cell proliferation [GO:0061351]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of axo-dendritic protein transport [GO:1905128]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000771]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of receptor-mediated endocytosis [GO:0048260]; smoothened signaling pathway [GO:0007224],GO:0001701; GO:0001822; GO:0001947; GO:0003341; GO:0003777; GO:0005524; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007224; GO:0007368; GO:0007507; GO:0008017; GO:0008089; GO:0008544; GO:0009952; GO:0009953; GO:0010457; GO:0010838; GO:0016887; GO:0016939; GO:0019894; GO:0021542; GO:0021904; GO:0021915; GO:0030507; GO:0030900; GO:0031514; GO:0032391; GO:0032839; GO:0034454; GO:0036334; GO:0043005; GO:0043025; GO:0043616; GO:0044458; GO:0044877; GO:0048260; GO:0050679; GO:0060122; GO:0060271; GO:0061351; GO:0090316; GO:0098794; GO:0098937; GO:0098971; GO:0098978; GO:0120170; GO:1904115; GO:1905128; GO:1905515; GO:2000771
1221,Pocillopora_acuta_HIv2___RNAseq.g18000.t1,353.6304028,-0.616261174,1.300387213,7.69E-06,9.10E-05,,Q4J9D2,1.47E-30,Uncharacterized protein Saci_1252,,
1222,Pocillopora_acuta_HIv2___RNAseq.g29496.t1,253.3221145,-0.658895553,1.254917979,7.69E-06,9.10E-05,,NA,NA,NA,NA,NA
1223,Pocillopora_acuta_HIv2___RNAseq.g15902.t1,119.7271845,-0.620609519,1.297897601,7.72E-06,9.13E-05,,NA,NA,NA,NA,NA
1224,Pocillopora_acuta_HIv2___RNAseq.g30723.t1,262.890876,-0.996517274,1.703194467,7.73E-06,9.14E-05,,Q63ZW7,4.72E-10,InaD-like protein (Inadl protein) (Channel-interacting PDZ domain-containing protein) (Pals1-associated tight junction protein) (Protein associated to tight junctions),establishment of apical/basal cell polarity [GO:0035089]; tight junction assembly [GO:0120192],GO:0005737; GO:0005886; GO:0005923; GO:0016324; GO:0032991; GO:0035003; GO:0035089; GO:0045177; GO:0048471; GO:0070160; GO:0120192
1225,Pocillopora_acuta_HIv2___RNAseq.g14123.t1,141.0867134,-0.27705654,1.076241749,7.80E-06,9.21E-05,,Q0IHW3,1.13E-78,Protein Smaug homolog 1 (Smaug 1) (Sterile alpha motif domain-containing protein 4A),regulation of mRNA stability [GO:0043488],GO:0003723; GO:0005737; GO:0030371; GO:0030425; GO:0043488; GO:0045202
1226,Pocillopora_acuta_HIv2___RNAseq.g24994.t1,301.733152,-0.466547368,1.170382381,7.82E-06,9.22E-05,,Q5TZ18,1.32E-15,Neuron navigator 3,liver morphogenesis [GO:0072576]; neurogenesis [GO:0022008]; pancreas development [GO:0031016],GO:0003779; GO:0005524; GO:0005640; GO:0005794; GO:0016887; GO:0022008; GO:0030027; GO:0030175; GO:0031016; GO:0072576
1227,Pocillopora_acuta_HIv2___RNAseq.g20579.t1,130.7933281,-2.846962029,5.352553752,7.89E-06,9.30E-05,,Q3ZAV0,1.80E-19,Coiled-coil domain-containing protein 60,,
1228,Pocillopora_acuta_HIv2___RNAseq.g7035.t1,997.2665562,-0.269515715,1.027693557,7.92E-06,9.33E-05,,P41384,1.72E-30,Cyclin-dependent kinases regulatory subunit (SUC1 homolog),cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],GO:0000307; GO:0007346; GO:0019005; GO:0019901; GO:0042393; GO:0043130; GO:0051301; GO:0061575
1229,Pocillopora_acuta_HIv2___RNAseq.g4321.t1,121.8474514,-0.895657245,1.656894591,7.98E-06,9.39E-05,,NA,NA,NA,NA,NA
1230,Pocillopora_acuta_HIv2___RNAseq.g21305.t1,321.8083351,-0.475666826,1.194196673,8.08E-06,9.50E-05,,O95490,4.16E-93,Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016524; GO:0030246
1231,Pocillopora_acuta_HIv2___RNAseq.g556.t1,264.233335,-0.823393116,1.537495277,8.13E-06,9.55E-05,,Q94A68,4.83E-16,"Uncharacterized oxidoreductase At1g06690, chloroplastic (EC 1.-.-.-)",,GO:0005576; GO:0009507; GO:0009535; GO:0009941; GO:0010287; GO:0016491
1232,Pocillopora_acuta_HIv2___RNAseq.g15923.t1,125.7901506,-0.287238678,1.080638549,8.15E-06,9.57E-05,,NA,NA,NA,NA,NA
1233,Pocillopora_acuta_HIv2___RNAseq.g25336.t1,3879.280989,-4.647924567,1.995888671,8.19E-06,9.61E-05,,NA,NA,NA,NA,NA
1234,Pocillopora_acuta_HIv2___RNAseq.g21260.t1,885.1874767,-0.676203948,1.287062352,8.35E-06,9.78E-05,,Q75AK8,1.13E-94,ATP phosphoribosyltransferase (ATP-PRT) (ATP-PRTase) (EC 2.4.2.17),L-histidine biosynthetic process [GO:0000105],GO:0000105; GO:0000287; GO:0003879; GO:0005524; GO:0005737
1235,Pocillopora_acuta_HIv2___RNAseq.g26716.t1,935.0491242,-2.472196558,0.633121052,8.40E-06,9.84E-05,,NA,NA,NA,NA,NA
1236,Pocillopora_acuta_HIv2___RNAseq.g7820.t1,189.5642873,-0.273556851,1.074800337,8.43E-06,9.86E-05,,Q5QD08,5.35E-28,Trace amine-associated receptor 7f (TaR-7f) (Trace amine receptor 7f) (mTaar7f),sensory perception of chemical stimulus [GO:0007606],GO:0001594; GO:0005886; GO:0007606
1237,Pocillopora_acuta_HIv2___TS.g950.t1,895.3462079,-0.426559439,1.094539192,8.44E-06,9.86E-05,,Q8K268,0,ATP-binding cassette sub-family F member 3,defense response to virus [GO:0051607],GO:0005524; GO:0016887; GO:0051607
1238,Pocillopora_acuta_HIv2___RNAseq.g3484.t1,104.1416998,-0.877129191,1.632320517,8.44E-06,9.86E-05,,P0C7P0,9.01E-25,"CDGSH iron-sulfur domain-containing protein 3, mitochondrial (MitoNEET-related protein 2) (Miner2) (Mitochondrial inner NEET protein) (MiNT)",protein maturation by [2Fe-2S] cluster transfer [GO:0106034],GO:0005739; GO:0046872; GO:0051537; GO:0106034
1239,Pocillopora_acuta_HIv2___RNAseq.g29210.t1,51.16677331,-7.187802539,2.677107706,8.50E-06,9.92E-05,,NA,NA,NA,NA,NA
1240,Pocillopora_acuta_HIv2___RNAseq.13026_t,123.729474,-0.999189115,1.861193876,8.61E-06,0.00010044,,NA,NA,NA,NA,NA
1241,Pocillopora_acuta_HIv2___RNAseq.g30806.t1,802.0096112,3.778097893,0.994121275,8.65E-06,0.000100796,,Q9NXG6,1.54E-55,Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4),regulation of erythrocyte differentiation [GO:0045646],GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0031418; GO:0045646; GO:0160082
1242,Pocillopora_acuta_HIv2___TS.g18901.t1,82.72583454,-7.379094147,3.749521113,8.66E-06,0.000100872,,NA,NA,NA,NA,NA
1243,Pocillopora_acuta_HIv2___TS.g6162.t1,483.8789814,-0.469225181,1.116674569,8.69E-06,0.000101118,,P79955,1.58E-147,Carboxy-terminal kinesin 2 (XCTK2),microtubule-based movement [GO:0007018],GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017
1244,Pocillopora_acuta_HIv2___RNAseq.g20718.t1,515.313742,5.173624092,2.257852188,8.76E-06,0.000101808,,Q9SCN0,9.13E-15,Probable glycosyltransferase STELLO2 (EC 2.4.-.-),plant-type cell wall cellulose biosynthetic process [GO:0052324]; regulation of plant-type cell wall cellulose biosynthetic process [GO:2001009],GO:0000139; GO:0005794; GO:0016757; GO:0042802; GO:0052324; GO:2001009
1245,Pocillopora_acuta_HIv2___TS.g11023.t1,192.6398854,-0.26635428,1.071744814,8.79E-06,0.000102173,,O75691,0,Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6),"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]",GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040; GO:0042274
1246,Pocillopora_acuta_HIv2___RNAseq.g4879.t1,8387.622106,-5.089770682,2.283200448,8.86E-06,0.000102803,,O93429,8.28E-60,Serotransferrin,antibacterial humoral response [GO:0019731]; iron ion transport [GO:0006826],GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0019731; GO:0046872; GO:0055037
1247,Pocillopora_acuta_HIv2___RNAseq.g8687.t1,793.7801889,-0.400985578,1.087296018,8.95E-06,0.000103849,,NA,NA,NA,NA,NA
1248,Pocillopora_acuta_HIv2___RNAseq.g26133.t1,48.16509837,-9.793932831,3.686833002,8.97E-06,0.000103949,,NA,NA,NA,NA,NA
1249,Pocillopora_acuta_HIv2___RNAseq.g1009.t1,243.3786282,-0.949310953,1.74006503,9.03E-06,0.000104552,,Q8BTM8,1.18E-38,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),"actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319]",GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051209; GO:0051220; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224
1250,Pocillopora_acuta_HIv2___RNAseq.g16665.t1,2103.551669,4.734372562,1.745787161,9.04E-06,0.000104552,,Q09YM8,9.73E-09,Cortactin-binding protein 2 (CortBP2),,GO:0005938; GO:0043197; GO:0090443
1251,Pocillopora_acuta_HIv2___RNAseq.g25244.t1,467.3263853,-0.324886172,1.096185212,9.06E-06,0.000104783,,P97677,1.08E-103,Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1),astrocyte development [GO:0014002]; auditory receptor cell fate commitment [GO:0009912]; cell fate determination [GO:0001709]; cell-cell signaling [GO:0007267]; cerebellar molecular layer formation [GO:0021688]; cerebellar Purkinje cell layer structural organization [GO:0021693]; clathrin-dependent endocytosis [GO:0072583]; compartment pattern specification [GO:0007386]; determination of left/right symmetry [GO:0007368]; endothelial tip cell fate specification [GO:0097102]; energy homeostasis [GO:0097009]; heart looping [GO:0001947]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; lateral inhibition [GO:0046331]; left/right axis specification [GO:0070986]; loop of Henle development [GO:0072070]; marginal zone B cell differentiation [GO:0002315]; myeloid cell differentiation [GO:0030099]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; organ growth [GO:0035265]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; proximal/distal pattern formation [GO:0009954]; regulation of blood pressure [GO:0008217]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of growth [GO:0040008]; regulation of neurogenesis [GO:0050767]; regulation of skeletal muscle tissue growth [GO:0048631]; regulation of somitogenesis [GO:0014807]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle tissue growth [GO:0048630]; skin epidermis development [GO:0098773]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; type B pancreatic cell development [GO:0003323],GO:0001709; GO:0001756; GO:0001757; GO:0001947; GO:0002085; GO:0002315; GO:0003323; GO:0005112; GO:0005509; GO:0005886; GO:0005912; GO:0007219; GO:0007267; GO:0007368; GO:0007386; GO:0007399; GO:0008217; GO:0008284; GO:0008285; GO:0009912; GO:0009954; GO:0010628; GO:0014002; GO:0014807; GO:0016324; GO:0021510; GO:0021688; GO:0021693; GO:0030099; GO:0030155; GO:0030182; GO:0030857; GO:0030947; GO:0030957; GO:0031410; GO:0032693; GO:0034351; GO:0035265; GO:0040008; GO:0042491; GO:0045121; GO:0045596; GO:0045605; GO:0045608; GO:0045638; GO:0045662; GO:0045665; GO:0045746; GO:0045747; GO:0045807; GO:0045944; GO:0046331; GO:0048018; GO:0048630; GO:0048631; GO:0048633; GO:0048665; GO:0048839; GO:0050767; GO:0051302; GO:0060041; GO:0060042; GO:0060563; GO:0060853; GO:0070986; GO:0072006; GO:0072014; GO:0072070; GO:0072583; GO:0097009; GO:0097102; GO:0097110; GO:0097150; GO:0098773; GO:1900746; GO:1903672; GO:2000726
1252,Pocillopora_acuta_HIv2___RNAseq.g18400.t1,923.1389406,-0.291237192,1.03696749,9.12E-06,0.000105399,,Q9NU22,0,Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein),ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit export from nucleus [GO:0000055],GO:0000027; GO:0000055; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0030687; GO:0045111
1253,Pocillopora_acuta_HIv2___TS.g1888.t1,279.9177131,-0.758903378,1.36047705,9.15E-06,0.000105632,,NA,NA,NA,NA,NA
1254,Pocillopora_acuta_HIv2___RNAseq.g4354.t1,70.71196866,-7.426216195,3.483302743,9.23E-06,0.000106411,,NA,NA,NA,NA,NA
1255,Pocillopora_acuta_HIv2___RNAseq.g7919.t1,412.3796614,-0.873160446,1.496568011,9.30E-06,0.000107134,,Q5R6W3,3.31E-39,Probable RNA-binding protein 18 (RNA-binding motif protein 18),,GO:0003723; GO:0005654; GO:0005829; GO:0045171
1256,Pocillopora_acuta_HIv2___RNAseq.g4202.t1,32661.32449,2.822766836,0.7665224,9.39E-06,0.000108153,Apolipophorin,Q9U943,1.28E-76,Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)],Wnt signaling pathway [GO:0016055],GO:0005319; GO:0005576; GO:0008289; GO:0016055
1257,Pocillopora_acuta_HIv2___RNAseq.g11192.t1,127.8003669,-7.275541223,3.717264776,9.42E-06,0.00010834,,NA,NA,NA,NA,NA
1258,Pocillopora_acuta_HIv2___RNAseq.g8581.t1,44.94653832,-9.707455632,3.733667856,9.51E-06,0.00010926,,NA,NA,NA,NA,NA
1259,Pocillopora_acuta_HIv2___TS.g14552.t1,1206.965415,-4.246637601,1.370325838,9.51E-06,0.00010926,,P58365,0,Cadherin-23 (Otocadherin),adult locomotory behavior [GO:0008344]; auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; cell-cell adhesion [GO:0098609]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; righting reflex [GO:0060013]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0005911; GO:0006816; GO:0007156; GO:0007605; GO:0007626; GO:0008344; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060013; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098609; GO:0098683; GO:0098684
1260,Pocillopora_acuta_HIv2___RNAseq.g24413.t1,2120.418758,2.952265399,0.826662242,9.52E-06,0.000109296,Toll-like receptor 2,B2LT62,2.13E-19,Toll-like receptor 2 (CD antigen CD282),cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224],GO:0002224; GO:0004888; GO:0005794; GO:0006954; GO:0030670; GO:0042497; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727
1261,Pocillopora_acuta_HIv2___RNAseq.g7219.t1,2365.962114,5.162607883,1.724608991,9.57E-06,0.000109762,,Q09YI1,3.67E-17,Cortactin-binding protein 2 (CortBP2),regulation of synapse organization [GO:0050807],GO:0005938; GO:0043197; GO:0050807; GO:0090443; GO:0098978
1262,Pocillopora_acuta_HIv2___RNAseq.g4277.t1,350.1499295,-0.504439781,1.135281179,9.67E-06,0.000110827,,Q6GNJ8,3.38E-59,Vacuolar protein sorting-associated protein 72 homolog (Transcription factor-like 1),transcription initiation-coupled chromatin remodeling [GO:0045815],GO:0003677; GO:0005634; GO:0045815; GO:0140713; GO:0140849
1263,Pocillopora_acuta_HIv2___TS.g10825.t1,23047.68433,2.33574347,0.59429735,9.74E-06,0.000111553,Thrombospondin type-1 domain-containing,Q9NS62,1.96E-10,Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module),focal adhesion assembly [GO:0048041],GO:0005576; GO:0005768; GO:0005829; GO:0005925; GO:0010008; GO:0048041; GO:0050840; GO:0071944
1264,Pocillopora_acuta_HIv2___TS.g26638.t1,397.8042345,-0.694328596,1.290722712,9.78E-06,0.000111872,,Q5ZLP2,1.08E-131,Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein homolog),apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptotic inflammatory response [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372],GO:0005737; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0042802; GO:0043066; GO:0046570; GO:0051289; GO:0070269; GO:0070372
1265,Pocillopora_acuta_HIv2___RNAseq.g23623.t1,346.0604024,0.488784689,1.1799928,9.87E-06,0.000112868,,NA,NA,NA,NA,NA
1266,Pocillopora_acuta_HIv2___RNAseq.g25351.t1,48599.95964,2.505378941,0.654341721,9.91E-06,0.000113274,Mammalian ependymin-related protein 1 (MERP-1),A6QLI0,1.15E-31,Mammalian ependymin-related protein 1 (MERP-1),cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005576; GO:0005764; GO:0007160; GO:0008289; GO:0043202
1267,Pocillopora_acuta_HIv2___RNAseq.g27028.t2b,940.6784881,-0.192136229,1.025020642,9.93E-06,0.000113298,,Q9UHG0,4.96E-22,Doublecortin domain-containing protein 2 (Protein RU2S),cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605],GO:0001764; GO:0005737; GO:0005815; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0006968; GO:0007605; GO:0015630; GO:0019894; GO:0030111; GO:0034451; GO:0035556; GO:0045880; GO:0048813; GO:0060091; GO:0060271; GO:0072686; GO:1902017
1268,Pocillopora_acuta_HIv2___RNAseq.g14729.t1,1792.451682,4.895347501,2.837363785,9.93E-06,0.000113298,,NA,NA,NA,NA,NA
1269,Pocillopora_acuta_HIv2___RNAseq.g20413.t2,268.659268,-4.47847454,3.646379019,1.00E-05,0.000114409,,P49961,3.37E-43,Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39),blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; nucleoside diphosphate catabolic process [GO:0009134]; platelet aggregation [GO:0070527],GO:0003924; GO:0004050; GO:0004382; GO:0005524; GO:0005886; GO:0005901; GO:0007155; GO:0007596; GO:0009134; GO:0016020; GO:0016887; GO:0017110; GO:0017111; GO:0036384; GO:0043262; GO:0043273; GO:0045134; GO:0070062; GO:0070527; GO:0103023; GO:1990003
1270,Pocillopora_acuta_HIv2___RNAseq.g22682.t1b,1326.13612,4.08047154,1.396646855,1.01E-05,0.000114469,,NA,NA,NA,NA,NA
1271,Pocillopora_acuta_HIv2___RNAseq.g29671.t1,391.9262303,-0.63895116,1.231847257,1.01E-05,0.000114662,,Q9P2R3,0,Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif),"endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0005765; GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0031267; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0070062; GO:0090160; GO:1901981
1272,Pocillopora_acuta_HIv2___TS.g23133.t3,4216.885581,2.864842545,0.788146616,1.01E-05,0.000114662,,Q61838,0,Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit],embryo implantation [GO:0007566],GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007566; GO:0044877; GO:0048403; GO:0048406; GO:0062023
1273,Pocillopora_acuta_HIv2___RNAseq.g26613.t1,376.8972024,-1.158650813,2.070907653,1.01E-05,0.000114878,,Q8BUG5,1.67E-101,Calcyphosin-2 (Calcyphosine-2),,GO:0005509
1274,Pocillopora_acuta_HIv2___RNAseq.g9864.t1,245.2295124,-1.526315742,3.172382857,1.01E-05,0.000114933,,NA,NA,NA,NA,NA
1275,Pocillopora_acuta_HIv2___RNAseq.2618_t,181.7508694,-3.211474242,5.404938855,1.02E-05,0.000115157,,Q9UHJ3,2.82E-10,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635
1276,Pocillopora_acuta_HIv2___RNAseq.g14883.t1,216.5948689,3.313354029,0.989217887,1.02E-05,0.000115584,,NA,NA,NA,NA,NA
1277,Pocillopora_acuta_HIv2___RNAseq.g21588.t1a,368.3857097,4.742280251,2.479020935,1.03E-05,0.000116136,,Q8BYW1,3.48E-08,Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25),"actin filament organization [GO:0007015]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; signal transduction [GO:0007165]",GO:0001891; GO:0005096; GO:0006911; GO:0007015; GO:0007165; GO:0051058
1278,Pocillopora_acuta_HIv2___RNAseq.g13580.t1,563.4123148,-0.368937591,1.068205811,1.03E-05,0.000116136,,Q32L41,4.42E-33,GTP cyclohydrolase 1 feedback regulatory protein (GFRP) (GTP cyclohydrolase I feedback regulatory protein),negative regulation of biosynthetic process [GO:0009890],GO:0005634; GO:0005737; GO:0005829; GO:0009890; GO:0031965; GO:0044549
1279,Pocillopora_acuta_HIv2___RNAseq.g12617.t1,93.71181604,-7.151087388,3.400215502,1.03E-05,0.00011645,,Q54RB9,1.02E-13,Calcium-binding mitochondrial carrier protein (Mitochondrial substrate carrier family protein O),aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490],GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490
1280,Pocillopora_acuta_HIv2___RNAseq.g8914.t1,4734.095104,4.727648508,2.661726406,1.04E-05,0.000117476,,O75096,0,Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7),amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395
1281,Pocillopora_acuta_HIv2___RNAseq.g21460.t2a,320.6585907,-8.428385229,4.021381576,1.05E-05,0.000118616,Zona_pellucida,NA,NA,NA,NA,NA
1282,Pocillopora_acuta_HIv2___RNAseq.g23429.t1,283.2344198,-0.633722879,1.298492185,1.05E-05,0.000118629,,Q5ZJP7,2.31E-36,BTB/POZ domain-containing protein KCTD7,membrane hyperpolarization [GO:0060081]; protein homooligomerization [GO:0051260],GO:0005829; GO:0005886; GO:0051260; GO:0060081
1283,Pocillopora_acuta_HIv2___TS.g8967.t1,101.9523428,6.796752047,4.413860899,1.05E-05,0.00011865,,O05485,3.77E-29,Extracellular protease (EC 3.4.24.-),proteolysis [GO:0006508],GO:0004222; GO:0006508; GO:0046872
1284,Pocillopora_acuta_HIv2___RNAseq.g3311.t3,551.3040421,-0.337176002,1.053262605,1.06E-05,0.000119155,,D3Z2X2,8.81E-94,Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein),flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316],GO:0005524; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0045505; GO:0051959; GO:0120316
1285,Pocillopora_acuta_HIv2___RNAseq.g16328.t1,40.55214305,-9.532857685,3.580554445,1.07E-05,0.000120456,,NA,NA,NA,NA,NA
1286,Pocillopora_acuta_HIv2___RNAseq.g5707.t1,57.12932907,-9.956507474,3.932198496,1.09E-05,0.000123125,,Q559T8,2.38E-06,Probable serine/threonine-protein kinase DDB_G0272282 (EC 2.7.11.1),intracellular signal transduction [GO:0035556],GO:0004674; GO:0005524; GO:0035091; GO:0035556; GO:0106310
1287,Pocillopora_acuta_HIv2___RNAseq.g24791.t1,613.4036211,-0.635590491,1.235543138,1.12E-05,0.00012632,,A0A1X7TVA9,1.11E-11,Death domain-containing ATP nucleosidase (DDAN) (EC 3.5.99.-),nucleoside metabolic process [GO:0009116],GO:0009116; GO:0016787
1288,Pocillopora_acuta_HIv2___TS.g234.t1,762.7770075,-0.794089953,1.414721436,1.13E-05,0.000126376,,G3UZ78,9.34E-150,Androglobin,proteolysis [GO:0006508]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283],GO:0004198; GO:0006508; GO:0007283; GO:0007286; GO:0019825; GO:0020037; GO:0036126; GO:0046872; GO:0097225; GO:0097227
1289,Pocillopora_acuta_HIv2___TS.g10620.t1,534.5729237,-0.311332947,1.045285018,1.13E-05,0.000126376,,A2RUB6,1.48E-11,Coiled-coil domain-containing protein 66,cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; microtubule bundle formation [GO:0001578]; regulation of protein localization to cilium [GO:1903564]; retina homeostasis [GO:0001895],GO:0001578; GO:0001750; GO:0001895; GO:0001917; GO:0005813; GO:0005829; GO:0005874; GO:0005929; GO:0008017; GO:0030054; GO:0034451; GO:0036064; GO:0042803; GO:0050908; GO:0060271; GO:0090543; GO:1903564
1290,Pocillopora_acuta_HIv2___RNAseq.g19671.t1,478.5085863,-0.755667523,1.351787718,1.13E-05,0.000126376,,Q28DV3,0,Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-),circadian regulation of gene expression [GO:0032922]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752],GO:0000122; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005737; GO:0017053; GO:0032922; GO:0033558; GO:0042752; GO:0160008; GO:0160009; GO:0160010
1291,Pocillopora_acuta_HIv2___RNAseq.g27669.t1,513.4115085,-0.469786238,1.121489849,1.15E-05,0.000128948,,Q8IZD9,0,Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP),neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264],GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0017124; GO:0031267; GO:0048011; GO:0051056
1292,Pocillopora_acuta_HIv2___RNAseq.g20516.t1,130.0856985,-3.413343561,3.9639579,1.15E-05,0.000129256,,NA,NA,NA,NA,NA
1293,Pocillopora_acuta_HIv2___RNAseq.18788_t,50.28418892,-9.596110967,3.784633781,1.16E-05,0.000129286,,P31422,1.26E-121,Metabotropic glutamate receptor 3 (mGluR3),"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]",GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170
1294,Pocillopora_acuta_HIv2___RNAseq.g13628.t1,1074.959123,-0.503765168,1.153209807,1.16E-05,0.000129895,,Q86V25,5.98E-98,Tubulinyl-Tyr carboxypeptidase 2 (EC 3.4.17.17) (Vasohibin-2) (Vasohibin-like protein),axon development [GO:0061564]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; syncytium formation by plasma membrane fusion [GO:0000768],GO:0000768; GO:0001938; GO:0003779; GO:0004181; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0006508; GO:0008017; GO:0045765; GO:0045766; GO:0060716; GO:0061564; GO:0106423; GO:0140253
1295,Pocillopora_acuta_HIv2___RNAseq.g2050.t1,406.971031,0.317017766,1.088893798,1.17E-05,0.000130487,,NA,NA,NA,NA,NA
1296,Pocillopora_acuta_HIv2___RNAseq.g25911.t1,427.1042938,-4.034420373,2.653672217,1.18E-05,0.000131538,,NA,NA,NA,NA,NA
1297,Pocillopora_acuta_HIv2___TS.g5338.t1,2352.957244,5.347139032,2.558804983,1.18E-05,0.000131606,Collagenase 3,P45452,4.05E-45,Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13),bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645],GO:0001958; GO:0003417; GO:0004175; GO:0004222; GO:0004252; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030282; GO:0030574; GO:0031012; GO:0060349; GO:1904645
1298,Pocillopora_acuta_HIv2___RNAseq.g183.t1,340.729076,4.637959777,2.191840902,1.18E-05,0.000131606,,B7WFQ1,7.31E-42,Uncharacterized skeletal organic matrix protein 2 (Uncharacterized SOMP-2),,GO:0016020
1299,Pocillopora_acuta_HIv2___RNAseq.g26381.t1,407.8996419,-0.42158863,1.096645625,1.19E-05,0.000132656,,Q8TAC1,3.21E-38,Rieske domain-containing protein,,GO:0046872; GO:0051537
1300,Pocillopora_acuta_HIv2___TS.g21618.t1,284.2305741,-0.428048649,1.090934786,1.21E-05,0.000134223,,E9Q6P5,2.94E-65,Tetratricopeptide repeat protein 7B (TPR repeat protein 7B),phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659],GO:0005829; GO:0005886; GO:0046854; GO:0072659
1301,Pocillopora_acuta_HIv2___RNAseq.g15566.t1,484.9780567,-0.285423307,1.041600326,1.21E-05,0.000134758,,A0JJX5,1.11E-16,Synaptotagmin-4 (NTMC2T2.2) (Synaptotagmin D),lipid transport [GO:0006869],GO:0006869; GO:0008289; GO:0012505; GO:0016020; GO:0046872
1302,Pocillopora_acuta_HIv2___RNAseq.g27045.t1b,233.1222178,0.609283801,1.292296524,1.23E-05,0.000136731,Protein Wnt-7b,P56706,2.82E-43,Protein Wnt-7b,"canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; central nervous system vasculogenesis [GO:0022009]; chemoattraction of dopaminergic neuron axon [GO:0036516]; chorio-allantoic fusion [GO:0060710]; developmental growth involved in morphogenesis [GO:0060560]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; homeostatic process [GO:0042592]; in utero embryonic development [GO:0001701]; inner medullary collecting duct development [GO:0072061]; intracellular oxygen homeostasis [GO:0032364]; lens fiber cell development [GO:0070307]; lobar bronchus development [GO:0060482]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; mammary gland epithelium development [GO:0061180]; metanephric collecting duct development [GO:0072205]; metanephric epithelium development [GO:0072207]; metanephric loop of Henle development [GO:0072236]; metanephros morphogenesis [GO:0003338]; neuron differentiation [GO:0030182]; outer medullary collecting duct development [GO:0072060]; positive regulation of JNK cascade [GO:0046330]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell projection size [GO:0032536]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; response to glucocorticoid [GO:0051384]; stem cell proliferation [GO:0072089]; synapse organization [GO:0050808]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0001701; GO:0003338; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0016055; GO:0016332; GO:0021871; GO:0022009; GO:0030182; GO:0030324; GO:0030666; GO:0032364; GO:0032536; GO:0036516; GO:0042592; GO:0045165; GO:0045669; GO:0046330; GO:0048018; GO:0048144; GO:0048568; GO:0050808; GO:0051384; GO:0060070; GO:0060071; GO:0060425; GO:0060428; GO:0060482; GO:0060535; GO:0060560; GO:0060669; GO:0060710; GO:0061180; GO:0070062; GO:0070307; GO:0071300; GO:0072053; GO:0072054; GO:0072060; GO:0072061; GO:0072089; GO:0072205; GO:0072207; GO:0072236
1303,Pocillopora_acuta_HIv2___RNAseq.g6274.t1,113.9945549,-3.888767393,1.270883813,1.24E-05,0.000137292,,Q5F4A1,2.41E-54,G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase),apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872
1304,Pocillopora_acuta_HIv2___RNAseq.g14489.t1,220.230371,-0.981454696,1.796629391,1.24E-05,0.000137824,,Q7TSH8,0,Transmembrane protein 94 (Endoplasmic reticulum magnesium ATPase),embryonic brain development [GO:1990403]; embryonic heart tube development [GO:0035050]; intracellular magnesium ion homeostasis [GO:0010961]; magnesium ion transport from cytosol to endoplasmic reticulum [GO:0160176],GO:0005789; GO:0010961; GO:0015444; GO:0035050; GO:0160176; GO:1990403
1305,Pocillopora_acuta_HIv2___RNAseq.g30214.t1,394.1106281,-4.261330829,1.469171054,1.25E-05,0.000138293,,B2RQL2,6.59E-30,Storkhead-box protein 1,cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of mitotic cell cycle [GO:0007346]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000977; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0006357; GO:0007346; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0045787; GO:0048839; GO:0051301; GO:0051881; GO:0051897; GO:0071500; GO:1900087; GO:1901858; GO:1902882; GO:1904120
1306,Pocillopora_acuta_HIv2___RNAseq.g24683.t1,108.8836607,-6.145756435,2.94500195,1.26E-05,0.000139262,,H3ZPL1,1.23E-48,Aromatic-amino-acid aminotransferase 1 (ARAT-I) (AROAT) (EC 2.6.1.57),biosynthetic process [GO:0009058],GO:0009058; GO:0030170; GO:0080130
1307,Pocillopora_acuta_HIv2___RNAseq.g27330.t1,670.7302836,-0.277252038,1.034259218,1.26E-05,0.000139262,,Q9W352,7.33E-123,CXXC-type zinc finger protein 1 (PHD finger and CXXC domain-containing protein 1),positive regulation of DNA-templated transcription [GO:0045893],GO:0003677; GO:0008270; GO:0035064; GO:0045893; GO:0048188
1308,Pocillopora_acuta_HIv2___RNAseq.g25908.t1,329.7575899,-0.721387135,1.332784248,1.28E-05,0.000141172,,NA,NA,NA,NA,NA
1309,Pocillopora_acuta_HIv2___RNAseq.g28740.t1,514.3005557,-0.517421234,1.141865001,1.29E-05,0.000142295,,P56273,3.13E-11,E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Xdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2),apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein ubiquitination [GO:0016567]; regulation of biological quality [GO:0065008]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468],GO:0002039; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006915; GO:0010468; GO:0016567; GO:0042802; GO:0043066; GO:0046872; GO:0051726; GO:0061630; GO:0065008
1310,Pocillopora_acuta_HIv2___TS.g26640.t2,321.2171535,-1.030222158,1.902977861,1.29E-05,0.000142848,,P34568,1.94E-12,Speckle-type POZ protein homolog (BTB and MATH domain-containing protein 43) (HIB homolog),proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162],GO:0005634; GO:0005737; GO:0016567; GO:0016607; GO:0030162; GO:0031625; GO:0043161
1311,Pocillopora_acuta_HIv2___RNAseq.g5755.t1,258.5369586,-4.783216087,4.287073549,1.30E-05,0.000142949,TRP C5,Q9QX29,2.00E-47,Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5),calcium ion transmembrane transport [GO:0070588]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630],GO:0003779; GO:0005886; GO:0007204; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:0098793; GO:1902630
1312,Pocillopora_acuta_HIv2___RNAseq.g8057.t1,481.2988213,-0.327095729,1.074481285,1.32E-05,0.000145165,,NA,NA,NA,NA,NA
1313,Pocillopora_acuta_HIv2___RNAseq.g19739.t1,367.3688676,-0.403666226,1.082786336,1.33E-05,0.000146903,TRP V4,A0A1D5PXA5,1.52E-11,Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Vanilloid receptor-related osmotically activated channel) (VR-OAC),intracellular calcium ion homeostasis [GO:0006874]; osmosensory signaling pathway [GO:0007231],GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005886; GO:0005912; GO:0006874; GO:0007231; GO:0008289; GO:0016324; GO:0017124; GO:0035091; GO:0046872
1314,Pocillopora_acuta_HIv2___RNAseq.g16526.t1,568.2100531,4.964938839,2.322148922,1.34E-05,0.000147412,,P47179,6.41E-12,Cell wall protein DAN4 (Delayed anaerobic protein 4),fungal-type cell wall organization [GO:0031505],GO:0005199; GO:0005576; GO:0005886; GO:0009277; GO:0031505; GO:0071944; GO:0098552
1315,Pocillopora_acuta_HIv2___RNAseq.g19797.t1,467.8559366,-0.586070759,1.234096105,1.35E-05,0.000147958,Protein patched homolog 1,Q61115,0,Protein patched homolog 1 (PTC) (PTC1),animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell proliferation [GO:0050673]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; liver regeneration [GO:0097421]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube formation [GO:0001841]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal cell differentiation [GO:0045606]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of cell population proliferation [GO:0042127]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; spermatid development [GO:0007286]; spinal cord motor neuron differentiation [GO:0021522]; stem cell proliferation [GO:0072089],GO:0000122; GO:0001658; GO:0001701; GO:0001709; GO:0001841; GO:0001843; GO:0003007; GO:0005113; GO:0005119; GO:0005576; GO:0005794; GO:0005886; GO:0005901; GO:0005929; GO:0007165; GO:0007286; GO:0007346; GO:0007389; GO:0007420; GO:0008158; GO:0008201; GO:0008270; GO:0008285; GO:0008544; GO:0009410; GO:0009612; GO:0009887; GO:0009953; GO:0009957; GO:0010157; GO:0010839; GO:0010875; GO:0015485; GO:0016485; GO:0021522; GO:0021904; GO:0021997; GO:0030326; GO:0030332; GO:0030496; GO:0030850; GO:0030879; GO:0032355; GO:0032526; GO:0032880; GO:0035137; GO:0040008; GO:0040015; GO:0042127; GO:0042593; GO:0043616; GO:0044294; GO:0044295; GO:0044877; GO:0045177; GO:0045606; GO:0045668; GO:0045879; GO:0045892; GO:0045893; GO:0048471; GO:0048568; GO:0048745; GO:0050673; GO:0050680; GO:0051782; GO:0060037; GO:0060603; GO:0060644; GO:0061005; GO:0061053; GO:0071397; GO:0071679; GO:0072089; GO:0072203; GO:0072205; GO:0072659; GO:0097108; GO:0097421; GO:2000647
1316,Pocillopora_acuta_HIv2___RNAseq.g14927.t1,332.9280669,-0.656953197,1.266971749,1.35E-05,0.00014807,,NA,NA,NA,NA,NA
1317,Pocillopora_acuta_HIv2___TS.g7532.t1,412.2777798,-0.500159559,1.153048325,1.35E-05,0.000148382,,Q13183,6.04E-155,Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter),alpha-ketoglutarate transport [GO:0015742]; cellular response to lithium ion [GO:0071285]; fumarate transport [GO:0015741]; succinate transmembrane transport [GO:0071422],GO:0005886; GO:0015138; GO:0015139; GO:0015141; GO:0015361; GO:0015741; GO:0015742; GO:0016020; GO:0016324; GO:0017153; GO:0070062; GO:0071285; GO:0071422
1318,Pocillopora_acuta_HIv2___RNAseq.g30748.t1,439.4255023,-0.337163809,1.052284574,1.36E-05,0.000148709,,Q757F3,1.29E-06,Mitochondrial ATPase complex subunit ATP10,mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615],GO:0005743; GO:0033615; GO:0051082
1319,Pocillopora_acuta_HIv2___RNAseq.g3423.t2,188.524505,-1.134393736,1.934255833,1.36E-05,0.000149274,,Q80UG8,0,Tubulin monoglutamylase TTLL4 (EC 6.3.2.-) (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4),microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222],GO:0000226; GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0120222
1320,Pocillopora_acuta_HIv2___TS.g26942.t1,644.7684826,-0.33690063,1.052179171,1.37E-05,0.000149636,,Q5MCW4,2.56E-73,Zinc finger protein 569,regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872
1321,Pocillopora_acuta_HIv2___RNAseq.g3862.t1,1050.681342,-0.596708901,1.23476184,1.37E-05,0.000150162,,P18460,1.97E-104,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2),apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of macromolecule metabolic process [GO:0060255],GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284; GO:0017134; GO:0030154; GO:0043235; GO:0043410; GO:0060255
1322,Pocillopora_acuta_HIv2___RNAseq.g21614.t1,378.2385366,-0.282703808,1.047404315,1.38E-05,0.000150531,,NA,NA,NA,NA,NA
1323,Pocillopora_acuta_HIv2___RNAseq.g5181.t1,400.629188,4.752939786,2.107489428,1.38E-05,0.000150887,,Q9HCK4,3.69E-30,Roundabout homolog 2,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412],GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609
1324,Pocillopora_acuta_HIv2___RNAseq.g29231.t1,641.4170009,-0.5870587,1.194712075,1.38E-05,0.000150887,,Q5F364,0,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908],GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729
1325,Pocillopora_acuta_HIv2___TS.g1975.t1,348.2224813,-0.461342789,1.110103948,1.38E-05,0.000151091,,B8VIU6,1.79E-27,Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5),,GO:0005576
1326,Pocillopora_acuta_HIv2___RNAseq.g3641.t1,136.5541889,-0.263440137,1.069800369,1.41E-05,0.000153767,Melanopsin-A,Q2KNE5,1.13E-12,Melanopsin-A (Mammalian-like melanopsin) (Melanopsin-M) (Opsin-4-A) (Opsin-4M),cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; visual perception [GO:0007601],GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0009881; GO:0071482
1327,Pocillopora_acuta_HIv2___RNAseq.g11710.t1,813.8437137,-0.290216556,1.042046644,1.42E-05,0.00015433,,Q5JWR5,0,Protein DOP1A,Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],GO:0000139; GO:0005768; GO:0005798; GO:0005802; GO:0005829; GO:0006895; GO:0015031
1328,Pocillopora_acuta_HIv2___RNAseq.g30322.t1,2426.550282,3.008006647,0.896585758,1.42E-05,0.00015433,Mannan-binding lectin serine protease 1,P98064,1.04E-155,Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain],"complement activation, lectin pathway [GO:0001867]; zymogen activation [GO:0031638]",GO:0001867; GO:0004252; GO:0005509; GO:0005615; GO:0005654; GO:0005829; GO:0031638; GO:0042803; GO:0048306
1329,Pocillopora_acuta_HIv2___RNAseq.g30171.t1,242.7058278,-0.591126219,1.218129736,1.42E-05,0.000154476,,Q4P983,1.56E-15,"Presequence translocated-associated motor subunit PAM17, mitochondrial",protein import into mitochondrial matrix [GO:0030150],GO:0001405; GO:0030150
1330,Pocillopora_acuta_HIv2___RNAseq.g3019.t1,591.1597161,-0.467841536,1.159770792,1.43E-05,0.00015506,,Q4R381,0,Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (Enhancer of zeste homolog 2),"heterochromatin formation [GO:0031507]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]",GO:0000122; GO:0003682; GO:0010718; GO:0031507; GO:0032259; GO:0035098; GO:0042752; GO:0043406; GO:0043547; GO:0045814; GO:0045892; GO:0046976; GO:0048387; GO:0048511; GO:0071902; GO:0140951; GO:1990841
1331,Pocillopora_acuta_HIv2___RNAseq.g12292.t1,44.21671189,-9.404799258,3.635682445,1.43E-05,0.00015506,Fucolectin,Q7SIC1,4.31E-15,Fucolectin,"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]",GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088
1332,Pocillopora_acuta_HIv2___TS.g17409.t1,258.3056416,-1.12489184,1.933904049,1.43E-05,0.000155707,,Q969V4,2.94E-141,Tektin-1,cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317],GO:0005634; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0160111
1333,Pocillopora_acuta_HIv2___RNAseq.g15036.t2,215.5716488,-5.706833239,3.367738712,1.45E-05,0.000157145,,Q17RW2,3.49E-11,Collagen alpha-1(XXIV) chain,extracellular matrix organization [GO:0030198],GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0062023
1334,Pocillopora_acuta_HIv2___RNAseq.g22119.t1,47.64856871,-9.441114535,3.707637973,1.47E-05,0.000159097,,NA,NA,NA,NA,NA
1335,Pocillopora_acuta_HIv2___RNAseq.g30418.t1,88.42995375,-0.979907067,1.812547087,1.47E-05,0.000159428,,NA,NA,NA,NA,NA
1336,Pocillopora_acuta_HIv2___RNAseq.g55.t1,152.6787045,-0.672174743,1.360874199,1.48E-05,0.00015976,,NA,NA,NA,NA,NA
1337,Pocillopora_acuta_HIv2___RNAseq.g31267.t1,82.95208612,-0.875301558,1.625241948,1.50E-05,0.000161764,,NA,NA,NA,NA,NA
1338,Pocillopora_acuta_HIv2___TS.g549.t1,638.8632591,-0.637496343,1.242524435,1.50E-05,0.000162159,,Q1LY46,3.82E-168,Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1),calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; intracellular monoatomic cation homeostasis [GO:0030003]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; potassium ion transport [GO:0006813]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],GO:0005509; GO:0005743; GO:0006813; GO:0006816; GO:0006851; GO:0007007; GO:0015369; GO:0030003; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093
1339,Pocillopora_acuta_HIv2___RNAseq.g24740.t1,361.4954799,-0.373706908,1.085142534,1.50E-05,0.000162425,,Q6ZUK4,4.87E-22,Transmembrane protein 26,,GO:0016020
1340,Pocillopora_acuta_HIv2___RNAseq.g11254.t1,2215.167726,-4.784707467,2.925480755,1.51E-05,0.000162473,,NA,NA,NA,NA,NA
1341,Pocillopora_acuta_HIv2___RNAseq.g13234.t1,7877.7362,-4.81323068,3.363618236,1.52E-05,0.000163665,Prostatic spermine-binding protein,NA,NA,NA,NA,NA
1342,Pocillopora_acuta_HIv2___RNAseq.g18973.t1,307.7865718,-0.381840712,1.129321568,1.52E-05,0.000163665,,Q5ZID0,2.80E-81,NmrA-like family domain-containing protein 1,,GO:0005634; GO:0048471
1343,Pocillopora_acuta_HIv2___RNAseq.g13701.t1,210.6999776,-0.422398957,1.095721194,1.52E-05,0.000163678,,Q54CI5,6.82E-26,DPH4 homolog (DnaJ homolog subfamily C member 24),protein histidyl modification to diphthamide [GO:0017183],GO:0001671; GO:0017183; GO:0046872
1344,Pocillopora_acuta_HIv2___RNAseq.g27797.t1,599.1739533,-0.359030642,1.060132896,1.52E-05,0.000163678,,NA,NA,NA,NA,NA
1345,Pocillopora_acuta_HIv2___RNAseq.g18957.t1,90.38030891,-0.644551186,1.331976904,1.53E-05,0.000164013,,NA,NA,NA,NA,NA
1346,Pocillopora_acuta_HIv2___RNAseq.g25079.t1,726.6108473,-4.502899143,2.423707589,1.54E-05,0.000165485,,NA,NA,NA,NA,NA
1347,Pocillopora_acuta_HIv2___RNAseq.g17209.t1,642.848831,-0.219270413,1.038371279,1.54E-05,0.000165662,,Q04336,0,Uncharacterized protein YMR196W,oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487],GO:0004573; GO:0005737; GO:0006487; GO:0009311
1348,Pocillopora_acuta_HIv2___RNAseq.g3159.t1,334.8730624,-0.470100162,1.116012237,1.57E-05,0.000168326,,Q5G266,6.26E-52,Neurotrypsin (EC 3.4.21.-) (Serine protease 12),exocytosis [GO:0006887]; proteolysis [GO:0006508],GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195
1349,Pocillopora_acuta_HIv2___RNAseq.g30747.t1,578.5286072,-0.202756637,1.025471289,1.58E-05,0.000169387,,Q9CPV0,1.67E-47,Transmembrane protein 107,cilium assembly [GO:0060271]; cilium organization [GO:0044782]; craniofacial suture morphogenesis [GO:0097094]; detection of nodal flow [GO:0003127]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021],GO:0003127; GO:0007368; GO:0010468; GO:0016020; GO:0021532; GO:0035869; GO:0036038; GO:0042733; GO:0044782; GO:0060021; GO:0060271; GO:0097094; GO:1904491; GO:1905515
1350,Pocillopora_acuta_HIv2___RNAseq.g4878.t1,2068.419755,4.111703701,3.426021551,1.60E-05,0.00017115,Melanotransferrin,O97490,3.41E-67,Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228),iron ion transport [GO:0006826],GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0046872; GO:0055037; GO:0098552
1351,Pocillopora_acuta_HIv2___RNAseq.g28814.t1,142.6435088,-6.971463379,4.245880638,1.60E-05,0.000171192,,NA,NA,NA,NA,NA
1352,Pocillopora_acuta_HIv2___RNAseq.g18304.t2,371.7014678,0.452491806,1.149228388,1.60E-05,0.000171192,,NA,NA,NA,NA,NA
1353,Pocillopora_acuta_HIv2___RNAseq.g23496.t1,89.98489564,-0.292801722,1.082943727,1.60E-05,0.000171192,,Q86Y13,6.75E-12,E3 ubiquitin-protein ligase DZIP3 (EC 2.3.2.27) (DAZ-interacting protein 3) (RING-type E3 ubiquitin transferase DZIP3) (RNA-binding ubiquitin ligase of 138 kDa) (hRUL138),protein polyubiquitination [GO:0000209],GO:0000209; GO:0003723; GO:0004842; GO:0005737; GO:0019902; GO:0031593; GO:0046872; GO:0061630
1354,Pocillopora_acuta_HIv2___RNAseq.29542_t,369.4453994,-0.653120904,1.267913141,1.61E-05,0.000171846,,O00305,1.05E-71,Voltage-dependent L-type calcium channel subunit beta-4 (CAB4) (Calcium channel voltage-dependent subunit beta 4),"adult walking behavior [GO:0007628]; cAMP metabolic process [GO:0046058]; cellular response to leukemia inhibitory factor [GO:1990830]; chemical synaptic transmission [GO:0007268]; detection of light stimulus involved in visual perception [GO:0050908]; gamma-aminobutyric acid secretion [GO:0014051]; gamma-aminobutyric acid signaling pathway [GO:0007214]; muscle cell development [GO:0055001]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuromuscular junction development [GO:0007528]; neuronal action potential propagation [GO:0019227]; Peyer's patch development [GO:0048541]; positive regulation of protein localization to nucleolus [GO:1904751]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of voltage-gated calcium channel activity [GO:1901385]; spleen development [GO:0048536]; synaptic transmission, glutamatergic [GO:0035249]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]",GO:0005829; GO:0005886; GO:0005891; GO:0007214; GO:0007268; GO:0007528; GO:0007628; GO:0008285; GO:0009898; GO:0014051; GO:0016607; GO:0019227; GO:0019901; GO:0035249; GO:0045202; GO:0046058; GO:0048536; GO:0048538; GO:0048541; GO:0050852; GO:0050908; GO:0055001; GO:0098793; GO:0098978; GO:0099626; GO:1901385; GO:1904751; GO:1990830; GO:2000134; GO:2000300
1355,Pocillopora_acuta_HIv2___TS.g13522.t1b,222.2563078,-0.843075457,1.470131358,1.61E-05,0.000171846,,Q8T882,3.10E-150,Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase),,GO:0050325
1356,Pocillopora_acuta_HIv2___RNAseq.g23211.t1,234.6486998,-0.765343459,1.45309844,1.65E-05,0.000176503,,Q9UGM3,4.85E-157,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein),defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031],GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062
1357,Pocillopora_acuta_HIv2___TS.g26689.t1,151.1341613,-0.264969152,1.070806122,1.68E-05,0.00017884,,P07607,6.63E-119,Thymidylate synthase (TS) (TSase) (EC 2.1.1.45),cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; regulation of translation [GO:0006417]; response to cytokine [GO:0034097]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860],GO:0000900; GO:0003729; GO:0004799; GO:0005542; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0006417; GO:0007623; GO:0009410; GO:0009636; GO:0019860; GO:0032259; GO:0032570; GO:0033189; GO:0034097; GO:0035999; GO:0042803; GO:0045471; GO:0046683; GO:0048589; GO:0051216; GO:0051384; GO:0051593; GO:0060574; GO:0097421; GO:1901363; GO:1990825
1358,Pocillopora_acuta_HIv2___TS.g9370.t1,3756.792176,3.285102511,1.07725875,1.68E-05,0.000179334,,Q5R9H4,0,APOBEC1 complementation factor (APOBEC1-stimulating protein),mRNA processing [GO:0006397]; protein stabilization [GO:0050821],GO:0003727; GO:0005737; GO:0005783; GO:0006397; GO:0030895; GO:0050821
1359,Pocillopora_acuta_HIv2___TS.g23724.t1a,3514.210144,4.525568551,1.486372615,1.72E-05,0.000182779,Uncharacterized skeletal organic matrix protein-3,B8RJM0,1.96E-36,Uncharacterized skeletal organic matrix protein 3 (Uncharacterized SOMP-3),,GO:0016020
1360,Pocillopora_acuta_HIv2___RNAseq.g15293.t1,1839.704643,4.555609702,1.975274044,1.72E-05,0.000182841,,NA,NA,NA,NA,NA
1361,Pocillopora_acuta_HIv2___RNAseq.g18490.t1,283.7196476,-0.684238253,1.275884436,1.72E-05,0.000183111,,NA,NA,NA,NA,NA
1362,Pocillopora_acuta_HIv2___TS.g11629.t1a,411.0246969,0.174509132,1.0235463,1.73E-05,0.000183445,,P42674,4.10E-26,Blastula protease 10 (EC 3.4.24.-),proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0005938; GO:0006508; GO:0008270; GO:0048471
1363,Pocillopora_acuta_HIv2___RNAseq.g19870.t1,593.2766289,-2.72908396,4.206614,1.73E-05,0.000183445,,Q9Z0U4,7.43E-73,Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1),"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932]",GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430
1364,Pocillopora_acuta_HIv2___RNAseq.g19362.t3,87.09333254,-0.456497429,1.173911922,1.73E-05,0.000183854,,NA,NA,NA,NA,NA
1365,Pocillopora_acuta_HIv2___TS.g22619.t2,346.3776223,-0.601510537,1.2740523,1.74E-05,0.000184611,,NA,NA,NA,NA,NA
1366,Pocillopora_acuta_HIv2___RNAseq.g14658.t1,605.9268316,-0.498340222,1.195963412,1.75E-05,0.000184841,,O18405,4.70E-129,Surfeit locus protein 4 homolog,Golgi organization [GO:0007030]; protein transport [GO:0015031],GO:0005783; GO:0005789; GO:0005793; GO:0007030; GO:0012505; GO:0015031; GO:0045169
1367,Pocillopora_acuta_HIv2___RNAseq.g11861.t1a,483.4406688,-0.328386374,1.065452054,1.75E-05,0.000184841,,Q5FW12,6.34E-99,TIP41-like protein,,GO:0005737
1368,Pocillopora_acuta_HIv2___RNAseq.g3933.t1,171.0875703,-0.874077134,1.520135403,1.77E-05,0.000187416,,NA,NA,NA,NA,NA
1369,Pocillopora_acuta_HIv2___RNAseq.g22260.t1,196.8403883,-0.722989705,1.385072491,1.77E-05,0.000187416,Twist neighbor protein (CARP 9),Q6PHG8,4.41E-32,DNA-directed RNA polymerase I subunit RPA43 (DNA-directed RNA polymerase I subunit F) (Twist neighbor protein),DNA-templated transcription initiation [GO:0006352]; transcription elongation by RNA polymerase I [GO:0006362],GO:0005736; GO:0006352; GO:0006362
1370,Pocillopora_acuta_HIv2___TS.g16484.t1,154.4546171,-3.453197631,4.276966136,1.78E-05,0.000187765,Sodium- and chloride-dependent GABA transporter 2 (GAT-2),P31649,0,Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13),amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734],GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718
1371,Pocillopora_acuta_HIv2___RNAseq.g21034.t1,472.4548888,-0.522397658,1.150572558,1.78E-05,0.000188111,,NA,NA,NA,NA,NA
1372,Pocillopora_acuta_HIv2___RNAseq.g16818.t1,415.6099241,-0.595168935,1.201884392,1.79E-05,0.000188567,,NA,NA,NA,NA,NA
1373,Pocillopora_acuta_HIv2___RNAseq.g15079.t1,441.2360448,-0.342634812,1.055742639,1.79E-05,0.000189009,,NA,NA,NA,NA,NA
1374,Pocillopora_acuta_HIv2___RNAseq.g27847.t2,281.0126893,-0.718247354,1.311408799,1.81E-05,0.000190235,,P47173,3.09E-37,Uncharacterized protein YJR142W,,GO:0044715
1375,Pocillopora_acuta_HIv2___RNAseq.30019_t,2423.827242,4.614915305,1.668430638,1.82E-05,0.000191837,,NA,NA,NA,NA,NA
1376,Pocillopora_acuta_HIv2___RNAseq.g4924.t1,291.670879,-0.807757426,1.482934863,1.85E-05,0.000193995,,Q64591,4.90E-140,"2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial (EC 1.3.1.124) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH])",fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162],GO:0005739; GO:0006635; GO:0008670; GO:0042802; GO:0070402; GO:0120162; GO:1902494
1377,Pocillopora_acuta_HIv2___RNAseq.g4009.t1,188.2189433,0.405024181,1.142188588,1.85E-05,0.00019418,,NA,NA,NA,NA,NA
1378,Pocillopora_acuta_HIv2___TS.g20447.t1,224.6019581,3.504649777,1.236740331,1.85E-05,0.000194614,,NA,NA,NA,NA,NA
1379,Pocillopora_acuta_HIv2___RNAseq.g7535.t1,366.7929981,-0.432487498,1.091623565,1.86E-05,0.00019498,,NA,NA,NA,NA,NA
1380,Pocillopora_acuta_HIv2___RNAseq.g18736.t1,149.5238348,-0.270522156,1.073499157,1.87E-05,0.000195953,,Q8NAT2,2.47E-59,Tudor domain-containing protein 5,P granule organization [GO:0030719]; piRNA processing [GO:0034587]; retrotransposon silencing by piRNA-directed DNA methylation [GO:0141196]; siRNA-mediated retrotransposon silencing by heterochromatin formation [GO:0141007]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283],GO:0007283; GO:0007286; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0071546; GO:0141007; GO:0141196
1381,Pocillopora_acuta_HIv2___RNAseq.g28398.t1,252.9711864,-6.693268433,4.110953088,1.87E-05,0.000196379,Synphilin-1,Q9Y6H5,2.51E-30,Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein),cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928],GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0046928; GO:0090083
1382,Pocillopora_acuta_HIv2___RNAseq.g16248.t1,333.9222349,-0.597614071,1.203512149,1.88E-05,0.000197181,,NA,NA,NA,NA,NA
1383,Pocillopora_acuta_HIv2___TS.g16066.t1,41.26135797,-9.332119605,3.653400127,1.89E-05,0.000197496,,NA,NA,NA,NA,NA
1384,Pocillopora_acuta_HIv2___RNAseq.g28816.t1,119.3454923,-4.438908042,1.861527595,1.89E-05,0.000197496,,Q5I020,3.91E-74,Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8),zinc ion import into organelle [GO:0062111],GO:0005886; GO:0030658; GO:0030667; GO:0046872; GO:0062111; GO:0140826
1385,Pocillopora_acuta_HIv2___RNAseq.g18655.t1,291.2561081,-0.535628185,1.233770058,1.89E-05,0.000197496,,Q640B4,1.84E-14,Crossover junction endonuclease MUS81 (EC 3.1.22.-),DNA catabolic process [GO:0006308]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302],GO:0003677; GO:0005634; GO:0006302; GO:0006308; GO:0006310; GO:0008821; GO:0046872
1386,Pocillopora_acuta_HIv2___RNAseq.g8875.t1,388.4701661,-0.327341255,1.057522951,1.89E-05,0.000197676,,Q96AY4,6.01E-87,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301
1387,Pocillopora_acuta_HIv2___RNAseq.g26331.t1,1081.697047,4.088714692,2.060683559,1.90E-05,0.000198395,,Q5ZMH1,0,Septin-2,cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224],GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0008021; GO:0008104; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640
1388,Pocillopora_acuta_HIv2___RNAseq.g30932.t1,352.6992462,-0.289131088,1.047910423,1.91E-05,0.000198569,TRP A1,Q18297,1.59E-139,Transient receptor potential cation channel subfamily A member 1 homolog,,GO:0005216; GO:0005886; GO:0043025; GO:0097730
1389,Pocillopora_acuta_HIv2___RNAseq.g9789.t1,220.4385351,-6.701441934,4.260296859,1.93E-05,0.000200976,,Q8C0S1,0,DIS3-like exonuclease 1 (EC 3.1.13.1),mRNA catabolic process [GO:0006402]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075],GO:0000175; GO:0000177; GO:0003723; GO:0005813; GO:0005829; GO:0005886; GO:0006396; GO:0006401; GO:0006402; GO:0008859; GO:0016075; GO:0019899
1390,Pocillopora_acuta_HIv2___RNAseq.g5859.t1,52.25457012,-9.723777045,4.002962517,1.95E-05,0.000202399,,P16157,8.66E-29,Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin),cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014
1391,Pocillopora_acuta_HIv2___RNAseq.g623.t1,259.2342389,-2.523968049,6.541154253,1.95E-05,0.000202949,,F1MKX4,0,Proteasome activator complex subunit 4 (Proteasome activator PA200),DNA damage response [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; sperm DNA condensation [GO:0035092],GO:0005634; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035092; GO:0070577; GO:0070628; GO:1990111
1392,Pocillopora_acuta_HIv2___RNAseq.g3826.t1,12381.15371,2.770263858,0.803614557,1.97E-05,0.000204186,,Q9ER58,5.79E-23,"Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2)",cellular response to leukemia inhibitory factor [GO:1990830]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811],GO:0005509; GO:0005539; GO:0005576; GO:0010811; GO:0030198; GO:0050840; GO:0062023; GO:1990830
1393,Pocillopora_acuta_HIv2___RNAseq.g2005.t1,462.2859046,-0.165614035,1.023567834,1.99E-05,0.000206402,,NA,NA,NA,NA,NA
1394,Pocillopora_acuta_HIv2___RNAseq.g23210.t1,91.1601051,6.905406142,4.365271435,1.99E-05,0.000206526,,A2AJ76,1.35E-106,Hemicentin-2,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808],GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023
1395,Pocillopora_acuta_HIv2___TS.g18137.t1,635.6466127,-0.299088545,1.064653886,1.99E-05,0.000206822,,O95429,7.21E-12,BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains),cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA modification [GO:0090367]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; ruffle assembly [GO:0097178],GO:0000774; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0010763; GO:0016020; GO:0030838; GO:0031625; GO:0033138; GO:0043066; GO:0044877; GO:0045785; GO:0050821; GO:0051087; GO:0051496; GO:0051897; GO:0071356; GO:0071364; GO:0072659; GO:0090367; GO:0097178; GO:1903215
1396,Pocillopora_acuta_HIv2___TS.g12642.t2,639.2045621,-0.18637768,1.023853226,2.01E-05,0.000207993,,A7SMW7,0,"L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2)",,GO:0005739; GO:0047545
1397,Pocillopora_acuta_HIv2___RNAseq.g20060.t1,4926.13035,-2.486611141,0.688071357,2.01E-05,0.00020851,,NA,NA,NA,NA,NA
1398,Pocillopora_acuta_HIv2___RNAseq.g12569.t1,846.502287,-0.247772667,1.022273266,2.03E-05,0.00021006,,Q3MQ24,3.34E-122,Autophagy protein 5,apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; immune system process [GO:0002376]; piecemeal microautophagy of the nucleus [GO:0034727]; regulation of cilium assembly [GO:1902017],GO:0000422; GO:0002376; GO:0005776; GO:0005930; GO:0006914; GO:0006915; GO:0006995; GO:0034045; GO:0034274; GO:0034727; GO:0044233; GO:0061908; GO:1902017
1399,Pocillopora_acuta_HIv2___RNAseq.g22964.t1,1389.158355,-4.62397155,2.602682826,2.05E-05,0.00021166,,Q6QNK2,6.08E-29,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607
1400,Pocillopora_acuta_HIv2___RNAseq.g28800.t1,5118.41942,2.514337395,0.694191052,2.05E-05,0.000212142,,O42401,5.96E-15,Matrilin-3,,GO:0005509; GO:0005576; GO:0062023
1401,Pocillopora_acuta_HIv2___RNAseq.g6469.t1,291.5911845,-0.421196206,1.087935409,2.06E-05,0.000212594,,A8MY62,7.50E-65,Putative beta-lactamase-like 1,,
1402,Pocillopora_acuta_HIv2___RNAseq.g12074.t1,345.1612538,-0.376065829,1.072041158,2.07E-05,0.000213454,,Q3SZZ0,1.09E-132,Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2),ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],GO:0000027; GO:0003723; GO:0005730; GO:0006364; GO:0019843
1403,Pocillopora_acuta_HIv2___RNAseq.g11676.t1,261.4242273,-0.535464127,1.200260528,2.08E-05,0.000214031,,Q9CZJ1,1.52E-71,Probable U3 small nucleolar RNA-associated protein 11 (U3 snoRNA-associated protein 11) (UTP11-like protein),nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],GO:0005615; GO:0005730; GO:0005737; GO:0006364; GO:0007399; GO:0032040; GO:0042274; GO:0043065
1404,Pocillopora_acuta_HIv2___RNAseq.g13760.t1,738.7511772,-0.23654685,1.033565173,2.08E-05,0.000214452,,F6R2G2,5.34E-12,NLR family CARD domain-containing protein 4 (Ice protease-activating factor) (Ipaf),apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981],GO:0005524; GO:0005829; GO:0006915; GO:0006954; GO:0016045; GO:0042742; GO:0042981; GO:0045087
1405,Pocillopora_acuta_HIv2___RNAseq.g21579.t1,345.4455076,-0.60100881,1.258022333,2.10E-05,0.00021648,,P0C218,0,Probable ATP-dependent RNA helicase DDX20 (EC 3.6.1.15) (EC 3.6.4.13) (DEAD box protein 20),spliceosomal snRNP assembly [GO:0000387],GO:0000387; GO:0003677; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0016887; GO:0032797; GO:0034719
1406,Pocillopora_acuta_HIv2___RNAseq.g3486.t1,1322.778036,3.085738554,0.986724038,2.14E-05,0.000220411,,Q9VL06,2.54E-27,E3 ubiquitin-protein ligase Ufd4 (EC 2.3.2.26) (Ubiquitin fusion-degradation 4-like),negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0006511; GO:0016607; GO:0032436; GO:0043161; GO:0046872; GO:0061630; GO:0070373; GO:0070534
1407,Pocillopora_acuta_HIv2___RNAseq.g28671.t1,523.7196978,-0.47532555,1.126245051,2.15E-05,0.000221019,,NA,NA,NA,NA,NA
1408,Pocillopora_acuta_HIv2___RNAseq.g2207.t1,411.9994812,-0.405459369,1.100467047,2.15E-05,0.000221019,,A6H8T2,2.21E-145,Dynein axonemal intermediate chain 7,,GO:0005930; GO:0008017; GO:0048487
1409,Pocillopora_acuta_HIv2___RNAseq.12432_t,484.2356155,-0.318174271,1.04277361,2.16E-05,0.000221572,,P19492,3.39E-87,"Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3)","long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]; regulation of receptor recycling [GO:0001919]; response to fungicide [GO:0060992]; response to lithium ion [GO:0010226]; synaptic transmission, glutamatergic [GO:0035249]",GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005886; GO:0008328; GO:0010226; GO:0014069; GO:0016020; GO:0022849; GO:0030425; GO:0032279; GO:0032281; GO:0032991; GO:0035249; GO:0042734; GO:0043025; GO:0043083; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0048787; GO:0050804; GO:0051289; GO:0051290; GO:0060291; GO:0060992; GO:0098688; GO:0098839; GO:0098978; GO:0099507; GO:1904315
1410,Pocillopora_acuta_HIv2___RNAseq.g24766.t1,946.3452537,2.883586283,0.862280099,2.16E-05,0.00022164,,Q868Z9,1.25E-120,Papilin,extracellular matrix organization [GO:0030198],GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198
1411,Pocillopora_acuta_HIv2___RNAseq.g21731.t1,247.0812755,0.359976166,1.111659253,2.16E-05,0.000221757,,P24032,1.15E-65,"Myosin regulatory light chain 2, smooth muscle minor isoform (MLC-2) (DTNB) (G1) (Isoform L20-B1)",,GO:0005509; GO:0005737; GO:0016459
1412,Pocillopora_acuta_HIv2___RNAseq.g1857.t1,272.6057355,-0.885429559,1.634897399,2.17E-05,0.000222422,,NA,NA,NA,NA,NA
1413,Pocillopora_acuta_HIv2___RNAseq.g28647.t1,303.4914213,-0.519766765,1.138839318,2.17E-05,0.000222422,,Q3ZBL9,2.03E-62,Cyclin-H,DNA-templated transcription [GO:0006351]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0005634; GO:0005675; GO:0006351; GO:0006357; GO:0016538; GO:0070985
1414,Pocillopora_acuta_HIv2___RNAseq.g8794.t1,3354.946691,3.154487321,0.984735471,2.17E-05,0.000222427,,NA,NA,NA,NA,NA
1415,Pocillopora_acuta_HIv2___RNAseq.g30770.t1,428.5112715,-0.669329262,1.263239545,2.19E-05,0.000224212,,NA,NA,NA,NA,NA
1416,Pocillopora_acuta_HIv2___RNAseq.g21300.t1,277.0649454,-0.377444983,1.07634074,2.20E-05,0.000225028,,Q9W2H1,1.00E-24,TM2 domain-containing protein biscotti (TM2D1),positive regulation of Notch signaling pathway [GO:0045747],GO:0005886; GO:0045747
1417,Pocillopora_acuta_HIv2___RNAseq.g30017.t1,404.0776273,-0.356389285,1.052574543,2.21E-05,0.000225226,,NA,NA,NA,NA,NA
1418,Pocillopora_acuta_HIv2___TS.g15865.t1,333.2660301,-0.508869219,1.141982746,2.21E-05,0.00022584,,Q63HN8,0,E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213) (EC 2.3.2.-) (Mysterin) (RING finger protein 213),angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],GO:0001525; GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005737; GO:0005811; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051
1419,Pocillopora_acuta_HIv2___TS.g15601.t1,302.9998513,0.263093923,1.052768312,2.22E-05,0.00022629,,Q9W770,6.09E-09,Spondin-1 (F-spondin),cell adhesion [GO:0007155],GO:0005576; GO:0007155; GO:0031012; GO:0046872
1420,Pocillopora_acuta_HIv2___RNAseq.g15874.t1,70.79564423,-6.191368837,4.541689633,2.22E-05,0.00022629,,NA,NA,NA,NA,NA
1421,Pocillopora_acuta_HIv2___RNAseq.11055_t,315.8730339,-0.571791578,1.183910886,2.23E-05,0.000226797,,NA,NA,NA,NA,NA
1422,Pocillopora_acuta_HIv2___RNAseq.g4612.t1,81.10777597,-6.849405255,3.527348297,2.24E-05,0.000228056,,Q7Z4Q2,9.58E-43,HEAT repeat-containing protein 3,erythrocyte maturation [GO:0043249]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273],GO:0006606; GO:0042273; GO:0043249; GO:0051082
1423,Pocillopora_acuta_HIv2___TS.g28937.t1,610.014783,-0.525167918,1.180096135,2.25E-05,0.000228398,,Q9EPK7,0,Exportin-7 (Exp7) (Ran-binding protein 16),nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611],GO:0005049; GO:0005643; GO:0005737; GO:0006611; GO:0006913; GO:0031267
1424,Pocillopora_acuta_HIv2___RNAseq.g21341.t1,379.7905506,-0.229892097,1.034312493,2.26E-05,0.000229097,,Q8IYG6,1.91E-76,Leucine-rich repeat-containing protein 56,cell projection organization [GO:0030030],GO:0005929; GO:0030030
1425,Pocillopora_acuta_HIv2___TS.g26917.t1,287.7700771,-0.715302257,1.334136627,2.27E-05,0.000230394,,Q76KB1,2.36E-11,Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-),"gene expression [GO:0010467]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]",GO:0000139; GO:0004394; GO:0010467; GO:0015014; GO:0015015; GO:0030202; GO:0042802; GO:0060676
1426,Pocillopora_acuta_HIv2___TS.g30120.t1,166.5991387,-0.59082591,1.255179984,2.28E-05,0.000230898,,Q7SY06,2.82E-70,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase) (HACD) (Protein-tyrosine phosphatase-like A domain-containing protein 1),fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761],GO:0005783; GO:0005789; GO:0018812; GO:0030148; GO:0030497; GO:0042761; GO:0102158
1427,Pocillopora_acuta_HIv2___RNAseq.g26589.t1,6569.481314,2.337937376,0.635532028,2.28E-05,0.000230898,,Q5VXJ0,5.57E-109,Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2),cornification [GO:0070268]; lipid catabolic process [GO:0016042],GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268
1428,Pocillopora_acuta_HIv2___RNAseq.g16252.t1,194.8327348,-0.526106328,1.148117442,2.29E-05,0.00023199,,Q3T0B6,2.07E-30,"Complement component 1 Q subcomponent-binding protein, mitochondrial","apoptotic process [GO:0006915]; complement activation, classical pathway [GO:0006958]; cytosolic ribosome assembly [GO:0042256]; DNA damage response [GO:0006974]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon production [GO:0032689]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380]",GO:0000122; GO:0001849; GO:0003714; GO:0003729; GO:0004857; GO:0005540; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005759; GO:0005886; GO:0006397; GO:0006915; GO:0006958; GO:0006974; GO:0008380; GO:0009986; GO:0030449; GO:0030984; GO:0031690; GO:0032689; GO:0032695; GO:0032991; GO:0039534; GO:0039536; GO:0042256; GO:0043065; GO:0043491; GO:0045087; GO:0045785; GO:0048025; GO:0050687; GO:0051897; GO:0070131; GO:0090023; GO:0097177; GO:1900026; GO:1901165; GO:2000042; GO:2000510
1429,Pocillopora_acuta_HIv2___RNAseq.g21497.t1,214.9712828,-0.7551059,1.439122367,2.30E-05,0.000232366,,NA,NA,NA,NA,NA
1430,Pocillopora_acuta_HIv2___RNAseq.g18425.t1,1910.411249,2.149461557,0.567510332,2.31E-05,0.000233391,,Q0EEE2,1.85E-99,Patched domain-containing protein 3 (RND-type protein RNDEu-3),,GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0097225
1431,Pocillopora_acuta_HIv2___RNAseq.g29410.t1,84.29306131,-0.745434973,1.440342357,2.31E-05,0.000233412,,Q921L8,2.29E-64,Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11),cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593],GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0006493; GO:0007220; GO:0007368; GO:0008593; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314
1432,Pocillopora_acuta_HIv2___RNAseq.g12578.t1,553.5776559,-0.29545217,1.038231894,2.31E-05,0.000233446,,Q8R2M2,1.25E-47,Deoxynucleotidyltransferase terminal-interacting protein 2,ribosomal small subunit biogenesis [GO:0042274]; RNA processing [GO:0006396],GO:0005654; GO:0005694; GO:0005730; GO:0006396; GO:0032040; GO:0042274
1433,Pocillopora_acuta_HIv2___RNAseq.g11678.t1,223.891756,-0.798590539,1.50053531,2.32E-05,0.000233595,,Q8WVE0,3.78E-83,EEF1A lysine methyltransferase 1 (EC 2.1.1.-) (N(6)-adenine-specific DNA methyltransferase 2) (Protein-lysine N-methyltransferase N6AMT2) (eEF1A-KMT),peptidyl-lysine methylation [GO:0018022],GO:0003676; GO:0005829; GO:0008168; GO:0016279; GO:0018022; GO:0042054
1434,Pocillopora_acuta_HIv2___RNAseq.g1706.t1,617.54654,-0.263231533,1.035290446,2.32E-05,0.000233595,,D4A770,6.56E-148,FERRY endosomal RAB5 effector complex subunit 3,regulation of mast cell degranulation [GO:0043304],GO:0005737; GO:0005769; GO:0032991; GO:0043304
1435,Pocillopora_acuta_HIv2___RNAseq.g28944.t1,397.5311321,-0.426876838,1.085117678,2.33E-05,0.000235317,,Q53T59,1.21E-21,HCLS1-binding protein 3 (HS1-binding protein 3) (HSP1BP-3),regulation of apoptotic process [GO:0042981],GO:0005739; GO:0005783; GO:0035091; GO:0042981
1436,Pocillopora_acuta_HIv2___RNAseq.g24075.t1,349.2161565,-0.335848165,1.102411321,2.38E-05,0.000239661,,A4FV72,3.91E-161,Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Rotamase E),"mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]",GO:0000398; GO:0000413; GO:0003729; GO:0003755; GO:0005634; GO:0005737; GO:0006457; GO:0008143; GO:0016018; GO:0043231; GO:0071007; GO:0071013
1437,Pocillopora_acuta_HIv2___TS.g14467.t1,261.9948436,-0.576567735,1.175911087,2.41E-05,0.000243029,,NA,NA,NA,NA,NA
1438,Pocillopora_acuta_HIv2___RNAseq.g25216.t1b,1114.511523,-0.872062302,1.557029509,2.42E-05,0.000243384,Sacsin,Q9NZJ4,0,Sacsin (DnaJ homolog subfamily C member 29),negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084
1439,Pocillopora_acuta_HIv2___TS.g14528.t1b,111.4069005,-0.93160234,1.582466808,2.43E-05,0.000244173,,Q3ZAV0,1.21E-19,Coiled-coil domain-containing protein 60,,
1440,Pocillopora_acuta_HIv2___TS.g23740.t1,77.60239141,-1.071081613,2.014233881,2.46E-05,0.000246795,,NA,NA,NA,NA,NA
1441,Pocillopora_acuta_HIv2___RNAseq.g30986.t1,274.4278043,-0.554595914,1.183066129,2.46E-05,0.000246795,Toll-like receptor 6,Q704V6,1.45E-11,Toll-like receptor 6 (CD antigen CD286),cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224],GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227
1442,Pocillopora_acuta_HIv2___RNAseq.g30961.t2,101.1858275,-2.68070304,0.737339124,2.46E-05,0.000246795,,NA,NA,NA,NA,NA
1443,Pocillopora_acuta_HIv2___RNAseq.g8520.t1,75.45588398,-9.929254061,4.225915861,2.46E-05,0.000246795,,Q96RW7,2.26E-24,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711
1444,Pocillopora_acuta_HIv2___TS.g26333.t1,364.8155351,-7.470983121,6.154428854,2.47E-05,0.000247162,,Q9C0D5,1.07E-15,"Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)",dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; regulation of postsynapse organization [GO:0099175]; visual learning [GO:0008542],GO:0007520; GO:0008542; GO:0014069; GO:0030425; GO:0043025; GO:0043679; GO:0097062; GO:0098978; GO:0099175
1445,Pocillopora_acuta_HIv2___RNAseq.g7718.t1,490.7704876,-0.348981561,1.05307983,2.47E-05,0.000247162,,P16065,0,Speract receptor (EC 4.6.1.2) (Guanylate cyclase),cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168],GO:0001653; GO:0004016; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0035556
1446,Pocillopora_acuta_HIv2___RNAseq.g565.t1,2194.070175,4.65528088,2.325286064,2.49E-05,0.000248846,Frizzled-5 (Fz-5),Q13467,4.39E-52,Frizzled-5 (Fz-5) (hFz5) (FzE5),"angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye morphogenesis [GO:0048596]; eye development [GO:0001654]; glandular epithelial cell maturation [GO:0002071]; intestinal epithelial cell maturation [GO:0060574]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; post-embryonic camera-type eye development [GO:0031077]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of mitophagy [GO:1901524]; Spemann organizer formation [GO:0060061]; synapse assembly [GO:0007416]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]",GO:0000139; GO:0000578; GO:0001525; GO:0001540; GO:0001654; GO:0002071; GO:0002726; GO:0004930; GO:0005886; GO:0005923; GO:0007416; GO:0008285; GO:0008289; GO:0008595; GO:0009986; GO:0017147; GO:0019901; GO:0030182; GO:0030424; GO:0030425; GO:0030669; GO:0031077; GO:0031625; GO:0031901; GO:0032729; GO:0032731; GO:0032760; GO:0033077; GO:0035567; GO:0042813; GO:0043204; GO:0044877; GO:0045202; GO:0045944; GO:0048471; GO:0048596; GO:0060061; GO:0060070; GO:0060561; GO:0060574; GO:0060670; GO:0060715; GO:0060716; GO:0060718; GO:0071219; GO:1901382; GO:1901524; GO:1903955; GO:2000810
1447,Pocillopora_acuta_HIv2___RNAseq.g2420.t1,514.8534976,-3.090592758,0.986152789,2.51E-05,0.000250662,,NA,NA,NA,NA,NA
1448,Pocillopora_acuta_HIv2___RNAseq.g13638.t1,535.685515,-0.317605287,1.046349853,2.52E-05,0.000252188,,Q80T85,1.08E-142,DDB1- and CUL4-associated factor 5 (WD repeat-containing protein 22),negative regulation of fatty acid biosynthetic process [GO:0045717]; protein ubiquitination [GO:0016567],GO:0005737; GO:0005739; GO:0016567; GO:0045717; GO:0080008
1449,Pocillopora_acuta_HIv2___RNAseq.g11783.t1,69.8533719,-0.287182255,1.080307842,2.54E-05,0.000253922,,P01123,6.67E-54,GTP-binding protein YPT1 (Protein YP2) (Rab GTPase YPT1) (Transport GTPase YPT1),"autophagosome assembly [GO:0000045]; COPII-coated vesicle budding [GO:0090114]; cytoplasm to vacuole targeting by the Cvt pathway [GO:0032258]; early endosome to Golgi transport [GO:0034498]; endocytic recycling [GO:0032456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi vesicle budding [GO:0048194]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; pre-mRNA catabolic process [GO:1990261]; protein localization to phagophore assembly site [GO:0034497]; regulation of endoplasmic reticulum unfolded protein response [GO:1900101]; reticulophagy [GO:0061709]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; SNARE complex disassembly [GO:0035494]",GO:0000045; GO:0000139; GO:0000149; GO:0000407; GO:0003924; GO:0005525; GO:0005739; GO:0005789; GO:0005795; GO:0005801; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0012505; GO:0016236; GO:0031410; GO:0032258; GO:0032456; GO:0034045; GO:0034497; GO:0034498; GO:0035493; GO:0035494; GO:0048194; GO:0048211; GO:0061709; GO:0090114; GO:1900101; GO:1990261
1450,Pocillopora_acuta_HIv2___RNAseq.g29828.t1,957.537009,-4.211262147,3.220741397,2.55E-05,0.00025435,,J7GQ11,1.39E-80,L-tyrosine decarboxylase (TDC) (EC 4.1.1.25),carboxylic acid metabolic process [GO:0019752],GO:0004837; GO:0019752; GO:0030170; GO:0036468
1451,Pocillopora_acuta_HIv2___TS.g6057.t1,334.1629933,0.121745709,1.023647185,2.56E-05,0.000255365,,NA,NA,NA,NA,NA
1452,Pocillopora_acuta_HIv2___RNAseq.g25494.t1,218.9550106,-0.967738384,1.60299354,2.57E-05,0.00025591,,Q60803,7.20E-131,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0001817; GO:0002224; GO:0005164; GO:0005737; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0050688; GO:0061630; GO:0070534
1453,Pocillopora_acuta_HIv2___TS.g16828.t1b,395.7385809,-0.443658481,1.148201435,2.58E-05,0.000256734,,Q9UBS9,1.48E-63,SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1),ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850],GO:0001503; GO:0005737; GO:0005791; GO:0016020; GO:0030867; GO:0032967; GO:0045669; GO:0046850
1454,Pocillopora_acuta_HIv2___RNAseq.g21394.t1,430.6205368,-0.55304456,1.168294571,2.59E-05,0.000258143,,P18294,0,"Creatine kinase, flagellar (EC 2.7.3.2)",cell projection organization [GO:0030030]; phosphocreatine biosynthetic process [GO:0046314],GO:0004111; GO:0005524; GO:0005615; GO:0005737; GO:0005856; GO:0030030; GO:0031514; GO:0046314
1455,Pocillopora_acuta_HIv2___TS.g26046.t2,86.28239299,-6.565245149,3.191499378,2.62E-05,0.000260121,Adenosine 3'-phospho 5'-phosphosulfate transporter 2,Q922Q5,2.24E-152,Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (Solute carrier family 35 member B3),3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; transmembrane transport [GO:0055085],GO:0000139; GO:0005739; GO:0005789; GO:0015297; GO:0046963; GO:0046964; GO:0055085
1456,Pocillopora_acuta_HIv2___RNAseq.g5401.t1,227.9270503,-6.313038709,3.643279451,2.64E-05,0.000262728,,O00750,0,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta),autophagosome organization [GO:1905037]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015],GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0009267; GO:0016303; GO:0030139; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0048015; GO:1905037
1457,Pocillopora_acuta_HIv2___RNAseq.g2419.t1,485.9496022,-3.053926829,0.974867448,2.69E-05,0.000267009,,NA,NA,NA,NA,NA
1458,Pocillopora_acuta_HIv2___RNAseq.g4957.t1,710.7120327,-0.187735948,1.027012475,2.71E-05,0.000268642,,O14841,0,5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase),glutathione metabolic process [GO:0006749],GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802
1459,Pocillopora_acuta_HIv2___RNAseq.g21575.t1,114.3479272,-0.603743074,1.291035764,2.73E-05,0.000270426,,Q9NSA2,2.47E-103,A-type voltage-gated potassium channel KCND1 (Potassium voltage-gated channel subfamily D member 1) (Shal-type potassium channel KCND1) (Voltage-gated potassium channel subunit Kv4.1),action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260],GO:0001508; GO:0005250; GO:0005886; GO:0008076; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805
1460,Pocillopora_acuta_HIv2___TS.g29624.t2,474.5159857,-0.824016189,1.423670953,2.74E-05,0.0002715,,O88572,0,Low-density lipoprotein receptor-related protein 6 (LRP-6),anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of developmental process [GO:0051093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of morphogenesis of an epithelium [GO:1905331]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of anatomical structure morphogenesis [GO:0022603]; regulation of cell development [GO:0060284]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0022603; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045893; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051091; GO:0051093; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1905331; GO:1990963; GO:2000051; GO:2000149; GO:2000151; GO:2000164; GO:2000166; GO:2000168; GO:2000648
1461,Pocillopora_acuta_HIv2___RNAseq.g12116.t1,194.3698693,-0.646894562,1.240399816,2.77E-05,0.000273793,,Q99JY8,1.60E-47,Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b),"Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingosine metabolic process [GO:0006670]; wound healing [GO:0042060]",GO:0000139; GO:0001568; GO:0001702; GO:0001933; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007155; GO:0007165; GO:0007229; GO:0008195; GO:0010595; GO:0016020; GO:0016323; GO:0022409; GO:0030111; GO:0033116; GO:0033631; GO:0034109; GO:0042060; GO:0042392; GO:0042577; GO:0045121; GO:0046839; GO:0050731; GO:0050821; GO:0051091; GO:0060020; GO:0070971; GO:0098609; GO:0106235; GO:1902068
1462,Pocillopora_acuta_HIv2___RNAseq.g13082.t1,57.23343899,-6.737713045,3.391452165,2.77E-05,0.000273954,,Q5T280,8.00E-133,Putative methyltransferase C9orf114 (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (SPOUT domain-containing methyltransferase 1),cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; methylation [GO:0032259]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608],GO:0000776; GO:0003723; GO:0005737; GO:0008168; GO:0010608; GO:0031616; GO:0032259; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0072686
1463,Pocillopora_acuta_HIv2___TS.g29582.t1,496.3653879,-0.783119102,1.386795811,2.79E-05,0.000275369,,Q9NU19,0,TBC1 domain family member 22B,,GO:0005096; GO:0071889
1464,Pocillopora_acuta_HIv2___RNAseq.g12571.t1,93.99964903,-0.71617251,1.40131753,2.80E-05,0.000277068,,NA,NA,NA,NA,NA
1465,Pocillopora_acuta_HIv2___TS.g26127.t2b,3433.774392,4.342323181,2.207977041,2.82E-05,0.000278192,GLI_pathogenesis_related_2,Q27409,2.40E-33,Adhesive plaque matrix protein (Foot protein 1) (MGFP-1) (MGFP1),,GO:0005576
1466,Pocillopora_acuta_HIv2___RNAseq.g17226.t1,291.104969,-6.936117269,7.971494557,2.85E-05,0.00028086,,Q8WV93,9.39E-77,AFG1-like ATPase (Lactation elevated protein 1) (EC 3.6.-.-) (Protein AFG1 homolog),"mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]",GO:0005524; GO:0005737; GO:0005739; GO:0006123; GO:0007005; GO:0016887; GO:0031966; GO:0035694
1467,Pocillopora_acuta_HIv2___RNAseq.15780_t,415.9349074,-0.449893853,1.143994396,2.87E-05,0.000283096,,Q9ER33,1.78E-118,Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3) (Gustatory cyclic nucleotide-gated cation channel) (CNGgust),inorganic cation import across plasma membrane [GO:0098659]; membrane depolarization [GO:0051899]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; sodium ion transport [GO:0006814],GO:0001750; GO:0005221; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0006814; GO:0017022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0034220; GO:0043025; GO:0043194; GO:0043204; GO:0044877; GO:0045296; GO:0046549; GO:0051591; GO:0051899; GO:0060041; GO:0097386; GO:0098655; GO:0098659; GO:0120199; GO:1902495
1468,Pocillopora_acuta_HIv2___RNAseq.g29507.t1,985.7594685,1.723452939,4.220770503,2.87E-05,0.000283096,,NA,NA,NA,NA,NA
1469,Pocillopora_acuta_HIv2___RNAseq.g18952.t1,85.06162611,-0.273840461,1.074729715,2.88E-05,0.000283843,,NA,NA,NA,NA,NA
1470,Pocillopora_acuta_HIv2___RNAseq.g30763.t1,145.7830344,-0.264429641,1.070690651,2.91E-05,0.000285934,,A1A5V9,1.26E-32,Elongator complex protein 5 (Dermal papilla-derived protein 6 homolog) (Retinoic acid-induced protein 12),positive regulation of cell migration [GO:0030335]; tRNA modification [GO:0006400]; tRNA wobble uridine modification [GO:0002098],GO:0002098; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0030335; GO:0033588
1471,Pocillopora_acuta_HIv2___TS.g11018.t1,148.6049551,-0.49003603,1.147438795,2.92E-05,0.00028723,,NA,NA,NA,NA,NA
1472,Pocillopora_acuta_HIv2___TS.g21484.t1,501.7090799,-0.342038386,1.053158776,2.93E-05,0.000288234,,P36404,2.52E-110,ADP-ribosylation factor-like protein 2,bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; protein folding [GO:0006457]; regulation of aerobic respiration [GO:1903715]; regulation of glycolytic process [GO:0006110]; regulation of microtubule polymerization [GO:0031113],GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005794; GO:0005813; GO:0005829; GO:0005925; GO:0006110; GO:0006457; GO:0007098; GO:0010811; GO:0015630; GO:0016328; GO:0019003; GO:0031113; GO:0031116; GO:0034260; GO:0051457; GO:0070830; GO:1903715
1473,Pocillopora_acuta_HIv2___TS.g9115.t1b,537.475337,-0.639920869,1.23919356,2.97E-05,0.00029167,,Q55E58,4.19E-17,Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1),cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856],GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310
1474,Pocillopora_acuta_HIv2___RNAseq.g16162.t1,1084.499104,-1.180932128,2.253131493,2.98E-05,0.000292127,,P12256,5.72E-42,Penicillin V acylase (PVA) (EC 3.5.1.11) (BspPVA) (Penicillin V amidase) (Penicillin amidohydrolase),response to antibiotic [GO:0046677],GO:0008953; GO:0046677
1475,Pocillopora_acuta_HIv2___RNAseq.g21909.t1,343.9150515,-0.417629046,1.08442764,2.98E-05,0.000292127,,Q9M571,2.39E-94,Phosphoethanolamine N-methyltransferase (EC 2.1.1.103),methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656],GO:0000234; GO:0005737; GO:0006656; GO:0032259; GO:0052667
1476,Pocillopora_acuta_HIv2___RNAseq.g1823.t1,636.4457219,-0.315377483,1.070762128,3.06E-05,0.000300042,,A7M7B9,1.86E-109,Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase),"base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair [GO:0006289]",GO:0000703; GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006289; GO:0046872; GO:0051539; GO:0140078
1477,Pocillopora_acuta_HIv2___RNAseq.g13700.t1,467.4537626,-0.735272053,1.327894206,3.08E-05,0.000301172,,Q9VFB2,4.65E-33,"Small ribosomal subunit protein uS10m (28S ribosomal protein S10, mitochondrial) (MRP-S10) (S10mt)",mitochondrial translation [GO:0032543],GO:0003735; GO:0005739; GO:0005763; GO:0032543
1478,Pocillopora_acuta_HIv2___TS.g21207.t2,344.712124,-0.461845553,1.117066889,3.08E-05,0.000301703,,D3ZVM4,2.81E-46,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637
1479,Pocillopora_acuta_HIv2___RNAseq.g9032.t1,258.0648352,-0.516096564,1.194746422,3.10E-05,0.000302851,,F4JTS8,3.53E-154,Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597),auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827],GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364
1480,Pocillopora_acuta_HIv2___TS.g15010.t1a,62.08835268,-0.804284089,1.51027784,3.10E-05,0.000303001,,Q99PL5,8.94E-15,Ribosome-binding protein 1 (Ribosome receptor protein) (RRp) (mRRp),protein transport [GO:0015031]; signal transduction [GO:0007165],GO:0005789; GO:0007165; GO:0015031
1481,Pocillopora_acuta_HIv2___RNAseq.g25329.t1,391.8983428,-0.595466147,1.207773978,3.10E-05,0.000303001,,Q5RDB5,3.89E-57,Protein cornichon homolog 1 (CNIH-1) (Cornichon family AMPA receptor auxiliary protein 1) (Protein cornichon homolog),endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],GO:0000139; GO:0005789; GO:0006888; GO:0030134
1482,Pocillopora_acuta_HIv2___RNAseq.g14859.t1,353.0939682,-0.756338898,1.308484916,3.13E-05,0.000305887,,Q91348,1.98E-127,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]","fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]",GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003; GO:0043540
1483,Pocillopora_acuta_HIv2___RNAseq.g18176.t2,148.0391234,0.972146105,1.792627749,3.16E-05,0.00030777,,Q8AWC7,3.98E-27,"Alpha-(1,3)-fucosyltransferase 11 (EC 2.4.1.-) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11)",fucosylation [GO:0036065]; protein glycosylation [GO:0006486],GO:0000139; GO:0006486; GO:0032580; GO:0036065; GO:0046920
1484,Pocillopora_acuta_HIv2___TS.g17632.t1,37.62146745,-9.167342885,3.707441084,3.16E-05,0.000308018,,Q3T1H5,2.54E-07,Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (TRAF and TNF receptor-associated protein),double-strand break repair [GO:0006302]; neuron development [GO:0048666],GO:0000287; GO:0003697; GO:0004518; GO:0005634; GO:0005730; GO:0005737; GO:0006302; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260
1485,Pocillopora_acuta_HIv2___RNAseq.g26153.t1,582.1238986,-0.221694958,1.030154984,3.16E-05,0.000308018,,Q5RFD3,1.33E-82,Proteasome activator complex subunit 3 (Activator of multicatalytic protease subunit 3) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma),apoptotic process [GO:0006915]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136],GO:0002039; GO:0005654; GO:0005737; GO:0006915; GO:0008537; GO:0061133; GO:0061136; GO:0097371; GO:2000045; GO:2001237
1486,Pocillopora_acuta_HIv2___RNAseq.g2001.t1,150.3104485,-0.992775812,1.83262647,3.17E-05,0.000308556,,NA,NA,NA,NA,NA
1487,Pocillopora_acuta_HIv2___RNAseq.g26731.t2,353.600298,-0.488319527,1.184560462,3.21E-05,0.000312201,,P81069,2.54E-64,GA-binding protein subunit beta-2 (GABP subunit beta-2) (GABPB-2) (GA-binding protein beta-2-1) (GABP subunit beta-2-1) (GABPB2-1),positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0000976; GO:0005634; GO:0042802; GO:0045944
1488,Pocillopora_acuta_HIv2___RNAseq.g11158.t1,532.9318039,-0.2364723,1.037257681,3.23E-05,0.000313976,,NA,NA,NA,NA,NA
1489,Pocillopora_acuta_HIv2___RNAseq.2795_t,408.2680069,-0.44390265,1.147317702,3.25E-05,0.000316074,,Q03049,5.74E-40,Putative uncharacterized oxidoreductase YDR541C (EC 1.1.1.-),response to furfural [GO:1901426],GO:0016616; GO:0033721; GO:1901426
1490,Pocillopora_acuta_HIv2___TS.g15363.t1,232.9400946,-0.631651493,1.288246019,3.27E-05,0.000317655,,NA,NA,NA,NA,NA
1491,Pocillopora_acuta_HIv2___RNAseq.g21338.t1,59.15845101,0.287375151,1.079251852,3.27E-05,0.000317655,CUB and peptidase domain-containing protein 2,B8V7S0,2.12E-84,CUB and peptidase domain-containing protein 1,acrosome reaction [GO:0007340]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007340
1492,Pocillopora_acuta_HIv2___RNAseq.g13323.t1,686.0591822,-4.229555629,2.71188024,3.29E-05,0.000318642,,Q5RDU7,1.11E-66,Protein yippee-like 5,cell population proliferation [GO:0008283],GO:0000151; GO:0005634; GO:0005737; GO:0005813; GO:0008283; GO:0030496; GO:0046872; GO:0097431
1493,Pocillopora_acuta_HIv2___RNAseq.g29053.t1,191.2630289,-0.263303409,1.070326994,3.30E-05,0.00031938,,Q6NRW3,4.05E-10,Kinetochore protein Spc24 (xSpc24),cell division [GO:0051301],GO:0005634; GO:0031262; GO:0051301
1494,Pocillopora_acuta_HIv2___RNAseq.g12272.t1,69.07930809,4.630467242,2.739125216,3.30E-05,0.000319618,,P18052,2.13E-67,Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28),insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of focal adhesion assembly [GO:0051893],GO:0004725; GO:0005925; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0051893; GO:0097060; GO:0098685
1495,Pocillopora_acuta_HIv2___RNAseq.g26745.t1b,303.7767364,-0.547733195,1.169059106,3.36E-05,0.000324616,,NA,NA,NA,NA,NA
1496,Pocillopora_acuta_HIv2___TS.g17019.t1,181.7507236,-0.943361228,1.619138553,3.38E-05,0.000326882,,NA,NA,NA,NA,NA
1497,Pocillopora_acuta_HIv2___RNAseq.g26352.t1,183.9600863,-0.683886702,1.340566732,3.38E-05,0.000326882,,Q8K078,7.83E-114,Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),monoatomic ion transport [GO:0006811]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403],GO:0006811; GO:0008514; GO:0015132; GO:0015347; GO:0015349; GO:0016323; GO:0042403; GO:0043252
1498,Pocillopora_acuta_HIv2___RNAseq.g12000.t1,559.482212,-0.513271587,1.140784011,3.39E-05,0.000327038,,Q99MM4,9.10E-37,TRAF-type zinc finger domain-containing protein 1 (Protein FLN29),negative regulation of innate immune response [GO:0045824]; response to cytokine [GO:0034097],GO:0005739; GO:0008270; GO:0034097; GO:0045824
1499,Pocillopora_acuta_HIv2___RNAseq.g25338.t1,89.54283916,-4.237073416,3.145597448,3.41E-05,0.000329111,,NA,NA,NA,NA,NA
1500,Pocillopora_acuta_HIv2___TS.g29372.t2,2289.767984,4.402736351,2.319823333,3.41E-05,0.000329173,,A0A0B5RUB0,2.18E-105,Trimethylamine transporter (TMA transporter) (TMA-specific transporter),,GO:0005886; GO:0022857
1501,Pocillopora_acuta_HIv2___RNAseq.g1028.t1,72.25847687,-0.288035451,1.080671206,3.42E-05,0.000329823,,Q5XIN7,0,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)",basement membrane organization [GO:0071711]; brain development [GO:0007420]; dentate gyrus development [GO:0021542]; gene expression [GO:0010467]; localization of cell [GO:0051674]; myelination [GO:0042552]; O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; reactive gliosis [GO:0150103]; sensory perception of sound [GO:0007605],GO:0000139; GO:0006486; GO:0006493; GO:0007420; GO:0007605; GO:0008375; GO:0010467; GO:0016020; GO:0016266; GO:0021542; GO:0030145; GO:0030246; GO:0035269; GO:0036211; GO:0042552; GO:0047223; GO:0051674; GO:0071711; GO:0150103
1502,Pocillopora_acuta_HIv2___RNAseq.g14126.t1,93.21313671,-6.453739754,4.911235255,3.45E-05,0.000332283,,Q8K2X3,7.77E-21,CST complex subunit STN1 (Alpha-accessory factor of 44 kDa) (AAF-44) (AAF44) (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog),negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance via telomere lengthening [GO:0010833],GO:0000781; GO:0001650; GO:0003697; GO:0005634; GO:0005654; GO:0010833; GO:0016233; GO:0032211; GO:0042162; GO:0043047; GO:0045111; GO:0045740; GO:1990879
1503,Pocillopora_acuta_HIv2___RNAseq.g14257.t1,609.6907121,4.178858556,1.718342393,3.45E-05,0.000332436,,P61917,3.99E-30,NPC intracellular cholesterol transporter 2 (EPI-1) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog),cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367],GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0030301; GO:0032367; GO:0033344
1504,Pocillopora_acuta_HIv2___RNAseq.g8459.t1,49.79933759,1.32433298,2.80330714,3.47E-05,0.000333524,,NA,NA,NA,NA,NA
1505,Pocillopora_acuta_HIv2___RNAseq.g22336.t1b,251.9369896,0.429980644,1.110779338,3.48E-05,0.000334163,,Q06805,6.96E-36,Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1),angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766],GO:0001525; GO:0004714; GO:0005524; GO:0005886; GO:0043235; GO:0045766
1506,Pocillopora_acuta_HIv2___RNAseq.g24137.t1,358.0472402,-0.264323634,1.041803371,3.50E-05,0.000335874,,NA,NA,NA,NA,NA
1507,Pocillopora_acuta_HIv2___RNAseq.g2094.t1b,284.077097,-4.205064462,1.476414136,3.50E-05,0.000336008,,A7SDW5,0,Eukaryotic translation initiation factor 3 subunit L (eIF3l),formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290
1508,Pocillopora_acuta_HIv2___RNAseq.8008_t,326.2896486,-0.685029734,1.275635906,3.50E-05,0.000336008,,Q8N0U4,8.03E-31,Protein FAM185A,,
1509,Pocillopora_acuta_HIv2___RNAseq.g12481.t1,34.1116058,-9.180384044,3.709483695,3.53E-05,0.000338243,Sulfotransferase 1C4,A0A2K5X3B6,1.03E-51,Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1),3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; flavonoid metabolic process [GO:0009812],GO:0004062; GO:0005829; GO:0008146; GO:0009812; GO:0050427
1510,Pocillopora_acuta_HIv2___RNAseq.g20674.t1,457.5498484,-0.23626469,1.024957694,3.53E-05,0.000338243,,Q9H6L4,1.59E-71,Armadillo repeat-containing protein 7,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],GO:0005681; GO:0006397; GO:0008380
1511,Pocillopora_acuta_HIv2___RNAseq.g20432.t1,404.8734978,0.780819197,1.375906878,3.54E-05,0.000338611,,Q9V3L1,0,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)],"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]",GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008146; GO:0008543; GO:0008587; GO:0015012; GO:0015014; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140
1512,Pocillopora_acuta_HIv2___RNAseq.g2059.t1,459.2693399,-0.726076976,1.321850343,3.54E-05,0.000338873,,Q9U6D3,1.60E-30,Calmodulin (CaM),,GO:0005509; GO:0030234
1513,Pocillopora_acuta_HIv2___RNAseq.g9286.t1,281.2329863,-0.339587385,1.048864479,3.55E-05,0.000339653,,Q9CR50,7.84E-89,RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363),positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0051865; GO:0061630; GO:0072344
1514,Pocillopora_acuta_HIv2___RNAseq.g12955.t1,549.1484872,2.530895077,0.733741994,3.57E-05,0.00034097,,NA,NA,NA,NA,NA
1515,Pocillopora_acuta_HIv2___TS.g12458.t1,357.6629468,0.281844943,1.065271828,3.59E-05,0.000343136,Adhesion G protein-coupled receptor E1,Q61549,2.62E-74,Adhesion G protein-coupled receptor E1 (Cell surface glycoprotein F4/80) (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor),adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166],GO:0002250; GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007189; GO:0009897; GO:0071944
1516,Pocillopora_acuta_HIv2___TS.g186.t2,1622.805595,2.278442116,0.634913837,3.60E-05,0.000343136,Solute carrier family 16 member 12,Q6P2X9,7.06E-28,Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12),creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449],GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0046449
1517,Pocillopora_acuta_HIv2___RNAseq.g8872.t1a,402.6880493,-0.349673587,1.06901979,3.60E-05,0.000343336,,A3KQV2,1.41E-30,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),,GO:0016020
1518,Pocillopora_acuta_HIv2___TS.g7992.t1,585.6739286,0.596507781,1.283392146,3.61E-05,0.000343939,,NA,NA,NA,NA,NA
1519,Pocillopora_acuta_HIv2___RNAseq.g12596.t1,300.8518469,-0.283720243,1.051405791,3.62E-05,0.000344367,,P24628,2.25E-12,D(2) dopamine receptor A (D2R-A) (D2R 1),adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; regulation of secretion by cell [GO:1903530],GO:0000139; GO:0004930; GO:0004952; GO:0005886; GO:0007195; GO:0045202; GO:1903530
1520,Pocillopora_acuta_HIv2___RNAseq.g7833.t1,316.0082959,-1.329614998,2.530414483,3.64E-05,0.000346164,,Q86U44,0,N6-adenosine-methyltransferase catalytic subunit (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70),"cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]",GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990204
1521,Pocillopora_acuta_HIv2___RNAseq.g13241.t1,500.8360752,-0.440013257,1.103162865,3.67E-05,0.0003486,,NA,NA,NA,NA,NA
1522,Pocillopora_acuta_HIv2___TS.g13626.t1,226.5035573,-0.644897097,1.23867783,3.69E-05,0.000351072,,NA,NA,NA,NA,NA
1523,Pocillopora_acuta_HIv2___RNAseq.g25458.t1,285.361324,-7.299823402,5.826017602,3.71E-05,0.000352273,,A7MCS3,1.35E-17,UPF0764 protein C16orf89 homolog,,GO:0005576; GO:0005829; GO:0016020
1524,Pocillopora_acuta_HIv2___RNAseq.g1690.t1,332.6762788,-0.253980222,1.049636873,3.74E-05,0.000354706,,Q4R8N2,0,Protein lin-9 homolog,DNA biosynthetic process [GO:0071897]; DNA-templated transcription [GO:0006351]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0003677; GO:0005654; GO:0006351; GO:0006357; GO:0017053; GO:0051726; GO:0071897
1525,Pocillopora_acuta_HIv2___RNAseq.g12035.t1a,253.179808,-0.329582379,1.051736745,3.74E-05,0.000354966,,Q02395,2.56E-13,Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2) (Metal-response element DNA-binding protein M96) (Polycomb-like protein 2) (mPCl2) (Zinc-regulated factor 1) (ZiRF1),"cellular response to leukemia inhibitory factor [GO:1990830]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of gene expression, epigenetic [GO:0045814]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]",GO:0000977; GO:0001222; GO:0001227; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0007379; GO:0019827; GO:0035064; GO:0040029; GO:0045814; GO:0046872; GO:0048863; GO:1990830
1526,Pocillopora_acuta_HIv2___RNAseq.21954_tb,71.14114126,-0.279446161,1.077059297,3.78E-05,0.000358124,,NA,NA,NA,NA,NA
1527,Pocillopora_acuta_HIv2___RNAseq.g27673.t1,3815.813361,-4.154528951,2.32518583,3.78E-05,0.000358124,,P63016,2.54E-98,Paired box protein Pax-6 (Oculorhombin),anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; blood vessel development [GO:0001568]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cerebral cortex regionalization [GO:0021796]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; cornea development in camera-type eye [GO:0061303]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epithelial cell development [GO:0002064]; establishment of mitotic spindle orientation [GO:0000132]; eye photoreceptor cell development [GO:0042462]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain-midbrain boundary formation [GO:0021905]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glucose homeostasis [GO:0042593]; habenula development [GO:0021986]; hindbrain development [GO:0030902]; insulin metabolic process [GO:1901142]; interkinetic nuclear migration [GO:0022027]; iris morphogenesis [GO:0061072]; keratinocyte differentiation [GO:0030216]; lacrimal gland development [GO:0032808]; learned vocalization behavior or vocal learning [GO:0098598]; lens development in camera-type eye [GO:0002088]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neural precursor cell proliferation [GO:0061351]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; olfactory bulb mitral cell layer development [GO:0061034]; oligodendrocyte cell fate specification [GO:0021778]; pallium development [GO:0021543]; pancreatic A cell development [GO:0003322]; pancreatic A cell differentiation [GO:0003310]; pituitary gland development [GO:0021983]; positive regulation of cell fate specification [GO:0042660]; positive regulation of core promoter binding [GO:1904798]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamatergic neuron differentiation [GO:0120008]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to organelle [GO:0033365]; regionalization [GO:0003002]; regulation of asymmetric cell division [GO:0009786]; regulation of cell migration [GO:0030334]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of neuron projection development [GO:0010975]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; retina development in camera-type eye [GO:0060041]; rhombomere morphogenesis [GO:0021593]; salivary gland morphogenesis [GO:0007435]; sensory neuron migration [GO:1904937]; signal transduction involved in regulation of gene expression [GO:0023019]; smoothened signaling pathway [GO:0007224]; spinal cord development [GO:0021510]; telencephalon regionalization [GO:0021978]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell differentiation [GO:0003309]; ventral spinal cord development [GO:0021517],GO:0000122; GO:0000132; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0000981; GO:0001221; GO:0001227; GO:0001228; GO:0001568; GO:0001709; GO:0001755; GO:0001764; GO:0001933; GO:0002052; GO:0002064; GO:0002067; GO:0002088; GO:0003002; GO:0003309; GO:0003310; GO:0003322; GO:0003677; GO:0003680; GO:0003682; GO:0003690; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0006366; GO:0007224; GO:0007399; GO:0007405; GO:0007406; GO:0007409; GO:0007411; GO:0007420; GO:0007435; GO:0008283; GO:0009611; GO:0009786; GO:0009950; GO:0009952; GO:0009953; GO:0010467; GO:0010468; GO:0010628; GO:0010975; GO:0019901; GO:0021510; GO:0021517; GO:0021543; GO:0021549; GO:0021593; GO:0021772; GO:0021778; GO:0021796; GO:0021798; GO:0021902; GO:0021905; GO:0021978; GO:0021983; GO:0021986; GO:0021987; GO:0022027; GO:0023019; GO:0030154; GO:0030182; GO:0030216; GO:0030334; GO:0030858; GO:0030900; GO:0030902; GO:0031490; GO:0031625; GO:0032808; GO:0032869; GO:0033365; GO:0035035; GO:0042462; GO:0042593; GO:0042660; GO:0043010; GO:0043565; GO:0044344; GO:0045165; GO:0045471; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0048505; GO:0048596; GO:0048708; GO:0050680; GO:0050767; GO:0060041; GO:0061034; GO:0061072; GO:0061303; GO:0061351; GO:0070410; GO:0070412; GO:0071333; GO:0071380; GO:0071466; GO:0071837; GO:0098598; GO:0120008; GO:1901142; GO:1902895; GO:1904798; GO:1904937; GO:1990830; GO:1990837; GO:2000178; GO:2001224
1528,Pocillopora_acuta_HIv2___RNAseq.g10529.t1,2425.590913,4.282607589,2.052888271,3.79E-05,0.000358609,,NA,NA,NA,NA,NA
1529,Pocillopora_acuta_HIv2___RNAseq.g17519.t1,1719.954967,1.080580682,1.94626641,3.80E-05,0.000359582,,Q9VBW3,4.30E-76,Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14),calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060],GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303
1530,Pocillopora_acuta_HIv2___RNAseq.g2721.t1,465.4537652,-0.371137631,1.098301406,3.82E-05,0.000360668,,O75600,0,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase)",amino acid metabolic process [GO:0006520]; biosynthetic process [GO:0009058]; threonine catabolic process [GO:0006567],GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006520; GO:0006567; GO:0008890; GO:0009058; GO:0016607; GO:0030170
1531,Pocillopora_acuta_HIv2___RNAseq.g6279.t1,62.08988093,-5.038534319,2.432145134,3.83E-05,0.000361702,,Q5F4A1,3.47E-68,G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase),apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872
1532,Pocillopora_acuta_HIv2___RNAseq.g31061.t1,140.1565029,-1.040026594,1.924642244,3.87E-05,0.000365123,,NA,NA,NA,NA,NA
1533,Pocillopora_acuta_HIv2___RNAseq.g29915.t1,399.452208,-0.42423996,1.11828572,3.94E-05,0.00037153,,Q5F361,0,TBC domain-containing protein kinase-like protein (FERRY endosomal RAB5 effector complex subunit 1),,GO:0004672; GO:0005096; GO:0005524; GO:0005769; GO:0005819; GO:0030496
1534,Pocillopora_acuta_HIv2___RNAseq.g20555.t1,53.47952693,-6.595735072,3.733918089,3.94E-05,0.00037153,,NA,NA,NA,NA,NA
1535,Pocillopora_acuta_HIv2___RNAseq.g28152.t1,295.3295722,0.338829604,1.074039691,4.03E-05,0.000379746,,NA,NA,NA,NA,NA
1536,Pocillopora_acuta_HIv2___RNAseq.g7618.t1,326.4963483,-3.59119695,3.934299019,4.04E-05,0.000380638,,NA,NA,NA,NA,NA
1537,Pocillopora_acuta_HIv2___RNAseq.g25666.t1,186.974128,-0.6036077,1.202988102,4.07E-05,0.000383008,,Q1MT80,4.45E-11,Guanylate-binding protein 4 (EC 3.6.5.-) (GTP-binding protein 4) (GBP-4) (Guanine nucleotide-binding protein 4),defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; neutrophil homeostasis [GO:0001780]; neutrophil-mediated killing of bacterium [GO:0070944]; regulation of apoptotic process [GO:0042981],GO:0001780; GO:0003924; GO:0005525; GO:0006954; GO:0042742; GO:0042981; GO:0045087; GO:0061702; GO:0070944
1538,Pocillopora_acuta_HIv2___RNAseq.g10799.t1a,673.3693209,-0.30315342,1.046833752,4.09E-05,0.000384247,,NA,NA,NA,NA,NA
1539,Pocillopora_acuta_HIv2___TS.g19790.t1,184.7274205,-2.116694166,5.444502882,4.10E-05,0.000385289,,O95833,4.17E-29,Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-),chloride transport [GO:0006821]; positive regulation of sprouting angiogenesis [GO:1903672]; signal transduction [GO:0007165],GO:0005254; GO:0005634; GO:0005737; GO:0005886; GO:0006821; GO:0007165; GO:0016020; GO:0016604; GO:0019153; GO:0031012; GO:0034707; GO:0070062; GO:1903672
1540,Pocillopora_acuta_HIv2___RNAseq.g434.t1,4373.177598,3.001068709,1.040104074,4.11E-05,0.00038644,Frizzled-5 (Fz-5),P58421,0,Frizzled-5 (Fz-5) (Xfz5),camera-type eye development [GO:0043010]; neuron development [GO:0048666]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; Wnt signaling pathway [GO:0016055],GO:0000139; GO:0004930; GO:0005886; GO:0016055; GO:0042127; GO:0043010; GO:0045595; GO:0048666
1541,Pocillopora_acuta_HIv2___RNAseq.g22527.t1,411.9409956,4.080597932,2.20461103,4.13E-05,0.000387648,,Q9DER7,0,Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid),cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485],GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154
1542,Pocillopora_acuta_HIv2___RNAseq.g19617.t1,393.33206,-0.218548303,1.026939366,4.15E-05,0.000389169,,O75970,0,Multiple PDZ domain protein (Multi-PDZ domain protein 1),tight junction assembly [GO:0120192],GO:0005737; GO:0005886; GO:0005923; GO:0014069; GO:0016324; GO:0016327; GO:0030425; GO:0045177; GO:0120192
1543,Pocillopora_acuta_HIv2___RNAseq.g14813.t1,417.4338628,-0.249407546,1.025934284,4.16E-05,0.000390255,,B2RR83,0,3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2),"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]",GO:0003723; GO:0004386; GO:0005524; GO:0005737; GO:0005783; GO:0007286; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247
1544,Pocillopora_acuta_HIv2___RNAseq.g29474.t1,113.1921086,-0.269034049,1.072493486,4.18E-05,0.000391972,,NA,NA,NA,NA,NA
1545,Pocillopora_acuta_HIv2___RNAseq.23729_t,453.5009021,-0.46271482,1.161762106,4.19E-05,0.000392668,Protocadherin-16,Q96JQ0,2.84E-91,Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1),branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659],GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0007156; GO:0007157; GO:0007389; GO:0008013; GO:0016020; GO:0016339; GO:0016342; GO:0016477; GO:0021915; GO:0022008; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0045296; GO:0048565; GO:0072137; GO:0072659; GO:0090102; GO:0098742
1546,Pocillopora_acuta_HIv2___RNAseq.g887.t1,291.7530663,-3.893396209,1.866343097,4.21E-05,0.000393623,,NA,NA,NA,NA,NA
1547,Pocillopora_acuta_HIv2___RNAseq.g14926.t1,314.4137933,-0.45775642,1.122442833,4.22E-05,0.00039497,,Q9CQ46,1.39E-78,Dynein regulatory complex protein 8 (EF-hand calcium-binding domain-containing protein 2),,GO:0005509; GO:0005737; GO:0005856; GO:0097228
1548,Pocillopora_acuta_HIv2___RNAseq.9201_t,478.9848415,-0.410052479,1.081694356,4.27E-05,0.000398451,,O17185,5.26E-46,Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38),potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322],GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0030322; GO:0036195; GO:0055120; GO:0071805
1549,Pocillopora_acuta_HIv2___RNAseq.g22076.t2a,541.2867319,-0.445233421,1.098273374,4.27E-05,0.000398451,,Q6P1B1,0,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0043069; GO:0070006
1550,Pocillopora_acuta_HIv2___RNAseq.g24746.t1,813.5578316,-0.194968021,1.030795505,4.28E-05,0.000399321,,Q8CHG5,0,Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1),apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0050727; GO:0061630; GO:0070979; GO:1990390
1551,Pocillopora_acuta_HIv2___RNAseq.g28616.t1,448.7731641,-0.219858534,1.028308629,4.29E-05,0.000399936,,Q9D0E3,3.53E-17,LysM and putative peptidoglycan-binding domain-containing protein 1,,GO:0005654
1552,Pocillopora_acuta_HIv2___RNAseq.g1273.t1,2144.390754,4.346886087,2.704338765,4.31E-05,0.000401866,,Q8N2E2,1.77E-45,von Willebrand factor D and EGF domain-containing protein,,GO:0005102; GO:0005576; GO:0009986
1553,Pocillopora_acuta_HIv2___RNAseq.g3581.t1,154.7758684,-0.884582159,1.534598078,4.33E-05,0.000402904,,NA,NA,NA,NA,NA
1554,Pocillopora_acuta_HIv2___RNAseq.g927.t1,182.0760864,-0.265239386,1.071073052,4.33E-05,0.000403218,,NA,NA,NA,NA,NA
1555,Pocillopora_acuta_HIv2___TS.g25911.t1a,164.936935,-0.504938441,1.173420912,4.36E-05,0.000405699,,Q96RS0,3.02E-103,Trimethylguanosine synthase (EC 2.1.1.-) (CLL-associated antigen KW-2) (Cap-specific guanine-N2 methyltransferase) (Hepatocellular carcinoma-associated antigen 137) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT),7-methylguanosine cap hypermethylation [GO:0036261]; ribonucleoprotein complex biogenesis [GO:0022613]; spliceosomal snRNP assembly [GO:0000387],GO:0000387; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008173; GO:0015030; GO:0022613; GO:0030532; GO:0036261; GO:0071164
1556,Pocillopora_acuta_HIv2___RNAseq.g30582.t1,397.3048407,0.292960892,1.055603089,4.39E-05,0.000408295,,NA,NA,NA,NA,NA
1557,Pocillopora_acuta_HIv2___RNAseq.g8037.t1,339.215313,-0.410039228,1.078858251,4.44E-05,0.000412149,,B8F9C9,3.52E-10,L-ectoine synthase (EC 4.2.1.108) (N-acetyldiaminobutyrate dehydratase),ectoine biosynthetic process [GO:0019491],GO:0019491; GO:0033990
1558,Pocillopora_acuta_HIv2___RNAseq.g12378.t1,643.7723136,4.087897141,1.479883512,4.50E-05,0.000417629,,P81546,8.83E-17,Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1),cellular response to UV-A [GO:0071492]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of cell population proliferation [GO:0008284]; regulation of integrin-mediated signaling pathway [GO:2001044]; response to cytokine [GO:0034097]; response to hormone [GO:0009725],GO:0002020; GO:0005125; GO:0005615; GO:0008083; GO:0008191; GO:0008284; GO:0009725; GO:0010951; GO:0031012; GO:0034097; GO:0043086; GO:0046872; GO:0051045; GO:0071492; GO:2001044
1559,Pocillopora_acuta_HIv2___TS.g1475.t2,651.2279164,-0.396778836,1.072731949,4.52E-05,0.000418911,,Q91V57,0,N-chimaerin (A-chimaerin) (Alpha-chimerin) (N-chimerin) (NC) (Rho GTPase-activating protein 2),ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],GO:0005096; GO:0008045; GO:0043087; GO:0046872; GO:0046875; GO:0048013; GO:0050770; GO:0051056
1560,Pocillopora_acuta_HIv2___RNAseq.g25648.t1,191.5677745,-3.892714645,2.071721733,4.52E-05,0.000418911,,NA,NA,NA,NA,NA
1561,Pocillopora_acuta_HIv2___RNAseq.g7079.t1,72.95577202,6.498783233,3.137874942,4.52E-05,0.000418911,,NA,NA,NA,NA,NA
1562,Pocillopora_acuta_HIv2___RNAseq.g19796.t1,351.9617731,0.999874976,1.74940679,4.54E-05,0.000420121,Protein patched homolog 1,Q90693,2.45E-152,Protein patched homolog 1 (PTC) (PTC1),negative regulation of smoothened signaling pathway [GO:0045879]; smoothened signaling pathway [GO:0007224],GO:0005119; GO:0005886; GO:0007224; GO:0008158; GO:0045879; GO:0097108
1563,Pocillopora_acuta_HIv2___RNAseq.g18399.t1,176.1812084,-0.656484536,1.345048543,4.55E-05,0.00042087,,P59910,2.74E-144,DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein),axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085],GO:0001534; GO:0005829; GO:0031514; GO:0036126; GO:0051082; GO:0051085; GO:0051087; GO:0120212; GO:1904158
1564,Pocillopora_acuta_HIv2___RNAseq.g7895.t1,734.8016757,1.123858095,2.072487203,4.58E-05,0.000423237,,Q63722,8.99E-22,Protein jagged-1 (Jagged1) (CD antigen CD339),animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; aorta morphogenesis [GO:0035909]; blood vessel remodeling [GO:0001974]; camera-type eye development [GO:0043010]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of gene expression [GO:0010628]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456]; wound healing [GO:0042060],GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003184; GO:0003215; GO:0005112; GO:0005509; GO:0005543; GO:0005886; GO:0005912; GO:0007219; GO:0009887; GO:0010628; GO:0016020; GO:0016324; GO:0022408; GO:0030182; GO:0030336; GO:0031100; GO:0032495; GO:0035909; GO:0042060; GO:0042127; GO:0042491; GO:0043010; GO:0045177; GO:0045596; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0048018; GO:0048839; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737
1565,Pocillopora_acuta_HIv2___RNAseq.g27948.t1,388.9562834,-0.279700732,1.066474505,4.60E-05,0.000425031,,Q6DHN0,3.19E-28,Transmembrane protein 53,negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; regulation of nucleocytoplasmic transport [GO:0046822],GO:0005640; GO:0030279; GO:0030514; GO:0031965; GO:0045668; GO:0046822
1566,Pocillopora_acuta_HIv2___RNAseq.g17907.t1b,417.1166434,-0.959742394,1.627389568,4.63E-05,0.000427437,,P35668,2.12E-138,Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase),,GO:0000287; GO:0004363; GO:0005524; GO:0042803; GO:0043295
1567,Pocillopora_acuta_HIv2___TS.g9644.t2,110.4136995,-5.11316588,2.71325394,4.64E-05,0.000428656,,Q68EL3,2.24E-29,BET1-like protein,"protein transport [GO:0015031]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0000139; GO:0005484; GO:0005829; GO:0015031; GO:0031201; GO:0042147; GO:2000156
1568,Pocillopora_acuta_HIv2___RNAseq.g1208.t1,544.9302176,0.733212508,1.457682278,4.65E-05,0.000428877,,Q05360,1.57E-176,Protein white,,GO:0005524; GO:0016020; GO:0016887; GO:0031409; GO:0140359
1569,Pocillopora_acuta_HIv2___RNAseq.g22947.t1,244.8837897,-0.83878427,1.55609192,4.66E-05,0.000429324,,Q6ING7,1.38E-144,FAD synthase (EC 2.7.7.2) (FAD pyrophosphorylase) (FMN adenylyltransferase) (Flavin adenine dinucleotide synthase) [Includes: Molybdenum cofactor biosynthesis protein-like region; FAD synthase region],FAD biosynthetic process [GO:0006747],GO:0003919; GO:0005524; GO:0005737; GO:0006747
1570,Pocillopora_acuta_HIv2___TS.g30914.t1,1235.882911,4.10907028,3.43635531,4.72E-05,0.000434478,,Q64487,0,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560
1571,Pocillopora_acuta_HIv2___RNAseq.g7611.t1,480.6744587,-0.402486259,1.115822515,4.81E-05,0.000443217,,E2JA28,1.33E-44,Dapdiamide synthesis protein DdaC (EC 1.-.-.-),antibiotic biosynthetic process [GO:0017000],GO:0016491; GO:0017000
1572,Pocillopora_acuta_HIv2___TS.g1788.t1,372.1353269,-0.453679123,1.101730456,4.83E-05,0.000444233,RWamide Cnidarian Neuropeptide (He et al 2023),NA,NA,NA,NA,NA
1573,Pocillopora_acuta_HIv2___TS.g21718.t2,241.3889796,-0.455053299,1.103416691,4.90E-05,0.000450526,,NA,NA,NA,NA,NA
1574,Pocillopora_acuta_HIv2___TS.g19701.t1a,597.0948114,-0.492298394,1.147013618,4.92E-05,0.000451889,,Q7TQ95,2.55E-76,Endoplasmic reticulum junction formation protein lunapark (ER junction formation factor lunapark) (Protein ulnaless),blood coagulation [GO:0007596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; regulation of chondrocyte differentiation [GO:0032330],GO:0005654; GO:0005789; GO:0007596; GO:0032330; GO:0035115; GO:0042733; GO:0042802; GO:0046872; GO:0071782; GO:0071786; GO:0071788; GO:0098826; GO:1903373
1575,Pocillopora_acuta_HIv2___RNAseq.g8058.t1,175.4662707,-3.869852213,3.636942604,4.95E-05,0.000454631,,Q8K3X3,0,"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)",'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219],GO:0005737; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070401
1576,Pocillopora_acuta_HIv2___RNAseq.g3776.t1,304.3814037,-4.146914231,2.672783476,4.96E-05,0.000454784,,Q95YM9,4.55E-06,Fibroblast growth factor receptor (HrFGFR) (EC 2.7.10.1),positive regulation of cell population proliferation [GO:0008284],GO:0005007; GO:0005524; GO:0008284; GO:0016020; GO:0017134; GO:0043235
1577,Pocillopora_acuta_HIv2___RNAseq.g17469.t1,2827.334053,2.894058414,0.946707968,4.97E-05,0.000456043,,NA,NA,NA,NA,NA
1578,Pocillopora_acuta_HIv2___RNAseq.g30875.t1,188.2528624,-0.804597744,1.482182037,4.98E-05,0.000456568,,Q2TBK2,2.02E-15,"Large ribosomal subunit protein bL9m (39S ribosomal protein L9, mitochondrial) (L9mt) (MRP-L9)",translation [GO:0006412],GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412
1579,Pocillopora_acuta_HIv2___RNAseq.g11626.t1,483.9696725,-0.134909085,1.017495552,4.98E-05,0.000456568,,Q4R630,3.96E-89,Kinetochore protein NDC80 homolog (Kinetochore protein Hec1) (Kinetochore-associated protein 2),attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; metaphase chromosome alignment [GO:0051310]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267],GO:0000776; GO:0005634; GO:0007052; GO:0007059; GO:0008017; GO:0031262; GO:0051301; GO:0051310; GO:0051315; GO:0090267; GO:0140483
1580,Pocillopora_acuta_HIv2___RNAseq.g7878.t1,151.0649848,-0.447666806,1.099478429,5.06E-05,0.000463541,,NA,NA,NA,NA,NA
1581,Pocillopora_acuta_HIv2___RNAseq.g11497.t1,636.6226731,3.476229201,1.161000491,5.07E-05,0.00046372,Solute carrier family 15 member 2,B0S6T2,9.93E-176,Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2),"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; peptide transport [GO:0015833]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; response to yeast [GO:0001878]; tripeptide import across plasma membrane [GO:0140207]",GO:0001878; GO:0005886; GO:0015031; GO:0015333; GO:0015833; GO:0015835; GO:0016324; GO:0030670; GO:0042937; GO:0045087; GO:0070424; GO:0071916; GO:0140206; GO:0140207
1582,Pocillopora_acuta_HIv2___RNAseq.g775.t1,686.7607299,4.247209586,3.202175458,5.09E-05,0.000464576,,Q924H0,2.76E-32,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408],GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408
1583,Pocillopora_acuta_HIv2___RNAseq.g17719.t1,60.67239749,-1.013434849,1.878992115,5.09E-05,0.000464576,,Q09575,9.25E-24,Uncharacterized protein K02A2.6,DNA integration [GO:0015074],GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575
1584,Pocillopora_acuta_HIv2___RNAseq.g4380.t1,174.3684903,-0.446005624,1.171778721,5.09E-05,0.000464576,,Q2TAR3,1.74E-112,Fez family zinc finger protein 2,cell differentiation [GO:0030154]; nervous system development [GO:0007399],GO:0003677; GO:0005634; GO:0007399; GO:0030154; GO:0046872
1585,Pocillopora_acuta_HIv2___RNAseq.g11724.t1,232.4606577,0.470154377,1.155210229,5.10E-05,0.000465488,,Q24799,5.35E-44,Myophilin,actin filament organization [GO:0007015],GO:0007015; GO:0015629; GO:0051015
1586,Pocillopora_acuta_HIv2___RNAseq.g9056.t1,1100.937389,4.08351763,2.480494654,5.15E-05,0.000469566,,Q80T79,4.49E-83,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),regulation of dendrite development [GO:0050773],GO:0005886; GO:0050773
1587,Pocillopora_acuta_HIv2___RNAseq.g5965.t1,344.4736941,-0.598094715,1.285358887,5.16E-05,0.000470302,,NA,NA,NA,NA,NA
1588,Pocillopora_acuta_HIv2___RNAseq.g10781.t1,247.2879939,-0.472972536,1.107687651,5.16E-05,0.000470372,,NA,NA,NA,NA,NA
1589,Pocillopora_acuta_HIv2___RNAseq.g14094.t1,86.27057005,-6.248274394,4.264188442,5.18E-05,0.000471371,,F1QMV3,2.74E-70,Trafficking protein particle complex subunit 6b (TRAPP complex subunit 6B),endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399],GO:0005783; GO:0005801; GO:0005802; GO:0006888; GO:0007399; GO:0030008
1590,Pocillopora_acuta_HIv2___RNAseq.g727.t1,31.10277962,-8.97614244,3.643076347,5.22E-05,0.000474481,,NA,NA,NA,NA,NA
1591,Pocillopora_acuta_HIv2___TS.g19792.t3c,397.742554,-1.237625332,2.071695926,5.26E-05,0.000478391,,Q55E58,5.83E-18,Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1),cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856],GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310
1592,Pocillopora_acuta_HIv2___RNAseq.g16864.t1,352.6207862,-0.422674219,1.0887361,5.30E-05,0.000481134,,A7SWH1,0,Pescadillo homolog,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]",GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0030687; GO:0043021; GO:0070545
1593,Pocillopora_acuta_HIv2___RNAseq.g23053.t1,1003.708857,-1.108282258,1.956621112,5.30E-05,0.000481134,,Q924A2,2.47E-40,Protein capicua homolog,brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; social behavior [GO:0035176]; transcription by RNA polymerase II [GO:0006366],GO:0000122; GO:0000977; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0006366; GO:0007420; GO:0007612; GO:0007613; GO:0032991; GO:0035176; GO:0045892; GO:0048286
1594,Pocillopora_acuta_HIv2___RNAseq.20239_t,629.7253809,-0.352481426,1.054059888,5.32E-05,0.000482456,,B4E2M5,1.18E-29,Ankyrin repeat domain-containing protein 66,,
1595,Pocillopora_acuta_HIv2___TS.g12436.t1a,71.77478989,-6.138743559,4.525205802,5.34E-05,0.000484124,,NA,NA,NA,NA,NA
1596,Pocillopora_acuta_HIv2___RNAseq.g24015.t1b,225.8428622,-0.627290771,1.272623424,5.40E-05,0.000489507,,Q9W6S8,2.16E-23,Survival motor neuron protein 1,"axon arborization [GO:0140060]; axon development [GO:0061564]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; mRNA splicing, via spliceosome [GO:0000398]; neuromast regeneration [GO:0070657]; neuromuscular junction development [GO:0007528]; neuron cellular homeostasis [GO:0070050]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of oxidative phosphorylation [GO:1903862]; protein complex oligomerization [GO:0051259]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of neuromuscular junction development [GO:1904396]; spliceosomal snRNP assembly [GO:0000387]; synaptic assembly at neuromuscular junction [GO:0051124]; tissue regeneration [GO:0042246]",GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0007409; GO:0007528; GO:0008045; GO:0015030; GO:0016358; GO:0030018; GO:0032797; GO:0032991; GO:0036464; GO:0042246; GO:0043005; GO:0043204; GO:0048675; GO:0048841; GO:0048936; GO:0051124; GO:0051259; GO:0061564; GO:0070050; GO:0070657; GO:0097504; GO:0140060; GO:1903862; GO:1904396
1597,Pocillopora_acuta_HIv2___RNAseq.g14097.t1,194.5145427,-0.971134371,1.632799167,5.43E-05,0.000491393,,F1QMV3,2.74E-70,Trafficking protein particle complex subunit 6b (TRAPP complex subunit 6B),endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399],GO:0005783; GO:0005801; GO:0005802; GO:0006888; GO:0007399; GO:0030008
1598,Pocillopora_acuta_HIv2___RNAseq.g16523.t1,522.9294863,-0.391192005,1.093440054,5.44E-05,0.000492217,,Q99MU0,1.47E-27,Protein DBF4 homolog A (ChDBF4),DNA replication [GO:0006260]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987],GO:0003676; GO:0006260; GO:0008270; GO:0010571; GO:0031431; GO:0043539; GO:1901987
1599,Pocillopora_acuta_HIv2___TS.g21741.t1,6778.307224,-3.739301628,2.63026343,5.46E-05,0.000494223,,NA,NA,NA,NA,NA
1600,Pocillopora_acuta_HIv2___RNAseq.24886_t,705.4395055,0.338807879,1.081805936,5.47E-05,0.000494223,,Q2HJ10,1.12E-120,Proton-coupled zinc antiporter SLC30A2 (Solute carrier family 30 member 2) (Zinc transporter 2) (ZnT-2),intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc ion import into lysosome [GO:0140916]; zinc ion import into mitochondrion [GO:0140917]; zinc ion import into zymogen granule [GO:0140915]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829],GO:0005385; GO:0005743; GO:0005765; GO:0005770; GO:0005886; GO:0006829; GO:0006882; GO:0010008; GO:0010043; GO:0030658; GO:0042589; GO:0042802; GO:0046872; GO:0071577; GO:0140826; GO:0140915; GO:0140916; GO:0140917
1601,Pocillopora_acuta_HIv2___RNAseq.g26098.t1,614.1207556,-0.189557907,1.02754476,5.48E-05,0.000494451,,Q5HYC2,3.72E-77,Uncharacterized bromodomain-containing protein 10,,GO:0005634
1602,Pocillopora_acuta_HIv2___TS.g25376.t1a,189.5750926,-0.795781322,1.489651533,5.48E-05,0.000494451,,Q6PFM0,9.40E-164,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR) (zfpsr),"cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]",GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006909; GO:0008380; GO:0018395; GO:0030154; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070815; GO:0106140
1603,Pocillopora_acuta_HIv2___RNAseq.22092_t,343.2336741,2.175268366,4.260413329,5.48E-05,0.000494451,,Q9JME2,2.70E-41,Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1),apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216
1604,Pocillopora_acuta_HIv2___TS.g18545.t1,57.07054719,-0.88344365,1.636815982,5.50E-05,0.000495993,,NA,NA,NA,NA,NA
1605,Pocillopora_acuta_HIv2___TS.g12980.t1,925.207349,-0.520461765,1.162017972,5.53E-05,0.000497957,,Q32PB0,7.12E-27,"Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB)",mitochondrial DNA replication [GO:0006264]; positive regulation of mitochondrial DNA replication [GO:0090297]; protein homotetramerization [GO:0051289],GO:0003682; GO:0003697; GO:0005739; GO:0006264; GO:0042645; GO:0051289; GO:0090297
1606,Pocillopora_acuta_HIv2___RNAseq.g3610.t1,346.2779932,0.328574978,1.071144113,5.54E-05,0.000498552,,NA,NA,NA,NA,NA
1607,Pocillopora_acuta_HIv2___RNAseq.g30304.t2,2520.387673,4.316327103,2.362738507,5.57E-05,0.000501015,Galaxin (CARP 3),D9IQ16,4.06E-39,Galaxin,,GO:0005576
1608,Pocillopora_acuta_HIv2___TS.g13143.t1,204.2831936,0.201933294,1.030212782,5.60E-05,0.000503288,,Q9D903,7.27E-68,Probable rRNA-processing protein EBP2,ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],GO:0005694; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273
1609,Pocillopora_acuta_HIv2___RNAseq.g8859.t1b,69.8733219,-6.301846369,4.187238338,5.60E-05,0.000503663,,NA,NA,NA,NA,NA
1610,Pocillopora_acuta_HIv2___RNAseq.g12733.t1,406.2474673,-0.404251326,1.116075624,5.64E-05,0.000506282,,Q68FK8,0,ATP-dependent RNA helicase A protein (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II),"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]",GO:0000380; GO:0000978; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0006260; GO:0006353; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0031490; GO:0032508; GO:0033679; GO:0034458; GO:0035195; GO:0035613; GO:0036464; GO:0043022; GO:0043138; GO:0044806; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0050684; GO:0051028; GO:0051092; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070937; GO:0071356; GO:0097165; GO:1905172; GO:1990518; GO:1990825; GO:1990841; GO:2000373; GO:2000765; GO:2000767
1611,Pocillopora_acuta_HIv2___RNAseq.g1838.t1,74.01630591,-6.129692827,4.596076879,5.65E-05,0.000506975,,Q8WWC4,3.30E-13,"m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1)",calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204],GO:0005743; GO:0005759; GO:0032979; GO:0036444; GO:0043022; GO:0051204; GO:0051560
1612,Pocillopora_acuta_HIv2___TS.g3225.t1,963.9714928,0.900132587,1.665525935,5.67E-05,0.000508857,,Q9VS29,4.20E-07,Cell adhesion molecule Dscam2 (Down syndrome cell adhesion molecule-like protein Dscam2),axon guidance [GO:0007411]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812],GO:0005886; GO:0007156; GO:0007411; GO:0007417; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632
1613,Pocillopora_acuta_HIv2___RNAseq.g9749.t1,558.595242,-0.182373329,1.025466511,5.68E-05,0.000509236,,Q03958,2.59E-33,Prefoldin subunit 6 (Protein Ke2),chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457],GO:0001540; GO:0005737; GO:0006457; GO:0016272; GO:0051082; GO:0051087; GO:0051131; GO:1905907; GO:1990062
1614,Pocillopora_acuta_HIv2___RNAseq.g12372.t1,1892.120473,4.034160063,1.999412661,5.68E-05,0.000509236,,H9JW44,1.09E-95,Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41),chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0046872
1615,Pocillopora_acuta_HIv2___RNAseq.g1942.t1,243.3802702,-1.421363187,2.96075024,5.72E-05,0.000512254,,NA,NA,NA,NA,NA
1616,Pocillopora_acuta_HIv2___RNAseq.g20683.t1,262.0524387,-0.625336672,1.217527988,5.72E-05,0.000512254,,NA,NA,NA,NA,NA
1617,Pocillopora_acuta_HIv2___RNAseq.g14832.t1,132.1490358,-0.59315401,1.289463636,5.73E-05,0.000512884,,Q9NXS3,1.66E-41,Kelch-like protein 28 (BTB/POZ domain-containing protein 5),,
1618,Pocillopora_acuta_HIv2___TS.g5112.t1,7861.559306,-2.938403262,1.032142431,5.77E-05,0.000516213,CARP6-partial,NA,NA,NA,NA,NA
1619,Pocillopora_acuta_HIv2___RNAseq.g19452.t1,173.4852159,-3.862602091,3.721711595,5.78E-05,0.00051654,,Q8BX94,3.58E-45,Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2),intracellular cholesterol transport [GO:0032367]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509],GO:0005546; GO:0005811; GO:0005829; GO:0005886; GO:0007009; GO:0008526; GO:0009898; GO:0015485; GO:0032367; GO:0051289; GO:0097038; GO:0098831; GO:0098978; GO:0099509; GO:0120020
1620,Pocillopora_acuta_HIv2___TS.g25063.t1a,441.3613178,-0.39364729,1.113103995,5.83E-05,0.000520464,,Q14191,4.42E-19,"Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (DNA helicase, RecQ-like type 3) (RecQ protein-like 2) (Werner syndrome protein) [Includes: 3'-5' exonuclease (EC 3.1.-.-); ATP-dependent helicase (EC 5.6.2.4) (DNA 3'-5' helicase WRN)]",base-excision repair [GO:0006284]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820],GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0003682; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006284; GO:0006302; GO:0006974; GO:0006979; GO:0008340; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0016607; GO:0016853; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090398; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773
1621,Pocillopora_acuta_HIv2___RNAseq.g3825.t1,386.4934779,0.07944125,1.021579994,5.85E-05,0.00052204,,NA,NA,NA,NA,NA
1622,Pocillopora_acuta_HIv2___RNAseq.g1239.t1,1155.762045,-2.228896071,3.13590697,5.86E-05,0.000522303,,Q552Z6,1.81E-12,GTP-binding protein A,,GO:0005525
1623,Pocillopora_acuta_HIv2___RNAseq.g14988.t1,232.9268389,-0.383252848,1.129712588,5.94E-05,0.000529163,,NA,NA,NA,NA,NA
1624,Pocillopora_acuta_HIv2___RNAseq.g27066.t1,7657.021663,2.377262935,0.707551773,6.05E-05,0.000538955,,NA,NA,NA,NA,NA
1625,Pocillopora_acuta_HIv2___RNAseq.g15163.t1,1240.286701,3.524300839,3.474066863,6.17E-05,0.000549424,,Q9W740,2.52E-25,Noggin-2,cartilage development [GO:0051216]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; osteoblast differentiation [GO:0001649],GO:0001649; GO:0005615; GO:0009953; GO:0030514; GO:0045596; GO:0051216
1626,Pocillopora_acuta_HIv2___RNAseq.g22289.t1,97.97999241,-0.70789569,1.38784716,6.26E-05,0.000557194,,P22739,2.18E-160,Potassium voltage-gated channel subfamily A member 2 (Voltage-gated potassium channel subunit Kv1.2) (xSHA2),neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260],GO:0005249; GO:0005251; GO:0005886; GO:0008076; GO:0019228; GO:0044224; GO:0051260; GO:0071805
1627,Pocillopora_acuta_HIv2___RNAseq.g24675.t1,35.5676223,-8.855576999,3.733341434,6.27E-05,0.000557398,,Q9GYF0,1.77E-06,Cholesterol uptake protein 1,cholesterol import [GO:0070508]; RNA transport [GO:0050658],GO:0003725; GO:0005764; GO:0005768; GO:0005794; GO:0005886; GO:0015485; GO:0031410; GO:0050658; GO:0051033; GO:0070508
1628,Pocillopora_acuta_HIv2___TS.g3196.t2,381.3082079,-0.453040065,1.108903599,6.28E-05,0.000557926,,Q5WNE3,1.50E-25,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (EC 3.5.1.52) (Peptide:N-glycanase) (PNGase),glycoprotein catabolic process [GO:0006516],GO:0000224; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006516; GO:0046872
1629,Pocillopora_acuta_HIv2___RNAseq.g28652.t1,962.2589197,4.158213225,2.499862022,6.30E-05,0.000559117,,NA,NA,NA,NA,NA
1630,Pocillopora_acuta_HIv2___RNAseq.9646_t,226.7232297,0.297151008,1.06112467,6.30E-05,0.000559117,,Q9CZT6,1.58E-47,Protein CMSS1 (Cms1 ribosomal small subunit homolog),,
1631,Pocillopora_acuta_HIv2___RNAseq.g12266.t1,80.15169844,0.590288005,1.247801521,6.31E-05,0.000559831,,O14522,1.71E-45,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho),cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; signal transduction [GO:0007165],GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0050807; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:0098839; GO:0098978; GO:1904893; GO:1990264
1632,Pocillopora_acuta_HIv2___RNAseq.g13820.t1,64.37015938,-0.692618069,1.376822782,6.33E-05,0.00056064,,NA,NA,NA,NA,NA
1633,Pocillopora_acuta_HIv2___TS.g15585.t1,3589.911017,3.877128093,2.486112569,6.34E-05,0.000561958,,Q5VST9,4.70E-15,Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK),protein localization to M-band [GO:0036309]; regulation of small GTPase mediated signal transduction [GO:0051056]; sarcomere organization [GO:0045214],GO:0004674; GO:0005085; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005829; GO:0005886; GO:0008307; GO:0010314; GO:0016604; GO:0030016; GO:0030018; GO:0030506; GO:0031430; GO:0031432; GO:0032266; GO:0036309; GO:0042383; GO:0043325; GO:0045214; GO:0046872; GO:0051056; GO:0070273; GO:0106310
1634,Pocillopora_acuta_HIv2___RNAseq.g26727.t1,2428.75311,-2.525501544,0.787266391,6.40E-05,0.000566386,,NA,NA,NA,NA,NA
1635,Pocillopora_acuta_HIv2___RNAseq.g28109.t1,2232.435672,3.932923962,2.503826694,6.42E-05,0.00056773,,P37889,1.21E-71,Fibulin-2 (FIBL-2),positive regulation of cell-substrate adhesion [GO:0010811],GO:0005509; GO:0005576; GO:0010811; GO:0050840; GO:0062023
1636,Pocillopora_acuta_HIv2___RNAseq.g16416.t1,174.478625,-0.783595271,1.389862382,6.43E-05,0.000568408,,Q2TBP2,7.71E-139,Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein),negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0045892; GO:0046872
1637,Pocillopora_acuta_HIv2___RNAseq.g8095.t1,523.4798553,-0.136703065,1.01830769,6.43E-05,0.000568408,,Q5R6Q7,2.21E-35,Sorting nexin-16,early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622],GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031313; GO:0031901; GO:0031902; GO:0035091; GO:0045022
1638,Pocillopora_acuta_HIv2___RNAseq.g15852.t1,117.5519408,-0.264769119,1.070317749,6.53E-05,0.000577038,,Q91WC1,1.03E-38,Protection of telomeres protein 1 (mPot1) (POT1-like telomere end-binding protein),chromosome organization [GO:0051276]; positive regulation of telomere maintenance [GO:0032206]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere capping [GO:0016233]; telomere maintenance via telomerase [GO:0007004],GO:0000781; GO:0000783; GO:0005654; GO:0007004; GO:0010521; GO:0016233; GO:0032206; GO:0032210; GO:0042162; GO:0043047; GO:0051276; GO:0070187; GO:0098505
1639,Pocillopora_acuta_HIv2___TS.g305.t1,340.3545745,-1.11982884,1.798302031,6.60E-05,0.000582419,,O75899,4.30E-126,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712
1640,Pocillopora_acuta_HIv2___RNAseq.g6282.t1,55.63973116,-0.438629303,1.158661871,6.62E-05,0.000583957,,A0JM56,8.93E-101,Leucine-rich repeat-containing protein 9,,GO:0005737
1641,Pocillopora_acuta_HIv2___RNAseq.g1462.t1,628.6839212,0.431404245,1.138239068,6.66E-05,0.000587377,,P0C6B8,0,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1","epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]",GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0045959; GO:0048014; GO:0098640; GO:0120193
1642,Pocillopora_acuta_HIv2___RNAseq.g21576.t1,287.8859495,-0.485667768,1.172180883,6.68E-05,0.00058804,,P17971,4.06E-69,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805
1643,Pocillopora_acuta_HIv2___RNAseq.g17191.t1,422.1557796,0.088348972,1.022668093,6.71E-05,0.000590362,,B2RXZ1,4.78E-88,Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1),"blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA processing [GO:0034587]; priRNA 3'-end processing [GO:1990431]; siRNA 3'-end processing [GO:1990432]; spermatogenesis [GO:0007283]",GO:0000175; GO:0000184; GO:0000289; GO:0001825; GO:0003723; GO:0004535; GO:0005634; GO:0005783; GO:0005789; GO:0007283; GO:0034587; GO:0046872; GO:1990431; GO:1990432
1644,Pocillopora_acuta_HIv2___RNAseq.g23141.t1,273.6474603,-0.408906028,1.083583151,6.79E-05,0.000596967,,Q2TBH9,0,Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8),intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],GO:0000139; GO:0006891; GO:0015031; GO:0017119
1645,Pocillopora_acuta_HIv2___RNAseq.g27381.t1,455.9113033,-0.748871141,1.392187761,6.84E-05,0.000601047,,F2K079,1.19E-44,4-hydroxybenzoate brominase (decarboxylating) (EC 1.14.19.55) (Decarboxylating-brominase flavoenzyme Bmp5),,GO:0004499; GO:0047822; GO:0050660; GO:0050661
1646,Pocillopora_acuta_HIv2___TS.g12175.t1,82.04998964,-0.601494491,1.273788733,6.90E-05,0.000606343,,NA,NA,NA,NA,NA
1647,Pocillopora_acuta_HIv2___RNAseq.g17949.t2,747.4931144,-3.228589797,1.407521111,6.93E-05,0.000608393,,NA,NA,NA,NA,NA
1648,Pocillopora_acuta_HIv2___RNAseq.g21709.t1,589.5071847,-0.62862494,1.234122483,6.94E-05,0.000609134,,A2AAY5,1.94E-53,SH3 and PX domain-containing protein 2B (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains),adipose tissue development [GO:0060612]; bone development [GO:0060348]; cranial skeletal system development [GO:1904888]; eye development [GO:0001654]; heart development [GO:0007507]; osteoblast fate commitment [GO:0002051]; podosome assembly [GO:0071800]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to membrane [GO:0072657]; regulation of brood size [GO:0060378]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801],GO:0001501; GO:0001654; GO:0002051; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0010628; GO:0016176; GO:0032266; GO:0040018; GO:0042169; GO:0042554; GO:0042995; GO:0045600; GO:0048705; GO:0051496; GO:0060348; GO:0060378; GO:0060612; GO:0070161; GO:0070273; GO:0071800; GO:0072657; GO:0080025; GO:1904179; GO:1904888
1649,Pocillopora_acuta_HIv2___TS.g4835.t2,2307.748082,2.549110955,0.803953629,6.96E-05,0.000610315,,O94854,9.82E-08,"Microtubule-actin cross-linking factor 1, isoforms 6/7 (Uncharacterized protein KIAA0754)",intermediate filament cytoskeleton organization [GO:0045104],GO:0005509; GO:0005737; GO:0005856; GO:0008017; GO:0045104
1650,Pocillopora_acuta_HIv2___RNAseq.g8690.t1,1186.976446,-3.707144131,3.277961262,7.00E-05,0.000613293,,Q6VFT5,3.36E-59,Forkhead box protein L2,anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; extraocular skeletal muscle development [GO:0002074]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-templated transcription [GO:0045893],GO:0000978; GO:0000981; GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0006309; GO:0009653; GO:0030154; GO:0043028; GO:0043065; GO:0043280; GO:0045893
1651,Pocillopora_acuta_HIv2___RNAseq.g22866.t1,370.0196318,-0.705546397,1.343538563,7.00E-05,0.000613293,,P42325,7.26E-72,Neurocalcin homolog (DrosNCa),"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]",GO:0005509; GO:0045938; GO:1902848
1652,Pocillopora_acuta_HIv2___RNAseq.g11142.t1,147.7386048,-0.660694798,1.369385684,7.05E-05,0.000617525,,Q8N945,1.73E-44,PRELI domain-containing protein 2,phospholipid transport [GO:0015914],GO:0005758; GO:0015914; GO:1990050
1653,Pocillopora_acuta_HIv2___RNAseq.g7681.t1,469.4125351,-0.198932563,1.031483832,7.06E-05,0.000617525,,E9PY46,0,Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2),cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589],GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:0120199; GO:1902017; GO:1905515; GO:1990403
1654,Pocillopora_acuta_HIv2___RNAseq.g27026.t1,87.87475765,-0.269105497,1.072366642,7.10E-05,0.000621012,,NA,NA,NA,NA,NA
1655,Pocillopora_acuta_HIv2___RNAseq.g23008.t1,441.8505358,-0.214284298,1.029214979,7.11E-05,0.000621012,,Q86BN8,2.86E-63,"Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (PTEN-like protein) (Protein-tyrosine phosphatase mitochondrial 1-like protein) (EC 3.1.3.16, EC 3.1.3.48)","dephosphorylation [GO:0016311]; liquid clearance, open tracheal system [GO:0035002]; phosphatidylglycerol biosynthetic process [GO:0006655]",GO:0004439; GO:0004725; GO:0005739; GO:0005743; GO:0006655; GO:0008962; GO:0016311; GO:0017018; GO:0035002
1656,Pocillopora_acuta_HIv2___RNAseq.g23082.t1,495.7121549,-0.213709863,1.036146027,7.11E-05,0.00062134,,Q5F415,0,TBC1 domain family member 23,"embryonic brain development [GO:1990403]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle tethering to Golgi [GO:0099041]",GO:0005802; GO:0005829; GO:0042147; GO:0099041; GO:1990403
1657,Pocillopora_acuta_HIv2___RNAseq.g26305.t1,235.3912759,-0.329298453,1.064193332,7.12E-05,0.000621928,,Q28BT8,0,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like),mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943],GO:0002943; GO:0006397; GO:0006417; GO:0017150; GO:0046872; GO:0050660; GO:0106414
1658,Pocillopora_acuta_HIv2___RNAseq.g24012.t1,616.5037928,-1.365888467,2.383815139,7.21E-05,0.000629189,,NA,NA,NA,NA,NA
1659,Pocillopora_acuta_HIv2___TS.g8175.t2,355.7826262,-0.241335013,1.032496378,7.22E-05,0.000629539,,Q7L9B9,6.80E-78,Endonuclease/exonuclease/phosphatase family domain-containing protein 1,DNA repair [GO:0006281]; positive regulation of cholesterol efflux [GO:0010875],GO:0003677; GO:0003824; GO:0005886; GO:0006281; GO:0010875
1660,Pocillopora_acuta_HIv2___TS.g3218.t1,667.0066388,4.069861895,2.494724104,7.25E-05,0.000632003,,NA,NA,NA,NA,NA
1661,Pocillopora_acuta_HIv2___RNAseq.g27045.t1a,138.940981,-0.25588832,1.066742026,7.28E-05,0.000633728,,Q460N5,7.22E-87,Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14),innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212],GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404
1662,Pocillopora_acuta_HIv2___TS.g29206.t1,203.5863983,-0.432564544,1.116009323,7.33E-05,0.000637737,,NA,NA,NA,NA,NA
1663,Pocillopora_acuta_HIv2___RNAseq.g11661.t1,442.3880799,-0.314643239,1.051590407,7.37E-05,0.000641395,,NA,NA,NA,NA,NA
1664,Pocillopora_acuta_HIv2___RNAseq.g26675.t1,11803.2317,2.447642208,0.761692688,7.39E-05,0.000642587,,NA,NA,NA,NA,NA
1665,Pocillopora_acuta_HIv2___RNAseq.g4039.t1,246.8865322,-0.251528062,1.06573273,7.42E-05,0.000644157,,Q14191,0,"Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (DNA helicase, RecQ-like type 3) (RecQ protein-like 2) (Werner syndrome protein) [Includes: 3'-5' exonuclease (EC 3.1.-.-); ATP-dependent helicase (EC 5.6.2.4) (DNA 3'-5' helicase WRN)]",base-excision repair [GO:0006284]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820],GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0003682; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006284; GO:0006302; GO:0006974; GO:0006979; GO:0008340; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0016607; GO:0016853; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090398; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773
1666,Pocillopora_acuta_HIv2___TS.g10338.t1,583.5401556,-0.205493357,1.033778543,7.44E-05,0.00064577,,Q6UX65,8.75E-33,DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77),apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601],GO:0001917; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016324; GO:0043231; GO:0045494
1667,Pocillopora_acuta_HIv2___RNAseq.g23755.t1,202.2242131,-0.313900392,1.041527645,7.49E-05,0.000650004,,D4G3R4,1.18E-22,tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA),tRNA decay [GO:0016078],GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0016798; GO:0090729
1668,Pocillopora_acuta_HIv2___TS.g30153.t1,398.1412243,-0.389267465,1.07224668,7.53E-05,0.000652767,,NA,NA,NA,NA,NA
1669,Pocillopora_acuta_HIv2___RNAseq.g11127.t1,193.6570137,-0.330075942,1.09474672,7.55E-05,0.000654185,,Q9GJX5,1.08E-60,Taurochenodeoxycholic 6 alpha-hydroxylase (EC 1.14.14.57) (CYPIVA21) (Cytochrome P450 4A21),,GO:0005506; GO:0005789; GO:0020037; GO:0033780
1670,Pocillopora_acuta_HIv2___RNAseq.g24500.t1,60.12860215,-6.429126386,2.757509332,7.57E-05,0.000655076,,NA,NA,NA,NA,NA
1671,Pocillopora_acuta_HIv2___RNAseq.g19484.t2,224.3344783,-0.416889653,1.092524665,7.57E-05,0.000655076,,O95786,2.00E-123,Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904
1672,Pocillopora_acuta_HIv2___RNAseq.g20345.t1,226.8951749,-1.303683076,2.408717702,7.60E-05,0.000657515,,NA,NA,NA,NA,NA
1673,Pocillopora_acuta_HIv2___RNAseq.g29245.t1,71.01456322,-0.750219343,1.441553363,7.64E-05,0.000660729,,C5P3T4,9.99E-08,Neutral protease 2 homolog MEP7 (EC 3.4.24.39) (Deuterolysin MEP7) (Metalloproteinase 7),proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0046872
1674,Pocillopora_acuta_HIv2___RNAseq.g21475.t1,427.9582596,0.210938932,1.032303212,7.71E-05,0.000665853,,P24821,4.14E-51,Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C),bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611],GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966
1675,Pocillopora_acuta_HIv2___RNAseq.g4348.t1,250.4429744,-0.535855975,1.182207927,7.71E-05,0.000665937,,NA,NA,NA,NA,NA
1676,Pocillopora_acuta_HIv2___RNAseq.g21875.t1,303.2432219,-0.552002306,1.241136085,7.73E-05,0.000667345,,Q5U4F6,1.84E-150,Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34),cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073],GO:0005813; GO:0005814; GO:0005829; GO:0005868; GO:0005929; GO:0005930; GO:0030175; GO:0035721; GO:0036064; GO:0042073; GO:0045503; GO:0045504; GO:0060271; GO:0097014
1677,Pocillopora_acuta_HIv2___RNAseq.g15848.t1,451.5470543,0.795484663,1.497736189,7.75E-05,0.00066826,,A4IGL7,0,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825
1678,Pocillopora_acuta_HIv2___RNAseq.g4959.t1,1090.458578,-2.854365495,1.019819185,7.78E-05,0.000670833,,Q9QXE4,6.14E-15,Tumor protein p53-inducible nuclear protein 1 (Stress-induced protein) (Thymus-expressed acidic protein) (TEAP) (p53-dependent damage-inducible nuclear protein 1) (p53DINP1),apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagosome assembly [GO:0000045]; cellular response to ethanol [GO:0071361]; cellular response to hydroperoxide [GO:0071447]; cellular response to methyl methanesulfonate [GO:0072703]; cellular response to UV [GO:0034644]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of myofibroblast differentiation [GO:1904761]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; response to heat [GO:0009408],GO:0000045; GO:0005634; GO:0005776; GO:0005829; GO:0006915; GO:0008285; GO:0009408; GO:0010508; GO:0010628; GO:0010629; GO:0016209; GO:0016605; GO:0030336; GO:0031410; GO:0034644; GO:0043065; GO:0045893; GO:0048102; GO:0048147; GO:0071361; GO:0071447; GO:0072703; GO:1904761
1679,Pocillopora_acuta_HIv2___RNAseq.g2138.t1,154.8573574,-0.712602188,1.320868857,7.90E-05,0.000680937,,Q8K2H6,1.81E-82,Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10),anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936],GO:0005680; GO:0005737; GO:0031145; GO:0051301; GO:0070936; GO:0070979; GO:0141198
1680,Pocillopora_acuta_HIv2___RNAseq.g22110.t1,288.5391375,0.555094806,1.23041841,7.92E-05,0.000681761,,NA,NA,NA,NA,NA
1681,Pocillopora_acuta_HIv2___RNAseq.g3645.t1,506.0658262,-0.314103666,1.047577472,7.95E-05,0.000683785,,P51151,4.44E-91,Ras-related protein Rab-9A,"negative regulation by host of symbiont catalytic activity [GO:0052403]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005789; GO:0005829; GO:0005886; GO:0015031; GO:0019003; GO:0030133; GO:0030670; GO:0032482; GO:0032588; GO:0032880; GO:0042147; GO:0042470; GO:0045335; GO:0045921; GO:0052403; GO:0070062
1682,Pocillopora_acuta_HIv2___RNAseq.g700.t1,61.19506575,-0.735415067,1.427452045,7.98E-05,0.000686494,,H2LRU7,9.44E-13,Polycystin-2 (Polycystic kidney disease 2 protein homolog),calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055],GO:0003127; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005789; GO:0005886; GO:0005929; GO:0007166; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662
1683,Pocillopora_acuta_HIv2___RNAseq.g758.t1,3358.459316,2.521384873,0.807327723,7.99E-05,0.000686787,,NA,NA,NA,NA,NA
1684,Pocillopora_acuta_HIv2___RNAseq.g25074.t1,179.0272917,-0.698887994,1.404237906,8.00E-05,0.000686926,,Q14166,1.23E-27,Tubulin--tyrosine ligase-like protein 12 (Inactive tubulin--tyrosine ligase-like protein 12),innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein modification process [GO:0036211]; regulation of mitotic cell cycle [GO:0007346],GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005886; GO:0007346; GO:0015631; GO:0030496; GO:0036211; GO:0045087; GO:0060339; GO:1990889
1685,Pocillopora_acuta_HIv2___RNAseq.g14893.t1,412.7197371,-0.385357631,1.085386918,8.04E-05,0.000689584,,Q6AZN0,7.58E-121,Dynein axonemal assembly factor 4,cilium movement [GO:0003341]; nervous system development [GO:0007399],GO:0003341; GO:0005634; GO:0007399; GO:0043005; GO:0120293
1686,Pocillopora_acuta_HIv2___TS.g800.t1,356.420591,-3.194758958,1.579551251,8.04E-05,0.000689584,,O95185,5.64E-06,Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C),anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; ectopic germ cell programmed cell death [GO:0035234]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental process [GO:0051094]; positive regulation of reproductive process [GO:2000243]; regulation of neuron migration [GO:2001222],GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0019901; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0033564; GO:0035234; GO:0043025; GO:0043065; GO:0045202; GO:0051094; GO:0061643; GO:1990791; GO:2000243; GO:2001222
1687,Pocillopora_acuta_HIv2___RNAseq.g14900.t1,720.4461424,-0.162573094,1.021921168,8.06E-05,0.000690462,,Q9D4F8,0,Gamma-tubulin complex component 4 (GCP-4),cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225],GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005813; GO:0005874; GO:0007020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0055037
1688,Pocillopora_acuta_HIv2___TS.g24030.t1,4457.238894,4.20726748,1.970079768,8.06E-05,0.000690462,,O35136,1.02E-41,Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12),axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155],GO:0007155; GO:0007413; GO:0016604; GO:0030424; GO:0042802; GO:0097060; GO:0098552
1689,Pocillopora_acuta_HIv2___RNAseq.g26200.t1,29175.77434,2.496641966,0.788011795,8.07E-05,0.000691241,Collagen alpha-2(I) chain (Alpha-2 type I collagen),P02466,3.84E-151,Collagen alpha-2(I) chain (Alpha-2 type I collagen),blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096
1690,Pocillopora_acuta_HIv2___RNAseq.g20665.t1,3005.839456,-3.572227054,3.254181899,8.10E-05,0.000693479,,Q09596,7.51E-40,Probable glutathione S-transferase 5 (EC 2.5.1.18) (GST class-sigma),innate immune response [GO:0045087],GO:0004364; GO:0045087
1691,Pocillopora_acuta_HIv2___RNAseq.g7984.t1,463.8739306,-0.602807836,1.20045622,8.11E-05,0.000693873,,O74212,3.72E-146,Acyl-lipid (8-3)-desaturase (EC 1.14.19.30) (Delta(5) fatty acid desaturase) (Delta-5 fatty acid desaturase),long-chain fatty acid biosynthetic process [GO:0042759]; unsaturated fatty acid biosynthetic process [GO:0006636],GO:0006636; GO:0016020; GO:0020037; GO:0042759; GO:0046872; GO:0102866
1692,Pocillopora_acuta_HIv2___TS.g28196.t1,42.20642268,-8.90105832,4.026291721,8.14E-05,0.000695864,,Q1ZXD6,1.41E-17,Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5),signal transduction [GO:0007165]; sorocarp development [GO:0030587],GO:0004672; GO:0004674; GO:0005085; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0007165; GO:0030587; GO:0106310
1693,Pocillopora_acuta_HIv2___RNAseq.g25265.t1,229.9593308,-0.76869807,1.413368779,8.16E-05,0.000697283,,Q5S006,7.24E-14,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-),"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]",GO:0000139; GO:0000287; GO:0001933; GO:0001934; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0005096; GO:0005524; GO:0005525; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0007029; GO:0007030; GO:0007165; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010508; GO:0010738; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031410; GO:0031647; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034614; GO:0035556; GO:0035564; GO:0035641; GO:0035751; GO:0036465; GO:0036479; GO:0040012; GO:0042802; GO:0042803; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051770; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:1900242; GO:1900244; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377
1694,Pocillopora_acuta_HIv2___TS.g1803.t1,495.8603931,-0.286565152,1.060561581,8.22E-05,0.000701493,,Q5R573,1.04E-100,Rab-like protein 2A,regulation of exocytosis [GO:0017157],GO:0003924; GO:0005525; GO:0017157
1695,Pocillopora_acuta_HIv2___RNAseq.g25363.t1a,752.5855754,-0.09776834,1.018271627,8.22E-05,0.000701493,,Q6UX73,1.92E-31,UPF0764 protein C16orf89,,GO:0005829; GO:0016020; GO:0042803; GO:0070062
1696,Pocillopora_acuta_HIv2___TS.g2252.t1,179.0710403,-0.589494738,1.200106447,8.35E-05,0.000711732,,Q96I24,2.47E-08,Far upstream element-binding protein 3 (FUSE-binding protein 3),DNA-templated transcription [GO:0006351]; intracellular mRNA localization [GO:0008298]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0006351; GO:0006357; GO:0008298; GO:0010628; GO:0016020; GO:0043025; GO:0043198; GO:0045893; GO:0045944
1697,Pocillopora_acuta_HIv2___RNAseq.g30377.t2,463.5583433,2.288482563,3.799579434,8.35E-05,0.000712008,Rhodopsin,O15973,9.93E-16,"Rhodopsin, GQ-coupled (GQ-rhodopsin)",cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; visual perception [GO:0007601],GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0071482
1698,Pocillopora_acuta_HIv2___TS.g6039.t1a,315.6115722,-0.207802115,1.03140597,8.41E-05,0.000716471,,Q5RA91,5.20E-52,Transcription initiation factor TFIID subunit 11 (TFIID subunit p30-beta) (Transcription initiation factor TFIID 28 kDa subunit) (TAF(II)28) (TAFII-28) (TAFII28),RNA polymerase II preinitiation complex assembly [GO:0051123],GO:0003713; GO:0005669; GO:0046982; GO:0051123
1699,Pocillopora_acuta_HIv2___RNAseq.g31141.t1,586.6831297,-0.745712502,1.359537816,8.42E-05,0.000716559,,Q9NZ56,2.04E-103,Formin-2,actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],GO:0003779; GO:0005634; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005819; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0015031; GO:0016192; GO:0016477; GO:0030036; GO:0030659; GO:0035556; GO:0040038; GO:0042177; GO:0043066; GO:0046907; GO:0048471; GO:0048477; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781
1700,Pocillopora_acuta_HIv2___RNAseq.g21356.t1,317.2762001,-0.574225555,1.195463773,8.43E-05,0.000717122,,A8E657,0,"Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)]",L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554],GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019878; GO:0033512; GO:0047130; GO:0047131
1701,Pocillopora_acuta_HIv2___RNAseq.8540_t,347.8054316,-0.748118913,1.37234517,8.45E-05,0.000718122,,Q5SPX3,9.49E-41,RING finger protein 215,ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005737; GO:0006511; GO:0016020; GO:0046872; GO:0061630
1702,Pocillopora_acuta_HIv2___RNAseq.g1836.t1,249.8458273,-0.54056562,1.235823315,8.46E-05,0.000718991,,Q5SSK3,8.71E-19,"Transcription elongation factor, mitochondrial",mitochondrial transcription [GO:0006390]; oxidative phosphorylation [GO:0006119]; transcription elongation by mitochondrial RNA polymerase [GO:0006392],GO:0003676; GO:0005759; GO:0006119; GO:0006390; GO:0006392; GO:0030337; GO:0042645; GO:1990904
1703,Pocillopora_acuta_HIv2___RNAseq.g7589.t2,180.9945629,-0.389215054,1.084334652,8.50E-05,0.000721591,,NA,NA,NA,NA,NA
1704,Pocillopora_acuta_HIv2___TS.g10300.t1,391.2877198,-4.238149522,3.128289337,8.52E-05,0.000722841,,Q0P5L5,2.74E-154,Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1),post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158],GO:0005783; GO:0005788; GO:0018158; GO:0043687; GO:0120147; GO:1903135
1705,Pocillopora_acuta_HIv2___TS.g12793.t1,70.0653514,-0.611194752,1.296430191,8.53E-05,0.000723679,,NA,NA,NA,NA,NA
1706,Pocillopora_acuta_HIv2___RNAseq.g15142.t1,228.6463046,-0.314501236,1.055703951,8.54E-05,0.0007243,,Q04841,1.42E-64,DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase),base-excision repair [GO:0006284],GO:0003677; GO:0003905; GO:0005654; GO:0005829; GO:0006284; GO:0008725; GO:0042645; GO:0043916; GO:0052821; GO:0052822
1707,Pocillopora_acuta_HIv2___RNAseq.g23791.t1,589.1883913,-0.289115876,1.05896437,8.56E-05,0.000725589,,Q6NXM2,0,RCC1 and BTB domain-containing protein 1 (Regulator of chromosome condensation and BTB domain-containing protein 1),chromatin organization [GO:0006325],GO:0005634; GO:0005737; GO:0006325
1708,Pocillopora_acuta_HIv2___RNAseq.g14375.t1,4079.040119,3.742598003,2.839329799,8.61E-05,0.000728857,,A6H584,7.12E-09,Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain),cell adhesion [GO:0007155],GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023
1709,Pocillopora_acuta_HIv2___RNAseq.g3566.t1,269.7317197,-0.426233926,1.086593648,8.64E-05,0.000731204,,P79769,1.02E-90,Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO),RNA metabolic process [GO:0016070],GO:0003697; GO:0003723; GO:0004519; GO:0005634; GO:0005737; GO:0016070; GO:0043565
1710,Pocillopora_acuta_HIv2___RNAseq.g4611.t1,213.6083626,-0.58240597,1.274354433,8.67E-05,0.000733386,,Q6GM82,5.17E-162,Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2),2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853
1711,Pocillopora_acuta_HIv2___RNAseq.g21484.t1,343.5322473,0.423919034,1.118486652,8.68E-05,0.000733998,,NA,NA,NA,NA,NA
1712,Pocillopora_acuta_HIv2___RNAseq.g31038.t1,1101.928076,-4.000477892,1.761292379,8.69E-05,0.000734146,,P50549,1.41E-68,ETS translocation variant 1 (Ets-related protein 81),axon guidance [GO:0007411]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0045944; GO:0048935; GO:1990837
1713,Pocillopora_acuta_HIv2___RNAseq.g11459.t1,263.2704507,0.380026971,1.12024333,8.71E-05,0.000735426,,NA,NA,NA,NA,NA
1714,Pocillopora_acuta_HIv2___RNAseq.g8991.t1,100.188364,-0.579712701,1.271202332,8.73E-05,0.000736775,,NA,NA,NA,NA,NA
1715,Pocillopora_acuta_HIv2___RNAseq.g4499.t2,557.2895551,-0.64381375,1.309576572,8.78E-05,0.000740634,,Q9PU85,2.43E-88,Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim),negative regulation of apoptotic process [GO:0043066],GO:0004674; GO:0005524; GO:0005737; GO:0043066; GO:0106310
1716,Pocillopora_acuta_HIv2___RNAseq.g22295.t2,213.5629717,-4.443051777,3.174749439,8.88E-05,0.000748365,,P79942,5.16E-78,Nocturnin (EC 3.1.3.-) (Carbon catabolite repression 4-like protein) (Rhythmic message 1) (RM1),circadian rhythm [GO:0007623]; NADP metabolic process [GO:0006739],GO:0004535; GO:0005634; GO:0005739; GO:0006739; GO:0007623; GO:0019178; GO:0046872; GO:0048471; GO:0102757
1717,Pocillopora_acuta_HIv2___RNAseq.g26657.t1,335.3418861,-0.483515036,1.124038957,9.07E-05,0.000763737,,P07314,9.26E-116,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750
1718,Pocillopora_acuta_HIv2___RNAseq.g16105.t1,278.0157791,-0.700588268,1.281782974,9.11E-05,0.000766966,,Q5XHG1,6.17E-120,Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III),cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; sphingomyelin catabolic process [GO:0006685],GO:0000139; GO:0004767; GO:0005635; GO:0005783; GO:0005789; GO:0006685; GO:0042383; GO:0046513; GO:0046872; GO:0050290; GO:0071356
1719,Pocillopora_acuta_HIv2___TS.g3293.t1,101.7413324,-0.911987206,1.658851486,9.13E-05,0.000767916,,Q9V0D5,7.78E-50,Malate dehydrogenase (EC 1.1.1.37),tricarboxylic acid cycle [GO:0006099],GO:0005737; GO:0006099; GO:0030060
1720,Pocillopora_acuta_HIv2___RNAseq.g21610.t1,717.4975546,-0.583867293,1.19630498,9.13E-05,0.000767916,,Q9BYN7,2.49E-39,Zinc finger protein 341,regulation of DNA-templated transcription [GO:0006355],GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0046872
1721,Pocillopora_acuta_HIv2___RNAseq.g28208.t1,170.1550802,-4.039440927,3.826808357,9.14E-05,0.000768119,,NA,NA,NA,NA,NA
1722,Pocillopora_acuta_HIv2___TS.g4359.t1,185.207156,0.416265337,1.116851258,9.35E-05,0.000785623,,P13590,1.16E-10,Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1),homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic membrane adhesion [GO:0099560],GO:0005886; GO:0007156; GO:0099560
1723,Pocillopora_acuta_HIv2___RNAseq.g29419.t1,310.3205049,-0.227149762,1.03758773,9.38E-05,0.000787092,,Q09199,1.28E-08,"Beta-1,4 N-acetylgalactosaminyltransferase 2 (EC 2.4.1.-)",lipid glycosylation [GO:0030259]; negative regulation of cell-cell adhesion [GO:0022408]; protein glycosylation [GO:0006486]; protein import [GO:0017038]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue regeneration [GO:0043403]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]; UDP-N-acetylglucosamine metabolic process [GO:0006047],GO:0000139; GO:0006047; GO:0006486; GO:0008376; GO:0017038; GO:0019276; GO:0022408; GO:0030259; GO:0043403; GO:0098528
1724,Pocillopora_acuta_HIv2___RNAseq.g13558.t1,126.3407652,-0.209326691,1.045482152,9.43E-05,0.00079097,,NA,NA,NA,NA,NA
1725,Pocillopora_acuta_HIv2___RNAseq.g28633.t1,60.10904752,-0.268134463,1.071766516,9.44E-05,0.000791366,,NA,NA,NA,NA,NA
1726,Pocillopora_acuta_HIv2___RNAseq.g25886.t1,285.7223857,0.095468962,1.023527549,9.47E-05,0.00079361,Solute carrier family 22 member 15,Q8IZD6,1.48E-57,Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1),amino acid transport [GO:0006865]; monoatomic ion transport [GO:0006811],GO:0005886; GO:0006811; GO:0006865; GO:0015199
1727,Pocillopora_acuta_HIv2___RNAseq.g4846.t1,430.3330564,-0.367784693,1.088484802,9.48E-05,0.000793941,,P41044,8.97E-58,Calbindin-32,regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509],GO:0005509; GO:0005634; GO:0005829; GO:0030425; GO:0043195; GO:0045202; GO:0061175; GO:0097467; GO:0099509; GO:1900271
1728,Pocillopora_acuta_HIv2___RNAseq.g14011.t1,440.4551826,-0.312467394,1.069448116,9.51E-05,0.000796069,,Q8R2K4,4.36E-114,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha),positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; RNA polymerase II preinitiation complex assembly [GO:0051123],GO:0000124; GO:0003713; GO:0005634; GO:0005669; GO:0006282; GO:0006355; GO:0016251; GO:0043484; GO:0045893; GO:0046695; GO:0046982; GO:0051123; GO:1904672
1729,Pocillopora_acuta_HIv2___RNAseq.g7176.t1,171.1950954,-0.505596808,1.130443251,9.53E-05,0.000797295,,Q7Z6M1,6.47E-101,Rab9 effector protein with kelch motifs (40 kDa Rab9 effector protein) (p40),receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904],GO:0005768; GO:0005829; GO:0006898; GO:0006904; GO:0010008; GO:0030133; GO:0032588; GO:0043231
1730,Pocillopora_acuta_HIv2___TS.g2284.t1,308.7487307,-0.155879768,1.021414083,9.56E-05,0.000799238,,A7RK30,8.85E-171,Quinone oxidoreductase-like protein 2 homolog (EC 1.-.-.-),,GO:0016491
1731,Pocillopora_acuta_HIv2___RNAseq.g10158.t1,1479.444567,-3.132213687,3.978901512,9.62E-05,0.000803614,,Q812E0,2.04E-137,Cytoplasmic polyadenylation element-binding protein 2 (CPE-BP2) (CPE-binding protein 2) (mCPEB-2),"cellular response to arsenic-containing substance [GO:0071243]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of translational elongation [GO:0045900]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]",GO:0000900; GO:0003730; GO:0005095; GO:0005634; GO:0005737; GO:0005840; GO:0008135; GO:0008187; GO:0032869; GO:0034599; GO:0035925; GO:0043005; GO:0043022; GO:0043023; GO:0043024; GO:0045202; GO:0045900; GO:0071243; GO:0071456; GO:0098978; GO:0099547; GO:1900248; GO:1990124; GO:2000766
1732,Pocillopora_acuta_HIv2___RNAseq.g6588.t1,536.9655598,-0.311399502,1.069166724,9.66E-05,0.0008064,,Q6ZMT4,2.29E-175,Lysine-specific demethylase 7A (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7) ([histone H3]-dimethyl-L-lysine9 demethylase 7A) (EC 1.14.11.65),midbrain development [GO:0030901]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016706; GO:0030901; GO:0032452; GO:0032454; GO:0035064; GO:0035575; GO:0045893; GO:0051864; GO:0071558; GO:0140683
1733,Pocillopora_acuta_HIv2___RNAseq.g10095.t1,589.8206745,0.586953787,1.268993651,9.73E-05,0.000812304,,NA,NA,NA,NA,NA
1734,Pocillopora_acuta_HIv2___RNAseq.g16095.t1,188.2824243,-3.651206302,2.764643887,9.76E-05,0.000814135,,P86733,5.24E-23,BPTI/Kunitz domain-containing protein,,GO:0004867; GO:0005576; GO:0005615
1735,Pocillopora_acuta_HIv2___RNAseq.g11232.t1,72.99496799,-0.923338945,1.676362008,9.79E-05,0.000816047,,Q9QUN9,4.04E-08,Dickkopf-related protein 3 (Dickkopf-3) (Dkk-3) (mDkk-3),adrenal gland development [GO:0030325]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of DNA-templated transcription [GO:0045892]; Wnt signaling pathway [GO:0016055],GO:0005576; GO:0005615; GO:0016055; GO:0030325; GO:0032348; GO:0039706; GO:0045892; GO:0048019; GO:0090090; GO:2000065
1736,Pocillopora_acuta_HIv2___RNAseq.g26340.t1,1514.872065,-3.088607418,2.972637676,9.84E-05,0.000820203,,Q8WPW2,3.90E-154,Pyridoxal 5'-phosphate synthase subunit SNZERR (PLP synthase subunit SNZERR) (EC 4.3.3.6) (Ethylene response protein) (PDX1),amino acid metabolic process [GO:0006520]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615],GO:0006520; GO:0008615; GO:0036381; GO:0042823
1737,Pocillopora_acuta_HIv2___RNAseq.g21571.t1,301.558258,-0.357758884,1.090927824,9.86E-05,0.000821033,,Q16445,8.56E-39,Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) (GABAAR subunit alpha-6),"chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]",GO:0004890; GO:0005886; GO:0007165; GO:0007214; GO:0008503; GO:0022851; GO:0032590; GO:0034707; GO:0043005; GO:0045202; GO:0051932; GO:0060078; GO:0098794; GO:0099192; GO:0099634; GO:1902476; GO:1902495; GO:1902711; GO:1904315; GO:1904862
1738,Pocillopora_acuta_HIv2___RNAseq.g21204.t1,462.5525316,-0.536859569,1.211877275,9.90E-05,0.000824011,,Q19425,7.83E-138,Sodium-coupled neutral amino acid transporter 9 homolog,amino acid transmembrane transport [GO:0003333],GO:0003333; GO:0005765; GO:0015179; GO:0031902; GO:0046872
1739,Pocillopora_acuta_HIv2___RNAseq.g24353.t1,120.7470053,3.653507813,1.745329293,9.98E-05,0.000830029,,NA,NA,NA,NA,NA
1740,Pocillopora_acuta_HIv2___RNAseq.g12044.t1,219.0321555,-0.385066377,1.068700176,9.99E-05,0.000830029,,Q7ZTI5,3.10E-46,Mediator of RNA polymerase II transcription subunit 21 (Mediator complex subunit 21) (RNA polymerase II holoenzyme component SRB7) (RNAPII complex component SRB7),regulation of transcription by RNA polymerase II [GO:0006357],GO:0003712; GO:0006357; GO:0016592
1741,Pocillopora_acuta_HIv2___RNAseq.g16804.t1,391.761712,-0.270882037,1.036690734,0.00010012,0.000831787,,Q8VI36,9.86E-160,Paxillin,branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; positive regulation of angiogenesis [GO:0045766]; regulation of cell shape [GO:0008360]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0005078; GO:0005178; GO:0005856; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008360; GO:0016477; GO:0019901; GO:0030027; GO:0030032; GO:0030159; GO:0031252; GO:0034446; GO:0038191; GO:0043542; GO:0044877; GO:0045766; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:1901652
1742,Pocillopora_acuta_HIv2___TS.g3312.t1,434.7445373,-0.372395764,1.073626582,0.000100546,0.000834846,,O75038,1.34E-180,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)",lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209],GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209
1743,Pocillopora_acuta_HIv2___RNAseq.g4386.t1,357.1962909,-0.222861135,1.030315209,0.000100868,0.000837035,,Q6GQN0,2.13E-90,Centrosomal protein of 41 kDa (Cep41) (Testis-specific gene A14 protein),angiogenesis [GO:0001525]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; neural crest cell migration [GO:0001755]; protein polyglutamylation [GO:0018095]; protein transport [GO:0015031],GO:0001525; GO:0001755; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0015031; GO:0018095; GO:0035082; GO:0036064; GO:0060271; GO:0070740
1744,Pocillopora_acuta_HIv2___TS.g16902.t2,226.5354816,0.235696152,1.037404862,0.000101109,0.000838552,,Q5BJQ5,2.21E-33,GTP-binding protein Rit2 (EC 3.6.5.2),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; regulation of protein phosphorylation [GO:0001932],GO:0001932; GO:0003682; GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007189; GO:0007265; GO:0010976; GO:0010977; GO:0019003; GO:0030100; GO:0030215; GO:0032489; GO:0032507; GO:0035556; GO:0043005; GO:0043410; GO:0044297; GO:0045121; GO:0045944; GO:0050848; GO:0097447
1745,Pocillopora_acuta_HIv2___RNAseq.g24133.t1,35.30655355,0.75529779,1.439548697,0.000101418,0.000840632,,Q60767,2.20E-09,Lymphocyte antigen 75 (Ly-75) (DEC-205) (CD antigen CD205),endocytosis [GO:0006897],GO:0006897; GO:0009897; GO:0030246; GO:0038023
1746,Pocillopora_acuta_HIv2___RNAseq.g4031.t1c,874.9003952,-1.425046716,2.207416142,0.000101565,0.00084137,,Q5R4J5,3.68E-42,Synaptotagmin-1 (Synaptotagmin I) (SytI),calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488],GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0019905; GO:0030154; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0042584; GO:0048488; GO:0048791; GO:0071277; GO:1903235
1747,Pocillopora_acuta_HIv2___RNAseq.g17053.t1,1087.582151,-0.528117131,1.142598429,0.000101935,0.000843952,,Q5QNQ6,1.55E-166,Oxysterol-binding protein 2,lipid transport [GO:0006869]; spermatid development [GO:0007286],GO:0001669; GO:0005829; GO:0005886; GO:0006869; GO:0007286; GO:0015485; GO:0097038; GO:0097440
1748,Pocillopora_acuta_HIv2___RNAseq.g25220.t1,179.7326808,-0.814527961,1.415887665,0.000102118,0.000844983,Sacsin,Q9NZJ4,0,Sacsin (DnaJ homolog subfamily C member 29),negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084
1749,Pocillopora_acuta_HIv2___RNAseq.g17517.t1,1733.32183,3.981522603,1.948526917,0.000102655,0.000848528,,Q9VBW3,2.87E-73,Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14),calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060],GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303
1750,Pocillopora_acuta_HIv2___TS.g25104.t1,221.0959101,-0.425763924,1.133331481,0.000102708,0.000848528,,Q6PEH9,5.64E-77,Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10),epiboly involved in gastrulation with mouth forming second [GO:0055113]; epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; response to zinc ion [GO:0010043]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829],GO:0001837; GO:0005385; GO:0005886; GO:0006829; GO:0010043; GO:0016324; GO:0030003; GO:0055113; GO:0071578; GO:0140410
1751,Pocillopora_acuta_HIv2___TS.g16941.t1,108.8561397,-1.402016883,2.355307703,0.000102768,0.000848528,,NA,NA,NA,NA,NA
1752,Pocillopora_acuta_HIv2___RNAseq.g19325.t1,242.8905441,-1.077477934,1.869264189,0.000102781,0.000848528,,Q567I9,3.97E-109,Cytochrome b5 domain-containing protein 1,cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356],GO:0003341; GO:0003356; GO:0005737; GO:0005856; GO:0042995; GO:0046872
1753,Pocillopora_acuta_HIv2___TS.g1166.t1,112.9418283,0.371061091,1.117777521,0.000102858,0.000848681,,B5X186,4.45E-26,Calumenin-A,,GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470
1754,Pocillopora_acuta_HIv2___RNAseq.g13877.t1,169.2361308,-1.144893173,2.042462911,0.000102928,0.000848773,,A0JPQ7,4.86E-29,Uncharacterized protein C19orf47 homolog,,GO:0005634
1755,Pocillopora_acuta_HIv2___RNAseq.g28215.t1,206.5525918,-0.336926016,1.05981014,0.000103175,0.000850324,,Q20191,2.05E-33,Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13),proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008270
1756,Pocillopora_acuta_HIv2___RNAseq.g18205.t1,60.1676414,-0.687099509,1.372093093,0.000103657,0.000853811,,NA,NA,NA,NA,NA
1757,Pocillopora_acuta_HIv2___TS.g7278.t1,68.85187424,1.562083245,2.915774485,0.000103718,0.000853829,,Q9Y4B6,1.28E-18,DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein),B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151],GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756
1758,Pocillopora_acuta_HIv2___RNAseq.g6896.t1,870.1717207,-3.50754417,2.756123085,0.000104319,0.000857955,,Q5BK26,0,Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5) (Liver NTE-related protein 1) (NTE-related esterase),phosphatidylcholine catabolic process [GO:0034638],GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0034638
1759,Pocillopora_acuta_HIv2___RNAseq.g30099.t1,107.8086393,-0.816100067,1.451744603,0.000104338,0.000857955,,Q8NB91,2.71E-18,Fanconi anemia group B protein (Protein FACB) (Fanconi anemia-associated polypeptide of 95 kDa) (FAAP95),interstrand cross-link repair [GO:0036297]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414],GO:0000785; GO:0005654; GO:0005829; GO:0036297; GO:0043240; GO:1905168; GO:1990414; GO:2000042
1760,Pocillopora_acuta_HIv2___RNAseq.g24322.t1,417.0214214,-0.204041949,1.031099045,0.000104501,0.000858804,,NA,NA,NA,NA,NA
1761,Pocillopora_acuta_HIv2___RNAseq.g10957.t1,385.7045181,-0.268765108,1.036966627,0.000105521,0.000866608,DnaJ homolog subfamily B member 2,Q9QYI5,6.81E-39,DnaJ homolog subfamily B member 2 (DnaJ homolog subfamily B member 10) (mDj8),chaperone-mediated protein folding [GO:0061077]; ERAD pathway [GO:0036503]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein ubiquitination [GO:0031396],GO:0001671; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0008285; GO:0030308; GO:0030544; GO:0031396; GO:0031593; GO:0031965; GO:0032436; GO:0032781; GO:0036503; GO:0042026; GO:0043130; GO:0043161; GO:0051082; GO:0061077; GO:0090084; GO:0140036; GO:1903644
1762,Pocillopora_acuta_HIv2___RNAseq.g1970.t1,1578.776478,2.323672239,3.374547604,0.00010557,0.000866608,Skeletal aspartic acid-rich protein 1 (CARP 4),B3EWY6,3.20E-87,Skeletal aspartic acid-rich protein 1,,GO:0005576
1763,Pocillopora_acuta_HIv2___RNAseq.g8795.t1,354.4396688,0.079743598,1.021617373,0.00010621,0.000871369,,Q9DC33,5.13E-103,High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein HMGX1) (Inhibitor of BRAF35) (iBRAF),chromatin organization [GO:0006325]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468],GO:0000122; GO:0003677; GO:0005634; GO:0006325; GO:0010468; GO:0033234; GO:0042802; GO:0045665
1764,Pocillopora_acuta_HIv2___RNAseq.g21536.t1,292.092284,-0.421876626,1.129034019,0.000106779,0.000875539,,Q9BU79,6.76E-36,Transmembrane protein 243 (MDR1- and mitochondrial taxol resistance-associated protein) (MM-TRAG),,GO:0016020
1765,Pocillopora_acuta_HIv2___RNAseq.g25323.t1,350.8258434,-0.329789129,1.07663561,0.000107285,0.000879193,,Q5R4K6,4.22E-11,Pleckstrin homology domain-containing family B member 2 (PH domain-containing family B member 2) (Evectin-2),regulation of cell differentiation [GO:0045595],GO:0045595; GO:0055038
1766,Pocillopora_acuta_HIv2___RNAseq.g29599.t1,223.2918328,-0.330238233,1.093854243,0.000107943,0.000884077,,Q5ZKJ5,5.74E-66,Transmembrane protein 180 (Major facilitator superfamily domain-containing 13A),,GO:0005886
1767,Pocillopora_acuta_HIv2___TS.g12130.t1,243.1154523,-0.296557015,1.046072586,0.000108486,0.00088803,,NA,NA,NA,NA,NA
1768,Pocillopora_acuta_HIv2___RNAseq.g25625.t1,170.5621197,-0.674702065,1.298562708,0.000108844,0.000890454,,NA,NA,NA,NA,NA
1769,Pocillopora_acuta_HIv2___TS.g24066.t1,6081.759582,2.272364676,0.712818521,0.000109711,0.000896981,,P27393,8.24E-154,Collagen alpha-2(IV) chain,extracellular matrix organization [GO:0030198],GO:0005581; GO:0005604; GO:0005615; GO:0030020; GO:0030198
1770,Pocillopora_acuta_HIv2___RNAseq.g7754.t1,235.0636848,-1.012013633,1.708373994,0.000109766,0.000896981,,NA,NA,NA,NA,NA
1771,Pocillopora_acuta_HIv2___RNAseq.g14354.t1,755.0494834,3.233674244,4.945037201,0.000110161,0.000899703,,NA,NA,NA,NA,NA
1772,Pocillopora_acuta_HIv2___RNAseq.g30565.t1,41.69783104,-5.907943103,3.507079191,0.000111231,0.00090793,,Q96DX5,7.26E-34,Ankyrin repeat and SOCS box protein 9 (ASB-9),intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005739; GO:0005829; GO:0016567; GO:0031466; GO:0035556; GO:0043161; GO:0045732; GO:1990756
1773,Pocillopora_acuta_HIv2___RNAseq.g18426.t1,629.9885739,-0.279294953,1.036918466,0.000111713,0.000911343,,NA,NA,NA,NA,NA
1774,Pocillopora_acuta_HIv2___TS.g25081.t1,679.7583093,-0.202010698,1.027990248,0.000112351,0.000916035,,Q95R48,3.19E-84,Organic cation transporter-like protein,monoatomic ion transport [GO:0006811]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018],GO:0006811; GO:0015101; GO:0015695; GO:0016020; GO:0030307; GO:0040018
1775,Pocillopora_acuta_HIv2___RNAseq.g27333.t1,260.4173032,-0.150311821,1.025672468,0.00011244,0.000916244,,P04274,1.17E-13,Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor),adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; diet induced thermogenesis [GO:0002024]; heat generation [GO:0031649]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366],GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0004941; GO:0005634; GO:0005769; GO:0005794; GO:0006366; GO:0006898; GO:0006939; GO:0008179; GO:0009409; GO:0010739; GO:0015459; GO:0016324; GO:0030501; GO:0031649; GO:0040015; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045453; GO:0045744; GO:0045944; GO:0045986; GO:0050873; GO:0051380; GO:0061885; GO:0071880; GO:0098992; GO:0120162; GO:1901098; GO:1904504; GO:1904646
1776,Pocillopora_acuta_HIv2___TS.g25584.t1,120.8397473,1.065178551,1.79800082,0.000112503,0.000916244,,Q7Z407,1.85E-20,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),regulation of dendrite development [GO:0050773],GO:0005886; GO:0050773
1777,Pocillopora_acuta_HIv2___RNAseq.g24149.t1,546.264484,-0.245322844,1.031720238,0.000113849,0.000926678,,Q96N46,9.05E-67,Tetratricopeptide repeat protein 14 (TPR repeat protein 14),,GO:0003676
1778,Pocillopora_acuta_HIv2___RNAseq.g7537.t1,319.2941703,-0.458988346,1.153198143,0.000114261,0.00092909,,NA,NA,NA,NA,NA
1779,Pocillopora_acuta_HIv2___RNAseq.g12376.t1,1045.73786,3.754533415,1.765689142,0.000114324,0.00092909,,H9JW44,5.86E-96,Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41),chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0046872
1780,Pocillopora_acuta_HIv2___RNAseq.g12049.t1,62.89910785,-1.035468165,1.913780046,0.000114338,0.00092909,,P00389,0,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),response to hormone [GO:0009725],GO:0003958; GO:0005789; GO:0005829; GO:0009725; GO:0010181; GO:0050660; GO:0050661
1781,Pocillopora_acuta_HIv2___RNAseq.g4961.t1,482.9847452,-0.332506138,1.077352791,0.000114898,0.000933019,,Q2T9W1,1.56E-23,Sorting nexin-20,protein transport [GO:0015031],GO:0005546; GO:0005634; GO:0005886; GO:0015031; GO:0031901; GO:0032266; GO:1901981
1782,Pocillopora_acuta_HIv2___RNAseq.g6986.t1,307.8214664,-0.733584841,1.391481493,0.00011495,0.000933019,,Q7Z2Z2,0,Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A),cytosolic ribosome assembly [GO:0042256]; GTP metabolic process [GO:0046039],GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0042256; GO:0043022; GO:0046039; GO:1990904
1783,Pocillopora_acuta_HIv2___RNAseq.g11725.t1,304.7160167,-0.419843589,1.126517535,0.000115474,0.000936744,,Q8NCR3,3.14E-79,Protein MFI (Mitochondrial fission factor interactor),negative regulation of mitochondrial fission [GO:0090258]; negative regulation of protein targeting to mitochondrion [GO:1903215],GO:0005741; GO:0005829; GO:0090258; GO:1903215
1784,Pocillopora_acuta_HIv2___RNAseq.g28066.t1,634.711732,-0.518584841,1.137027268,0.000116141,0.00094163,,G5EBX9,0,Serine/threonine-protein phosphatase with EF-hands pef-1 (CePPEF) (EC 3.1.3.16) (Phosphatase with EF hands 1),detection of stimulus involved in sensory perception [GO:0050906],GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0017018; GO:0030145; GO:0030424; GO:0030425; GO:0043025; GO:0043204; GO:0050906
1785,Pocillopora_acuta_HIv2___TS.g16747.t2,315.0729451,-0.204102125,1.032330241,0.000116428,0.000943426,,Q6ZUG5,5.47E-100,Uncharacterized protein FLJ43738,,
1786,Pocillopora_acuta_HIv2___TS.g8679.t1,382.0523413,-0.71405652,1.306967155,0.00011682,0.000946075,,O75123,5.86E-48,Zinc finger protein 623,regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872
1787,Pocillopora_acuta_HIv2___TS.g6827.t1,324.1351629,-0.374458807,1.073702398,0.000119191,0.000964501,,NA,NA,NA,NA,NA
1788,Pocillopora_acuta_HIv2___RNAseq.g17564.t1,708.2727843,-0.708528097,1.28599516,0.000119229,0.000964501,,Q8BLJ3,1.01E-63,PI-PLC X domain-containing protein 3,lipid catabolic process [GO:0016042]; signal transduction [GO:0007165],GO:0005737; GO:0007165; GO:0008081; GO:0016042; GO:0045202; GO:0098978
1789,Pocillopora_acuta_HIv2___RNAseq.g610.t1,104.2539153,-0.991772465,1.727426955,0.000119321,0.000964707,,Q05609,7.44E-21,Serine/threonine-protein kinase CTR1 (EC 2.7.11.1) (Protein CONSTITUTIVE TRIPLE RESPONSE1),ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182],GO:0001666; GO:0004674; GO:0004712; GO:0005524; GO:0005789; GO:0009686; GO:0009723; GO:0009744; GO:0009750; GO:0009873; GO:0010105; GO:0010182; GO:0046777; GO:0048510; GO:0106310; GO:2000035; GO:2000069
1790,Pocillopora_acuta_HIv2___RNAseq.g26670.t1,337.1738457,-0.437037995,1.129756359,0.000120537,0.000973996,,Q9I8C7,1.76E-78,Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10),,GO:0004888; GO:0005262; GO:0005886; GO:0022848; GO:0043005; GO:0045202; GO:0045211; GO:1902495
1791,Pocillopora_acuta_HIv2___TS.g15832.t1,7865.302784,2.469208006,0.827823818,0.000121364,0.000980131,Collagen alpha-2(I) chain (Alpha-2 type I collagen),P02466,7.07E-153,Collagen alpha-2(I) chain (Alpha-2 type I collagen),blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096
1792,Pocillopora_acuta_HIv2___RNAseq.g28024.t1,222.0491219,-0.717999303,1.321465721,0.000121448,0.000980259,,NA,NA,NA,NA,NA
1793,Pocillopora_acuta_HIv2___RNAseq.g9932.t1,236.1625552,0.557516858,1.235968948,0.000122038,0.000984468,Toll-like receptor 2,Q689D1,2.51E-06,Toll-like receptor 2 (CD antigen CD282),cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224],GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0038023; GO:0042497; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727
1794,Pocillopora_acuta_HIv2___RNAseq.g12731.t1,476.1373035,0.252826406,1.042839827,0.000122724,0.000989455,,Q08CL3,3.00E-23,Kelch repeat and BTB domain-containing protein 8 (T-cell activation kelch repeat protein) (TA-KRP),neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417],GO:0005794; GO:0005819; GO:0006417; GO:0006513; GO:0014029; GO:0014032; GO:0031463
1795,Pocillopora_acuta_HIv2___RNAseq.g26059.t1,333.1043935,-0.307042537,1.067919343,0.000122897,0.00098975,,Q6DCC6,3.32E-121,Putative GTP-binding protein 6,,GO:0005525; GO:0046872
1796,Pocillopora_acuta_HIv2___RNAseq.g8876.t1,28.73302484,-8.543047217,3.685030818,0.000122898,0.00098975,Homeobox protein not2 (Xnot-2),Q91770,1.98E-20,Homeobox protein not2 (Xnot-2) (Xnot2),negative regulation of DNA-templated transcription [GO:0045892]; notochord formation [GO:0014028],GO:0000981; GO:0003677; GO:0005634; GO:0014028; GO:0045892
1797,Pocillopora_acuta_HIv2___RNAseq.g6449.t1,391.5526894,-0.334703277,1.07856115,0.000123397,0.000993217,,P51612,5.28E-155,DNA repair protein complementing XP-C cells homolog (Xeroderma pigmentosum group C-complementing protein homolog) (p125),DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of gluconeogenesis [GO:0045721]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA-templated transcription [GO:0045893]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to auditory stimulus [GO:0010996]; response to UV-B [GO:0010224]; response to xenobiotic stimulus [GO:0009410]; UV-damage excision repair [GO:0070914],GO:0000109; GO:0000111; GO:0000720; GO:0003684; GO:0003697; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006281; GO:0006289; GO:0006298; GO:0006974; GO:0009410; GO:0010224; GO:0010996; GO:0031573; GO:0044877; GO:0045721; GO:0045893; GO:0061629; GO:0070914; GO:0071942; GO:0090734; GO:0140612; GO:1901990
1798,Pocillopora_acuta_HIv2___RNAseq.g16817.t1,270.5878299,-0.337632854,1.055490814,0.000123693,0.000995049,Toll-like receptor 6,Q9Y2C9,1.57E-14,Toll-like receptor 6 (CD antigen CD286),activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; nitric oxide metabolic process [GO:0046209]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],GO:0001540; GO:0001774; GO:0002224; GO:0002755; GO:0004888; GO:0005102; GO:0005794; GO:0005886; GO:0006954; GO:0006955; GO:0007165; GO:0007250; GO:0010628; GO:0030670; GO:0032717; GO:0032731; GO:0032755; GO:0034136; GO:0035355; GO:0035663; GO:0035666; GO:0038023; GO:0038124; GO:0042496; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043507; GO:0045087; GO:0045121; GO:0045429; GO:0046209; GO:0046982; GO:0061809; GO:0071723; GO:0071726; GO:0140052; GO:1900017; GO:1900227; GO:1903428; GO:1904646; GO:2001238
1799,Pocillopora_acuta_HIv2___RNAseq.g8587.t1,456.7612464,2.772786052,3.820139178,0.000123916,0.000996288,,Q19269,2.14E-45,Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14),proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008270
1800,Pocillopora_acuta_HIv2___RNAseq.g8670.t1,5976.079673,3.198283256,1.327508332,0.000124508,0.001000319,,P02752,1.20E-55,"Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form]",negative regulation of sensory perception of bitter taste [GO:1904661]; negative regulation of sensory perception of sweet taste [GO:1904657]; riboflavin transport [GO:0032218],GO:0009897; GO:0032217; GO:0032218; GO:0038023; GO:1902444; GO:1904657; GO:1904661
1801,Pocillopora_acuta_HIv2___RNAseq.g6972.t1,41.9246463,-5.793861716,3.656733787,0.000124556,0.001000319,,NA,NA,NA,NA,NA
1802,Pocillopora_acuta_HIv2___RNAseq.g2626.t1,237.0413662,5.690513028,2.267624291,0.000124638,0.001000427,,NA,NA,NA,NA,NA
1803,Pocillopora_acuta_HIv2___RNAseq.g28727.t1,51.67165515,-0.267563448,1.071961032,0.000124872,0.001001186,,Q5ZLG1,3.84E-87,Ras-related protein Rab-18,brain development [GO:0007420]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389],GO:0001654; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0005811; GO:0006886; GO:0007420; GO:0012505; GO:0016324; GO:0019003; GO:0034389
1804,Pocillopora_acuta_HIv2___RNAseq.g8551.t1,320.8631487,-0.278884205,1.067344804,0.000124899,0.001001186,,NA,NA,NA,NA,NA
1805,Pocillopora_acuta_HIv2___RNAseq.g15885.t1,54.51001779,-5.757604442,2.894761416,0.000124959,0.001001186,,Q15649,3.56E-26,Zinc finger HIT domain-containing protein 3 (HNF-4a coactivator) (Thyroid hormone receptor interactor 3) (Thyroid receptor-interacting protein 3) (TR-interacting protein 3) (TRIP-3),"box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of DNA-templated transcription [GO:0006355]; snoRNA localization [GO:0048254]",GO:0000463; GO:0000492; GO:0005634; GO:0005737; GO:0006355; GO:0046872; GO:0046966; GO:0048254; GO:0070761
1806,Pocillopora_acuta_HIv2___RNAseq.g14865.t1,374.8444523,-0.578379032,1.242572489,0.00012501,0.001001186,,NA,NA,NA,NA,NA
1807,Pocillopora_acuta_HIv2___RNAseq.g15236.t1,339.4080544,3.80130781,2.334250606,0.000125236,0.001002439,,Q2TBT8,6.44E-19,RING finger protein 151,protein ubiquitination [GO:0016567],GO:0008270; GO:0016567; GO:0061630
1808,Pocillopora_acuta_HIv2___TS.g21851.t1,477.3737453,0.384682848,1.095466887,0.000125883,0.001007062,,NA,NA,NA,NA,NA
1809,Pocillopora_acuta_HIv2___RNAseq.g25717.t1,185.4884299,-0.900082593,1.53258337,0.000126263,0.001009545,Mucin-like protein,B3EWY9,0,Mucin-like protein,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005615; GO:0007160; GO:0016020
1810,Pocillopora_acuta_HIv2___RNAseq.g26979.t1,16227.09302,2.278733151,0.72400632,0.00012732,0.001017435,,P83205,3.33E-135,Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain],cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590],GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090
1811,Pocillopora_acuta_HIv2___TS.g27114.t1a,169.6014533,-0.192369735,1.021882683,0.000129015,0.001030413,,Q4V7Q8,8.93E-17,Transmembrane protein 220,,GO:0016020
1812,Pocillopora_acuta_HIv2___RNAseq.g30085.t1,356.1171209,0.584296729,1.266323221,0.000129459,0.001033383,,A0A2J6RX17,6.53E-06,Nucleotide-binding leucine-rich repeat (NLR)-like protein (EC 3.5.99.-),nucleoside metabolic process [GO:0009116],GO:0009116; GO:0016787; GO:0043531
1813,Pocillopora_acuta_HIv2___RNAseq.g12797.t1,419.9741417,-0.316206451,1.050525865,0.000130772,0.001042827,,Q5ZHV2,0,"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Protein MAK10 homolog)",negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659],GO:0005737; GO:0031417; GO:0043066; GO:0048659
1814,Pocillopora_acuta_HIv2___RNAseq.g7248.t1,34.8871882,-8.607142655,3.920590177,0.000130837,0.001042827,,Q8WU66,9.09E-34,Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR),hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505],GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170
1815,Pocillopora_acuta_HIv2___RNAseq.g26700.t1,3564.825125,-2.851097043,1.082807614,0.000130858,0.001042827,,E9PUL5,2.16E-08,Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3),negative regulation of short-term synaptic potentiation [GO:1905513]; negative regulation of SNARE complex assembly [GO:0035544]; neuromuscular process controlling posture [GO:0050884]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629],GO:0005886; GO:0008021; GO:0016020; GO:0017075; GO:0017124; GO:0030672; GO:0031629; GO:0031982; GO:0035544; GO:0042734; GO:0043005; GO:0043197; GO:0043679; GO:0050884; GO:0098793; GO:0098839; GO:0098978; GO:0150037; GO:1905513
1816,Pocillopora_acuta_HIv2___RNAseq.g28803.t1b,11712.52697,2.240466621,0.710158676,0.000131086,0.001044067,Collagen alpha-2(I) chain (Alpha-2 type I collagen),P02466,4.64E-152,Collagen alpha-2(I) chain (Alpha-2 type I collagen),blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096
1817,Pocillopora_acuta_HIv2___TS.g7149.t2,312.848616,-2.390343439,3.577163907,0.000132068,0.00105131,,Q8CDT7,1.55E-28,Ciliary-associated calcium-binding coiled-coil protein 1,,GO:0005509; GO:0005737; GO:0005813; GO:0036126
1818,Pocillopora_acuta_HIv2___RNAseq.g11561.t1,274.3079939,-0.145420087,1.018140331,0.000132775,0.001056359,,Q6P2H3,1.96E-47,Centrosomal protein of 85 kDa (Cep85) (Coiled-coil domain-containing protein 21),cell migration [GO:0016477]; centriole assembly [GO:0098534]; centriole replication [GO:0007099]; chromosome segregation [GO:0007059]; negative regulation of protein kinase activity [GO:0006469]; regulation of mitotic centrosome separation [GO:0046602],GO:0000242; GO:0000922; GO:0005730; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005938; GO:0006469; GO:0007059; GO:0007099; GO:0016477; GO:0042802; GO:0046602; GO:0098534
1819,Pocillopora_acuta_HIv2___RNAseq.g4885.t1,56.91872047,-0.701797429,1.381180397,0.000133164,0.001058871,,NA,NA,NA,NA,NA
1820,Pocillopora_acuta_HIv2___RNAseq.g7645.t1,1667.130172,-3.744851896,1.729302353,0.000134038,0.001064743,,Q9BYK8,0,"3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein)",positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194],GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008859; GO:0016020; GO:0016887; GO:0030374; GO:0035194; GO:0043186; GO:0045944; GO:0046872
1821,Pocillopora_acuta_HIv2___RNAseq.g6843.t1,112.9376764,-0.602923266,1.261993448,0.000134138,0.001064743,,Q5R752,6.47E-09,Nuclear RNA export factor 1,mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973],GO:0003723; GO:0005634; GO:0005737; GO:0006406; GO:0016607; GO:0016973
1822,Pocillopora_acuta_HIv2___RNAseq.g20575.t1,171.4287044,0.364545981,1.111130258,0.000134234,0.001064743,,Q92626,9.24E-24,Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment],angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825
1823,Pocillopora_acuta_HIv2___RNAseq.g29607.t1,425.4450066,-0.401490071,1.068151442,0.000134249,0.001064743,,Q08D69,6.60E-138,Mediator of RNA polymerase II transcription subunit 16 (Mediator complex subunit 16),,GO:0016592
1824,Pocillopora_acuta_HIv2___RNAseq.g11841.t1,231.7885874,-0.391077297,1.107267705,0.000134271,0.001064743,,Q9BY27,1.02E-42,Protein DGCR6L (DiGeorge syndrome critical region 6-like protein),,GO:0005634
1825,Pocillopora_acuta_HIv2___TS.g2197.t1,567.4944008,-0.339866078,1.050699332,0.000134645,0.00106713,,NA,NA,NA,NA,NA
1826,Pocillopora_acuta_HIv2___TS.g2537.t1,171.0127244,-0.255654553,1.051600119,0.00013486,0.001068247,,A0JNG0,2.85E-128,Transmembrane protein 168,,GO:0017080; GO:0031965
1827,Pocillopora_acuta_HIv2___RNAseq.g10777.t1,187.4550841,-1.132423586,1.916725809,0.000135481,0.001072576,,Q8CAQ8,1.39E-70,MICOS complex subunit Mic60 (Mitochondrial inner membrane protein) (Mitofilin),cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; neuron cellular homeostasis [GO:0070050],GO:0005739; GO:0005743; GO:0005758; GO:0042407; GO:0043209; GO:0051560; GO:0061617; GO:0070050
1828,Pocillopora_acuta_HIv2___RNAseq.g26611.t1,274.9946381,-0.190947959,1.0272519,0.000136966,0.001082857,,F6YVB9,8.02E-66,Transcription factor E2F7 (E2F-7),"chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA endoreduplication [GO:0032877]; sprouting angiogenesis [GO:0002040]",GO:0000122; GO:0000978; GO:0001217; GO:0002040; GO:0003700; GO:0005634; GO:0005667; GO:0006977; GO:0032466; GO:0032877; GO:0060718; GO:0070365; GO:2000134
1829,Pocillopora_acuta_HIv2___RNAseq.g5559.t1,367.9897255,-0.279365245,1.058714147,0.00013697,0.001082857,,Q8DVP8,1.15E-06,Ribosome-binding factor A,maturation of SSU-rRNA [GO:0030490],GO:0005737; GO:0030490
1830,Pocillopora_acuta_HIv2___TS.g15232.t1a,167.8129076,-1.485652254,2.733044638,0.000137004,0.001082857,,NA,NA,NA,NA,NA
1831,Pocillopora_acuta_HIv2___RNAseq.g4326.t1,294.8305161,-0.282483631,1.041336875,0.0001372,0.001083809,,Q1LXK4,0,Putative helicase mov-10-B.1 (EC 3.6.4.13),miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194],GO:0000932; GO:0003723; GO:0005524; GO:0005829; GO:0016887; GO:0032574; GO:0035194; GO:0035279; GO:0043186
1832,Pocillopora_acuta_HIv2___RNAseq.g26031.t1a,11043.6237,-3.075647288,4.913517464,0.000137373,0.001084079,,Q505H7,1.53E-11,Protein IWS1 homolog (IWS1-like protein),mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380],GO:0005634; GO:0006397; GO:0008380; GO:0051028
1833,Pocillopora_acuta_HIv2___TS.g3558.t1,266.741206,-0.421514409,1.128264771,0.000137384,0.001084079,,P82968,2.37E-37,Four-domain proteases inhibitor (McaPI),cell differentiation [GO:0030154],GO:0004867; GO:0030154
1834,Pocillopora_acuta_HIv2___RNAseq.g5711.t2,347.7761686,-1.374014822,2.623576642,0.000137817,0.001086907,,Q8CGF6,1.70E-111,WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin),adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150],GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168
1835,Pocillopora_acuta_HIv2___RNAseq.g20624.t1,87.95702012,-0.689191838,1.283367543,0.000140001,0.00110353,,NA,NA,NA,NA,NA
1836,Pocillopora_acuta_HIv2___RNAseq.25352_t,86.27920298,0.776881423,1.46645038,0.000140348,0.001105665,,Q9Y618,6.34E-08,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",cerebellum development [GO:0021549]; estrous cycle [GO:0044849]; lactation [GO:0007595]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cellular ketone metabolic process [GO:0010565]; response to estradiol [GO:0032355]; response to organonitrogen compound [GO:0010243],GO:0000122; GO:0000785; GO:0003677; GO:0003682; GO:0003714; GO:0005112; GO:0005634; GO:0005654; GO:0007595; GO:0010243; GO:0010565; GO:0016020; GO:0016363; GO:0016604; GO:0017053; GO:0021549; GO:0032355; GO:0035259; GO:0042826; GO:0044849; GO:0045892; GO:0046965; GO:0060766; GO:1902894
1837,Pocillopora_acuta_HIv2___RNAseq.g4102.t1,256.4212174,-0.356923412,1.055151711,0.000140442,0.001105802,,NA,NA,NA,NA,NA
1838,Pocillopora_acuta_HIv2___RNAseq.12371_t,4891.918657,-2.541310468,0.876640385,0.000141038,0.001109884,,NA,NA,NA,NA,NA
1839,Pocillopora_acuta_HIv2___TS.g21852.t1,209.9138114,0.223681266,1.042915885,0.000141674,0.001114284,,NA,NA,NA,NA,NA
1840,Pocillopora_acuta_HIv2___RNAseq.g26015.t1,107.9601253,-1.057209292,1.755178185,0.000141966,0.001115976,,NA,NA,NA,NA,NA
1841,Pocillopora_acuta_HIv2___RNAseq.g3515.t1,95.72880929,3.465373656,3.035917863,0.00014276,0.001121608,,Q9UBC2,2.99E-08,Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R),endocytosis [GO:0006897]; endosomal transport [GO:0016197],GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0016197; GO:0030132; GO:0045296
1842,Pocillopora_acuta_HIv2___RNAseq.g24371.t1,354.7227833,-0.254883273,1.052754678,0.000143383,0.001125888,,Q6MG12,6.35E-20,Uncharacterized protein C6orf136 homolog,,
1843,Pocillopora_acuta_HIv2___RNAseq.g21321.t1a,173.5127957,-0.360968287,1.070494511,0.000143742,0.001128097,,NA,NA,NA,NA,NA
1844,Pocillopora_acuta_HIv2___RNAseq.g14741.t1,196.9404786,-2.987405146,3.679586105,0.000144155,0.001130723,,Q92733,8.99E-40,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),regulation of cell cycle [GO:0051726],GO:0005634; GO:0005654; GO:0016607; GO:0051726
1845,Pocillopora_acuta_HIv2___RNAseq.g4399.t2,947.1173738,-2.064725069,3.784189986,0.000144909,0.001135541,,Q14114,1.03E-27,Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2),ammon gyrus development [GO:0021541]; cellular response to cholesterol [GO:0071397]; cellular response to growth factor stimulus [GO:0071363]; chemical synaptic transmission [GO:0007268]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; layer formation in cerebral cortex [GO:0021819]; lipid metabolic process [GO:0006629]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of dendrite development [GO:1900006]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; proteolysis [GO:0006508]; reelin-mediated signaling pathway [GO:0038026]; regulation of apoptotic process [GO:0042981]; regulation of innate immune response [GO:0045088]; response to xenobiotic stimulus [GO:0009410]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517],GO:0001523; GO:0001540; GO:0004888; GO:0005041; GO:0005509; GO:0005615; GO:0005875; GO:0005886; GO:0005901; GO:0006508; GO:0006629; GO:0006897; GO:0007165; GO:0007268; GO:0008035; GO:0009410; GO:0009986; GO:0016020; GO:0019221; GO:0019894; GO:0021517; GO:0021541; GO:0021819; GO:0030229; GO:0030424; GO:0030425; GO:0034185; GO:0038024; GO:0038025; GO:0038026; GO:0042981; GO:0043025; GO:0043235; GO:0045088; GO:0045202; GO:0048306; GO:0048813; GO:0050731; GO:0050804; GO:0061003; GO:0071363; GO:0071397; GO:1900006
1846,Pocillopora_acuta_HIv2___RNAseq.g24682.t1,219.0496749,-0.723494094,1.329874621,0.000144948,0.001135541,,Q8IYT3,6.76E-108,Coiled-coil domain-containing protein 170,microtubule cytoskeleton organization [GO:0000226],GO:0000226; GO:0005794; GO:0008017; GO:0030054; GO:0036064
1847,Pocillopora_acuta_HIv2___RNAseq.g27398.t1,253.3122466,-0.435213044,1.136731935,0.000145004,0.001135541,,NA,NA,NA,NA,NA
1848,Pocillopora_acuta_HIv2___RNAseq.g25582.t1,237.9811082,-0.248827096,1.06418301,0.000145445,0.001138373,Chloroquine resistance transporter paralog 1,Q9GSB0,7.63E-10,Crt homolog 1 (Chloroquine resistance transporter paralog 1) (DdCRTp1),amino acid transport [GO:0006865],GO:0005774; GO:0006865; GO:0012506; GO:0042910
1849,Pocillopora_acuta_HIv2___RNAseq.g23414.t1,258.4078773,-3.237763037,1.772988928,0.000146139,0.001143192,,P35404,3.73E-12,5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B),adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; negative regulation of serotonin secretion [GO:0014063]; regulation of behavior [GO:0050795]; vasoconstriction [GO:0042310],GO:0004993; GO:0005886; GO:0007198; GO:0007268; GO:0014063; GO:0042310; GO:0045202; GO:0046849; GO:0050795; GO:0071312; GO:0071466
1850,Pocillopora_acuta_HIv2___RNAseq.g25250.t1,302.1147404,-1.167056989,2.007731686,0.000146765,0.001147467,,Q66J85,3.32E-39,AN1-type zinc finger protein 3 homolog,,GO:0003677; GO:0008270
1851,Pocillopora_acuta_HIv2___RNAseq.g12694.t1,229.1840438,-0.431988402,1.125568185,0.000147083,0.001149329,Putative helicase MOV-10,Q5ZKD7,0,Putative helicase MOV-10 (EC 3.6.4.13),3'-UTR-mediated mRNA destabilization [GO:0061158]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; retrotransposon silencing [GO:0010526],GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0061014; GO:0061158; GO:0150011
1852,Pocillopora_acuta_HIv2___RNAseq.g24544.t1,2097.921709,-0.903487885,1.513922865,0.000147598,0.001151698,,Q9BYT9,0,Anoctamin-3 (Transmembrane protein 16C),calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; establishment of localization in cell [GO:0051649]; monoatomic ion transmembrane transport [GO:0034220],GO:0005254; GO:0005886; GO:0016048; GO:0017128; GO:0034220; GO:0046983; GO:0050982; GO:0051649; GO:0061590; GO:0061591; GO:1902476
1853,Pocillopora_acuta_HIv2___RNAseq.g16249.t2,820.6089669,-0.702593459,1.290520099,0.000147733,0.001151698,,NA,NA,NA,NA,NA
1854,Pocillopora_acuta_HIv2___RNAseq.g17022.t1,333.7849193,-0.368233359,1.094602282,0.000147756,0.001151698,,A5D6V4,5.25E-55,Transmembrane protein 17B,cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]; smoothened signaling pathway [GO:0007224],GO:0007224; GO:0035869; GO:0036038; GO:0060170; GO:0060271; GO:1905515
1855,Pocillopora_acuta_HIv2___RNAseq.g9305.t1,678.5945625,-0.279920626,1.034750569,0.000147776,0.001151698,,Q8R151,2.93E-62,NFX1-type zinc finger-containing protein 1,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607
1856,Pocillopora_acuta_HIv2___TS.g29741.t1,81.18419956,-0.543760324,1.23725444,0.000147784,0.001151698,,Q96QE2,2.73E-179,Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13),myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104],GO:0002020; GO:0005365; GO:0005366; GO:0005737; GO:0005886; GO:0015798; GO:0016020; GO:0016324; GO:0030426; GO:0031090; GO:0042995; GO:0043231; GO:0044297; GO:0051117; GO:0055085; GO:0071944; GO:0097450; GO:0150104; GO:1902004
1857,Pocillopora_acuta_HIv2___RNAseq.g4496.t1,169.3171672,-0.567820403,1.244711957,0.000149251,0.001162506,,Q96QE2,0,Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13),myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104],GO:0002020; GO:0005365; GO:0005366; GO:0005737; GO:0005886; GO:0015798; GO:0016020; GO:0016324; GO:0030426; GO:0031090; GO:0042995; GO:0043231; GO:0044297; GO:0051117; GO:0055085; GO:0071944; GO:0097450; GO:0150104; GO:1902004
1858,Pocillopora_acuta_HIv2___RNAseq.g28216.t1,405.7773503,-0.252254095,1.039919997,0.00014954,0.001164126,,Q9ESL9,1.54E-19,Fibroblast growth factor 20 (FGF-20),animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear auditory receptor cell differentiation [GO:0042491]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell migration [GO:0030334]; regulation of neuron differentiation [GO:0045664],GO:0001934; GO:0005104; GO:0005615; GO:0005737; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010628; GO:0030154; GO:0030334; GO:0042491; GO:0043410; GO:0043524; GO:0045664; GO:0060043; GO:0070374; GO:0090722
1859,Pocillopora_acuta_HIv2___TS.g8915.t1,312.546407,-0.757838404,1.349185807,0.000150827,0.001173225,,Q3V096,2.86E-159,Ankyrin repeat domain-containing protein 42,positive regulation of cytokine production involved in inflammatory response [GO:1900017],GO:0005634; GO:0051059; GO:1900017
1860,Pocillopora_acuta_HIv2___RNAseq.g24327.t1,309.2842805,-0.333067858,1.077798513,0.000150871,0.001173225,Acid-sensing ion channel 3 (ASIC3),Q9UHC3,6.16E-41,Acid-sensing ion channel 3 (ASIC3) (hASIC3) (Amiloride-sensitive cation channel 3) (Neuronal amiloride-sensitive cation channel 3) (Testis sodium channel 1) (hTNaC1),detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; sensory perception [GO:0007600]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725],GO:0005261; GO:0005272; GO:0005886; GO:0007165; GO:0007600; GO:0009408; GO:0010447; GO:0015280; GO:0035725; GO:0042931; GO:0048471; GO:0050915; GO:0050965; GO:0050966; GO:0050968; GO:0160128
1861,Pocillopora_acuta_HIv2___RNAseq.g20572.t1,103.7126715,-0.556689031,1.253013777,0.000151184,0.001175025,,Q9CYF5,6.24E-78,RCC1-like G exchanging factor-like protein (RCC1-like protein) (Williams-Beuren syndrome chromosomal region 16 protein homolog),mitochondrial fusion [GO:0008053]; positive regulation of mitochondrial translation [GO:0070131],GO:0005085; GO:0005739; GO:0005743; GO:0008053; GO:0019843; GO:0070131
1862,Pocillopora_acuta_HIv2___RNAseq.g21418.t1,788.4386715,3.349891975,1.615964706,0.000151799,0.001179176,,P16241,2.72E-76,POU domain protein CF1A (Chorion factor 1A) (CF1-A) (Protein drifter) (Ventral veins lacking protein),brain development [GO:0007420]; brain segmentation [GO:0035284]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; peripheral nervous system development [GO:0007422]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of dendrite morphogenesis [GO:0048814]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002807; GO:0005634; GO:0006357; GO:0007420; GO:0007422; GO:0008045; GO:0035284; GO:0045944; GO:0048813; GO:0048814
1863,Pocillopora_acuta_HIv2___RNAseq.g8029.t1,359.2186135,-0.286731473,1.066506527,0.000152012,0.001180043,,NA,NA,NA,NA,NA
1864,Pocillopora_acuta_HIv2___TS.g15792.t1,1425.84151,1.848319777,4.166604186,0.000152194,0.001180043,Acidic skeletal organic matrix protein,B3EWY7,1.02E-70,Acidic skeletal organic matrix protein (Acidic SOMP),,GO:0005576
1865,Pocillopora_acuta_HIv2___TS.g15890.t2,143.1096193,0.729522493,1.436093167,0.000152223,0.001180043,,Q3U0J8,4.53E-53,TBC1 domain family member 2B,endocytosis [GO:0006897],GO:0005096; GO:0005769; GO:0005829; GO:0006897
1866,Pocillopora_acuta_HIv2___RNAseq.g7223.t1,358.2326815,-0.490989517,1.179020895,0.000152237,0.001180043,,NA,NA,NA,NA,NA
1867,Pocillopora_acuta_HIv2___RNAseq.g13857.t1,2577.46422,2.538916,3.464640477,0.000152842,0.001184099,,O19006,6.60E-91,Bone morphogenetic protein 2 (BMP-2),cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of odontoblast differentiation [GO:1901331],GO:0001503; GO:0005125; GO:0005615; GO:0008083; GO:0030154; GO:0051216; GO:1901331
1868,Pocillopora_acuta_HIv2___RNAseq.g17105.t1,268.7304801,0.095262734,1.021666008,0.000152976,0.001184501,,Q92847,4.18E-25,Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor),actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; insulin-like growth factor receptor signaling pathway [GO:0048009]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to L-glutamate [GO:1902065]; spermatogenesis [GO:0007283],GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032715; GO:0032720; GO:0032869; GO:0036321; GO:0040018; GO:0042802; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045923; GO:0046676; GO:0046697; GO:0048009; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097060; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0120058; GO:1902065; GO:1903672; GO:1904000; GO:1904349; GO:1905333; GO:1905564; GO:1990314; GO:2000110
1869,Pocillopora_acuta_HIv2___RNAseq.g1855.t1,449.8088168,-0.238754242,1.028357168,0.000153443,0.001187478,,Q6ZPJ3,4.36E-83,(E3-independent) E2 ubiquitin-conjugating enzyme UBE2O (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O),"positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0061630; GO:0061631; GO:0070534
1870,Pocillopora_acuta_HIv2___RNAseq.g14731.t1,2676.28324,2.894060239,1.179023153,0.000154203,0.001192723,,NA,NA,NA,NA,NA
1871,Pocillopora_acuta_HIv2___RNAseq.g17678.t1,25.30770567,-8.522112447,3.693315831,0.000154766,0.001196437,,Q7RTR2,2.35E-22,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)",canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110],GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223
1872,Pocillopora_acuta_HIv2___RNAseq.g26886.t1,80.75760635,3.301264131,1.334255628,0.000155625,0.001202433,,NA,NA,NA,NA,NA
1873,Pocillopora_acuta_HIv2___RNAseq.g9662.t1,1449.549855,-3.855902957,1.375636464,0.000155819,0.001203295,,NA,NA,NA,NA,NA
1874,Pocillopora_acuta_HIv2___RNAseq.g20858.t1,179.8758293,-0.347938038,1.051257723,0.000155997,0.001204022,,Q28ER3,9.22E-37,Baculoviral IAP repeat-containing protein 5.2 (Survivin 2) (Survivin),cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; protein phosphorylation [GO:0006468]; vasculature development [GO:0001944],GO:0000776; GO:0001944; GO:0005634; GO:0005737; GO:0005819; GO:0006468; GO:0007059; GO:0030496; GO:0032133; GO:0043066; GO:0045892; GO:0046872; GO:0046965; GO:0051301
1875,Pocillopora_acuta_HIv2___TS.g5415.t1,30.94872719,-5.874796049,2.321979435,0.000156859,0.001210028,C-type lectin domain family 1 member B,Q9P126,5.14E-19,C-type lectin domain family 1 member B (C-type lectin-like receptor 2) (CLEC-2),cell surface receptor signaling pathway [GO:0007166]; defense response [GO:0006952]; platelet formation [GO:0030220]; signal transduction [GO:0007165],GO:0004888; GO:0005886; GO:0006952; GO:0007165; GO:0007166; GO:0009986; GO:0030220; GO:0030246
1876,Pocillopora_acuta_HIv2___RNAseq.g27027.t1,348.0774974,-0.21756251,1.037951799,0.000158329,0.001220721,,Q63ZU0,2.53E-109,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168],GO:0004000; GO:0005764; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0046103; GO:0046936; GO:0060205; GO:0070161
1877,Pocillopora_acuta_HIv2___RNAseq.g24852.t1,526.8925312,-0.219840995,1.039298393,0.000158791,0.001223628,,NA,NA,NA,NA,NA
1878,Pocillopora_acuta_HIv2___RNAseq.g3565.t1,437.3045849,-0.343248683,1.104239986,0.000159359,0.00122735,,Q4R5T4,2.41E-118,RING finger protein 32,,GO:0005737; GO:0046872
1879,Pocillopora_acuta_HIv2___RNAseq.g14314.t2,598.7103044,-0.236205867,1.04928249,0.000159502,0.001227798,,Q9UKY4,0,Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2),basement membrane organization [GO:0071711]; dentate gyrus development [GO:0021542]; positive regulation of protein O-linked glycosylation [GO:1904100]; protein O-linked mannosylation [GO:0035269]; reactive gliosis [GO:0150103],GO:0000030; GO:0004169; GO:0005654; GO:0005730; GO:0005783; GO:0005789; GO:0005829; GO:0021542; GO:0035269; GO:0046872; GO:0071711; GO:0150103; GO:1904100
1880,Pocillopora_acuta_HIv2___RNAseq.g5342.t1,1956.291109,3.546506546,3.30489736,0.000159724,0.001228859,Jagged1,P78504,9.12E-17,Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339),angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of reproductive process [GO:2000241]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000241; GO:2000737
1881,Pocillopora_acuta_HIv2___RNAseq.g3666.t1a,167.7009382,-1.012993309,1.753573169,0.000159902,0.001229567,,Q6GPQ3,2.23E-17,Major facilitator superfamily domain-containing protein 8,,GO:0005765; GO:0022857
1882,Pocillopora_acuta_HIv2___TS.g15978.t1,347.5823553,-0.221619868,1.035543862,0.000161892,0.00124421,,NA,NA,NA,NA,NA
1883,Pocillopora_acuta_HIv2___RNAseq.g1033.t1,2322.631139,-2.097876443,0.660863325,0.000162442,0.001247772,,NA,NA,NA,NA,NA
1884,Pocillopora_acuta_HIv2___RNAseq.g8980.t1,106.1014952,3.478360611,2.366776067,0.000162553,0.001247963,,B8EIZ7,8.19E-180,Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148),,GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661
1885,Pocillopora_acuta_HIv2___RNAseq.g30759.t1,401.2297539,-3.704070319,1.84634657,0.000163448,0.001253538,,NA,NA,NA,NA,NA
1886,Pocillopora_acuta_HIv2___RNAseq.g4918.t1,351.7408426,-0.236801659,1.039567098,0.000163502,0.001253538,,Q5R9K8,4.06E-52,ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein),maintenance of protein location in nucleus [GO:0051457]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531],GO:0003713; GO:0005654; GO:0005758; GO:0005813; GO:0005819; GO:0005829; GO:0005929; GO:0030496; GO:0042531; GO:0051457
1887,Pocillopora_acuta_HIv2___RNAseq.g11237.t1,311.7519551,-0.119418748,1.020457426,0.000163539,0.001253538,,P9WKC1,2.25E-06,Putative diacyglycerol O-acyltransferase Rv1425 (EC 2.3.1.20) (Putative triacylglycerol synthase Rv1425),biological process involved in interaction with host [GO:0051701]; glycerol metabolic process [GO:0006071]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],GO:0001666; GO:0004144; GO:0005886; GO:0006071; GO:0008374; GO:0019432; GO:0051701; GO:0071731
1888,Pocillopora_acuta_HIv2___RNAseq.g27609.t1,647.1958438,-3.419233322,1.996685963,0.000164237,0.00125822,,Q01062,0,"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cardiac septum development [GO:0003279]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; coronary vasculature development [GO:0060976]; establishment of endothelial barrier [GO:0061028]; heart development [GO:0007507]; heart valve development [GO:0003170]; intracellular signal transduction [GO:0035556]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to hydrogen sulfide [GO:1904880]; ventricular septum development [GO:0003281]",GO:0000122; GO:0000287; GO:0003170; GO:0003279; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0007507; GO:0008270; GO:0010628; GO:0010749; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030424; GO:0030425; GO:0030552; GO:0030553; GO:0030911; GO:0035556; GO:0035904; GO:0036004; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0043949; GO:0043951; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0060976; GO:0061028; GO:0071222; GO:0071260; GO:0071320; GO:0071321; GO:0071560; GO:0090324; GO:0097011; GO:0097060; GO:0097457; GO:0106072; GO:1904613; GO:1904880
1889,Pocillopora_acuta_HIv2___RNAseq.g2255.t1,2924.517603,-3.639196896,1.952679686,0.000165372,0.00126625,,NA,NA,NA,NA,NA
1890,Pocillopora_acuta_HIv2___TS.g30160.t2,426.0476545,0.191130096,1.041057897,0.000165579,0.001267159,,NA,NA,NA,NA,NA
1891,Pocillopora_acuta_HIv2___TS.g9535.t1,183.3320561,-0.319492705,1.0672871,0.000166074,0.001270279,,Q6P0T2,1.66E-56,Transcription initiation factor TFIID subunit 8 (Protein taube nuss-like) (TBP-associated factor 8),cell differentiation [GO:0030154]; transcription initiation at RNA polymerase II promoter [GO:0006367],GO:0005669; GO:0005737; GO:0006367; GO:0030154; GO:0046982
1892,Pocillopora_acuta_HIv2___RNAseq.g5884.t1,145.2225902,-0.561519877,1.244840887,0.000166306,0.001270717,,F7E235,5.56E-46,Failed axon connections homolog,,GO:0016020
1893,Pocillopora_acuta_HIv2___RNAseq.g6925.t1,319.3071874,-0.285616092,1.060904927,0.000166307,0.001270717,,NA,NA,NA,NA,NA
1894,Pocillopora_acuta_HIv2___RNAseq.g28614.t1,290.7842962,-0.315110217,1.070509291,0.000166997,0.001275315,,E4ZUJ1,5.95E-08,Restriction of telomere capping protein 5,,GO:0005737
1895,Pocillopora_acuta_HIv2___RNAseq.g30369.t1,162.9015942,-0.287483479,1.039114307,0.00016727,0.001276727,,O76075,1.10E-53,DNA fragmentation factor subunit beta (EC 3.-.-.-) (Caspase-activated deoxyribonuclease) (CAD) (Caspase-activated DNase) (Caspase-activated nuclease) (CPAN) (DNA fragmentation factor 40 kDa subunit) (DFF-40),apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; negative regulation of apoptotic DNA fragmentation [GO:1902511],GO:0000785; GO:0003677; GO:0004520; GO:0004536; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006308; GO:0006309; GO:0019899; GO:0019904; GO:0030263; GO:0032991; GO:0042802; GO:0097718; GO:1902511
1896,Pocillopora_acuta_HIv2___RNAseq.g614.t1,2049.655009,3.458115378,1.862189548,0.000168383,0.00128454,Homeobox protein SIX4/5,Q61321,2.37E-90,Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3),embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; fungiform papilla morphogenesis [GO:0061197]; generation of neurons [GO:0048699]; inner ear morphogenesis [GO:0042472]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; metanephric mesenchyme development [GO:0072075]; myoblast migration [GO:0051451]; myotome development [GO:0061055]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of satellite cell differentiation [GO:1902725]; olfactory placode formation [GO:0030910]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; tongue development [GO:0043586]; trigeminal ganglion development [GO:0061551],GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007519; GO:0008582; GO:0008584; GO:0010468; GO:0030238; GO:0030910; GO:0032880; GO:0034504; GO:0042472; GO:0043066; GO:0043524; GO:0043565; GO:0043586; GO:0045214; GO:0045892; GO:0045893; GO:0045944; GO:0046661; GO:0048538; GO:0048699; GO:0048701; GO:0048704; GO:0050678; GO:0051451; GO:0060037; GO:0061055; GO:0061197; GO:0061551; GO:0072075; GO:0072095; GO:0072107; GO:0090190; GO:0098528; GO:1902725
1897,Pocillopora_acuta_HIv2___RNAseq.g26608.t1,1585.093707,-2.449786518,0.859896479,0.000169323,0.001291033,,P22735,5.10E-173,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),cell envelope organization [GO:0043163]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein modification process [GO:0036211],GO:0001533; GO:0003810; GO:0005829; GO:0005886; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031424; GO:0036211; GO:0042802; GO:0043163; GO:0045787; GO:0046872; GO:0070062
1898,Pocillopora_acuta_HIv2___RNAseq.g25208.t1,3909.737963,1.908093744,0.577153955,0.000169543,0.001292026,,A7ISW1,2.32E-79,Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase),"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]",GO:0005576; GO:0008270; GO:0016603; GO:0017186
1899,Pocillopora_acuta_HIv2___TS.g28573.t3,447.2399619,-0.92968607,1.504397661,0.000170156,0.001296019,,NA,NA,NA,NA,NA
1900,Pocillopora_acuta_HIv2___RNAseq.g20764.t1,109.5805878,-2.991152597,1.250042018,0.000170279,0.001296269,,A1R8N8,1.83E-10,D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase),mycothiol biosynthetic process [GO:0010125],GO:0000287; GO:0008375; GO:0010125; GO:0102710
1901,Pocillopora_acuta_HIv2___RNAseq.9964_t,279.7211654,-0.165919058,1.02254525,0.000170653,0.001298438,,Q7T0W5,3.15E-93,"Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)",rRNA methylation [GO:0031167],GO:0000179; GO:0003677; GO:0003723; GO:0005739; GO:0031167; GO:1904047
1902,Pocillopora_acuta_HIv2___TS.g24534.t2,219.8881012,-0.251172514,1.06543759,0.000173037,0.001315884,,Q32HN5,2.61E-32,Glyoxylate/hydroxypyruvate reductase A (EC 1.1.1.79) (EC 1.1.1.81) (2-ketoacid reductase),,GO:0005829; GO:0008465; GO:0030267; GO:0051287
1903,Pocillopora_acuta_HIv2___RNAseq.g23252.t1,147.4153815,0.54643171,1.247686438,0.000173991,0.001322444,,Q98892,2.81E-18,Opioid-binding protein/cell adhesion molecule homolog (Neurite inhibitor GP55-A) (OBCAM protein gamma isoform),cell adhesion [GO:0007155],GO:0005886; GO:0007155; GO:0098552
1904,Pocillopora_acuta_HIv2___RNAseq.g715.t1,367.3394106,3.236604013,1.714782256,0.00017694,0.001344152,,Q9JHA8,9.60E-26,von Willebrand factor A domain-containing protein 7 (Protein G7c),,GO:0005576
1905,Pocillopora_acuta_HIv2___RNAseq.g16215.t1,550.1474651,2.592242351,0.95020049,0.000177512,0.001347786,,NA,NA,NA,NA,NA
1906,Pocillopora_acuta_HIv2___TS.g17638.t1,2636.162981,-2.711325226,4.555242794,0.000177606,0.001347792,,NA,NA,NA,NA,NA
1907,Pocillopora_acuta_HIv2___RNAseq.g22954.t1,204.6751638,-0.692631591,1.270552512,0.000177764,0.001348102,,E7FAM5,8.96E-59,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177
1908,Pocillopora_acuta_HIv2___RNAseq.g4845.t1,236.1642875,-0.497114137,1.186912634,0.000177833,0.001348102,,P41044,1.01E-28,Calbindin-32,regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509],GO:0005509; GO:0005634; GO:0005829; GO:0030425; GO:0043195; GO:0045202; GO:0061175; GO:0097467; GO:0099509; GO:1900271
1909,Pocillopora_acuta_HIv2___RNAseq.g11660.t1,122.168409,-0.811603091,1.506710783,0.000179609,0.001360523,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Q9Y233,0,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17)",cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754],GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0010754; GO:0019933; GO:0030552; GO:0030553; GO:0046069; GO:0046872; GO:0047555
1910,Pocillopora_acuta_HIv2___TS.g13789.t1,172.2876544,-0.153178564,1.020336077,0.00017966,0.001360523,,Q6DJH2,1.35E-94,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC 2.7.8.7) (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT),fatty acid biosynthetic process [GO:0006633]; protein maturation [GO:0051604],GO:0000287; GO:0005829; GO:0006633; GO:0008897; GO:0051604
1911,Pocillopora_acuta_HIv2___RNAseq.g22671.t1,591.164474,0.712446145,1.309562223,0.000180856,0.001368868,,Q0EEE2,3.21E-85,Patched domain-containing protein 3 (RND-type protein RNDEu-3),,GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0097225
1912,Pocillopora_acuta_HIv2___TS.g958.t1,61.25804267,-2.958257071,4.168654026,0.000181303,0.00137153,,NA,NA,NA,NA,NA
1913,Pocillopora_acuta_HIv2___RNAseq.g15959.t1,114.4982578,-0.294448514,1.069857187,0.000181495,0.001372264,,B3EWZ8,1.05E-21,Ectin,,GO:0005576
1914,Pocillopora_acuta_HIv2___RNAseq.g26735.t1,923.0967397,2.970243158,1.409563238,0.000181651,0.001372725,,NA,NA,NA,NA,NA
1915,Pocillopora_acuta_HIv2___RNAseq.g7910.t1,535.6012883,-0.272071237,1.066029119,0.000182475,0.001378233,,O97827,1.54E-08,Adhesion G protein-coupled receptor L3 (Latrophilin-3),cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; neuron migration [GO:0001764]; signal transduction [GO:0007165]; synapse assembly [GO:0007416],GO:0001764; GO:0004930; GO:0005509; GO:0005615; GO:0005886; GO:0005911; GO:0007165; GO:0007166; GO:0007416; GO:0030246; GO:0030424; GO:0098742
1916,Pocillopora_acuta_HIv2___TS.g21126.t2,232.5146067,-0.167028959,1.018992648,0.000182933,0.00138097,,Q9CWG8,2.62E-127,"Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)","mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]",GO:0005739; GO:0019899; GO:0019918; GO:0032981; GO:0035243
1917,Pocillopora_acuta_HIv2___TS.g26039.t2b,319.1377795,-0.296249484,1.064170229,0.000183358,0.001383459,,Q6PAY6,1.72E-93,Hydroxyproline dehydrogenase (HYPDH) (EC 1.5.5.3) (Probable proline dehydrogenase 2) (EC 1.5.5.2) (Probable proline oxidase 2),proline catabolic process to glutamate [GO:0010133],GO:0004657; GO:0010133; GO:0016645
1918,Pocillopora_acuta_HIv2___RNAseq.g1929.t1,604.3690249,-0.321722528,1.07270014,0.000183506,0.001383855,Transcriptional regulator Myc,P49709,1.07E-19,Transcriptional regulator Myc (c-Myc),,GO:0000981; GO:0003677; GO:0005634; GO:0046983
1919,Pocillopora_acuta_HIv2___TS.g27524.t1b,296.7980752,-0.28053741,1.042011595,0.00018406,0.001387304,,Q4KM30,2.31E-57,Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2) (Palmitoyl protein thioesterase DESI1) (EC 3.1.2.22) (S-depalmitoylase DESI1),protein desumoylation [GO:0016926]; protein export from nucleus [GO:0006611]; protein modification by small protein removal [GO:0070646]; proteolysis [GO:0006508]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],GO:0005634; GO:0005829; GO:0006508; GO:0006611; GO:0008474; GO:0016926; GO:0016929; GO:0032434; GO:0032991; GO:0042802; GO:0052816; GO:0061676; GO:0070646
1920,Pocillopora_acuta_HIv2___TS.g21728.t1,241.4272867,-0.46312425,1.157407739,0.000184197,0.001387615,,P53995,0,Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein),anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936],GO:0005634; GO:0005680; GO:0007091; GO:0031145; GO:0051301; GO:0060090; GO:0070936; GO:0070979; GO:0141198
1921,Pocillopora_acuta_HIv2___TS.g370.t2,1450.613767,2.145663605,0.687841493,0.00018609,0.001401146,,NA,NA,NA,NA,NA
1922,Pocillopora_acuta_HIv2___RNAseq.g20778.t1,478.9550444,-0.215637535,1.030982823,0.000187094,0.001407978,,Q2TBW2,5.19E-82,"5-demethoxyubiquinone hydroxylase, mitochondrial (DMQ hydroxylase) (EC 1.14.99.60) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)",determination of adult lifespan [GO:0008340]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744],GO:0005634; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0016709; GO:0031314; GO:0046872; GO:2000377
1923,Pocillopora_acuta_HIv2___RNAseq.g9118.t1,3898.314631,3.529995154,2.419406277,0.000187263,0.001408515,,Q13219,0,Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A),cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548]; response to follicle-stimulating hormone [GO:0032354],GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0007565; GO:0008237; GO:0008270; GO:0030163; GO:0032354; GO:0071548
1924,Pocillopora_acuta_HIv2___TS.g5258.t1,290.9617428,-0.338992772,1.104655985,0.000188112,0.001414168,,NA,NA,NA,NA,NA
1925,Pocillopora_acuta_HIv2___RNAseq.g9423.t1,299.7390051,-2.383630073,0.79996778,0.000188612,0.001417189,,NA,NA,NA,NA,NA
1926,Pocillopora_acuta_HIv2___RNAseq.g4516.t1,3380.310507,-3.587543895,3.154246859,0.000189401,0.001422375,ZP domain-containing protein,G8HTB6,3.67E-25,ZP domain-containing protein,,GO:0016020
1927,Pocillopora_acuta_HIv2___TS.g15410.t1,276.3826766,-0.432588904,1.134643658,0.00018991,0.001425108,,Q5ZIG3,1.15E-92,Mitochondrial outer membrane protein SLC25A46 (Solute carrier family 25 member 46),axon development [GO:0061564]; cristae formation [GO:0042407]; mitochondrial fission [GO:0000266]; mitochondrial membrane fission [GO:0090149]; phospholipid homeostasis [GO:0055091]; respiratory chain complex IV assembly [GO:0008535],GO:0000266; GO:0005741; GO:0008535; GO:0042407; GO:0044877; GO:0055091; GO:0061564; GO:0090149
1928,Pocillopora_acuta_HIv2___RNAseq.g15474.t1,42.82082336,-4.590343392,2.19592182,0.000189962,0.001425108,,NA,NA,NA,NA,NA
1929,Pocillopora_acuta_HIv2___RNAseq.g11055.t1,248.971265,-0.465838513,1.159714348,0.000190617,0.001429282,,NA,NA,NA,NA,NA
1930,Pocillopora_acuta_HIv2___RNAseq.g28514.t1,361.633887,-0.463566004,1.121102981,0.000191834,0.001437662,,Q9UPM8,0,AP-4 complex subunit epsilon-1 (AP-4 adaptor complex subunit epsilon) (Adaptor-related protein complex 4 subunit epsilon-1) (Epsilon subunit of AP-4) (Epsilon-adaptin),intracellular protein transport [GO:0006886]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192],GO:0005802; GO:0006605; GO:0006886; GO:0008104; GO:0016192; GO:0030124; GO:0031904; GO:0032588; GO:0140312
1931,Pocillopora_acuta_HIv2___RNAseq.g28720.t1b,172.4649818,0.718882705,1.435236471,0.000192307,0.001439869,,Q5RBT2,2.36E-31,Aspartyl aminopeptidase (EC 3.4.11.21),proteolysis [GO:0006508],GO:0004177; GO:0005737; GO:0006508; GO:0008237; GO:0008270
1932,Pocillopora_acuta_HIv2___RNAseq.g9064.t1,144.7417521,0.418793707,1.119049433,0.000192328,0.001439869,,Q96PZ7,1.19E-74,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964],GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708
1933,Pocillopora_acuta_HIv2___RNAseq.g19855.t1,2206.249348,-3.267545404,2.071434781,0.000193997,0.001451596,Glycine betaine transporter 1,Q87NG3,7.74E-106,Glycine betaine transporter 1,amino acid transport [GO:0006865],GO:0005886; GO:0006865; GO:0022857
1934,Pocillopora_acuta_HIv2___TS.g4252.t1,88.8407183,-1.585403273,2.590742015,0.000194095,0.001451596,,NA,NA,NA,NA,NA
1935,Pocillopora_acuta_HIv2___RNAseq.g13342.t1,217.4021241,-0.118354882,1.020697005,0.00019492,0.001457012,,A0FI79,5.59E-127,"Phosphatidylinositol polyphosphate 5-phosphatase type IV (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.86)",phosphatidylinositol dephosphorylation [GO:0046856],GO:0001726; GO:0004439; GO:0004445; GO:0005634; GO:0005794; GO:0005886; GO:0005930; GO:0032580; GO:0034485; GO:0043813; GO:0046856
1936,Pocillopora_acuta_HIv2___RNAseq.g11214.t1,286.003492,-2.511778499,4.592032318,0.00019513,0.001457828,,P61752,1.54E-17,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),"chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; positive regulation of vasoconstriction [GO:0045907]",GO:0001696; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0045907
1937,Pocillopora_acuta_HIv2___RNAseq.g6144.t1a,285.9239585,-0.299500403,1.078846664,0.000195702,0.001461349,,Q9UGM3,3.81E-54,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein),defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031],GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062
1938,Pocillopora_acuta_HIv2___RNAseq.g20596.t1,317.527946,-0.374729483,1.097795167,0.000198084,0.00147837,,Q29448,4.38E-158,"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)",ketone body biosynthetic process [GO:0046951]; L-leucine catabolic process [GO:0006552],GO:0004419; GO:0005739; GO:0005759; GO:0005777; GO:0006552; GO:0046872; GO:0046951
1939,Pocillopora_acuta_HIv2___RNAseq.g21187.t1,188.1625914,-0.541653684,1.229005175,0.000199126,0.001485383,,O64411,9.31E-41,Polyamine oxidase 1 (EC 1.5.3.14) (EC 1.5.3.15),polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208],GO:0006598; GO:0009505; GO:0016491; GO:0046208; GO:0046592; GO:0048046; GO:0050660; GO:0052893; GO:0052896; GO:0052897; GO:0052900
1940,Pocillopora_acuta_HIv2___RNAseq.g11177.t1,195.3452936,-0.346960606,1.085190496,0.000200606,0.001495655,,Q56A06,0,Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2),calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269],GO:0000030; GO:0004169; GO:0005789; GO:0035269; GO:0055074
1941,Pocillopora_acuta_HIv2___RNAseq.g7909.t1,68.13483791,-4.793691068,6.014160524,0.000201359,0.00150049,L-rhamnose-binding lectin ELEL-1,C0HK24,3.03E-08,L-rhamnose-binding lectin ELEL-1,,GO:0030246
1942,Pocillopora_acuta_HIv2___RNAseq.g18345.t1,134.2261851,-0.764029845,1.395621592,0.000202552,0.001508603,,Q3U155,4.06E-74,Coiled-coil domain-containing protein 174,,GO:0005634
1943,Pocillopora_acuta_HIv2___RNAseq.g21258.t1,1148.632812,-0.842800916,1.424823519,0.000202685,0.001508817,,Q9QZL2,1.55E-19,Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (EC 2.8.2.21) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0),carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; sulfur compound metabolic process [GO:0006790]; T cell homeostasis [GO:0043029],GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0014012; GO:0030206; GO:0043029; GO:0048678; GO:0050698
1944,Pocillopora_acuta_HIv2___RNAseq.g1510.t1,67.94215199,-3.78832797,2.733475154,0.000203442,0.001513675,Tachylectin-2 ,Q27084,7.16E-78,Tachylectin-2 (Lectin L10c),innate immune response [GO:0045087],GO:0005576; GO:0030246; GO:0045087
1945,Pocillopora_acuta_HIv2___RNAseq.g2094.t1a,59.99560998,-1.281030024,2.657034452,0.000203887,0.001516209,,Q5RCY5,1.26E-63,Single-strand DNA endonuclease ASTE1 (EC 3.1.-.-) (Protein asteroid homolog 1),double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303],GO:0000014; GO:0000724; GO:0006303; GO:1990599
1946,Pocillopora_acuta_HIv2___RNAseq.g23425.t1,317.9803108,0.482485865,1.173358922,0.000204828,0.001522418,,NA,NA,NA,NA,NA
1947,Pocillopora_acuta_HIv2___RNAseq.g15904.t1,2168.242343,-1.508566241,3.03578828,0.000205319,0.001525284,,NA,NA,NA,NA,NA
1948,Pocillopora_acuta_HIv2___RNAseq.g21477.t1,251.6260158,3.413341174,2.661462822,0.000205835,0.001528335,,P24821,6.13E-40,Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C),bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611],GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966
1949,Pocillopora_acuta_HIv2___RNAseq.1177_t,435.8301087,-0.259595699,1.053818202,0.000207718,0.001541526,,Q9ERH3,0,WD repeat-containing protein 7 (TGF-beta resistance-associated protein TRAG),hematopoietic progenitor cell differentiation [GO:0002244],GO:0002244; GO:0005737; GO:0008021
1950,Pocillopora_acuta_HIv2___RNAseq.g7640.t1,265.7847729,-0.509515496,1.194534191,0.000209554,0.001554352,,Q498Z6,2.70E-53,"Small ribosomal subunit protein uS7m (28S ribosomal protein S7, mitochondrial) (MRP-S7) (S7mt)",mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],GO:0000028; GO:0003729; GO:0003735; GO:0005763; GO:0005840; GO:0006412; GO:0019843; GO:0032543
1951,Pocillopora_acuta_HIv2___RNAseq.g16053.t1,467.7271714,-0.402354152,1.091429574,0.000210047,0.001557212,,Q5U508,1.27E-128,Tubulin-specific chaperone E (Tubulin-folding cofactor E),post-chaperonin tubulin folding pathway [GO:0007023],GO:0005737; GO:0005856; GO:0007023
1952,Pocillopora_acuta_HIv2___RNAseq.g82.t1,64.93916175,-5.244625569,3.868394238,0.000211651,0.001568298,,Q9NRG9,6.33E-136,Aladin (Adracalin),fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822],GO:0000922; GO:0001578; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006913; GO:0007612; GO:0009566; GO:0015031; GO:0016020; GO:0031965; GO:0046822; GO:0051028; GO:0072686; GO:0090307
1953,Pocillopora_acuta_HIv2___RNAseq.g8820.t1,1129.709862,3.365071581,2.599586011,0.000212355,0.001572712,,Q3SYW2,2.58E-53,Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment],"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]",GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006958; GO:0009617; GO:0045087; GO:0046872
1954,Pocillopora_acuta_HIv2___RNAseq.g16430.t1,366.2405356,0.249766209,1.044978886,0.000212592,0.00157366,,NA,NA,NA,NA,NA
1955,Pocillopora_acuta_HIv2___TS.g15614.t1,252.8148427,-3.167827606,2.956319375,0.000212772,0.00157419,,Q54HT5,2.43E-07,Putative uncharacterized protein DDB_G0289245,,
1956,Pocillopora_acuta_HIv2___RNAseq.11267_t,1417.796265,-1.81642149,3.451483232,0.000213332,0.001577521,,Q05A36,4.03E-116,RNA-binding E3 ubiquitin-protein ligase MEX3C (EC 2.3.2.27) (RING finger and KH domain-containing protein 2) (RING-type E3 ubiquitin transferase MEX3C),chondrocyte hypertrophy [GO:0003415]; energy homeostasis [GO:0097009]; regulation of fat cell differentiation [GO:0045598],GO:0003415; GO:0003723; GO:0005634; GO:0005737; GO:0045598; GO:0046872; GO:0061630; GO:0097009
1957,Pocillopora_acuta_HIv2___RNAseq.g17176.t1,192.8403901,-0.239726676,1.041739941,0.000215502,0.001592757,,Q9P0Z9,6.33E-111,Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase),L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554],GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0008115; GO:0033514; GO:0050031; GO:0050660
1958,Pocillopora_acuta_HIv2___RNAseq.g19051.t1,23.53989081,-8.378538817,3.72142585,0.000216582,0.00159992,,NA,NA,NA,NA,NA
1959,Pocillopora_acuta_HIv2___RNAseq.g10165.t1,275.4533819,-0.379783078,1.10079799,0.000216958,0.001601878,,Q4SQ06,5.53E-22,Nucleolar protein 16,,GO:0005730
1960,Pocillopora_acuta_HIv2___RNAseq.g31296.t2,265.4507414,-0.461978703,1.104830541,0.000217373,0.001603908,,P46531,0,Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],GO:0000122; GO:0000139; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027
1961,Pocillopora_acuta_HIv2___RNAseq.g1763.t1,844.6168331,3.183952977,1.783983733,0.000217455,0.001603908,Homeobox protein aristaless-like 4,Q4LAL6,3.91E-36,Homeobox protein aristaless-like 4,regulation of transcription by RNA polymerase II [GO:0006357],GO:0000977; GO:0001228; GO:0005634; GO:0006357
1962,Pocillopora_acuta_HIv2___RNAseq.g9335.t1,5254.416936,-1.88304801,5.550443495,0.000217693,0.001604844,,NA,NA,NA,NA,NA
1963,Pocillopora_acuta_HIv2___RNAseq.g152.t1,317.9915882,-0.180391809,1.02534388,0.000223117,0.001643995,,Q0MQB1,3.94E-39,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (Complex I-19kD) (CI-19kD) (NADH-ubiquinone oxidoreductase 19 kDa subunit),"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]",GO:0005739; GO:0005747; GO:0005758; GO:0006120; GO:0032981; GO:0044877; GO:0045271
1964,Pocillopora_acuta_HIv2___RNAseq.g15165.t1,454.3778301,0.477826472,1.130118774,0.000224041,0.001649963,Noggin,Q13253,6.37E-37,Noggin,atrial cardiac muscle tissue morphogenesis [GO:0055009]; axial mesoderm development [GO:0048318]; BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cell differentiation in hindbrain [GO:0021533]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal system development [GO:0048706]; endocardial cushion formation [GO:0003272]; endoderm formation [GO:0001706]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; exploration behavior [GO:0035640]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart trabecula morphogenesis [GO:0061384]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; membranous septum morphogenesis [GO:0003149]; mesoderm formation [GO:0001707]; middle ear morphogenesis [GO:0042474]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac epithelial to mesenchymal transition [GO:0062044]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell migration [GO:0030336]; negative regulation of cytokine activity [GO:0060302]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural plate anterior/posterior regionalization [GO:0021999]; neural plate morphogenesis [GO:0001839]; neural tube closure [GO:0001843]; nodal signaling pathway [GO:0038092]; notochord morphogenesis [GO:0048570]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of transcription by RNA polymerase II [GO:0045944]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; prostatic bud formation [GO:0060513]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of neuronal synaptic plasticity [GO:0048168]; short-term synaptic potentiation [GO:1990926]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; somite development [GO:0061053]; spinal cord development [GO:0021510]; stem cell differentiation [GO:0048863]; ureteric bud formation [GO:0060676]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; visual learning [GO:0008542]; wound healing [GO:0042060],GO:0000122; GO:0001501; GO:0001649; GO:0001701; GO:0001706; GO:0001707; GO:0001837; GO:0001839; GO:0001843; GO:0003149; GO:0003151; GO:0003223; GO:0003272; GO:0005576; GO:0005615; GO:0007224; GO:0007399; GO:0008045; GO:0008542; GO:0008543; GO:0009953; GO:0010628; GO:0010629; GO:0019955; GO:0021510; GO:0021533; GO:0021983; GO:0021999; GO:0030336; GO:0030509; GO:0030514; GO:0035019; GO:0035640; GO:0038092; GO:0040036; GO:0042060; GO:0042474; GO:0042733; GO:0042803; GO:0045668; GO:0045944; GO:0048168; GO:0048318; GO:0048570; GO:0048706; GO:0048712; GO:0048863; GO:0050673; GO:0050679; GO:0051216; GO:0055009; GO:0060044; GO:0060173; GO:0060272; GO:0060291; GO:0060302; GO:0060325; GO:0060392; GO:0060412; GO:0060425; GO:0060513; GO:0060676; GO:0061037; GO:0061053; GO:0061384; GO:0061626; GO:0062044; GO:0090090; GO:0090190; GO:0090193; GO:0098793; GO:0099171; GO:1904888; GO:1990926; GO:2001234
1965,Pocillopora_acuta_HIv2___RNAseq.g15290.t1,2980.346016,3.850080312,1.792248989,0.000224802,0.001654727,,P00734,3.01E-53,Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain],acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; G protein-coupled receptor signaling pathway [GO:0007186]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid kinase activity [GO:0090218]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of blood coagulation [GO:0030193]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to wounding [GO:0009611],GO:0001530; GO:0001934; GO:0004252; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0006953; GO:0007166; GO:0007186; GO:0007596; GO:0008083; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010544; GO:0030168; GO:0030193; GO:0030194; GO:0030307; GO:0032024; GO:0032967; GO:0042730; GO:0045861; GO:0046427; GO:0048712; GO:0051281; GO:0051480; GO:0051838; GO:0051897; GO:0051918; GO:0061844; GO:0062023; GO:0070053; GO:0070062; GO:0070945; GO:0072562; GO:0090218; GO:1900016; GO:1900182; GO:1900738; GO:1990806; GO:2000379
1966,Pocillopora_acuta_HIv2___RNAseq.g24097.t1,153.212837,-1.001895268,1.881392197,0.000227042,0.001670367,,Q5F364,0,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908],GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729
1967,Pocillopora_acuta_HIv2___RNAseq.g11343.t1,2459.01676,-2.508387739,0.943953869,0.000227785,0.001674979,,NA,NA,NA,NA,NA
1968,Pocillopora_acuta_HIv2___RNAseq.g27801.t1,370.4854795,-0.396802854,1.074775659,0.000229573,0.001687266,,NA,NA,NA,NA,NA
1969,Pocillopora_acuta_HIv2___RNAseq.g8748.t1,27.74796872,-8.217913938,3.801024665,0.000231219,0.001698502,,NA,NA,NA,NA,NA
1970,Pocillopora_acuta_HIv2___RNAseq.g7238.t1,68.93390379,-0.646437299,1.32801513,0.000231453,0.001699359,,Q8WU66,2.79E-34,Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR),hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505],GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170
1971,Pocillopora_acuta_HIv2___RNAseq.g627.t1,1143.281911,-2.302445504,0.800683251,0.000232023,0.001702677,,Q5F3Z9,5.19E-57,Zinc finger CCCH domain-containing protein 14,regulation of mRNA stability [GO:0043488],GO:0005634; GO:0005737; GO:0008143; GO:0016607; GO:0043488; GO:0046872
1972,Pocillopora_acuta_HIv2___RNAseq.g17516.t1,94.96559184,0.347537652,1.105473769,0.000232483,0.001705193,,NA,NA,NA,NA,NA
1973,Pocillopora_acuta_HIv2___RNAseq.g6924.t1,223.0074893,3.257429445,2.091668861,0.000232924,0.001707452,,NA,NA,NA,NA,NA
1974,Pocillopora_acuta_HIv2___RNAseq.g2185.t1b,2655.894355,-3.347448284,3.310677738,0.000233028,0.001707452,,Q00223,2.33E-33,Putative gastrointestinal growth factor xP4 (TFF p4.1),,GO:0005576; GO:0008083
1975,Pocillopora_acuta_HIv2___TS.g12436.t1b,139.1775937,-0.478102329,1.181389206,0.000233351,0.001708958,,NA,NA,NA,NA,NA
1976,Pocillopora_acuta_HIv2___RNAseq.g11537.t1,24.12498217,-8.343013051,3.848457901,0.000234035,0.001713096,,NA,NA,NA,NA,NA
1977,Pocillopora_acuta_HIv2___RNAseq.g16286.t1,191.6933827,-0.252948335,1.033788961,0.000235502,0.001722968,,Q5RJZ1,0,Regulator of telomere elongation helicase 1 (EC 5.6.2.-),DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA strand displacement [GO:0000732]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657],GO:0000723; GO:0000732; GO:0000781; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006281; GO:0010569; GO:0016607; GO:0016887; GO:0031297; GO:0031965; GO:0032206; GO:0032508; GO:0043247; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1902990; GO:1904355; GO:1904358; GO:1904430; GO:1904506; GO:1904535
1978,Pocillopora_acuta_HIv2___TS.g19260.t1,36.07687858,-8.220283439,3.970081884,0.000236073,0.001726268,,A7SLX5,0,2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1),protein histidyl modification to diphthamide [GO:0017183],GO:0017183; GO:0032991; GO:0046872; GO:0051539; GO:0090560
1979,Pocillopora_acuta_HIv2___TS.g14217.t2,79.3250448,3.371238291,2.616577539,0.000238054,0.001739875,,Q28DL4,2.16E-19,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),intracellular signaling cassette [GO:0141124]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122],GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005938; GO:0008270; GO:0042981; GO:0043122; GO:0070534; GO:0141124
1980,Pocillopora_acuta_HIv2___RNAseq.g7933.t1,205.4840738,-0.359554455,1.090647264,0.000238602,0.001742998,,Q6P011,5.87E-53,ER membrane protein complex subunit 4 (Transmembrane protein 85),protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],GO:0005789; GO:0016020; GO:0045050; GO:0071816; GO:0072546
1981,Pocillopora_acuta_HIv2___TS.g17954.t1b,296.0194893,-0.238081267,1.023848184,0.000238803,0.001743588,,Q8N3S3,2.11E-116,Protein PHTF2,,GO:0005783; GO:0016020
1982,Pocillopora_acuta_HIv2___RNAseq.g19581.t2,87.83675953,-0.751860478,1.37771814,0.000239578,0.001748365,,Q16629,8.11E-35,"Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7)","cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; RNA splicing [GO:0008380]",GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0048025; GO:0051028; GO:0070062; GO:1990830
1983,Pocillopora_acuta_HIv2___RNAseq.26080_t,148.3304621,-0.482405784,1.176983484,0.000239908,0.001749892,,Q8VCK5,3.91E-150,Kelch-like protein 20 (Kelch-like ECT2-interacting protein),Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390
1984,Pocillopora_acuta_HIv2___RNAseq.g20561.t1b,138.6121869,-3.678555426,3.095615818,0.000242959,0.001771251,,Q9ULJ7,2.78E-80,Ankyrin repeat domain-containing protein 50,endocytic recycling [GO:0032456]; protein transport [GO:0015031],GO:0005768; GO:0015031; GO:0032456
1985,Pocillopora_acuta_HIv2___RNAseq.g12754.t1,420.6090459,-0.115149264,1.019075522,0.000243967,0.001777033,,Q8AY68,7.97E-58,SHC-transforming protein 1 (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1) (p60Shc),intracellular signal transduction [GO:0035556],GO:0005737; GO:0035556
1986,Pocillopora_acuta_HIv2___RNAseq.g15568.t1,314.9599561,-0.280000668,1.031104679,0.000243998,0.001777033,,Q12466,3.60E-23,Tricalbin-1,endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; ER to Golgi ceramide transport [GO:0035621]; phospholipid homeostasis [GO:0055091]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],GO:0005544; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0008289; GO:0032541; GO:0035621; GO:0046872; GO:0055091; GO:0060304; GO:0061817; GO:0071944; GO:0090158
1987,Pocillopora_acuta_HIv2___TS.g1359.t1,25529.28633,2.478151057,0.91451909,0.000244964,0.001783167,Collagen alpha chain,B8V7R6,0,Collagen alpha chain,,GO:0005201; GO:0005576; GO:0005581
1988,Pocillopora_acuta_HIv2___RNAseq.g11387.t1,269.6022842,-0.458098916,1.15355632,0.000245941,0.001789326,ALK tyrosine kinase receptor (He et al 2023),NA,NA,NA,NA,NA
1989,Pocillopora_acuta_HIv2___RNAseq.g7095.t1,284.503741,-0.07342088,1.021905807,0.000246057,0.001789326,,Q9VWN9,1.07E-47,Zinc finger SWIM domain-containing protein 8 homolog (Protein dorado),positive regulation of miRNA catabolic process [GO:2000627]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958],GO:0008270; GO:0016567; GO:0031462; GO:0140958; GO:1990756; GO:2000627
1990,Pocillopora_acuta_HIv2___TS.g1376.t2,280.4025692,-1.069845312,1.67281609,0.000246252,0.001789842,,A8XI14,1.34E-28,Sugar transporter SWEET1,carbohydrate transport [GO:0008643],GO:0000139; GO:0005794; GO:0005886; GO:0008643; GO:0016020; GO:0051119
1991,Pocillopora_acuta_HIv2___RNAseq.g11672.t1,50.85165756,-0.820121366,1.503892329,0.000246571,0.001791265,,NA,NA,NA,NA,NA
1992,Pocillopora_acuta_HIv2___RNAseq.g20216.t1,23.44562448,1.161254318,2.261148813,0.000247902,0.001800025,,Q80TR8,3.48E-35,DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1),B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151],GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008180; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756
1993,Pocillopora_acuta_HIv2___RNAseq.g26290.t1,318.3956539,-0.073167363,1.02186262,0.000249702,0.001812187,,NA,NA,NA,NA,NA
1994,Pocillopora_acuta_HIv2___RNAseq.g6231.t1,198.9067199,1.463964943,2.591085743,0.000249953,0.001813101,,NA,NA,NA,NA,NA
1995,Pocillopora_acuta_HIv2___RNAseq.10959_t,274.8225866,0.129935724,1.017311492,0.000250249,0.001814181,,Q91924,4.68E-70,Zinc finger protein SNAI2 (Protein slug-alpha) (Protein snail homolog 2) (Snail protein homolog Slug) (xSlu),neural crest cell fate specification [GO:0014036]; neural crest cell migration [GO:0001755]; neural crest formation [GO:0014029],GO:0001755; GO:0003677; GO:0005634; GO:0014029; GO:0014036; GO:0046872
1996,Pocillopora_acuta_HIv2___RNAseq.g18027.t1,1566.637349,2.427356145,0.891944012,0.000250353,0.001814181,,NA,NA,NA,NA,NA
1997,Pocillopora_acuta_HIv2___RNAseq.g13581.t1,1030.776157,-2.860712781,3.319828718,0.000250531,0.001814564,,Q5EAU9,3.56E-54,Regulator of microtubule dynamics protein 3 (RMD-3) (Protein FAM82A2) (Protein FAM82C),,GO:0000922; GO:0005634; GO:0005741
1998,Pocillopora_acuta_HIv2___RNAseq.g19647.t1,77.83975917,-3.206885891,3.51120274,0.000250978,0.00181689,,Q7T105,2.63E-65,Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1) (Xmi-er1),chromatin remodeling [GO:0006338]; regulation of DNA-templated transcription [GO:0006355],GO:0003677; GO:0005634; GO:0006338; GO:0006355; GO:0017053
1999,Pocillopora_acuta_HIv2___RNAseq.g243.t1,69.70758162,-3.234294177,1.375636849,0.00025128,0.001818165,,P0CI65,5.90E-38,Nephrocystin-3,cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055],GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546
2000,Pocillopora_acuta_HIv2___RNAseq.g23056.t1,294.3490495,-0.203909809,1.020567597,0.000251439,0.001818406,,NA,NA,NA,NA,NA
2001,Pocillopora_acuta_HIv2___RNAseq.g25186.t1,446.6192094,2.073299718,3.345593402,0.000252195,0.001822961,,P70191,7.73E-42,TNF receptor-associated factor 5,apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0005164; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0048255; GO:0051092; GO:0070534; GO:0097400
2002,Pocillopora_acuta_HIv2___RNAseq.g3490.t1,156.261551,-0.539223827,1.227815287,0.000252344,0.001823129,,V6CLA2,3.03E-13,E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26),determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028],GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936
2003,Pocillopora_acuta_HIv2___RNAseq.g12374.t1,3131.42127,3.801437143,1.761211532,0.000253966,0.001833929,,Q9VH14,3.51E-17,Tissue inhibitor of metalloproteinase,"basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; delamination [GO:0060232]; imaginal disc-derived wing expansion [GO:0048526]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; oogenesis [GO:0048477]; phototaxis [GO:0042331]; tracheal outgrowth, open tracheal system [GO:0007426]; tracheal pit formation in open tracheal system [GO:0035202]; ventral cord development [GO:0007419]; wing disc morphogenesis [GO:0007472]",GO:0002020; GO:0005615; GO:0007155; GO:0007419; GO:0007426; GO:0007472; GO:0008191; GO:0008270; GO:0030425; GO:0031012; GO:0035202; GO:0042331; GO:0048477; GO:0048526; GO:0051045; GO:0060232; GO:0071711
2004,Pocillopora_acuta_HIv2___RNAseq.g14245.t1,316.0119078,-0.130339217,1.013722314,0.000254431,0.001836373,,NA,NA,NA,NA,NA
2005,Pocillopora_acuta_HIv2___RNAseq.g22998.t1,287.4616846,-0.753554733,1.430480399,0.000254559,0.001836378,,Q2KIN5,9.80E-122,Porphobilinogen deaminase (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS),heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],GO:0004418; GO:0005737; GO:0006782; GO:0006783
2006,Pocillopora_acuta_HIv2___TS.g4426.t1,151.7275865,-0.304859523,1.040871856,0.00025535,0.001841165,,Q9BYW2,2.53E-17,Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP),angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of ossification [GO:0045778]; regulation of cytokinesis [GO:0032465]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; response to alkaloid [GO:0043279]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation by RNA polymerase II [GO:0006368],GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006298; GO:0006355; GO:0006368; GO:0010038; GO:0010468; GO:0010508; GO:0010569; GO:0010793; GO:0014070; GO:0016279; GO:0018023; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0043279; GO:0045778; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0140938; GO:0140955; GO:1902850; GO:1905634
2007,Pocillopora_acuta_HIv2___RNAseq.g23004.t1,645.6190418,-2.682721375,1.145353342,0.000255496,0.001841303,,Q6GPD0,6.04E-171,Rho GTPase-activating protein 32 (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS),signal transduction [GO:0007165],GO:0005096; GO:0005737; GO:0005886; GO:0007165; GO:0014069; GO:1901981
2008,Pocillopora_acuta_HIv2___RNAseq.g25761.t1,1143.879047,2.572732081,1.009337251,0.000255962,0.001843743,,A6NMZ7,1.41E-45,Collagen alpha-6(VI) chain,cell adhesion [GO:0007155],GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023
2009,Pocillopora_acuta_HIv2___RNAseq.15128_t,61.34246016,-1.19035844,2.32759012,0.000257303,0.001852477,,NA,NA,NA,NA,NA
2010,Pocillopora_acuta_HIv2___RNAseq.g13423.t1,273.4506398,-0.222290422,1.037665637,0.00026212,0.001886204,,Q6GMG8,1.19E-27,Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog),,GO:0000139; GO:0003677; GO:0005634; GO:0008270; GO:0009898; GO:0098559; GO:0098560; GO:0098574
2011,Pocillopora_acuta_HIv2___TS.g2757.t1,150.9176796,-3.023125171,3.489832968,0.000262248,0.001886204,,Q9BSF4,1.86E-33,Mitochondrial import inner membrane translocase subunit Tim29 (TIM29),protein insertion into mitochondrial inner membrane [GO:0045039],GO:0005743; GO:0005758; GO:0042721; GO:0045039; GO:0140318
2012,Pocillopora_acuta_HIv2___RNAseq.g4455.t1,194.0431139,-0.448997335,1.119051989,0.000262824,0.001889403,,NA,NA,NA,NA,NA
2013,Pocillopora_acuta_HIv2___RNAseq.g18157.t1,672.9692042,-0.075491305,1.018863338,0.000263828,0.001895684,,Q68W49,4.39E-07,Uncharacterized protein RT0683,glycoprotein metabolic process [GO:0009100],GO:0009100; GO:0016020; GO:0016740
2014,Pocillopora_acuta_HIv2___RNAseq.g22638.t1,17813.05165,2.417703238,0.909687738,0.000265595,0.001907434,,P08120,0,Collagen alpha-1(IV) chain (Collagen type IV alpha 1),basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; dorsal closure [GO:0007391]; extracellular matrix organization [GO:0030198]; intestinal epithelial structure maintenance [GO:0060729]; post-embryonic digestive tract morphogenesis [GO:0048621],GO:0005201; GO:0005587; GO:0005604; GO:0005615; GO:0007391; GO:0030020; GO:0030198; GO:0048621; GO:0055013; GO:0060729; GO:0062023; GO:0071711
2015,Pocillopora_acuta_HIv2___RNAseq.g7319.t1,210.7941194,-0.858267517,1.500583218,0.000266227,0.001911019,,Q9LJG8,4.52E-06,Trihelix transcription factor ASIL2 (6B-interacting protein 1-like 2) (Trihelix DNA-binding protein ASIL2),embryo development ending in seed dormancy [GO:0009793]; regulation of DNA-templated transcription [GO:0006355]; seed maturation [GO:0010431],GO:0000976; GO:0003700; GO:0005634; GO:0006355; GO:0009793; GO:0010431
2016,Pocillopora_acuta_HIv2___RNAseq.g14413.t1,697.0721659,-0.719080152,1.360740103,0.000266624,0.001912919,,Q8BS45,0,Intraflagellar transport protein 56 (Protein hop-sterile) (Tetratricopeptide repeat protein 26) (TPR repeat protein 26),axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286],GO:0005813; GO:0005929; GO:0007224; GO:0007286; GO:0008594; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0043005; GO:0046530; GO:0060271; GO:0061512; GO:0097546; GO:0120170; GO:1905198
2017,Pocillopora_acuta_HIv2___TS.g20189.t3,331.2471587,-0.642991581,1.314032647,0.000267016,0.001914784,,Q9Z1N9,0,Protein unc-13 homolog B (Munc13-2) (munc13),"cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; phagosome maturation [GO:0090382]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of exocytosis [GO:0045921]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]",GO:0001566; GO:0005509; GO:0005516; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0007268; GO:0007528; GO:0010808; GO:0016079; GO:0016081; GO:0016082; GO:0017075; GO:0019905; GO:0019992; GO:0030672; GO:0031594; GO:0031914; GO:0032009; GO:0035249; GO:0042734; GO:0043195; GO:0044305; GO:0045921; GO:0048172; GO:0048786; GO:0050714; GO:0060384; GO:0061669; GO:0061789; GO:0071333; GO:0090382; GO:0097060; GO:0097151; GO:0097470; GO:0098686; GO:0098793; GO:0098831; GO:0098978; GO:0099011; GO:0099161; GO:0099525; GO:1900426
2018,Pocillopora_acuta_HIv2___RNAseq.g687.t1,352.0862812,-1.138170622,2.181617158,0.000268315,0.001923148,,Q9H9S5,1.16E-146,Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase),adult walking behavior [GO:0007628]; basement membrane organization [GO:0071711]; bone mineralization [GO:0030282]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; connective tissue development [GO:0061448]; connective tissue replacement [GO:0097709]; creatine metabolic process [GO:0006600]; diaphragm development [GO:0060539]; filtration diaphragm assembly [GO:0036058]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; localization of cell [GO:0051674]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; muscle contraction [GO:0006936]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; oxygen metabolic process [GO:0072592]; pentitol metabolic process [GO:0019519]; pentose metabolic process [GO:0019321]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein import [GO:0017038]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262]; reelin-mediated signaling pathway [GO:0038026]; reproductive process [GO:0022414]; respiratory system process [GO:0003016]; response to activity [GO:0014823]; response to alcohol [GO:0097305]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue regeneration [GO:0043403],GO:0000139; GO:0001701; GO:0001764; GO:0002162; GO:0003007; GO:0003016; GO:0005615; GO:0005654; GO:0005791; GO:0005794; GO:0005829; GO:0006096; GO:0006600; GO:0006629; GO:0006936; GO:0006954; GO:0007420; GO:0007628; GO:0009410; GO:0010001; GO:0014823; GO:0016485; GO:0016780; GO:0017038; GO:0019321; GO:0019519; GO:0022414; GO:0030282; GO:0035269; GO:0035437; GO:0036058; GO:0038026; GO:0042383; GO:0042802; GO:0043010; GO:0043236; GO:0043403; GO:0043491; GO:0046872; GO:0050905; GO:0051262; GO:0051384; GO:0051674; GO:0060539; GO:0061448; GO:0071711; GO:0072592; GO:0097305; GO:0097709; GO:0098528; GO:0098723
2019,Pocillopora_acuta_HIv2___TS.g9252.t1,530.0397888,-0.576374428,1.205642525,0.000268519,0.001923657,,Q9NZM4,3.39E-26,BRD4-interacting chromatin-remodeling complex-associated protein (Glioma tumor suppressor candidate region gene 1 protein),chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000785; GO:0005634; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0045893; GO:0140288; GO:0140537; GO:1902459
2020,Pocillopora_acuta_HIv2___RNAseq.g21376.t1,309.5406104,-0.901340008,1.556773904,0.000269151,0.00192723,,NA,NA,NA,NA,NA
2021,Pocillopora_acuta_HIv2___RNAseq.g31075.t1,285.601801,-0.285994663,1.060960235,0.000270069,0.001932847,,NA,NA,NA,NA,NA
2022,Pocillopora_acuta_HIv2___RNAseq.g23455.t1,86.48515022,3.344835394,1.823218869,0.000270229,0.001933031,,P27401,5.78E-07,Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)],DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; proteolysis [GO:0006508]; symbiont entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732],GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0006508; GO:0015074; GO:0030430; GO:0042025; GO:0043657; GO:0044423; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732
2023,Pocillopora_acuta_HIv2___RNAseq.g28025.t1,909.9587467,-2.369398729,0.853684411,0.000270797,0.001936142,,Q9JLB4,4.52E-24,Cubilin (Intrinsic factor-cobalamin receptor),cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584],GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062
2024,Pocillopora_acuta_HIv2___RNAseq.g29951.t1,553.4805789,2.324626332,0.797927959,0.00027258,0.001947926,,NA,NA,NA,NA,NA
2025,Pocillopora_acuta_HIv2___RNAseq.g23588.t1,1186.734308,2.450675695,0.896132035,0.000273406,0.001952859,,Q01484,3.68E-69,Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin),atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259
2026,Pocillopora_acuta_HIv2___RNAseq.g5494.t1,338.0076768,-2.761884555,1.390770952,0.000273677,0.00195383,,Q3SZV6,2.06E-26,"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)",mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein import into mitochondrial matrix [GO:0030150],GO:0005744; GO:0030150; GO:0032981; GO:0033617
2027,Pocillopora_acuta_HIv2___RNAseq.g23433.t1,206.0989136,-0.59976658,1.198565819,0.000275009,0.001962371,,NA,NA,NA,NA,NA
2028,Pocillopora_acuta_HIv2___RNAseq.g23170.t1,353.5956625,0.306068013,1.07365758,0.000275752,0.001966707,,Q9NYR8,1.67E-35,Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2),estrogen biosynthetic process [GO:0006703]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; visual perception [GO:0007601],GO:0004303; GO:0004745; GO:0005829; GO:0005886; GO:0006694; GO:0006703; GO:0007601; GO:0042572; GO:0052650
2029,Pocillopora_acuta_HIv2___TS.g30532.t1,196.533479,-0.504796135,1.196676907,0.000276518,0.001971193,,Q9NYA1,1.68E-73,Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-),blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670],GO:0000287; GO:0001568; GO:0001727; GO:0003677; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006473; GO:0006670; GO:0006954; GO:0007420; GO:0008283; GO:0008289; GO:0008481; GO:0010800; GO:0010803; GO:0016020; GO:0016310; GO:0016407; GO:0017050; GO:0019722; GO:0030100; GO:0030139; GO:0030148; GO:0030307; GO:0030335; GO:0031398; GO:0031901; GO:0032651; GO:0032740; GO:0034612; GO:0035556; GO:0035924; GO:0038036; GO:0043066; GO:0043231; GO:0045766; GO:0045840; GO:0045931; GO:0045987; GO:0046512; GO:0046521; GO:0048146; GO:0050764; GO:0051092; GO:0051721; GO:0070301; GO:0071363; GO:0071897; GO:0098793; GO:0150077; GO:1900060; GO:1900745; GO:1901224; GO:1903978; GO:1905364
2030,Pocillopora_acuta_HIv2___RNAseq.g24454.t1,124.9705337,-0.416607239,1.125664344,0.000277536,0.00197748,,NA,NA,NA,NA,NA
2031,Pocillopora_acuta_HIv2___RNAseq.g18444.t1a,574.6470021,-0.466660626,1.098544704,0.00027788,0.001978955,,Q8BIG7,1.05E-54,Catechol O-methyltransferase domain-containing protein 1 (EC 2.1.1.-),methylation [GO:0032259],GO:0005739; GO:0008171; GO:0008757; GO:0016020; GO:0032259
2032,Pocillopora_acuta_HIv2___RNAseq.g6299.t1,72.0797018,-2.817847095,1.100624365,0.000278563,0.001982843,,NA,NA,NA,NA,NA
2033,Pocillopora_acuta_HIv2___TS.g17942.t1,290.9297405,-0.122214697,1.012919441,0.00027882,0.001983698,,Q66KL0,7.41E-27,Probable N-acetyltransferase camello (EC 2.3.1.-),gastrulation with mouth forming second [GO:0001702]; negative regulation of cell adhesion [GO:0007162],GO:0000139; GO:0001702; GO:0005794; GO:0007162; GO:0016747
2034,Pocillopora_acuta_HIv2___RNAseq.g8723.t1,339.3219034,-0.487066528,1.143376992,0.000279138,0.00198498,,D4A1X2,0,Exosome complex component 10 (EC 3.1.13.-),"CUT catabolic process [GO:0071034]; DNA repair [GO:0006281]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; ribosomal small subunit biogenesis [GO:0042274]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]",GO:0000166; GO:0000175; GO:0000176; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000791; GO:0000956; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006396; GO:0006401; GO:0032040; GO:0032211; GO:0042274; GO:0046872; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071051; GO:1904872; GO:1905746
2035,Pocillopora_acuta_HIv2___RNAseq.g28270.t1,299.7999027,-6.330536063,5.439556585,0.00028004,0.001990419,,O08734,1.42E-26,Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK),animal organ regeneration [GO:0031100]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; epithelial cell proliferation [GO:0050673]; establishment of localization in cell [GO:0051649]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; homeostasis of number of cells [GO:0048872]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; leukocyte homeostasis [GO:0001776]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],GO:0001776; GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0008053; GO:0008285; GO:0008630; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0014070; GO:0015288; GO:0031018; GO:0031072; GO:0031100; GO:0031334; GO:0031966; GO:0032471; GO:0033137; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0048872; GO:0050673; GO:0051087; GO:0051400; GO:0051649; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097145; GO:0097192; GO:1900103; GO:1901029; GO:1901030; GO:1902262
2036,Pocillopora_acuta_HIv2___RNAseq.25881_t,160.2035222,-0.564782845,1.243050118,0.000280318,0.001991417,Collagen triple helix repeat-containing protein 1,Q96CG8,2.24E-45,Collagen triple helix repeat-containing protein 1,"cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016528; GO:0017147; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177
2037,Pocillopora_acuta_HIv2___TS.g12917.t1,299.8460073,-0.295027061,1.060953442,0.000280711,0.001993226,,B7ZUF3,4.60E-136,Actin-histidine N-methyltransferase (EC 2.1.1.85) (Protein-L-histidine N-tele-methyltransferase) (SET domain-containing protein 3),actin modification [GO:0030047]; peptidyl-histidine methylation [GO:0018021]; positive regulation of DNA-templated transcription [GO:0045893],GO:0003713; GO:0003779; GO:0005737; GO:0018021; GO:0018064; GO:0030047; GO:0045893; GO:0046975
2038,Pocillopora_acuta_HIv2___RNAseq.g802.t1,510.719433,3.32025759,1.493563368,0.000282713,0.002006456,,Q90Z00,1.16E-08,Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A),anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589],GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0018108; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699
2039,Pocillopora_acuta_HIv2___RNAseq.g16973.t1,38.98652823,-0.25860206,1.067996574,0.000283778,0.002013031,,NA,NA,NA,NA,NA
2040,Pocillopora_acuta_HIv2___RNAseq.g27067.t1,1363.70016,1.13792474,1.913294246,0.000285477,0.002024089,,NA,NA,NA,NA,NA
2041,Pocillopora_acuta_HIv2___TS.g26977.t1,174.2317889,-0.505294801,1.135785841,0.000286098,0.002027496,,Q9W6H5,1.59E-55,SUMO-conjugating enzyme UBC9-A (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9-A) (SUMO-protein ligase A) (Ubiquitin carrier protein 9-A) (Ubiquitin carrier protein I-A) (Ubiquitin-conjugating enzyme E2 I-A) (Ubiquitin-protein ligase I-A),cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; hematopoietic stem cell homeostasis [GO:0061484]; protein sumoylation [GO:0016925]; regeneration [GO:0031099]; regulation of mitotic nuclear division [GO:0007088],GO:0001947; GO:0005524; GO:0005634; GO:0007059; GO:0007088; GO:0016925; GO:0019789; GO:0031099; GO:0036306; GO:0051301; GO:0060216; GO:0061484; GO:0061656
2042,Pocillopora_acuta_HIv2___RNAseq.g8074.t1,235.6410622,-0.366620516,1.062365737,0.000287155,0.00203399,,Q8R151,7.17E-09,NFX1-type zinc finger-containing protein 1,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607
2043,Pocillopora_acuta_HIv2___RNAseq.g14426.t1,202.9773658,-3.178527474,2.178145375,0.00028971,0.002051087,,Q9H0C5,2.86E-16,BTB/POZ domain-containing protein 1 (Hepatitis C virus NS5A-transactivated protein 8) (HCV NS5A-transactivated protein 8),muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393],GO:0000932; GO:0005654; GO:0005829; GO:0007517; GO:0016567; GO:0022008; GO:0032991; GO:0036464; GO:0042802; GO:0043393; GO:0097602
2044,Pocillopora_acuta_HIv2___RNAseq.g26113.t1,182.8806745,-0.641049322,1.343670965,0.000291263,0.002061071,,A7RF00,1.51E-163,Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein),L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],GO:0005634; GO:0005737; GO:0019284; GO:0019509; GO:0046523
2045,Pocillopora_acuta_HIv2___RNAseq.g5127.t1,179.8381217,-0.491477114,1.121395254,0.000292079,0.002065835,,Q07E28,4.23E-15,Cortactin-binding protein 2 (CortBP2),regulation of synapse organization [GO:0050807],GO:0005938; GO:0043197; GO:0050807; GO:0090443; GO:0098978
2046,Pocillopora_acuta_HIv2___RNAseq.g8806.t1,206.1474789,-0.150340333,1.019958445,0.000294243,0.002080124,,Q9UDY8,4.88E-64,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321
2047,Pocillopora_acuta_HIv2___RNAseq.g4571.t1,129.2554408,-0.46700104,1.161680216,0.000296292,0.002092071,,Q9EQD2,3.01E-25,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408],GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408
2048,Pocillopora_acuta_HIv2___RNAseq.g6270.t1,176.1553875,-0.186573552,1.020128592,0.000296341,0.002092071,,Q9Y2Y1,1.32E-57,DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III 12.5 kDa subunit) (RPC12.5) (RNA polymerase III subunit C11) (HsC11p) (RPC11) (hRPC11),defense response to virus [GO:0051607]; innate immune response [GO:0045087]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase III [GO:0006383],GO:0003676; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0006386; GO:0008270; GO:0045087; GO:0051607
2049,Pocillopora_acuta_HIv2___RNAseq.g7076.t1,1274.537131,3.527245853,1.516794515,0.000296367,0.002092071,,NA,NA,NA,NA,NA
2050,Pocillopora_acuta_HIv2___RNAseq.g11921.t1,187.9492311,-0.347337403,1.085997306,0.000296666,0.002093163,,A7RFA1,2.55E-168,Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein),catabolic process [GO:0009056],GO:0008270; GO:0009056; GO:0016787
2051,Pocillopora_acuta_HIv2___RNAseq.g15832.t1,1352.417978,3.389429521,2.196470444,0.000296963,0.002094237,,B3EWZ5,2.52E-152,MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1),,GO:0005576; GO:0016020
2052,Pocillopora_acuta_HIv2___RNAseq.g14247.t1,252.9924311,-0.454124941,1.137198055,0.000297631,0.002097923,,Q5VRY0,2.99E-81,DEAD-box ATP-dependent RNA helicase 39 (EC 3.6.4.13),mitochondrial large ribosomal subunit assembly [GO:1902775],GO:0003723; GO:0003724; GO:0005524; GO:0005739; GO:0016887; GO:1902775
2053,Pocillopora_acuta_HIv2___RNAseq.g6741.t1,1443.786641,0.887958814,1.570326587,0.000298178,0.002100756,,A4IGD2,3.00E-08,N-acetylaspartate synthetase (NAA synthetase) (EC 2.3.1.17) (N-acetyltransferase 8-like protein),,GO:0005739; GO:0005789; GO:0017188; GO:0031966; GO:0043231
2054,Pocillopora_acuta_HIv2___RNAseq.g15951.t1,127.8171498,1.007952861,1.749073004,0.000298889,0.00210474,,NA,NA,NA,NA,NA
2055,Pocillopora_acuta_HIv2___RNAseq.g2577.t1,2312.203196,2.787873276,1.240984407,0.000300131,0.002112452,,B2RVL6,9.01E-80,Zinc finger CCHC domain-containing protein 24,,GO:0003676; GO:0008270
2056,Pocillopora_acuta_HIv2___RNAseq.g11589.t1,43.62564062,-4.39866458,1.768624497,0.000302013,0.002124666,,Q86YH6,1.29E-83,All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2) (EC 2.5.1.91) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2),cerebellum development [GO:0021549]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744],GO:0004659; GO:0005759; GO:0005829; GO:0006744; GO:0008299; GO:0021549; GO:0032478; GO:0046982; GO:0050878; GO:0052923; GO:0097269; GO:1990234
2057,Pocillopora_acuta_HIv2___RNAseq.g24648.t1,463.3145433,-0.258626243,1.053824179,0.000302723,0.002128627,,P97376,3.19E-69,Protein FRG1 (FSHD region gene 1 protein),mRNA processing [GO:0006397]; muscle organ development [GO:0007517]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],GO:0003723; GO:0005730; GO:0006364; GO:0006397; GO:0007517; GO:0008380; GO:0015030; GO:0030018; GO:0051015; GO:0055120; GO:0071013
2058,Pocillopora_acuta_HIv2___TS.g21744.t2,279.0222382,-0.188431735,1.025249406,0.000304829,0.002142396,Aromatic amino acid transporter 1,Q3U9N9,1.48E-11,Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1),aromatic amino acid transport [GO:0015801]; thyroid hormone generation [GO:0006590]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460],GO:0005302; GO:0005886; GO:0006590; GO:0008028; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0030054; GO:0043231; GO:0070327; GO:0070460
2059,Pocillopora_acuta_HIv2___RNAseq.g15155.t1,1418.716851,1.876555367,0.601359591,0.000307236,0.002158259,,NA,NA,NA,NA,NA
2060,Pocillopora_acuta_HIv2___RNAseq.g9066.t1,473.9050133,1.987805557,0.650324225,0.000308269,0.002164467,,NA,NA,NA,NA,NA
2061,Pocillopora_acuta_HIv2___RNAseq.g1346.t1,309.0091603,-0.34265902,1.080520937,0.000309129,0.002168755,,NA,NA,NA,NA,NA
2062,Pocillopora_acuta_HIv2___RNAseq.g3788.t1,210.8732247,-2.515458435,2.732579216,0.00030918,0.002168755,,Q6DG32,1.12E-98,Solute carrier family 25 member 36-A,mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleotide import into mitochondrion [GO:1990519],GO:0000002; GO:0005739; GO:0005743; GO:0015218; GO:1990519
2063,Pocillopora_acuta_HIv2___TS.g17224.t2,948.35661,-0.846907149,1.42817438,0.000309645,0.002170968,,Q5TM68,1.96E-46,Mediator of DNA damage checkpoint protein 1,DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein localization to site of double-strand break [GO:1990166],GO:0000076; GO:0005634; GO:0005694; GO:0006281; GO:0035861; GO:0060261; GO:0140463; GO:0140566; GO:1990166
2064,Pocillopora_acuta_HIv2___TS.g23178.t1,7125.514684,2.606088501,1.069485236,0.000309804,0.002171028,,A0MSJ1,4.25E-146,Collagen alpha-1(XXVII) chain B,bone mineralization [GO:0030282]; extracellular matrix organization [GO:0030198]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501],GO:0001501; GO:0005581; GO:0005615; GO:0030020; GO:0030198; GO:0030282; GO:0046872; GO:0048570; GO:0062023
2065,Pocillopora_acuta_HIv2___TS.g435.t1,746.4676811,-2.487362511,0.973709966,0.000311585,0.002182453,,NA,NA,NA,NA,NA
2066,Pocillopora_acuta_HIv2___RNAseq.g25504.t1,34.3360567,-0.78315885,1.470886367,0.000312455,0.002187491,,B8VIU6,2.64E-12,Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5),,GO:0005576
2067,Pocillopora_acuta_HIv2___RNAseq.g25867.t1,750.9977822,-2.756631438,3.078558769,0.000314852,0.002203204,,Q0VCA2,7.31E-30,Arrestin domain-containing protein 3,protein transport [GO:0015031],GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031
2068,Pocillopora_acuta_HIv2___TS.g23497.t1b,237.0411795,-0.685962096,1.270883588,0.000315919,0.002209602,,O18806,6.79E-21,Coagulation factor VIII (Procoagulant component),"acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597]",GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491
2069,Pocillopora_acuta_HIv2___RNAseq.g20669.t1,343.7723535,-1.062240812,1.671885907,0.000316576,0.002213127,,P46428,2.23E-31,Glutathione S-transferase (EC 2.5.1.18) (GST class-sigma),,GO:0004364
2070,Pocillopora_acuta_HIv2___TS.g15106.t1,53.83553691,-0.899805361,1.68238273,0.000316778,0.002213471,,Q54TD7,4.34E-43,ATP-dependent RNA helicase ddx24 (EC 3.6.4.13) (DEAD box protein 24),,GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887
2071,Pocillopora_acuta_HIv2___RNAseq.g7710.t1,698.7774754,-0.228975009,1.030525761,0.000317754,0.002219217,,P49656,5.35E-103,"Inward rectifier potassium channel 2 (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2)",cardiac muscle cell action potential involved in contraction [GO:0086002]; magnesium ion transport [GO:0015693]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076],GO:0005242; GO:0005546; GO:0006813; GO:0008076; GO:0014861; GO:0015693; GO:0016020; GO:0034765; GO:0042802; GO:0051289; GO:0055119; GO:0060306; GO:0086002; GO:0086008; GO:0086091; GO:0090076; GO:1990573
2072,Pocillopora_acuta_HIv2___TS.g8003.t2,611.8843732,0.886268404,1.475039724,0.000318997,0.002226821,,NA,NA,NA,NA,NA
2073,Pocillopora_acuta_HIv2___RNAseq.g19687.t1,82.4098037,-1.399495116,2.243972994,0.00031925,0.002227514,,NA,NA,NA,NA,NA
2074,Pocillopora_acuta_HIv2___RNAseq.g13644.t1a,215.2551627,-0.302022467,1.044270793,0.000319537,0.002228274,,NA,NA,NA,NA,NA
2075,Pocillopora_acuta_HIv2___RNAseq.g7585.t1,4729.513434,-2.185793837,0.771330181,0.000319667,0.002228274,,Q5T089,9.66E-06,MORN repeat-containing protein 1,,
2076,Pocillopora_acuta_HIv2___TS.g8275.t1,401.495413,-1.748259531,3.99144581,0.000321256,0.002238269,,P08059,0,Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI),gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096],GO:0004347; GO:0005125; GO:0005615; GO:0005829; GO:0006094; GO:0006096; GO:0048029; GO:0051156; GO:0097367
2077,Pocillopora_acuta_HIv2___RNAseq.g2037.t1,67.59595895,2.689198351,1.002643631,0.000321915,0.002241781,,Q6JEL3,3.36E-34,Kelch-like protein 10,cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286],GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873
2078,Pocillopora_acuta_HIv2___TS.g30418.t1,154.979399,-0.362763046,1.092420584,0.000326852,0.002275066,,Q8R4N0,2.79E-105,"Citramalyl-CoA lyase, mitochondrial (EC 4.1.3.25) ((3S)-malyl-CoA thioesterase) (EC 3.1.2.30) (Beta-methylmalate synthase) (EC 2.3.3.-) (Citrate lyase subunit beta-like protein, mitochondrial) (Citrate lyase beta-like) (Malate synthase) (EC 2.3.3.9)",positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064],GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064; GO:0106121
2079,Pocillopora_acuta_HIv2___RNAseq.g28255.t1,1346.055774,-2.490663373,1.014643356,0.000329155,0.002289991,,Q6DIR8,0,Paladin,,GO:0005829
2080,Pocillopora_acuta_HIv2___RNAseq.g14739.t1,196.5001618,-0.819419227,1.483208163,0.00032995,0.002294419,,NA,NA,NA,NA,NA
2081,Pocillopora_acuta_HIv2___RNAseq.g12286.t1,225.8849725,-2.867117271,1.160262602,0.000332523,0.002311205,Fucolectin-4,Q9I928,1.20E-13,Fucolectin-4,"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]",GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088
2082,Pocillopora_acuta_HIv2___RNAseq.g21947.t1,438.5841065,0.558519439,1.217636081,0.000333185,0.00231469,,Q5BJJ7,7.49E-45,Protein BCCIP homolog,DNA repair [GO:0006281]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052],GO:0000226; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0006281; GO:0007052; GO:0034453; GO:0090307; GO:0097431
2083,Pocillopora_acuta_HIv2___RNAseq.g7899.t1,164.1474002,-0.630700263,1.330716046,0.000333447,0.002315402,,NA,NA,NA,NA,NA
2084,Pocillopora_acuta_HIv2___TS.g89.t3,138.4387101,-0.386144499,1.107363369,0.000337954,0.002345571,,Q5R405,2.87E-24,Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit),regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation-coupled chromatin remodeling [GO:0140673],GO:0003729; GO:0006357; GO:0032044; GO:0032784; GO:0140673
2085,Pocillopora_acuta_HIv2___RNAseq.g27943.t1,252.20791,-0.361895958,1.062686625,0.000338207,0.002346201,,P91427,1.88E-87,Probable phosphoglycerate kinase (EC 2.7.2.3),gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310],GO:0004618; GO:0005524; GO:0005829; GO:0006094; GO:0006096; GO:0016310; GO:0043531
2086,Pocillopora_acuta_HIv2___RNAseq.g8312.t1,328.1664847,-0.246981804,1.050877515,0.000340209,0.002358959,,Q6NRK9,6.52E-64,Cyclin-Q (Cyclin-related protein FAM58A),regulation of transcription by RNA polymerase II [GO:0006357],GO:0006357; GO:0016538
2087,Pocillopora_acuta_HIv2___RNAseq.g12892.t1,323.7032148,2.710755374,2.996735965,0.000341067,0.002363769,,Q2KHZ8,1.26E-164,Lysosomal acid glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase),autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006],GO:0004336; GO:0004348; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0030259; GO:0032006; GO:0046527; GO:0050295
2088,Pocillopora_acuta_HIv2___RNAseq.g10662.t1,206.6669832,-0.093858446,1.016845068,0.000341518,0.002365766,,NA,NA,NA,NA,NA
2089,Pocillopora_acuta_HIv2___RNAseq.g15537.t1,233.9662036,-0.53150541,1.220678699,0.000342223,0.002369515,,NA,NA,NA,NA,NA
2090,Pocillopora_acuta_HIv2___RNAseq.g23847.t1,239.2341721,-0.421973833,1.127742233,0.000342416,0.002369719,,Q9VQ56,1.41E-66,Fez family zinc finger protein erm (Earmuff),axon target recognition [GO:0007412]; axonogenesis involved in innervation [GO:0060385]; cell dedifferentiation [GO:0043697]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of gene expression [GO:0010628]; positive regulation of netrin-activated signaling pathway [GO:1902843]; positive regulation of neuron differentiation [GO:0045666]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827],GO:0000976; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0007406; GO:0007412; GO:0010628; GO:0010629; GO:0019827; GO:0043025; GO:0043565; GO:0043697; GO:0044295; GO:0045666; GO:0045892; GO:0046872; GO:0050767; GO:0060385; GO:0072499; GO:1902692; GO:1902843
2091,Pocillopora_acuta_HIv2___RNAseq.g17110.t1,1561.271245,0.910542834,1.61475749,0.000343264,0.002374446,,Q08378,6.04E-48,Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa) (GCP170) (Golgin-160),,GO:0000139; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0016020; GO:0032580; GO:0045296
2092,Pocillopora_acuta_HIv2___TS.g17614.t3,148.8473813,0.085497389,1.02222345,0.00034443,0.002381374,,Q96AX1,7.21E-148,Vacuolar protein sorting-associated protein 33A (hVPS33A),autophagosome maturation [GO:0097352]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192],GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0010008; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0034058; GO:0035542; GO:0035751; GO:0048070; GO:0048471; GO:0097352
2093,Pocillopora_acuta_HIv2___RNAseq.g2544.t1,233.8152548,0.38980546,1.096051339,0.000344906,0.002383526,Monocarboxylate transporter 10 (MCT 10),A1L1W9,1.85E-67,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],GO:0005302; GO:0005886; GO:0008028; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0070327
2094,Pocillopora_acuta_HIv2___RNAseq.g28910.t1,2807.767046,3.321814546,1.973555859,0.000345663,0.002387617,,O00339,4.12E-72,Matrilin-2,axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678],GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216
2095,Pocillopora_acuta_HIv2___RNAseq.g6624.t1,106.7174508,-0.792975705,1.37837854,0.000346118,0.002389622,,Q28I85,0,POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A),,GO:0005737; GO:0005856
2096,Pocillopora_acuta_HIv2___RNAseq.g2842.t1,663.5475297,-0.330572796,1.076855617,0.000348119,0.002402285,,NA,NA,NA,NA,NA
2097,Pocillopora_acuta_HIv2___TS.g11679.t1,18441.47839,0.18434711,1.033421343,0.000349023,0.002407376,,NA,NA,NA,NA,NA
2098,Pocillopora_acuta_HIv2___RNAseq.g20688.t1,4154.693217,-1.937449618,0.645117961,0.000349892,0.002411946,Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR),Q8WU66,2.96E-18,Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR),hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505],GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170
2099,Pocillopora_acuta_HIv2___RNAseq.g26278.t1,93.39659012,0.424423998,1.083088403,0.000350019,0.002411946,,NA,NA,NA,NA,NA
2100,Pocillopora_acuta_HIv2___RNAseq.5656_t,23.66433791,-5.660669989,2.7799842,0.000354852,0.002444086,,NA,NA,NA,NA,NA
2101,Pocillopora_acuta_HIv2___RNAseq.g13188.t1,134.7510415,-0.316352712,1.09329386,0.000355814,0.002449546,,NA,NA,NA,NA,NA
2102,Pocillopora_acuta_HIv2___RNAseq.g12553.t1,424.6526386,-0.921300693,1.762053234,0.000356068,0.002450128,,P16112,1.27E-13,Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2],cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; proteolysis [GO:0006508]; skeletal system development [GO:0001501],GO:0001501; GO:0002052; GO:0005201; GO:0005540; GO:0005576; GO:0005615; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0043202; GO:0045202; GO:0046872; GO:0062023; GO:0072534
2103,Pocillopora_acuta_HIv2___TS.g22255.t1,323.3436838,-0.59821251,1.205507161,0.000356238,0.002450134,,NA,NA,NA,NA,NA
2104,Pocillopora_acuta_HIv2___RNAseq.g1863.t1,1426.300509,-2.673683217,1.19901548,0.000356481,0.002450636,,Q8TD57,0,Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b),cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285],GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729
2105,Pocillopora_acuta_HIv2___RNAseq.g5911.t1,116.5638091,0.310802116,1.0701936,0.000358932,0.002466312,,P98160,1.01E-24,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide],angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of endothelial cell proliferation [GO:0001938]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224],GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031100; GO:0043202; GO:0050750; GO:0062023; GO:0070052; GO:0070062; GO:0072359; GO:0098797
2106,Pocillopora_acuta_HIv2___RNAseq.g6304.t1,576.2768002,-0.374717698,1.064403225,0.000360708,0.002477342,,Q5IGR8,0,Exostosin-1a (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase 1a) (Multiple exostoses protein 1 homolog a),heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486],GO:0005789; GO:0005794; GO:0006486; GO:0008375; GO:0015012; GO:0015020; GO:0046872; GO:0050508; GO:0050509
2107,Pocillopora_acuta_HIv2___RNAseq.g29055.t1,155.0859001,-0.240065998,1.025641772,0.000361546,0.002481921,,Q5ZKH0,4.62E-32,General transcription factor IIH subunit 5 (General transcription factor IIH polypeptide 5) (TFB5 ortholog) (TFIIH basal transcription factor complex TTD-A subunit) (TFIIH subunit p8),"nucleotide-excision repair, preincision complex assembly [GO:0006294]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]",GO:0000439; GO:0005654; GO:0005675; GO:0005737; GO:0006294; GO:0006366; GO:0006367
2108,Pocillopora_acuta_HIv2___RNAseq.g25094.t1,464.9225331,-0.644182254,1.230022458,0.000361948,0.002483499,,NA,NA,NA,NA,NA
2109,Pocillopora_acuta_HIv2___TS.g27154.t2,473.7524683,0.405253724,1.118185652,0.000362474,0.002485928,,Q12952,1.79E-46,Forkhead box protein L1 (Forkhead-related protein FKHL11) (Forkhead-related transcription factor 7) (FREAC-7),anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495],GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007495; GO:0007507; GO:0008301; GO:0009653; GO:0030111; GO:0030154; GO:0030166; GO:0043565; GO:0061146
2110,Pocillopora_acuta_HIv2___TS.g6704.t2,102.7494607,-0.524455082,1.212621803,0.000365444,0.002505107,,NA,NA,NA,NA,NA
2111,Pocillopora_acuta_HIv2___RNAseq.g23886.t1,1411.881308,3.256121298,1.734087265,0.000367754,0.002519753,,P07942,0,Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta),cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446],GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005788; GO:0007155; GO:0021812; GO:0030335; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0050679; GO:0051149; GO:0062023; GO:0070062; GO:0098637; GO:0110011; GO:2001046
2112,Pocillopora_acuta_HIv2___TS.g26218.t1,5184.380103,-1.767434403,0.56848338,0.000369176,0.0025283,,NA,NA,NA,NA,NA
2113,Pocillopora_acuta_HIv2___RNAseq.g16037.t1,1991.338554,2.443954287,0.985726589,0.000370655,0.002537224,,Q96AY4,4.01E-24,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301
2114,Pocillopora_acuta_HIv2___RNAseq.g30567.t1,218.2695338,-0.528744233,1.225323614,0.000370934,0.002537932,,NA,NA,NA,NA,NA
2115,Pocillopora_acuta_HIv2___RNAseq.g16772.t1,257.6974344,3.170790171,2.478936481,0.00037228,0.002545939,,NA,NA,NA,NA,NA
2116,Pocillopora_acuta_HIv2___TS.g30706.t1,241.3365605,1.019856045,1.958690579,0.000375842,0.002569081,,P33450,4.31E-16,Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito],"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]",GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0090175; GO:0090176; GO:0090251; GO:0098609
2117,Pocillopora_acuta_HIv2___RNAseq.g25643.t1,32.7608848,-0.260799525,1.068574148,0.000376243,0.002570608,,Q99PW8,2.75E-37,Kinesin-like protein KIF17 (MmKIF17),anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098794; GO:0098971; GO:1990075
2118,Pocillopora_acuta_HIv2___RNAseq.g27607.t1,306.9908273,-0.131282998,1.013748913,0.000378184,0.002582648,,Q2KIP7,2.65E-72,Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2),"cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell growth [GO:0001558]",GO:0001558; GO:0005634; GO:0005737; GO:0005819; GO:0006302; GO:0008432; GO:0016035; GO:0033138; GO:0042177; GO:0042772; GO:0045893; GO:0051301; GO:1904667
2119,Pocillopora_acuta_HIv2___RNAseq.g25859.t1,195.3465586,-0.172735084,1.023896809,0.00037934,0.002589324,,NA,NA,NA,NA,NA
2120,Pocillopora_acuta_HIv2___RNAseq.g14639.t1,232.8527125,-0.239399066,1.050766101,0.000381448,0.002602482,,P48508,4.73E-65,Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit),apoptotic mitochondrial changes [GO:0008637]; blood vessel diameter maintenance [GO:0097746]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],GO:0004357; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007584; GO:0008637; GO:0009410; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035729; GO:0035733; GO:0043524; GO:0044344; GO:0044752; GO:0044877; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990830; GO:2001237
2121,Pocillopora_acuta_HIv2___RNAseq.g26349.t1,328.3559389,-0.130188539,1.017705547,0.000381763,0.002603402,,Q3UY34,4.06E-06,Protein CUSTOS,negative regulation of Wnt signaling pathway [GO:0030178]; Spemann organizer formation [GO:0060061]; Wnt signaling pathway [GO:0016055],GO:0005635; GO:0016055; GO:0030178; GO:0060061
2122,Pocillopora_acuta_HIv2___RNAseq.g4073.t1,505.37799,2.736604142,3.148900182,0.000381996,0.002603767,,P17124,1.31E-44,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),"chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; positive regulation of vasoconstriction [GO:0045907]",GO:0001696; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0045907
2123,Pocillopora_acuta_HIv2___TS.g20534.t1,511.1984852,-0.150256038,1.020127213,0.000385511,0.002625689,,Q1ZXH8,5.76E-20,Guanine exchange factor for Rac 30,aggregation involved in sorocarp development [GO:0031152]; intracellular signal transduction [GO:0035556]; sorocarp development [GO:0030587],GO:0005085; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005938; GO:0016020; GO:0030587; GO:0030670; GO:0031152; GO:0031267; GO:0032009; GO:0035556; GO:0046872
2124,Pocillopora_acuta_HIv2___RNAseq.g20678.t1b,6419.057177,-1.870542486,0.618408958,0.000385575,0.002625689,,Q6DK93,4.71E-19,Cornifelin homolog,,
2125,Pocillopora_acuta_HIv2___TS.g2427.t1,60.1061979,-0.723993279,1.389009406,0.00038592,0.002626799,,Q99JI4,1.14E-09,26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (p42A),proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005838; GO:0022624; GO:0043161
2126,Pocillopora_acuta_HIv2___RNAseq.g19367.t1,1104.627374,-2.677667495,1.24391777,0.000391546,0.002662831,,Q9WU20,0,Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53),methionine biosynthetic process [GO:0009086]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],GO:0004489; GO:0009086; GO:0035999; GO:0046653; GO:0050660; GO:0050661; GO:0071949; GO:0106313
2127,Pocillopora_acuta_HIv2___RNAseq.g27039.t1,5675.97668,3.345600949,1.51349231,0.000391582,0.002662831,Protein Wnt-8b,P51029,9.02E-25,Protein Wnt-8b,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055],GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679
2128,Pocillopora_acuta_HIv2___RNAseq.g12406.t1,147.2185514,-0.668119288,1.369255339,0.000391811,0.00266314,,P11121,3.15E-31,Calmodulin (CaM),,GO:0005509; GO:0030234
2129,Pocillopora_acuta_HIv2___RNAseq.g5894.t1,212.7711483,-0.171872659,1.022580431,0.000393748,0.002675044,,Q94K49,6.31E-09,Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 (EC 3.1.-.-),epigenetic regulation of gene expression [GO:0040029],GO:0003682; GO:0004518; GO:0005634; GO:0035098; GO:0035102; GO:0040029; GO:0046872
2130,Pocillopora_acuta_HIv2___TS.g4251.t1b,497.7810817,-1.096621327,1.781224029,0.000394475,0.002678729,,NA,NA,NA,NA,NA
2131,Pocillopora_acuta_HIv2___RNAseq.g10516.t1,280.1903167,-0.31681385,1.071321797,0.000394858,0.002680068,,Q92547,1.31E-64,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212],GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166
2132,Pocillopora_acuta_HIv2___RNAseq.g7809.t1,1634.908702,-2.545357933,1.11028793,0.000397479,0.002696046,,NA,NA,NA,NA,NA
2133,Pocillopora_acuta_HIv2___TS.g23877.t1,125.9952675,-0.774169226,1.399753137,0.000397585,0.002696046,,Q4UMH6,3.80E-56,Putative ankyrin repeat protein RF_0381,guanosine tetraphosphate metabolic process [GO:0015969],GO:0015969
2134,Pocillopora_acuta_HIv2___RNAseq.g29317.t1,399.0398172,-0.412218855,1.110340085,0.000397826,0.002696417,,Q14527,0,Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3),DNA repair [GO:0006281]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767],GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006281; GO:0008094; GO:0008270; GO:0016020; GO:0016363; GO:0016567; GO:0016818; GO:0031625; GO:0042789; GO:0045944; GO:0050767; GO:0061630; GO:0090575; GO:0140658
2135,Pocillopora_acuta_HIv2___RNAseq.g12002.t1,197.3914752,-0.565810768,1.246085024,0.000401794,0.002721145,,Q9US12,5.99E-31,Putative zinc metalloproteinase C607.06c (EC 3.4.24.-),proteolysis [GO:0006508],GO:0005634; GO:0005829; GO:0006508; GO:0008237; GO:0030246; GO:0032153; GO:0046872
2136,Pocillopora_acuta_HIv2___RNAseq.g19706.t1,38.66544594,-0.813934212,1.541952499,0.00040185,0.002721145,,NA,NA,NA,NA,NA
2137,Pocillopora_acuta_HIv2___RNAseq.g862.t1,92.98150498,-0.368343899,1.068217853,0.000402914,0.00272707,,Q6AZW2,4.99E-93,Aldo-keto reductase family 1 member A1-A (Alcohol dehydrogenase [NADP(+)] A) (EC 1.1.1.2) (Aldehyde reductase-A) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-),aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; glucose homeostasis [GO:0042593]; sprouting angiogenesis [GO:0002040],GO:0002040; GO:0004032; GO:0005829; GO:0016324; GO:0042593; GO:0046185; GO:0110095; GO:0160163
2138,Pocillopora_acuta_HIv2___RNAseq.g29617.t1,448.9897368,-3.126877279,2.122127209,0.000404096,0.002733789,,Q5ZMH1,8.79E-168,Septin-2,cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224],GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0008021; GO:0008104; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640
2139,Pocillopora_acuta_HIv2___RNAseq.g30155.t1,105.4140788,-0.521245253,1.157563104,0.000404865,0.002737716,,Q6ZWQ7,1.72E-25,Signal peptidase complex subunit 3 (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit),protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465],GO:0005787; GO:0006465; GO:0045047
2140,Pocillopora_acuta_HIv2___TS.g13674.t1,169.552213,-0.656871403,1.271419137,0.000405152,0.002738376,,NA,NA,NA,NA,NA
2141,Pocillopora_acuta_HIv2___TS.g8763.t3,343.9294203,-0.092222268,1.016250273,0.000406762,0.002747968,,Q9JLV6,2.19E-146,Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase (EC 3.1.3.32) (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase (EC 2.7.1.78)],DNA damage response [GO:0006974]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; protein K63-linked ubiquitination [GO:0070534],GO:0003690; GO:0005524; GO:0005634; GO:0006281; GO:0006303; GO:0006974; GO:0019005; GO:0035861; GO:0046403; GO:0046404; GO:0051103; GO:0070534; GO:1990756
2142,Pocillopora_acuta_HIv2___TS.g23932.t1,273.5082415,-1.702420858,3.198861505,0.000411203,0.002776679,,P52784,0,"ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase)","canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]",GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0046872; GO:0048029; GO:0061621; GO:0070095
2143,Pocillopora_acuta_HIv2___TS.g2803.t1a,250.5419937,-0.199357865,1.027049474,0.000414504,0.002796688,,NA,NA,NA,NA,NA
2144,Pocillopora_acuta_HIv2___RNAseq.g1667.t1,183.3823841,-0.300957931,1.065798667,0.000414553,0.002796688,,Q641G4,2.68E-108,Condensin-2 complex subunit H2 (Non-SMC condensin II complex subunit H2),chromosome condensation [GO:0030261],GO:0005634; GO:0030261
2145,Pocillopora_acuta_HIv2___TS.g15692.t1,21.42593358,-8.050387564,3.860333859,0.000415471,0.002801573,,NA,NA,NA,NA,NA
2146,Pocillopora_acuta_HIv2___RNAseq.g29895.t1,397.9871785,3.124442806,1.199805808,0.000415785,0.002802384,Heart- and neural crest derivatives-expressed protein 2,P57102,3.63E-27,"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)",cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription by RNA polymerase II [GO:0006357]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878],GO:0000977; GO:0000981; GO:0001947; GO:0003007; GO:0003142; GO:0003144; GO:0003342; GO:0003357; GO:0005634; GO:0006357; GO:0007507; GO:0010002; GO:0030859; GO:0030878; GO:0035051; GO:0035118; GO:0046983; GO:0048485; GO:0048703; GO:0055007; GO:0060047; GO:0071908
2147,Pocillopora_acuta_HIv2___RNAseq.g3405.t1,194.7528846,0.184774193,1.024952469,0.000417731,0.002814188,,P95896,2.08E-127,Amidase (EC 3.5.1.4),,GO:0004040; GO:0043864
2148,Pocillopora_acuta_HIv2___RNAseq.g28774.t1,255.8446004,-0.778708514,1.442961841,0.000418517,0.002818168,,Q8N0X2,0,Sperm-associated antigen 16 protein (Pf20 protein homolog),axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288],GO:0005576; GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:0090660; GO:0120197; GO:1990716
2149,Pocillopora_acuta_HIv2___RNAseq.g15784.t1,122.2931152,-1.87141073,3.219022095,0.000419476,0.002822367,,Q8K301,0,Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52),maturation of SSU-rRNA [GO:0030490],GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887; GO:0030490
2150,Pocillopora_acuta_HIv2___RNAseq.g12745.t1,1468.13091,2.43178773,1.003981631,0.000419531,0.002822367,,Q9Y5Z4,1.25E-35,Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL),,GO:0005576; GO:0005737; GO:0005739; GO:0020037; GO:0035578; GO:0070062
2151,Pocillopora_acuta_HIv2___RNAseq.g20993.t1,83.93624093,0.370715401,1.077135917,0.00042056,0.002827976,,NA,NA,NA,NA,NA
2152,Pocillopora_acuta_HIv2___RNAseq.g15929.t1,147.0203409,-0.437119161,1.138922685,0.000422503,0.002839722,,NA,NA,NA,NA,NA
2153,Pocillopora_acuta_HIv2___RNAseq.20998_t,509.4593809,0.406196551,1.080073623,0.000423292,0.002843703,,Q9DBI0,4.71E-41,Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2),BMP signaling pathway [GO:0030509]; fibrinolysis [GO:0042730]; intracellular iron ion homeostasis [GO:0006879]; membrane protein proteolysis [GO:0033619]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264],GO:0000122; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0006879; GO:0016020; GO:0030509; GO:0030514; GO:0033619; GO:0042730; GO:0045892; GO:0045944; GO:0060586; GO:0097264
2154,Pocillopora_acuta_HIv2___TS.g1077.t1,258.0812382,-0.443126026,1.094413164,0.000424258,0.002848871,,Q2HJE0,4.82E-52,Autophagy-related protein 101,autophagosome assembly [GO:0000045],GO:0000045; GO:0000407; GO:0019901; GO:1990316
2155,Pocillopora_acuta_HIv2___TS.g3374.t1,83.58792263,-0.596901174,1.288608459,0.000425415,0.002855317,,NA,NA,NA,NA,NA
2156,Pocillopora_acuta_HIv2___RNAseq.g24688.t1,1510.136906,3.007525289,1.905536065,0.000426297,0.002859908,,Q9ULB1,6.92E-34,Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha),"adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]",GO:0005246; GO:0005509; GO:0005730; GO:0005783; GO:0005886; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030534; GO:0031965; GO:0031982; GO:0033130; GO:0035176; GO:0038023; GO:0042297; GO:0042734; GO:0042995; GO:0043025; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:2000463
2157,Pocillopora_acuta_HIv2___TS.g8141.t1,859.3487087,-0.357765035,1.090509384,0.000427587,0.002867229,,P48416,1.09E-102,Cytochrome P450 10 (EC 1.14.-.-) (CYPX),,GO:0004497; GO:0005506; GO:0016705; GO:0020037
2158,Pocillopora_acuta_HIv2___TS.g19217.t1,105.6714112,-0.677766775,1.329956239,0.000427789,0.002867256,,NA,NA,NA,NA,NA
2159,Pocillopora_acuta_HIv2___TS.g24743.t1,131.0302976,2.649646225,1.138381067,0.0004284,0.002870023,,Q8NDA2,7.89E-19,Hemicentin-2,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808],GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023
2160,Pocillopora_acuta_HIv2___TS.g3363.t2a,250.428859,-0.30062265,1.061199567,0.000430892,0.002885377,,O95801,5.29E-86,Tetratricopeptide repeat protein 4 (TPR repeat protein 4),defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457],GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879
2161,Pocillopora_acuta_HIv2___RNAseq.g16536.t1,317.9305641,-0.803276292,1.385244237,0.000431355,0.002887142,,NA,NA,NA,NA,NA
2162,Pocillopora_acuta_HIv2___RNAseq.g16781.t1,2783.434027,3.03434115,3.373059102,0.00043162,0.002887584,,NA,NA,NA,NA,NA
2163,Pocillopora_acuta_HIv2___RNAseq.g14965.t1,527.7772423,-0.428731442,1.07574055,0.000432177,0.002889972,,Q32KV4,7.74E-123,Cytoplasmic dynein 2 light intermediate chain 1,intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017],GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005930; GO:0035721; GO:0035735; GO:0035869; GO:0036064; GO:0045504; GO:1902017
2164,Pocillopora_acuta_HIv2___RNAseq.g29237.t1,3340.466295,0.820063584,1.454572922,0.000432469,0.002890589,,O05485,5.65E-28,Extracellular protease (EC 3.4.24.-),proteolysis [GO:0006508],GO:0004222; GO:0006508; GO:0046872
2165,Pocillopora_acuta_HIv2___RNAseq.g9877.t1,236.5022912,-0.410712632,1.111533667,0.000434832,0.002904734,,NA,NA,NA,NA,NA
2166,Pocillopora_acuta_HIv2___RNAseq.g10855.t1,430.3750918,2.88509966,1.517552796,0.000434987,0.002904734,,Q8HYN8,5.31E-09,Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; regulation of metabolic process [GO:0019222],GO:0004930; GO:0004978; GO:0005737; GO:0005886; GO:0007189; GO:0019222
2167,Pocillopora_acuta_HIv2___RNAseq.g18446.t1,169.6703938,-0.39323566,1.129548572,0.000435686,0.002908061,,Q5ZK69,2.94E-123,Proteasomal ATPase-associated factor 1 (WD repeat-containing protein 71),,GO:0000502
2168,Pocillopora_acuta_HIv2___RNAseq.g24643.t1,309.9205411,-0.405440844,1.077960228,0.000437594,0.002919443,,Q8BMG1,1.85E-24,ATR-interacting protein (ATM and Rad3-related-interacting protein),DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779],GO:0000077; GO:0005634; GO:0005654; GO:0006139; GO:0006281; GO:0070310; GO:0070530; GO:2000779
2169,Pocillopora_acuta_HIv2___RNAseq.g11391.t1,1682.584693,2.861750378,2.644331069,0.000440575,0.002937391,,NA,NA,NA,NA,NA
2170,Pocillopora_acuta_HIv2___RNAseq.g29952.t1,1303.879185,2.859691532,1.476392238,0.00044069,0.002937391,,NA,NA,NA,NA,NA
2171,Pocillopora_acuta_HIv2___RNAseq.g2282.t1,208.8348177,-0.28389152,1.060300103,0.000441344,0.002940399,,NA,NA,NA,NA,NA
2172,Pocillopora_acuta_HIv2___RNAseq.g20712.t1,452.7954353,-1.007062704,1.710842601,0.000441998,0.002943398,,Q08CS6,7.06E-17,DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-),dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],GO:0004500; GO:0005507; GO:0005615; GO:0006589; GO:0030667; GO:0042420; GO:0042421
2173,Pocillopora_acuta_HIv2___RNAseq.g2519.t1,2787.364493,-1.83447773,4.040764108,0.00044555,0.002964402,,O75899,1.20E-86,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712
2174,Pocillopora_acuta_HIv2___TS.g22351.t2,823.9902196,1.524674697,3.054817716,0.000445562,0.002964402,,P04927,6.84E-11,S-antigen protein,,GO:0020003
2175,Pocillopora_acuta_HIv2___RNAseq.g13944.t1,463.7836144,-0.135935776,1.018447785,0.00044916,0.002986965,,P74334,3.04E-79,"Apocarotenoid-15,15'-oxygenase (ACO) (8'-apo-beta-carotenal 15,15'-oxygenase) (EC 1.13.11.75) (Diox1)",carotene catabolic process [GO:0016121],GO:0010436; GO:0016121; GO:0046872; GO:0102162
2176,Pocillopora_acuta_HIv2___TS.g13451.t1,135.6435151,0.21175148,1.040355554,0.000450145,0.002992139,,Q8T882,2.28E-124,Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase),,GO:0050325
2177,Pocillopora_acuta_HIv2___TS.g28207.t1,188.339515,-2.244876096,3.157856656,0.00045039,0.002992394,,A0A8V1ABE9,2.07E-122,D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase),D-serine catabolic process [GO:0036088],GO:0005737; GO:0008270; GO:0008721; GO:0030170; GO:0030425; GO:0036088
2178,Pocillopora_acuta_HIv2___TS.g23176.t1,24.8894875,-7.900709439,3.917223571,0.00045236,0.003004101,,NA,NA,NA,NA,NA
2179,Pocillopora_acuta_HIv2___TS.g28611.t1c,196.0558535,-0.700382402,1.395145539,0.000455555,0.003023898,,P70584,0,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)",acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550],GO:0003853; GO:0003995; GO:0004085; GO:0005739; GO:0005759; GO:0006550; GO:0006631; GO:0006635; GO:0006637; GO:0009055; GO:0016937; GO:0042802; GO:0050660; GO:0102035
2180,Pocillopora_acuta_HIv2___TS.g3265.t1,667.5505144,3.173260611,1.667972617,0.000455759,0.003023898,,Q64487,3.22E-154,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560
2181,Pocillopora_acuta_HIv2___RNAseq.27995_t,85.05863204,-0.910188587,1.6194025,0.000456629,0.003028281,,Q8N682,1.12E-19,DNA damage-regulated autophagy modulator protein 1 (Damage-regulated autophagy modulator),apoptotic process [GO:0006915]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506],GO:0005737; GO:0005764; GO:0005765; GO:0006914; GO:0006915; GO:0010506
2182,Pocillopora_acuta_HIv2___TS.g12121.t1,3563.488093,2.835880198,4.371071361,0.000456856,0.0030284,,F4JKH6,2.72E-13,Protein REDUCED CHLOROPLAST COVERAGE 2 (Protein TPR-domain suppressor of STIMPY),chloroplast localization [GO:0019750],GO:0003729; GO:0005634; GO:0005829; GO:0005886; GO:0019750
2183,Pocillopora_acuta_HIv2___RNAseq.g30884.t1,109.5291844,0.555629128,1.242277882,0.000457563,0.003031696,,NA,NA,NA,NA,NA
2184,Pocillopora_acuta_HIv2___RNAseq.g30665.t1,163.374932,-0.482040243,1.186697145,0.000458465,0.00303628,,NA,NA,NA,NA,NA
2185,Pocillopora_acuta_HIv2___RNAseq.11667_t,93.15706454,-2.156338463,5.250585938,0.000459808,0.00304378,,NA,NA,NA,NA,NA
2186,Pocillopora_acuta_HIv2___TS.g3883.t1,1043.086033,2.170797327,0.790368974,0.000460026,0.003043829,,P50238,1.41E-43,Cysteine-rich protein 1 (CRP-1) (Cysteine-rich heart protein) (CRHP) (hCRHP) (Cysteine-rich intestinal protein) (CRIP),cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; heart development [GO:0007507]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; prostate gland stromal morphogenesis [GO:0060741]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043],GO:0005737; GO:0006955; GO:0007507; GO:0008270; GO:0008630; GO:0010043; GO:0010468; GO:0042277; GO:0060741; GO:0071236; GO:0071493
2187,Pocillopora_acuta_HIv2___RNAseq.g5347.t1,2005.248131,1.479623274,2.63681595,0.000461793,0.003054124,,Q5XJN2,6.82E-53,Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30),cell redox homeostasis [GO:0045454]; hematopoietic stem cell proliferation [GO:0071425]; immune system process [GO:0002376],GO:0002376; GO:0005576; GO:0005764; GO:0016667; GO:0016671; GO:0045454; GO:0047134; GO:0071425
2188,Pocillopora_acuta_HIv2___RNAseq.g3526.t1,213.7667126,-0.394986561,1.074745305,0.00046227,0.003054909,,Q8VE19,0,GATOR2 complex protein MIOS,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; central nervous system myelin formation [GO:0032289]; oligodendrocyte differentiation [GO:0048709]; oligodendrocyte progenitor proliferation [GO:0070444]; positive regulation of TORC1 signaling [GO:1904263]; protein-containing complex localization [GO:0031503],GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0030054; GO:0031503; GO:0031669; GO:0032289; GO:0034198; GO:0046872; GO:0048709; GO:0061700; GO:0070444; GO:1904263
2189,Pocillopora_acuta_HIv2___RNAseq.g27887.t1,63.48783153,3.666475832,1.472157932,0.000462334,0.003054909,,Q9P215,3.62E-21,Pogo transposable element with KRAB domain,regulation of DNA-templated transcription [GO:0006355],GO:0003677; GO:0005634; GO:0005654; GO:0006355
2190,Pocillopora_acuta_HIv2___RNAseq.g22361.t1,523.4766981,2.968632055,2.259755727,0.000466083,0.003078279,,A0A1U8QWA2,0,Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)],secondary metabolite biosynthetic process [GO:0044550]; small molecule metabolic process [GO:0044281],GO:0016491; GO:0031177; GO:0044281; GO:0044550
2191,Pocillopora_acuta_HIv2___TS.g21810.t1,320.1930336,0.368903186,1.087097245,0.000467145,0.003083879,,Q66IV5,5.68E-46,Arpin,directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336]; negative regulation of lamellipodium morphogenesis [GO:2000393],GO:0030027; GO:0030336; GO:0033058; GO:0051126; GO:2000393
2192,Pocillopora_acuta_HIv2___RNAseq.g28879.t1,331.2992029,-0.069681751,1.021509203,0.000470674,0.003105763,,Q9PW80,4.12E-39,Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (Decapentaplegic and Vg-related 1 RNA-binding protein) (IGF-II mRNA-binding protein 3) (VICKZ family member 3) (Vg1 RNA-binding protein) (Vg1-RBP),CRD-mediated mRNA stabilization [GO:0070934]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of embryonic development [GO:0045995]; regulation of translation [GO:0006417]; sex determination [GO:0007530],GO:0000932; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007281; GO:0007399; GO:0007530; GO:0008354; GO:0010494; GO:0045995; GO:0051028; GO:0070934; GO:1990247
2193,Pocillopora_acuta_HIv2___RNAseq.g9586.t1,225.2688722,-0.127484105,1.018671931,0.000479073,0.003159743,,Q63ZP1,1.00E-114,PHD finger protein 10,nervous system development [GO:0007399],GO:0007399; GO:0046872; GO:0071564
2194,Pocillopora_acuta_HIv2___RNAseq.8707_t,159.930875,-0.332726273,1.09094558,0.000480436,0.003167285,,Q9QY93,1.60E-52,dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21-C6),dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143],GO:0000287; GO:0005829; GO:0006253; GO:0009143; GO:0016462; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840
2195,Pocillopora_acuta_HIv2___RNAseq.g14493.t1,401.2832952,-0.224783977,1.04804343,0.000480754,0.003167942,,Q9JL56,4.57E-60,Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16),ethanolamine metabolic process [GO:0006580]; G protein-coupled receptor signaling pathway [GO:0007186]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644],GO:0004622; GO:0005886; GO:0006580; GO:0006644; GO:0007186; GO:0008081; GO:0008889; GO:0016020; GO:0030659; GO:0046872; GO:0047395; GO:0070291
2196,Pocillopora_acuta_HIv2___RNAseq.g22120.t1,26.03582644,-5.325349221,3.62821353,0.000481506,0.003171447,,Q9CXI3,3.56E-117,DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X),dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421
2197,Pocillopora_acuta_HIv2___RNAseq.g28697.t1,151.8531539,-0.292439732,1.06332665,0.000481797,0.00317192,,Q5I0K7,2.24E-59,UDP-N-acetylglucosamine transferase subunit ALG13 (EC 2.4.1.141) (Asparagine-linked glycosylation 13 homolog),dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; negative regulation of TORC1 signaling [GO:1904262]; protein N-linked glycosylation [GO:0006487]; regulation of synaptic plasticity [GO:0048167],GO:0004577; GO:0005737; GO:0006487; GO:0006488; GO:0043541; GO:0048167; GO:0098554; GO:1904262
2198,Pocillopora_acuta_HIv2___RNAseq.g24039.t1,207.2252869,-0.423342375,1.131367597,0.000483679,0.003182863,,NA,NA,NA,NA,NA
2199,Pocillopora_acuta_HIv2___RNAseq.g8734.t2,86.72915081,-0.385729747,1.129443414,0.000484009,0.003183588,,Q7T1N4,3.13E-47,"Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal)",cellular response to pH [GO:0071467]; protein homotrimerization [GO:0070207]; sodium ion transmembrane transport [GO:0035725],GO:0005886; GO:0015280; GO:0035725; GO:0070207; GO:0071467; GO:0160128
2200,Pocillopora_acuta_HIv2___RNAseq.g16937.t1,283.8567047,-0.202778177,1.029211,0.000484575,0.003185861,,P0C7B7,2.70E-16,Cys-loop ligand-gated ion channel (ELIC),regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165],GO:0004888; GO:0005230; GO:0005886; GO:0007165; GO:0042391; GO:0042802; GO:0043005
2201,Pocillopora_acuta_HIv2___RNAseq.g26889.t1,277.7992125,-0.184984933,1.025723515,0.000487207,0.003201706,,F8J3H2,1.58E-31,Holothin acyltransferase (EC 2.3.1.-),response to antibiotic [GO:0046677],GO:0016747; GO:0046677
2202,Pocillopora_acuta_HIv2___RNAseq.g16641.t1,42.74837629,-0.58688089,1.268173307,0.000489738,0.003215538,,NA,NA,NA,NA,NA
2203,Pocillopora_acuta_HIv2___RNAseq.g14748.t1,2261.553332,2.040124632,0.725299901,0.000489756,0.003215538,,P13234,5.81E-135,Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) (Calspermin),adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; neuron-neuron synaptic transmission [GO:0007270]; nucleocytoplasmic transport [GO:0006913]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein export from nucleus [GO:0046827]; postsynapse to nucleus signaling pathway [GO:0099527]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; signal transduction [GO:0007165],GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006913; GO:0006954; GO:0007165; GO:0007270; GO:0007616; GO:0009931; GO:0035556; GO:0043011; GO:0045893; GO:0046827; GO:0098794; GO:0098978; GO:0098982; GO:0099170; GO:0099527; GO:0106310
2204,Pocillopora_acuta_HIv2___RNAseq.g3080.t1,444.300902,-0.656045167,1.219353969,0.000492069,0.003227773,,Q8BGQ2,1.24E-34,Cysteine/serine-rich nuclear protein 2 (CSRNP-2) (Protein FAM130A1) (TGF-beta-induced apoptosis protein 12) (TAIP-12),apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006915; GO:0019902; GO:0043565; GO:0045944
2205,Pocillopora_acuta_HIv2___TS.g25624.t1,436.6536254,4.296093971,3.619355919,0.000492089,0.003227773,,NA,NA,NA,NA,NA
2206,Pocillopora_acuta_HIv2___RNAseq.g11345.t1,1518.017442,-1.09841619,1.676919723,0.000492289,0.003227773,,P28289,4.12E-83,Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod),actin filament organization [GO:0007015]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694],GO:0003779; GO:0005523; GO:0005829; GO:0005856; GO:0005865; GO:0005884; GO:0006936; GO:0007015; GO:0008344; GO:0016020; GO:0030016; GO:0030017; GO:0030239; GO:0030863; GO:0051694; GO:0070307
2207,Pocillopora_acuta_HIv2___RNAseq.g1967.t1,132.1660592,-0.292367983,1.040274186,0.000493072,0.003231443,,Q9H6K1,1.05E-98,Protein ILRUN (Inflammation and lipid regulator with UBA-like and NBR1-like domains protein),innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon production [GO:0032480],GO:0000407; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0016236; GO:0016607; GO:0032480; GO:0032720; GO:0043130; GO:0043392; GO:0045087; GO:0050687; GO:1900181
2208,Pocillopora_acuta_HIv2___RNAseq.g12619.t1,190.0231601,-1.891794849,4.216045588,0.000496737,0.003253986,,Q8LGG8,2.57E-09,Universal stress protein A-like protein,,GO:0005829; GO:0005886; GO:0016208
2209,Pocillopora_acuta_HIv2___RNAseq.g12721.t1,198.1051096,-0.237379828,1.03110627,0.000497162,0.0032553,,D3Z5L6,1.90E-59,MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT),serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296],GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610
2210,Pocillopora_acuta_HIv2___RNAseq.g805.t1,877.3338751,3.168123686,1.691749017,0.000497654,0.003257046,,D3ZB51,2.71E-09,Protein turtle homolog B (Immunoglobulin superfamily member 9B),homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; synaptic membrane adhesion [GO:0099560],GO:0007156; GO:0007399; GO:0014069; GO:0019900; GO:0030425; GO:0043005; GO:0043025; GO:0045211; GO:0060077; GO:0097151; GO:0098982; GO:0099560; GO:0099629
2211,Pocillopora_acuta_HIv2___RNAseq.g3016.t1,1002.550513,-3.083593674,1.614264836,0.000500163,0.003271983,,P07756,0,"Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I)",'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; liver development [GO:0001889]; midgut development [GO:0007494]; monoatomic anion homeostasis [GO:0055081]; nitric oxide metabolic process [GO:0046209]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to cAMP [GO:0051591]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to oleic acid [GO:0034201]; response to starvation [GO:0042594]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311],GO:0000050; GO:0001889; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005886; GO:0006207; GO:0006541; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019433; GO:0030955; GO:0032094; GO:0032496; GO:0032991; GO:0033762; GO:0034201; GO:0036094; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0046872; GO:0048545; GO:0050667; GO:0051384; GO:0051591; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341
2212,Pocillopora_acuta_HIv2___RNAseq.g28861.t1,1115.117075,0.504526816,1.193094631,0.000503089,0.003289639,,P48758,3.28E-112,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)",glucocorticoid metabolic process [GO:0008211]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805],GO:0004090; GO:0005737; GO:0005902; GO:0006805; GO:0008106; GO:0008211; GO:0016616; GO:0042373; GO:0047020; GO:0047021; GO:0050221; GO:0160163
2213,Pocillopora_acuta_HIv2___RNAseq.g26444.t1,349.0530269,-0.328406219,1.065221693,0.000503657,0.003291863,,Q17QM4,3.71E-107,Ethanolaminephosphotransferase 1 (EC 2.7.8.1) (Selenoprotein I) (SelI),phosphatidylethanolamine biosynthetic process [GO:0006646],GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0046872
2214,Pocillopora_acuta_HIv2___RNAseq.g16302.t1a,98.93323474,3.034201627,1.700960112,0.000504084,0.003293167,,NA,NA,NA,NA,NA
2215,Pocillopora_acuta_HIv2___RNAseq.g28921.t1,75.11434679,0.87993896,1.529423122,0.000506554,0.003306685,,Q1ZXH8,1.98E-08,Guanine exchange factor for Rac 30,aggregation involved in sorocarp development [GO:0031152]; intracellular signal transduction [GO:0035556]; sorocarp development [GO:0030587],GO:0005085; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005938; GO:0016020; GO:0030587; GO:0030670; GO:0031152; GO:0031267; GO:0032009; GO:0035556; GO:0046872
2216,Pocillopora_acuta_HIv2___RNAseq.g26455.t1,2244.830155,2.395896216,2.513396803,0.00050661,0.003306685,,NA,NA,NA,NA,NA
2217,Pocillopora_acuta_HIv2___RNAseq.g29023.t1,153.3030902,-0.280583655,1.059845145,0.000508027,0.003313967,,NA,NA,NA,NA,NA
2218,Pocillopora_acuta_HIv2___RNAseq.g12316.t1,112.0632941,-0.808703584,1.414752317,0.000508184,0.003313967,,Q60HD0,5.38E-97,"Sulfite oxidase, mitochondrial (EC 1.8.3.1)",sulfur compound metabolic process [GO:0006790],GO:0005758; GO:0006790; GO:0008482; GO:0030151; GO:0043546
2219,Pocillopora_acuta_HIv2___TS.g7995.t1,267.1959605,-0.155517568,1.020846745,0.000508432,0.003314091,,P98160,4.35E-19,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide],angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of endothelial cell proliferation [GO:0001938]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224],GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031100; GO:0043202; GO:0050750; GO:0062023; GO:0070052; GO:0070062; GO:0072359; GO:0098797
2220,Pocillopora_acuta_HIv2___RNAseq.g26127.t1,376.7499066,-0.200141666,1.029656418,0.000510177,0.003323963,,Q8BHS3,0,Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22),"cellular response to xenobiotic stimulus [GO:0071466]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]",GO:0000974; GO:0005634; GO:0005654; GO:0005737; GO:0017070; GO:0033120; GO:0036002; GO:0042307; GO:0045292; GO:0046827; GO:0046872; GO:0048306; GO:0071006; GO:0071007; GO:0071466
2221,Pocillopora_acuta_HIv2___RNAseq.g3612.t1,332.1982141,-0.125132593,1.018894227,0.000510716,0.003325976,,NA,NA,NA,NA,NA
2222,Pocillopora_acuta_HIv2___RNAseq.g26430.t1,51.24550716,-0.850890112,1.540533074,0.000516668,0.003362466,,Q93V51,1.08E-17,Protein LEAD-SENSITIVE 1 (Protein Pb-SENSITIVE 1),cellular response to lead ion [GO:0071284]; lead ion transport [GO:0015692]; phytochelatin biosynthetic process [GO:0046938]; response to lead ion [GO:0010288],GO:0005737; GO:0010288; GO:0015692; GO:0046938; GO:0071284
2223,Pocillopora_acuta_HIv2___TS.g25979.t1,125.805154,0.349369535,1.056280218,0.000516784,0.003362466,TRP C4,Q9UBN4,6.24E-60,Short transient receptor potential channel 4 (TrpC4) (Trp-related protein 4) (hTrp-4) (hTrp4),calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480],GO:0005262; GO:0005886; GO:0005901; GO:0006816; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0034703; GO:0034704; GO:0045296; GO:0048709; GO:0051480; GO:0070509; GO:0070588; GO:0070679
2224,Pocillopora_acuta_HIv2___RNAseq.g12507.t1,117.4410901,-0.361390266,1.060470329,0.000520749,0.003386743,,O76075,1.45E-54,DNA fragmentation factor subunit beta (EC 3.-.-.-) (Caspase-activated deoxyribonuclease) (CAD) (Caspase-activated DNase) (Caspase-activated nuclease) (CPAN) (DNA fragmentation factor 40 kDa subunit) (DFF-40),apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; negative regulation of apoptotic DNA fragmentation [GO:1902511],GO:0000785; GO:0003677; GO:0004520; GO:0004536; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006308; GO:0006309; GO:0019899; GO:0019904; GO:0030263; GO:0032991; GO:0042802; GO:0097718; GO:1902511
2225,Pocillopora_acuta_HIv2___RNAseq.g28585.t1,244.3926132,2.833988242,2.554275398,0.000521687,0.003391319,,NA,NA,NA,NA,NA
2226,Pocillopora_acuta_HIv2___RNAseq.g23105.t1,34.03702875,-0.249569838,1.064462071,0.000524922,0.0034097,,NA,NA,NA,NA,NA
2227,Pocillopora_acuta_HIv2___RNAseq.g18401.t1,512.5329179,-0.093204925,1.018521148,0.000524986,0.0034097,,A7S2N8,0,E3 UFM1-protein ligase 1 homolog (EC 2.3.2.-) (E3 UFM1-protein transferase 1 homolog),protein K69-linked ufmylation [GO:1990592]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; response to endoplasmic reticulum stress [GO:0034976],GO:0005789; GO:0032434; GO:0034976; GO:0061666; GO:0071568; GO:1990592
2228,Pocillopora_acuta_HIv2___RNAseq.g8468.t2,208.9747774,-0.470643581,1.17955014,0.000526602,0.003418658,,P48462,1.53E-140,Serine/threonine-protein phosphatase beta isoform (EC 3.1.3.16) (Protein flap wing),cell adhesion [GO:0007155]; chromosome segregation [GO:0007059]; female germline ring canal formation [GO:0007301]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesoderm development [GO:0007498]; negative regulation of JNK cascade [GO:0046329]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of actomyosin contractile ring contraction [GO:0031991]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; regulation of morphogenesis of an epithelium [GO:1905330]; striated muscle tissue development [GO:0014706],GO:0000164; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0005979; GO:0005981; GO:0007059; GO:0007155; GO:0007300; GO:0007301; GO:0007312; GO:0007476; GO:0007498; GO:0014706; GO:0017018; GO:0031991; GO:0045879; GO:0046329; GO:0046872; GO:0090263; GO:1905330
2229,Pocillopora_acuta_HIv2___RNAseq.g25540.t1,355.9578177,0.647357763,1.313332871,0.000528578,0.003429949,,NA,NA,NA,NA,NA
2230,Pocillopora_acuta_HIv2___TS.g28685.t1,239.6497951,3.295742481,1.541957008,0.000528835,0.003430077,,NA,NA,NA,NA,NA
2231,Pocillopora_acuta_HIv2___RNAseq.g764.t1,3728.930059,2.30938904,0.948232538,0.000530342,0.003438311,,NA,NA,NA,NA,NA
2232,Pocillopora_acuta_HIv2___RNAseq.g6172.t1,176.1959758,-0.703529211,1.380617852,0.000530935,0.003440613,,Q9VCZ3,5.06E-41,Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R),adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410],GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880
2233,Pocillopora_acuta_HIv2___RNAseq.g16174.t1,137.0217683,-0.374694427,1.092325951,0.00053173,0.003444217,,P42942,5.06E-71,Uncharacterized GTP-binding protein YGR210C,,GO:0005525; GO:0005737; GO:0016887
2234,Pocillopora_acuta_HIv2___RNAseq.g18763.t1,1126.261463,2.121139136,0.775384761,0.000532377,0.003446865,,P50430,3.56E-139,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),anterior head development [GO:0097065]; autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065
2235,Pocillopora_acuta_HIv2___RNAseq.g29282.t1,232.5769206,0.277905135,1.056373492,0.000532902,0.003448721,,Q8VC51,9.11E-149,Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene homolog),Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004],GO:0000781; GO:0003723; GO:0005697; GO:0005829; GO:0006281; GO:0007004; GO:0015030; GO:0030576; GO:0031625; GO:0032203; GO:0034337; GO:0035861; GO:0042393; GO:0042802; GO:0044877; GO:0045739; GO:0051087; GO:0051973; GO:0070034; GO:0090666; GO:0090671; GO:1904851; GO:1904867; GO:1905168; GO:2000781; GO:2001034
2236,Pocillopora_acuta_HIv2___RNAseq.g362.t1,579.0215046,-0.637528612,1.244656185,0.000536064,0.003467633,,Q864U1,5.32E-28,Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1),chordate embryonic development [GO:0043009]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357]; sex-chromosome dosage compensation [GO:0007549],GO:0000724; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005694; GO:0005737; GO:0006357; GO:0006633; GO:0007095; GO:0007549; GO:0008270; GO:0031436; GO:0043009; GO:0045717; GO:0045893; GO:0045944; GO:0051865; GO:0070063; GO:0070531; GO:0085020
2237,Pocillopora_acuta_HIv2___RNAseq.g24945.t1,371.4493408,-0.259261685,1.055792455,0.000536654,0.003469897,,Q6DF46,2.83E-166,"Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial (EC 1.14.13.-) (Coenzyme Q10 monooxygenase 6)",ubiquinone biosynthetic process [GO:0006744],GO:0005794; GO:0006744; GO:0008681; GO:0016712; GO:0031314; GO:0042995; GO:0071949; GO:0106364
2238,Pocillopora_acuta_HIv2___RNAseq.g6037.t1,834.3955557,2.535596009,1.196228572,0.000537468,0.003473608,,NA,NA,NA,NA,NA
2239,Pocillopora_acuta_HIv2___RNAseq.g16946.t1,308.9901629,-0.50513461,1.12227165,0.000540002,0.003488425,,P62749,3.78E-121,Hippocalcin-like protein 1 (Neural visinin-like protein 3) (NVL-3) (NVP-3) (Visinin-like protein 3) (VILIP-3),,GO:0005509; GO:0016020
2240,Pocillopora_acuta_HIv2___RNAseq.g8449.t1,230.1201257,-0.176864789,1.018383527,0.00054034,0.003489052,,Q5SUV1,2.73E-138,"Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Putative heme chaperone)",porphyrin-containing compound biosynthetic process [GO:0006779],GO:0004109; GO:0005737; GO:0005739; GO:0006779; GO:0020037; GO:0046872; GO:0051539
2241,Pocillopora_acuta_HIv2___RNAseq.g22262.t1,54.61327302,2.685509277,4.441881266,0.000540598,0.003489158,,P54422,4.68E-26,Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain],glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; proteolysis [GO:0006508],GO:0005576; GO:0006508; GO:0006750; GO:0006751; GO:0036374; GO:0103068
2242,Pocillopora_acuta_HIv2___TS.g1462.t1,972.0938489,1.114147109,1.835475363,0.000545099,0.003516642,,P98133,0,Fibrillin-1 (MP340) [Cleaved into: Asprosin],anatomical structure morphogenesis [GO:0009653],GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0008201; GO:0009653; GO:0031012
2243,Pocillopora_acuta_HIv2___TS.g30936.t1,142.6268897,-0.404952724,1.11562907,0.000546833,0.003526256,,NA,NA,NA,NA,NA
2244,Pocillopora_acuta_HIv2___RNAseq.g706.t1,4411.726442,2.851795682,2.820698962,0.000549114,0.00353939,,NA,NA,NA,NA,NA
2245,Pocillopora_acuta_HIv2___RNAseq.g618.t1,549.3725768,-2.368976329,2.805553284,0.00055047,0.003546545,,Q9Y3B3,9.19E-42,Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27),endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0030126; GO:0030127; GO:0030133; GO:0030134; GO:0033116; GO:0038024
2246,Pocillopora_acuta_HIv2___RNAseq.g19308.t1,60.11774486,2.315731322,0.861527979,0.000552287,0.00355667,,NA,NA,NA,NA,NA
2247,Pocillopora_acuta_HIv2___RNAseq.g28746.t1,1193.654227,-3.174302222,1.712339991,0.000552963,0.00355944,,A8MY62,2.07E-49,Putative beta-lactamase-like 1,,
2248,Pocillopora_acuta_HIv2___TS.g16509.t1,223.4654504,-0.240956447,1.051285125,0.000561759,0.003614451,,O15084,0,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK),,GO:0005654; GO:0005829
2249,Pocillopora_acuta_HIv2___RNAseq.g26775.t1,951.8880129,-0.543043238,1.150117606,0.000562646,0.003618546,Sodium-dependent neutral amino acid transporter,Q9D687,0,Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1),neutral amino acid transport [GO:0015804]; response to nutrient [GO:0007584]; sodium ion transmembrane transport [GO:0035725],GO:0005886; GO:0007584; GO:0015175; GO:0015293; GO:0015804; GO:0016324; GO:0031526; GO:0035725
2250,Pocillopora_acuta_HIv2___RNAseq.g9188.t1,197.1443564,-0.16881328,1.023113297,0.00056633,0.003640623,TRP ML3,Q8R4F0,1.56E-124,Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3),inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626],GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005765; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171; GO:0072345
2251,Pocillopora_acuta_HIv2___TS.g810.t1,59.3792188,-0.524457988,1.168835219,0.000567158,0.003644323,,F1M3J4,1.02E-20,ATP-binding cassette subfamily C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4),bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747],GO:0001409; GO:0005524; GO:0005886; GO:0008559; GO:0009410; GO:0014070; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:1904772
2252,Pocillopora_acuta_HIv2___RNAseq.g28504.t1,1178.745036,3.174387476,2.152248884,0.000568543,0.0036516,,O89029,2.03E-13,Matrilin-4 (MAT-4),extracellular matrix organization [GO:0030198]; response to axon injury [GO:0048678],GO:0005509; GO:0005576; GO:0030198; GO:0048678; GO:0062023; GO:0120216
2253,Pocillopora_acuta_HIv2___RNAseq.g26117.t1b,157.3271384,-3.469821212,4.130299405,0.000569692,0.00365736,,NA,NA,NA,NA,NA
2254,Pocillopora_acuta_HIv2___RNAseq.g9553.t1b,710.8004256,2.015612524,0.720557219,0.000570055,0.00365806,,A0A411L030,9.60E-39,Proline hydroxylase buaE (EC 1.14.11.-) (2-oxoglutarate-dependent dioxygenase buaE) (Burnettramic acids biosynthesis cluster protein E),antibiotic biosynthetic process [GO:0017000]; small molecule biosynthetic process [GO:0044283],GO:0017000; GO:0044283; GO:0046872; GO:0051213
2255,Pocillopora_acuta_HIv2___RNAseq.g29506.t1,560.3853795,-1.9876086,3.090085037,0.000571287,0.003664344,,Q9BSR8,2.00E-87,Protein YIPF4 (YIP1 family member 4),endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle fusion with Golgi apparatus [GO:0048280],GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006888; GO:0043231; GO:0048280
2256,Pocillopora_acuta_HIv2___TS.g27153.t2,357.9559926,-2.830650268,1.364261745,0.000572921,0.003673194,,A6H8I2,0,Small G protein signaling modulator 3 homolog (RUN and TBC1 domain-containing protein 3),,
2257,Pocillopora_acuta_HIv2___RNAseq.g8148.t1,2320.131581,3.403786805,1.75761567,0.000578447,0.003706984,,Q96RW7,0,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711
2258,Pocillopora_acuta_HIv2___RNAseq.g2330.t1c,520.8299467,-0.314250912,1.053037448,0.000578887,0.003708155,,E9Q238,3.71E-59,KN motif and ankyrin repeat domains 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein),actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; cortical microtubule organization [GO:0043622]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; podocyte cell migration [GO:0090521]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114],GO:0005737; GO:0005856; GO:0005938; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030336; GO:0030674; GO:0030837; GO:0032587; GO:0035024; GO:0043622; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393
2259,Pocillopora_acuta_HIv2___TS.g8252.t1,265.1766476,-0.21516775,1.03185608,0.000579318,0.003709274,,Q3SYW0,4.94E-47,F-box only protein 15,,GO:0019005
2260,Pocillopora_acuta_HIv2___RNAseq.g13823.t1,2705.406232,2.723716262,2.568172856,0.000582549,0.003728313,"Mucin4-like protein, Sushi domain-containing",B3EWY9,0,Mucin-like protein,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005615; GO:0007160; GO:0016020
2261,Pocillopora_acuta_HIv2___RNAseq.g24156.t1,226.5075827,-0.124082663,1.019550869,0.000583405,0.003732141,,NA,NA,NA,NA,NA
2262,Pocillopora_acuta_HIv2___RNAseq.g11960.t1,114.8276993,-2.864165387,1.27280183,0.000586581,0.003750801,,Q1RLX4,9.93E-70,Trafficking protein particle complex subunit 11 (Protein foie gras),Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192],GO:0001889; GO:0005794; GO:0006487; GO:0007030; GO:0009306; GO:0016192; GO:0055088; GO:0060041; GO:1905897
2263,Pocillopora_acuta_HIv2___RNAseq.g17811.t1,229.174306,-0.325901736,1.065107659,0.000588061,0.003758599,,Q6P825,5.46E-126,Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog),monoatomic ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626],GO:0005741; GO:0006626; GO:0006811; GO:0008320; GO:0015288; GO:0030150; GO:0046930
2264,Pocillopora_acuta_HIv2___RNAseq.g2586.t1c,338.0495913,-2.238606698,0.875621658,0.000590597,0.00377175,,NA,NA,NA,NA,NA
2265,Pocillopora_acuta_HIv2___RNAseq.g7078.t1,364.7208573,0.361538349,1.093274744,0.00059064,0.00377175,,Q14517,2.19E-08,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754],GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609; GO:1904385; GO:1904754
2266,Pocillopora_acuta_HIv2___RNAseq.g19632.t1,199.949483,0.49333767,1.195019535,0.000591114,0.003773114,,Q8WWY8,2.02E-37,Lipase member H (LIPH) (EC 3.1.1.-) (LPD lipase-related protein) (Membrane-associated phosphatidic acid-selective phospholipase A1-alpha) (mPA-PLA1 alpha) (Phospholipase A1 member B),lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654],GO:0004620; GO:0005615; GO:0005886; GO:0006654; GO:0008201; GO:0016042; GO:0052689
2267,Pocillopora_acuta_HIv2___RNAseq.g18025.t1,231.8868454,2.025566961,0.729213295,0.0005942,0.003791135,,NA,NA,NA,NA,NA
2268,Pocillopora_acuta_HIv2___TS.g1350.t1,11229.36111,2.436018096,1.083986399,0.00059699,0.003807262,Collagen alpha-2(I) chain (Alpha-2 type I collagen),P02466,8.40E-152,Collagen alpha-2(I) chain (Alpha-2 type I collagen),blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096
2269,Pocillopora_acuta_HIv2___TS.g8725.t1,131.4996175,-0.926834496,1.623988919,0.000599292,0.003820252,,A5YKK6,4.71E-26,CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1),"miRNA-mediated post-transcriptional gene silencing [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; trophectodermal cell differentiation [GO:0001829]",GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0001829; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:1900153; GO:2000036
2270,Pocillopora_acuta_HIv2___RNAseq.g3724.t1,2912.482156,-2.087993645,0.792800159,0.000600713,0.003827627,,P14207,2.02E-53,"Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP)",cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; inflammatory response [GO:0006954]; positive regulation of cell population proliferation [GO:0008284]; sperm-egg recognition [GO:0035036],GO:0005542; GO:0005576; GO:0005886; GO:0006954; GO:0007155; GO:0007342; GO:0008284; GO:0009897; GO:0009986; GO:0015884; GO:0035036; GO:0038023; GO:0061714
2271,Pocillopora_acuta_HIv2___TS.g16387.t1,1616.474445,-2.267180118,0.912104205,0.000601393,0.003830271,,Q24UI6,7.04E-55,Translation initiation factor IF-2,,GO:0003743; GO:0003924; GO:0005525; GO:0005737
2272,Pocillopora_acuta_HIv2___RNAseq.g5879.t1,440.2613471,-0.650595724,1.233223859,0.000603149,0.003839763,,Q6DDS9,4.63E-155,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (Ku80),DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; telomere maintenance [GO:0000723],GO:0000723; GO:0003678; GO:0003684; GO:0005524; GO:0006303; GO:0006310; GO:0016787; GO:0042162; GO:0043564
2273,Pocillopora_acuta_HIv2___RNAseq.g6137.t1,388.5120869,-0.110787755,1.018747674,0.000604123,0.003842435,,Q7TQF2,0,F-box only protein 10,apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005737; GO:0006511; GO:0006915; GO:0016567; GO:0042981
2274,Pocillopora_acuta_HIv2___RNAseq.g9252.t1,119.8793233,0.351484379,1.102290401,0.000604273,0.003842435,,Q6V4S5,4.75E-92,Protein sidekick-2,camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219
2275,Pocillopora_acuta_HIv2___RNAseq.g7450.t1,126.0995811,-2.815506784,1.962219581,0.000604384,0.003842435,,NA,NA,NA,NA,NA
2276,Pocillopora_acuta_HIv2___TS.g19213.t1,431.4896682,-0.860843506,1.463778411,0.000604631,0.003842435,,Q9Z1X1,5.75E-07,Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein) (vp115),endoplasmic reticulum-plasma membrane tethering [GO:0061817]; intermembrane lipid transfer [GO:0120009],GO:0005509; GO:0005544; GO:0005789; GO:0005886; GO:0008429; GO:0031210; GO:0035091; GO:0042802; GO:0061817; GO:0120009; GO:0120014
2277,Pocillopora_acuta_HIv2___RNAseq.g6836.t1,25.21476967,-7.731031712,4.083167334,0.000605555,0.003846615,,Q8WU66,5.46E-17,Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR),hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505],GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170
2278,Pocillopora_acuta_HIv2___TS.g30131.t1,1929.241125,2.349771956,1.024859761,0.000607235,0.003855599,,P24369,3.40E-74,Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP),bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821],GO:0000413; GO:0003755; GO:0005654; GO:0005737; GO:0005788; GO:0005790; GO:0006457; GO:0016018; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0043231; GO:0044829; GO:0048471; GO:0050821; GO:0060348; GO:0061077; GO:0070063
2279,Pocillopora_acuta_HIv2___RNAseq.g21198.t2,211.5269951,0.659903743,1.345358044,0.000607636,0.003856451,,NA,NA,NA,NA,NA
2280,Pocillopora_acuta_HIv2___RNAseq.g23492.t1,61.12436542,2.922905964,2.070911166,0.000608936,0.003863005,,NA,NA,NA,NA,NA
2281,Pocillopora_acuta_HIv2___RNAseq.g20057.t1,40.15389903,-0.792324518,1.481072458,0.000609777,0.003866643,,NA,NA,NA,NA,NA
2282,Pocillopora_acuta_HIv2___RNAseq.g7058.t1,208.0178328,0.439903278,1.124119278,0.000612457,0.003880697,,Q8TE59,0,A disintegrin and metalloproteinase with thrombospondin motifs 19 (ADAM-TS 19) (ADAM-TS19) (ADAMTS-19) (EC 3.4.24.-),aortic valve morphogenesis [GO:0003180]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; mitral valve morphogenesis [GO:0003183]; proteolysis [GO:0006508]; pulmonary valve morphogenesis [GO:0003184]; tricuspid valve morphogenesis [GO:0003186]; ventricular septum morphogenesis [GO:0060412],GO:0003180; GO:0003183; GO:0003184; GO:0003186; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0030199; GO:0031012; GO:0046872; GO:0060412
2283,Pocillopora_acuta_HIv2___RNAseq.g17222.t1,129.9911832,-0.963482581,1.642996153,0.00061253,0.003880697,,Q9Z0F6,1.03E-75,Cell cycle checkpoint control protein RAD9A (mRAD9) (EC 3.1.11.2) (DNA repair exonuclease rad9 homolog A) (Rad9-like protein),cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231],GO:0000076; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0008311; GO:0008630; GO:0017124; GO:0019901; GO:0030896; GO:0031573; GO:0042826; GO:0071479; GO:1902231
2284,Pocillopora_acuta_HIv2___RNAseq.g14174.t1,219.2554013,-0.176783089,1.024112901,0.000621038,0.003932876,,Q3TUU5,1.04E-47,Testis-expressed protein 30,,
2285,Pocillopora_acuta_HIv2___RNAseq.g1930.t1,1599.434044,-2.400134652,1.064825467,0.000621668,0.003935145,,P52160,2.39E-29,Transcriptional regulator Myc-A (c-Myc-A) (zc-Myc),hematopoietic stem cell differentiation [GO:0060218]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vasculature development [GO:1901342]; vasculature development [GO:0001944],GO:0000978; GO:0000981; GO:0001944; GO:0003677; GO:0005634; GO:0006357; GO:0008284; GO:0046983; GO:0060218; GO:1901342
2286,Pocillopora_acuta_HIv2___TS.g13806.t1a,492.2854746,-2.511226632,1.458267748,0.000622247,0.00393709,,Q9P2G9,0,Kelch-like protein 8,protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005654; GO:0006511; GO:0016567; GO:0031463
2287,Pocillopora_acuta_HIv2___RNAseq.g2187.t1,318.2465869,-0.164754959,1.022249211,0.000625279,0.003954541,,Q96FG2,7.07E-90,ELMO domain-containing protein 3 (RNA-binding motif and ELMO domain-containing protein 1) (RNA-binding motif protein 29) (RNA-binding protein 29),,GO:0005737; GO:0005856; GO:0032420; GO:0060091
2288,Pocillopora_acuta_HIv2___RNAseq.g18501.t1,113.7136645,-4.846002291,2.519046096,0.00063102,0.003987452,,Q13490,1.05E-31,Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2),"apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; non-canonical NF-kappaB signal transduction [GO:0038061]; placenta development [GO:0001890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]",GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0045088; GO:0045471; GO:0045595; GO:0050727; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:2000116; GO:2000377
2289,Pocillopora_acuta_HIv2___TS.g13157.t1,122.704007,-0.196189283,1.025471785,0.000631034,0.003987452,,NA,NA,NA,NA,NA
2290,Pocillopora_acuta_HIv2___RNAseq.g20702.t1,86.59654613,-0.315040087,1.078909851,0.000634038,0.004004683,,A0A2J6RX17,6.61E-17,Nucleotide-binding leucine-rich repeat (NLR)-like protein (EC 3.5.99.-),nucleoside metabolic process [GO:0009116],GO:0009116; GO:0016787; GO:0043531
2291,Pocillopora_acuta_HIv2___RNAseq.g24776.t1,165.2820172,-0.528843744,1.208925694,0.000635426,0.004011701,,Q99PW8,1.69E-57,Kinesin-like protein KIF17 (MmKIF17),anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098794; GO:0098971; GO:1990075
2292,Pocillopora_acuta_HIv2___RNAseq.g16387.t1,778.6719646,-0.327293085,1.074363602,0.000636355,0.00401581,,O18638,5.10E-55,Out at first protein,,
2293,Pocillopora_acuta_HIv2___RNAseq.g24245.t1,158.8235057,-0.271206557,1.053250376,0.000639754,0.004034613,,NA,NA,NA,NA,NA
2294,Pocillopora_acuta_HIv2___RNAseq.g3667.t1,170.1057408,-0.28559562,1.061582922,0.000639892,0.004034613,,Q9FGF0,1.61E-06,Phosphoglycerate mutase-like protein 1,,GO:0005829; GO:0009536
2295,Pocillopora_acuta_HIv2___RNAseq.g21280.t1,1104.529509,3.134756373,1.909199118,0.000641791,0.004044818,,NA,NA,NA,NA,NA
2296,Pocillopora_acuta_HIv2___RNAseq.g16425.t1,183.2539119,-0.093873064,1.02114766,0.000642639,0.004048401,,A9ULE9,8.23E-49,DnaJ homolog subfamily C member 22,,GO:0016020
2297,Pocillopora_acuta_HIv2___RNAseq.g676.t1,201.5109122,-0.180108181,1.024298084,0.000643993,0.004055163,,Q8BQH6,1.88E-08,CUB domain-containing protein 2,,GO:0016020
2298,Pocillopora_acuta_HIv2___RNAseq.g2851.t1,58.5546497,-2.090077254,3.326547356,0.000644867,0.0040589,,NA,NA,NA,NA,NA
2299,Pocillopora_acuta_HIv2___RNAseq.g25436.t1,482.642447,2.714623215,2.417249813,0.000646617,0.004068149,,NA,NA,NA,NA,NA
2300,Pocillopora_acuta_HIv2___TS.g29856.t1,173.1919601,-0.327883868,1.066501047,0.000648767,0.004079895,,Q96M69,1.67E-164,Leucine-rich repeat and guanylate kinase domain-containing protein,axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],GO:0001669; GO:0002177; GO:0004385; GO:0005524; GO:0005829; GO:0007283; GO:0030154; GO:0035082; GO:0042995
2301,Pocillopora_acuta_HIv2___RNAseq.g28678.t1,1207.915902,-2.71256532,2.211136728,0.000655505,0.00411948,,D3UW23,0,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A),proteolysis [GO:0006508],GO:0004177; GO:0005886; GO:0006508; GO:0008237; GO:0008270
2302,Pocillopora_acuta_HIv2___RNAseq.g17108.t1,206.2097728,-0.311664647,1.080306418,0.000655631,0.00411948,,Q94BZ1,1.43E-72,Protein ZINC INDUCED FACILITATOR-LIKE 1 (Protein ZIF-LIKE 1),basipetal auxin transport [GO:0010540]; gravitropism [GO:0009630]; regulation of stomatal closure [GO:0090333]; response to water deprivation [GO:0009414]; root development [GO:0048364],GO:0005886; GO:0009414; GO:0009630; GO:0009705; GO:0010540; GO:0022821; GO:0048364; GO:0090333
2303,Pocillopora_acuta_HIv2___RNAseq.g2221.t1,740.3286473,-2.868487379,1.973724516,0.000656916,0.004125764,,Q76KP1,5.51E-61,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)",,GO:0008376; GO:0032580; GO:0033842
2304,Pocillopora_acuta_HIv2___RNAseq.g11208.t1,163.0471294,-0.264971826,1.056138541,0.000657925,0.004130307,,P24462,2.30E-105,Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2),estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805],GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0006694; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0019825; GO:0020037; GO:0042572; GO:0042573; GO:0050649; GO:0062183; GO:0070330; GO:0070989; GO:0101020; GO:0101021
2305,Pocillopora_acuta_HIv2___RNAseq.g18587.t1,535.1488993,-0.398591401,1.074573051,0.000658482,0.004131393,,Q8HXM1,1.17E-120,Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64),mRNA 3'-end processing [GO:0031124],GO:0003729; GO:0005634; GO:0005847; GO:0031124; GO:0071920
2306,Pocillopora_acuta_HIv2___TS.g28041.t2,131.5003091,-0.688592827,1.270195725,0.000658669,0.004131393,,P79763,9.38E-65,Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of protein kinase A signaling [GO:0010738],GO:0004963; GO:0005886; GO:0007186; GO:0007189; GO:0008528; GO:0008584; GO:0009755; GO:0010738; GO:0016020; GO:0033686; GO:0042699; GO:0043235; GO:0051897; GO:0070374; GO:0071372
2307,Pocillopora_acuta_HIv2___RNAseq.g9728.t1,316.023963,-0.241861201,1.036905879,0.000660738,0.004141029,,Q99943,7.96E-59,1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15),CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961],GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016024
2308,Pocillopora_acuta_HIv2___RNAseq.g21001.t1,125.2984684,-0.39923142,1.076391499,0.000660778,0.004141029,,Q6PIW4,0,Fidgetin-like protein 1 (EC 3.6.4.-),ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569],GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0070062; GO:0071479; GO:2001243
2309,Pocillopora_acuta_HIv2___RNAseq.g7511.t1,599.3503256,0.542854282,1.145892079,0.00066443,0.004162109,,NA,NA,NA,NA,NA
2310,Pocillopora_acuta_HIv2___RNAseq.g10956.t1,126.3594295,-0.21885547,1.033687333,0.000664785,0.004162532,,S3D784,3.30E-35,2-oxoglutarate-dependent dioxygenase gloF (EC 1.14.-.-) (Pneumocandin biosynthesis cluster protein F) (Proline hydroxylase),small molecule biosynthetic process [GO:0044283],GO:0044283; GO:0046872; GO:0051213
2311,Pocillopora_acuta_HIv2___RNAseq.g15804.t1,189.4530753,-0.154828772,1.025879774,0.000666108,0.004169011,,Q7ZXK9,0,Notchless protein homolog 1,Notch signaling pathway [GO:0007219],GO:0005730; GO:0007219
2312,Pocillopora_acuta_HIv2___RNAseq.g22142.t1,72.10824213,2.919288271,1.902142964,0.000667347,0.004174957,,NA,NA,NA,NA,NA
2313,Pocillopora_acuta_HIv2___RNAseq.g12528.t1,624.3517126,-2.249162985,3.003154464,0.000672926,0.004208039,,Q91ZM9,1.15E-07,Docking protein 5 (Downstream of tyrosine kinase 5),cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; neuron differentiation [GO:0030182]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386],GO:0005737; GO:0007169; GO:0007265; GO:0030182; GO:0043410; GO:0051386
2314,Pocillopora_acuta_HIv2___RNAseq.10263_t,3036.535359,2.561601612,1.441015677,0.000673743,0.004211332,,Q8IWU5,1.83E-153,Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form],bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; liver regeneration [GO:0097421]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelin production [GO:1904472]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of hepatocyte proliferation [GO:2000345]; response to wounding [GO:0009611],GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009611; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0090263; GO:0097421; GO:1904472; GO:2000345
2315,Pocillopora_acuta_HIv2___RNAseq.23419_t,347.6799538,-0.226625155,1.039984416,0.000676604,0.004227388,,P07106,7.75E-34,Acyl-CoA-binding domain-containing protein 5 (Endozepine-related protein) (Membrane-associated diazepam-binding inhibitor) (MA-DBI),fatty acid metabolic process [GO:0006631]; pexophagy [GO:0000425],GO:0000062; GO:0000425; GO:0005737; GO:0005777; GO:0005778; GO:0006631
2316,Pocillopora_acuta_HIv2___RNAseq.g25841.t1,165.6043595,-0.301474934,1.066232524,0.000679121,0.004240565,,Q9D0K0,8.00E-76,TBC1 domain family member 7,activation of GTPase activity [GO:0090630]; cellular response to starvation [GO:0009267]; negative regulation of cilium assembly [GO:1902018]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of protein ubiquitination [GO:0031398]; response to growth factor [GO:0070848],GO:0005096; GO:0005765; GO:0005829; GO:0009267; GO:0031267; GO:0031398; GO:0031410; GO:0032007; GO:0033596; GO:0036064; GO:0070848; GO:0090630; GO:1902018; GO:1904262
2317,Pocillopora_acuta_HIv2___RNAseq.g10557.t1,571.9352759,2.640235643,1.002648272,0.0006793,0.004240565,,Q7T2H2,5.67E-28,Fibroblast growth factor receptor-like 1,negative regulation of cell population proliferation [GO:0008285],GO:0005007; GO:0005886; GO:0008201; GO:0008285; GO:0017134
2318,Pocillopora_acuta_HIv2___RNAseq.g8160.t1,284.9400709,-0.06269162,1.020783678,0.000680911,0.004248788,,Q84XU2,1.29E-08,Serine/threonine-protein phosphatase 5 (EC 3.1.3.16),chloroplast-nucleus signaling pathway [GO:0010019]; negative regulation of chlorophyll biosynthetic process [GO:1902325]; nucleocytoplasmic transport [GO:0006913]; red or far-red light signaling pathway [GO:0010017],GO:0004721; GO:0004722; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0006913; GO:0009506; GO:0010017; GO:0010019; GO:0016607; GO:0017018; GO:0031965; GO:0046872; GO:0046906; GO:1902325
2319,Pocillopora_acuta_HIv2___TS.g25570.t1,120.6133448,-0.209578543,1.026485613,0.000682264,0.004255398,,NA,NA,NA,NA,NA
2320,Pocillopora_acuta_HIv2___TS.g22744.t2,521.3514471,0.255605118,1.056348385,0.000686635,0.004280816,,NA,NA,NA,NA,NA
2321,Pocillopora_acuta_HIv2___RNAseq.g28759.t1,232.9092498,-0.309142448,1.046392525,0.000687186,0.004282406,,A1L209,3.28E-68,Ataxin-7-like protein 3 (SAGA-associated factor 11 homolog),chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000124; GO:0003713; GO:0006325; GO:0006357; GO:0008270; GO:0045893; GO:0071819
2322,Pocillopora_acuta_HIv2___TS.g8220.t1,290.1521517,-0.256758107,1.054965411,0.000687633,0.004283342,,P00491,1.79E-105,Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase),allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418],GO:0000255; GO:0001882; GO:0002060; GO:0004731; GO:0005576; GO:0005737; GO:0005829; GO:0006139; GO:0006148; GO:0006149; GO:0006157; GO:0006166; GO:0006204; GO:0006738; GO:0006955; GO:0009165; GO:0009410; GO:0032743; GO:0034418; GO:0034774; GO:0042102; GO:0042301; GO:0042802; GO:0043101; GO:0046059; GO:0046638; GO:0047975; GO:0070062; GO:1904813
2323,Pocillopora_acuta_HIv2___TS.g1079.t2,226.3425495,-0.289142853,1.062684394,0.00068946,0.004292878,,A1L2K1,1.49E-12,Meteorin-like protein,brown fat cell differentiation [GO:0050873]; energy homeostasis [GO:0097009]; negative regulation of inflammatory response [GO:0050728]; positive regulation of brown fat cell differentiation [GO:0090336]; response to cold [GO:0009409]; response to muscle activity [GO:0014850],GO:0005179; GO:0005615; GO:0009409; GO:0014850; GO:0050728; GO:0050873; GO:0090336; GO:0097009
2324,Pocillopora_acuta_HIv2___RNAseq.g9084.t1,3736.009127,2.907138939,1.402211733,0.000692686,0.004311107,,Q8SQ75,1.50E-56,Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment],"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]",GO:0004252; GO:0005601; GO:0006508; GO:0006958; GO:0009617; GO:0045087; GO:0046872; GO:0070062
2325,Pocillopora_acuta_HIv2___TS.g8131.t1,198.1893027,1.078414961,2.095793484,0.00069429,0.004319233,,Q8C419,2.94E-67,Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158),brain development [GO:0007420]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of neurotransmitter secretion [GO:0001956]; protein localization to plasma membrane [GO:0072659]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synapse organization [GO:0050807],GO:0001956; GO:0004888; GO:0005634; GO:0005886; GO:0007186; GO:0007420; GO:0008047; GO:0008277; GO:0016020; GO:0042734; GO:0042995; GO:0045211; GO:0050807; GO:0050890; GO:0072659; GO:0098839; GO:0160079
2326,Pocillopora_acuta_HIv2___RNAseq.g22465.t1,218.7872845,-0.178446461,1.02922807,0.00069551,0.00432496,,NA,NA,NA,NA,NA
2327,Pocillopora_acuta_HIv2___RNAseq.g77.t2,587.0452805,-0.191629031,1.017825944,0.000696945,0.00433202,,P49282,0,Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2),cadmium ion transmembrane transport [GO:0070574]; cobalt ion transport [GO:0006824]; copper ion import across plasma membrane [GO:0098705]; dendrite morphogenesis [GO:0048813]; erythrocyte development [GO:0048821]; establishment of localization in cell [GO:0051649]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal-level iron ion homeostasis [GO:0060586]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; transition metal ion transport [GO:0000041],GO:0000041; GO:0005375; GO:0005381; GO:0005384; GO:0005506; GO:0005507; GO:0005634; GO:0005741; GO:0005765; GO:0005768; GO:0005794; GO:0005886; GO:0006778; GO:0006779; GO:0006783; GO:0006824; GO:0006826; GO:0006828; GO:0007611; GO:0008270; GO:0010008; GO:0010039; GO:0010042; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015099; GO:0015295; GO:0016151; GO:0016324; GO:0030145; GO:0031526; GO:0031901; GO:0031902; GO:0033212; GO:0034755; GO:0045177; GO:0045178; GO:0046870; GO:0048471; GO:0048813; GO:0048821; GO:0050897; GO:0051649; GO:0055038; GO:0060586; GO:0070574; GO:0070826; GO:0098705; GO:1903561
2328,Pocillopora_acuta_HIv2___RNAseq.g23714.t1,166.2949175,0.222534975,1.0328316,0.000701181,0.00435648,,NA,NA,NA,NA,NA
2329,Pocillopora_acuta_HIv2___TS.g6554.t1,129.1971534,-0.549189336,1.230766469,0.000702823,0.004364806,,Q4R8E0,6.82E-92,Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Hemin-sensitive initiation factor 2-alpha kinase),HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; negative regulation of translation [GO:0017148]; positive regulation of mitophagy [GO:1901526],GO:0004694; GO:0005524; GO:0005737; GO:0017148; GO:0106310; GO:0140467; GO:0140468; GO:1901526
2330,Pocillopora_acuta_HIv2___RNAseq.g2273.t1,3039.324358,-1.866500295,0.668846347,0.000703583,0.00436765,Putative ammonium transporter 1,P54145,6.92E-138,Putative ammonium transporter 1,ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488],GO:0005886; GO:0008519; GO:0072488; GO:0097272
2331,Pocillopora_acuta_HIv2___RNAseq.g22626.t1,274.0040902,-0.260674624,1.055203039,0.000705887,0.004380072,,B7P877,2.33E-80,Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (NCBP 20 kDa subunit) (CBP20),"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulatory ncRNA-mediated gene silencing [GO:0031047]",GO:0000339; GO:0000398; GO:0005634; GO:0005846; GO:0031047; GO:0045292
2332,Pocillopora_acuta_HIv2___RNAseq.g14894.t1,294.0768994,-0.13023119,1.016630745,0.000706942,0.00438474,,Q8BG93,9.44E-50,Nucleotide triphosphate diphosphatase NUDT15 (EC 3.6.1.9) (MutT homolog 2) (mMTH2) (Nucleoside diphosphate-linked moiety X motif 15) (Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15) (Nudix hydrolase 15),dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; mitotic cell cycle [GO:0000278]; purine deoxyribonucleoside triphosphate catabolic process [GO:0009217]; purine nucleotide catabolic process [GO:0006195]; regulation of proteasomal protein catabolic process [GO:0061136]; response to reactive oxygen species [GO:0000302]; xenobiotic catabolic process [GO:0042178],GO:0000278; GO:0000302; GO:0005829; GO:0006195; GO:0006203; GO:0008413; GO:0009217; GO:0035539; GO:0042178; GO:0042262; GO:0046872; GO:0061136
2333,Pocillopora_acuta_HIv2___RNAseq.g15892.t1,78.11375139,-0.562248397,1.245905178,0.000707989,0.004389352,,Q5F2F2,1.38E-56,Protein ABHD15 (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15),adipose tissue development [GO:0060612]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042],GO:0005576; GO:0016042; GO:0034338; GO:0044255; GO:0047372; GO:0060612
2334,Pocillopora_acuta_HIv2___RNAseq.g11480.t1,169.8782353,-0.360430088,1.089807814,0.000708724,0.004392022,,Q8BGK5,4.05E-112,Solute carrier family 35 member F1,,GO:0022857; GO:0030672
2335,Pocillopora_acuta_HIv2___TS.g19616.t2b,636.7822122,-1.604462259,2.355250341,0.000709329,0.004393889,Cnidocyte marker protein (formin-like),NA,NA,NA,NA,NA
2336,Pocillopora_acuta_HIv2___RNAseq.g17079.t1,111.8976212,-0.431396826,1.133341572,0.000711064,0.004402753,,Q5E9H5,0,Mitochondrial chaperone BCS1 (BCS1-like protein),mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979],GO:0005524; GO:0005743; GO:0016887; GO:0032979; GO:0034551
2337,Pocillopora_acuta_HIv2___RNAseq.g19202.t1,183.0860902,-0.168699924,1.024079835,0.000712488,0.004409679,,NA,NA,NA,NA,NA
2338,Pocillopora_acuta_HIv2___RNAseq.g21868.t1,328.4570084,-0.223292063,1.029710235,0.000713115,0.004411677,,Q4KM92,1.41E-119,Pseudouridylate synthase 1 homolog (EC 5.4.99.-) (tRNA pseudouridine synthase 1) (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I),mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119],GO:0000049; GO:0002153; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0006397; GO:0008380; GO:0009982; GO:0030374; GO:0031119; GO:0045944; GO:0106029; GO:0160147; GO:1990481
2339,Pocillopora_acuta_HIv2___TS.g2465.t1,192.1729471,-0.393444352,1.10800572,0.000714914,0.004420914,,Q61603,4.40E-34,Glycine receptor subunit alpha-4,chloride transmembrane transport [GO:1902476]; response to amino acid [GO:0043200],GO:0004888; GO:0005886; GO:0016594; GO:0016934; GO:0022824; GO:0030425; GO:0030594; GO:0034707; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0098690; GO:0099634; GO:1902476; GO:1902495
2340,Pocillopora_acuta_HIv2___RNAseq.g4013.t1,171.1186115,-1.085369629,1.800843327,0.000719559,0.004447733,,NA,NA,NA,NA,NA
2341,Pocillopora_acuta_HIv2___RNAseq.820_t,2229.992694,1.872800775,0.670853867,0.000720188,0.004449723,,Q91821,0,Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase),apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777],GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006915; GO:0008283; GO:0008289; GO:0030097; GO:0043065; GO:0046777; GO:0061351; GO:0106310
2342,Pocillopora_acuta_HIv2___RNAseq.g5896.t1,3440.596142,2.254377901,2.364534052,0.000723851,0.004470113,,Q9I8W5,8.72E-24,Probable N-acetyltransferase camello (EC 2.3.1.-) (Xcml),gastrulation with mouth forming second [GO:0001702]; negative regulation of cell adhesion [GO:0007162],GO:0000139; GO:0001702; GO:0005794; GO:0007162; GO:0008080
2343,Pocillopora_acuta_HIv2___RNAseq.g13189.t1,163.558283,-0.409875033,1.112813369,0.000724106,0.004470113,,Q6P606,3.55E-30,LysM and putative peptidoglycan-binding domain-containing protein 4,,GO:0016020
2344,Pocillopora_acuta_HIv2___RNAseq.g28577.t1,46.98120077,2.994241991,2.370158795,0.000728794,0.004497132,,G5EBQ8,3.60E-107,Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2),cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063],GO:0004100; GO:0005886; GO:0006031; GO:0006038; GO:0030428; GO:0061063; GO:0071944
2345,Pocillopora_acuta_HIv2___TS.g341.t1,253.2034924,-0.289502381,1.069167441,0.000729233,0.004497924,,NA,NA,NA,NA,NA
2346,Pocillopora_acuta_HIv2___RNAseq.27948_t,210.5907076,-0.658174243,1.320817618,0.000730938,0.004506513,,O88427,0,Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2),aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; sodium ion transmembrane transport [GO:0035725],GO:0001518; GO:0005244; GO:0005886; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0019228; GO:0030425; GO:0032342; GO:0034651; GO:0035725; GO:0042383; GO:0043005; GO:0043204; GO:0045211; GO:0045956; GO:0046872; GO:0048787; GO:0070509; GO:0086010; GO:0098662; GO:0098978; GO:0106134
2347,Pocillopora_acuta_HIv2___RNAseq.g1172.t1,134.3542905,-0.588880637,1.190798095,0.000732238,0.004512608,,A6QLU6,1.10E-15,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189
2348,Pocillopora_acuta_HIv2___RNAseq.g23315.t1,44.49442259,-0.48862055,1.190643991,0.000733935,0.004518594,,P90648,2.78E-09,Myosin heavy chain kinase B (MHCK-B) (EC 2.7.11.7),mitotic cytokinesis [GO:0000281]; myosin II filament disassembly [GO:0031037]; protein autophosphorylation [GO:0046777]; response to differentiation-inducing factor 1 [GO:1903013],GO:0000281; GO:0004674; GO:0005524; GO:0005737; GO:0005826; GO:0016905; GO:0031037; GO:0045159; GO:0046777; GO:1903013
2349,Pocillopora_acuta_HIv2___RNAseq.g237.t1,386.0133349,-2.352279379,1.046698191,0.000733982,0.004518594,,A0JM23,2.01E-36,Nephrocystin-3,"cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]",GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095
2350,Pocillopora_acuta_HIv2___RNAseq.g23361.t1,51.93698323,-1.309997558,2.520221027,0.000734147,0.004518594,,Q26614,5.37E-07,Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1),,GO:0005007; GO:0005524; GO:0005886; GO:0017134; GO:0043235
2351,Pocillopora_acuta_HIv2___TS.g1340.t1b,4631.38078,1.952575795,0.72977298,0.000735368,0.004524184,,Q28668,6.52E-72,Collagen alpha-2(I) chain (Alpha-2 type I collagen),extracellular matrix organization [GO:0030198],GO:0005581; GO:0005615; GO:0030020; GO:0030198; GO:0046872; GO:0062023
2352,Pocillopora_acuta_HIv2___TS.g25280.t2,475.0705773,-0.168038503,1.025100101,0.000739459,0.004547422,,A7S7F2,0,Bystin,rRNA processing [GO:0006364],GO:0005730; GO:0005737; GO:0006364; GO:0030515; GO:0030688
2353,Pocillopora_acuta_HIv2___RNAseq.g11037.t1,135.3444632,-0.425334903,1.088626704,0.000743088,0.004567795,,NA,NA,NA,NA,NA
2354,Pocillopora_acuta_HIv2___RNAseq.g9463.t1,185.1397633,-0.146675079,1.019750243,0.000744493,0.004574087,,Q66IC8,6.37E-12,Dynein light chain Tctex-type 5 (Tctex1 domain-containing protein 1),cilium assembly [GO:0060271]; microtubule-based movement [GO:0007018],GO:0005737; GO:0005868; GO:0007018; GO:0045505; GO:0060271
2355,Pocillopora_acuta_HIv2___RNAseq.g1315.t1,470.9765446,1.990110422,3.01855813,0.000744744,0.004574087,,Q0V9P1,3.74E-22,Histamine N-methyltransferase (HMT) (EC 2.1.1.8),histamine catabolic process [GO:0001695]; methylation [GO:0032259],GO:0001695; GO:0005737; GO:0032259; GO:0046539
2356,Pocillopora_acuta_HIv2___RNAseq.g11157.t1,322.2248725,0.786076004,1.423403523,0.000745374,0.004575469,,NA,NA,NA,NA,NA
2357,Pocillopora_acuta_HIv2___TS.g14240.t1,40.64357697,2.88463425,1.27595925,0.000745602,0.004575469,,NA,NA,NA,NA,NA
2358,Pocillopora_acuta_HIv2___RNAseq.g6252.t1,168.3547591,-0.267716208,1.056895028,0.000746132,0.004576781,,A4FV84,1.82E-105,mRNA turnover protein 4 homolog (Ribosome assembly factor MRTO4),nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],GO:0000027; GO:0000956; GO:0005730; GO:0005737; GO:0006364; GO:0030687; GO:0042273
2359,Pocillopora_acuta_HIv2___TS.g15652.t1,69.65753826,-0.738442078,1.303189313,0.000748225,0.004587678,,Q8N1B4,9.74E-83,Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein),"ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein targeting [GO:0006605]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated cholesterol transport [GO:0090119]",GO:0000938; GO:0005794; GO:0005829; GO:0006605; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0019905; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:0090119; GO:1990745
2360,Pocillopora_acuta_HIv2___RNAseq.g4388.t1,120.8519015,-0.543359855,1.169674513,0.000754675,0.00462526,,P46825,3.11E-22,Kinesin light chain (KLC),microtubule-based movement [GO:0007018],GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894
2361,Pocillopora_acuta_HIv2___RNAseq.g29074.t1,232.8981025,-0.444810015,1.134166458,0.000756882,0.004636821,,Q8TD35,7.10E-13,Protein LKAAEAR1 (LKAAEAR motif-containing protein 1),,
2362,Pocillopora_acuta_HIv2___RNAseq.g26271.t1,456.8979788,-2.552878794,1.648084481,0.000758127,0.004642487,,P68373,0,Tubulin alpha-1C chain (EC 3.6.5.-) (Alpha-tubulin 6) (Alpha-tubulin isotype M-alpha-6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain],microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278],GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0005881; GO:0016787; GO:0045121; GO:0046872
2363,Pocillopora_acuta_HIv2___RNAseq.g8922.t1,605.5330101,2.220396767,2.773892722,0.000758641,0.004643664,,Q00685,0,Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain],"complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]",GO:0004866; GO:0005615; GO:0006954; GO:0006958; GO:0045087
2364,Pocillopora_acuta_HIv2___RNAseq.g7074.t1,133.8084898,2.815241278,1.417619717,0.000759943,0.00464967,,NA,NA,NA,NA,NA
2365,Pocillopora_acuta_HIv2___RNAseq.g15355.t1,153.2269977,-0.362769031,1.115782111,0.000760294,0.004649846,,NA,NA,NA,NA,NA
2366,Pocillopora_acuta_HIv2___RNAseq.g12699.t1,107.9759055,-0.451429341,1.121448515,0.000762964,0.004664209,Putative helicase MOV-10,Q5ZKD7,0,Putative helicase MOV-10 (EC 3.6.4.13),3'-UTR-mediated mRNA destabilization [GO:0061158]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; retrotransposon silencing [GO:0010526],GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0061014; GO:0061158; GO:0150011
2367,Pocillopora_acuta_HIv2___RNAseq.g14761.t1,130.3144284,-0.263123154,1.049089739,0.000767563,0.004690341,,A3KPW7,1.02E-58,Protein prenyltransferase alpha subunit repeat-containing protein 1,,GO:0005737; GO:0008318
2368,Pocillopora_acuta_HIv2___RNAseq.g29181.t1,178.0502234,-0.085890714,1.022549961,0.000768478,0.004693948,,NA,NA,NA,NA,NA
2369,Pocillopora_acuta_HIv2___TS.g29599.t2,283.2534326,-1.591720905,2.28754946,0.000769439,0.004697835,,Q8IYQ7,0,Threonine synthase-like 1 (TSH1),,GO:0005737
2370,Pocillopora_acuta_HIv2___TS.g2746.t1,2190.075886,-2.139704268,0.885143789,0.000772017,0.004711584,,NA,NA,NA,NA,NA
2371,Pocillopora_acuta_HIv2___RNAseq.g11389.t1,225.7572023,-0.3715105,1.095216244,0.000773325,0.004717573,,Q68EX9,1.58E-128,Chitinase domain-containing protein 1,carbohydrate metabolic process [GO:0005975],GO:0005576; GO:0005764; GO:0005975; GO:0008061
2372,Pocillopora_acuta_HIv2___RNAseq.g9734.t1,321.14471,2.614169693,2.104944158,0.000774271,0.004721356,,NA,NA,NA,NA,NA
2373,Pocillopora_acuta_HIv2___RNAseq.g1271.t1,658.6720161,-0.93961097,1.523989532,0.000775942,0.004727896,,Q9W6C5,0,Programmed cell death 6-interacting protein (Signal transduction protein Xp95),mitotic cytokinesis [GO:0000281]; multivesicular body sorting pathway [GO:0071985]; protein transport [GO:0015031],GO:0000281; GO:0005813; GO:0005829; GO:0005923; GO:0015031; GO:0042470; GO:0070062; GO:0071985; GO:0090543
2374,Pocillopora_acuta_HIv2___RNAseq.g11717.t1,191.6083675,-0.221681982,1.048674496,0.000775997,0.004727896,,Q91ZV2,2.61E-20,"Discoidin, CUB and LCCL domain-containing protein 2 (Endothelial and smooth muscle cell-derived neuropilin-like protein)",negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060],GO:0005886; GO:0009986; GO:0030308; GO:0038023; GO:0042060
2375,Pocillopora_acuta_HIv2___TS.g21346.t1,723.2856069,-0.489349135,1.114309915,0.0007792,0.00474541,,P53451,0,T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta),response to hypoxia [GO:0001666],GO:0001666; GO:0005524; GO:0005737; GO:0016887; GO:0051082; GO:0140662
2376,Pocillopora_acuta_HIv2___RNAseq.g12545.t1,120.5731353,-0.233248922,1.038884018,0.00078099,0.004754311,,Q64029,3.58E-06,DNA repair protein complementing XP-A cells homolog (Xeroderma pigmentosum group A-complementing protein homolog),"base-excision repair [GO:0006284]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; UV-damage excision repair [GO:0070914]",GO:0000110; GO:0000715; GO:0003684; GO:0006284; GO:0046872; GO:0070914; GO:1901255
2377,Pocillopora_acuta_HIv2___RNAseq.g9103.t1,365.3843148,-0.273620262,1.02731285,0.000782323,0.00476042,,Q803A6,0,Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein),cell division [GO:0051301]; DNA-templated DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062],GO:0003682; GO:0005634; GO:0006261; GO:0007062; GO:0051301
2378,Pocillopora_acuta_HIv2___RNAseq.g10457.t1,141.0323026,0.080972842,1.021655664,0.000787504,0.004789931,,Q5RB07,8.30E-123,tRNA (34-2'-O)-methyltransferase regulator WDR6 (WD repeat-containing protein 6),wobble position ribose methylation [GO:0002130],GO:0000049; GO:0002130; GO:0005737; GO:0030234
2379,Pocillopora_acuta_HIv2___TS.g19694.t1a,372.6429835,-0.24770693,1.05264954,0.000788826,0.004795958,,NA,NA,NA,NA,NA
2380,Pocillopora_acuta_HIv2___RNAseq.g30593.t1,319.5977335,1.690148663,2.441626773,0.000789696,0.004799226,,Q2HJI8,3.45E-51,Ras-related protein Rab-8B,endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; protein secretion [GO:0009306],GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0008021; GO:0009306; GO:0010008; GO:0019003; GO:0030140; GO:0030670; GO:0032456; GO:0045335
2381,Pocillopora_acuta_HIv2___RNAseq.g7893.t1,237.535508,-0.325225026,1.051402647,0.000792007,0.004811254,,A3KG59,4.57E-115,Xaa-Arg dipeptidase (EC 3.4.13.4),proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246
2382,Pocillopora_acuta_HIv2___RNAseq.g26095.t1,150.1542586,-0.169276878,1.022592929,0.000792636,0.004813052,,A7SKJ3,0,2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2),protein histidyl modification to diphthamide [GO:0017183],GO:0017183; GO:0032991; GO:0046872; GO:0051539; GO:0090560
2383,Pocillopora_acuta_HIv2___RNAseq.g15577.t1,225.9464304,-2.027240789,0.769182658,0.000794654,0.00482328,,P05123,1.79E-103,Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK),phosphocreatine biosynthetic process [GO:0046314]; response to heat [GO:0009408],GO:0004111; GO:0005524; GO:0005615; GO:0005737; GO:0009408; GO:0046314
2384,Pocillopora_acuta_HIv2___RNAseq.g23748.t1,228.3949867,-0.231802317,1.049516305,0.000797298,0.004837298,,Q6UWJ1,9.96E-174,Transmembrane and coiled-coil domain-containing protein 3 (Putative LAG1-interacting protein),,GO:0015386; GO:0016020
2385,Pocillopora_acuta_HIv2___RNAseq.g23724.t1,366.3537325,-0.170373106,1.023935039,0.000802561,0.004867189,,NA,NA,NA,NA,NA
2386,Pocillopora_acuta_HIv2___RNAseq.g21024.t1,133.1952129,-0.866641679,1.526378667,0.000803087,0.004868335,,Q02974,3.54E-102,Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase),carbohydrate catabolic process [GO:0016052]; fructose catabolic process [GO:0006001]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043],GO:0004454; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006000; GO:0006001; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0016052; GO:0032868; GO:0061624; GO:0070873
2387,Pocillopora_acuta_HIv2___RNAseq.g763.t1,97.73459882,-2.955692976,1.64826942,0.00080451,0.004873497,,O70277,2.65E-20,Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22),negative regulation of translation [GO:0017148]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252],GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252
2388,Pocillopora_acuta_HIv2___TS.g16637.t1,42.85597667,-0.659119567,1.322333242,0.000804612,0.004873497,,Q55E58,7.67E-21,Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1),cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856],GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310
2389,Pocillopora_acuta_HIv2___TS.g22883.t1,2589.678088,2.580151242,1.954840284,0.000805466,0.004876626,,NA,NA,NA,NA,NA
2390,Pocillopora_acuta_HIv2___RNAseq.g11124.t1,8118.198741,2.031826501,0.787588849,0.000806168,0.004878835,,NA,NA,NA,NA,NA
2391,Pocillopora_acuta_HIv2___TS.g30620.t3,50.64877593,-0.545846215,1.166119081,0.000808785,0.004892623,,NA,NA,NA,NA,NA
2392,Pocillopora_acuta_HIv2___TS.g18665.t1,106.1683129,-4.462327839,3.316234244,0.00080998,0.004897807,,NA,NA,NA,NA,NA
2393,Pocillopora_acuta_HIv2___TS.g27515.t1,242.4773346,-0.200983851,1.027422904,0.000813348,0.004916116,,Q8TAT6,0,Nuclear protein localization protein 4 homolog (Protein NPL4),"ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0051117; GO:0070530
2394,Pocillopora_acuta_HIv2___TS.g4178.t2,100.9808849,-0.189078394,1.028137154,0.000821226,0.004961662,,Q90WM5,1.15E-29,Doublesex- and mab-3-related transcription factor 3,male sex differentiation [GO:0046661],GO:0000978; GO:0000981; GO:0005634; GO:0046661; GO:0046872
2395,Pocillopora_acuta_HIv2___TS.g18622.t1b,4572.98017,3.382436118,1.749561224,0.000822388,0.004966608,,A2ASQ1,1.54E-86,Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)],cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; enzyme-linked receptor protein signaling pathway [GO:0007167]; motor neuron apoptotic process [GO:0097049]; negative regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; regulation of synaptic activity [GO:0060025]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416],GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0007009; GO:0007167; GO:0007268; GO:0007416; GO:0007528; GO:0007623; GO:0009986; GO:0015031; GO:0030154; GO:0030548; GO:0032092; GO:0033691; GO:0035022; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045887; GO:0045944; GO:0048018; GO:0050431; GO:0050731; GO:0050807; GO:0051491; GO:0055117; GO:0060025; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0097049; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:1904395; GO:2000541; GO:2000673
2396,Pocillopora_acuta_HIv2___TS.g23305.t1,272.7108889,0.984959987,1.572387337,0.000825695,0.004984469,,B8EIZ7,4.47E-146,Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148),,GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661
2397,Pocillopora_acuta_HIv2___RNAseq.g14769.t1,2602.286415,2.820369054,2.084993944,0.000826035,0.004984469,,Q61555,0,Fibrillin-2 [Cleaved into: Placensin],anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023
2398,Pocillopora_acuta_HIv2___RNAseq.g21967.t1,1724.851874,1.925302107,0.71497618,0.000829626,0.005004047,,P53634,5.21E-171,Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)],immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913],GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006955; GO:0008234; GO:0008239; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235
2399,Pocillopora_acuta_HIv2___RNAseq.g15938.t1,191.5134699,2.338292423,1.005493219,0.000832396,0.005018667,,NA,NA,NA,NA,NA
2400,Pocillopora_acuta_HIv2___TS.g19445.t1,250.0231289,-0.102973158,1.013966436,0.000835464,0.005035061,,P48726,2.24E-35,Serine/threonine-protein phosphatase PP2A catalytic subunit 1 (PPN 1) (EC 3.1.3.16),mitotic cell cycle [GO:0000278],GO:0000278; GO:0004722; GO:0005634; GO:0005829; GO:0017018; GO:0046872
2401,Pocillopora_acuta_HIv2___RNAseq.g20666.t1,917.5104749,-3.012561105,1.633604774,0.000838024,0.005048389,,P46434,7.02E-34,Glutathione S-transferase 1 (EC 2.5.1.18),glutathione metabolic process [GO:0006749],GO:0004364; GO:0006749
2402,Pocillopora_acuta_HIv2___TS.g28827.t1,585.9161959,2.140971515,0.871288865,0.000844635,0.005083035,,NA,NA,NA,NA,NA
2403,Pocillopora_acuta_HIv2___RNAseq.g5009.t1,549.4565637,-0.79162343,1.407520946,0.00084465,0.005083035,,P97760,3.79E-168,DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II 33 kDa polypeptide) (RPB33) (DNA-directed RNA polymerase II subunit C) (RPB31),transcription by RNA polymerase II [GO:0006366],GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005737; GO:0006366; GO:0046983
2404,Pocillopora_acuta_HIv2___RNAseq.g24449.t1,114.361388,-1.305323455,2.147349173,0.000845083,0.005083035,,NA,NA,NA,NA,NA
2405,Pocillopora_acuta_HIv2___RNAseq.g18421.t1,333.8106625,-0.197255158,1.029119683,0.000845181,0.005083035,,Q6PCF7,5.74E-107,Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z),apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567],GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0061631
2406,Pocillopora_acuta_HIv2___RNAseq.g25624.t1,683.2970567,0.787233728,1.359829588,0.000846972,0.005091686,,D3YXG0,2.88E-22,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711
2407,Pocillopora_acuta_HIv2___TS.g23516.t1,240.2134047,-0.87077205,1.460358514,0.000849308,0.005103471,,NA,NA,NA,NA,NA
2408,Pocillopora_acuta_HIv2___RNAseq.g14912.t2,230.4678041,-0.590322629,1.263598245,0.000849638,0.005103471,Sodium channel protein type 9 subunit alpha,Q15858,0,Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel) (hNE-Na) (Peripheral sodium channel 1) (PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7),behavioral response to pain [GO:0048266]; cardiac muscle cell action potential involved in contraction [GO:0086002]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954]; post-embryonic development [GO:0009791]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814],GO:0001518; GO:0005248; GO:0005886; GO:0006814; GO:0006954; GO:0007623; GO:0009636; GO:0009791; GO:0019233; GO:0030424; GO:0035725; GO:0048266; GO:0050965; GO:0050974; GO:0086002
2409,Pocillopora_acuta_HIv2___RNAseq.g11156.t1,598.963173,1.958478273,2.485767214,0.000853711,0.005125809,,NA,NA,NA,NA,NA
2410,Pocillopora_acuta_HIv2___RNAseq.g18161.t1,273.5035008,-0.101730516,1.021115492,0.000855801,0.005136224,,P26149,6.82E-57,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type II) (3-beta-HSD II) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (EC 5.3.3.1) (Delta-5-3-ketosteroid isomerase)],androgen biosynthetic process [GO:0006702]; C21-steroid hormone biosynthetic process [GO:0006700]; C21-steroid hormone metabolic process [GO:0008207]; hippocampus development [GO:0021766]; negative regulation of iron ion transport [GO:0034757]; response to corticosterone [GO:0051412]; steroid biosynthetic process [GO:0006694],GO:0003854; GO:0004769; GO:0005737; GO:0005783; GO:0005789; GO:0006694; GO:0006700; GO:0006702; GO:0008207; GO:0016616; GO:0021766; GO:0031966; GO:0034757; GO:0043231; GO:0051412
2411,Pocillopora_acuta_HIv2___RNAseq.g26806.t1,182.7982957,0.207728556,1.045414404,0.000858269,0.005148902,,NA,NA,NA,NA,NA
2412,Pocillopora_acuta_HIv2___RNAseq.g13531.t1,133.6383469,-0.345342702,1.061006387,0.000863084,0.005175639,,P0CS66,6.69E-13,Palmitoyltransferase AKR1 (EC 2.3.1.225) (Ankyrin repeat-containing protein AKR1),,GO:0000139; GO:0016409; GO:0019706; GO:0031901
2413,Pocillopora_acuta_HIv2___RNAseq.g16499.t1,159.9030636,-0.498002271,1.188574183,0.000868581,0.005206446,,Q4KMD7,3.20E-62,Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52),"co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; snRNA processing [GO:0016180]",GO:0003723; GO:0003730; GO:0005524; GO:0005730; GO:0005739; GO:0005847; GO:0008270; GO:0016180; GO:0016607; GO:0050265; GO:0140767; GO:0180010; GO:1990817
2414,Pocillopora_acuta_HIv2___RNAseq.g5827.t1,296.5956052,-0.311891512,1.04589349,0.000874798,0.005241541,,NA,NA,NA,NA,NA
2415,Pocillopora_acuta_HIv2___RNAseq.g16844.t1,101.4468315,-2.814370174,2.314886141,0.000877035,0.00525277,,Q96PQ7,3.95E-24,Kelch-like protein 5,,GO:0003779; GO:0005737; GO:0005829; GO:0005856
2416,Pocillopora_acuta_HIv2___RNAseq.g8915.t1,1709.590923,-2.521524313,1.300471813,0.000877483,0.005253274,,P10079,9.58E-16,Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1),,GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579
2417,Pocillopora_acuta_HIv2___RNAseq.g4609.t1,116.972185,-0.233402249,1.031710105,0.000883273,0.005285751,,Q61382,1.07E-39,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1),apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165],GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007165; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699
2418,Pocillopora_acuta_HIv2___RNAseq.g11181.t1,214.9862409,-0.363639543,1.085994117,0.00088759,0.005308358,,O95243,2.06E-44,Methyl-CpG-binding domain protein 4 (EC 3.2.2.-) (Methyl-CpG-binding endonuclease 1) (Methyl-CpG-binding protein MBD4) (Mismatch-specific DNA N-glycosylase),depyrimidination [GO:0045008]; DNA repair [GO:0006281]; response to estradiol [GO:0032355],GO:0003677; GO:0003696; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0008263; GO:0016607; GO:0019104; GO:0032355; GO:0045008
2419,Pocillopora_acuta_HIv2___RNAseq.g19734.t1,57.45517591,-0.584837698,1.263707933,0.000887785,0.005308358,,NA,NA,NA,NA,NA
2420,Pocillopora_acuta_HIv2___TS.g4253.t1,277.4546427,-1.068361912,1.670095175,0.000890535,0.005322603,,NA,NA,NA,NA,NA
2421,Pocillopora_acuta_HIv2___TS.g1660.t1,373.9894384,-0.197501841,1.02928543,0.000892208,0.005330402,,Q86SG6,0,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8) (Nima-related protein kinase 12a),animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330],GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310
2422,Pocillopora_acuta_HIv2___RNAseq.g25990.t1,169.7124115,-0.410163655,1.117196218,0.000894406,0.005341325,,Q924T3,1.29E-23,"DNA repair protein XRCC4 (X-ray repair cross-complementing protein 4) [Cleaved into: Protein XRCC4, C-terminus (XRCC4/C)]",central nervous system development [GO:0007417]; DN2 thymocyte differentiation [GO:1904155]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; fibroblast proliferation [GO:0048144]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; protein localization to site of double-strand break [GO:1990166]; response to gamma radiation [GO:0010332]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165]; telomeric DNA-containing double minutes formation [GO:0061819]; V(D)J recombination [GO:0033151],GO:0000781; GO:0001701; GO:0002328; GO:0003677; GO:0005737; GO:0005958; GO:0006266; GO:0006302; GO:0006303; GO:0007417; GO:0010165; GO:0010212; GO:0010332; GO:0022008; GO:0032807; GO:0033151; GO:0033152; GO:0035861; GO:0043524; GO:0045190; GO:0048144; GO:0048146; GO:0050769; GO:0051103; GO:0051402; GO:0061819; GO:0070419; GO:0070522; GO:1904155; GO:1905765; GO:1990166
2423,Pocillopora_acuta_HIv2___TS.g27891.t1,208.8451495,-0.628336908,1.28049128,0.000896127,0.005349393,,P55786,0,Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S),cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508],GO:0000209; GO:0004177; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0016020; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955
2424,Pocillopora_acuta_HIv2___RNAseq.g27665.t1,136.7430703,0.549314119,1.183048281,0.000896499,0.005349405,,E9Q236,0,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4),bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; fatty acid derivative transport [GO:1901571]; leukotriene transport [GO:0071716]; organic hydroxy compound transport [GO:0015850]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855],GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015431; GO:0015432; GO:0015562; GO:0015665; GO:0015721; GO:0015732; GO:0015747; GO:0015850; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:1901571
2425,Pocillopora_acuta_HIv2___RNAseq.g20160.t1,1122.970644,-1.819943298,3.018312174,0.000900643,0.00537192,,NA,NA,NA,NA,NA
2426,Pocillopora_acuta_HIv2___RNAseq.g23065.t1,145.0643016,-0.7441073,1.306841583,0.000902273,0.005379421,,Q9BRN9,4.96E-79,TM2 domain-containing protein 3 (Beta-amyloid-binding protein-like protein 2) (BBP-like protein 2),lateral inhibition [GO:0046331]; positive regulation of Notch signaling pathway [GO:0045747],GO:0005886; GO:0045747; GO:0046331
2427,Pocillopora_acuta_HIv2___TS.g15651.t1,79.73260066,-0.500367722,1.204756613,0.000903499,0.005384512,,A0A1L8GXM0,9.45E-20,DNA repair protein RAD50.L (EC 3.6.-.-),DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; meiotic cell cycle [GO:0051321]; metaphase chromosome alignment [GO:0051310]; R-loop processing [GO:0062176]; telomere maintenance [GO:0000723],GO:0000723; GO:0000729; GO:0000781; GO:0005524; GO:0016887; GO:0030870; GO:0035861; GO:0043539; GO:0046872; GO:0051310; GO:0051321; GO:0062176; GO:0110025
2428,Pocillopora_acuta_HIv2___RNAseq.g2022.t1,204.47026,-0.207068607,1.0462011,0.000911812,0.005431819,,NA,NA,NA,NA,NA
2429,Pocillopora_acuta_HIv2___RNAseq.g8705.t1,114.9958873,-0.795591424,1.376755853,0.000912612,0.005434292,,Q9WV70,6.45E-172,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273],GO:0000122; GO:0000786; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006915; GO:0030690; GO:0030691; GO:0042273; GO:0042393
2430,Pocillopora_acuta_HIv2___RNAseq.g9715.t1,184.2858756,-2.536642458,1.420720365,0.000912979,0.005434292,,NA,NA,NA,NA,NA
2431,Pocillopora_acuta_HIv2___RNAseq.g21516.t1,636.706584,0.719285491,1.371485399,0.000915021,0.005444208,,B8VIW9,0,Fibronectin type III domain-containing protein (Neuroglian-like protein),axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609],GO:0005886; GO:0007411; GO:0030424; GO:0098609
2432,Pocillopora_acuta_HIv2___RNAseq.g26701.t1,1070.525506,-2.36453067,1.456234264,0.000915716,0.005446103,,Q8CQD9,2.31E-10,Accumulation-associated protein,,GO:0005576
2433,Pocillopora_acuta_HIv2___RNAseq.g5642.t1b,665.8383877,0.428380174,1.114995674,0.000918433,0.005460015,,Q9SAJ7,1.05E-69,Metal tolerance protein 9 (AtMTP9),,GO:0005774; GO:0008324; GO:0016020
2434,Pocillopora_acuta_HIv2___TS.g4404.t1,147.5549932,0.547119968,1.241188755,0.0009197,0.005465302,,NA,NA,NA,NA,NA
2435,Pocillopora_acuta_HIv2___TS.g29687.t1,208.6569675,-0.509251183,1.13116504,0.000927558,0.005509732,,P21463,6.73E-24,Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; B cell differentiation [GO:0030183]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glycoprotein [GO:1904588]; cellular response to thyrotropin-releasing hormone [GO:1905229]; cochlea morphogenesis [GO:0090103]; dopaminergic neuron differentiation [GO:0071542]; hormone-mediated signaling pathway [GO:0009755]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of multicellular organism growth [GO:0040018]; regulation of locomotion [GO:0040012]; thyroid-stimulating hormone signaling pathway [GO:0038194],GO:0004996; GO:0005886; GO:0007166; GO:0007189; GO:0008284; GO:0008344; GO:0008528; GO:0009755; GO:0016323; GO:0030183; GO:0038023; GO:0038194; GO:0040012; GO:0040018; GO:0043235; GO:0044877; GO:0060119; GO:0060122; GO:0071542; GO:0090103; GO:0120162; GO:1904588; GO:1905229
2436,Pocillopora_acuta_HIv2___RNAseq.g9334.t1,6238.798772,-1.871727361,0.695723994,0.000928677,0.005514112,,P16621,0,Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR),axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124],GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386
2437,Pocillopora_acuta_HIv2___RNAseq.g9589.t2,2396.757667,2.989364106,1.904033249,0.000930236,0.005521106,Homeobox protein OTX1 B,Q91994,3.89E-37,Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B),inner ear morphogenesis [GO:0042472]; lateral semicircular canal development [GO:0060875]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal pigment epithelium development [GO:0003406],GO:0000978; GO:0000981; GO:0003406; GO:0005634; GO:0006357; GO:0042472; GO:0060875
2438,Pocillopora_acuta_HIv2___TS.g14842.t1,71.89614916,-0.447713441,1.092444231,0.000930915,0.005522868,,NA,NA,NA,NA,NA
2439,Pocillopora_acuta_HIv2___RNAseq.g14505.t1,13007.13583,-1.652137996,0.579779812,0.000932226,0.005528378,"Actin, cytoplasmic",P12716,0,"Actin, cytoplasmic (EC 3.6.4.-) [Cleaved into: Actin, cytoplasmic, intermediate form]",,GO:0005524; GO:0005737; GO:0005856; GO:0016787
2440,Pocillopora_acuta_HIv2___RNAseq.g18396.t1,133.9298906,-0.509977377,1.171705068,0.000934028,0.005536794,,NA,NA,NA,NA,NA
2441,Pocillopora_acuta_HIv2___RNAseq.g26227.t1,347.2427948,-0.244582956,1.052839747,0.000936603,0.005549788,,Q9YGN6,9.65E-98,Single-strand selective monofunctional uracil DNA glycosylase (EC 3.2.2.-),base-excision repair [GO:0006284],GO:0003677; GO:0005634; GO:0006284; GO:0017065
2442,Pocillopora_acuta_HIv2___RNAseq.g11563.t1,510.9331753,-1.283676366,1.999922726,0.000939448,0.005562463,,Q28BR5,0,"Presequence protease, mitochondrial (EC 3.4.24.-) (Pitrilysin metalloproteinase 1)",proteolysis [GO:0006508],GO:0004222; GO:0005759; GO:0006508; GO:0046872
2443,Pocillopora_acuta_HIv2___RNAseq.g28061.t1,246.0671045,-0.171857287,1.022560961,0.000939512,0.005562463,,NA,NA,NA,NA,NA
2444,Pocillopora_acuta_HIv2___RNAseq.g21911.t1,606.5001475,2.194522132,0.929294852,0.000941172,0.005570013,,NA,NA,NA,NA,NA
2445,Pocillopora_acuta_HIv2___RNAseq.g9068.t1,271.6763301,2.882356698,1.488177321,0.000942295,0.005574378,,P04186,2.84E-55,Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment],"B cell proliferation [GO:0042100]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]",GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006957; GO:0009617; GO:0042100
2446,Pocillopora_acuta_HIv2___RNAseq.g8488.t1,2529.151272,-2.188434154,0.929429924,0.000944429,0.005584721,,P23098,0,"Dynein beta chain, ciliary",cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0031514; GO:0045505; GO:0051959
2447,Pocillopora_acuta_HIv2___RNAseq.g12956.t1,244.5141259,-0.279830998,1.03548564,0.000944954,0.005585537,,Q8IV33,8.66E-63,Uncharacterized protein KIAA0825,,
2448,Pocillopora_acuta_HIv2___RNAseq.g15699.t1,865.1462502,1.716625806,0.609079622,0.000945795,0.005587833,,P54357,2.63E-35,Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain),actin filament-based movement [GO:0030048],GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036
2449,Pocillopora_acuta_HIv2___RNAseq.g29182.t1,169.3041143,0.086276062,1.022287361,0.000946115,0.005587833,,NA,NA,NA,NA,NA
2450,Pocillopora_acuta_HIv2___RNAseq.g18481.t1,1297.408416,-0.764383173,1.298213527,0.000948371,0.005598874,Frizzled-10-A,Q9DEB5,5.52E-178,Frizzled-10-A (Fz-10A) (Xfz10-A),Wnt signaling pathway [GO:0016055],GO:0004930; GO:0005886; GO:0016055
2451,Pocillopora_acuta_HIv2___RNAseq.g20872.t1,174.845995,-0.238767328,1.049478838,0.000952889,0.005623249,,NA,NA,NA,NA,NA
2452,Pocillopora_acuta_HIv2___RNAseq.g86.t1,152.2816421,-0.082931004,1.02250214,0.00095445,0.005630163,,O75899,8.41E-154,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712
2453,Pocillopora_acuta_HIv2___RNAseq.g23028.t1,83.40882881,-0.375286894,1.072590138,0.000955253,0.005632605,,NA,NA,NA,NA,NA
2454,Pocillopora_acuta_HIv2___RNAseq.g13452.t1,228.4081758,-0.403939936,1.114062871,0.000955865,0.005633919,,Q9JI78,6.49E-10,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (mPNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase),glycoprotein catabolic process [GO:0006516],GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006516; GO:0046872; GO:0062023
2455,Pocillopora_acuta_HIv2___RNAseq.g31079.t1,550.7714469,-0.307041528,1.046316696,0.000957346,0.005640349,,Q5S6T3,1.30E-89,D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein) (Notch1-induced protein),axon guidance [GO:0007411]; isoprenoid biosynthetic process [GO:0008299]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269],GO:0005829; GO:0006486; GO:0007411; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0070567
2456,Pocillopora_acuta_HIv2___TS.g3875.t2,131.9790927,-0.526889072,1.20632049,0.000958348,0.005643951,,Q52KK4,4.22E-40,H/ACA ribonucleoprotein complex non-core subunit NAF1,box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; rRNA processing [GO:0006364]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669],GO:0000493; GO:0001522; GO:0003723; GO:0005634; GO:0005732; GO:0005737; GO:0006364; GO:0042254; GO:0042802; GO:0043489; GO:0070034; GO:0090669; GO:1904358; GO:1905323
2457,Pocillopora_acuta_HIv2___RNAseq.g27486.t1,453.0991047,-0.613604863,1.221224723,0.000961244,0.005658702,,NA,NA,NA,NA,NA
2458,Pocillopora_acuta_HIv2___RNAseq.g3099.t1,443.207179,-2.654991877,1.686988603,0.00097059,0.005711398,,NA,NA,NA,NA,NA
2459,Pocillopora_acuta_HIv2___RNAseq.g18108.t1,272.8216938,-0.230377471,1.031514417,0.000973293,0.005724976,,Q0VCH8,1.25E-59,Transmembrane protein 65,cardiac conduction [GO:0061337]; cardiac ventricle development [GO:0003231]; regulation of cardiac conduction [GO:1903779],GO:0003231; GO:0005739; GO:0005743; GO:0005886; GO:0061337; GO:1903779
2460,Pocillopora_acuta_HIv2___TS.g10811.t1,491.8972064,-1.281904232,2.051375348,0.000974606,0.005730369,,Q9JLG8,0,Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog),proteolysis [GO:0006508],GO:0004198; GO:0005737; GO:0006508; GO:0046872
2461,Pocillopora_acuta_HIv2___RNAseq.g23898.t1,814.3690813,2.375195123,2.038035392,0.000975246,0.0057318,,Q9JHA8,2.31E-27,von Willebrand factor A domain-containing protein 7 (Protein G7c),,GO:0005576
2462,Pocillopora_acuta_HIv2___TS.g24890.t1,159.5555598,3.076222617,1.323275138,0.000977382,0.005742017,,Q5ZJP7,1.09E-37,BTB/POZ domain-containing protein KCTD7,membrane hyperpolarization [GO:0060081]; protein homooligomerization [GO:0051260],GO:0005829; GO:0005886; GO:0051260; GO:0060081
2463,Pocillopora_acuta_HIv2___TS.g27992.t2d,149.5998081,-0.489317907,1.174549932,0.000980534,0.0057582,,Q60ZN5,1.77E-12,Protein sidekick homolog (Neuronal IgCAM protein 4),cell adhesion [GO:0007155]; system development [GO:0048731],GO:0007155; GO:0016020; GO:0048731
2464,Pocillopora_acuta_HIv2___TS.g12320.t1,73.66092492,1.406727463,3.18952981,0.00098118,0.005758489,,Q60HG8,4.27E-14,Alpha-crystallin B chain (Alpha(B)-crystallin),negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; protein refolding [GO:0042026]; response to heat [GO:0009408],GO:0005212; GO:0005576; GO:0005634; GO:0005737; GO:0005764; GO:0009408; GO:0032991; GO:0042026; GO:0042803; GO:0043066; GO:0045892; GO:0046872; GO:0051082
2465,Pocillopora_acuta_HIv2___RNAseq.g30994.t1a,1228.790792,-2.489327101,2.95334714,0.00098138,0.005758489,Solute carrier family 23 member 2,B0JZG0,0,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2),sodium ion transport [GO:0006814],GO:0005886; GO:0006814; GO:0015293
2466,Pocillopora_acuta_HIv2___RNAseq.g15306.t2,110.1172319,-0.315054963,1.091934472,0.000987737,0.005793444,,Q6AY08,1.08E-10,Flagellum-associated coiled-coil domain-containing protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein homolog),,GO:0001520; GO:0005737; GO:0031410; GO:0036126
2467,Pocillopora_acuta_HIv2___RNAseq.g14607.t1,1821.935832,-2.801776556,2.23489445,0.000990795,0.005809023,,NA,NA,NA,NA,NA
2468,Pocillopora_acuta_HIv2___RNAseq.g128.t1,127.5641191,-0.348166492,1.084468517,0.00099292,0.00581912,,NA,NA,NA,NA,NA
2469,Pocillopora_acuta_HIv2___TS.g26763.t2a,191.8845938,-0.24322594,1.051278662,0.000993711,0.005821402,,Q6ZV73,3.41E-40,"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)",actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087],GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872
2470,Pocillopora_acuta_HIv2___TS.g6576.t2,502.2647561,2.024426623,0.801608966,0.001000989,0.005861663,,Q9VY77,1.21E-67,LIM domain-containing protein jub,cytoskeleton organization [GO:0007010]; follicle cell of egg chamber development [GO:0030707]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666],GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311
2471,Pocillopora_acuta_HIv2___RNAseq.g19558.t1,99.71858024,-0.648705949,1.325949578,0.001003434,0.005873603,,P51869,6.92E-130,Cytochrome P450 4F4 (CYPIVF4) (Leukotriene-B4 20-monooxygenase) (EC 1.14.14.94),arachidonic acid metabolic process [GO:0019369]; leukotriene B4 catabolic process [GO:0036101]; omega-hydroxylase P450 pathway [GO:0097267]; prostaglandin catabolic process [GO:1905344]; response to 3-methylcholanthrene [GO:1904681],GO:0005506; GO:0005789; GO:0008391; GO:0019369; GO:0020037; GO:0036101; GO:0050051; GO:0097267; GO:1904681; GO:1905344
2472,Pocillopora_acuta_HIv2___RNAseq.g15972.t1,1348.217968,2.874812648,1.786966743,0.001004026,0.005874689,,NA,NA,NA,NA,NA
2473,Pocillopora_acuta_HIv2___RNAseq.g25995.t1,387.3925139,0.334508203,1.073779664,0.001006423,0.005886333,,Q09225,5.22E-74,Nose resistant to fluoxetine protein 6 (Protein nrf-6),lipid transport [GO:0006869],GO:0006869; GO:0008289; GO:0016020; GO:0016747
2474,Pocillopora_acuta_HIv2___TS.g15602.t1,134.7752877,1.434625083,2.314464127,0.001007142,0.005888157,,NA,NA,NA,NA,NA
2475,Pocillopora_acuta_HIv2___RNAseq.g4068.t1,231.0319047,-2.88483176,2.833465627,0.001007573,0.005888295,,Q9BQA1,1.73E-59,Methylosome protein WDR77 (Androgen receptor cofactor p44) (Methylosome protein 50) (MEP-50) (WD repeat-containing protein 77) (p44/Mep50),"epithelial cell proliferation involved in prostate gland development [GO:0060767]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; spliceosomal snRNP assembly [GO:0000387]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0000209; GO:0000387; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006357; GO:0006511; GO:0007309; GO:0008284; GO:0008327; GO:0030374; GO:0031465; GO:0034709; GO:0048026; GO:0060528; GO:0060767; GO:0060770; GO:1990756
2476,Pocillopora_acuta_HIv2___RNAseq.g9109.t1,508.209312,-0.119577268,1.017994679,0.001008585,0.005890421,,P15215,5.37E-142,Laminin subunit gamma-1 (Laminin B2 chain),animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; endodermal digestive tract morphogenesis [GO:0061031]; extracellular matrix assembly [GO:0085029]; midgut development [GO:0007494]; salivary gland morphogenesis [GO:0007435]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888],GO:0005576; GO:0005604; GO:0007411; GO:0007435; GO:0007494; GO:0009887; GO:0009888; GO:0033627; GO:0034446; GO:0061031; GO:0070831; GO:0071711; GO:0085029
2477,Pocillopora_acuta_HIv2___RNAseq.g25248.t1a,397.7973395,-1.325919553,2.099954957,0.001008751,0.005890421,,Q7SXM7,0,U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31),"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244]",GO:0000244; GO:0000381; GO:0000398; GO:0005634; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030622; GO:0046540; GO:0060041; GO:0071005; GO:0071011; GO:0071339; GO:0097526
2478,Pocillopora_acuta_HIv2___RNAseq.g21032.t1,1708.358252,2.005079313,0.789179517,0.001012154,0.00590791,,A4ZNR5,8.21E-14,Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B),negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],GO:0005509; GO:0005737; GO:0005886; GO:0016055; GO:0030178; GO:0090090
2479,Pocillopora_acuta_HIv2___RNAseq.g8890.t1,29.98779359,-1.458834515,2.68906702,0.001019166,0.005946144,,Q7ZTV5,4.87E-16,Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of protein kinase A signaling [GO:0010738],GO:0004963; GO:0005886; GO:0007186; GO:0007189; GO:0008528; GO:0008584; GO:0009755; GO:0010738; GO:0016020; GO:0042699; GO:0043235; GO:0051897; GO:0070374; GO:0071372
2480,Pocillopora_acuta_HIv2___RNAseq.g2736.t1,570.3458124,0.808934345,1.489682875,0.001019527,0.005946144,,NA,NA,NA,NA,NA
2481,Pocillopora_acuta_HIv2___RNAseq.g8916.t1,2710.001334,3.000819561,2.039102613,0.001023108,0.005964627,,Q9QYP1,0,Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7),amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395
2482,Pocillopora_acuta_HIv2___RNAseq.g16957.t1,448.0458481,-0.977392543,1.60780026,0.001024216,0.005968679,,Q06831,1.86E-37,Transcription factor SOX-4,"ascending aorta morphogenesis [GO:0035910]; atrial septum primum morphogenesis [GO:0003289]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucose stimulus [GO:0071333]; endocrine pancreas development [GO:0031018]; gene expression [GO:0010467]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hematopoietic stem cell homeostasis [GO:0061484]; kidney morphogenesis [GO:0060993]; mesenchyme development [GO:0060485]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of N-terminal peptidyl-lysine acetylation [GO:2000761]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein stabilization [GO:0050821]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]; somatic stem cell population maintenance [GO:0035019]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; ventricular septum morphogenesis [GO:0060412]",GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0002328; GO:0003183; GO:0003215; GO:0003289; GO:0003357; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005739; GO:0006355; GO:0007399; GO:0007420; GO:0007507; GO:0008284; GO:0008285; GO:0010467; GO:0014009; GO:0021510; GO:0021782; GO:0030182; GO:0030217; GO:0031018; GO:0031397; GO:0031647; GO:0032024; GO:0035019; GO:0035198; GO:0035910; GO:0042593; GO:0043065; GO:0043516; GO:0045588; GO:0045662; GO:0045663; GO:0045727; GO:0045893; GO:0045944; GO:0048485; GO:0048593; GO:0050821; GO:0060412; GO:0060485; GO:0060563; GO:0060993; GO:0061484; GO:0071333; GO:0090263; GO:2000761
2483,Pocillopora_acuta_HIv2___TS.g4588.t1,1270.795672,-1.692907163,3.085180699,0.001035628,0.006032755,,Q6BEB4,3.66E-59,Transcription factor Sp5,bone morphogenesis [GO:0060349]; cellular response to organic cyclic compound [GO:0071407]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0036342; GO:0046872; GO:0060349; GO:0071407
2484,Pocillopora_acuta_HIv2___RNAseq.g14149.t1,335.8055512,-0.439138907,1.087295259,0.001036436,0.006035029,,Q8BRF7,0,Sec1 family domain-containing protein 1 (Syntaxin-binding protein 1-like 2),"cell morphogenesis [GO:0000902]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",GO:0000139; GO:0000902; GO:0001666; GO:0005789; GO:0005798; GO:0005801; GO:0006886; GO:0006888; GO:0006890; GO:0006892; GO:0009636; GO:0019905; GO:0032580; GO:0044877; GO:0051223; GO:0060628; GO:1902902
2485,Pocillopora_acuta_HIv2___TS.g12990.t1,319.3232344,-1.415129641,2.544703023,0.001041806,0.006063854,,P57769,1.16E-43,Sorting nexin-16,early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622],GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022
2486,Pocillopora_acuta_HIv2___RNAseq.g14228.t1,47.31365063,0.547115373,1.186509641,0.001048787,0.006101173,,P41636,4.93E-140,4-coumarate--CoA ligase (4CL) (EC 6.2.1.12) (4-coumaroyl-CoA synthase),phenylpropanoid metabolic process [GO:0009698],GO:0005524; GO:0009698; GO:0016207
2487,Pocillopora_acuta_HIv2___TS.g3354.t2,148.2448393,-0.446006663,1.134463842,0.001049261,0.006101173,,Q8BG58,1.14E-43,Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4),regulation of erythrocyte differentiation [GO:0045646],GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0031418; GO:0045646; GO:0160082
2488,Pocillopora_acuta_HIv2___RNAseq.g8053.t1,167.1145414,-0.336629624,1.079079747,0.001049651,0.006101173,,A2VDS1,5.45E-173,Selenocysteine lyase (EC 4.4.1.16),,GO:0005829; GO:0009000; GO:0016740
2489,Pocillopora_acuta_HIv2___RNAseq.g13718.t1,929.2844392,-2.39216092,2.630419815,0.001049905,0.006101173,,Q7TN83,7.64E-08,Synaptotagmin-16 (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein),,GO:0005543; GO:0016020; GO:0042802
2490,Pocillopora_acuta_HIv2___RNAseq.g15865.t1,158.3135122,-0.243120649,1.051867431,0.001050844,0.006104182,,Q62193,1.83E-71,Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34),base-excision repair [GO:0006284]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723],GO:0000723; GO:0000724; GO:0000781; GO:0003677; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006284; GO:0006289; GO:0006298; GO:0010569; GO:0016605; GO:0034502; GO:0035861; GO:0042162; GO:2000001
2491,Pocillopora_acuta_HIv2___RNAseq.g12518.t1,213.2880087,-0.833584119,1.360689367,0.001051763,0.006106251,,Q9TR36,4.22E-107,Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta) (Phosphatidylinositol-transfer protein 36 kDa isoform) (PI-TP 36 kda isoform),"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",GO:0000139; GO:0005737; GO:0005789; GO:0005794; GO:0006890; GO:0008525; GO:0008526; GO:0031210; GO:0035091; GO:0120019; GO:0140338
2492,Pocillopora_acuta_HIv2___TS.g23144.t1,1933.985739,2.902574428,2.098794963,0.001052045,0.006106251,,Q00685,6.80E-149,Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain],"complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]",GO:0004866; GO:0005615; GO:0006954; GO:0006958; GO:0045087
2493,Pocillopora_acuta_HIv2___TS.g18753.t1,148.5854047,-0.338070172,1.079479885,0.001055267,0.006122496,,Q9CR24,2.10E-49,Mitochondrial coenzyme A diphosphatase NUDT8 (EC 3.6.1.-) (EC 3.6.1.77) (Nucleoside diphosphate-linked moiety X motif 8) (Nudix motif 8),acetyl-CoA catabolic process [GO:0046356]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA catabolic process [GO:1902859]; succinyl-CoA catabolic process [GO:1901289],GO:0000287; GO:0005739; GO:0005759; GO:0010945; GO:0015938; GO:0030145; GO:0036114; GO:0044580; GO:0046356; GO:1901289; GO:1902859; GO:2001294
2494,Pocillopora_acuta_HIv2___RNAseq.g3746.t1,1372.879084,-0.966910213,1.536261686,0.001057635,0.006133774,Hippocalcin-like protein 1,P37235,1.27E-68,Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3),,GO:0005509; GO:0016020
2495,Pocillopora_acuta_HIv2___RNAseq.g9955.t1,485.4289056,-1.975411271,2.672887276,0.00105828,0.006135055,,Q9VNJ5,4.89E-33,Protein dispatched,germ cell migration [GO:0008354]; patched ligand maturation [GO:0007225]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc pattern formation [GO:0035222],GO:0005886; GO:0007224; GO:0007225; GO:0007367; GO:0008354; GO:0016020; GO:0022857; GO:0035222; GO:0035230
2496,Pocillopora_acuta_HIv2___RNAseq.g24174.t1,754.9862167,-2.061806709,2.261280794,0.001068334,0.006190857,,Q4G5Y1,2.70E-97,Kelch domain-containing protein 2 (Endothelial differentiation inhibitory protein TNG),proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],GO:0005634; GO:0016567; GO:0016604; GO:0031462; GO:0031965; GO:0043161; GO:0140627; GO:1990756
2497,Pocillopora_acuta_HIv2___RNAseq.g25727.t1,445.2805966,-2.415830935,1.36243261,0.00107174,0.006208108,,Q54271,1.52E-53,Phosphonopyruvate decarboxylase (PnPy decarboxylase) (EC 4.1.1.82),antibiotic biosynthetic process [GO:0017000]; organic phosphonate biosynthetic process [GO:0032923],GO:0000287; GO:0017000; GO:0030976; GO:0032923; GO:0033980
2498,Pocillopora_acuta_HIv2___RNAseq.g7839.t1,253.4406693,-0.452802778,1.142356303,0.001078681,0.006245407,,A0A0R4IC37,0,Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specific factor 1),,GO:0003676; GO:0005654
2499,Pocillopora_acuta_HIv2___TS.g11495.t1,75.14280346,-0.439982676,1.141525869,0.001079043,0.006245407,,Q66L32,1.53E-24,Mitochondrial import inner membrane translocase subunit Tim8 A,protein transport [GO:0015031],GO:0005743; GO:0015031; GO:0046872
2500,Pocillopora_acuta_HIv2___RNAseq.g2884.t1,1112.131707,2.039163223,3.492907299,0.001090613,0.006309848,,A9Y006,1.15E-87,Aquaporin-3 (Aquaglyceroporin-3),glycerol transmembrane transport [GO:0015793]; polyol transmembrane transport [GO:0015791]; water transport [GO:0006833],GO:0005886; GO:0006833; GO:0015166; GO:0015204; GO:0015250; GO:0015254; GO:0015791; GO:0015793; GO:0016323
2501,Pocillopora_acuta_HIv2___RNAseq.g13818.t1,1420.882919,2.425344453,1.642699716,0.001091982,0.006315244,,O95084,4.31E-42,Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13),proteolysis [GO:0006508],GO:0004252; GO:0005634; GO:0005788; GO:0006508; GO:0070062
2502,Pocillopora_acuta_HIv2___RNAseq.6831_t,280.7710488,-0.119350687,1.019553957,0.001092449,0.006315423,,Q9Y580,6.17E-24,RNA-binding protein 7 (RNA-binding motif protein 7),"meiotic cell cycle [GO:0051321]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; snRNA catabolic process [GO:0016076]",GO:0000381; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0016076; GO:0017069; GO:0051321; GO:0071889; GO:0097157
2503,Pocillopora_acuta_HIv2___RNAseq.g17729.t1,153.3879007,-0.15809855,1.017510226,0.001094914,0.006327144,,NA,NA,NA,NA,NA
2504,Pocillopora_acuta_HIv2___RNAseq.g27019.t1,242.0182047,-0.286519243,1.061784675,0.001099635,0.006350374,,Q2KIN6,4.19E-43,Protein Mpv17,regulation of mitochondrial DNA metabolic process [GO:1901858],GO:0005737; GO:0005739; GO:0005743; GO:0015267; GO:1901858
2505,Pocillopora_acuta_HIv2___RNAseq.g6724.t1,129.1164046,-0.497380113,1.190436456,0.001099812,0.006350374,,O43592,0,Exportin-T (Exportin(tRNA)) (tRNA exportin),intracellular protein transport [GO:0006886]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528],GO:0000049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0006886; GO:0016363; GO:0031267; GO:0071528
2506,Pocillopora_acuta_HIv2___RNAseq.g6284.t1,124.9193173,-1.880511643,0.706290614,0.001106232,0.00638489,,A4YI89,5.39E-12,3-hydroxypropionyl-coenzyme A dehydratase (3-hydroxypropionyl-CoA dehydratase) (EC 4.2.1.116),fatty acid metabolic process [GO:0006631],GO:0006631; GO:0043956
2507,Pocillopora_acuta_HIv2___RNAseq.g15779.t1,112.4854434,-0.302952375,1.062648158,0.001106893,0.006386159,,Q6NS38,6.92E-89,DNA oxidative demethylase ALKBH2 (EC 1.14.11.33) (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2) (Oxy DC1),DNA alkylation repair [GO:0006307],GO:0000182; GO:0005634; GO:0005654; GO:0005730; GO:0006307; GO:0008198; GO:0035516; GO:0051747
2508,Pocillopora_acuta_HIv2___TS.g3052.t1,273.7836439,0.432733843,1.118326309,0.001108973,0.006395607,,NA,NA,NA,NA,NA
2509,Pocillopora_acuta_HIv2___RNAseq.g26743.t1,533.3213828,-2.377074993,1.740401262,0.001118793,0.00644967,,P27545,1.95E-75,Ceramide synthase 1 (CerS1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299),brain development [GO:0007420]; ceramide biosynthetic process [GO:0046513]; negative regulation of glucose import [GO:0046325],GO:0005783; GO:0005789; GO:0007420; GO:0016410; GO:0043231; GO:0046325; GO:0046513; GO:0050291
2510,Pocillopora_acuta_HIv2___RNAseq.26508_t,840.7710811,2.400620333,2.795114352,0.001121732,0.006464035,,Q9JJS0,3.30E-27,"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You)",chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smoothened signaling pathway [GO:0045880]; signal transduction [GO:0007165],GO:0003413; GO:0005509; GO:0005615; GO:0007165; GO:0008289; GO:0009986; GO:0019897; GO:0042802; GO:0045669; GO:0045778; GO:0045880; GO:0097108; GO:1902732
2511,Pocillopora_acuta_HIv2___RNAseq.g2697.t1,133.0087139,-0.506114148,1.188625281,0.001122648,0.00646674,,Q53GS9,0,Ubiquitin carboxyl-terminal hydrolase 39 (EC 3.4.19.12) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein),"cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008270; GO:0008380; GO:0016579; GO:0016787; GO:0046540; GO:0051301
2512,Pocillopora_acuta_HIv2___RNAseq.g30082.t1,261.0849692,-0.176826487,1.027813765,0.001125196,0.006478833,Solute carrier family 25 member 43,Q5U3V7,1.72E-98,Solute carrier family 25 member 43,transmembrane transport [GO:0055085],GO:0005743; GO:0055085
2513,Pocillopora_acuta_HIv2___RNAseq.g27047.t1,2115.76228,2.507238868,2.436226266,0.001128171,0.006493383,Protein Wnt-8a,P51028,5.66E-55,Protein Wnt-8a,anterior/posterior pattern specification [GO:0009952]; brain segmentation [GO:0035284]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in pronephros development [GO:0039015]; central nervous system development [GO:0007417]; determination of dorsal identity [GO:0048263]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; endoderm development [GO:0007492]; eye development [GO:0001654]; hindbrain development [GO:0030902]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mesodermal cell fate commitment [GO:0001710]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural crest cell fate specification [GO:0014036]; neural plate anterior/posterior regionalization [GO:0021999]; neural plate pattern specification [GO:0060896]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; post-anal tail morphogenesis [GO:0036342]; regulation of anterior head development [GO:2000742]; regulation of cell population proliferation [GO:0042127]; somitogenesis [GO:0001756]; Spemann organizer formation [GO:0060061]; spinal cord anterior/posterior patterning [GO:0021512]; Wnt signaling pathway [GO:0016055],GO:0000578; GO:0001654; GO:0001707; GO:0001710; GO:0001756; GO:0005109; GO:0005125; GO:0005615; GO:0007398; GO:0007417; GO:0007492; GO:0007498; GO:0009950; GO:0009952; GO:0009953; GO:0009986; GO:0010628; GO:0014036; GO:0016055; GO:0021512; GO:0021999; GO:0030182; GO:0030902; GO:0030903; GO:0035284; GO:0036342; GO:0039015; GO:0042074; GO:0042127; GO:0045165; GO:0045743; GO:0048263; GO:0060061; GO:0060070; GO:0060896; GO:0090090; GO:0090263; GO:0097189; GO:2000742
2514,Pocillopora_acuta_HIv2___RNAseq.g13205.t1,1874.071411,2.499633301,1.275930576,0.001131903,0.006512269,,NA,NA,NA,NA,NA
2515,Pocillopora_acuta_HIv2___RNAseq.g17611.t1,44238.83161,1.848369584,0.708377741,0.001132366,0.006512342,,NA,NA,NA,NA,NA
2516,Pocillopora_acuta_HIv2___TS.g27519.t1,742.0155428,-1.522062666,2.572156369,0.001134027,0.006519301,,Q9VVU5,8.47E-19,COP9 signalosome complex subunit 1b (Dch1-2) (Signalosome subunit 1b),female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821],GO:0000338; GO:0005737; GO:0007281; GO:0008180; GO:0036099; GO:0048140; GO:0048142; GO:0050821
2517,Pocillopora_acuta_HIv2___RNAseq.g5050.t1,486.7773112,-0.234981561,1.027655392,0.001135101,0.006522885,,Q98925,1.57E-27,Interferon regulatory factor 2 (IRF-2),immune system process [GO:0002376]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0002376; GO:0005634; GO:0006357
2518,Pocillopora_acuta_HIv2___RNAseq.g22551.t1,122.8736882,0.400241629,1.109960226,0.0011365,0.006528329,,NA,NA,NA,NA,NA
2519,Pocillopora_acuta_HIv2___TS.g13509.t1,95.98280558,-0.634150652,1.232525707,0.001137335,0.006530536,,NA,NA,NA,NA,NA
2520,Pocillopora_acuta_HIv2___RNAseq.953_t,1081.978676,-2.243790058,2.404050103,0.001137808,0.006530658,Glycine betaine/proline/choline/ectoine transporter VP1456,Q87PP5,5.95E-102,Glycine betaine/proline/choline/ectoine transporter VP1456,amino acid transport [GO:0006865],GO:0005886; GO:0006865; GO:0022857
2521,Pocillopora_acuta_HIv2___TS.g14962.t1,1936.999862,-2.154056949,0.980528875,0.001138315,0.006530973,,Q6NS52,0,Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta),diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617],GO:0004143; GO:0005509; GO:0005524; GO:0005737; GO:0005886; GO:0006654; GO:0007205; GO:0009617; GO:0035556; GO:0046339; GO:0046473; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175
2522,Pocillopora_acuta_HIv2___TS.g30518.t2,71.27156673,-0.49706573,1.186843746,0.001150372,0.006597537,,Q5ZL55,2.23E-26,Charged multivesicular body protein 6 (Chromatin-modifying protein 6),late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900],GO:0000815; GO:0005771; GO:0006900; GO:0015031; GO:0031902; GO:0032511
2523,Pocillopora_acuta_HIv2___RNAseq.g4951.t1,333.5079162,-0.382382215,1.116026804,0.001156418,0.006629582,,A0A2R8QPS5,2.70E-09,Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner 1),"intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0000139; GO:0005085; GO:0005829; GO:0006886; GO:0034066; GO:0042147
2524,Pocillopora_acuta_HIv2___RNAseq.g8077.t1,98.16026414,-0.437187655,1.131555555,0.001160538,0.006650562,,NA,NA,NA,NA,NA
2525,Pocillopora_acuta_HIv2___RNAseq.g682.t1,2333.470915,2.8041029,1.737378223,0.001163273,0.006663594,Roundabout homolog 1,O55005,1.77E-28,Roundabout homolog 1,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; heart development [GO:0007507]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; neuron projection extension [GO:1990138]; olfactory bulb interneuron development [GO:0021891]; oligodendrocyte development [GO:0014003]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; regulation of dendrite morphogenesis [GO:0048814]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse organization [GO:0050808]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412],GO:0001822; GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0003281; GO:0005737; GO:0005886; GO:0007156; GO:0007411; GO:0007507; GO:0008046; GO:0008285; GO:0009986; GO:0010628; GO:0010629; GO:0014003; GO:0016199; GO:0021510; GO:0021836; GO:0021891; GO:0030275; GO:0030336; GO:0030424; GO:0030425; GO:0030673; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043025; GO:0045747; GO:0048814; GO:0050772; GO:0050808; GO:0050925; GO:0051964; GO:0060412; GO:0060763; GO:0060976; GO:0070100; GO:0071456; GO:1900748; GO:1990138
2526,Pocillopora_acuta_HIv2___RNAseq.g27433.t1,732.8683303,2.386555335,1.409314822,0.001164674,0.006668982,,NA,NA,NA,NA,NA
2527,Pocillopora_acuta_HIv2___RNAseq.10616_t,908.1913683,2.214114202,1.038902218,0.001168584,0.006688611,,J9VG42,9.96E-06,Transcription factor MBS1 (Mbp1/Swi4-like protein 1),,GO:0001228; GO:0003677; GO:0090575
2528,Pocillopora_acuta_HIv2___RNAseq.g22728.t1,308.9282201,-0.220453674,1.034528517,0.001169234,0.006688611,,NA,NA,NA,NA,NA
2529,Pocillopora_acuta_HIv2___RNAseq.g22526.t1,114.6328252,-0.379564844,1.09964516,0.00116949,0.006688611,,NA,NA,NA,NA,NA
2530,Pocillopora_acuta_HIv2___RNAseq.g6263.t1,75.94424699,-0.447484574,1.132405288,0.001171453,0.006697189,,NA,NA,NA,NA,NA
2531,Pocillopora_acuta_HIv2___RNAseq.g9223.t1,116.6111282,-1.873458496,3.424016434,0.001177332,0.006728145,,Q684M4,3.34E-167,Kelch-like ECH-associated protein 1,cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; negative regulation of response to oxidative stress [GO:1902883]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006355; GO:0006511; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0034451; GO:0034599; GO:0042802; GO:0045604; GO:0061629; GO:0071353; GO:0097718; GO:1902883; GO:1990756
2532,Pocillopora_acuta_HIv2___RNAseq.g30810.t1,210.081976,-0.310227488,1.05962075,0.001178508,0.006732204,,O64700,6.92E-107,Urease accessory protein G (AtUREG),protein maturation by nickel ion transfer [GO:0110147]; urea catabolic process [GO:0043419],GO:0003924; GO:0005525; GO:0016151; GO:0043419; GO:0110147; GO:0150006
2533,Pocillopora_acuta_HIv2___RNAseq.g2827.t1,2015.114506,-1.242856341,2.117561551,0.001180121,0.006738759,,O43581,9.75E-12,Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII),calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119],GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:1900242; GO:1990926; GO:1990927
2534,Pocillopora_acuta_HIv2___RNAseq.g30568.t1,212.3436788,-0.280713358,1.060759228,0.001187085,0.00677585,,NA,NA,NA,NA,NA
2535,Pocillopora_acuta_HIv2___TS.g4503.t1,315.9932593,0.219440175,1.04098816,0.001187769,0.006777076,,NA,NA,NA,NA,NA
2536,Pocillopora_acuta_HIv2___RNAseq.g31298.t1,355.9382189,-0.060408504,1.020614218,0.001189546,0.006784543,,Q9Z2L6,2.36E-42,"Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80)",intracellular monoatomic cation homeostasis [GO:0030003],GO:0003993; GO:0004446; GO:0005615; GO:0005788; GO:0005886; GO:0008707; GO:0016158; GO:0016312; GO:0030003; GO:0030351; GO:0030352; GO:0034417; GO:0046030; GO:0052745; GO:0052826; GO:0052827
2537,Pocillopora_acuta_HIv2___RNAseq.g28959.t1,301.7454617,-0.072041799,1.021706831,0.00119605,0.006818949,,P10079,1.48E-86,Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1),,GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579
2538,Pocillopora_acuta_HIv2___TS.g11806.t1,197.6810264,-0.699649364,1.29812137,0.001204206,0.006862738,,Q5RHX6,3.45E-93,DCN1-like protein 4 (DCNL4) (DCUN1 domain-containing protein 4) (Defective in cullin neddylation protein 1-like protein 4),positive regulation of protein neddylation [GO:2000436]; protein neddylation [GO:0045116],GO:0000151; GO:0005634; GO:0031624; GO:0032182; GO:0045116; GO:0097602; GO:2000436
2539,Pocillopora_acuta_HIv2___RNAseq.g4028.t1,1336.23794,-1.778103396,2.856906651,0.001204959,0.00686433,,O43581,5.45E-110,Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII),calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119],GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:1900242; GO:1990926; GO:1990927
2540,Pocillopora_acuta_HIv2___RNAseq.g1993.t1,94.83685995,-0.281525976,1.060135454,0.001207105,0.006873848,,Q569B5,5.51E-10,Leucine-rich repeat-containing protein 14,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122],GO:0005737; GO:0019900; GO:0032088; GO:0034122
2541,Pocillopora_acuta_HIv2___RNAseq.g8087.t1,1383.604197,2.961070997,1.831121731,0.001207938,0.006875882,,Q8R151,5.27E-143,NFX1-type zinc finger-containing protein 1,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607
2542,Pocillopora_acuta_HIv2___RNAseq.g14891.t1,267.1658019,-0.590635556,1.242637208,0.001211933,0.006893847,,Q60803,4.73E-101,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0001817; GO:0002224; GO:0005164; GO:0005737; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0050688; GO:0061630; GO:0070534
2543,Pocillopora_acuta_HIv2___TS.g9584.t1,167.7652762,-0.066519783,1.021134614,0.001212047,0.006893847,Solute carrier family 15 member 4,Q68F72,2.79E-79,Solute carrier family 15 member 4,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptide transport [GO:0015833]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015833; GO:0015835; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206
2544,Pocillopora_acuta_HIv2___RNAseq.g16484.t1,2367.064121,2.772169474,2.147477341,0.001213729,0.006898794,,Q9VBW3,7.07E-96,Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14),calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060],GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303
2545,Pocillopora_acuta_HIv2___RNAseq.g27337.t1,784.2096806,2.963520732,2.018167376,0.001213871,0.006898794,,Q6PBD4,1.72E-41,Transcription factor HES-4 (Hairy and enhancer of split 4) (Protein hairy-2),eye photoreceptor cell development [GO:0042462]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neurogenesis [GO:0050768]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; photoreceptor cell maintenance [GO:0045494]; prechordal plate formation [GO:0021501],GO:0000122; GO:0002088; GO:0005634; GO:0007219; GO:0007517; GO:0014029; GO:0021501; GO:0033504; GO:0042462; GO:0043066; GO:0043565; GO:0045494; GO:0045892; GO:0046982; GO:0048642; GO:0050768
2546,Pocillopora_acuta_HIv2___RNAseq.g18068.t1,414.8036341,-0.285802132,1.04222002,0.001215714,0.006906556,,P19493,5.44E-107,"Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4)","chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of synapse structure or activity [GO:0050803]; response to fungicide [GO:0060992]; synaptic transmission, glutamatergic [GO:0035249]",GO:0004970; GO:0004971; GO:0005886; GO:0007268; GO:0008328; GO:0014069; GO:0030425; GO:0032281; GO:0032983; GO:0034220; GO:0034392; GO:0035249; GO:0042802; GO:0043025; GO:0043195; GO:0043197; GO:0045202; GO:0048787; GO:0050803; GO:0050804; GO:0051968; GO:0060078; GO:0060992; GO:0098839; GO:0098978; GO:0099507; GO:0099565; GO:1904315
2547,Pocillopora_acuta_HIv2___RNAseq.g9102.t1,241.9304287,-0.364835375,1.060767592,0.001224402,0.006953182,,Q6DGW9,6.95E-90,Calcium load-activated calcium channel (CLAC channel) (GEL complex subunit TMCO1) (Transmembrane and coiled-coil domain-containing protein 1),calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063],GO:0000139; GO:0005262; GO:0005789; GO:0006983; GO:0032469; GO:0043022; GO:0070588; GO:0160063; GO:0160064
2548,Pocillopora_acuta_HIv2___RNAseq.g16050.t1,1242.562353,-2.289200265,1.125662678,0.001225068,0.006954232,,Q04859,0,Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase) (Protein kinase RCK),cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],GO:0001750; GO:0001917; GO:0003713; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0005930; GO:0006468; GO:0030496; GO:0031514; GO:0032391; GO:0035556; GO:0042073; GO:0045494; GO:0046777; GO:0046872; GO:0060271; GO:0072686; GO:0106310; GO:1902856; GO:1905515
2549,Pocillopora_acuta_HIv2___RNAseq.g14250.t1,97.97453239,0.115239553,1.020842832,0.001226385,0.006958977,,Q13308,2.76E-69,Inactive tyrosine-protein kinase 7 (Colon carcinoma kinase 4) (CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7),actin cytoskeleton organization [GO:0030036]; axis elongation [GO:0003401]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; convergent extension [GO:0060026]; coronary vasculature development [GO:0060976]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; lung-associated mesenchyme development [GO:0060484]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuron projection development [GO:0010976]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; ventricular septum development [GO:0003281]; wound healing [GO:0042060],GO:0001736; GO:0001822; GO:0003281; GO:0003401; GO:0004672; GO:0005524; GO:0005886; GO:0005911; GO:0005925; GO:0007156; GO:0007165; GO:0008046; GO:0010976; GO:0015026; GO:0016477; GO:0030036; GO:0030424; GO:0042060; GO:0043025; GO:0045198; GO:0050808; GO:0060026; GO:0060484; GO:0060828; GO:0060976; GO:0071300; GO:0090103; GO:0090179; GO:0090263
2550,Pocillopora_acuta_HIv2___RNAseq.g20376.t1a,209.2573476,-0.151347775,1.022341798,0.001230568,0.006979973,,Q641M3,4.15E-29,Transmembrane protein 18,fat cell differentiation [GO:0045444],GO:0003677; GO:0031965; GO:0045444
2551,Pocillopora_acuta_HIv2___RNAseq.g24165.t1,618.2562751,-0.098253792,1.017367759,0.001231577,0.006982958,,E9Q6E9,1.21E-12,SUMO-interacting motif-containing protein 1 (Platform element for inhibition of autolytic degradation),,GO:0005737; GO:0016605; GO:0030017; GO:0030414; GO:0032184
2552,Pocillopora_acuta_HIv2___RNAseq.g23638.t1,1021.220702,2.468111763,1.383815618,0.001233294,0.006989956,,Q4R8M9,7.10E-20,Gametocyte-specific factor 1 (Protein FAM112B),cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],GO:0005737; GO:0007283; GO:0030154; GO:0046872
2553,Pocillopora_acuta_HIv2___RNAseq.g12405.t1,226.4159612,-0.20783033,1.046650014,0.001238654,0.007017583,,P04353,1.21E-52,Calmodulin (CaM),,GO:0005509
2554,Pocillopora_acuta_HIv2___RNAseq.g31347.t1,3829.187256,1.73063445,0.642448953,0.001241631,0.007031693,,P81439,1.30E-28,Equistatin (EI) (Cysteine proteinase inhibitor),,GO:0004869; GO:0005615
2555,Pocillopora_acuta_HIv2___RNAseq.g1193.t1,183.6031681,-0.595374671,1.281199109,0.001243804,0.007041245,,NA,NA,NA,NA,NA
2556,Pocillopora_acuta_HIv2___RNAseq.g27596.t1,285.2377953,-1.006294881,1.627819618,0.001245817,0.007049881,,NA,NA,NA,NA,NA
2557,Pocillopora_acuta_HIv2___RNAseq.g16854.t2,243.0394554,0.292239548,1.062801868,0.001247777,0.007058212,,Q0DXS3,4.36E-44,Probable RNA-dependent RNA polymerase 1 (OsRDR1) (EC 2.7.7.48),positive regulation of post-transcriptional gene silencing [GO:0060148]; response to salicylic acid [GO:0009751]; response to virus [GO:0009615]; siRNA processing [GO:0030422]; wax biosynthetic process [GO:0010025],GO:0003723; GO:0003968; GO:0009615; GO:0009751; GO:0010025; GO:0030422; GO:0031380; GO:0060148
2558,Pocillopora_acuta_HIv2___RNAseq.g16553.t1,159.761146,-1.29839657,2.071856983,0.001251738,0.007077847,,Q5U584,4.28E-62,SH3 domain-binding protein 5-like (SH3BP-5-like),intracellular signal transduction [GO:0035556],GO:0005085; GO:0035556
2559,Pocillopora_acuta_HIv2___RNAseq.1501_t,141.0208526,-0.257136348,1.054877157,0.001255769,0.007097278,,P53454,5.01E-32,D(5)-like dopamine receptor,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880],GO:0004930; GO:0005886; GO:0071880
2560,Pocillopora_acuta_HIv2___RNAseq.g20541.t1,57.76365977,0.566112083,1.223534549,0.001256155,0.007097278,,Q7T3Q7,9.85E-27,Opsin-VA (Vertebrate ancient opsin),phototransduction [GO:0007602],GO:0004930; GO:0007602; GO:0009881; GO:0016020
2561,Pocillopora_acuta_HIv2___RNAseq.g17470.t1,177.2077799,-0.247472095,1.051356623,0.001260802,0.007120748,Solute carrier family 22 member 15-like,Q7ZX53,1.33E-110,Solute carrier family 22 member 15-like,monoatomic ion transport [GO:0006811],GO:0006811; GO:0016020; GO:0022857
2562,Pocillopora_acuta_HIv2___RNAseq.g13070.t1,903.1462722,-1.959535361,0.794838487,0.00126243,0.007127162,,A7SKE9,6.57E-147,Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4),formation of cytoplasmic translation initiation complex [GO:0001732],GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0016282; GO:0033290
2563,Pocillopora_acuta_HIv2___TS.g13222.t1b,83516.76588,1.993794002,0.851509637,0.001264353,0.007135233,Vitellogenin-A2,P18709,1.42E-50,Vitellogenin-A2 (VTG A2) [Cleaved into: Lipovitellin I; Lipovitellin II; Phosvitin],,GO:0005319; GO:0045735
2564,Pocillopora_acuta_HIv2___RNAseq.g8140.t2,174.2798822,-0.438547041,1.137108148,0.001272199,0.007176713,,Q9NVG8,6.25E-155,TBC1 domain family member 13,intracellular protein transport [GO:0006886],GO:0005096; GO:0005829; GO:0006886; GO:0016020; GO:0031267
2565,Pocillopora_acuta_HIv2___RNAseq.g6636.t2,94.35952936,0.286025297,1.063735488,0.001277673,0.007204778,,Q5R4I2,4.77E-09,E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8),cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168
2566,Pocillopora_acuta_HIv2___TS.g19767.t1,220.732269,-0.30342236,1.067167379,0.00127912,0.007210129,,NA,NA,NA,NA,NA
2567,Pocillopora_acuta_HIv2___RNAseq.g12278.t1,173.3626761,3.480384916,3.024238843,0.001289645,0.007266207,,P18052,5.24E-63,Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28),insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of focal adhesion assembly [GO:0051893],GO:0004725; GO:0005925; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0051893; GO:0097060; GO:0098685
2568,Pocillopora_acuta_HIv2___TS.g11521.t2a,139.6735796,-0.29121522,1.063146301,0.001290073,0.007266207,,P46926,4.49E-160,Glucosamine-6-phosphate isomerase 1 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 1) (GNPDA 1) (GlcN6P deaminase 1) (Oscillin),carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; single fertilization [GO:0007338]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],GO:0004342; GO:0005737; GO:0005829; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0006091; GO:0007338; GO:0016853; GO:0019262; GO:0042802; GO:0070062
2569,Pocillopora_acuta_HIv2___RNAseq.g22283.t1,4427.241657,-1.853125193,0.738485212,0.001292744,0.007278417,,Q76B49,4.79E-46,CD63 antigen (CD antigen CD63),cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],GO:0002092; GO:0005576; GO:0005765; GO:0005886; GO:0007160; GO:0009986; GO:0015031; GO:0016477; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0097487; GO:1900746; GO:2001046
2570,Pocillopora_acuta_HIv2___RNAseq.g10655.t1,194.7028006,-0.185470814,1.019505593,0.001298717,0.0073092,,P85515,0,Alpha-centractin (Centractin),spermatogenesis [GO:0007283],GO:0002177; GO:0005524; GO:0005813; GO:0005814; GO:0005869; GO:0005938; GO:0007283; GO:0030137
2571,Pocillopora_acuta_HIv2___RNAseq.g6413.t1,17.44337972,-1.092538745,2.34645064,0.001300397,0.007315808,,NA,NA,NA,NA,NA
2572,Pocillopora_acuta_HIv2___RNAseq.g251.t1,422.4030821,-0.300270924,1.042236381,0.001304704,0.007337184,,Q6P5F6,4.24E-53,Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10),epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577],GO:0001837; GO:0002903; GO:0005385; GO:0005886; GO:0006882; GO:0016324; GO:0030003; GO:0030890; GO:0050861; GO:0071577; GO:0071578; GO:0140410
2573,Pocillopora_acuta_HIv2___RNAseq.g25331.t1,455.1641893,-0.822097209,1.477416811,0.001305992,0.007341573,,Q9UJV9,0,Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41) (DEAD box protein abstrakt homolog),"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; mRNA splicing, via spliceosome [GO:0000398]",GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006915; GO:0008283; GO:0016020; GO:0016887; GO:0030154; GO:0046872; GO:0071013
2574,Pocillopora_acuta_HIv2___RNAseq.g30311.t1,894.836454,-0.203547695,1.029134099,0.001306965,0.007344191,,Q6ZUK4,1.58E-27,Transmembrane protein 26,,GO:0016020
2575,Pocillopora_acuta_HIv2___RNAseq.g10974.t1,95.26752668,-0.575719789,1.170394723,0.001308242,0.007348512,,B0BLT0,4.92E-40,Zinc finger protein 593,ribosome biogenesis [GO:0042254],GO:0003676; GO:0005730; GO:0005737; GO:0008270; GO:0042254; GO:1990275
2576,Pocillopora_acuta_HIv2___RNAseq.g9963.t1,258.2729574,-0.705695257,1.264346823,0.001310506,0.007358368,,O15439,0,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4),bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855],GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104
2577,Pocillopora_acuta_HIv2___RNAseq.g19920.t1,68.67262401,-0.649180105,1.223576886,0.001313442,0.007371991,,NA,NA,NA,NA,NA
2578,Pocillopora_acuta_HIv2___RNAseq.g5814.t1,2911.128651,-0.688974002,1.304878278,0.001314414,0.007374585,,Q9UGM3,4.17E-93,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein),defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031],GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062
2579,Pocillopora_acuta_HIv2___RNAseq.g21250.t1a,76.42462364,-0.318315562,1.083846704,0.001317363,0.007388269,,NA,NA,NA,NA,NA
2580,Pocillopora_acuta_HIv2___RNAseq.g15584.t1,1587.90695,-2.222622669,1.438317342,0.00133776,0.00749975,,P05123,0,Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK),phosphocreatine biosynthetic process [GO:0046314]; response to heat [GO:0009408],GO:0004111; GO:0005524; GO:0005615; GO:0005737; GO:0009408; GO:0046314
2581,Pocillopora_acuta_HIv2___RNAseq.g1800.t1,103.5309325,-1.554584887,2.527545964,0.001341678,0.007518803,,E7FAM5,2.92E-50,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177
2582,Pocillopora_acuta_HIv2___RNAseq.g22369.t1,1789.895506,1.98383639,0.828718179,0.001342609,0.007521109,,Q58D55,0,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),carbohydrate metabolic process [GO:0005975],GO:0004565; GO:0005764; GO:0005773; GO:0005975
2583,Pocillopora_acuta_HIv2___RNAseq.g9373.t1,462.5264924,2.019987697,5.728486719,0.001346039,0.007537404,,Q32KW9,1.23E-49,Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1),positive regulation of flagellated sperm motility [GO:1902093],GO:0003924; GO:0005525; GO:0005811; GO:0016020; GO:0036126; GO:0097226; GO:1902093
2584,Pocillopora_acuta_HIv2___TS.g2155.t2,254.0994666,-0.195874721,1.043931989,0.001352357,0.00756985,,O42395,1.36E-28,CCHC-type zinc finger nucleic acid binding protein (Cellular nucleic acid-binding protein) (CNBP) (Zinc finger protein 9),positive regulation of cytoplasmic translation [GO:2000767],GO:0003677; GO:0003727; GO:0003729; GO:0005634; GO:0005737; GO:0005783; GO:0008270; GO:0045182; GO:2000767
2585,Pocillopora_acuta_HIv2___RNAseq.g7832.t1a,381.9048867,-0.553701418,1.176159429,0.001353173,0.007571488,,Q642H7,7.33E-76,Synembryn-A (Protein Ric-8A),G protein-coupled receptor signaling pathway [GO:0007186],GO:0001965; GO:0005085; GO:0005737; GO:0005886; GO:0007186
2586,Pocillopora_acuta_HIv2___RNAseq.g10514.t1,251.7009667,-1.520684697,2.433871264,0.001354299,0.007574856,,Q92547,0,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212],GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166
2587,Pocillopora_acuta_HIv2___RNAseq.g28832.t1,446.6429521,-0.488175162,1.161286785,0.001355071,0.007575606,,A1A5K2,2.98E-170,CLIP-associating protein 1-B (Cytoplasmic linker-associated protein 1-B) (Protein Orbit homolog) (Xorbit) (Xorbit/CLASP),cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of supramolecular fiber organization [GO:1902903],GO:0000776; GO:0005794; GO:0005813; GO:0005819; GO:0005874; GO:0007020; GO:0031023; GO:0031110; GO:0034453; GO:0051301; GO:1902903
2588,Pocillopora_acuta_HIv2___TS.g12538.t2,194.9528297,-0.402073058,1.115498706,0.00135548,0.007575606,,Q6UWP7,9.42E-100,Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1),cardiolipin acyl-chain remodeling [GO:0035965]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149],GO:0003841; GO:0005783; GO:0005789; GO:0005829; GO:0006654; GO:0008374; GO:0012505; GO:0016020; GO:0016024; GO:0016746; GO:0035965; GO:0036149
2589,Pocillopora_acuta_HIv2___RNAseq.g25936.t1,4149.599142,2.928458995,2.07026009,0.001357965,0.007586563,,NA,NA,NA,NA,NA
2590,Pocillopora_acuta_HIv2___RNAseq.g12306.t1,727.1139275,1.164650522,1.975185386,0.001366107,0.007629101,,B7ZCC9,1.01E-57,Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; neurogenesis [GO:0022008],GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0022008
2591,Pocillopora_acuta_HIv2___RNAseq.g11231.t1,94.46978057,-0.386761192,1.10397662,0.001375408,0.007678078,,Q90839,8.82E-10,Dickkopf-related protein 3 (Dickkopf-3) (Dkk-3) (Lens fiber protein CLFEST4),negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055],GO:0005615; GO:0016055; GO:0039706; GO:0048019; GO:0090090
2592,Pocillopora_acuta_HIv2___RNAseq.g30026.t2,185.5775556,-0.311748017,1.058380811,0.001389328,0.007752791,Synapsin-2,Q63537,7.88E-65,Synapsin-2 (Synapsin II),calcium-ion regulated exocytosis [GO:0017156]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle cycle [GO:0099504],GO:0005524; GO:0005886; GO:0007269; GO:0008021; GO:0008092; GO:0014069; GO:0017156; GO:0030672; GO:0031201; GO:0042802; GO:0043195; GO:0045202; GO:0046928; GO:0048306; GO:0097091; GO:0098685; GO:0098793; GO:0098850; GO:0098978; GO:0099504
2593,Pocillopora_acuta_HIv2___RNAseq.g28794.t1,4693.201461,2.453084748,1.518737772,0.001393345,0.007772208,Collagen alpha-2(I) chain (Alpha-2 type I collagen),P02466,2.00E-164,Collagen alpha-2(I) chain (Alpha-2 type I collagen),blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096
2594,Pocillopora_acuta_HIv2___RNAseq.g6838.t1,174.8381209,-0.608734153,1.282715326,0.001400942,0.007808742,,Q8WU66,1.00E-34,Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR),hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505],GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170
2595,Pocillopora_acuta_HIv2___RNAseq.g24158.t1,332.365729,-0.388831206,1.059768245,0.001400974,0.007808742,,Q93ZE5,3.70E-84,"Oxaloacetate tautomerase FAHD1, mitochondrial (EC 5.3.2.2) (Fumarylacetoacetate hydrolase domain-containing protein 1) (FAH domain-containing protein 1)",oxaloacetate metabolic process [GO:0006107],GO:0005507; GO:0005739; GO:0005829; GO:0006107; GO:0047621; GO:0050163
2596,Pocillopora_acuta_HIv2___RNAseq.g22967.t1,231.1897566,-0.183535489,1.024459131,0.001410836,0.007860684,,Q4R5Y0,3.02E-35,Cilia- and flagella-associated protein 68,flagellated sperm motility [GO:0030317],GO:0005634; GO:0005930; GO:0030317; GO:0036126; GO:0160111
2597,Pocillopora_acuta_HIv2___TS.g29592.t2,198.5841677,-0.475428706,1.109910403,0.001414923,0.007880421,,Q08BB2,1.70E-148,N-fatty-acyl-amino acid synthase/hydrolase PM20D1.2 (EC 3.5.1.114) (EC 3.5.1.14) (Peptidase M20 domain-containing protein 1.2),adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; amide catabolic process [GO:0043605]; amino acid metabolic process [GO:0006520]; cellular lipid metabolic process [GO:0044255]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; proteolysis [GO:0006508]; respiratory electron transport chain [GO:0022904],GO:0004046; GO:0004181; GO:0005615; GO:0006508; GO:0006520; GO:0006631; GO:0016811; GO:0016829; GO:0022904; GO:0043604; GO:0043605; GO:0044255; GO:0046872; GO:0097009; GO:1990845
2598,Pocillopora_acuta_HIv2___RNAseq.g4559.t1,63.92462671,-0.416878559,1.125539632,0.001425999,0.007938261,,Q9UR07,6.62E-49,Transposon Tf2-11 polyprotein (Retrotransposable element Tf2 155 kDa protein),DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508],GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0006508; GO:0015074; GO:0046872
2599,Pocillopora_acuta_HIv2___RNAseq.g16836.t1,133.7243122,-0.217651107,1.048760379,0.001426406,0.007938261,,NA,NA,NA,NA,NA
2600,Pocillopora_acuta_HIv2___RNAseq.g16267.t1,272.8654465,-0.75385508,1.340978292,0.001432165,0.007967243,,O35790,4.08E-74,N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase (EC 3.5.1.89) (Phosphatidylinositol-glycan biosynthesis class L protein) (PIG-L),GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254],GO:0000225; GO:0005783; GO:0005789; GO:0006506; GO:0016254
2601,Pocillopora_acuta_HIv2___RNAseq.g5633.t1,124.6297277,-0.50121242,1.11522776,0.00143334,0.007970714,,B5X4H8,1.75E-115,Riboflavin transporter 2 (RFT2),,GO:0005886; GO:0032217
2602,Pocillopora_acuta_HIv2___RNAseq.g3088.t1,1522.716377,2.03658746,1.697058484,0.001436609,0.007985825,,Q6AZT7,0,Nephrocystin-3,"cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]",GO:0005929; GO:0016055; GO:0060027; GO:0060271; GO:0090090; GO:2000095
2603,Pocillopora_acuta_HIv2___TS.g4495.t1,228.7315766,0.967879162,1.739043254,0.001446655,0.008038579,,NA,NA,NA,NA,NA
2604,Pocillopora_acuta_HIv2___RNAseq.g17948.t1,6554.252974,1.739239347,0.664361078,0.001450129,0.008054788,,NA,NA,NA,NA,NA
2605,Pocillopora_acuta_HIv2___RNAseq.g28452.t1,574.7812507,-0.084033485,1.015142485,0.001453161,0.008068532,,P97814,3.59E-92,Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1),actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],GO:0001725; GO:0001931; GO:0003779; GO:0005737; GO:0005826; GO:0005884; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0019903; GO:0030027; GO:0030041; GO:0032154; GO:0045087; GO:0048471; GO:0051015
2606,Pocillopora_acuta_HIv2___TS.g7609.t1b,211.4602564,-2.266662806,2.66696743,0.00145421,0.008071254,,Q5RB83,2.60E-75,Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (O-phosphoserine phosphohydrolase),L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563],GO:0000287; GO:0005829; GO:0006563; GO:0006564; GO:0036424
2607,Pocillopora_acuta_HIv2___TS.g21861.t1,48.21590316,-0.512421683,1.208794691,0.001461537,0.00810796,,NA,NA,NA,NA,NA
2608,Pocillopora_acuta_HIv2___RNAseq.g28858.t1,1376.338229,-2.435220217,1.318061167,0.001461944,0.00810796,Cnidocyte marker protein (Collectin-11),Q3SXB8,1.44E-06,Collectin-11 (Collectin kidney protein 1) (CL-K1),"antimicrobial humoral response [GO:0019730]; complement activation, lectin pathway [GO:0001867]; developmental process [GO:0032502]",GO:0001867; GO:0003677; GO:0005509; GO:0005537; GO:0005581; GO:0005615; GO:0019730; GO:0032502; GO:0042806; GO:0070492; GO:0120153
2609,Pocillopora_acuta_HIv2___RNAseq.g5829.t1,46.80394985,-0.46994483,1.168352422,0.001464718,0.00812023,,Q9EP86,1.49E-35,Neuropeptide FF receptor 1 (G-protein coupled receptor 147) (RFamide-related peptide receptor OT7T022),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218],GO:0005886; GO:0005929; GO:0007186; GO:0007218; GO:0008188; GO:0032870; GO:0042277
2610,Pocillopora_acuta_HIv2___RNAseq.g20480.t1,422.5960622,-0.531457898,1.164326107,0.001465629,0.008122166,,NA,NA,NA,NA,NA
2611,Pocillopora_acuta_HIv2___RNAseq.g3142.t1a,165.5356633,-1.008493142,1.57650999,0.001470309,0.008142637,Myotrophin,Q7T2B9,6.59E-14,Myotrophin,regulation of barbed-end actin filament capping [GO:2000812],GO:0005634; GO:0005737; GO:0048471; GO:2000812
2612,Pocillopora_acuta_HIv2___TS.g10394.t2,384.9954297,-0.091263456,1.021376459,0.001470449,0.008142637,,Q3UGF1,0,WD repeat-containing protein 19 (Intraflagellar transport 144 homolog),cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; protein-containing complex assembly [GO:0065003]; receptor clustering [GO:0043113]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],GO:0000902; GO:0001701; GO:0001750; GO:0005737; GO:0005856; GO:0005886; GO:0005929; GO:0007224; GO:0008406; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0043113; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0060831; GO:0061055; GO:0061512; GO:0065003; GO:0097730; GO:1903441
2613,Pocillopora_acuta_HIv2___RNAseq.g17218.t1,282.9393236,-0.257779966,1.056071081,0.001471265,0.008144041,,Q9NWD8,5.64E-22,Transmembrane protein 248,,GO:0016020
2614,Pocillopora_acuta_HIv2___RNAseq.g24321.t1,333.9539024,-0.619781539,1.240770066,0.001476722,0.00817112,,Q4VWF8,0,"2,3-bisphosphoglycerate-independent phosphoglycerate mutase (iPGM) (EC 5.4.2.12) (Cofactor-independent phosphoglycerate mutase homolog)",glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096],GO:0005737; GO:0006007; GO:0006096; GO:0030145; GO:0046537
2615,Pocillopora_acuta_HIv2___TS.g30980.t1a,202.4193667,-0.224370106,1.049690102,0.001482405,0.008199431,,Q96FV9,0,THO complex subunit 1 (Nuclear matrix protein p84) (p84N5) (hTREX84),apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; signal transduction [GO:0007165],GO:0000346; GO:0000347; GO:0000445; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607
2616,Pocillopora_acuta_HIv2___RNAseq.g13856.t1,416.5010119,-2.041595428,2.566873518,0.001494754,0.008264572,,D3Z902,4.81E-56,F-box/WD repeat-containing protein 7,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570],GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205
2617,Pocillopora_acuta_HIv2___TS.g20791.t1c,370.595298,-0.321049982,1.051959346,0.001499987,0.008290336,,Q7ZTY6,9.54E-45,Integrator complex subunit 15,,GO:0032039
2618,Pocillopora_acuta_HIv2___RNAseq.g17420.t1,191.9543946,-0.245719999,1.049272822,0.001500879,0.008292099,,Q96JB2,0,Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94),"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0005829; GO:0005886; GO:0006486; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0007030; GO:0017119; GO:0032580; GO:0032588; GO:0033365; GO:0050821; GO:0070085
2619,Pocillopora_acuta_HIv2___RNAseq.g23397.t1,84.73286536,-0.370083358,1.095046482,0.001505522,0.008314574,,NA,NA,NA,NA,NA
2620,Pocillopora_acuta_HIv2___RNAseq.g20910.t1,16.25408596,-1.00051802,2.036704535,0.001507965,0.00832079,,NA,NA,NA,NA,NA
2621,Pocillopora_acuta_HIv2___TS.g22239.t1,25.66255672,-1.076405123,1.968723491,0.001508014,0.00832079,,NA,NA,NA,NA,NA
2622,Pocillopora_acuta_HIv2___RNAseq.g29436.t1,120.9277659,-0.288816869,1.062776829,0.001508373,0.00832079,,Q5SPB6,5.04E-59,Glutathione-specific gamma-glutamylcyclotransferase 1 (Gamma-GCG 1) (EC 4.3.2.7) (Cation transport regulator-like protein 1),apoptotic process [GO:0006915]; glutathione catabolic process [GO:0006751]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to unfolded protein [GO:0006986],GO:0005112; GO:0005737; GO:0005802; GO:0005829; GO:0006751; GO:0006915; GO:0006986; GO:0007219; GO:0010955; GO:0022008; GO:0045746; GO:0061928
2623,Pocillopora_acuta_HIv2___RNAseq.g12927.t1,81.95203412,-2.644075309,1.562284878,0.00152359,0.00839635,,NA,NA,NA,NA,NA
2624,Pocillopora_acuta_HIv2___RNAseq.g21518.t1,1281.137936,1.633916795,2.84301663,0.001523771,0.00839635,,Q8JZQ5,0,Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase),amine metabolic process [GO:0009308]; cellular response to copper ion starvation [GO:0035874]; putrescine metabolic process [GO:0009445]; response to antibiotic [GO:0046677],GO:0005507; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0009308; GO:0009445; GO:0035874; GO:0046677; GO:0048038; GO:0050232; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0097159
2625,Pocillopora_acuta_HIv2___TS.g24662.t1,21.01563644,-3.159702745,3.021060692,0.001523812,0.00839635,,P97686,4.39E-08,Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related),angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; clustering of voltage-gated sodium channels [GO:0045162]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuronal action potential propagation [GO:0019227]; protein localization [GO:0008104]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; retinal ganglion cell axon guidance [GO:0031290],GO:0001525; GO:0005576; GO:0005886; GO:0007155; GO:0007156; GO:0007411; GO:0007417; GO:0008104; GO:0010975; GO:0019227; GO:0030424; GO:0030506; GO:0031290; GO:0033268; GO:0043194; GO:0045162; GO:0045202; GO:0045211; GO:0070593; GO:0086080; GO:0098609; GO:0098632; GO:0098839; GO:0098978; GO:0099175
2626,Pocillopora_acuta_HIv2___RNAseq.g28818.t1,1048.181059,1.837512202,0.73683773,0.00152463,0.00839766,,Q6XYQ8,5.38E-20,Synaptotagmin-10 (Synaptotagmin X) (SytX),calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; sensory perception of smell [GO:0007608],GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0017156; GO:0030276; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0098793; GO:0098978
2627,Pocillopora_acuta_HIv2___RNAseq.19150_t,1429.284416,2.404076861,2.145902334,0.00152771,0.008411422,,NA,NA,NA,NA,NA
2628,Pocillopora_acuta_HIv2___RNAseq.g19600.t1,907.2612269,-2.178341839,1.462790865,0.001531905,0.008431307,,Q6P8Y1,2.60E-98,Calcyphosin-like protein,,GO:0005509; GO:0005737
2629,Pocillopora_acuta_HIv2___TS.g4840.t1,26.71779728,2.966639698,1.929338544,0.001537521,0.008456754,Solute carrier family 46 member 1,Q7ZWG6,8.43E-25,Proton-coupled folate transporter (Solute carrier family 46 member 1),transmembrane transport [GO:0055085],GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085
2630,Pocillopora_acuta_HIv2___TS.g11388.t2,390.6691295,-0.677329451,1.227925351,0.001537698,0.008456754,,NA,NA,NA,NA,NA
2631,Pocillopora_acuta_HIv2___RNAseq.g7572.t1,172.2917291,-0.268742325,1.058089889,0.001563261,0.008594074,,Q91955,2.82E-17,Myotrophin (Granule cell differentiation protein) (Protein V-1),positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein metabolic process [GO:0051247]; regulation of barbed-end actin filament capping [GO:2000812],GO:0005634; GO:0005737; GO:0005829; GO:0010557; GO:0010613; GO:0030307; GO:0030424; GO:0048471; GO:0051092; GO:0051247; GO:2000812
2632,Pocillopora_acuta_HIv2___RNAseq.g25672.t1b,327.7925396,-0.122417303,1.017822833,0.00156932,0.008624104,,A4UUI3,6.69E-12,Guanylate-binding protein 4 (EC 3.6.5.-) (GTP-binding protein 4) (GBP-4) (Guanine nucleotide-binding protein 4),cellular response to type II interferon [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of defense response to virus [GO:0050688],GO:0000122; GO:0000139; GO:0001933; GO:0003924; GO:0005525; GO:0005634; GO:0031397; GO:0031410; GO:0032687; GO:0042308; GO:0042832; GO:0048471; GO:0050688; GO:0050830; GO:0055105; GO:0071346
2633,Pocillopora_acuta_HIv2___RNAseq.g9309.t1,27.5165488,-3.100357939,2.78324462,0.001573452,0.00864353,,Q0R4F1,0,ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1),DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723],GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0016887; GO:0043139
2634,Pocillopora_acuta_HIv2___RNAseq.g30102.t1,193.2913783,-3.877136666,5.347234768,0.001579118,0.008671359,,O16616,6.42E-13,E3 ubiquitin-protein ligase trim-21 (EC 2.3.2.27),protein ubiquitination [GO:0016567],GO:0005737; GO:0008270; GO:0016567; GO:0016740
2635,Pocillopora_acuta_HIv2___RNAseq.g29611.t1,28007.02152,1.51696409,0.552298659,0.00159628,0.008762272,,NA,NA,NA,NA,NA
2636,Pocillopora_acuta_HIv2___RNAseq.g15220.t1,887.6740337,-1.684699154,2.768814017,0.001597737,0.008766948,,NA,NA,NA,NA,NA
2637,Pocillopora_acuta_HIv2___RNAseq.21012_t,36.48997601,2.666095277,1.384646178,0.001598919,0.008770104,Mannan-binding lectin serine protease 1,Q8CHN8,1.18E-40,Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain],"complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; zymogen activation [GO:0031638]",GO:0001867; GO:0004252; GO:0005509; GO:0005615; GO:0006956; GO:0008233; GO:0031638; GO:0042803; GO:0048306
2638,Pocillopora_acuta_HIv2___TS.g29156.t1,96.82003845,-2.48815632,2.402454943,0.001604204,0.008795755,,NA,NA,NA,NA,NA
2639,Pocillopora_acuta_HIv2___RNAseq.g6063.t1,118.7291444,-0.655965776,1.332433375,0.001606377,0.008804336,,NA,NA,NA,NA,NA
2640,Pocillopora_acuta_HIv2___RNAseq.g9756.t1,1987.641269,1.718100989,0.669401035,0.001620517,0.008878467,,Q5ZJF4,2.94E-91,Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx),cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042],GO:0004623; GO:0005615; GO:0005739; GO:0005764; GO:0005829; GO:0016042; GO:0045454; GO:0047184; GO:0051920
2641,Pocillopora_acuta_HIv2___RNAseq.g6891.t1,262.7700069,-0.356192186,1.061437634,0.001622047,0.008883486,,NA,NA,NA,NA,NA
2642,Pocillopora_acuta_HIv2___RNAseq.g842.t1,667.5199686,2.318064473,1.529151431,0.001625486,0.008898952,,NA,NA,NA,NA,NA
2643,Pocillopora_acuta_HIv2___RNAseq.g1257.t1,271.1264592,-0.163439945,1.026857877,0.001634389,0.008944306,,Q1LZC5,1.32E-50,Ankyrin repeat domain-containing protein 54,positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531],GO:0005634; GO:0005737; GO:0019887; GO:0030496; GO:0045648; GO:1902531
2644,Pocillopora_acuta_HIv2___RNAseq.g15469.t1,26.49731039,-0.516253184,1.209649627,0.001642502,0.008984073,,NA,NA,NA,NA,NA
2645,Pocillopora_acuta_HIv2___RNAseq.g17833.t1,16.08607745,-0.987544325,1.998933861,0.001642898,0.008984073,,NA,NA,NA,NA,NA
2646,Pocillopora_acuta_HIv2___RNAseq.g21210.t1,148.6479159,-0.249274347,1.052888906,0.001647148,0.009003911,,O15146,9.01E-64,"Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)",cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; memory [GO:0007613]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340],GO:0001934; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007528; GO:0007613; GO:0008582; GO:0010628; GO:0010976; GO:0017147; GO:0030154; GO:0031594; GO:0043235; GO:0045211; GO:0046777; GO:0046872; GO:0051897; GO:0071340; GO:2000541
2647,Pocillopora_acuta_HIv2___RNAseq.g21055.t1,1810.231981,2.276872701,1.234005121,0.001651035,0.00902175,,Q6P1B1,0,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0043069; GO:0070006
2648,Pocillopora_acuta_HIv2___RNAseq.g22499.t1,212.4075042,-0.255986788,1.054951678,0.00165636,0.009047429,,Q80WQ4,2.14E-52,Probable tRNA methyltransferase 9B (Probable tRNA methyltransferase 9-like protein) (EC 2.1.1.-),tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098],GO:0000049; GO:0002098; GO:0005634; GO:0005737; GO:0008757; GO:0030488; GO:0106335
2649,Pocillopora_acuta_HIv2___RNAseq.g21587.t1,263.394906,-0.461420561,1.151297966,0.001659386,0.009060533,,Q9Y2M2,6.34E-77,Protein SSUH2 homolog (Protein ssu-2 homolog),odontogenesis [GO:0042476],GO:0005634; GO:0005737; GO:0031072; GO:0042476; GO:0051082
2650,Pocillopora_acuta_HIv2___RNAseq.g5689.t1,772.7916241,-0.764396603,1.272505511,0.001663932,0.009081931,,Q5ZLV4,1.33E-148,"RNA cytosine-C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-, EC 2.1.1.203)",regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416],GO:0000049; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0010793; GO:0016428; GO:0030488; GO:0036416; GO:0062152; GO:0070062; GO:2000736
2651,Pocillopora_acuta_HIv2___TS.g11808.t1,40.94581854,-0.413466281,1.145585589,0.001672676,0.009126211,,NA,NA,NA,NA,NA
2652,Pocillopora_acuta_HIv2___RNAseq.g28809.t1,745.50664,2.098734201,1.024443411,0.001678852,0.009156453,,NA,NA,NA,NA,NA
2653,Pocillopora_acuta_HIv2___TS.g8323.t1a,101.4003674,-0.247732204,1.052180529,0.001680297,0.009160879,Solute carrier family 12 member 6,Q924N4,0,Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3),ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; cellular hypotonic salinity response [GO:0071477]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805],GO:0005886; GO:0006884; GO:0007268; GO:0008519; GO:0015379; GO:0016323; GO:0019901; GO:0030424; GO:0045202; GO:0046872; GO:0055064; GO:0055075; GO:0071333; GO:0071477; GO:0071805; GO:0140157; GO:1902476; GO:1990573
2654,Pocillopora_acuta_HIv2___RNAseq.g18328.t2,85.75663494,-0.362156075,1.060836426,0.001684045,0.009175864,,NA,NA,NA,NA,NA
2655,Pocillopora_acuta_HIv2___RNAseq.g27793.t1,505.8032919,-1.687366942,2.348961299,0.001684314,0.009175864,,Q9N293,8.75E-35,"Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5)",lipid metabolic process [GO:0006629]; protein O-linked glycosylation [GO:0006493],GO:0000139; GO:0006493; GO:0006629; GO:0008499
2656,Pocillopora_acuta_HIv2___RNAseq.g27206.t1,1311.004597,-1.74748947,1.84899921,0.001696438,0.009238435,,Q86U86,0,Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D),chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368],GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819
2657,Pocillopora_acuta_HIv2___RNAseq.g15432.t1,151.3733497,0.078831189,1.021205674,0.001698636,0.009246922,,Q5RKZ7,0,"Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]",Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],GO:0005525; GO:0005829; GO:0006777; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799; GO:1904047
2658,Pocillopora_acuta_HIv2___TS.g7609.t1a,37.41739389,-2.305135116,2.358872852,0.001704358,0.009274581,,NA,NA,NA,NA,NA
2659,Pocillopora_acuta_HIv2___RNAseq.g2490.t1,27.00578609,-0.567411775,1.242515033,0.001706205,0.009281137,,NA,NA,NA,NA,NA
2660,Pocillopora_acuta_HIv2___RNAseq.g16243.t1,22.45465405,-0.629072014,1.294437404,0.001713741,0.009318629,,Q96F81,1.70E-77,Protein dispatched homolog 1,determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]; protein homotrimerization [GO:0070207]; regulation of protein secretion [GO:0050708]; smoothened signaling pathway [GO:0007224],GO:0007224; GO:0007225; GO:0007368; GO:0009880; GO:0009953; GO:0015833; GO:0016020; GO:0016323; GO:0050708; GO:0060539; GO:0070207; GO:1904680
2661,Pocillopora_acuta_HIv2___RNAseq.g14360.t1,1548.373449,2.772044574,1.956175231,0.001715541,0.009324907,,NA,NA,NA,NA,NA
2662,Pocillopora_acuta_HIv2___RNAseq.g23274.t1,257.2451962,-0.870378935,1.512898967,0.001718893,0.009339618,,P35546,3.77E-83,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],anatomical structure morphogenesis [GO:0009653]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797
2663,Pocillopora_acuta_HIv2___RNAseq.g7271.t1,502.2536494,-0.426775918,1.080854011,0.001720815,0.009346553,,Q8TBZ9,8.64E-36,Testis-expressed protein 47,,
2664,Pocillopora_acuta_HIv2___RNAseq.g24135.t1,229.1539691,-0.27364974,1.059532927,0.001735009,0.009420107,,Q9NVI1,0,Fanconi anemia group I protein (Protein FACI),interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398],GO:0000785; GO:0003677; GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0031398; GO:0036297; GO:0070182; GO:1990391
2665,Pocillopora_acuta_HIv2___RNAseq.g5315.t1,288.9148726,-0.244056294,1.031605333,0.00173756,0.00943042,,NA,NA,NA,NA,NA
2666,Pocillopora_acuta_HIv2___RNAseq.g15927.t1,122.6877945,-0.396509975,1.109211841,0.001744126,0.009462506,,NA,NA,NA,NA,NA
2667,Pocillopora_acuta_HIv2___TS.g18770.t2,1578.701986,-1.279912903,2.127638902,0.001748202,0.009481064,,NA,NA,NA,NA,NA
2668,Pocillopora_acuta_HIv2___RNAseq.g23169.t1,248.6351122,-0.280490106,1.060115378,0.001748926,0.009481435,,Q0P595,6.34E-146,NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7),DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; epigenetic regulation of gene expression [GO:0040029]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; R-loop processing [GO:0062176]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; retrotransposon silencing [GO:0010526]; rRNA transcription [GO:0009303],GO:0000122; GO:0000785; GO:0001649; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005731; GO:0005737; GO:0006281; GO:0006357; GO:0006476; GO:0007129; GO:0009303; GO:0010526; GO:0010821; GO:0016740; GO:0031397; GO:0034979; GO:0035861; GO:0036054; GO:0036055; GO:0040029; GO:0045722; GO:0045943; GO:0046825; GO:0046872; GO:0061697; GO:0061698; GO:0062176; GO:0070403; GO:0097372; GO:0106230; GO:0106231; GO:0140861; GO:1901836; GO:2000234
2669,Pocillopora_acuta_HIv2___RNAseq.g9134.t1,101.7181473,-0.44476155,1.139977793,0.001771134,0.009598233,,Q96AY4,2.13E-63,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301
2670,Pocillopora_acuta_HIv2___RNAseq.g6073.t1,17.88068402,-1.09380253,2.325840602,0.00177277,0.009603503,,NA,NA,NA,NA,NA
2671,Pocillopora_acuta_HIv2___RNAseq.g16626.t1,122.656541,-0.411355515,1.075670315,0.001781922,0.009649464,,NA,NA,NA,NA,NA
2672,Pocillopora_acuta_HIv2___RNAseq.g14651.t1,80.78760059,-0.540670689,1.222003749,0.001784106,0.009657678,,Q4R7W3,6.03E-153,Ras-specific guanine nucleotide-releasing factor RalGPS2 (Ral GEF with PH domain and SH3-binding motif 2) (RalA exchange factor RalGPS2),Ras protein signal transduction [GO:0007265],GO:0005085; GO:0005737; GO:0005886; GO:0007265
2673,Pocillopora_acuta_HIv2___RNAseq.g15254.t1,77.1876456,-0.485643789,1.174788216,0.001786217,0.009665488,,Q08CH3,4.30E-70,MPN domain-containing protein (EC 3.4.-.-),double-strand break repair [GO:0006302]; proteolysis [GO:0006508],GO:0006302; GO:0006508; GO:0008237; GO:0031593; GO:0046872; GO:0070531; GO:0070552
2674,Pocillopora_acuta_HIv2___RNAseq.g9077.t1,64.02917618,0.54310497,1.200564991,0.001797862,0.009724862,,Q80T79,3.69E-55,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),regulation of dendrite development [GO:0050773],GO:0005886; GO:0050773
2675,Pocillopora_acuta_HIv2___RNAseq.g28464.t1,554.4710502,-0.082284396,1.020079946,0.001803274,0.009748196,TRP A1,O75762,1.73E-139,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor),calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955],GO:0005262; GO:0005886; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070588; GO:0097604
2676,Pocillopora_acuta_HIv2___RNAseq.g9098.t1,2116.398731,2.012238897,2.48572557,0.001803524,0.009748196,,O60235,1.87E-36,Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain],proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585],GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0007585; GO:0008233; GO:0070062
2677,Pocillopora_acuta_HIv2___RNAseq.g12088.t1,135.0263358,2.388186771,2.841087128,0.001807945,0.009768442,,Q9EQD2,2.18E-33,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408],GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408
2678,Pocillopora_acuta_HIv2___RNAseq.g24398.t1,181.3964141,-0.322863253,1.049013468,0.001820711,0.009833745,,Q28DL4,2.26E-25,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),intracellular signaling cassette [GO:0141124]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122],GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005938; GO:0008270; GO:0042981; GO:0043122; GO:0070534; GO:0141124
2679,Pocillopora_acuta_HIv2___RNAseq.g15936.t1,217.5557637,0.917729846,1.695826937,0.001822973,0.009842284,,NA,NA,NA,NA,NA
2680,Pocillopora_acuta_HIv2___TS.g1420.t1b,141.8134017,-2.40573887,1.273928559,0.001824334,0.009842582,,NA,NA,NA,NA,NA
2681,Pocillopora_acuta_HIv2___RNAseq.g9175.t1,118.9313411,-0.603266846,1.270584733,0.001824389,0.009842582,,Q5VVJ2,2.30E-126,"Deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)",chromatin remodeling [GO:0006338]; immune system process [GO:0002376]; pigmentation [GO:0043473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; regulation of cell migration [GO:0030334]; regulation of hair follicle development [GO:0051797]; regulation of hemopoiesis [GO:1903706],GO:0002376; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006338; GO:0006508; GO:0030334; GO:0032991; GO:0042393; GO:0043473; GO:0045944; GO:0046872; GO:0051797; GO:0140492; GO:0140950; GO:1903706
2682,Pocillopora_acuta_HIv2___RNAseq.g21223.t1,300.3810868,0.171332706,1.035399782,0.001825201,0.00984329,,O57382,2.11E-14,Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid),cell differentiation [GO:0030154]; proteolysis [GO:0006508],GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154
2683,Pocillopora_acuta_HIv2___RNAseq.g22516.t1,700.3940638,-0.358973278,1.059773336,0.00182768,0.009849592,,Q5SQX6,0,Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121),apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833],GO:0000902; GO:0005634; GO:0005737; GO:0006915; GO:0007411; GO:0030031; GO:0030833; GO:0031175; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0097484; GO:0098609
2684,Pocillopora_acuta_HIv2___RNAseq.g19603.t1,197.6278995,0.669163012,1.324789729,0.001827731,0.009849592,Peropsin,O35214,3.65E-40,Visual pigment-like receptor peropsin,cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; visual perception [GO:0007601],GO:0001750; GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0071482
2685,Pocillopora_acuta_HIv2___RNAseq.g867.t4,2036.783889,-0.674672433,1.251628191,0.00182943,0.009855077,,P10894,0,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1)",G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; release of sequestered calcium ion into cytosol [GO:0051209],GO:0004435; GO:0005509; GO:0005516; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0031965; GO:0046488; GO:0048015; GO:0051209
2686,Pocillopora_acuta_HIv2___RNAseq.g13445.t1,113.4605677,-0.409787686,1.117188472,0.001832124,0.00986591,,P97858,6.41E-126,Solute carrier family 35 member B1 (ATP/ADP exchanger ER) (AXER) (Endoplasmic reticulum ATP/ADP translocase) (UDP-galactose transporter-related protein 1) (UGTrel1),UDP-galactose transmembrane transport [GO:0072334],GO:0000139; GO:0005459; GO:0005460; GO:0005471; GO:0005789; GO:0072334
2687,Pocillopora_acuta_HIv2___TS.g24259.t1,62.74423437,-2.646954899,1.899441798,0.001833293,0.009868533,,Q8R3W5,4.44E-13,tRNA-splicing endonuclease subunit Sen15 (tRNA-intron endonuclease Sen15),"mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]",GO:0003676; GO:0005730; GO:0006388; GO:0006397
2688,Pocillopora_acuta_HIv2___RNAseq.g5388.t1,1054.285765,2.067301034,2.030487742,0.001836967,0.009884632,,D3YXG0,8.08E-06,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711
2689,Pocillopora_acuta_HIv2___RNAseq.g30952.t1,104.0921844,-1.956440951,2.56610967,0.001842107,0.009908605,,Q9Z1K5,4.83E-30,E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (UbcH7-binding protein) (UbcM4-interacting protein 77) (Ubiquitin-conjugating enzyme E2-binding protein 1),protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0015030; GO:0016567; GO:0016604; GO:0019005; GO:0031462; GO:0031463; GO:0031464; GO:0031624; GO:0031625; GO:0061630; GO:0097413
2690,Pocillopora_acuta_HIv2___TS.g19590.t1,522.3826719,-2.081425282,0.963043349,0.001844677,0.009918741,,Q8VEE0,5.75E-98,Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-epimerase),"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]",GO:0004750; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0030246; GO:0046872; GO:0048029
2691,Pocillopora_acuta_HIv2___TS.g8165.t1a,116.3636236,0.076126298,1.021107923,0.001859739,0.00999601,,Q3V050,2.17E-103,Multidrug and toxin extrusion protein 2 (MATE-2) (mMATE-2) (H(+)/organic cation antiporter kidney-specific) (Solute carrier family 47 member 2),organic cation transport [GO:0015695]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961],GO:0005886; GO:0015101; GO:0015695; GO:0016020; GO:0022857; GO:0042910; GO:0140968; GO:1990961
2692,Pocillopora_acuta_HIv2___RNAseq.g21912.t1,1446.169222,-2.264699763,2.549768165,0.001864416,0.010017428,Homeobox protein HMX3,Q504H8,1.00E-48,Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1),cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; otolith development [GO:0048840]; posterior lateral line development [GO:0048916]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510],GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0021510; GO:0030154; GO:0042472; GO:0048840; GO:0048916; GO:0048920
2693,Pocillopora_acuta_HIv2___TS.g6477.t1,126.6860314,-0.311342147,1.069972762,0.001866865,0.010026861,,Q642A0,8.26E-34,p53 and DNA damage-regulated protein 1,protein folding [GO:0006457],GO:0005737; GO:0006457; GO:0016272; GO:0051082; GO:1990062
2694,Pocillopora_acuta_HIv2___RNAseq.g949.t1,537.9750171,-1.939147365,0.867423917,0.001879778,0.01009247,,Q5RBX7,1.35E-34,Signal recognition particle 14 kDa protein (SRP14),SRP-dependent cotranslational protein targeting to membrane [GO:0006614],GO:0005786; GO:0006614; GO:0008312; GO:0030942
2695,Pocillopora_acuta_HIv2___TS.g28689.t1,160.3460306,1.094302278,2.120137581,0.001883202,0.0101071,,NA,NA,NA,NA,NA
2696,Pocillopora_acuta_HIv2___RNAseq.g25967.t1,162.0143093,-0.396765883,1.111338325,0.00189861,0.010186017,,Q6N075,5.48E-125,Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2),molybdate ion transport [GO:0015689]; monoatomic ion transport [GO:0006811],GO:0005886; GO:0006811; GO:0015098; GO:0015689; GO:0016020
2697,Pocillopora_acuta_HIv2___RNAseq.g28339.t1,1279.961015,-1.160241235,1.909884167,0.001904786,0.010215358,,NA,NA,NA,NA,NA
2698,Pocillopora_acuta_HIv2___RNAseq.g26011.t1,154.81058,-2.267953866,2.17960333,0.001911581,0.010248002,,NA,NA,NA,NA,NA
2699,Pocillopora_acuta_HIv2___RNAseq.g13672.t1,133.713373,-2.576878622,2.979224144,0.00191346,0.010253552,,P43166,2.26E-47,Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII),"neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]",GO:0004089; GO:0005737; GO:0005829; GO:0006730; GO:0008270; GO:0032230; GO:0032849; GO:0051453; GO:0070050; GO:2001225
2700,Pocillopora_acuta_HIv2___RNAseq.g20667.t1,391.5107094,-0.870973119,1.431800348,0.001914034,0.010253552,,P46434,5.20E-34,Glutathione S-transferase 1 (EC 2.5.1.18),glutathione metabolic process [GO:0006749],GO:0004364; GO:0006749
2701,Pocillopora_acuta_HIv2___TS.g4401.t1,256.9489793,2.00604823,1.754731563,0.00192567,0.010312067,,NA,NA,NA,NA,NA
2702,Pocillopora_acuta_HIv2___RNAseq.g2410.t1,569.2691979,-2.097796778,1.297129546,0.001937814,0.010373255,Hippocampus abundant transcript 1 protein,P70187,0,Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A),acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283],GO:0001675; GO:0007283; GO:0007286; GO:0007289; GO:0016020; GO:0022857; GO:0030382
2703,Pocillopora_acuta_HIv2___RNAseq.g23123.t1,175.4778736,0.352006869,1.07736464,0.001941925,0.010391416,,NA,NA,NA,NA,NA
2704,Pocillopora_acuta_HIv2___RNAseq.g17508.t1b,2272.769262,2.754200083,1.96039481,0.001950115,0.010431387,,Q8CG08,2.54E-19,Collagen triple helix repeat-containing protein 1,"cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177
2705,Pocillopora_acuta_HIv2___TS.g989.t1,117.771398,-0.427097474,1.085072609,0.001953908,0.010447812,,Q14674,4.17E-88,Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase),apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; mitotic sister chromatid separation [GO:0051306]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508],GO:0000070; GO:0000212; GO:0000281; GO:0003824; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0040001; GO:0045143; GO:0045842; GO:0045875; GO:0051306; GO:0051307; GO:0072686
2706,Pocillopora_acuta_HIv2___RNAseq.g4746.t1,3648.602322,2.045408597,0.982894698,0.001967616,0.010517222,,NA,NA,NA,NA,NA
2707,Pocillopora_acuta_HIv2___RNAseq.g8098.t1,11539.419,1.919712891,0.851982302,0.001972539,0.01053964,,Q95029,1.75E-127,Cathepsin L1 (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain],digestion [GO:0007586]; immune response [GO:0006955]; positive regulation of apoptotic signaling pathway [GO:2001235]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],GO:0004197; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0006955; GO:0007586; GO:0008233; GO:0008234; GO:0008656; GO:0044754; GO:0045169; GO:0051603; GO:2001235
2708,Pocillopora_acuta_HIv2___TS.g12347.t1,97.41794879,-0.222599191,1.048312775,0.001984592,0.010600128,,Q07326,2.69E-29,Phosphatidylinositol-glycan biosynthesis class F protein (PIG-F) (GPI11 homolog),GPI anchor biosynthetic process [GO:0006506],GO:0004307; GO:0005789; GO:0006506; GO:0051377
2709,Pocillopora_acuta_HIv2___RNAseq.g17121.t1,527.8450424,-0.791031461,1.384247372,0.001985845,0.0106029,,NA,NA,NA,NA,NA
2710,Pocillopora_acuta_HIv2___RNAseq.g1784.t1,100.7076707,-0.12360807,1.02291774,0.001988123,0.010608394,,Q07157,2.20E-10,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493],GO:0002102; GO:0005516; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005921; GO:0005923; GO:0007043; GO:0008284; GO:0016323; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0032991; GO:0034334; GO:0035633; GO:0036305; GO:0042995; GO:0043066; GO:0043296; GO:0045177; GO:0045216; GO:0045296; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810
2711,Pocillopora_acuta_HIv2___RNAseq.g3840.t1,611.1665613,-2.278105951,1.430518803,0.00198834,0.010608394,,O75366,0,Advillin (p92),actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480],GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480
2712,Pocillopora_acuta_HIv2___RNAseq.g11264.t1,296.3014774,-0.439534839,1.147053884,0.002003423,0.010684923,,NA,NA,NA,NA,NA
2713,Pocillopora_acuta_HIv2___RNAseq.g9841.t1,87.78949951,-0.139467409,1.023336535,0.002005656,0.010692887,,O42449,1.27E-54,Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase),hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403],GO:0004800; GO:0005789; GO:0042403; GO:0042446
2714,Pocillopora_acuta_HIv2___RNAseq.g24307.t1,336.8184023,2.103613283,1.049750899,0.002006931,0.010694827,,NA,NA,NA,NA,NA
2715,Pocillopora_acuta_HIv2___RNAseq.g242.t1,25.27770269,-1.486937549,3.426710984,0.00200822,0.010694827,,NA,NA,NA,NA,NA
2716,Pocillopora_acuta_HIv2___RNAseq.g10739.t1,289.7572651,-1.408019137,2.237654058,0.002008238,0.010694827,,A0A0C2SRU0,1.49E-78,Decarboxylase iboD (EC 4.1.1.-) (Ibotenic acid biosynthesis cluster protein D),phospholipid biosynthetic process [GO:0008654],GO:0004609; GO:0008654
2717,Pocillopora_acuta_HIv2___RNAseq.g18294.t1b,206.959235,-2.063127204,2.05851991,0.002015669,0.010730453,,NA,NA,NA,NA,NA
2718,Pocillopora_acuta_HIv2___RNAseq.g18037.t1,1017.017637,-0.760193669,1.299256353,0.002016533,0.010731102,,NA,NA,NA,NA,NA
2719,Pocillopora_acuta_HIv2___RNAseq.g18290.t1,953.9673035,2.539032216,1.917315566,0.002028723,0.010792001,,NA,NA,NA,NA,NA
2720,Pocillopora_acuta_HIv2___RNAseq.g22722.t1,716.0880929,-1.155219976,1.820696476,0.002033565,0.01081378,,G5EDU6,2.38E-50,Transcription factor ovo-like homolog lin-48 (Abnormal cell lineage protein 48),animal organ morphogenesis [GO:0009887]; epidermal cell differentiation [GO:0009913]; hindgut morphogenesis [GO:0007442]; nematode male tail tip morphogenesis [GO:0045138]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to salt stress [GO:0009651],GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007442; GO:0009651; GO:0009887; GO:0009913; GO:0045138; GO:0046872
2721,Pocillopora_acuta_HIv2___RNAseq.g7038.t1,237.0402435,-0.615029056,1.202616784,0.002034959,0.01081433,,Q4QR88,1.94E-39,TIMELESS-interacting protein,cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA damage checkpoint signaling [GO:0000077]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; replication fork arrest [GO:0043111]; replication fork processing [GO:0031297]; response to UV [GO:0009411],GO:0000076; GO:0000077; GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0008284; GO:0009411; GO:0031297; GO:0031298; GO:0031573; GO:0043111; GO:0044770; GO:0051301
2722,Pocillopora_acuta_HIv2___RNAseq.g16098.t1,300.417488,-0.74548637,1.314596725,0.002035164,0.01081433,,NA,NA,NA,NA,NA
2723,Pocillopora_acuta_HIv2___TS.g21983.t1b,246.7740072,-0.286656708,1.061944148,0.002037652,0.010823576,,Q05B60,1.11E-53,Uridine diphosphate glucose pyrophosphatase NUDT14 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 14) (Nudix motif 14),nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693],GO:0005737; GO:0006753; GO:0008768; GO:0019693; GO:0042802; GO:0046872; GO:0047631
2724,Pocillopora_acuta_HIv2___RNAseq.g9554.t1,665.8325494,2.133514136,2.550215808,0.002042623,0.010846,,Q9UDT6,4.44E-10,CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein),cytoplasmic microtubule organization [GO:0031122],GO:0005634; GO:0005875; GO:0005938; GO:0008017; GO:0031122; GO:0035371; GO:0051010
2725,Pocillopora_acuta_HIv2___RNAseq.g13027.t1,552.9782057,1.932158682,1.785259099,0.002046966,0.010865071,,NA,NA,NA,NA,NA
2726,Pocillopora_acuta_HIv2___RNAseq.g12938.t1,210.3333629,-0.501593543,1.184893376,0.002061575,0.010936358,,O95149,4.16E-100,Snurportin-1 (RNA U transporter 1),protein import into nucleus [GO:0006606]; RNA import into nucleus [GO:0006404]; snRNA import into nucleus [GO:0061015],GO:0000339; GO:0005643; GO:0005654; GO:0005829; GO:0005886; GO:0006404; GO:0006606; GO:0042564; GO:0061015; GO:0061608
2727,Pocillopora_acuta_HIv2___TS.g3674.t2,395.3486739,-0.425814388,1.085191959,0.002061909,0.010936358,,A2ASS6,4.97E-19,Titin (EC 2.7.11.1) (Connectin),adult heart development [GO:0007512]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of relaxation of cardiac muscle [GO:1901897]; sarcomere organization [GO:0045214]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591],GO:0001701; GO:0001756; GO:0003007; GO:0004674; GO:0004713; GO:0005200; GO:0005516; GO:0005524; GO:0005634; GO:0005859; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0021591; GO:0030017; GO:0030018; GO:0030506; GO:0031430; GO:0031672; GO:0031674; GO:0035995; GO:0043056; GO:0045214; GO:0046872; GO:0048738; GO:0055002; GO:0055003; GO:0055008; GO:0060419; GO:0106310; GO:1901897
2728,Pocillopora_acuta_HIv2___RNAseq.27755_t,94.72283384,-0.336286865,1.07914043,0.002064957,0.010948513,,A7S1L6,5.09E-180,GDP-fucose transporter 1 (Solute carrier family 35 member C1 homolog),GDP-fucose import into Golgi lumen [GO:0036085]; protein O-linked fucosylation [GO:0036066],GO:0000139; GO:0005457; GO:0005794; GO:0015297; GO:0036066; GO:0036085
2729,Pocillopora_acuta_HIv2___RNAseq.g29862.t1,130.1996691,-0.364027676,1.090726627,0.002067317,0.010949806,,NA,NA,NA,NA,NA
2730,Pocillopora_acuta_HIv2___TS.g11864.t1,585.8688485,-0.236737985,1.04974692,0.002067395,0.010949806,,O18894,0,H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3),,GO:0005247; GO:0005524; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0010008; GO:0012506; GO:0015297; GO:0030165; GO:0031901; GO:0031902; GO:0055037
2731,Pocillopora_acuta_HIv2___RNAseq.g31256.t1,180.9484426,-1.167220569,1.874248017,0.002067797,0.010949806,,Q5BJN5,1.38E-47,Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4),'de novo' post-translational protein folding [GO:0051084]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to oxidative stress [GO:0034599]; establishment of protein localization to mitochondrion [GO:0072655]; mitochondrial DNA repair [GO:0043504]; mitochondrial respiratory chain complex assembly [GO:0033108]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cellular respiration [GO:1901857]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]; regulation of protein export from nucleus [GO:0046825],GO:0005739; GO:0005758; GO:0015035; GO:0018171; GO:0022417; GO:0033108; GO:0034599; GO:0043504; GO:0045041; GO:0046825; GO:0051084; GO:0072655; GO:1901857; GO:1990830
2732,Pocillopora_acuta_HIv2___TS.g5006.t1b,819.9710198,2.022048877,1.009501984,0.002068628,0.010949806,,Q90Z00,2.94E-45,Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A),anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589],GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0018108; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699
2733,Pocillopora_acuta_HIv2___RNAseq.g1809.t1,156.5459899,-0.86425986,1.53093441,0.002068986,0.010949806,,P62916,3.64E-07,Transcription initiation factor IIB (EC 2.3.1.48) (General transcription factor TFIIB) (RNA polymerase II alpha initiation factor),chromosome organization [GO:0051276]; gene expression [GO:0010467]; meiotic sister chromatid cohesion [GO:0051177]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083],GO:0000776; GO:0000793; GO:0000979; GO:0000993; GO:0001174; GO:0003677; GO:0004402; GO:0005634; GO:0005669; GO:0005694; GO:0006366; GO:0006367; GO:0006473; GO:0008270; GO:0010467; GO:0016251; GO:0016407; GO:0017025; GO:0019083; GO:0032153; GO:0032993; GO:0042585; GO:0046966; GO:0051123; GO:0051177; GO:0051225; GO:0051276; GO:0090575; GO:0097550; GO:0140297; GO:1990114; GO:1990841
2734,Pocillopora_acuta_HIv2___RNAseq.g8393.t1,113.252527,-0.635339388,1.207105813,0.002071897,0.010961198,,Q4V7Q6,7.27E-170,Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3),autophagy [GO:0006914]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506],GO:0004674; GO:0005524; GO:0005737; GO:0006914; GO:0010506; GO:0045879; GO:0045880; GO:0046777; GO:0106310
2735,Pocillopora_acuta_HIv2___TS.g5715.t1,124.5429903,-0.275337604,1.058360338,0.002073875,0.010967654,,NA,NA,NA,NA,NA
2736,Pocillopora_acuta_HIv2___RNAseq.17185_t,338.9585283,0.594824241,1.260333952,0.002076615,0.010978129,,D3Z8N4,1.85E-52,Kelch-like protein 20,Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390
2737,Pocillopora_acuta_HIv2___RNAseq.g4024.t1,648.1947853,-0.850881821,1.446138309,0.002089398,0.01104167,,NA,NA,NA,NA,NA
2738,Pocillopora_acuta_HIv2___RNAseq.g7785.t1,168.7201358,-0.61838738,1.310796834,0.00209238,0.011053389,,Q8WTR2,7.82E-52,Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase TS-DSP1) (Low molecular weight dual specificity phosphatase 3) (LMW-DSP3) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1) (SAPK pathway-regulating phosphatase 1),negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860],GO:0004725; GO:0004860; GO:0005078; GO:0005737; GO:0006469; GO:0008138; GO:0008579; GO:0017018; GO:0030295; GO:0031435; GO:0043410; GO:0043507; GO:0043508; GO:0045860; GO:0046329; GO:0046330
2739,Pocillopora_acuta_HIv2___RNAseq.g10479.t1,249.8337935,-1.519958998,2.296998964,0.00210225,0.011101476,,Q5ZJJ8,3.48E-152,Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1),regulation of proteasome assembly [GO:0090364],GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0017018; GO:0046872; GO:0090364; GO:1904855
2740,Pocillopora_acuta_HIv2___TS.g13579.t1,35.87888775,-0.543470338,1.220902894,0.002113397,0.011156267,,Q504A5,9.64E-29,Probable thiopurine S-methyltransferase (Thiopurine methyltransferase) (EC 2.1.1.67),methylation [GO:0032259],GO:0005737; GO:0008119; GO:0032259
2741,Pocillopora_acuta_HIv2___RNAseq.g8978.t1,118.6268252,1.277876554,1.909050267,0.002150099,0.011344012,,B8EIZ7,6.75E-177,Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148),,GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661
2742,Pocillopora_acuta_HIv2___TS.g26912.t1,3498.535743,1.643691165,0.652933583,0.002150531,0.011344012,,P50460,1.34E-21,Cysteine and glycine-rich protein 2 (Beta-cysteine-rich protein) (Beta-CRP) (Cysteine-rich protein 2) (CRP2),muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214],GO:0005634; GO:0005737; GO:0008307; GO:0030018; GO:0042805; GO:0045214; GO:0046872; GO:0060537
2743,Pocillopora_acuta_HIv2___RNAseq.g16773.t1,517.1739508,1.686980991,2.421797637,0.002153413,0.011355074,,NA,NA,NA,NA,NA
2744,Pocillopora_acuta_HIv2___RNAseq.g26860.t1,579.249932,-2.414275722,1.714633105,0.002155003,0.011359317,,NA,NA,NA,NA,NA
2745,Pocillopora_acuta_HIv2___RNAseq.g27228.t1,183.7692828,-0.263971464,1.038464053,0.002158189,0.011371968,,A1L0Y2,2.69E-59,Neuralized-like protein 4,,GO:0005737; GO:0005814
2746,Pocillopora_acuta_HIv2___RNAseq.g29232.t1,112.8915235,-0.306465764,1.052054468,0.002165197,0.011401731,,NA,NA,NA,NA,NA
2747,Pocillopora_acuta_HIv2___RNAseq.g23713.t1,110.3818181,-0.227087473,1.049821287,0.002165414,0.011401731,,Q86A72,8.64E-14,Recoverin family protein DDB_G0274781,,GO:0005509
2748,Pocillopora_acuta_HIv2___RNAseq.g14837.t1,1136.336677,2.439439236,2.208904611,0.002166553,0.011403575,,Q9CR40,1.04E-41,Kelch-like protein 28 (BTB/POZ domain-containing protein 5),,
2749,Pocillopora_acuta_HIv2___TS.g23673.t1,128.0185899,2.400195983,1.372317237,0.002168197,0.011408074,,Q8IX30,1.31E-09,"Signal peptide, CUB and EGF-like domain-containing protein 3",positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165],GO:0005509; GO:0005615; GO:0005886; GO:0007165; GO:0009986; GO:0030513; GO:0036122; GO:0042802; GO:0045669; GO:0070700
2750,Pocillopora_acuta_HIv2___TS.g4273.t1b,533.3738821,-0.37871354,1.099954112,0.002173596,0.011432325,,Q90WN5,1.48E-113,REST corepressor 1 (Protein CoREST) (xCoREST),chromatin organization [GO:0006325],GO:0005634; GO:0006325
2751,Pocillopora_acuta_HIv2___RNAseq.g12293.t1,2187.868414,-2.041820939,0.99846315,0.002209732,0.011618165,,O14522,2.01E-135,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho),cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; signal transduction [GO:0007165],GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0050807; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:0098839; GO:0098978; GO:1904893; GO:1990264
2752,Pocillopora_acuta_HIv2___RNAseq.g12419.t1,232.64407,-2.225340973,1.538239988,0.002211384,0.011622286,,Q66KE8,7.41E-90,Coiled-coil domain-containing protein 78 (xCCDC78),cell projection organization [GO:0030030]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535],GO:0005737; GO:0005814; GO:0030030; GO:0098535; GO:0098536
2753,Pocillopora_acuta_HIv2___TS.g28706.t1,311.4225131,-0.326481266,1.066125319,0.002212123,0.011622286,,Q5R959,9.31E-24,Protein sprouty homolog 2 (Spry-2),animal organ development [GO:0048513]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],GO:0005829; GO:0005874; GO:0010719; GO:0030512; GO:0031397; GO:0032587; GO:0040037; GO:0046580; GO:0048513; GO:0070373; GO:1902747
2754,Pocillopora_acuta_HIv2___TS.g29999.t1a,389.4269372,-1.852820678,0.816733928,0.002230516,0.011714665,,Q9DBN9,5.38E-165,Probable ATP-dependent RNA helicase DDX59 (EC 3.6.4.13) (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5),,GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0046872
2755,Pocillopora_acuta_HIv2___RNAseq.g20372.t1,47.38078254,-0.833678435,1.410647266,0.002235915,0.011738759,,NA,NA,NA,NA,NA
2756,Pocillopora_acuta_HIv2___RNAseq.g9023.t1,88.89528549,-0.649040628,1.218398413,0.002239238,0.011751935,LIM homeobox protein 3,P50481,2.04E-17,LIM/homeobox protein Lhx3 (LIM homeobox protein 3) (Homeobox protein LIM-3) (Homeobox protein P-LIM),apoptotic process [GO:0006915]; dorsal/ventral pattern formation [GO:0009953]; inner ear development [GO:0048839]; lung development [GO:0030324]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; pituitary gland development [GO:0021983]; placenta development [GO:0001890]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prolactin secreting cell differentiation [GO:0060127]; regulation of transcription by RNA polymerase II [GO:0006357]; somatotropin secreting cell differentiation [GO:0060126]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron cell fate specification [GO:0021520]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; ventral spinal cord interneuron specification [GO:0021521],GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001221; GO:0001223; GO:0001228; GO:0001890; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006915; GO:0008045; GO:0008270; GO:0009953; GO:0021520; GO:0021521; GO:0021526; GO:0021527; GO:0021983; GO:0030182; GO:0030324; GO:0043066; GO:0045893; GO:0045944; GO:0048839; GO:0060126; GO:0060127; GO:0060129; GO:0061629
2757,Pocillopora_acuta_HIv2___RNAseq.g1898.t2a,117.5629585,0.24819195,1.033157789,0.002240579,0.011754709,,Q9HAQ2,2.98E-47,Kinesin-like protein KIF9,extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of flagellated sperm motility [GO:1901317]; regulation of podosome assembly [GO:0071801],GO:0002102; GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0022617; GO:0031982; GO:0036126; GO:0042802; GO:0071801; GO:1901317; GO:1903008
2758,Pocillopora_acuta_HIv2___RNAseq.26630_tb,245.8242645,-0.179641679,1.023480997,0.002263348,0.011869855,,Q8NI36,2.00E-11,WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP),ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; visual perception [GO:0007601],GO:0003723; GO:0005654; GO:0006364; GO:0007601; GO:0032040; GO:0034388; GO:0042274
2759,Pocillopora_acuta_HIv2___RNAseq.g24896.t1,966.6003332,2.468918032,2.046165083,0.002267401,0.011886803,,P51512,1.58E-53,Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP),chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501],GO:0001501; GO:0001958; GO:0004222; GO:0005615; GO:0005796; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094
2760,Pocillopora_acuta_HIv2___RNAseq.g3156.t1,105.2607918,-0.266259701,1.056565109,0.002283984,0.011969402,,Q2VLG4,7.39E-49,Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)],acute-phase response [GO:0006953],GO:0005576; GO:0006953; GO:0009897
2761,Pocillopora_acuta_HIv2___RNAseq.g4371.t1,520.0120434,-0.625217097,1.204731952,0.002289268,0.011992748,,P07207,0,Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein],"actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]",GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048
2762,Pocillopora_acuta_HIv2___RNAseq.g25721.t1,308.6203871,-0.579441397,1.175724073,0.002294026,0.012013323,,Q6P6X9,1.57E-67,Nucleoporin NUP35 (35 kDa nucleoporin) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53),mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999],GO:0003676; GO:0005543; GO:0006607; GO:0006999; GO:0017056; GO:0031965; GO:0044613; GO:0044615; GO:0051028
2763,Pocillopora_acuta_HIv2___RNAseq.g4954.t1,467.3799116,-2.08869717,2.122592671,0.002296004,0.012017178,,Q9NXC2,1.49E-115,Glucose-fructose oxidoreductase domain-containing protein 1 (EC 1.-.-.-),,GO:0000166; GO:0005576; GO:0016491
2764,Pocillopora_acuta_HIv2___RNAseq.g26564.t1,49.19997104,-0.64751436,1.319023463,0.002296424,0.012017178,,P44836,7.26E-07,Probable hemoglobin and hemoglobin-haptoglobin-binding protein 3,siderophore transmembrane transport [GO:0044718],GO:0009279; GO:0015344; GO:0044718
2765,Pocillopora_acuta_HIv2___TS.g19593.t1b,112.1525106,-0.410315247,1.098020466,0.002302073,0.012042382,,Q8N983,3.81E-32,"Large ribosomal subunit protein mL43 (39S ribosomal protein L43, mitochondrial) (L43mt) (MRP-L43) (Mitochondrial ribosomal protein bMRP36a)",mitochondrial translation [GO:0032543]; translation [GO:0006412],GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543
2766,Pocillopora_acuta_HIv2___RNAseq.g23202.t1,21.2901663,-0.69169443,1.350984029,0.002312038,0.012090136,,P32004,5.28E-07,Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171),axon development [GO:0061564]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chemotaxis [GO:0006935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; synapse organization [GO:0050808],GO:0005886; GO:0005925; GO:0006935; GO:0007155; GO:0007156; GO:0007160; GO:0007399; GO:0007411; GO:0008046; GO:0009986; GO:0016477; GO:0019904; GO:0030424; GO:0030425; GO:0031175; GO:0043025; GO:0044295; GO:0045773; GO:0050808; GO:0061564; GO:0062023
2767,Pocillopora_acuta_HIv2___TS.g12472.t1,20.85952037,-0.66780719,1.329182054,0.002313368,0.012092719,,NA,NA,NA,NA,NA
2768,Pocillopora_acuta_HIv2___TS.g25911.t1b,63.94692379,-0.488766401,1.176575822,0.002320989,0.012128175,,Q5SV06,1.52E-23,Spermatogenesis-associated protein 22,fertilization [GO:0009566]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA repair synthesis [GO:0000711]; regulation of meiotic cell cycle [GO:0051445]; reproductive system development [GO:0061458]; spermatocyte division [GO:0048137],GO:0000711; GO:0005694; GO:0007129; GO:0007276; GO:0009566; GO:0048137; GO:0051445; GO:0061458
2769,Pocillopora_acuta_HIv2___RNAseq.g29504.t1,139.7487283,-0.293026076,1.065056038,0.002334956,0.012196752,,Q9Y5X4,3.86E-32,Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor),cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; eye photoreceptor cell development [GO:0042462]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601],GO:0000122; GO:0000978; GO:0001228; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0007165; GO:0007601; GO:0007602; GO:0008270; GO:0008283; GO:0008285; GO:0010628; GO:0030154; GO:0042462; GO:0043565; GO:0045944; GO:0060041
2770,Pocillopora_acuta_HIv2___RNAseq.g28689.t1,1571.160023,0.355733764,1.094403724,0.002354812,0.012296027,,Q5R733,2.71E-137,Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1),cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; regulation of mRNA 3'-end processing [GO:0031440],GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0008135; GO:0014069; GO:0016020; GO:0030425; GO:0031440; GO:0032869; GO:0035925; GO:0043022; GO:0046872; GO:0071230; GO:0071456; GO:1990124; GO:2000766
2771,Pocillopora_acuta_HIv2___RNAseq.g28195.t1,4609.473006,2.020691337,1.039773143,0.002356711,0.012301505,Serine protease inhibitor dipetalogastin,O96790,9.75E-24,Serine protease inhibitor dipetalogastin (Dipetalin),negative regulation of coagulation [GO:0050819],GO:0004867; GO:0005576; GO:0050819
2772,Pocillopora_acuta_HIv2___TS.g22759.t1,62.04236404,-0.225401975,1.036574059,0.002366489,0.012348087,,NA,NA,NA,NA,NA
2773,Pocillopora_acuta_HIv2___RNAseq.g1320.t1,212.5428825,-0.143167223,1.017691328,0.002367716,0.012350035,,Q00534,3.25E-132,Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE),astrocyte development [GO:0014002]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],GO:0000082; GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007165; GO:0007219; GO:0008285; GO:0009615; GO:0010389; GO:0010468; GO:0010628; GO:0014002; GO:0021542; GO:0021670; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045596; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0048699; GO:0050680; GO:0051301; GO:0051726; GO:0060218; GO:0097131; GO:0097132; GO:0097133; GO:0098770; GO:0106310; GO:1902036; GO:2000145; GO:2000773
2774,Pocillopora_acuta_HIv2___RNAseq.g24761.t1,3524.039064,-2.649109464,1.889617267,0.00237696,0.012393782,,P79134,7.56E-108,Annexin A6 (Annexin VI) (Annexin-6),apoptotic signaling pathway [GO:0097190]; biomineral tissue development [GO:0031214]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; regulation of muscle contraction [GO:0006937],GO:0001725; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0005925; GO:0006816; GO:0006937; GO:0008201; GO:0012506; GO:0016020; GO:0019899; GO:0030061; GO:0031214; GO:0031982; GO:0035374; GO:0038024; GO:0042383; GO:0042470; GO:0042584; GO:0048306; GO:0048471; GO:0051015; GO:0051283; GO:0051560; GO:0070509; GO:0070588; GO:0097190
2775,Pocillopora_acuta_HIv2___TS.g15954.t1b,136.3509809,-0.168211321,1.023118172,0.002382818,0.01241985,,Q924L9,3.54E-151,"Folylpolyglutamate synthase, mitochondrial (EC 6.3.2.17) (Folylpoly-gamma-glutamate synthetase) (FPGS) (Tetrahydrofolate synthase) (Tetrahydrofolylpolyglutamate synthase)",one-carbon metabolic process [GO:0006730],GO:0004326; GO:0005524; GO:0005743; GO:0005759; GO:0005829; GO:0006730; GO:0046872
2776,Pocillopora_acuta_HIv2___RNAseq.g16060.t1,99.74888972,-0.696660203,1.241842942,0.002384892,0.012426181,,Q9CXP9,1.07E-69,Exonuclease V (Exo V) (mExo5) (EC 3.1.-.-) (Defects in morphology protein 1 homolog),interstrand cross-link repair [GO:0036297],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0036297; GO:0045145; GO:0046872; GO:0051539
2777,Pocillopora_acuta_HIv2___TS.g25474.t1,227.1007713,-0.141994637,1.017914753,0.002387907,0.012437411,,NA,NA,NA,NA,NA
2778,Pocillopora_acuta_HIv2___TS.g14528.t1a,288.4536286,1.629107087,2.393821634,0.002397863,0.01248477,,Q92626,1.01E-22,Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment],angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825
2779,Pocillopora_acuta_HIv2___RNAseq.g24452.t1,198.7824849,-0.291772491,1.063601011,0.002401265,0.012497986,,Q09128,1.91E-67,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (24-OHase) (Vitamin D(3) 24-hydroxylase) (EC 1.14.15.16) (Cytochrome P450 24A1) (Cytochrome P450-CC24)",cellular response to vitamin D [GO:0071305]; osteoblast differentiation [GO:0001649]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359],GO:0001649; GO:0005506; GO:0005739; GO:0008403; GO:0020037; GO:0030342; GO:0033280; GO:0042359; GO:0042369; GO:0062180; GO:0062181; GO:0070576; GO:0070643; GO:0071305
2780,Pocillopora_acuta_HIv2___RNAseq.g25209.t1,116.4236581,-0.215493621,1.048269336,0.002410806,0.012543129,,Q9UBX3,6.06E-122,Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10),"dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; lipid transport [GO:0006869]; malate transmembrane transport [GO:0071423]; monoatomic ion transport [GO:0006811]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]",GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006869; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0035435; GO:0046166; GO:0070221; GO:0071422; GO:0071423
2781,Pocillopora_acuta_HIv2___TS.g2835.t1,79.43482685,-1.412736654,2.012494211,0.002421657,0.012595053,,Q5F4A1,3.58E-61,G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase),apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872
2782,Pocillopora_acuta_HIv2___RNAseq.g18716.t1,619.55571,1.524918739,2.434157722,0.00242263,0.012595588,,Q96PM5,8.02E-24,RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2),error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987; GO:0072344
2783,Pocillopora_acuta_HIv2___RNAseq.g16948.t1,2941.748489,-2.091229157,1.109130994,0.002428026,0.012619107,,P42325,2.16E-121,Neurocalcin homolog (DrosNCa),"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]",GO:0005509; GO:0045938; GO:1902848
2784,Pocillopora_acuta_HIv2___RNAseq.g24201.t1,115.3540104,-0.249257004,1.053468194,0.00243151,0.012632672,,P08842,0,Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase),epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706],GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0033163; GO:0043231; GO:0046872
2785,Pocillopora_acuta_HIv2___RNAseq.g7520.t1,504.1304414,-0.50136979,1.128420409,0.002433872,0.012640402,,NA,NA,NA,NA,NA
2786,Pocillopora_acuta_HIv2___RNAseq.g3907.t1,317.9138781,-0.145189284,1.011256678,0.002452459,0.012732364,,Q96RW7,3.51E-36,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711
2787,Pocillopora_acuta_HIv2___RNAseq.g3780.t1,5713.700406,1.574732336,0.62378699,0.002455991,0.012746127,"Protein kinase C-binding protein NELL1, Kielin-Like",Q2VWQ2,5.25E-13,Protein kinase C-binding protein NELL1 (NEL-like protein 1),generation of neurons [GO:0048699]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667],GO:0005080; GO:0005509; GO:0005615; GO:0005635; GO:0005737; GO:0008201; GO:0010468; GO:0030501; GO:0033689; GO:0042177; GO:0042802; GO:0043065; GO:0045667; GO:0045669; GO:0045778; GO:0048471; GO:0048699
2788,Pocillopora_acuta_HIv2___RNAseq.g28209.t1,2192.247276,-2.245816964,2.048265284,0.002462983,0.012777827,,NA,NA,NA,NA,NA
2789,Pocillopora_acuta_HIv2___TS.g15590.t1,303.5101998,3.247619577,2.143230692,0.00247139,0.012816849,,Q96RW7,2.07E-06,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711
2790,Pocillopora_acuta_HIv2___RNAseq.g20162.t1,52.25418309,-0.306136161,1.06778816,0.002495782,0.012935468,,Q7TNV1,4.12E-14,Ceramide synthase (EC 2.3.1.-) (Protein FAM57B) (TLC domain-containing protein 3B),ceramide biosynthetic process [GO:0046513]; lipid homeostasis [GO:0055088]; negative regulation of fat cell differentiation [GO:0045599],GO:0000139; GO:0005783; GO:0005789; GO:0045599; GO:0046513; GO:0050291; GO:0055088
2791,Pocillopora_acuta_HIv2___TS.g25606.t1,181.8448564,-0.733867587,1.317852618,0.002496052,0.012935468,,NA,NA,NA,NA,NA
2792,Pocillopora_acuta_HIv2___RNAseq.g21499.t1,333.0552494,-0.262573859,1.028257893,0.002511895,0.013012911,,Q5R413,8.13E-43,mRNA-decapping enzyme 1B (EC 3.6.1.62),"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]",GO:0000184; GO:0000290; GO:0000932; GO:0003729; GO:0005634; GO:0008047; GO:0031087; GO:0140933
2793,Pocillopora_acuta_HIv2___RNAseq.g17782.t1,71.27951867,-0.321138007,1.073116232,0.002525717,0.01307983,,NA,NA,NA,NA,NA
2794,Pocillopora_acuta_HIv2___RNAseq.g8004.t1,599.1055254,-2.026636967,1.064247287,0.002540099,0.013149601,,Q96EV8,1.80E-25,Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein),actin cytoskeleton organization [GO:0030036]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; kidney development [GO:0001822]; melanosome organization [GO:0032438]; memory [GO:0007613]; negative regulation of dendritic spine morphogenesis [GO:0061002]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transmembrane transport [GO:0071806]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; retina development in camera-type eye [GO:0060041],GO:0001822; GO:0001934; GO:0001956; GO:0002092; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0007596; GO:0007613; GO:0008089; GO:0010008; GO:0010628; GO:0014059; GO:0014069; GO:0015630; GO:0016528; GO:0030036; GO:0030424; GO:0030426; GO:0030496; GO:0030672; GO:0031083; GO:0031175; GO:0032438; GO:0033162; GO:0042383; GO:0043005; GO:0043025; GO:0043197; GO:0045211; GO:0048490; GO:0048812; GO:0048813; GO:0060041; GO:0060155; GO:0060159; GO:0060271; GO:0061002; GO:0061646; GO:0071806; GO:0098685; GO:0098686; GO:0098978; GO:1904115; GO:2000300
2795,Pocillopora_acuta_HIv2___RNAseq.g13824.t1,254.4075582,0.414080443,1.135718049,0.002543887,0.013164501,Carbonic anhydrase 2,P00918,4.49E-47,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0006730; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225
2796,Pocillopora_acuta_HIv2___RNAseq.g17731.t1,199.7866206,-2.085806936,1.235948951,0.002550222,0.013189007,,Q7RTR2,1.44E-83,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)",canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110],GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223
2797,Pocillopora_acuta_HIv2___RNAseq.g25237.t1,576.4690521,-1.936198009,1.786811944,0.002550446,0.013189007,,Q43469,2.49E-124,Delta(8)-fatty-acid desaturase (EC 1.14.19.29) (Delta(8)-sphingolipid desaturase) (Sphingolipid 8-(E/Z)-desaturase),sphingolipid metabolic process [GO:0006665],GO:0006665; GO:0016020; GO:0046872; GO:0052631
2798,Pocillopora_acuta_HIv2___TS.g15485.t1,36.69734135,-0.775708397,1.344281543,0.002556245,0.013214272,,Q09575,4.25E-105,Uncharacterized protein K02A2.6,DNA integration [GO:0015074],GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575
2799,Pocillopora_acuta_HIv2___RNAseq.g10385.t1,500.5563382,1.900934267,0.893357102,0.002558426,0.013216447,,Q8N441,3.27E-39,Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5),cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412],GO:0001501; GO:0003179; GO:0005007; GO:0005794; GO:0005886; GO:0008201; GO:0008285; GO:0017134; GO:0030133; GO:0042802; GO:0044291; GO:0060412; GO:0060539; GO:0098742
2800,Pocillopora_acuta_HIv2___RNAseq.g9944.t1,76.35988256,-0.257827734,1.054237478,0.002558494,0.013216447,,Q99N34,1.19E-18,DNA fragmentation factor subunit beta (EC 3.-.-.-) (Caspase-activated deoxyribonuclease) (CAD) (Caspase-activated DNase) (DNA fragmentation factor 40 kDa subunit) (DFF-40),apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; negative regulation of apoptotic DNA fragmentation [GO:1902511],GO:0000785; GO:0003677; GO:0004518; GO:0004520; GO:0004536; GO:0005634; GO:0005829; GO:0006308; GO:0006309; GO:0019899; GO:0019904; GO:0030263; GO:0032991; GO:0042802; GO:0097718; GO:1902511
2801,Pocillopora_acuta_HIv2___RNAseq.g21957.t1,266.0220062,-2.474166531,2.255984818,0.002559714,0.013218031,,Q6UVY6,1.84E-14,DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X),dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421
2802,Pocillopora_acuta_HIv2___RNAseq.g8495.t1,227.0074452,-0.13738436,1.014767757,0.002572784,0.013280781,,Q96P65,1.32E-21,Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870; GO:0042277
2803,Pocillopora_acuta_HIv2___RNAseq.g16480.t1,139.1107323,-0.324666213,1.075133166,0.00257409,0.013282783,,O95236,7.53E-06,Apolipoprotein L3 (Apolipoprotein L-III) (ApoL-III) (TNF-inducible protein CG12-1) (CG12_1),inflammatory response [GO:0006954]; lipoprotein metabolic process [GO:0042157]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],GO:0005319; GO:0005576; GO:0005737; GO:0006954; GO:0008289; GO:0016020; GO:0042157; GO:0043123
2804,Pocillopora_acuta_HIv2___RNAseq.g9839.t1,3421.841446,1.416937883,0.538794651,0.002577492,0.013295591,,O42412,1.77E-54,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403],GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042446
2805,Pocillopora_acuta_HIv2___TS.g9744.t1,42.2436685,-2.380997397,2.062523118,0.002592345,0.013367445,,NA,NA,NA,NA,NA
2806,Pocillopora_acuta_HIv2___RNAseq.g24672.t1,86.60845207,-2.428491128,1.556813629,0.002603861,0.013422042,,Q8U3Y2,4.89E-77,Glyoxylate reductase (EC 1.1.1.26),,GO:0005737; GO:0047964; GO:0051287
2807,Pocillopora_acuta_HIv2___RNAseq.g4384.t1,197.5287718,-0.305731062,1.066399151,0.002608281,0.013440033,,NA,NA,NA,NA,NA
2808,Pocillopora_acuta_HIv2___RNAseq.g879.t1,653.2364044,-0.472255383,1.094952249,0.002612234,0.013455608,,Q9CR88,1.65E-25,"Small ribosomal subunit protein uS14m (28S ribosomal protein S14, mitochondrial) (MRP-S14) (S14mt)",mitochondrial translation [GO:0032543]; translation [GO:0006412],GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0031965; GO:0032543
2809,Pocillopora_acuta_HIv2___RNAseq.g21842.t1,568.0444439,0.856287516,1.607390048,0.002613753,0.013458643,,Q9VCA2,9.75E-66,Organic cation transporter protein,apoptotic process [GO:0006915]; monoatomic ion transport [GO:0006811],GO:0006811; GO:0006915; GO:0016020; GO:0022857
2810,Pocillopora_acuta_HIv2___RNAseq.g19852.t1,300.3930634,-0.28380511,1.061218254,0.002626643,0.013520203,,P17972,1.96E-114,Potassium voltage-gated channel protein Shaw (Shaw2),action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; sleep [GO:0030431],GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0022843; GO:0030431; GO:0032590; GO:0032809; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805
2811,Pocillopora_acuta_HIv2___RNAseq.g12753.t1,639.7647245,0.865540775,1.464657288,0.002638088,0.013574283,,P54319,0,Phospholipase A-2-activating protein (PLA2P) (PLAP),cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; nervous system development [GO:0007399]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],GO:0005634; GO:0005737; GO:0006693; GO:0006954; GO:0007399; GO:0010992; GO:0016005; GO:0016236; GO:0032430; GO:0043130; GO:0043161; GO:0043162; GO:0045202; GO:0070062; GO:0071222; GO:1900045; GO:1903423; GO:1903861; GO:2001224
2812,Pocillopora_acuta_HIv2___RNAseq.g14116.t1,241.8188965,-0.288275863,1.028706838,0.002649602,0.013627558,,P23790,3.96E-67,Serum response factor (SRF),actin cytoskeleton organization [GO:0030036]; positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0000981; GO:0003700; GO:0005634; GO:0010736; GO:0030036; GO:0045944; GO:0046983
2813,Pocillopora_acuta_HIv2___RNAseq.g12566.t1,195.3421672,-0.462957394,1.09978682,0.002651847,0.013627558,,Q8CHT3,3.83E-91,Integrator complex subunit 5 (Int5),snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016180; GO:0031965; GO:0032039; GO:0034472
2814,Pocillopora_acuta_HIv2___RNAseq.g12141.t1,108.3836782,-0.337693102,1.080068372,0.002652141,0.013627558,,Q6AXN4,5.21E-89,Nucleoporin NDC1 (Transmembrane protein 48),homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; protein transport [GO:0015031]; spermatogenesis [GO:0007283],GO:0005635; GO:0005643; GO:0005737; GO:0006999; GO:0007129; GO:0007283; GO:0015031; GO:0017056; GO:0030674; GO:0031965; GO:0051028; GO:0051292; GO:0051664; GO:0070762
2815,Pocillopora_acuta_HIv2___RNAseq.16206_t,420.2730822,0.42455033,1.143252961,0.002652974,0.013627558,,Q566C7,1.90E-41,Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP-1) (EC 3.6.1.52) (Diadenosine hexaphosphate hydrolase) (Ap6A hydrolase) (EC 3.6.1.61) (Endopolyphosphatase) (EC 3.6.1.10) (Nucleoside diphosphate-linked moiety X motif 3) (Nudix motif 3) (m7GpppN-mRNA hydrolase) (EC 3.6.1.62) (m7GpppX diphosphatase) (EC 3.6.1.59),adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate catabolic process [GO:0071544]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; RNA decapping [GO:0110154],GO:0000287; GO:0000298; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0008486; GO:0030145; GO:0034431; GO:0034432; GO:0045202; GO:0052840; GO:0052842; GO:0052845; GO:0052848; GO:0071543; GO:0071544; GO:0098978; GO:0110154; GO:0140932; GO:0140933; GO:1901907; GO:1901909; GO:1901911
2816,Pocillopora_acuta_HIv2___RNAseq.26564_t,6653.232483,-2.173801993,2.395489904,0.002653153,0.013627558,,P58197,8.90E-87,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559],GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:0140536; GO:1990837; GO:2000378
2817,Pocillopora_acuta_HIv2___RNAseq.g3523.t1,2327.91634,1.879666647,1.579851073,0.002656274,0.013638745,,Q6DIV6,1.08E-72,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800
2818,Pocillopora_acuta_HIv2___RNAseq.g22403.t1,175.2396498,-0.353999718,1.08182954,0.002660381,0.013654987,,O95185,5.49E-09,Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C),anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; ectopic germ cell programmed cell death [GO:0035234]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental process [GO:0051094]; positive regulation of reproductive process [GO:2000243]; regulation of neuron migration [GO:2001222],GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0019901; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0033564; GO:0035234; GO:0043025; GO:0043065; GO:0045202; GO:0051094; GO:0061643; GO:1990791; GO:2000243; GO:2001222
2819,Pocillopora_acuta_HIv2___RNAseq.g17049.t1,470.8778481,-0.538811682,1.134347574,0.002664019,0.013666889,,A5PJV8,1.92E-08,Mitotic-spindle organizing protein 2 (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2),,GO:0000931; GO:0005737; GO:0005813; GO:0005819
2820,Pocillopora_acuta_HIv2___TS.g27338.t1,112.5318577,-0.247074773,1.050393056,0.00266459,0.013666889,,Q9CZH7,8.90E-07,Matrix-remodeling-associated protein 7,,GO:0016020
2821,Pocillopora_acuta_HIv2___RNAseq.g12741.t1,360.2251434,-0.248394743,1.046298281,0.002666822,0.013673489,,O42409,8.59E-97,Zinc finger protein Gfi-1b (Growth factor-independent protein 1B),chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0001227; GO:0005654; GO:0006325; GO:0006357; GO:0046872
2822,Pocillopora_acuta_HIv2___RNAseq.g31072.t1,2299.439868,-0.750818901,1.31751456,0.002676254,0.013716986,,NA,NA,NA,NA,NA
2823,Pocillopora_acuta_HIv2___RNAseq.g30027.t1,1878.08236,2.185437218,2.187315219,0.002682795,0.01374564,,O97563,8.09E-19,Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4),negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; response to cytokine [GO:0034097]; response to hormone [GO:0009725],GO:0002020; GO:0005615; GO:0008191; GO:0009725; GO:0031012; GO:0034097; GO:0046872; GO:0051045
2824,Pocillopora_acuta_HIv2___RNAseq.g19642.t1,89.09954636,-0.528282495,1.204567855,0.002690998,0.013782789,,Q2KHT8,7.81E-172,"Dimethyladenosine transferase (EC 2.1.1.183) (18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (18S rRNA dimethylase) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)",positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]; rRNA methylation [GO:0031167],GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0031167; GO:0032040; GO:0042274; GO:0052909; GO:2000234
2825,Pocillopora_acuta_HIv2___TS.g15.t2,171.4341066,-0.246732489,1.038552954,0.002694278,0.013794702,,A2ACJ2,2.31E-12,Fanconi anemia core complex-associated protein 100 (Fanconi anemia-associated protein of 100 kDa),interstrand cross-link repair [GO:0036297],GO:0000785; GO:0003677; GO:0005654; GO:0005829; GO:0036297; GO:0043240
2826,Pocillopora_acuta_HIv2___RNAseq.g7981.t1c,72.09860018,-0.269878678,1.057141191,0.002700667,0.013822524,,O74212,4.22E-141,Acyl-lipid (8-3)-desaturase (EC 1.14.19.30) (Delta(5) fatty acid desaturase) (Delta-5 fatty acid desaturase),long-chain fatty acid biosynthetic process [GO:0042759]; unsaturated fatty acid biosynthetic process [GO:0006636],GO:0006636; GO:0016020; GO:0020037; GO:0042759; GO:0046872; GO:0102866
2827,Pocillopora_acuta_HIv2___TS.g25969.t1,361.6098158,-0.40977012,1.07527731,0.002714527,0.013888548,,Q2YDR3,4.30E-93,"Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (3'(2'), 5'-bisphosphate nucleotidase 2) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3)",inositol biosynthetic process [GO:0006021]; phosphatidylinositol phosphate biosynthetic process [GO:0046854],GO:0006021; GO:0008254; GO:0008934; GO:0012505; GO:0016020; GO:0046854; GO:0046872; GO:0052832; GO:0052833
2828,Pocillopora_acuta_HIv2___RNAseq.g28606.t1,1750.272209,-1.134058284,1.874917523,0.002728652,0.013955878,,NA,NA,NA,NA,NA
2829,Pocillopora_acuta_HIv2___RNAseq.g7917.t1,325.6843123,-0.293258766,1.041854452,0.002736038,0.013988709,,Q3TQF0,5.90E-71,F-box only protein 31,anaphase-promoting complex-dependent catabolic process [GO:0031145]; DNA damage response [GO:0006974]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron migration [GO:2001224]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0005813; GO:0006974; GO:0016567; GO:0019005; GO:0030332; GO:0031145; GO:0031146; GO:0031571; GO:0043025; GO:0050775; GO:2001224
2830,Pocillopora_acuta_HIv2___RNAseq.g25311.t1,653.9232872,-0.369360147,1.057749928,0.002742144,0.014014974,,NA,NA,NA,NA,NA
2831,Pocillopora_acuta_HIv2___RNAseq.g3097.t1,290.1255829,-2.085393335,1.715004419,0.002753878,0.014069974,,NA,NA,NA,NA,NA
2832,Pocillopora_acuta_HIv2___RNAseq.g11722.t1,37.3521509,2.280692608,1.757664187,0.002775036,0.014173064,,NA,NA,NA,NA,NA
2833,Pocillopora_acuta_HIv2___RNAseq.g6249.t1,161.1808447,-0.23407639,1.040111421,0.002776764,0.014176885,,Q00174,7.02E-06,Laminin subunit alpha (Laminin A chain),"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]",GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0062023; GO:0071711
2834,Pocillopora_acuta_HIv2___RNAseq.g29389.t1,80.77274609,-0.39366165,1.109760061,0.002793671,0.014258171,,A0A2B4RNI3,5.93E-24,Cyclic GMP-AMP synthase-like receptor 2 (Sp-cGLR2) (EC 2.7.7.86),innate immune response [GO:0045087],GO:0005524; GO:0005525; GO:0045087; GO:0046872; GO:0061501
2835,Pocillopora_acuta_HIv2___TS.g1898.t1,51.41263549,-0.762505119,1.395278407,0.002802068,0.014295985,,Q8A2I1,6.60E-49,Chondroitin sulfate ABC exolyase (EC 4.2.2.21) (Chondroitin ABC exoeliminase) (Chondroitin ABC lyase II) (Chondroitin sulfate ABC lyase II) (ChS ABC lyase II) (Chondroitinase ABC II) (cABC II) (Exochondroitinase ABC),carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207],GO:0005576; GO:0005975; GO:0016837; GO:0030207; GO:0030246; GO:0030340; GO:0030341; GO:0033999; GO:0034000; GO:0034001; GO:0042597; GO:0046872
2836,Pocillopora_acuta_HIv2___TS.g21212.t1,71.0531707,-2.36543837,1.39798457,0.002836329,0.014462765,,NA,NA,NA,NA,NA
2837,Pocillopora_acuta_HIv2___TS.g26022.t1,81.92047395,-0.676068792,1.366270278,0.002836758,0.014462765,,Q9UIX4,5.61E-08,Voltage-gated potassium channel regulatory subunit KCNG1 (Potassium voltage-gated channel subfamily G member 1) (Voltage-gated potassium channel subunit Kv6.1) (kH2),action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of potassium ion transmembrane transport [GO:1901379],GO:0001508; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0016020; GO:0051260; GO:0071805; GO:1901379
2838,Pocillopora_acuta_HIv2___RNAseq.g29675.t1,136.5376883,0.170150611,1.033936291,0.002838244,0.014465245,,Q4QQW8,9.50E-79,Putative phospholipase B-like 2 (EC 3.1.1.-) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2),phospholipid catabolic process [GO:0009395],GO:0004620; GO:0005576; GO:0005764; GO:0009395; GO:0043202
2839,Pocillopora_acuta_HIv2___RNAseq.g26959.t1,415.3765536,-2.031344246,1.402744523,0.002841136,0.014474882,,Q6GPV5,6.93E-50,E3 ubiquitin-protein ligase RNF181 (EC 2.3.2.27) (RING finger protein 181),protein ubiquitination [GO:0016567],GO:0016567; GO:0046872; GO:0061630
2840,Pocillopora_acuta_HIv2___RNAseq.g25004.t1,153.4418582,-0.127777128,1.01245367,0.002849721,0.014513509,,E7FAM5,2.20E-98,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177
2841,Pocillopora_acuta_HIv2___RNAseq.g13617.t2,2007.477008,-1.919399805,1.387781858,0.002852552,0.014520229,,Q17RD7,2.94E-77,Synaptotagmin-16 (Chr14Syt) (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein),,GO:0005543; GO:0042802
2842,Pocillopora_acuta_HIv2___RNAseq.g24783.t1,498.7729645,0.14436004,1.026229174,0.002853048,0.014520229,,NA,NA,NA,NA,NA
2843,Pocillopora_acuta_HIv2___RNAseq.g21465.t1,280.0627427,-0.293717452,1.044118974,0.002870479,0.014603802,,P78382,4.50E-72,CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (CST) (Solute carrier family 35 member A1),carbohydrate metabolic process [GO:0005975]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; protein modification process [GO:0036211],GO:0000139; GO:0005456; GO:0005794; GO:0005886; GO:0005975; GO:0015297; GO:0015782; GO:0016020; GO:0036211
2844,Pocillopora_acuta_HIv2___RNAseq.g24836.t1,441.3330499,-1.652058506,0.692356494,0.002898331,0.014737171,,NA,NA,NA,NA,NA
2845,Pocillopora_acuta_HIv2___RNAseq.g1851.t1,120.8482259,-0.200264797,1.032065708,0.002898731,0.014737171,,Q5R7A2,3.28E-164,"Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase)",dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487],GO:0004578; GO:0006487; GO:0006488; GO:0098554
2846,Pocillopora_acuta_HIv2___RNAseq.g1638.t1,309.4770822,1.907581373,2.037257718,0.002902587,0.014751589,,P10079,2.53E-115,Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1),,GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579
2847,Pocillopora_acuta_HIv2___RNAseq.g12682.t1,2977.742647,-1.899883842,0.980477279,0.00290469,0.014757088,,O35598,5.45E-143,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),adherens junction organization [GO:0034332]; amyloid-beta formation [GO:0034205]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; signaling receptor ligand precursor processing [GO:0140448],GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005802; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0006913; GO:0007162; GO:0007219; GO:0007220; GO:0008021; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034205; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042169; GO:0042803; GO:0043025; GO:0043065; GO:0043197; GO:0045211; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0061001; GO:0062023; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098794; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:0140448; GO:1901342; GO:1902945
2848,Pocillopora_acuta_HIv2___RNAseq.g17922.t1,194.4569192,-0.396442954,1.082186097,0.002916539,0.014812085,,Q6TMK8,1.25E-60,PRELI domain containing protein 3B (BCR/ABL-regulated protein) (Protein slowmo homolog 2),,GO:0005758; GO:1990050
2849,Pocillopora_acuta_HIv2___TS.g24829.t1a,2915.502679,-1.461269557,0.576426351,0.002925944,0.014854633,,NA,NA,NA,NA,NA
2850,Pocillopora_acuta_HIv2___RNAseq.g24812.t1,246.6911087,-0.236258771,1.035441228,0.002932151,0.014880924,,Q66KX4,7.11E-25,Mediator of RNA polymerase II transcription subunit 29 (Intersex-like protein) (Mediator complex subunit 29),,GO:0016592
2851,Pocillopora_acuta_HIv2___RNAseq.g5756.t1,154.3976081,-0.39931459,1.109159673,0.002934097,0.014885576,,NA,NA,NA,NA,NA
2852,Pocillopora_acuta_HIv2___RNAseq.g11949.t1,61.20382945,-0.751873417,1.457338844,0.002936204,0.014891042,,Q0P3X7,1.92E-11,Synaptic plasticity regulator PANTS (Plasticity-associated neural transcript short),negative regulation of long-term synaptic potentiation [GO:1900272]; regulation of synaptic plasticity [GO:0048167],GO:0043083; GO:0045202; GO:0048167; GO:1900272
2853,Pocillopora_acuta_HIv2___RNAseq.g18991.t1,138.0720947,-0.160389193,1.028616289,0.002946782,0.014939454,,A4IF63,2.21E-14,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630
2854,Pocillopora_acuta_HIv2___RNAseq.g833.t1,806.1594708,-0.925614266,1.514502963,0.002968238,0.015042956,,Q5R5X8,1.78E-50,Adenylyl cyclase-associated protein 2 (CAP 2),actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902],GO:0000902; GO:0003779; GO:0005737; GO:0005886; GO:0007015; GO:0008179; GO:0019933
2855,Pocillopora_acuta_HIv2___RNAseq.g30830.t1,78.97591473,-0.436824436,1.12909394,0.002976036,0.015077191,Uncharacterized biomineralization protein LOC111342641,NA,NA,NA,NA,NA
2856,Pocillopora_acuta_HIv2___RNAseq.g28039.t1,157.0944953,-0.480051559,1.16168317,0.002986705,0.015123378,,A6H7B8,1.84E-58,Post-GPI attachment to proteins factor 2,GPI anchor biosynthetic process [GO:0006506],GO:0000139; GO:0005789; GO:0006506
2857,Pocillopora_acuta_HIv2___TS.g11948.t1,114.4630032,-0.89257,1.45310328,0.002987244,0.015123378,,Q2KIQ4,6.99E-135,"4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase)",isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],GO:0002083; GO:0005743; GO:0006744; GO:0008299; GO:0008412; GO:0047293
2858,Pocillopora_acuta_HIv2___RNAseq.g29143.t2,4185.187881,1.479854005,0.587461908,0.002995577,0.015160259,,Q9HCK4,1.34E-91,Roundabout homolog 2,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412],GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609
2859,Pocillopora_acuta_HIv2___RNAseq.g17619.t1,251.0802819,-0.800445537,1.381820098,0.002998992,0.015172233,,Q9DBM1,2.12E-141,G patch domain-containing protein 1,mRNA processing [GO:0006397],GO:0003723; GO:0005634; GO:0006397; GO:0071013
2860,Pocillopora_acuta_HIv2___TS.g31470.t2,249.5666063,0.355011757,1.083795092,0.003004388,0.015194219,,P07450,1.14E-16,Carbonic anhydrase 3 (EC 4.2.1.1) (Carbonate dehydratase III) (Carbonic anhydrase III) (CA-III),one-carbon metabolic process [GO:0006730],GO:0004089; GO:0005737; GO:0005829; GO:0006730; GO:0008270
2861,Pocillopora_acuta_HIv2___RNAseq.g254.t1,272.0954031,-0.25008422,1.037615593,0.003007577,0.015201373,,P35406,1.28E-43,D(1) dopamine receptor (Dopamine D1 receptor),adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881],GO:0004938; GO:0060170; GO:0071881
2862,Pocillopora_acuta_HIv2___RNAseq.g10180.t1,3100.04406,-1.966343467,1.223475945,0.003007904,0.015201373,Homeobox protein Nkx-2.5,P42583,1.46E-41,Homeobox protein Nkx-2.5 (xNKx-2.5) (Homeobox protein NK-2 homolog E),,GO:0000978; GO:0000981; GO:0005634; GO:0032991; GO:0032993
2863,Pocillopora_acuta_HIv2___RNAseq.g31081.t1,2788.557666,2.58240352,2.065203605,0.003012549,0.015219526,,Q29121,9.66E-164,Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form],protein O-linked glycosylation [GO:0006493],GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580
2864,Pocillopora_acuta_HIv2___RNAseq.g12410.t1,6201.149239,-1.889430594,0.93482567,0.003032724,0.015316105,Excitatory amino acid transporter 2 (GLT-1),P43006,6.62E-159,Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2),adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; monoatomic anion transmembrane transport [GO:0098656]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; visual behavior [GO:0007632],GO:0005313; GO:0005314; GO:0005886; GO:0006750; GO:0007399; GO:0007632; GO:0008509; GO:0009410; GO:0009416; GO:0009611; GO:0009986; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031982; GO:0033229; GO:0035264; GO:0042734; GO:0043197; GO:0043198; GO:0043200; GO:0044297; GO:0044306; GO:0045121; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070778; GO:0070779; GO:0071314; GO:0097449; GO:0098656; GO:0098712; GO:0098796; GO:0098810; GO:0098978; GO:0140009
2865,Pocillopora_acuta_HIv2___RNAseq.g4872.t1,141.2808596,-0.309909057,1.079266969,0.003034545,0.01531995,,S4R2K0,4.77E-43,"Peptide deformylase, mitochondrial (EC 3.5.1.88) (Polypeptide deformylase)",co-translational protein modification [GO:0043686]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412],GO:0005739; GO:0006412; GO:0008284; GO:0042586; GO:0043686; GO:0046872
2866,Pocillopora_acuta_HIv2___TS.g7557.t1,245.7911539,-0.551674589,1.155456421,0.003043004,0.015357298,,Q8QFR2,0,Protein HIRA,DNA-templated transcription [GO:0006351]; nucleosome assembly [GO:0006334]; regulation of DNA-templated transcription [GO:0006355],GO:0005634; GO:0006334; GO:0006351; GO:0006355
2867,Pocillopora_acuta_HIv2___RNAseq.g28041.t1,212.4016821,-1.515776636,2.128516926,0.003053243,0.015403595,,NA,NA,NA,NA,NA
2868,Pocillopora_acuta_HIv2___RNAseq.g13338.t1,132.8112312,-1.544990179,2.10647575,0.003056509,0.015414696,,P86854,4.98E-19,Perlucin-like protein,,GO:0005576; GO:0030246; GO:0038023
2869,Pocillopora_acuta_HIv2___RNAseq.9717_t,38.81865937,-0.515371382,1.205633279,0.003060262,0.015428243,,Q8CEE0,2.48E-78,Centrosomal protein of 57 kDa (Cep57) (Testis-specific protein 57) (Translokin),fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286],GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034451; GO:0042803; GO:0043015; GO:0051260
2870,Pocillopora_acuta_HIv2___RNAseq.g24377.t1,155.396566,-0.132886655,1.018225272,0.003062044,0.015431848,,NA,NA,NA,NA,NA
2871,Pocillopora_acuta_HIv2___RNAseq.g28344.t1b,71.39637091,-0.294207703,1.063599776,0.003067381,0.015453361,,A5HUI5,0,Aminopeptidase A (AP-A) (APA) (EC 3.4.11.7) (Glutamyl aminopeptidase) (EAP),proteolysis [GO:0006508],GO:0004177; GO:0005886; GO:0006508; GO:0008237; GO:0008270
2872,Pocillopora_acuta_HIv2___RNAseq.g17491.t1,59.16472174,-0.389109054,1.094119772,0.003083842,0.015530883,,Q96AY4,1.27E-79,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301
2873,Pocillopora_acuta_HIv2___RNAseq.g6912.t1,978.7527398,-0.606018836,1.170234898,0.003097067,0.015592055,,NA,NA,NA,NA,NA
2874,Pocillopora_acuta_HIv2___RNAseq.g20762.t1,86.49795933,-1.764990734,2.000990482,0.003117159,0.015687748,,A1R8N8,2.28E-12,D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase),mycothiol biosynthetic process [GO:0010125],GO:0000287; GO:0008375; GO:0010125; GO:0102710
2875,Pocillopora_acuta_HIv2___TS.g10169.t1,98.32802546,-0.125620031,1.01911188,0.003122639,0.015707177,,NA,NA,NA,NA,NA
2876,Pocillopora_acuta_HIv2___RNAseq.g164.t1,142.8902979,-0.304046611,1.064374282,0.003123191,0.015707177,,NA,NA,NA,NA,NA
2877,Pocillopora_acuta_HIv2___RNAseq.g30553.t1,168.7880045,-0.247278168,1.05092621,0.003127984,0.015725814,,D3Z902,9.15E-20,F-box/WD repeat-containing protein 7,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570],GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205
2878,Pocillopora_acuta_HIv2___TS.g29496.t1,1258.168643,2.007076714,1.393698965,0.003129398,0.015727455,,NA,NA,NA,NA,NA
2879,Pocillopora_acuta_HIv2___TS.g22765.t2,158.1447788,-0.677821952,1.36242774,0.003146613,0.015808478,,NA,NA,NA,NA,NA
2880,Pocillopora_acuta_HIv2___RNAseq.g25873.t1,50.50719656,2.310113228,1.404827286,0.00315543,0.015847268,,Q9VLR9,1.91E-13,Metallophosphoesterase 1 homolog (EC 3.1.-.-) (Post-GPI attachment to proteins 5 ortholog),endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506],GO:0005793; GO:0006506; GO:0006888; GO:0008081; GO:0016020; GO:0046872
2881,Pocillopora_acuta_HIv2___RNAseq.g694.t1,351.4140486,-0.228354971,1.047438699,0.003166392,0.015896806,,NA,NA,NA,NA,NA
2882,Pocillopora_acuta_HIv2___RNAseq.g10951.t1,114.9090588,-0.539018909,1.225245289,0.003175673,0.015935838,,A6QLU6,2.83E-74,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189
2883,Pocillopora_acuta_HIv2___RNAseq.g22367.t1,303.6849409,-0.513604676,1.133514094,0.00317637,0.015935838,,P23780,0,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),galactose catabolic process [GO:0019388]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005773; GO:0005794; GO:0016787; GO:0016936; GO:0019388; GO:0042803; GO:0051413; GO:1904016
2884,Pocillopora_acuta_HIv2___RNAseq.g21382.t1,68.2734536,-0.307714813,1.037850376,0.003178742,0.015942206,,A4IHD2,0,Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2),,GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0016887; GO:0140658
2885,Pocillopora_acuta_HIv2___RNAseq.g23814.t1,154.9299643,-0.595601158,1.261633137,0.003180016,0.01594307,,Q4R6I5,9.96E-72,Clathrin heavy chain linker domain-containing protein 1,,
2886,Pocillopora_acuta_HIv2___TS.g12085.t1a,66.0814647,-0.210349427,1.046032974,0.00318998,0.01598748,,Q8WUM0,7.94E-170,Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133),mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; paraxial mesoderm development [GO:0048339]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]; somite development [GO:0061053]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],GO:0000776; GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0016020; GO:0016973; GO:0017056; GO:0021915; GO:0022008; GO:0031080; GO:0031965; GO:0048339; GO:0061053; GO:0072006
2887,Pocillopora_acuta_HIv2___RNAseq.g7911.t1,177.4279159,-0.289414313,1.064504685,0.00319289,0.015996522,,A2AX52,4.98E-14,Collagen alpha-4(VI) chain,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023
2888,Pocillopora_acuta_HIv2___RNAseq.g26575.t1,441.9409462,-2.052671484,1.798621854,0.003198186,0.016017508,,P97603,7.05E-08,Neogenin,"axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; protein secretion [GO:0009306]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550]",GO:0001764; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009306; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0044295; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550
2889,Pocillopora_acuta_HIv2___RNAseq.g19159.t1,4254.381749,2.607113508,1.844143947,0.0032023,0.016032561,Solute carrier family 7 member 4,Q8BLQ7,4.17E-90,Cationic amino acid transporter 4 (CAT-4) (CAT4) (Solute carrier family 7 member 4),amino acid transport [GO:0006865]; carboxylic acid transmembrane transport [GO:1905039],GO:0005886; GO:0006865; GO:0015171; GO:1905039
2890,Pocillopora_acuta_HIv2___RNAseq.g11573.t2,212.8937616,-0.359360384,1.088367453,0.003208619,0.016058638,,E1C2Z0,1.69E-131,Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like),chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297],GO:0000724; GO:0003697; GO:0006325; GO:0031297; GO:0043596; GO:0090734
2891,Pocillopora_acuta_HIv2___RNAseq.g21482.t1,100.169709,-0.608121311,1.244506202,0.003210851,0.016064249,,M9NDE3,6.25E-37,Protein bark beetle (Protein anakonda),"cell-cell junction maintenance [GO:0045217]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]",GO:0005912; GO:0005918; GO:0016020; GO:0016328; GO:0030246; GO:0034976; GO:0035002; GO:0035159; GO:0045217; GO:0061689; GO:1904274
2892,Pocillopora_acuta_HIv2___RNAseq.g3520.t1,293.3505254,-0.686887116,1.232528117,0.003216085,0.016084875,,Q6DIV6,3.49E-80,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800
2893,Pocillopora_acuta_HIv2___TS.g19498.t1,44.15146303,-0.527168518,1.194972579,0.003229191,0.01614484,Piezo-type mechanosensitive ion channel,Q9H5I5,1.21E-39,Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B),cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; monoatomic cation transport [GO:0006812]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612],GO:0005261; GO:0005886; GO:0006812; GO:0008381; GO:0009612; GO:0032420; GO:0032437; GO:0032809; GO:0042391; GO:0050974; GO:0050982; GO:0071260; GO:0140135
2894,Pocillopora_acuta_HIv2___RNAseq.g13459.t1,134.7935882,-0.572728351,1.205109013,0.003231612,0.016151362,,Q3THF9,8.11E-75,"Coenzyme Q-binding protein COQ10 homolog B, mitochondrial",cellular respiration [GO:0045333],GO:0005739; GO:0005743; GO:0045333; GO:0048039
2895,Pocillopora_acuta_HIv2___TS.g6518.t1,277.043664,1.367445726,2.024900271,0.003232775,0.01615159,,NA,NA,NA,NA,NA
2896,Pocillopora_acuta_HIv2___RNAseq.g21479.t1,86.70289718,1.492666978,2.127945866,0.003235093,0.01615759,,P24821,8.17E-40,Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C),bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611],GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966
2897,Pocillopora_acuta_HIv2___RNAseq.g9253.t1,161.3040645,2.275898334,1.764447887,0.003236568,0.01615938,,Q64487,8.98E-10,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560
2898,Pocillopora_acuta_HIv2___RNAseq.g8443.t1,118.5524283,-1.341113406,1.880325432,0.003252394,0.016231904,,Q24133,1.59E-86,DnaJ protein homolog 1 (DROJ1),chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408],GO:0005829; GO:0006457; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0140297
2899,Pocillopora_acuta_HIv2___RNAseq.g25798.t1,502.4902446,-1.739641273,1.586243343,0.003253339,0.016231904,,P76482,1.58E-10,Uncharacterized protein YfbL,proteolysis [GO:0006508],GO:0006508; GO:0008235; GO:0016020
2900,Pocillopora_acuta_HIv2___RNAseq.g7781.t1,61.24474749,-0.295849175,1.064069557,0.003257302,0.016246076,,B5XGE7,3.99E-72,Trafficking protein particle complex subunit 2-like protein,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],GO:0005634; GO:0005783; GO:0005794; GO:0006888; GO:0030008; GO:0048471
2901,Pocillopora_acuta_HIv2___RNAseq.g16639.t1,44.54179127,-0.815317739,1.485359318,0.00326069,0.016257366,,NA,NA,NA,NA,NA
2902,Pocillopora_acuta_HIv2___RNAseq.g31305.t1,493.2768196,-0.793924134,1.32820489,0.003264182,0.016269169,,Q5SPW0,0,Vacuolar protein sorting-associated protein 54 (Tumor antigen SLP-8p homolog),"apoptotic DNA fragmentation [GO:0006309]; astrocyte differentiation [GO:0048708]; cellular response to progesterone stimulus [GO:0071393]; gene expression [GO:0010467]; Golgi to vacuole transport [GO:0006896]; homeostasis of number of cells [GO:0048872]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; intracellular calcium ion homeostasis [GO:0006874]; L-glutamate import [GO:0051938]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lysosomal transport [GO:0007041]; microglia differentiation [GO:0014004]; mitochondrion organization [GO:0007005]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; musculoskeletal movement [GO:0050881]; negative regulation of motor neuron apoptotic process [GO:2000672]; neural tissue regeneration [GO:0097719]; neurofilament cytoskeleton organization [GO:0060052]; neuroinflammatory response [GO:0150076]; neuromuscular synaptic transmission [GO:0007274]; neuron apoptotic process [GO:0051402]; neuron projection morphogenesis [GO:0048812]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein targeting to ER [GO:0045047]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; regulation of growth [GO:0040008]; respiratory electron transport chain [GO:0022904]; response to antibiotic [GO:0046677]; response to calcium ion [GO:0051592]; retrograde transport, endosome to Golgi [GO:0042147]; skeletal muscle tissue development [GO:0007519]; skeletal muscle tissue growth [GO:0048630]; spermatid differentiation [GO:0048515]; sphingolipid catabolic process [GO:0030149]; striated muscle contraction [GO:0006941]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; thrombin-activated receptor signaling pathway [GO:0070493]; ubiquitin recycling [GO:0010992]; vacuole organization [GO:0007033]; vesicle-mediated cholesterol transport [GO:0090119]",GO:0000938; GO:0001701; GO:0005654; GO:0005737; GO:0005739; GO:0005802; GO:0005829; GO:0006309; GO:0006622; GO:0006623; GO:0006874; GO:0006896; GO:0006941; GO:0007005; GO:0007033; GO:0007041; GO:0007274; GO:0007519; GO:0008104; GO:0010467; GO:0010992; GO:0014004; GO:0016020; GO:0019905; GO:0022904; GO:0030149; GO:0034394; GO:0035108; GO:0035128; GO:0035249; GO:0040008; GO:0042147; GO:0045047; GO:0045202; GO:0046677; GO:0048471; GO:0048515; GO:0048630; GO:0048708; GO:0048812; GO:0048872; GO:0048873; GO:0050881; GO:0051402; GO:0051592; GO:0051932; GO:0051938; GO:0060052; GO:0060173; GO:0061744; GO:0070493; GO:0071393; GO:0090119; GO:0097049; GO:0097719; GO:0150076; GO:2000672
2903,Pocillopora_acuta_HIv2___RNAseq.g2445.t1,2116.819544,1.932864353,1.029831881,0.00326555,0.016270381,,Q9HCI5,9.11E-15,Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein) (DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen),negative regulation of transcription by RNA polymerase II [GO:0000122],GO:0000122; GO:0005634; GO:0005886; GO:0030425; GO:0045211; GO:0048471
2904,Pocillopora_acuta_HIv2___RNAseq.g15527.t1,321.710751,-1.005695083,1.566103002,0.003274721,0.016310456,,Q5R5U3,2.04E-169,Zinc finger protein 271,,GO:0003677; GO:0005634; GO:0046872
2905,Pocillopora_acuta_HIv2___RNAseq.g4533.t1,319.9191262,-0.881920116,1.45210981,0.003278426,0.016323288,,P09960,0,Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4),leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; peptide catabolic process [GO:0043171]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509],GO:0003723; GO:0004177; GO:0004301; GO:0004463; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0008270; GO:0010043; GO:0019370; GO:0019538; GO:0043171; GO:0043434; GO:0045148; GO:0060509; GO:0070006; GO:0070062; GO:1904724; GO:1904813
2906,Pocillopora_acuta_HIv2___RNAseq.g3636.t1,130.1964356,-0.069904143,1.021445098,0.003287396,0.01636232,Homeobox protein Hox-A3a,Q1KL12,3.18E-27,Homeobox protein Hox-A3a,,GO:0000981; GO:0003677; GO:0005634
2907,Pocillopora_acuta_HIv2___RNAseq.g10697.t1,472.1096081,0.366480643,1.062180726,0.003289331,0.016366319,,Q9H4G4,2.18E-15,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374
2908,Pocillopora_acuta_HIv2___RNAseq.g29942.t1,7120.046923,2.294083157,2.272504745,0.003302362,0.016425502,,NA,NA,NA,NA,NA
2909,Pocillopora_acuta_HIv2___RNAseq.g20783.t2,213.6245775,-0.777980878,1.452212345,0.003312453,0.016470032,,Q96MN2,2.26E-13,"NACHT, LRR and PYD domains-containing protein 4 (Cancer/testis antigen 58) (CT58) (PAAD and NACHT-containing protein 2) (PAN2) (PYRIN and NACHT-containing protein 2) (PYRIN-containing APAF1-like protein 4) (PYPAF4) (Ribonuclease inhibitor 2)",inflammatory response [GO:0006954]; negative regulation of innate immune response [GO:0045824]; regulation of inflammatory response [GO:0050727],GO:0005524; GO:0005737; GO:0005829; GO:0006954; GO:0045824; GO:0050727; GO:0060090
2910,Pocillopora_acuta_HIv2___RNAseq.1286_t,1420.684454,-1.523915007,0.624614914,0.003315188,0.016477967,,Q95108,1.33E-38,"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)",cell redox homeostasis [GO:0045454],GO:0005739; GO:0015035; GO:0045454
2911,Pocillopora_acuta_HIv2___RNAseq.g26791.t2,54.98831839,-0.580648441,1.178627362,0.003319523,0.016493842,,NA,NA,NA,NA,NA
2912,Pocillopora_acuta_HIv2___TS.g2442.t1,908.7922701,0.75455366,1.344423957,0.003328037,0.016530472,,Q5R930,2.01E-56,Methionine-R-sulfoxide reductase B3 (MsrB3) (EC 1.8.4.12) (EC 1.8.4.14),protein repair [GO:0030091]; response to oxidative stress [GO:0006979],GO:0005739; GO:0005783; GO:0006979; GO:0008270; GO:0030091; GO:0033743; GO:0033745
2913,Pocillopora_acuta_HIv2___RNAseq.g19750.t1,187.5260645,-0.131295568,1.01227773,0.003332008,0.016544511,,Q0P5F0,2.49E-32,Lysosomal acid phosphatase (LAP) (EC 3.1.3.2),lysosome organization [GO:0007040],GO:0003993; GO:0005764; GO:0005765; GO:0007040; GO:0043202
2914,Pocillopora_acuta_HIv2___RNAseq.g17193.t1,432.0851937,-1.236475853,1.86034617,0.003337112,0.01656417,,NA,NA,NA,NA,NA
2915,Pocillopora_acuta_HIv2___TS.g13540.t1,58.04966854,-0.924009155,1.524034315,0.003340078,0.016573202,,NA,NA,NA,NA,NA
2916,Pocillopora_acuta_HIv2___RNAseq.g16108.t1,274.87651,-1.149207609,1.751214181,0.003343691,0.016585441,,Q9DG67,0,DNA repair and recombination protein RAD54B (EC 3.6.4.-) (RAD54 homolog B),double-strand break repair via homologous recombination [GO:0000724]; reciprocal meiotic recombination [GO:0007131],GO:0000724; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0015616; GO:0016787; GO:0140658
2917,Pocillopora_acuta_HIv2___RNAseq.g30425.t2,973.4708365,-1.562124244,2.264624051,0.003346035,0.016591376,,Q5TZA2,0,Rootletin (Ciliary rootlet coiled-coil protein),cellular homeostasis [GO:0019725]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of localization in cell [GO:0051649]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365],GO:0001917; GO:0003779; GO:0005198; GO:0005200; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019725; GO:0019894; GO:0032053; GO:0033365; GO:0035253; GO:0045494; GO:0045724; GO:0051649; GO:0051656; GO:0070062; GO:0097729; GO:0120219; GO:1903566
2918,Pocillopora_acuta_HIv2___RNAseq.g30739.t1,315.6014013,-0.416358554,1.06924212,0.003361369,0.016661698,,NA,NA,NA,NA,NA
2919,Pocillopora_acuta_HIv2___TS.g19199.t1,90.65263506,-0.956879116,1.786486813,0.00336491,0.016673539,,NA,NA,NA,NA,NA
2920,Pocillopora_acuta_HIv2___RNAseq.g25239.t1,87.03229018,-0.280357615,1.050882322,0.00337017,0.016693885,,Q3U1C6,2.90E-109,Putative deoxyribonuclease TATDN3 (EC 3.1.21.-),,GO:0004518; GO:0005634; GO:0005739; GO:0046872
2921,Pocillopora_acuta_HIv2___RNAseq.g9540.t1,567.0471049,-0.700121059,1.286505613,0.003372567,0.01670004,,Q505F5,3.69E-94,Leucine-rich repeat-containing protein 47,phenylalanyl-tRNA aminoacylation [GO:0006432],GO:0003723; GO:0004826; GO:0006432
2922,Pocillopora_acuta_HIv2___RNAseq.g21788.t1,55.40211517,-0.250371981,1.033650154,0.003376139,0.016712003,,NA,NA,NA,NA,NA
2923,Pocillopora_acuta_HIv2___RNAseq.g17217.t1,833.1572478,-1.015445999,1.520951258,0.003377794,0.016714477,,NA,NA,NA,NA,NA
2924,Pocillopora_acuta_HIv2___RNAseq.g25038.t1,453.4486926,1.45287707,2.11454281,0.003385288,0.016745831,,NA,NA,NA,NA,NA
2925,Pocillopora_acuta_HIv2___RNAseq.g11932.t1,608.6988965,-1.43477791,1.957374761,0.003392514,0.016775835,,Q5I0D1,1.73E-148,Glyoxalase domain-containing protein 4,,GO:0005739
2926,Pocillopora_acuta_HIv2___RNAseq.g23618.t1,134.3798153,-2.325204281,1.881976771,0.003395326,0.016784003,,NA,NA,NA,NA,NA
2927,Pocillopora_acuta_HIv2___RNAseq.11061_t,102.2362864,-0.510617827,1.196918557,0.003401199,0.016807293,,Q9LQV2,1.80E-133,RNA-dependent RNA polymerase 1 (AtRDRP1) (EC 2.7.7.48) (RNA-directed RNA polymerase 1),defense response [GO:0006952]; positive regulation of post-transcriptional gene silencing [GO:0060148]; response to salicylic acid [GO:0009751]; response to virus [GO:0009615]; siRNA processing [GO:0030422]; wax biosynthetic process [GO:0010025],GO:0003723; GO:0003968; GO:0006952; GO:0009615; GO:0009751; GO:0010025; GO:0030422; GO:0060148
2928,Pocillopora_acuta_HIv2___RNAseq.g8028.t1,675.2094826,0.762132697,1.435557935,0.003406169,0.016826103,,NA,NA,NA,NA,NA
2929,Pocillopora_acuta_HIv2___TS.g5148.t1,1566.534219,-1.41767623,1.942541916,0.003420795,0.016892583,,P52209,0,"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)","D-gluconate catabolic process [GO:0046177]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]",GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0046177; GO:0050661; GO:0070062
2930,Pocillopora_acuta_HIv2___TS.g23962.t1,316.3652154,-1.789076492,0.844609558,0.003423459,0.016899422,,NA,NA,NA,NA,NA
2931,Pocillopora_acuta_HIv2___TS.g21138.t3,167.4125063,0.981098959,1.793238477,0.003424516,0.016899422,,Q07130,1.17E-90,UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase),glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011],GO:0003983; GO:0005737; GO:0005977; GO:0005978; GO:0006011; GO:0046872
2932,Pocillopora_acuta_HIv2___RNAseq.g8746.t1,111.3819418,-0.253005793,1.041164568,0.003430479,0.016923072,,NA,NA,NA,NA,NA
2933,Pocillopora_acuta_HIv2___RNAseq.g18344.t1,159.5078558,-0.302043982,1.067583166,0.003443309,0.016980574,,NA,NA,NA,NA,NA
2934,Pocillopora_acuta_HIv2___RNAseq.g3318.t1,19.43526306,-0.628725692,1.286470935,0.003447644,0.016992792,,B8V7S0,4.29E-72,CUB and peptidase domain-containing protein 1,acrosome reaction [GO:0007340]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007340
2935,Pocillopora_acuta_HIv2___RNAseq.g20774.t1,197.140174,-1.986637073,1.249332602,0.003448136,0.016992792,,A1R8N8,8.97E-12,D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase),mycothiol biosynthetic process [GO:0010125],GO:0000287; GO:0008375; GO:0010125; GO:0102710
2936,Pocillopora_acuta_HIv2___RNAseq.g11673.t1,4278.690444,-1.645434688,0.722960878,0.003464936,0.017069767,,P70030,1.80E-91,"POU domain, class 3, transcription factor 2-B (Transcription factor POU3-B) (XlPOU3B)",brain development [GO:0007420],GO:0000981; GO:0003677; GO:0005634; GO:0007420
2937,Pocillopora_acuta_HIv2___TS.g18617.t1,133.2197162,-0.203261914,1.03450362,0.003466571,0.017072008,,NA,NA,NA,NA,NA
2938,Pocillopora_acuta_HIv2___RNAseq.g14970.t1,75.27782466,-0.380960058,1.094347028,0.003468288,0.017074649,,F1QMY1,1.80E-20,Dynein light chain Tctex-type protein 2B (Tctex1 domain-containing protein 2),intraciliary retrograde transport [GO:0035721]; microtubule-based movement [GO:0007018],GO:0005737; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0045505; GO:0120293
2939,Pocillopora_acuta_HIv2___RNAseq.g17560.t1,109.1315289,-0.236511374,1.052203781,0.00347089,0.017081645,,NA,NA,NA,NA,NA
2940,Pocillopora_acuta_HIv2___RNAseq.g17242.t1,281.1215552,-1.009593037,1.543374388,0.003479107,0.017116259,,NA,NA,NA,NA,NA
2941,Pocillopora_acuta_HIv2___RNAseq.g30727.t1,48.92835078,-0.537252499,1.220421855,0.00349702,0.017192819,,Q8VI24,5.21E-11,DNA-binding protein SATB2 (Special AT-rich sequence-binding protein 2),cartilage development [GO:0051216]; chromatin remodeling [GO:0006338]; embryonic pattern specification [GO:0009880]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021],GO:0000118; GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001764; GO:0002076; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006338; GO:0006357; GO:0009880; GO:0010468; GO:0016363; GO:0042826; GO:0043565; GO:0045944; GO:0048704; GO:0051216; GO:0060021
2942,Pocillopora_acuta_HIv2___RNAseq.g7055.t1,1701.150685,0.534058874,1.197547589,0.003497046,0.017192819,,Q9UKP4,0,A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) (COMPase),cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in protein catabolic process [GO:0051603],GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773
2943,Pocillopora_acuta_HIv2___RNAseq.g24660.t1,1374.351715,-1.153127073,1.722641748,0.00350249,0.017213734,,Q5XIL0,1.81E-09,E3 ubiquitin-protein ligase RNF167 (EC 2.3.2.27) (RING finger protein 167),"cellular response to leucine starvation [GO:1990253]; lysosome localization [GO:0032418]; negative regulation of cell cycle [GO:0045786]; negative regulation of TORC1 signaling [GO:1904262]; organelle localization [GO:0051640]; positive regulation of TORC1 signaling [GO:1904263]; protein K29-linked ubiquitination [GO:0035519]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of synaptic transmission, glutamatergic [GO:0051966]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0000209; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006511; GO:0008270; GO:0032418; GO:0035519; GO:0036020; GO:0045786; GO:0051640; GO:0051966; GO:0061630; GO:0070534; GO:1904262; GO:1904263; GO:1990253
2944,Pocillopora_acuta_HIv2___RNAseq.g279.t1,378.1523488,0.594189353,1.229849495,0.003511536,0.017252329,,Q7SYB2,6.74E-06,THO complex subunit 1,apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]; signal transduction [GO:0007165],GO:0000445; GO:0003677; GO:0003723; GO:0005654; GO:0005829; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0042981
2945,Pocillopora_acuta_HIv2___RNAseq.g17275.t1,67.80118827,-0.170784402,1.025817241,0.003515251,0.017264719,,Q0VGW4,1.70E-105,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (FXNA-like protease),proteolysis [GO:0006508],GO:0005789; GO:0006508; GO:0008235; GO:0046872
2946,Pocillopora_acuta_HIv2___RNAseq.g6737.t1,2988.27371,1.614081084,0.695738125,0.003527682,0.017319889,,P41969,3.10E-30,ETS domain-containing protein Elk-1,cellular response to gamma radiation [GO:0071480]; cellular response to lipid [GO:0071396]; cellular response to testosterone stimulus [GO:0071394]; gene expression [GO:0010467]; hippocampal neuron apoptotic process [GO:0110088]; liver development [GO:0001889]; lung development [GO:0030324]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to light stimulus [GO:0009416],GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0009416; GO:0010467; GO:0030324; GO:0030374; GO:0030425; GO:0031966; GO:0043025; GO:0043679; GO:0045471; GO:0045893; GO:0045944; GO:0061629; GO:0071394; GO:0071396; GO:0071480; GO:0071774; GO:0110088
2947,Pocillopora_acuta_HIv2___RNAseq.g17898.t1,385.4426982,-0.27879873,1.036417288,0.003530988,0.017330236,,Q3UJP5,1.86E-46,Cilia- and flagella-associated protein 418,photoreceptor cell morphogenesis [GO:0008594],GO:0001917; GO:0005737; GO:0005829; GO:0008594
2948,Pocillopora_acuta_HIv2___RNAseq.g110.t1,751.282739,-0.786165522,1.367496139,0.003533523,0.017336795,,Q55E58,1.18E-21,Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1),cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856],GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310
2949,Pocillopora_acuta_HIv2___RNAseq.g2258.t1,1914.015037,-1.683267846,1.583866675,0.00354259,0.01737539,Arginine kinase,O15992,0,Arginine kinase (AK) (EC 2.7.3.3),phosphocreatine biosynthetic process [GO:0046314],GO:0004054; GO:0004111; GO:0005524; GO:0046314
2950,Pocillopora_acuta_HIv2___RNAseq.g14417.t1,293.9730793,1.831967791,1.721902548,0.003559343,0.017451638,,NA,NA,NA,NA,NA
2951,Pocillopora_acuta_HIv2___RNAseq.g4211.t1,205.3932835,-0.138955378,1.018656966,0.003563082,0.017464051,,Q8VCK5,3.54E-124,Kelch-like protein 20 (Kelch-like ECT2-interacting protein),Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390
2952,Pocillopora_acuta_HIv2___TS.g21857.t1,165.6227423,-1.953449219,1.150836345,0.003573999,0.017511627,,Q7Z443,2.58E-49,Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3),cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; sensory perception of sour taste [GO:0050915],GO:0001581; GO:0005262; GO:0005886; GO:0006812; GO:0016020; GO:0030246; GO:0034703; GO:0043235; GO:0050915; GO:0050982; GO:0070062; GO:0071468
2953,Pocillopora_acuta_HIv2___TS.g5718.t2,68.58349202,-0.323095818,1.079253369,0.003584969,0.017559426,,P0CF65,3.90E-10,Protein cereblon,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005634; GO:0005737; GO:0016567; GO:0031464; GO:0043161; GO:0046872
2954,Pocillopora_acuta_HIv2___RNAseq.g25971.t1,356.6160303,-1.003739505,1.599951499,0.003604926,0.017647909,,NA,NA,NA,NA,NA
2955,Pocillopora_acuta_HIv2___RNAseq.g5327.t1,231.1766442,-0.159360827,1.019324463,0.003605474,0.017647909,,D3ZDK2,1.04E-42,Ubiquitin-conjugating enzyme E2 D1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D1) (Ubiquitin carrier protein D1) (Ubiquitin-conjugating enzyme E2(17)KB 1) (Ubiquitin-conjugating enzyme E2-17 kDa 1) (Ubiquitin-protein ligase D1),negative regulation of TORC1 signaling [GO:1904262]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0031398; GO:0031625; GO:0032991; GO:0043161; GO:0061630; GO:0061631; GO:0070936; GO:1902916; GO:1904262
2956,Pocillopora_acuta_HIv2___RNAseq.g8599.t1c,175.5327851,-0.612423076,1.23566581,0.003608526,0.017656875,,F1M3J4,2.73E-07,ATP-binding cassette subfamily C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4),bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747],GO:0001409; GO:0005524; GO:0005886; GO:0008559; GO:0009410; GO:0014070; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:1904772
2957,Pocillopora_acuta_HIv2___TS.g26429.t1,534.2345094,-2.016133431,1.757064346,0.003617442,0.017694516,,NA,NA,NA,NA,NA
2958,Pocillopora_acuta_HIv2___RNAseq.g16274.t1,2066.545477,0.932897411,1.513104644,0.003623825,0.017719743,,Q21313,0,Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1),animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; reproductive process [GO:0022414]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888],GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0022414; GO:0040017; GO:0042127; GO:0051788; GO:0071711
2959,Pocillopora_acuta_HIv2___RNAseq.g25874.t1,16.87116222,1.642318557,4.381772386,0.003631691,0.017752206,,Q9UR07,5.10E-30,Transposon Tf2-11 polyprotein (Retrotransposable element Tf2 155 kDa protein),DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508],GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0006508; GO:0015074; GO:0046872
2960,Pocillopora_acuta_HIv2___RNAseq.g17416.t1,5807.49047,1.736605904,0.803840359,0.003634482,0.017759846,,Q8CAL5,1.62E-40,Glypican-5 [Cleaved into: Secreted glypican-5],cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475],GO:0005576; GO:0005796; GO:0005886; GO:0009986; GO:0016477; GO:0062023; GO:0090263; GO:0098552; GO:1905475
2961,Pocillopora_acuta_HIv2___RNAseq.g4582.t1,115.5746738,-0.327949953,1.041525509,0.003646568,0.017810522,,NA,NA,NA,NA,NA
2962,Pocillopora_acuta_HIv2___RNAseq.g12614.t2,522.3359707,-1.480251143,1.949240079,0.003647315,0.017810522,,A2AL36,3.89E-109,Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110),aorta development [GO:0035904]; axoneme assembly [GO:0035082]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; female germ-line stem cell asymmetric division [GO:0048132]; kidney development [GO:0001822]; ventricular septum development [GO:0003281],GO:0001822; GO:0003279; GO:0003281; GO:0005813; GO:0005829; GO:0005930; GO:0034451; GO:0035082; GO:0035904; GO:0048132; GO:0048471; GO:0060976; GO:0070840; GO:0072687; GO:0090543; GO:0090619; GO:0097431; GO:0120103
2963,Pocillopora_acuta_HIv2___RNAseq.g7952.t1,422.7175108,-0.475219671,1.112462265,0.0036488,0.017811761,,O35218,0,Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit),mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398],GO:0003723; GO:0005847; GO:0006398; GO:0098794; GO:0098978
2964,Pocillopora_acuta_HIv2___RNAseq.g28252.t1,5381.46974,2.291641697,1.953997652,0.003671182,0.01791497,Solute carrier family 6 member 1,P30531,0,Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1),"amino acid transport [GO:0006865]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; inorganic anion import across plasma membrane [GO:0098658]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]",GO:0005332; GO:0005886; GO:0006865; GO:0007268; GO:0007613; GO:0008306; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0015185; GO:0015378; GO:0016020; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051936; GO:0051939; GO:0098658; GO:0098719; GO:0098982; GO:0150104; GO:1902476
2965,Pocillopora_acuta_HIv2___TS.g17088.t1,149.0820603,-0.048819245,1.017590372,0.003676188,0.01793335,,A6RMZ2,5.46E-09,ATP-dependent rRNA helicase spb4 (EC 3.6.4.13),assembly of large subunit precursor of preribosome [GO:1902626]; maturation of LSU-rRNA [GO:0000470],GO:0000470; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0016887; GO:0030686; GO:0030687; GO:1902626
2966,Pocillopora_acuta_HIv2___TS.g24593.t1,608.6250355,-0.877226361,1.461987772,0.003686929,0.017979683,,B4F6W9,0,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0008270; GO:0033696; GO:0045995; GO:0061630; GO:0140861
2967,Pocillopora_acuta_HIv2___RNAseq.g25739.t1,677.434319,2.037775554,1.929277492,0.003692768,0.01800209,,P52800,2.26E-12,Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L),adherens junction organization [GO:0034332]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; keratinocyte proliferation [GO:0043616]; lymph vessel development [GO:0001945]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron projection development [GO:0010977]; nephric duct morphogenesis [GO:0072178]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; presynapse assembly [GO:0099054]; regulation of chemotaxis [GO:0050920]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; T cell costimulation [GO:0031295]; venous blood vessel morphogenesis [GO:0048845],GO:0001945; GO:0002042; GO:0005102; GO:0005886; GO:0005912; GO:0007155; GO:0007411; GO:0008284; GO:0009887; GO:0010839; GO:0010977; GO:0030425; GO:0031295; GO:0034332; GO:0042734; GO:0043616; GO:0046875; GO:0048013; GO:0048514; GO:0048845; GO:0050920; GO:0072178; GO:0098685; GO:0098839; GO:0098978; GO:0099054; GO:0099072; GO:0099149; GO:1903849; GO:2000727
2968,Pocillopora_acuta_HIv2___RNAseq.g30616.t1,68.41595835,-0.376038278,1.060988233,0.00369506,0.018007192,,Q99PL5,6.39E-06,Ribosome-binding protein 1 (Ribosome receptor protein) (RRp) (mRRp),protein transport [GO:0015031]; signal transduction [GO:0007165],GO:0005789; GO:0007165; GO:0015031
2969,Pocillopora_acuta_HIv2___RNAseq.g5279.t1,280.9411362,2.183703885,1.073489524,0.003715148,0.018098989,,NA,NA,NA,NA,NA
2970,Pocillopora_acuta_HIv2___TS.g10039.t1,58.23032023,-0.489059906,1.176698846,0.00373074,0.018168827,,V6CLA2,7.09E-11,E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26),determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028],GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936
2971,Pocillopora_acuta_HIv2___RNAseq.g12092.t1,313.2824011,-0.705969897,1.342230843,0.003738692,0.018201427,,Q5ZKE7,1.28E-82,UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK),'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225],GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006225; GO:0033862; GO:0036430; GO:0036431; GO:0046705
2972,Pocillopora_acuta_HIv2___RNAseq.g30836.t1,893.5126117,-1.094466364,1.739367268,0.003747016,0.018235814,,Q9QWN8,9.69E-61,"Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)",actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cellular response to ethanol [GO:0071361]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of postsynaptic specialization assembly [GO:0099150]; synapse assembly [GO:0007416]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192],GO:0000139; GO:0005200; GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007416; GO:0008021; GO:0008091; GO:0016079; GO:0016081; GO:0016192; GO:0016324; GO:0016363; GO:0017158; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0048471; GO:0051015; GO:0051693; GO:0071361; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099150; GO:0099173; GO:0099186; GO:0099189
2973,Pocillopora_acuta_HIv2___RNAseq.g942.t1,2094.469038,1.181265011,1.916679207,0.003753832,0.018262839,Homeobox protein Nkx-2.2a,Q90481,1.26E-37,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893
2974,Pocillopora_acuta_HIv2___RNAseq.g17071.t1,6072.974039,1.501171094,0.621760029,0.003756129,0.01826787,,NA,NA,NA,NA,NA
2975,Pocillopora_acuta_HIv2___RNAseq.g27566.t1,2397.190262,1.880592414,1.019008666,0.003811674,0.018531783,Hephaestin-like protein,B3EWZ9,0,Hephaestin-like protein (EC 1.-.-.-),copper ion transport [GO:0006825],GO:0005507; GO:0005576; GO:0006825; GO:0016020; GO:0016491
2976,Pocillopora_acuta_HIv2___TS.g9271.t1,348.035712,1.376354315,1.965489917,0.003815953,0.018546352,,NA,NA,NA,NA,NA
2977,Pocillopora_acuta_HIv2___TS.g23869.t1,114.4764514,-1.068934342,1.666874547,0.003820252,0.018560218,,Q4UMH6,9.68E-57,Putative ankyrin repeat protein RF_0381,guanosine tetraphosphate metabolic process [GO:0015969],GO:0015969
2978,Pocillopora_acuta_HIv2___TS.g1918.t1,1647.601877,1.616670167,0.708313873,0.003821372,0.018560218,,P53199,5.91E-08,"Sterol-4-alpha-carboxylate 3-dehydrogenase ERG26, decarboxylating (EC 1.1.1.170) (C-3 sterol dehydrogenase ERG26) (C-4 decarboxylase ERG26) (Ergosterol biosynthetic protein 26)",ergosterol biosynthetic process [GO:0006696],GO:0000252; GO:0005783; GO:0005789; GO:0006696; GO:0047012; GO:0103066; GO:0103067
2979,Pocillopora_acuta_HIv2___RNAseq.g16181.t1,229.8150179,-0.307360663,1.049212582,0.003823012,0.018561949,,Q8BZI6,2.27E-54,Protein GUCD1 (Guanylyl cyclase domain-containing protein 1) (Protein LLN4),,
2980,Pocillopora_acuta_HIv2___RNAseq.g17093.t1,549.0524577,-1.912666265,1.115780465,0.003833988,0.018608995,,Q9H706,2.63E-09,GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1),cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],GO:0005886; GO:0007173; GO:0008284; GO:0051781; GO:0070064; GO:0070374; GO:0071364
2981,Pocillopora_acuta_HIv2___RNAseq.g31383.t1,305.3690152,-1.939631388,1.237503439,0.003839221,0.018628144,,Q9SY73,4.23E-66,NADPH-dependent pterin aldehyde reductase (EC 1.1.1.-),folic acid-containing compound metabolic process [GO:0006760],GO:0005829; GO:0006760; GO:0016616
2982,Pocillopora_acuta_HIv2___TS.g31645.t1,105.3235583,-0.282347588,1.061485865,0.003851117,0.018679597,,Q9D0P0,5.58E-78,Emopamil-binding protein-like (Emopamil-binding-related protein),sterol metabolic process [GO:0016125],GO:0005783; GO:0005789; GO:0016125; GO:0047750
2983,Pocillopora_acuta_HIv2___RNAseq.g3702.t1,406.5429823,-0.880941274,1.447026884,0.00385957,0.018714321,,A0A481NSZ4,2.25E-23,Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP),defense response to bacterium [GO:0042742]; innate immune response [GO:0045087],GO:0005615; GO:0008289; GO:0042742; GO:0045087
2984,Pocillopora_acuta_HIv2___RNAseq.g27717.t1,111.6722279,-0.427206724,1.127418197,0.003863967,0.018729362,,Q96DM1,1.63E-70,PiggyBac transposable element-derived protein 4,,
2985,Pocillopora_acuta_HIv2___RNAseq.g18380.t1,396.6319731,2.568075016,1.772482005,0.003879039,0.018796123,,NA,NA,NA,NA,NA
2986,Pocillopora_acuta_HIv2___RNAseq.1687_t,95.95991472,-0.157338237,1.020542481,0.003890401,0.018844862,,P55006,9.29E-72,Retinol dehydrogenase 7 (EC 1.1.1.105) (Retinol dehydrogenase 3) (Retinol dehydrogenase type III) (RODH III),retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],GO:0004745; GO:0005783; GO:0008202; GO:0042572; GO:0043231
2987,Pocillopora_acuta_HIv2___RNAseq.g19800.t1,83.13050055,-1.102713792,1.856632067,0.003895609,0.018863774,,Q96AY4,1.89E-49,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301
2988,Pocillopora_acuta_HIv2___RNAseq.g25943.t1,354.901153,0.289357668,1.051913378,0.00389734,0.018865353,,Q9H694,0,Protein bicaudal C homolog 1 (Bic-C),determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of canonical Wnt signaling pathway [GO:0090090],GO:0001822; GO:0003723; GO:0005737; GO:0007368; GO:0007507; GO:0090090
2989,Pocillopora_acuta_HIv2___TS.g11492.t1a,118.6419281,-0.136978393,1.020180008,0.003898544,0.018865353,,O70340,2.78E-23,Neuronal pentraxin-2 (NP2) (Neuronal pentraxin II) (NP-II),associative learning [GO:0008306]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645],GO:0008306; GO:0030246; GO:0043083; GO:0045202; GO:0046872; GO:0098793; GO:0098892; GO:0098978; GO:0099645
2990,Pocillopora_acuta_HIv2___RNAseq.g11533.t2c,63.9602247,-1.145389191,2.34811425,0.003905429,0.018892351,,Q505D9,8.52E-16,Tripartite motif-containing protein 67,negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060],GO:0005737; GO:0005856; GO:0008270; GO:0010976; GO:0046580; GO:2000060
2991,Pocillopora_acuta_HIv2___RNAseq.g15342.t1,243.7135536,-0.657633532,1.284128786,0.003907433,0.018894041,,P41224,1.91E-11,Thyrotroph embryonic factor,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511],GO:0000978; GO:0000981; GO:0001228; GO:0003690; GO:0005634; GO:0006357; GO:0042802; GO:0043565; GO:0044877; GO:0045944; GO:0048511; GO:1990837
2992,Pocillopora_acuta_HIv2___RNAseq.g12347.t1,220.7650629,-1.999794992,1.601955006,0.003908391,0.018894041,,P53349,1.16E-128,Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1),apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of actin filament bundle assembly [GO:0032232]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein polyubiquitination [GO:0000209]; regulation of cell migration [GO:0030334]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]; wound healing [GO:0042060],GO:0000165; GO:0000209; GO:0002011; GO:0003382; GO:0004672; GO:0004674; GO:0004706; GO:0004708; GO:0004709; GO:0004842; GO:0005524; GO:0005737; GO:0005829; GO:0006511; GO:0007179; GO:0007254; GO:0008092; GO:0008270; GO:0008432; GO:0008637; GO:0030054; GO:0030334; GO:0030838; GO:0031434; GO:0031941; GO:0032232; GO:0042060; GO:0043010; GO:0043065; GO:0043410; GO:0043507; GO:0044877; GO:0045893; GO:0045944; GO:0046330; GO:0046625; GO:0050434; GO:0051019; GO:0061029; GO:0090263; GO:0106310
2993,Pocillopora_acuta_HIv2___RNAseq.g5760.t1,272.8286064,-0.254526952,1.050121779,0.003919414,0.018940996,TRP C5,Q9QX29,4.45E-58,Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5),calcium ion transmembrane transport [GO:0070588]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630],GO:0003779; GO:0005886; GO:0007204; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:0098793; GO:1902630
2994,Pocillopora_acuta_HIv2___RNAseq.g28795.t1,11904.62985,1.913863019,1.133955898,0.003921586,0.018945164,,NA,NA,NA,NA,NA
2995,Pocillopora_acuta_HIv2___RNAseq.g22898.t1,803.3800397,-0.711378163,1.247976801,0.003936187,0.01900935,,Q5F364,0,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908],GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729
2996,Pocillopora_acuta_HIv2___RNAseq.g7884.t1,65.69597906,-0.299817874,1.079951726,0.003941074,0.019026599,,NA,NA,NA,NA,NA
2997,Pocillopora_acuta_HIv2___RNAseq.g9726.t1,96.63906512,-0.688191424,1.369445577,0.003943635,0.019032613,,NA,NA,NA,NA,NA
2998,Pocillopora_acuta_HIv2___TS.g24153.t1,229.3747195,-1.04838549,1.618730955,0.003946781,0.019032711,,NA,NA,NA,NA,NA
2999,Pocillopora_acuta_HIv2___TS.g6970.t3,196.1997077,-0.265512994,1.055981072,0.003947181,0.019032711,,Q8IUR5,0,Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 1) (Transmembrane and tetratricopeptide repeat-containing 1),protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396],GO:0000030; GO:0004169; GO:0005783; GO:0006396; GO:0016020; GO:0035269
3000,Pocillopora_acuta_HIv2___RNAseq.g15849.t1,142.7167624,-0.100251747,1.013936712,0.003947603,0.019032711,,NA,NA,NA,NA,NA
3001,Pocillopora_acuta_HIv2___TS.g7845.t1,624.3952495,1.804566992,0.946421071,0.00398246,0.019194368,,NA,NA,NA,NA,NA
3002,Pocillopora_acuta_HIv2___RNAseq.g26855.t1,148.0898292,-0.290212569,1.064080611,0.003988181,0.019215538,,Q9Y6A2,1.02E-97,Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1),bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805],GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044
3003,Pocillopora_acuta_HIv2___TS.g27082.t3c,151.6796886,-0.473936433,1.106143352,0.00399397,0.019237023,,Q6GQV0,7.88E-07,Tubulin epsilon and delta complex protein 2,positive regulation of smoothened signaling pathway [GO:0045880],GO:0005737; GO:0005814; GO:0005929; GO:0045880
3004,Pocillopora_acuta_HIv2___RNAseq.g896.t1,96.40405261,-0.271502975,1.034153013,0.003999281,0.019256192,,NA,NA,NA,NA,NA
3005,Pocillopora_acuta_HIv2___TS.g31606.t1,76.1679292,-0.28018351,1.0377749,0.004012847,0.01931508,,O35474,1.13E-11,EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1),cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811],GO:0005509; GO:0005576; GO:0007155; GO:0010811
3006,Pocillopora_acuta_HIv2___RNAseq.g15356.t1,646.1872576,-0.4299156,1.10153274,0.004021937,0.019352393,,C0HL13,0,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005886; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167
3007,Pocillopora_acuta_HIv2___TS.g12846.t1,763.4072219,1.50561251,2.039620288,0.004051154,0.019486495,,Q9JMH4,7.32E-06,Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog],extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581],GO:0005581; GO:0005604; GO:0005615; GO:0016020; GO:0030020; GO:0030056; GO:0030198; GO:0031581
3008,Pocillopora_acuta_HIv2___RNAseq.g25513.t1,53.97623658,-0.740238189,1.301683943,0.004059468,0.019512904,,NA,NA,NA,NA,NA
3009,Pocillopora_acuta_HIv2___RNAseq.g23634.t1,3369.653926,-2.167353269,1.874338688,0.004059802,0.019512904,,C3ZAH2,1.28E-88,Acireductone dioxygenase (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD') (Fe-ARD) (EC 1.13.11.54) (Acireductone dioxygenase (Ni(2+)-requiring)) (ARD) (Ni-ARD) (EC 1.13.11.53),L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555],GO:0005506; GO:0005634; GO:0005737; GO:0006555; GO:0010308; GO:0010309; GO:0016151; GO:0019509
3010,Pocillopora_acuta_HIv2___RNAseq.g11410.t1,981.9416584,-1.192980068,1.702340828,0.004060691,0.019512904,,Q6Q759,2.10E-100,Sperm-associated antigen 17 (Projection protein PF6 homolog),axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283],GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953
3011,Pocillopora_acuta_HIv2___TS.g11680.t1,5027.488027,2.267754333,2.145766154,0.004070638,0.019536694,,NA,NA,NA,NA,NA
3012,Pocillopora_acuta_HIv2___RNAseq.g24112.t1,219.4235079,-0.632155821,1.192196642,0.00407068,0.019536694,,Q5F3G0,4.08E-43,Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19),regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],GO:0005096; GO:0005737; GO:0007165; GO:0051056
3013,Pocillopora_acuta_HIv2___RNAseq.g21051.t1,99.11221138,-0.376834077,1.096990959,0.004071682,0.019536694,,Q6QNK2,2.26E-72,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607
3014,Pocillopora_acuta_HIv2___RNAseq.g25270.t1,1919.362353,1.425788646,1.9123037,0.004071828,0.019536694,,H9JW44,4.16E-64,Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41),chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0046872
3015,Pocillopora_acuta_HIv2___RNAseq.g30230.t1,669.0393462,-0.987443681,1.57254054,0.004072396,0.019536694,,Q19269,6.50E-55,Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14),proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008270
3016,Pocillopora_acuta_HIv2___RNAseq.g26259.t1,150.0331351,-0.322630972,1.087303602,0.004095759,0.01964226,,A6QPB3,1.56E-07,Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog],extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581],GO:0005581; GO:0005604; GO:0005615; GO:0008201; GO:0016020; GO:0030020; GO:0030056; GO:0030198; GO:0031581; GO:0062023
3017,Pocillopora_acuta_HIv2___RNAseq.g15128.t1,520.5637127,-1.122945198,1.686565158,0.004101949,0.019665424,,P51892,0,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260],GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0046872; GO:0051301; GO:0071897
3018,Pocillopora_acuta_HIv2___RNAseq.g2139.t1,132.2591042,-0.311204966,1.05928841,0.004109176,0.019693548,,Q8C9A2,9.35E-90,Endonuclease V (EC 3.1.26.-),DNA repair [GO:0006281],GO:0000287; GO:0003677; GO:0003727; GO:0005730; GO:0005737; GO:0006281; GO:0010494; GO:0016888; GO:0016891
3019,Pocillopora_acuta_HIv2___RNAseq.g30557.t1,222.0288609,-0.187795926,1.040217925,0.004113462,0.019707558,,Q9BQQ7,1.74E-10,Receptor-transporting protein 3 (3CxxC-type zinc finger protein 3) (Transmembrane protein 7),detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612],GO:0001580; GO:0005737; GO:0006612; GO:0016020; GO:0031849; GO:0046872; GO:0051205
3020,Pocillopora_acuta_HIv2___RNAseq.g4502.t1,264.52405,-1.171206824,1.571558945,0.004121159,0.019734946,,Q66H61,0,Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS),brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stress-activated MAPK cascade [GO:0032873],GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005829; GO:0006425; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234
3021,Pocillopora_acuta_HIv2___RNAseq.g23870.t1,356.2727243,-1.052929885,1.55988524,0.004121908,0.019734946,,Q9VY28,3.89E-33,"Small ribosomal subunit protein mS25 (28S ribosomal protein S25, mitochondrial) (MRP-S25) (S25mt)",mitochondrial translation [GO:0032543],GO:0003735; GO:0005739; GO:0005763; GO:0032543
3022,Pocillopora_acuta_HIv2___RNAseq.g10854.t2,1353.649913,-1.044566386,1.664447367,0.004146953,0.01984829,,Q2KIH7,0,Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase),L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571],GO:0004505; GO:0005506; GO:0006559; GO:0006571
3023,Pocillopora_acuta_HIv2___RNAseq.g20148.t1,300.0801312,-0.523200162,1.203942178,0.004153271,0.01987195,,Q9Y4W2,4.64E-23,Ribosomal biogenesis protein LAS1L (Endoribonuclease LAS1L) (EC 3.1.-.-) (Protein LAS1 homolog),maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364],GO:0000460; GO:0000470; GO:0003723; GO:0004519; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0030687; GO:0071339; GO:0090730
3024,Pocillopora_acuta_HIv2___RNAseq.g27542.t1,191.4015346,-0.53648314,1.217902294,0.004159126,0.019893384,,B2GV77,5.39E-51,NTF2-related export protein 2,poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031],GO:0005634; GO:0005737; GO:0015031; GO:0016973; GO:0042272; GO:0044613; GO:0048471
3025,Pocillopora_acuta_HIv2___RNAseq.g8441.t1,394.7803979,2.532368104,1.751309055,0.004173209,0.019948816,,NA,NA,NA,NA,NA
3026,Pocillopora_acuta_HIv2___RNAseq.g12289.t1,169.1858648,-1.787703483,2.012976632,0.004173473,0.019948816,,P16621,3.70E-13,Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR),axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124],GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386
3027,Pocillopora_acuta_HIv2___RNAseq.g18594.t1,473.7472809,-0.950645647,1.4528954,0.004177401,0.019959224,,Q95K40,3.17E-39,Coiled-coil domain-containing protein 83,,
3028,Pocillopora_acuta_HIv2___RNAseq.g15574.t1,34.16738311,-1.805923163,2.480051855,0.004178411,0.019959224,,P24722,4.44E-50,"Creatine kinase, testis isozyme (EC 2.7.3.2)",phosphocreatine biosynthetic process [GO:0046314],GO:0004111; GO:0005524; GO:0046314
3029,Pocillopora_acuta_HIv2___RNAseq.g30182.t1,412.2140222,-0.559163999,1.159107379,0.004192071,0.020017865,,Q8JI28,1.74E-43,Tolloid-like protein 1 (EC 3.4.24.-) (Metalloprotease xolloid-like) (Xenopus tolloid-like protein 1) (Xlr),cell differentiation [GO:0030154]; proteolysis [GO:0006508],GO:0004222; GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0008270; GO:0030154
3030,Pocillopora_acuta_HIv2___RNAseq.g29821.t1,110.0885727,-0.321861922,1.073746915,0.004207367,0.020084274,,NA,NA,NA,NA,NA
3031,Pocillopora_acuta_HIv2___RNAseq.g22482.t1,240.4416515,-0.062347934,1.020614788,0.004210023,0.020090322,,Q7ZVK4,1.36E-147,Vacuolar protein-sorting-associated protein 36 (ESCRT-II complex subunit VPS36),protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],GO:0000814; GO:0005768; GO:0031902; GO:0032266; GO:0043130; GO:0043328
3032,Pocillopora_acuta_HIv2___RNAseq.g12848.t1,330.8246357,0.708554643,1.238170114,0.004215785,0.020111186,,A2RT67,6.29E-134,DENN domain-containing protein 3,endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; regulation of Rab protein signal transduction [GO:0032483],GO:0005085; GO:0008333; GO:0030163; GO:0031410; GO:0032483
3033,Pocillopora_acuta_HIv2___RNAseq.g25709.t3,975.148066,2.099191032,1.99819003,0.004259009,0.020310685,,NA,NA,NA,NA,NA
3034,Pocillopora_acuta_HIv2___RNAseq.g25665.t1,117.6349577,-1.180004266,1.720105332,0.004279224,0.020400359,,NA,NA,NA,NA,NA
3035,Pocillopora_acuta_HIv2___RNAseq.g12368.t1,208.9507687,-0.472585578,1.129659418,0.004281771,0.020405775,,Q8CID0,8.06E-125,Cysteine-rich protein 2-binding protein (CSRP2-binding protein) (ADA2A-containing complex subunit 2) (ATAC2) (CRP2-binding partner) (CRP2BP) (Lysine acetyltransferase 14),G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043],GO:0000086; GO:0004402; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0090043; GO:0140672
3036,Pocillopora_acuta_HIv2___RNAseq.g8632.t1,65.21081743,-0.587277524,1.265262147,0.004301046,0.020490887,,Q9JHA8,4.17E-69,von Willebrand factor A domain-containing protein 7 (Protein G7c),,GO:0005576
3037,Pocillopora_acuta_HIv2___RNAseq.g4955.t2,727.1311619,1.865664088,1.120594532,0.004306044,0.020507944,,O14841,0,5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase),glutathione metabolic process [GO:0006749],GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802
3038,Pocillopora_acuta_HIv2___TS.g9126.t1,399.8800564,-1.145959941,1.749963361,0.004314968,0.02054368,,Q6DFR2,0,E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B),cell surface receptor signaling pathway [GO:0007166]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583],GO:0001784; GO:0004842; GO:0005509; GO:0005737; GO:0007166; GO:0016567; GO:2000583
3039,Pocillopora_acuta_HIv2___RNAseq.g1833.t1,56.97007433,-0.359493726,1.109737299,0.004316525,0.020544327,,Q29RY7,1.26E-21,Fibroleukin (Fibrinogen-like protein 2),,GO:0005615; GO:0009986; GO:0016504; GO:0062023
3040,Pocillopora_acuta_HIv2___RNAseq.g9585.t2,373.9870465,0.158012802,1.027431007,0.004317984,0.020544515,Homeobox protein goosecoid,P54366,5.77E-29,Homeobox protein goosecoid,negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0042803; GO:0045892; GO:0046982
3041,Pocillopora_acuta_HIv2___TS.g14732.t1,953.1252244,0.801470394,1.384048334,0.004335376,0.020614456,,Q9QY94,0,Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225),angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670],GO:0001525; GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006542; GO:0010594; GO:0018345; GO:0019706; GO:0046872; GO:1903670
3042,Pocillopora_acuta_HIv2___TS.g24038.t1,80.67909159,-0.265213107,1.054805168,0.004335658,0.020614456,,Q7TSA6,6.59E-11,Proline and serine-rich protein 3,,GO:0005737; GO:0005813
3043,Pocillopora_acuta_HIv2___RNAseq.g12045.t1,2823.081971,1.798212624,1.040254652,0.00433696,0.020614456,,Q8IVN8,6.21E-24,Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin),,GO:0005576; GO:0062023
3044,Pocillopora_acuta_HIv2___TS.g23951.t1,112.2661585,-0.479256011,1.155460135,0.004339717,0.020614527,,NA,NA,NA,NA,NA
3045,Pocillopora_acuta_HIv2___RNAseq.g23763.t1,138.3984438,-0.977910191,1.545269412,0.004339825,0.020614527,,G5EFP5,6.16E-44,"Alpha-(1,3)-fucosyltransferase fut-3 (EC 2.4.1.65) (Fucosyltransferase fut-3)",fucosylation [GO:0036065]; protein glycosylation [GO:0006486],GO:0006486; GO:0017060; GO:0032580; GO:0036065
3046,Pocillopora_acuta_HIv2___RNAseq.g848.t1,611.9133368,-1.258742205,1.64928358,0.004346935,0.020641519,,Q5NVP8,2.01E-51,Protein lin-52 homolog,regulation of DNA-templated transcription [GO:0006355],GO:0006355; GO:0070176
3047,Pocillopora_acuta_HIv2___TS.g13017.t1,482.0571901,1.754255168,2.058915168,0.004356041,0.02067797,,Q95LD9,2.80E-43,Aryl hydrocarbon receptor (Ah receptor) (AhR),"cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]",GO:0001094; GO:0001223; GO:0002819; GO:0002841; GO:0004879; GO:0005634; GO:0005737; GO:0005829; GO:0006805; GO:0009410; GO:0009636; GO:0017025; GO:0019933; GO:0030888; GO:0032922; GO:0034753; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837
3048,Pocillopora_acuta_HIv2___RNAseq.g24029.t1,216.4912704,-1.235819758,2.556183739,0.004363236,0.020705331,,H1AFJ5,6.19E-57,Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA),sodium ion transmembrane transport [GO:0035725],GO:0001669; GO:0005737; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725
3049,Pocillopora_acuta_HIv2___RNAseq.g30132.t1,479.0752567,-0.478568002,1.1103905,0.004377725,0.020767271,,Q96NL6,1.32E-84,Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1),cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162],GO:0005813; GO:0005814; GO:0005829; GO:0017080; GO:0030276; GO:0045162; GO:0060271; GO:0071439; GO:0097539
3050,Pocillopora_acuta_HIv2___TS.g27885.t3,171.1037052,0.121839178,1.022283543,0.004391347,0.020825063,,Q05941,1.57E-76,Neuronal acetylcholine receptor subunit alpha-7,"acetylcholine receptor signaling pathway [GO:0095500]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; dopamine biosynthetic process [GO:0042416]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; intracellular calcium ion homeostasis [GO:0006874]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of norepinephrine secretion [GO:0014061]; regulation of response to drug [GO:2001023]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to carbamate [GO:0046681]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]",GO:0001540; GO:0001666; GO:0001933; GO:0001934; GO:0001988; GO:0005216; GO:0005886; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007271; GO:0007611; GO:0007613; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0010628; GO:0014061; GO:0015464; GO:0015643; GO:0016020; GO:0016324; GO:0017081; GO:0019228; GO:0019901; GO:0022848; GO:0030317; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0032094; GO:0032225; GO:0032279; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042416; GO:0042698; GO:0042734; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043410; GO:0044853; GO:0045202; GO:0045211; GO:0045471; GO:0045766; GO:0046681; GO:0048149; GO:0050727; GO:0050728; GO:0050804; GO:0050808; GO:0050890; GO:0050893; GO:0051117; GO:0051247; GO:0051649; GO:0051823; GO:0060112; GO:0070373; GO:0070374; GO:0095500; GO:0097061; GO:0097110; GO:0098690; GO:0098815; GO:0098897; GO:0098981; GO:0099171; GO:0099634; GO:0140059; GO:1900273; GO:1902004; GO:1902430; GO:1902991; GO:1904315; GO:1904645; GO:1905144; GO:1905906; GO:2000463; GO:2001023
3051,Pocillopora_acuta_HIv2___RNAseq.g9097.t1,188.5801912,-0.328284218,1.067564167,0.00439647,0.020842526,,Q80U63,2.56E-17,Mitofusin-2 (EC 3.6.5.-) (Hypertension-related protein 1) (Mitochondrial assembly regulatory factor) (HSG protein) (Transmembrane GTPase MFN2),aerobic respiration [GO:0009060]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of sarcomere organization [GO:0060299]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986],GO:0001825; GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007005; GO:0007006; GO:0008053; GO:0008285; GO:0009060; GO:0010628; GO:0010667; GO:0010729; GO:0010918; GO:0015630; GO:0031267; GO:0031625; GO:0034497; GO:0042802; GO:0043394; GO:0045786; GO:0045792; GO:0046326; GO:0046580; GO:0046628; GO:0048312; GO:0048593; GO:0048662; GO:0051020; GO:0051560; GO:0051646; GO:0060253; GO:0060299; GO:0061003; GO:0061734; GO:0090201; GO:0090258; GO:0120162; GO:1901857; GO:1903427; GO:1903428; GO:1904706; GO:1904707; GO:1905461; GO:2000386; GO:2000866; GO:2000872
3052,Pocillopora_acuta_HIv2___RNAseq.g8669.t1b,164.220994,-0.183140716,1.039299748,0.004415436,0.020925578,,P70085,6.14E-93,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)",hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; steroid biosynthetic process [GO:0006694],GO:0004508; GO:0005506; GO:0006694; GO:0016020; GO:0016829; GO:0020037; GO:0042446; GO:0042448
3053,Pocillopora_acuta_HIv2___RNAseq.g25735.t1,123.3438932,-0.27146136,1.058551983,0.004425361,0.020965744,,O46607,4.94E-37,Epididymal secretory glutathione peroxidase (EC 1.11.1.9) (Epididymis-specific glutathione peroxidase-like protein) (EGLP) (Glutathione peroxidase 5) (GPx-5) (GSHPx-5),response to oxidative stress [GO:0006979],GO:0004602; GO:0005576; GO:0006979
3054,Pocillopora_acuta_HIv2___RNAseq.26910_t,203.1465908,-0.420439028,1.08102548,0.004430039,0.020981035,,Q95245,2.57E-68,Transmembrane ascorbate-dependent reductase CYB561 (EC 7.2.1.-) (Cytochrome b-561) (Cytochrome b561),ascorbate homeostasis [GO:0140576],GO:0005765; GO:0016491; GO:0042584; GO:0046872; GO:0140575; GO:0140576
3055,Pocillopora_acuta_HIv2___TS.g7019.t1,414.808456,0.399736013,1.125627298,0.00443864,0.021014889,,Q9UGM3,1.67E-58,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein),defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031],GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062
3056,Pocillopora_acuta_HIv2___RNAseq.g19080.t1,97.0624387,-0.236498848,1.0506075,0.004444875,0.021037524,,Q96EQ9,9.38E-93,Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361),double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiosis I [GO:0007127]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007127; GO:0007129; GO:0007283; GO:0007292; GO:0008270; GO:0010468; GO:0010844; GO:0010845; GO:0032259; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0045944; GO:0046975; GO:0048232; GO:0060903; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:0140999; GO:1905516; GO:1990918
3057,Pocillopora_acuta_HIv2___RNAseq.g7172.t1,427.3747659,1.826890201,1.651687634,0.004449081,0.021050541,,O50224,3.48E-08,ATP-dependent DNA helicase RecG (EC 3.6.4.12),DNA recombination [GO:0006310]; DNA repair [GO:0006281],GO:0003677; GO:0003678; GO:0005524; GO:0006281; GO:0006310; GO:0016887
3058,Pocillopora_acuta_HIv2___RNAseq.g3778.t1,847.93706,-1.92771431,1.501948056,0.004459525,0.021093057,,Q9UDY8,6.11E-11,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321
3059,Pocillopora_acuta_HIv2___RNAseq.g22491.t1,280.5859406,-0.826822508,1.411707345,0.004484664,0.02120503,,NA,NA,NA,NA,NA
3060,Pocillopora_acuta_HIv2___RNAseq.g22363.t1,377.9649458,-0.684891975,1.267608888,0.004507205,0.021304646,,P35433,0,Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT),'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; animal organ regeneration [GO:0031100]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; G1/S transition of mitotic cell cycle [GO:0000082]; glutamine catabolic process [GO:0006543]; GMP biosynthetic process [GO:0006177]; kidney development [GO:0001822]; lactation [GO:0007595]; maternal process involved in female pregnancy [GO:0060135]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; response to xenobiotic stimulus [GO:0009410],GO:0000082; GO:0001822; GO:0004044; GO:0006164; GO:0006177; GO:0006189; GO:0006543; GO:0007595; GO:0009113; GO:0009410; GO:0031100; GO:0032869; GO:0042802; GO:0044208; GO:0046872; GO:0051539; GO:0060135; GO:0071466; GO:0097294
3061,Pocillopora_acuta_HIv2___RNAseq.g2110.t1,395.2977568,1.310085462,2.386802062,0.004509421,0.021308154,,Q67XX3,2.98E-08,Arginine-specific demethylase JMJ22 (EC 1.14.11.-) (Arginine-specific histone demethylase JMJ22) (F-box protein JMJ22) (Jumonji domain-containing protein 22) (AtJMJ22) (Protein JUMONJI 22) ([histone H4]-dimethyl-L-arginine(3) monodemethylase JMJ22),epigenetic regulation of gene expression [GO:0040029]; gibberellic acid mediated signaling pathway [GO:0009740]; gibberellin mediated signaling pathway [GO:0010476]; positive regulation of seed germination [GO:0010030]; regulation of photomorphogenesis [GO:0010099]; response to red light [GO:0010114],GO:0000976; GO:0000987; GO:0005634; GO:0009740; GO:0010030; GO:0010099; GO:0010114; GO:0010476; GO:0016491; GO:0040029; GO:0046872
3062,Pocillopora_acuta_HIv2___RNAseq.g15961.t1,152.1662001,-0.160089657,1.015553029,0.00451842,0.021343704,,NA,NA,NA,NA,NA
3063,Pocillopora_acuta_HIv2___RNAseq.g9195.t1,396.477358,-0.297548328,1.03628047,0.004526302,0.021373958,,Q5XPI4,6.77E-26,E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123),protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; proteolysis involved in protein catabolic process [GO:0051603]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0031965; GO:0046872; GO:0051603; GO:0051604; GO:0061630
3064,Pocillopora_acuta_HIv2___RNAseq.g4759.t1,110.7061185,0.66765099,1.220515992,0.004544962,0.021455069,,NA,NA,NA,NA,NA
3065,Pocillopora_acuta_HIv2___RNAseq.g11031.t1,206.1909297,-0.389621591,1.105230876,0.004553653,0.021486598,,NA,NA,NA,NA,NA
3066,Pocillopora_acuta_HIv2___RNAseq.g7667.t1,654.3126397,-1.921831869,1.788332125,0.004554612,0.021486598,,Q8IV36,0,Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog),,GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0016020; GO:0070062; GO:0098548
3067,Pocillopora_acuta_HIv2___RNAseq.g22365.t1,351.0007712,-0.71516804,1.248488802,0.004564081,0.02152425,,O08875,1.08E-128,Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Calcium/calmodulin-dependent protein kinase type I-like CPG16) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1),axon extension [GO:0048675]; axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; forebrain development [GO:0030900]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; protein localization to nucleus [GO:0034504]; regulation of postsynapse assembly [GO:0150052]; response to virus [GO:0009615],GO:0001764; GO:0004672; GO:0004674; GO:0005524; GO:0007409; GO:0007420; GO:0009615; GO:0014069; GO:0021952; GO:0030424; GO:0030426; GO:0030900; GO:0034504; GO:0048675; GO:0048812; GO:0048813; GO:0098794; GO:0098978; GO:0106310; GO:0150052; GO:1900181
3068,Pocillopora_acuta_HIv2___RNAseq.g15948.t1,179.2169045,2.10332743,1.679818414,0.004566089,0.021526701,,Q923Y9,9.89E-08,Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1),G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950],GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0008227; GO:0043950
3069,Pocillopora_acuta_HIv2___RNAseq.g25723.t1,825.389466,-0.764228245,1.342433914,0.004569382,0.021535203,,A7RU46,0,Nck-associated protein 1 homolog,cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; neuron projection morphogenesis [GO:0048812],GO:0000902; GO:0007155; GO:0016477; GO:0030031; GO:0030866; GO:0031209; GO:0048812
3070,Pocillopora_acuta_HIv2___RNAseq.g24762.t1,15.28283044,-2.367802846,2.771399187,0.004588245,0.021617063,,NA,NA,NA,NA,NA
3071,Pocillopora_acuta_HIv2___TS.g8000.t1,1199.683099,0.827297869,1.383344692,0.004590229,0.021619367,,O16025,0,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677
3072,Pocillopora_acuta_HIv2___RNAseq.g21181.t1,523.5987827,-1.893900958,1.553694932,0.004592694,0.021623933,,Q6DJG6,3.73E-22,BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex),cell division [GO:0051301]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212],GO:0005634; GO:0005737; GO:0006302; GO:0007095; GO:0010212; GO:0045739; GO:0051301; GO:0070531; GO:0070552; GO:0140861
3073,Pocillopora_acuta_HIv2___RNAseq.g28241.t1,177.5834788,-0.258614626,1.055072514,0.004610445,0.02170045,,Q6Q4H1,1.62E-73,Bifunctional arginine demethylase and lysyl-hydroxylase PSR (EC 1.14.11.-) (Phosphatidylserine receptor),peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909],GO:0005634; GO:0005737; GO:0006909; GO:0018395; GO:0033749; GO:0046872; GO:0070815; GO:0106140
3074,Pocillopora_acuta_HIv2___TS.g16722.t1,103.5347815,-0.299717595,1.06564563,0.004614715,0.02171348,,Q921L8,4.37E-93,Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11),cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593],GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0006493; GO:0007220; GO:0007368; GO:0008593; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314
3075,Pocillopora_acuta_HIv2___RNAseq.g4791.t1,744.7836246,1.835498223,1.940936588,0.004626051,0.021759742,,O18806,1.36E-09,Coagulation factor VIII (Procoagulant component),"acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597]",GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491
3076,Pocillopora_acuta_HIv2___RNAseq.g8337.t1,267.6384035,0.342897586,1.072269981,0.004651833,0.021873898,,NA,NA,NA,NA,NA
3077,Pocillopora_acuta_HIv2___RNAseq.g18645.t1,131.7815715,-0.472169767,1.15987507,0.004653465,0.021874462,,E7F5E1,1.73E-123,Centrosomal protein of 162 kDa (Cep162),cilium assembly [GO:0060271]; heart looping [GO:0001947],GO:0001947; GO:0005813; GO:0005814; GO:0005879; GO:0060271
3078,Pocillopora_acuta_HIv2___RNAseq.g14040.t1,313.0362942,-0.162398546,1.03282925,0.004655675,0.021877741,,Q2KI52,1.52E-24,Centriolar and ciliogenesis-associated protein HYLS1 (Hydrolethalus syndrome protein 1 homolog),cilium assembly [GO:0060271],GO:0005737; GO:0005814; GO:0005929; GO:0060271; GO:0097730
3079,Pocillopora_acuta_HIv2___RNAseq.g14359.t1,471.4911973,1.874721296,1.923427687,0.004658879,0.021885685,,NA,NA,NA,NA,NA
3080,Pocillopora_acuta_HIv2___RNAseq.g11377.t1,104.5812896,-0.214397321,1.032476056,0.004662518,0.02189567,,Q9DBN1,1.36E-27,Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2),establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939],GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939
3081,Pocillopora_acuta_HIv2___RNAseq.g14775.t1,330.9202692,-0.892037159,1.443500239,0.00466409,0.02189594,,Q91612,7.07E-29,Indian hedgehog protein (IHH) (EC 3.1.-.-) (Banded hedgehog protein) (X-BHH) [Cleaved into: Indian hedgehog protein N-product],cell-cell signaling [GO:0007267]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; self proteolysis [GO:0097264],GO:0000139; GO:0005113; GO:0005576; GO:0005789; GO:0005886; GO:0007267; GO:0008233; GO:0016540; GO:0034189; GO:0045880; GO:0046872; GO:0097264; GO:0140853
3082,Pocillopora_acuta_HIv2___TS.g19330.t1,1304.045582,0.921848557,1.424198233,0.004700075,0.022057717,,P38571,3.73E-137,Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Diacylglycerol lipase) (Lipase A) (Sterol esterase) (Triacylglycerol ester hydrolase) (Triacylglycerol lipase),acute inflammatory response [GO:0002526]; adaptive thermogenesis [GO:1990845]; adipose tissue development [GO:0060612]; ATP biosynthetic process [GO:0006754]; blood vessel endothelial cell differentiation [GO:0060837]; bone marrow development [GO:0048539]; cell morphogenesis [GO:0000902]; cell proliferation in bone marrow [GO:0071838]; cellular lipid biosynthetic process [GO:0097384]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol storage [GO:0010878]; common myeloid progenitor cell proliferation [GO:0035726]; defecation [GO:0030421]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endothelial cell proliferation [GO:0001935]; fat cell proliferation [GO:0070341]; fatty acid metabolic process [GO:0006631]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells within a tissue [GO:0048873]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; lipid import into cell [GO:0140354]; lipoprotein catabolic process [GO:0042159]; liver morphogenesis [GO:0072576]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; lysosome organization [GO:0007040]; macrophage homeostasis [GO:0061519]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; multicellular organismal-level chemical homeostasis [GO:0140962]; myeloid cell apoptotic process [GO:0033028]; myeloid cell differentiation [GO:0030099]; positive regulation of T cell receptor signaling pathway [GO:0050862]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of mitochondrial membrane potential [GO:0051881]; respiratory burst involved in inflammatory response [GO:0002536]; response to cold [GO:0009409]; response to dietary excess [GO:0002021]; response to rapamycin [GO:1901355]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; small GTPase-mediated signal transduction [GO:0007264]; spleen development [GO:0048536]; sterol metabolic process [GO:0016125]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; tissue remodeling [GO:0048771]; TOR signaling [GO:0031929]; triglyceride metabolic process [GO:0006641]; triglyceride-rich lipoprotein particle clearance [GO:0071830]; vitamin A metabolic process [GO:0006776],GO:0000278; GO:0000902; GO:0001650; GO:0001935; GO:0002021; GO:0002244; GO:0002526; GO:0002536; GO:0004771; GO:0005654; GO:0005764; GO:0005829; GO:0006006; GO:0006096; GO:0006631; GO:0006641; GO:0006695; GO:0006754; GO:0006776; GO:0006897; GO:0007005; GO:0007040; GO:0007264; GO:0008333; GO:0008340; GO:0009409; GO:0009410; GO:0010467; GO:0010878; GO:0016042; GO:0016125; GO:0016298; GO:0030099; GO:0030217; GO:0030324; GO:0030421; GO:0031929; GO:0033028; GO:0033189; GO:0033344; GO:0034383; GO:0035726; GO:0042098; GO:0042159; GO:0043202; GO:0043231; GO:0048536; GO:0048539; GO:0048771; GO:0048873; GO:0050862; GO:0051881; GO:0055088; GO:0060612; GO:0060837; GO:0061519; GO:0070231; GO:0070341; GO:0071830; GO:0071838; GO:0072576; GO:0097384; GO:0140354; GO:0140962; GO:1901355; GO:1903409; GO:1990845
3083,Pocillopora_acuta_HIv2___RNAseq.g20580.t1,46.23971956,-0.256765031,1.036494706,0.004711363,0.02210352,,NA,NA,NA,NA,NA
3084,Pocillopora_acuta_HIv2___TS.g5226.t1,327.5757633,2.19359629,1.759372118,0.004714907,0.022112975,,NA,NA,NA,NA,NA
3085,Pocillopora_acuta_HIv2___RNAseq.g6619.t1,177.6264625,0.567565248,1.148449444,0.004731525,0.022183719,,Q8IWY4,3.86E-09,"Signal peptide, CUB and EGF-like domain-containing protein 1",adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; signal transduction [GO:0007165],GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007165; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0042802; GO:0045446; GO:0045880
3086,Pocillopora_acuta_HIv2___RNAseq.g6675.t1,451.4095374,0.939219848,1.499321118,0.004739368,0.022213291,,NA,NA,NA,NA,NA
3087,Pocillopora_acuta_HIv2___RNAseq.g12223.t1,1942.759639,-1.866115847,2.06818145,0.004745347,0.022234109,,P25228,3.56E-96,Ras-related protein Rab-3,cytoskeletal matrix organization at active zone [GO:0048789]; exocytosis [GO:0006887]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; symbiont entry into host cell [GO:0046718]; vesicle-mediated transport [GO:0016192],GO:0000287; GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0007269; GO:0008021; GO:0009306; GO:0016192; GO:0031489; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0046718; GO:0046928; GO:0048172; GO:0048786; GO:0048789; GO:0048790
3088,Pocillopora_acuta_HIv2___RNAseq.g24899.t1,1384.373643,1.415110621,1.944689272,0.004751356,0.022251005,,Q9R0S3,1.48E-79,Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP),collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508],GO:0001822; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0042756; GO:0098552
3089,Pocillopora_acuta_HIv2___TS.g9052.t1,367.0261102,1.870995729,1.199378037,0.004752029,0.022251005,,NA,NA,NA,NA,NA
3090,Pocillopora_acuta_HIv2___RNAseq.g22211.t1,214.4790419,-0.293196598,1.061114196,0.004764842,0.02230378,,Q96QP1,5.08E-48,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310
3091,Pocillopora_acuta_HIv2___RNAseq.g1994.t1,344.8154687,-2.372886402,1.335228661,0.004780189,0.022368378,,NA,NA,NA,NA,NA
3092,Pocillopora_acuta_HIv2___TS.g13467.t1,1087.05816,-1.848902603,1.217442723,0.004832254,0.022600396,,NA,NA,NA,NA,NA
3093,Pocillopora_acuta_HIv2___TS.g23602.t1,770.1244203,1.768097779,0.964179713,0.004832897,0.022600396,,Q2PZL6,0,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609
3094,Pocillopora_acuta_HIv2___RNAseq.g22297.t1,83.24456514,-0.137629589,1.02288411,0.004834768,0.022601835,Protein Wnt-8b,P51029,1.25E-68,Protein Wnt-8b,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055],GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679
3095,Pocillopora_acuta_HIv2___RNAseq.g4919.t1,187.6328118,-3.348336212,2.65896447,0.004847873,0.022655779,,Q01484,1.12E-24,Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin),atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259
3096,Pocillopora_acuta_HIv2___RNAseq.g26474.t1a,14692.8902,-1.826353873,1.026057503,0.004869071,0.022741666,,P09057,9.03E-160,Ornithine decarboxylase (ODC) (EC 4.1.1.17),cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615],GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471
3097,Pocillopora_acuta_HIv2___RNAseq.g1240.t1,475.1140983,-0.86709678,1.372164639,0.004869396,0.022741666,,A8HYJ1,4.25E-14,"Translocase of chloroplast 34 homolog, chloroplastic (Cr-TOC34) (TOC34p) (EC 3.6.5.-)",protein transport [GO:0015031],GO:0005525; GO:0009707; GO:0015031; GO:0016787; GO:0046872
3098,Pocillopora_acuta_HIv2___RNAseq.g23426.t1,355.0979501,-0.931665379,1.430625202,0.004873039,0.022751335,,Q8WW35,3.67E-52,Dynein light chain Tctex-type protein 2B (Tctex1 domain-containing protein 2),cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; microtubule-based movement [GO:0007018]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799],GO:0005737; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0045505; GO:0060271; GO:0120293; GO:1902017; GO:1905799
3099,Pocillopora_acuta_HIv2___TS.g9450.t1,233.3135405,-0.608625171,1.21577326,0.004901626,0.022877418,,Q9NX57,2.00E-39,Ras-related protein Rab-20,cellular response to type II interferon [GO:0071346]; intracellular protein transport [GO:0006886]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385],GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0012505; GO:0030670; GO:0043231; GO:0045335; GO:0071346; GO:0090383; GO:0090385
3100,Pocillopora_acuta_HIv2___TS.g13071.t1,26.33219863,-0.996134229,1.615198109,0.004915982,0.022937021,,Q09575,8.42E-105,Uncharacterized protein K02A2.6,DNA integration [GO:0015074],GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575
3101,Pocillopora_acuta_HIv2___RNAseq.g29865.t1,203.2411266,-0.176110654,1.036231948,0.004931998,0.023004326,,A0JMY5,0,NF-X1-type zinc finger protein NFXL1,,GO:0003700; GO:0005634; GO:0008270; GO:0016020
3102,Pocillopora_acuta_HIv2___RNAseq.g4128.t2,1313.595859,-1.643234714,0.794984815,0.004940129,0.023034826,Terminal uridylyltransferase 4,B2RX14,0,Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11),interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; retrotransposon silencing by mRNA destabilization [GO:0141008]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827],GO:0001556; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0071076; GO:0141008; GO:1990074
3103,Pocillopora_acuta_HIv2___RNAseq.g21224.t1,1123.077221,0.627639579,1.287858639,0.004963673,0.023137148,,NA,NA,NA,NA,NA
3104,Pocillopora_acuta_HIv2___RNAseq.g15940.t1,166.2943204,0.98133708,1.783716103,0.004966984,0.023145122,,NA,NA,NA,NA,NA
3105,Pocillopora_acuta_HIv2___RNAseq.g562.t1,543.0109041,1.947357937,1.548427226,0.004969901,0.023151255,Frizzled-5 (Fz-5),Q8CHL0,1.31E-52,Frizzled-5 (Fz-5),"angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye development [GO:0031076]; embryonic camera-type eye morphogenesis [GO:0048596]; eye development [GO:0001654]; glandular epithelial cell maturation [GO:0002071]; intestinal epithelial cell maturation [GO:0060574]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; post-embryonic camera-type eye development [GO:0031077]; presynapse assembly [GO:0099054]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; Spemann organizer formation [GO:0060061]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055]",GO:0000139; GO:0000578; GO:0001525; GO:0001540; GO:0001654; GO:0001944; GO:0002071; GO:0002726; GO:0004930; GO:0005769; GO:0005794; GO:0005886; GO:0005923; GO:0008285; GO:0008289; GO:0008595; GO:0009986; GO:0016055; GO:0017147; GO:0019901; GO:0030424; GO:0030425; GO:0031076; GO:0031077; GO:0031625; GO:0032729; GO:0032731; GO:0032760; GO:0033077; GO:0035567; GO:0042813; GO:0043204; GO:0044877; GO:0045202; GO:0045944; GO:0048471; GO:0048596; GO:0060061; GO:0060070; GO:0060561; GO:0060574; GO:0060670; GO:0060715; GO:0060716; GO:0060718; GO:0071219; GO:0098978; GO:0099054; GO:1901382; GO:2000810
3106,Pocillopora_acuta_HIv2___RNAseq.g24815.t1,21.05440993,-1.147434513,2.07120514,0.004971771,0.02315251,,Q9NUC0,1.31E-06,SERTA domain-containing protein 4,,GO:0005634
3107,Pocillopora_acuta_HIv2___TS.g14050.t1,158.6669258,-1.731397369,0.885543457,0.004975168,0.023160874,,NA,NA,NA,NA,NA
3108,Pocillopora_acuta_HIv2___TS.g23568.t2d,533.6820887,-2.315615924,2.368186278,0.005011193,0.023321067,,Q04073,1.56E-152,DNA-binding protein P3A2,regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0005634; GO:0006357
3109,Pocillopora_acuta_HIv2___TS.g7403.t1,174.6933031,-0.155434969,1.016812729,0.005013365,0.023321067,,NA,NA,NA,NA,NA
3110,Pocillopora_acuta_HIv2___RNAseq.g3811.t1,137.2967721,-0.910086149,1.418000678,0.005014416,0.023321067,,NA,NA,NA,NA,NA
3111,Pocillopora_acuta_HIv2___RNAseq.18045_t,1074.823805,0.860764532,1.414595763,0.005029165,0.023382139,Homeobox protein Nkx-2.2,O95096,1.16E-45,Homeobox protein Nkx-2.2 (Homeobox protein NK-2 homolog B),astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; negative regulation of neuron differentiation [GO:0045665]; neuroendocrine cell differentiation [GO:0061101]; neuron fate specification [GO:0048665]; oligodendrocyte development [GO:0014003]; optic nerve development [GO:0021554]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell fate commitment [GO:0003327]; ventral spinal cord interneuron fate determination [GO:0060580],GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003323; GO:0003326; GO:0003327; GO:0003329; GO:0005634; GO:0005654; GO:0006357; GO:0007224; GO:0007420; GO:0009749; GO:0010628; GO:0014003; GO:0021522; GO:0021530; GO:0021554; GO:0030154; GO:0030858; GO:0032570; GO:0045665; GO:0045666; GO:0048565; GO:0048665; GO:0048708; GO:0048714; GO:0060580; GO:0061101
3112,Pocillopora_acuta_HIv2___TS.g23391.t1,270.0855118,2.040077453,1.849207586,0.00503272,0.02339115,,Q923L3,1.44E-86,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964],GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708
3113,Pocillopora_acuta_HIv2___RNAseq.g22880.t1,160.8643239,-0.625936966,1.178129818,0.005041016,0.023422184,,Q7RTR2,1.57E-19,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)",canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110],GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223
3114,Pocillopora_acuta_HIv2___RNAseq.g5089.t1,120.4911783,-1.786818237,1.784835504,0.005048359,0.023448768,,Q1RMU2,3.22E-20,Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD),innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of mitotic cell cycle [GO:0007346]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; Wnt signaling pathway [GO:0016055],GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0032088; GO:0036064; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0061578; GO:0070266; GO:0070536; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493; GO:2001238; GO:2001242
3115,Pocillopora_acuta_HIv2___RNAseq.g1336.t1,15.72472377,-1.583791213,2.598807709,0.005060443,0.023497351,,Q55E58,6.49E-20,Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1),cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856],GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310
3116,Pocillopora_acuta_HIv2___RNAseq.g6643.t3,116.7898596,-0.602848972,1.258622415,0.005063758,0.023500756,,NA,NA,NA,NA,NA
3117,Pocillopora_acuta_HIv2___RNAseq.g24678.t1,620.4864201,0.902046733,1.461754237,0.005064426,0.023500756,,P79148,2.18E-19,Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor),"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of heart contraction [GO:0045823]; positive regulation of MAPK cascade [GO:0043410]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]",GO:0002025; GO:0004940; GO:0005769; GO:0005886; GO:0043410; GO:0045187; GO:0045823; GO:0071880
3118,Pocillopora_acuta_HIv2___RNAseq.g6698.t1,263.5760885,1.225856589,1.819041475,0.005083268,0.023580623,,NA,NA,NA,NA,NA
3119,Pocillopora_acuta_HIv2___RNAseq.g20178.t1,111.2500862,-0.501646393,1.120190424,0.005098025,0.0236415,,NA,NA,NA,NA,NA
3120,Pocillopora_acuta_HIv2___TS.g26909.t1,252.6049056,-1.069595249,1.614603376,0.005113582,0.023706043,,NA,NA,NA,NA,NA
3121,Pocillopora_acuta_HIv2___RNAseq.g25282.t1,3864.940436,-1.321656341,0.548289833,0.005127675,0.023763757,,NA,NA,NA,NA,NA
3122,Pocillopora_acuta_HIv2___TS.g21325.t1,430.2237298,-0.351797403,1.087175107,0.005129325,0.023763792,,Q6GNV7,8.95E-46,Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog),pyridoxine transport [GO:0031923],GO:0005765; GO:0022857; GO:0031923
3123,Pocillopora_acuta_HIv2___RNAseq.g5905.t1,386.0808033,-0.408924055,1.066000727,0.005136976,0.023791617,,P48147,0,Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme),proteolysis [GO:0006508],GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012
3124,Pocillopora_acuta_HIv2___RNAseq.6617_t,379.7297221,1.662742737,3.193517829,0.005144573,0.023819174,,NA,NA,NA,NA,NA
3125,Pocillopora_acuta_HIv2___RNAseq.g21299.t1,137.327489,-0.872274713,1.415448257,0.005146622,0.023821038,,P14184,2.28E-09,Lipopolysaccharide cholinephosphotransferase LicD (EC 2.7.8.-),glycoprotein metabolic process [GO:0009100]; lipopolysaccharide biosynthetic process [GO:0009103],GO:0009100; GO:0009103; GO:0016740
3126,Pocillopora_acuta_HIv2___RNAseq.g4762.t1,147.4794585,-1.574842842,1.936986107,0.005182535,0.023979587,,NA,NA,NA,NA,NA
3127,Pocillopora_acuta_HIv2___TS.g20588.t1,2606.308391,1.21825259,1.855344759,0.00518739,0.023994373,,NA,NA,NA,NA,NA
3128,Pocillopora_acuta_HIv2___TS.g28604.t1,2013.848598,2.215746925,1.752941825,0.005190359,0.024000433,,O54962,1.64E-17,"Barrier-to-autointegration factor (LAP2-binding protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed]",chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; DNA integration [GO:0015074]; establishment of integrated proviral latency [GO:0075713]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of innate immune response [GO:0045824]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral genome replication [GO:0045071]; response to oxidative stress [GO:0006979],GO:0000785; GO:0000793; GO:0003677; GO:0003690; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006325; GO:0006979; GO:0007084; GO:0010836; GO:0015074; GO:0032480; GO:0042802; GO:0042803; GO:0045071; GO:0045824; GO:0051276; GO:0075713; GO:0160049
3129,Pocillopora_acuta_HIv2___RNAseq.g808.t1,225.7831858,-0.293143339,1.029351967,0.005211779,0.024084922,,A4F7P5,8.39E-16,Erythromycin 3''-O-methyltransferase (EC 2.1.1.254) (Erythromycin biosynthesis protein G),antibiotic biosynthetic process [GO:0017000]; methylation [GO:0032259],GO:0008757; GO:0017000; GO:0032259; GO:0102307; GO:0102308
3130,Pocillopora_acuta_HIv2___RNAseq.g10671.t1,126.13124,-0.326579273,1.0713256,0.005211961,0.024084922,,Q6P4W0,2.82E-33,BRISC complex subunit Abraxas 2 (Abraxas brother protein 1) (BRISC complex subunit Abro1) (Protein FAM175B),attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931],GO:0000278; GO:0000922; GO:0002931; GO:0005737; GO:0005874; GO:0007059; GO:0008017; GO:0008608; GO:0031593; GO:0051301; GO:0070536; GO:0070552; GO:0090307
3131,Pocillopora_acuta_HIv2___RNAseq.g9061.t1,368.7731641,0.850753221,1.424522103,0.005222526,0.024126033,,Q80T79,1.51E-65,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),regulation of dendrite development [GO:0050773],GO:0005886; GO:0050773
3132,Pocillopora_acuta_HIv2___TS.g3024.t4,5769.893346,-1.344419553,0.561093952,0.005230996,0.024157449,,Q62770,1.10E-08,Protein unc-13 homolog C (Munc13-3),"chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; negative regulation of synaptic plasticity [GO:0031914]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of neurotransmitter secretion [GO:0046928]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]",GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007268; GO:0016079; GO:0016081; GO:0016082; GO:0017075; GO:0019905; GO:0019992; GO:0030672; GO:0031594; GO:0031914; GO:0035249; GO:0042734; GO:0043195; GO:0044305; GO:0046928; GO:0061789; GO:0098688; GO:0098793; GO:0098831; GO:0099525
3133,Pocillopora_acuta_HIv2___RNAseq.g12189.t1,184.6082726,-0.317063484,1.047937065,0.005237407,0.024179333,,NA,NA,NA,NA,NA
3134,Pocillopora_acuta_HIv2___RNAseq.g26907.t1,273.853953,-0.12366351,1.021757673,0.005257393,0.024263858,,Q55CD9,5.14E-127,Probable NADH dehydrogenase (EC 7.1.1.2),NADH oxidation [GO:0006116],GO:0003954; GO:0005739; GO:0006116; GO:0008137; GO:0016491
3135,Pocillopora_acuta_HIv2___RNAseq.g9049.t1,14251.43731,1.35739534,0.572658744,0.005263594,0.024284728,,P55008,8.21E-51,Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1),"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; cellular response to type II interferon [GO:0071346]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; ruffle assembly [GO:0097178]",GO:0001726; GO:0001774; GO:0001891; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0006911; GO:0006954; GO:0008284; GO:0010468; GO:0016601; GO:0030027; GO:0030041; GO:0030046; GO:0030335; GO:0032587; GO:0032722; GO:0032755; GO:0034599; GO:0042102; GO:0048471; GO:0048661; GO:0048662; GO:0050921; GO:0051015; GO:0051017; GO:0051764; GO:0071346; GO:0071672; GO:0071673; GO:0071677; GO:0090026; GO:0090271; GO:0097178; GO:0097386; GO:1900087; GO:2000406
3136,Pocillopora_acuta_HIv2___RNAseq.g10747.t1,184.5709841,-0.77893698,1.471549656,0.005267959,0.024297117,,Q5F349,3.41E-89,Protein O-mannose kinase (POMK) (EC 2.7.1.183) (Protein kinase-like protein SgK196) (Sugen kinase 196),carbohydrate phosphorylation [GO:0046835]; protein O-linked glycosylation [GO:0006493],GO:0004672; GO:0005524; GO:0005789; GO:0006493; GO:0016773; GO:0019200; GO:0046835
3137,Pocillopora_acuta_HIv2___RNAseq.g25228.t1,276.9910262,-1.059832141,1.690871563,0.005284291,0.024364673,,Q8BUV3,3.50E-161,Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)],establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; maintenance of postsynaptic specialization structure [GO:0098880]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970],GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006777; GO:0007529; GO:0008092; GO:0009898; GO:0014069; GO:0019897; GO:0030425; GO:0032324; GO:0042802; GO:0043025; GO:0045184; GO:0045211; GO:0046872; GO:0060077; GO:0060090; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098794; GO:0098879; GO:0098880; GO:0098970; GO:0098982; GO:0099091; GO:0099572; GO:0099634; GO:0099645
3138,Pocillopora_acuta_HIv2___RNAseq.g28980.t1,762.196423,-0.805639995,1.357854183,0.00529921,0.024425677,,Q9NR20,0,Dual specificity tyrosine-phosphorylation-regulated kinase 4 (EC 2.7.12.1),,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0043231; GO:0046872; GO:0106310
3139,Pocillopora_acuta_HIv2___RNAseq.g6852.t1,194.6442384,-1.036682962,1.570923974,0.005311097,0.02447267,,Q54TD7,1.82E-43,ATP-dependent RNA helicase ddx24 (EC 3.6.4.13) (DEAD box protein 24),,GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887
3140,Pocillopora_acuta_HIv2___RNAseq.g18343.t1,57.08097607,-0.268628556,1.056649108,0.005321139,0.024511133,,Q9UNX4,7.36E-08,WD repeat-containing protein 3,maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274],GO:0003723; GO:0005654; GO:0005730; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388; GO:0042274
3141,Pocillopora_acuta_HIv2___RNAseq.g20170.t1,65.86398797,-1.188843649,1.700340883,0.005324199,0.024517421,,P42688,5.12E-24,Tyrosine-protein kinase SRK2 (EC 2.7.10.2),cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; innate immune response [GO:0045087],GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0007169; GO:0030154; GO:0031234; GO:0045087
3142,Pocillopora_acuta_HIv2___TS.g18053.t1,43.01280153,-0.522955686,1.207006925,0.005360573,0.024677062,,P0DXC0,3.84E-136,Cyclic GMP-AMP synthase-like receptor 3 (Sp-cGLR3) (Cyclic-di-AMP synthase cGLR3) (EC 2.7.7.85),innate immune response [GO:0045087],GO:0003690; GO:0005524; GO:0005525; GO:0016779; GO:0045087; GO:0046872
3143,Pocillopora_acuta_HIv2___RNAseq.g17414.t1,438.9543487,-0.529982923,1.187558887,0.005369546,0.024710502,,Q9H300,3.44E-71,"Presenilin-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]",membrane protein proteolysis [GO:0033619]; mitochondrial fusion [GO:0008053]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of mitochondrion organization [GO:0010821]; regulation of mitophagy [GO:1901524]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]; signal peptide processing [GO:0006465],GO:0004175; GO:0004252; GO:0005634; GO:0005739; GO:0005743; GO:0006465; GO:0006508; GO:0008053; GO:0010821; GO:0016485; GO:0030162; GO:0033619; GO:0090201; GO:1901524; GO:1903214; GO:2000377; GO:2001243
3144,Pocillopora_acuta_HIv2___RNAseq.g5185.t1,64.28842625,0.420780004,1.114952471,0.005385437,0.024775753,,NA,NA,NA,NA,NA
3145,Pocillopora_acuta_HIv2___RNAseq.g30407.t1,66.89605292,0.765531234,1.383982355,0.005387965,0.024778532,,P30974,4.49E-27,Tachykinin-like peptides receptor 86C (NKD),G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217],GO:0002121; GO:0004995; GO:0005886; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016020
3146,Pocillopora_acuta_HIv2___RNAseq.g3199.t1,691.3393837,0.964827171,1.514990896,0.005389468,0.024778532,,Q62371,1.28E-27,"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)",biomineral tissue development [GO:0031214]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of neuron projection development [GO:0010976]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of wound healing [GO:0090303]; regulation of bone mineralization [GO:0030500]; regulation of tissue remodeling [GO:0034103]; response to muscle stretch [GO:0035994],GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0007169; GO:0008284; GO:0010763; GO:0010976; GO:0015629; GO:0016324; GO:0018108; GO:0030199; GO:0030500; GO:0031214; GO:0032967; GO:0034103; GO:0035988; GO:0035994; GO:0038062; GO:0038063; GO:0043066; GO:0043235; GO:0045669; GO:0045860; GO:0048146; GO:0051091; GO:0051897; GO:0071456; GO:0071560; GO:0090091; GO:0090303; GO:1900087; GO:1901299; GO:1904385; GO:1904707; GO:1904754; GO:1904899; GO:2000491
3147,Pocillopora_acuta_HIv2___RNAseq.g17386.t1,205.3077439,1.191372474,1.821374965,0.005393385,0.024788664,,NA,NA,NA,NA,NA
3148,Pocillopora_acuta_HIv2___RNAseq.g29129.t1,470.1262927,-0.968361813,1.508859201,0.005403695,0.02482816,,NA,NA,NA,NA,NA
3149,Pocillopora_acuta_HIv2___RNAseq.g5862.t1,40.30323922,-0.825360432,1.388353126,0.005413769,0.024858699,,NA,NA,NA,NA,NA
3150,Pocillopora_acuta_HIv2___RNAseq.g18624.t1,658.6643978,-0.876906875,1.44069001,0.005413779,0.024858699,,M0R8U1,0,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729
3151,Pocillopora_acuta_HIv2___RNAseq.g3656.t1,72.40503933,-0.437525975,1.130097833,0.005431193,0.024930134,,Q9GZS1,5.71E-48,DNA-directed RNA polymerase I subunit RPA49 (RNA polymerase I subunit A49) (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53),nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation by RNA polymerase I [GO:0006362]; transcription initiation at RNA polymerase I promoter [GO:0006361],GO:0001179; GO:0001188; GO:0001650; GO:0003677; GO:0005654; GO:0005730; GO:0005736; GO:0006361; GO:0006362; GO:0042790
3152,Pocillopora_acuta_HIv2___RNAseq.g10504.t1,1931.380478,1.842072038,1.020547734,0.005432784,0.024930134,,NA,NA,NA,NA,NA
3153,Pocillopora_acuta_HIv2___RNAseq.g5975.t1,105.9563037,-0.304076922,1.067123797,0.00543852,0.024948544,,Q9HB75,1.37E-07,p53-induced death domain-containing protein 1 (EC 3.4.21.-) (Leucine-rich repeat and death domain-containing protein) [Cleaved into: PIDD-N; PIDD-C; PIDD-CC],"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoprocessing [GO:0016540]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]",GO:0004175; GO:0005123; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0007165; GO:0008625; GO:0016540; GO:0043065; GO:0043066; GO:0043122; GO:0051092; GO:1905369
3154,Pocillopora_acuta_HIv2___TS.g29319.t1,869.443334,-2.098516352,1.79221431,0.005486566,0.025159457,,Q8CFV2,9.75E-39,Protein FAM149A,,
3155,Pocillopora_acuta_HIv2___RNAseq.g20820.t1,85.55312584,-0.287469035,1.062702435,0.005487976,0.025159457,,Q719N3,1.00E-59,Monocyte to macrophage differentiation factor (Macrophage/microglia activation-associated factor) (MAF) (Progestin and adipoQ receptor family member 11) (Progestin and adipoQ receptor family member XI),positive regulation of neuron differentiation [GO:0045666]; regulation of protein localization [GO:0032880],GO:0004672; GO:0005765; GO:0005794; GO:0031902; GO:0032880; GO:0045666; GO:0140911
3156,Pocillopora_acuta_HIv2___TS.g11290.t1,95.68076118,-0.278598565,1.05847896,0.005495634,0.025186582,C-type mannose receptor 2,Q64449,1.08E-24,C-type mannose receptor 2 (Lectin lambda) (Macrophage mannose receptor 2) (CD antigen CD280),collagen catabolic process [GO:0030574]; endocytosis [GO:0006897],GO:0005518; GO:0005886; GO:0006897; GO:0009986; GO:0030246; GO:0030574; GO:0038023
3157,Pocillopora_acuta_HIv2___RNAseq.g28748.t1,1100.285655,-0.665624523,1.20864949,0.005510293,0.025242848,,Q498J7,0,Zygotic DNA replication licensing factor mcm6-A (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 6-A) (zMCM6-A) (zMCM6a),DNA replication initiation [GO:0006270]; regulation of DNA-templated DNA replication initiation [GO:0030174],GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0046872
3158,Pocillopora_acuta_HIv2___TS.g29383.t1,495.1310866,0.792840577,1.48485164,0.005512144,0.025242848,,NA,NA,NA,NA,NA
3159,Pocillopora_acuta_HIv2___RNAseq.g4185.t1,150.1042472,-0.579456705,1.237807429,0.005516279,0.025242848,,Q28DB0,4.99E-149,Tetratricopeptide repeat protein 39B (TPR repeat protein 39B),lipid metabolic process [GO:0006629],GO:0006629
3160,Pocillopora_acuta_HIv2___RNAseq.g25274.t1,793.4663494,1.659684976,2.183036158,0.005516314,0.025242848,,Q8BX37,1.74E-164,Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form),,GO:0003993; GO:0005576; GO:0046872
3161,Pocillopora_acuta_HIv2___TS.g9882.t2,230.6763404,-0.773014607,1.314086472,0.005516637,0.025242848,,B4J6N6,4.01E-24,Ell-associated factor Eaf,cellular response to heat [GO:0034605]; positive regulation of DNA-templated transcription [GO:0045893]; transcription elongation by RNA polymerase II [GO:0006368],GO:0005654; GO:0006368; GO:0032783; GO:0034605; GO:0045893
3162,Pocillopora_acuta_HIv2___RNAseq.g2156.t1,60.64045389,-0.644908938,1.275534713,0.00553926,0.025338348,,Q8BKN6,3.38E-99,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1) (Heparan sulfate 3-O-sulfotransferase 3A1),branching involved in ureteric bud morphogenesis [GO:0001658]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012],GO:0000139; GO:0001658; GO:0006024; GO:0008467; GO:0015012
3163,Pocillopora_acuta_HIv2___RNAseq.g13873.t1,62.59708435,0.236403512,1.039229343,0.005546841,0.025365002,,O62742,3.97E-154,Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X),bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; regulation of phospholipid biosynthetic process [GO:0071071],GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032367; GO:0033814; GO:0050632; GO:0050633; GO:0071071; GO:0120019; GO:0120020
3164,Pocillopora_acuta_HIv2___TS.g12529.t1,184.9129031,-0.495718058,1.164254964,0.005560122,0.025417699,,Q9Y6V7,0,Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49),positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364],GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0006364; GO:0016887; GO:0030307; GO:0044357
3165,Pocillopora_acuta_HIv2___RNAseq.g23395.t1,56.05875254,-0.394695333,1.108576479,0.005573495,0.025470784,,NA,NA,NA,NA,NA
3166,Pocillopora_acuta_HIv2___RNAseq.g29811.t1,83.33916532,-0.310751752,1.068541823,0.005620999,0.025679764,,P13466,1.19E-06,Gelation factor (Actin-binding protein 120) (ABP-120),actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cell motility [GO:0048870]; chemotaxis to cAMP [GO:0043327]; hyperosmotic response [GO:0006972]; lamellipodium assembly [GO:0030032]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; pseudopodium assembly [GO:0031269]; regulation of pseudopodium assembly [GO:0031272]; response to cAMP [GO:0051591]; sorocarp development [GO:0030587]; thermotaxis [GO:0043052],GO:0001891; GO:0005737; GO:0005886; GO:0005938; GO:0006909; GO:0006972; GO:0016477; GO:0030032; GO:0030036; GO:0030587; GO:0030864; GO:0031012; GO:0031143; GO:0031252; GO:0031267; GO:0031269; GO:0031272; GO:0042331; GO:0043052; GO:0043327; GO:0043422; GO:0048870; GO:0051015; GO:0051019; GO:0051591; GO:0051764; GO:0061802; GO:0061803; GO:0070685; GO:0097575
3167,Pocillopora_acuta_HIv2___RNAseq.g30925.t1,248.9201329,-0.353924275,1.085543125,0.005636101,0.025733502,,NA,NA,NA,NA,NA
3168,Pocillopora_acuta_HIv2___RNAseq.g29813.t1,87.01491575,2.616612556,1.9090932,0.00563632,0.025733502,,Q01456,9.87E-13,Ovarian abundant message protein (Protein OAM),,
3169,Pocillopora_acuta_HIv2___RNAseq.g14663.t1b,1001.552054,-2.036436717,1.680798683,0.005638744,0.025736446,,NA,NA,NA,NA,NA
3170,Pocillopora_acuta_HIv2___RNAseq.g1873.t1,452.3936927,0.273234448,1.046792216,0.005661103,0.025830345,,Q8WWZ7,0,Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5),cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691],GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043691; GO:0140359; GO:1903064
3171,Pocillopora_acuta_HIv2___RNAseq.g27978.t1,1346.567429,-0.966757032,1.548664374,0.005666414,0.025846422,Plasma membrane calcium-transporting ATPase 4 (PMCA4),P23634,1.01E-131,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832],GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005901; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051001; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902083; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145
3172,Pocillopora_acuta_HIv2___TS.g5347.t1,849.5778195,-1.094625871,1.622462872,0.005673773,0.025871832,,O09012,0,Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (PXR1P) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1),"cell development [GO:0048468]; cellular lipid metabolic process [GO:0044255]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]",GO:0000038; GO:0000268; GO:0000425; GO:0001764; GO:0005052; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006635; GO:0007005; GO:0007006; GO:0007029; GO:0007031; GO:0016558; GO:0016560; GO:0016562; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0034614; GO:0040018; GO:0044255; GO:0044721; GO:0045046; GO:0048468; GO:0050905; GO:0140597
3173,Pocillopora_acuta_HIv2___RNAseq.g4483.t1,353.5161562,-0.220342152,1.01666164,0.005686656,0.025922405,,NA,NA,NA,NA,NA
3174,Pocillopora_acuta_HIv2___RNAseq.g11777.t1,861.4227856,-0.312028496,1.041538165,0.005689325,0.0259264,,P22102,0,Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)],'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; tetrahydrofolate biosynthetic process [GO:0046654],GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006544; GO:0009168; GO:0021549; GO:0021987; GO:0044208; GO:0046084; GO:0046654; GO:0046872; GO:0070062; GO:0097294
3175,Pocillopora_acuta_HIv2___RNAseq.g9592.t1,81.95794011,-0.42488596,1.125776268,0.005697047,0.025953415,,B2RY50,0,Outer dynein arm-docking complex subunit 2 (Armadillo repeat-containing protein 4),cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591],GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546
3176,Pocillopora_acuta_HIv2___RNAseq.g13643.t1,516.1816017,-1.824304627,1.107112405,0.005703573,0.025974963,,Q9JJ93,6.18E-21,Uncharacterized protein C14orf119 homolog,,GO:0005739; GO:0005829
3177,Pocillopora_acuta_HIv2___RNAseq.g21699.t1,249.1315496,-0.853084532,1.408779724,0.00570866,0.025989945,,Q5SWK7,1.54E-34,RING finger protein 145 (EC 2.3.2.27),proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005789; GO:0008270; GO:0012505; GO:0043161; GO:0061630
3178,Pocillopora_acuta_HIv2___TS.g24851.t1b,102.8544451,-0.305486553,1.068445877,0.0057348,0.02610074,,O70546,0,Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously transcribed TPR protein on the X chromosome) (Ubiquitously transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A),cellular response to angiotensin [GO:1904385]; cellular response to endothelin [GO:1990859]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to vitamin D [GO:0071305]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord morphogenesis [GO:0048570]; positive regulation of cell size [GO:0045793]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of gene expression [GO:0010468]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525],GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0010628; GO:0021915; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0036211; GO:0042802; GO:0044666; GO:0045793; GO:0045944; GO:0046872; GO:0048333; GO:0048568; GO:0048570; GO:0071305; GO:0071456; GO:0071558; GO:0071560; GO:0072359; GO:1903298; GO:1904385; GO:1990859
3179,Pocillopora_acuta_HIv2___RNAseq.g12231.t1,629.6267388,-1.541526488,0.725189205,0.005739893,0.026115699,,NA,NA,NA,NA,NA
3180,Pocillopora_acuta_HIv2___TS.g25022.t1b,326.1313137,-1.914898872,4.102165611,0.0057494,0.026150732,,NA,NA,NA,NA,NA
3181,Pocillopora_acuta_HIv2___RNAseq.g30618.t1,116.9333427,-0.263243119,1.029353919,0.005760927,0.026194923,,NA,NA,NA,NA,NA
3182,Pocillopora_acuta_HIv2___RNAseq.g6227.t1,707.0277094,0.643608058,1.216877888,0.005793681,0.026335577,,NA,NA,NA,NA,NA
3183,Pocillopora_acuta_HIv2___RNAseq.g615.t1,1155.863116,0.947944086,1.505575314,0.005824732,0.026468403,Homeobox protein SIX6,O95475,7.11E-120,Homeobox protein SIX6 (Homeodomain protein OPTX2) (Optic homeobox 2) (Sine oculis homeobox homolog 6),animal organ morphogenesis [GO:0009887]; eye development [GO:0001654]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601],GO:0000785; GO:0000978; GO:0000981; GO:0001654; GO:0005634; GO:0005667; GO:0006357; GO:0007601; GO:0009887; GO:1990837
3184,Pocillopora_acuta_HIv2___TS.g6334.t2,47.73101031,-0.28129389,1.05979895,0.005828478,0.026477105,,Q8N8U2,8.98E-50,Chromodomain Y-like protein 2 (CDY-like 2),,GO:0003714; GO:0005634; GO:0035064
3185,Pocillopora_acuta_HIv2___RNAseq.g14750.t1,399.5401431,1.82961941,1.964740304,0.005842557,0.02653273,,Q9Y2Y9,6.76E-44,Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1),negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008285; GO:0045647; GO:0046872; GO:1990837
3186,Pocillopora_acuta_HIv2___RNAseq.g12555.t1,139.4603702,-0.113874845,1.019549647,0.00584832,0.026550566,,Q7SYK1,0,Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.64) (Guanine insertion enzyme) (tRNA-guanine transglycosylase),tRNA-guanine transglycosylation [GO:0101030],GO:0005741; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0101030
3187,Pocillopora_acuta_HIv2___RNAseq.g29819.t1,656.2702915,1.963530795,1.841043199,0.005866503,0.026624757,,NA,NA,NA,NA,NA
3188,Pocillopora_acuta_HIv2___RNAseq.g27031.t1,1984.42921,1.730825005,1.006185047,0.005888936,0.026718184,,Q91ZU6,3.40E-10,Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2),axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],GO:0001725; GO:0003779; GO:0005198; GO:0005509; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007409; GO:0008017; GO:0008090; GO:0009898; GO:0014069; GO:0014704; GO:0015629; GO:0015630; GO:0016020; GO:0030018; GO:0030056; GO:0030424; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042383; GO:0042803; GO:0045098; GO:0045104; GO:0046907; GO:0048471; GO:0051010; GO:0097038; GO:1904115
3189,Pocillopora_acuta_HIv2___RNAseq.g14482.t1,74.4078439,-0.122685202,1.018326035,0.005906894,0.026791254,,Q8TBF5,1.63E-15,Phosphatidylinositol-glycan biosynthesis class X protein (PIG-X),GPI anchor biosynthetic process [GO:0006506],GO:0005789; GO:0006506
3190,Pocillopora_acuta_HIv2___RNAseq.g17245.t1,1184.699141,-0.918273811,1.494464105,0.005910913,0.026801081,,NA,NA,NA,NA,NA
3191,Pocillopora_acuta_HIv2___RNAseq.g2635.t1,693.035521,-0.503290473,1.122967501,0.005943677,0.02694119,,Q8WV41,2.63E-127,Sorting nexin-33 (SH3 and PX domain-containing protein 3),cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038],GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010
3192,Pocillopora_acuta_HIv2___RNAseq.g19230.t1,924.7085737,-1.020987724,1.442727118,0.00595231,0.026970103,,Q7SYJ9,4.88E-77,Sperm-associated antigen 7 homolog,,GO:0003676
3193,Pocillopora_acuta_HIv2___RNAseq.g11605.t1,275.0886001,-0.750262921,1.320593499,0.005953785,0.026970103,,Q9NVP1,0,ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18) (Myc-regulated DEAD box protein) (MrDb),"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]",GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0016020; GO:0016887
3194,Pocillopora_acuta_HIv2___RNAseq.g8484.t1,684.4932806,-0.909089289,1.460719316,0.005963663,0.027006393,,Q6Q0C0,0,E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7),apoptotic process [GO:0006915]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; ribosomal large subunit assembly [GO:0000027],GO:0000027; GO:0000151; GO:0004842; GO:0005730; GO:0005886; GO:0006915; GO:0007219; GO:0008270; GO:0016567; GO:0031410; GO:0035519; GO:0043231; GO:0043410; GO:0043525; GO:0061630; GO:0070372; GO:2000060; GO:2001235
3195,Pocillopora_acuta_HIv2___TS.g157.t1,384.7301105,0.990926735,1.642118855,0.005988897,0.027104245,,Q68UT7,1.92E-119,Hormonally up-regulated neu tumor-associated kinase (EC 2.7.11.1),intracellular signal transduction [GO:0035556],GO:0004674; GO:0005524; GO:0005737; GO:0035556; GO:0106310
3196,Pocillopora_acuta_HIv2___RNAseq.g15698.t1,842.3786493,1.719067035,0.893757817,0.005989019,0.027104245,,P54357,8.01E-10,Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain),actin filament-based movement [GO:0030048],GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036
3197,Pocillopora_acuta_HIv2___TS.g3644.t2,2525.755138,1.348078695,0.576646724,0.006008183,0.027182469,,P97379,4.85E-46,Ras GTPase-activating protein-binding protein 2 (G3BP-2) (GAP SH3 domain-binding protein 2),innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of stress granule assembly [GO:0062029]; protein homooligomerization [GO:0051260]; small GTPase-mediated signal transduction [GO:0007264]; stress granule assembly [GO:0034063],GO:0003729; GO:0005829; GO:0007264; GO:0010494; GO:0034063; GO:0045087; GO:0051028; GO:0051260; GO:0062029; GO:0140693; GO:1990904
3198,Pocillopora_acuta_HIv2___RNAseq.g13475.t1,1418.427761,0.869544305,1.437665127,0.006053365,0.02737832,,Q9Y2Y6,7.18E-32,Transmembrane protein 98 (Protein TADA1),negative regulation of myelination [GO:0031642]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein processing [GO:0010955]; T-helper 1 cell differentiation [GO:0045063],GO:0005615; GO:0005783; GO:0005789; GO:0005886; GO:0010955; GO:0031642; GO:0045063; GO:0048715; GO:0070062; GO:1900181
3199,Pocillopora_acuta_HIv2___RNAseq.g19240.t1,329.9055928,-0.930650296,1.449058554,0.006055899,0.02738122,"Testis-specific conserved, cAMP-dependent type II PK-anchoring protein",A6X8Z9,8.37E-08,"Testis-specific expressed protein 55 (Testis-specific conserved, cAMP-dependent type II PK-anchoring protein)",,GO:0005634
3200,Pocillopora_acuta_HIv2___RNAseq.g626.t1,825.4784509,-1.724116508,1.957165542,0.006116872,0.02764826,,Q9VXE5,2.68E-145,Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein),compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408],GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0006468; GO:0007010; GO:0007030; GO:0016319; GO:0031267; GO:0035556; GO:0043408; GO:0045315; GO:0045792; GO:0048639; GO:0048749; GO:0106310; GO:2000047
3201,Pocillopora_acuta_HIv2___RNAseq.g5143.t1,44.57632232,-0.821035935,1.393872276,0.006118856,0.027648589,,NA,NA,NA,NA,NA
3202,Pocillopora_acuta_HIv2___RNAseq.g12290.t1,272.6192892,-1.352239508,1.823759027,0.006124615,0.02766597,Fucolectin,Q7SIC1,1.31E-14,Fucolectin,"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]",GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088
3203,Pocillopora_acuta_HIv2___RNAseq.g6607.t1,1352.433312,-0.804409445,1.311974641,0.006134422,0.027695076,,Q8BL66,3.76E-76,Early endosome antigen 1,"chemical synaptic transmission, postsynaptic [GO:0099565]; endocytosis [GO:0006897]; modulation by host of viral process [GO:0044788]; vesicle fusion [GO:0006906]",GO:0005545; GO:0005768; GO:0005769; GO:0005829; GO:0005969; GO:0006897; GO:0006906; GO:0030742; GO:0031410; GO:0031901; GO:0042803; GO:0044308; GO:0044788; GO:0046872; GO:0055037; GO:0098685; GO:0098842; GO:0098978; GO:0099565
3204,Pocillopora_acuta_HIv2___RNAseq.g13220.t1,43.72241435,-0.394729414,1.109642695,0.006134888,0.027695076,,Q8WNR0,3.17E-23,High affinity copper uptake protein 1 (Copper transporter 1) (CTR1) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form],angiogenesis [GO:0001525]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; plasma membrane copper ion transport [GO:0015679]; protein complex oligomerization [GO:0051259]; silver ion transmembrane transport [GO:1902601]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; xenobiotic transport [GO:0042908],GO:0001525; GO:0005375; GO:0005507; GO:0005886; GO:0006825; GO:0015080; GO:0015677; GO:0015679; GO:0016323; GO:0016324; GO:0031901; GO:0031902; GO:0036324; GO:0042908; GO:0042910; GO:0051259; GO:0055038; GO:1902601
3205,Pocillopora_acuta_HIv2___RNAseq.g13758.t1,301.5873924,-0.372797758,1.067712502,0.006140382,0.02771123,,Q6ZMV9,0,Kinesin-like protein KIF6,microtubule-based movement [GO:0007018],GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887
3206,Pocillopora_acuta_HIv2___RNAseq.g29674.t1,113.2664292,1.707433944,0.895568255,0.006165867,0.027817559,,E2JA28,5.73E-07,Dapdiamide synthesis protein DdaC (EC 1.-.-.-),antibiotic biosynthetic process [GO:0017000],GO:0016491; GO:0017000
3207,Pocillopora_acuta_HIv2___RNAseq.g2565.t1,1916.736784,1.784327759,2.18221254,0.006190793,0.027921307,Secreted frizzled-related protein 5,Q9XSC1,1.10E-27,Secreted frizzled-related protein 5 (sFRP-5),canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; negative regulation of Wnt signaling pathway [GO:0030178]; non-canonical Wnt signaling pathway [GO:0035567],GO:0005615; GO:0017147; GO:0030154; GO:0030178; GO:0035567; GO:0060070
3208,Pocillopora_acuta_HIv2___RNAseq.g22839.t1,532.2130931,0.580607239,1.179264815,0.006193371,0.027924225,,Q01887,4.12E-117,Tyrosine-protein kinase RYK (EC 2.7.10.1) (Kinase VIK) (Met-related kinase) (NYK-R),"axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; chemorepulsion of axon [GO:0061643]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell proliferation in midbrain [GO:1904935]; positive regulation of MAPK cascade [GO:0043410]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007409; GO:0007411; GO:0016020; GO:0016055; GO:0017147; GO:0022038; GO:0030182; GO:0031175; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048787; GO:0048843; GO:0048846; GO:0050919; GO:0060071; GO:0061643; GO:0071679; GO:0098839; GO:0098978; GO:1904935; GO:1904948
3209,Pocillopora_acuta_HIv2___RNAseq.g15513.t1,134.9063715,-0.354065048,1.095863453,0.006198677,0.027939442,,Q32P85,9.61E-26,"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)",microtubule-based movement [GO:0007018],GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505
3210,Pocillopora_acuta_HIv2___RNAseq.g1905.t1,47.69989549,-0.443030883,1.139530425,0.006216887,0.028012789,,Q5F3A6,5.76E-43,Ubiquitin thioesterase OTU1 (EC 3.4.19.12),endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536],GO:0004843; GO:0005737; GO:0016236; GO:0016579; GO:0030968; GO:0035523; GO:0035871; GO:0036503; GO:0046872; GO:0070536; GO:0071108; GO:1990167; GO:1990168
3211,Pocillopora_acuta_HIv2___RNAseq.6832_t,2401.025736,1.331011844,1.872508795,0.006225769,0.028044073,,Q9UPX0,2.77E-78,Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B),cell adhesion [GO:0007155]; nervous system development [GO:0007399],GO:0007155; GO:0007399; GO:0014069; GO:0043005; GO:0045211
3212,Pocillopora_acuta_HIv2___RNAseq.g19138.t1,461.048357,-0.423096856,1.119321528,0.006231259,0.028060065,,A2BIG9,2.75E-29,"N-alpha-acetyltransferase 38, NatC auxiliary subunit (LSM domain-containing protein 1)",negative regulation of apoptotic process [GO:0043066],GO:0003723; GO:0005634; GO:0005737; GO:0031417; GO:0043066
3213,Pocillopora_acuta_HIv2___TS.g25091.t1,701.4671619,-0.569118825,1.150548966,0.006237596,0.028079862,,Q8HYI9,5.86E-39,Prefoldin subunit 5,negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; protein folding [GO:0006457]; retina development in camera-type eye [GO:0060041]; RNA polymerase I assembly [GO:1990113]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase III assembly [GO:1990115],GO:0001540; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0016272; GO:0045111; GO:0045892; GO:0051082; GO:0060041; GO:0090090; GO:1905907; GO:1990113; GO:1990114; GO:1990115
3214,Pocillopora_acuta_HIv2___RNAseq.g2202.t1,132.0027456,-0.210953476,1.046939685,0.006280484,0.028259344,,NA,NA,NA,NA,NA
3215,Pocillopora_acuta_HIv2___RNAseq.g30379.t1,1005.608984,0.162802727,1.024347349,0.006281374,0.028259344,,Q80YS6,3.18E-07,Actin filament-associated protein 1 (110 kDa actin filament-associated protein) (AFAP-110),regulation of signal transduction [GO:0009966],GO:0001725; GO:0003779; GO:0005829; GO:0005884; GO:0005925; GO:0009966; GO:0017124; GO:0042169
3216,Pocillopora_acuta_HIv2___RNAseq.g28871.t1,1051.684971,-1.536756591,0.73541974,0.006295833,0.028315588,,NA,NA,NA,NA,NA
3217,Pocillopora_acuta_HIv2___RNAseq.g16572.t1,56.25203401,0.806575713,1.334707511,0.006304622,0.028346303,,NA,NA,NA,NA,NA
3218,Pocillopora_acuta_HIv2___RNAseq.g10565.t2,85.98172534,-0.502486918,1.18646637,0.00630915,0.028357846,,Q5RA22,0,Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (EC 3.1.3.99) (Cytosolic nucleoside phosphotransferase 5'N) (EC 2.7.1.77),adenosine metabolic process [GO:0046085]; dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP metabolic process [GO:0046040],GO:0005524; GO:0005829; GO:0008253; GO:0042802; GO:0046037; GO:0046040; GO:0046054; GO:0046085; GO:0046872; GO:0050146; GO:0050483; GO:0050484; GO:0106411
3219,Pocillopora_acuta_HIv2___RNAseq.g14910.t1,168.0830333,-0.676081756,1.288142613,0.006320001,0.028397792,,Q9D483,5.09E-154,DNA-directed RNA polymerase III subunit RPC3 (RNA polymerase III subunit C3) (DNA-directed RNA polymerase III subunit C),defense response to virus [GO:0051607]; DNA-templated transcription [GO:0006351]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728],GO:0003697; GO:0005654; GO:0005666; GO:0006351; GO:0016779; GO:0032728; GO:0045087; GO:0045089; GO:0051607
3220,Pocillopora_acuta_HIv2___RNAseq.g25833.t1,439.0680938,-0.752521101,1.289113947,0.006323421,0.028404337,,Q0V8S9,4.18E-08,Contactin-associated protein-like 5 (Cell recognition molecule Caspr5),cell adhesion [GO:0007155],GO:0007155; GO:0016020
3221,Pocillopora_acuta_HIv2___RNAseq.g26299.t1,441.6215868,-1.670498856,0.900729133,0.00633206,0.028434311,,Q6P4K6,1.03E-40,Serine/threonine-protein kinase 11-interacting protein,,GO:0005737
3222,Pocillopora_acuta_HIv2___RNAseq.g29898.t1,1879.116105,-2.034549382,1.859233321,0.006348358,0.028498649,,P16068,5.26E-167,Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit),cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482],GO:0004383; GO:0005525; GO:0005737; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0038060; GO:0046872; GO:0070482; GO:0071732
3223,Pocillopora_acuta_HIv2___RNAseq.g21221.t1,192.8940294,0.757099706,1.421446428,0.006357324,0.028530043,,O57382,7.10E-17,Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid),cell differentiation [GO:0030154]; proteolysis [GO:0006508],GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154
3224,Pocillopora_acuta_HIv2___RNAseq.g20958.t1,28.12508675,-0.815491774,1.455385123,0.006398821,0.028707365,,NA,NA,NA,NA,NA
3225,Pocillopora_acuta_HIv2___RNAseq.g1540.t1,77.22523566,-0.355244469,1.086309653,0.00640169,0.028711331,,NA,NA,NA,NA,NA
3226,Pocillopora_acuta_HIv2___RNAseq.g132.t1a,1606.915546,-0.830346087,1.400491799,0.006426481,0.02881257,,A6QPB3,9.49E-16,Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog],extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581],GO:0005581; GO:0005604; GO:0005615; GO:0008201; GO:0016020; GO:0030020; GO:0030056; GO:0030198; GO:0031581; GO:0062023
3227,Pocillopora_acuta_HIv2___RNAseq.g24849.t1,204.1788353,-0.381141357,1.093089957,0.006428247,0.02881257,,NA,NA,NA,NA,NA
3228,Pocillopora_acuta_HIv2___TS.g24807.t1,6598.607299,-1.319020306,0.567959203,0.006430824,0.028815191,,Q96RW7,1.03E-15,Hemicentin-1 (Fibulin-6) (FIBL-6),actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711
3229,Pocillopora_acuta_HIv2___RNAseq.g26311.t1,550.8129419,-0.723357951,1.252408007,0.006445922,0.028873897,,P53349,1.40E-34,Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1),apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of actin filament bundle assembly [GO:0032232]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein polyubiquitination [GO:0000209]; regulation of cell migration [GO:0030334]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]; wound healing [GO:0042060],GO:0000165; GO:0000209; GO:0002011; GO:0003382; GO:0004672; GO:0004674; GO:0004706; GO:0004708; GO:0004709; GO:0004842; GO:0005524; GO:0005737; GO:0005829; GO:0006511; GO:0007179; GO:0007254; GO:0008092; GO:0008270; GO:0008432; GO:0008637; GO:0030054; GO:0030334; GO:0030838; GO:0031434; GO:0031941; GO:0032232; GO:0042060; GO:0043010; GO:0043065; GO:0043410; GO:0043507; GO:0044877; GO:0045893; GO:0045944; GO:0046330; GO:0046625; GO:0050434; GO:0051019; GO:0061029; GO:0090263; GO:0106310
3230,Pocillopora_acuta_HIv2___RNAseq.g5096.t1,550.2278078,1.701701659,1.770656056,0.006448076,0.028874602,,NA,NA,NA,NA,NA
3231,Pocillopora_acuta_HIv2___RNAseq.g12844.t1,697.013834,-0.781489188,1.304642626,0.006455026,0.02889678,,Q5EA19,1.57E-55,ADP-ribosylation factor-like protein 15,,GO:0003924; GO:0005525
3232,Pocillopora_acuta_HIv2___RNAseq.g8050.t1,392.7088782,-0.282033897,1.059126563,0.006457188,0.028897514,,Q6ZMY6,1.66E-92,WD repeat-containing protein 88 (PQQ repeat and WD repeat-containing protein),,
3233,Pocillopora_acuta_HIv2___TS.g6431.t1,39.37622694,-0.403204787,1.109499764,0.00646203,0.028905289,,Q9WV08,3.14E-13,Apelin receptor (Angiotensin receptor-like 1) (G-protein coupled receptor APJ) (MSR),adult heart development [GO:0007512]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; apelin receptor signaling pathway [GO:0060183]; atrioventricular valve development [GO:0003171]; blood vessel development [GO:0001568]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; heart development [GO:0007507]; heart looping [GO:0001947]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of inhibitory G protein-coupled receptor phosphorylation [GO:1904325]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of body fluid levels [GO:0050878]; regulation of gap junction assembly [GO:1903596]; regulation of gene expression [GO:0010468]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412],GO:0001525; GO:0001568; GO:0001570; GO:0001944; GO:0001947; GO:0003171; GO:0003272; GO:0005886; GO:0007186; GO:0007369; GO:0007507; GO:0007512; GO:0010468; GO:0010629; GO:0035886; GO:0035904; GO:0043951; GO:0045766; GO:0050878; GO:0051281; GO:0060182; GO:0060183; GO:0060412; GO:0060841; GO:0060976; GO:1903589; GO:1903596; GO:1904325
3234,Pocillopora_acuta_HIv2___RNAseq.g6225.t1,57.04852847,-0.265533537,1.044721565,0.006462922,0.028905289,,Q4V7N4,7.31E-49,Translation machinery-associated protein 16,ribosomal large subunit biogenesis [GO:0042273],GO:0005634; GO:0042273; GO:1990275
3235,Pocillopora_acuta_HIv2___RNAseq.g18101.t1,316.5581597,-0.556895578,1.135591212,0.00647051,0.028930278,,Q6TDP4,1.20E-36,Kelch-like protein 17 (Actinfilin),actin cytoskeleton organization [GO:0030036]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252],GO:0005615; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0032839; GO:0043025; GO:0051015; GO:0060090; GO:0098978; GO:0140252
3236,Pocillopora_acuta_HIv2___TS.g2830.t1,177.1003159,-1.504816851,0.700277747,0.006474936,0.028941122,,Q5F4A1,2.40E-18,G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase),apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872
3237,Pocillopora_acuta_HIv2___TS.g3555.t1,796.7141851,-0.872276122,1.370561213,0.00649204,0.029007069,,O00468,5.85E-07,Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)],clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808],GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007213; GO:0007528; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062
3238,Pocillopora_acuta_HIv2___RNAseq.g3532.t1,2305.543937,-1.818498634,1.156457607,0.006493701,0.029007069,,Q5E9E2,1.04E-88,"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)",actomyosin structure organization [GO:0031032],GO:0005509; GO:0005737; GO:0005938; GO:0016460; GO:0031032; GO:0042641; GO:0097513
3239,Pocillopora_acuta_HIv2___RNAseq.g4092.t1,889.8792497,-0.823138716,1.319636512,0.006510484,0.029073059,,A7YY35,2.70E-08,Uncharacterized protein KIAA2012 homolog,,
3240,Pocillopora_acuta_HIv2___TS.g11214.t1,137.8983918,0.237156599,1.035825688,0.006512911,0.029074921,,NA,NA,NA,NA,NA
3241,Pocillopora_acuta_HIv2___RNAseq.g21831.t1,1714.446684,-1.70036733,1.082990929,0.006527479,0.029130964,,O35066,1.36E-32,Kinesin-like protein KIF3C,microtubule-based movement [GO:0007018]; positive regulation of neuron projection development [GO:0010976],GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008021; GO:0010976; GO:0015630; GO:0016887; GO:0019894; GO:0030424; GO:0030425; GO:0030426; GO:0035371; GO:0043025; GO:0071598
3242,Pocillopora_acuta_HIv2___TS.g20605.t1,740.0860615,0.854691752,1.387125976,0.006542655,0.029189686,,NA,NA,NA,NA,NA
3243,Pocillopora_acuta_HIv2___RNAseq.g16244.t1,118.9244373,-0.410815273,1.115649787,0.006639941,0.029614585,,Q8VDP6,1.87E-88,CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase),CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661],GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341
3244,Pocillopora_acuta_HIv2___RNAseq.22810_t,56.26855788,-0.085555881,1.021450456,0.00665207,0.029654774,,NA,NA,NA,NA,NA
3245,Pocillopora_acuta_HIv2___RNAseq.g24929.t1,669.4005445,-1.064286407,1.588272426,0.006653052,0.029654774,,NA,NA,NA,NA,NA
3246,Pocillopora_acuta_HIv2___RNAseq.g14733.t1,230.2253246,0.422919368,1.120131306,0.006708793,0.029894017,,NA,NA,NA,NA,NA
3247,Pocillopora_acuta_HIv2___TS.g29912.t2,1245.445923,1.385737063,1.528951801,0.006726473,0.029963568,,E7FDW2,1.57E-61,E3 ubiquitin-protein ligase PDZRN3-B (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3-B),neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567],GO:0005737; GO:0007528; GO:0016567; GO:0045202; GO:0046872; GO:0061630
3248,Pocillopora_acuta_HIv2___RNAseq.g30117.t1,1197.667612,-0.409724122,1.070046524,0.006729077,0.029965941,,NA,NA,NA,NA,NA
3249,Pocillopora_acuta_HIv2___TS.g3256.t1,295.2955623,-1.071980502,1.600315153,0.006755427,0.030074022,Fucolectin-3,Q9I929,3.19E-13,Fucolectin-3,"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]",GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088
3250,Pocillopora_acuta_HIv2___RNAseq.g14772.t1,631.8154075,1.703387245,1.095559871,0.006766785,0.030115315,,NA,NA,NA,NA,NA
3251,Pocillopora_acuta_HIv2___RNAseq.15134_t,488.6212632,-0.522599932,1.160111101,0.006784518,0.030184948,,Q99PV3,0,Muskelin,actin cytoskeleton organization [GO:0030036]; cell-matrix adhesion [GO:0007160]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport in synapse [GO:0099003],GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005737; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030036; GO:0042802; GO:0042803; GO:0098895; GO:0098968; GO:0098982; GO:0099003; GO:0099164
3252,Pocillopora_acuta_HIv2___RNAseq.g16522.t1,189.63339,-0.114115996,1.021956494,0.006801611,0.030242918,,O42602,3.62E-31,Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852],GO:0005886; GO:0007166; GO:0007189; GO:0015056; GO:0051458; GO:0071376; GO:2000852
3253,Pocillopora_acuta_HIv2___RNAseq.g12054.t1,845.4536983,-1.620953665,1.594262831,0.006801729,0.030242918,,Q5EAJ7,0,Major vault protein (MVP),,GO:0005634; GO:0005737; GO:1990904
3254,Pocillopora_acuta_HIv2___RNAseq.g16254.t1,374.3346947,-1.420267478,1.655830853,0.006819821,0.03031404,,Q3KP44,3.99E-26,Ankyrin repeat domain-containing protein 55,,
3255,Pocillopora_acuta_HIv2___RNAseq.g22674.t1,265.7377902,2.215361608,1.857736876,0.006833551,0.030363476,,NA,NA,NA,NA,NA
3256,Pocillopora_acuta_HIv2___RNAseq.g5564.t1,202.2246475,-0.602398785,1.168930273,0.006835141,0.030363476,,Q9VGA4,5.42E-06,Protein MBD-R2,chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000785; GO:0000791; GO:0003677; GO:0005634; GO:0005700; GO:0005705; GO:0006325; GO:0006357; GO:0044545; GO:0045944; GO:0046872; GO:1990841
3257,Pocillopora_acuta_HIv2___RNAseq.g12336.t1,233.8222298,-1.028412468,1.533328079,0.006877036,0.030536309,,NA,NA,NA,NA,NA
3258,Pocillopora_acuta_HIv2___RNAseq.g31032.t1,473.8566109,-0.712743544,1.280085782,0.00687827,0.030536309,,Q99LM2,2.49E-164,CDK5 regulatory subunit-associated protein 3,apoptotic nuclear changes [GO:0030262]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of reticulophagy [GO:0140501]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]; ribosome disassembly [GO:0032790],GO:0000079; GO:0001889; GO:0001933; GO:0005634; GO:0005730; GO:0005737; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0007095; GO:0007346; GO:0008283; GO:0010921; GO:0030262; GO:0030332; GO:0030968; GO:0031398; GO:0032088; GO:0032790; GO:0032991; GO:0034976; GO:0042177; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0044877; GO:0045944; GO:0051019; GO:0051059; GO:0060318; GO:0071569; GO:0071901; GO:0097371; GO:0140501; GO:1900182; GO:1901798; GO:1990756
3259,Pocillopora_acuta_HIv2___RNAseq.g6431.t1,534.3571233,-0.483729387,1.115284505,0.006947631,0.030834776,,P70618,6.62E-155,Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha),angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; fatty acid oxidation [GO:0019395]; glucose import [GO:0046323]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of DNA-templated transcription [GO:0006355]; regulation of ossification [GO:0030278]; regulation of synaptic membrane adhesion [GO:0099179]; regulation of transcription by RNA polymerase II [GO:0006357]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transcription by RNA polymerase II [GO:0006366]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],GO:0000077; GO:0000165; GO:0000902; GO:0000922; GO:0001502; GO:0001525; GO:0001649; GO:0001890; GO:0002021; GO:0002062; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006006; GO:0006355; GO:0006357; GO:0006366; GO:0006915; GO:0006974; GO:0007178; GO:0007519; GO:0009749; GO:0010628; GO:0010831; GO:0016301; GO:0019395; GO:0019899; GO:0019903; GO:0030278; GO:0030316; GO:0031098; GO:0031663; GO:0032495; GO:0032496; GO:0032735; GO:0032868; GO:0035331; GO:0035556; GO:0035924; GO:0035994; GO:0038066; GO:0042307; GO:0042770; GO:0045648; GO:0045663; GO:0045944; GO:0046323; GO:0046326; GO:0048010; GO:0048273; GO:0048863; GO:0051146; GO:0051403; GO:0051525; GO:0060045; GO:0060348; GO:0071222; GO:0071223; GO:0071356; GO:0071479; GO:0071493; GO:0071560; GO:0090090; GO:0090336; GO:0090400; GO:0098978; GO:0099179; GO:0106310; GO:1900015; GO:1901741; GO:2000379
3260,Pocillopora_acuta_HIv2___TS.g4805.t1,112.8636827,-0.215627065,1.04860524,0.006956844,0.030863634,,P17926,7.06E-99,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),DNA replication [GO:0006260]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0005634; GO:0006260; GO:0006357; GO:0045893
3261,Pocillopora_acuta_HIv2___RNAseq.g6273.t1,715.7482719,-1.617989221,0.8915484,0.006958401,0.030863634,,Q5F4A1,1.91E-75,G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase),apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872
3262,Pocillopora_acuta_HIv2___RNAseq.g24349.t1,61.50096842,-0.480176594,1.154221697,0.006974539,0.030925731,,NA,NA,NA,NA,NA
3263,Pocillopora_acuta_HIv2___RNAseq.3321_t,739.3721013,-0.736660896,1.279160961,0.00699806,0.031020514,,Q6AYP4,1.40E-29,Zinc finger C2HC domain-containing protein 1C,,GO:0046872
3264,Pocillopora_acuta_HIv2___RNAseq.g18209.t1,614.5837804,-1.185259443,1.69817062,0.007018848,0.031103131,,P49695,2.93E-30,Probable serine/threonine-protein kinase PkwA (EC 2.7.11.1),,GO:0004674; GO:0005524; GO:0106310
3265,Pocillopora_acuta_HIv2___RNAseq.g23661.t1,164.099075,-1.265346971,1.582870454,0.007031422,0.031149309,,NA,NA,NA,NA,NA
3266,Pocillopora_acuta_HIv2___RNAseq.g11318.t1,3151.418307,1.670925369,0.971473137,0.00703986,0.031177141,,NA,NA,NA,NA,NA
3267,Pocillopora_acuta_HIv2___TS.g10759.t1,128.8643822,-0.394519459,1.099769077,0.007052663,0.031224277,,Q7Z494,8.91E-11,Nephrocystin-3,"atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]",GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095
3268,Pocillopora_acuta_HIv2___RNAseq.g17925.t1,516.2401979,-0.460143825,1.125991635,0.007056038,0.031229663,,O75191,0,Xylulose kinase (Xylulokinase) (EC 2.7.1.17),carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997],GO:0004856; GO:0005524; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0019640; GO:0042732
3269,Pocillopora_acuta_HIv2___TS.g11857.t2,566.9430429,-1.932933977,1.685438497,0.007070639,0.031282971,,Q6NTV6,1.90E-82,Inverted formin-2,actin cytoskeleton organization [GO:0030036],GO:0003779; GO:0030036; GO:0031267
3270,Pocillopora_acuta_HIv2___RNAseq.g19659.t1,60.71442848,-0.366688676,1.052306465,0.007072408,0.031282971,,Q3B8D7,4.61E-23,Dynein light chain Tctex-type 5-A (Tctex1 domain-containing protein 1-A),,
3271,Pocillopora_acuta_HIv2___RNAseq.g9209.t1,151.2785792,-0.358625116,1.063836503,0.007076956,0.031293514,,NA,NA,NA,NA,NA
3272,Pocillopora_acuta_HIv2___TS.g10252.t2,286.8480918,0.675921975,1.345490324,0.007091985,0.031350387,,Q9WVM6,3.28E-31,Tolloid-like protein 2 (EC 3.4.24.-),cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of skeletal muscle tissue growth [GO:0048632]; protein processing [GO:0016485],GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0048632
3273,Pocillopora_acuta_HIv2___TS.g5728.t1,48.59308965,-1.895117163,1.76931667,0.007096614,0.031361265,,NA,NA,NA,NA,NA
3274,Pocillopora_acuta_HIv2___RNAseq.g29033.t1,69.16140335,-0.417071447,1.117828043,0.00711237,0.031421296,,NA,NA,NA,NA,NA
3275,Pocillopora_acuta_HIv2___TS.g31609.t2,1410.380418,1.458843503,0.687000986,0.007117437,0.031434077,,Q9DAN9,4.14E-25,Sperm axonemal maintenance protein CFAP97D1 (CFAP97 domain-containing protein 1),sperm axoneme assembly [GO:0007288],GO:0007288
3276,Pocillopora_acuta_HIv2___RNAseq.g16358.t1,18.66450009,-0.575061221,1.22855463,0.007133327,0.03149464,,NA,NA,NA,NA,NA
3277,Pocillopora_acuta_HIv2___RNAseq.10474_t,952.3698193,-0.178446455,1.025751764,0.00715148,0.031553419,,Q5R947,1.04E-135,U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4),ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],GO:0006364; GO:0030515; GO:0032040; GO:0034457; GO:0042134; GO:0042274
3278,Pocillopora_acuta_HIv2___RNAseq.g1418.t1,97.19998942,-0.221974864,1.048774971,0.007152041,0.031553419,,NA,NA,NA,NA,NA
3279,Pocillopora_acuta_HIv2___RNAseq.g25999.t1,2200.926235,-1.562332689,0.808314801,0.007153184,0.031553419,,Q2HJ23,1.37E-50,Microtubule-associated proteins 1A/1B light chain 3A (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (MAP1A/MAP1B light chain 3 A) (MAP1A/MAP1B LC3 A) (Microtubule-associated protein 1 light chain 3 alpha),autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995],GO:0000045; GO:0000421; GO:0000422; GO:0005543; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0008429; GO:0012505; GO:0031090; GO:0031410; GO:0031625; GO:0097352
3280,Pocillopora_acuta_HIv2___RNAseq.g1720.t1,926.3032326,-1.642499008,0.921543685,0.007181682,0.031669467,,Q8BH18,1.07E-163,Transmembrane protein 117,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059],GO:0005783; GO:0005886; GO:0070059
3281,Pocillopora_acuta_HIv2___RNAseq.g3051.t1,4957.841057,-1.421725342,0.666141207,0.007193423,0.031711574,,P02640,0,Villin-1,actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617],GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392
3282,Pocillopora_acuta_HIv2___RNAseq.g19611.t1,148.3483675,-0.145189193,1.019280846,0.007204968,0.03175279,,Q8C6C9,1.08E-61,Protein LEG1 homolog,,GO:0005615
3283,Pocillopora_acuta_HIv2___RNAseq.g30726.t1,3698.971987,2.091102701,1.963455264,0.007209195,0.031753028,High-affinity sodium-dependent carnitine cotransporter,O76082,1.84E-83,Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5),(R)-carnitine transmembrane transport [GO:1902270]; (R)-carnitine transport [GO:1900749]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961],GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006814; GO:0009609; GO:0009925; GO:0015199; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016324; GO:0030165; GO:0031526; GO:0034341; GO:0034612; GO:0042910; GO:0060731; GO:0070062; GO:0070715; GO:0150104; GO:1900749; GO:1901235; GO:1902270; GO:1902603; GO:1990961
3284,Pocillopora_acuta_HIv2___RNAseq.g20862.t1,41.61383246,-0.375262292,1.098673516,0.007209413,0.031753028,,Q9VVU5,7.44E-20,COP9 signalosome complex subunit 1b (Dch1-2) (Signalosome subunit 1b),female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821],GO:0000338; GO:0005737; GO:0007281; GO:0008180; GO:0036099; GO:0048140; GO:0048142; GO:0050821
3285,Pocillopora_acuta_HIv2___RNAseq.g16123.t1,182.9315447,0.462186534,1.14105704,0.007224203,0.031808485,,Q9VCA2,1.26E-104,Organic cation transporter protein,apoptotic process [GO:0006915]; monoatomic ion transport [GO:0006811],GO:0006811; GO:0006915; GO:0016020; GO:0022857
3286,Pocillopora_acuta_HIv2___RNAseq.g24792.t1,260.0994095,-0.364768053,1.059594305,0.007245343,0.031891856,,Q03601,2.31E-12,RING finger protein nhl-1,negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567],GO:0000209; GO:0004842; GO:0016567; GO:0017148; GO:0030371; GO:0043161; GO:0046872; GO:0061630
3287,Pocillopora_acuta_HIv2___RNAseq.g3839.t1,1229.595627,1.611282453,0.875189136,0.007266706,0.031976159,,NA,NA,NA,NA,NA
3288,Pocillopora_acuta_HIv2___RNAseq.g1695.t1,212.282018,-0.443878989,1.131826474,0.00729951,0.032110738,,NA,NA,NA,NA,NA
3289,Pocillopora_acuta_HIv2___RNAseq.g18779.t1,1389.657609,-1.375445512,0.623630902,0.007329586,0.03223324,,Q32P51,2.27E-39,Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2),"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]",GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013
3290,Pocillopora_acuta_HIv2___RNAseq.g8406.t1,1412.217767,-1.264439136,1.574912435,0.007340069,0.03226953,,Q9JHS4,0,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial",ATP metabolic process [GO:0046034]; proteolysis involved in protein catabolic process [GO:0051603],GO:0004176; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662
3291,Pocillopora_acuta_HIv2___TS.g24842.t1,1060.968387,0.647648278,1.306693783,0.007381926,0.03244369,,A2AJ76,4.51E-49,Hemicentin-2,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808],GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023
3292,Pocillopora_acuta_HIv2___RNAseq.g13086.t1,801.4953744,-0.385413009,1.098103131,0.007399284,0.032510098,,Q9BZC7,0,ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2),central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; ganglioside metabolic process [GO:0001573]; glycosphingolipid metabolic process [GO:0006687]; intracellular sphingolipid homeostasis [GO:0090156]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative regulation of steroid metabolic process [GO:0045939]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of steroid metabolic process [GO:0019218]; response to cholesterol [GO:0070723]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin metabolic process [GO:0006684]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104],GO:0000166; GO:0001573; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006629; GO:0006684; GO:0006687; GO:0006869; GO:0007626; GO:0009410; GO:0010008; GO:0016020; GO:0016887; GO:0019218; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0045939; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0140359; GO:0150104; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008
3293,Pocillopora_acuta_HIv2___RNAseq.g14084.t2,1622.620141,1.626959585,0.85294555,0.0074028,0.032515671,,NA,NA,NA,NA,NA
3294,Pocillopora_acuta_HIv2___RNAseq.g23187.t1,112.6856074,-0.394883566,1.0701611,0.007407351,0.032525782,,O42127,9.70E-84,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1),apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284],GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284
3295,Pocillopora_acuta_HIv2___TS.g13497.t1c,2223.129732,-1.726486397,1.177112925,0.007409918,0.032527181,,Q94738,0,97 kDa heat shock protein (Heat shock protein 110),,GO:0005524; GO:0005634; GO:0005829; GO:0140662
3296,Pocillopora_acuta_HIv2___RNAseq.g28156.t1,14.87547012,0.440854673,1.115830338,0.007413846,0.032531374,,NA,NA,NA,NA,NA
3297,Pocillopora_acuta_HIv2___RNAseq.g12402.t1,50.97496518,-0.528335849,1.144188401,0.007415372,0.032531374,,Q09575,9.88E-21,Uncharacterized protein K02A2.6,DNA integration [GO:0015074],GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575
3298,Pocillopora_acuta_HIv2___RNAseq.g24196.t1,123.5633197,1.735988371,1.195920084,0.007428028,0.032577015,,P70115,2.37E-13,Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; regulation of metabolic process [GO:0019222],GO:0004978; GO:0005737; GO:0005886; GO:0007189; GO:0019222
3299,Pocillopora_acuta_HIv2___TS.g27453.t1,64.00145365,-0.394629329,1.106473737,0.007444563,0.032639636,,Q9VBP9,7.45E-07,Nuclear protein localization protein 4 homolog,cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0031625; GO:0043130; GO:0043161; GO:0045879; GO:0046872; GO:0071795; GO:0098586
3300,Pocillopora_acuta_HIv2___RNAseq.g10767.t1,931.0846552,-0.395244821,1.067013949,0.00745529,0.032676762,,Q640V2,1.95E-155,E3 ubiquitin-protein ligase RMND5A (EC 2.3.2.27) (Protein RMD5 homolog A),proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209],GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0043161; GO:0046872; GO:0061630
3301,Pocillopora_acuta_HIv2___RNAseq.g22643.t1,4097.704299,-0.85988884,1.461282434,0.007461628,0.032694636,,O57321,8.52E-151,Excitatory amino acid transporter 1 (SEAAT1) (Sodium-dependent glutamate/aspartate transporter) (GLAST),chloride transmembrane transport [GO:1902476]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; potassium ion transmembrane transport [GO:0071805],GO:0005314; GO:0005886; GO:0015501; GO:0046872; GO:0070779; GO:0071805; GO:0098712; GO:0140009; GO:1902476
3302,Pocillopora_acuta_HIv2___TS.g26330.t1,157.2097686,-0.14732711,1.025980796,0.007470716,0.032722532,,Q96GQ5,1.83E-101,RUS family member 1,,GO:0016020
3303,Pocillopora_acuta_HIv2___RNAseq.g25552.t1,139.5920028,-0.312746565,1.073498783,0.00747252,0.032722532,,NA,NA,NA,NA,NA
3304,Pocillopora_acuta_HIv2___RNAseq.g9126.t1,195.0967464,-0.655659642,1.188093815,0.007478277,0.032737831,,NA,NA,NA,NA,NA
3305,Pocillopora_acuta_HIv2___TS.g1429.t1,896.0654563,-0.846656329,1.272265448,0.007490226,0.032770408,,Q08D64,0,ATP-binding cassette sub-family B member 6 (ABC-type heme transporter ABCB6) (EC 7.6.2.5),cellular detoxification of cadmium ion [GO:0098849]; heme metabolic process [GO:0042168]; heme transmembrane transport [GO:0035351]; intracellular copper ion homeostasis [GO:0006878]; melanosome assembly [GO:1903232]; porphyrin-containing compound metabolic process [GO:0006778]; tetrapyrrole metabolic process [GO:0033013],GO:0000139; GO:0005524; GO:0005739; GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005886; GO:0006778; GO:0006878; GO:0015439; GO:0016887; GO:0031901; GO:0031902; GO:0032585; GO:0033013; GO:0033162; GO:0035351; GO:0036020; GO:0042168; GO:0046906; GO:0070062; GO:0098849; GO:0140359; GO:1903232
3306,Pocillopora_acuta_HIv2___TS.g3473.t1,87.69186781,-0.388582785,1.105104675,0.007490249,0.032770408,,Q06705,1.51E-24,Phosphatidylinositol transfer protein CSR1 (CHS5 SPA2 rescue protein 1) (SEC14 homolog protein 2),Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of phosphatidylglycerol biosynthetic process [GO:1901352]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid catabolic process [GO:0009395]; phospholipid transport [GO:0015914]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247],GO:0005628; GO:0005739; GO:0005768; GO:0005783; GO:0005811; GO:0005829; GO:0006893; GO:0008526; GO:0009395; GO:0015914; GO:0043001; GO:0045717; GO:0046488; GO:1901352; GO:2001247
3307,Pocillopora_acuta_HIv2___RNAseq.g26903.t1,53.30060984,0.079097712,1.020899368,0.007508864,0.032841912,,Q8K4L0,0,ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (DEAD box protein 54),RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364],GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016070; GO:0016887; GO:0030331
3308,Pocillopora_acuta_HIv2___RNAseq.g3266.t1,498.7499493,-1.394303567,1.79497171,0.007525432,0.03290443,,Q4R6V2,0,T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon),,GO:0005524; GO:0005813; GO:0005832; GO:0016887; GO:0031681; GO:0051082; GO:0140662
3309,Pocillopora_acuta_HIv2___TS.g26645.t1,970.9519603,0.328564853,1.070294268,0.007533664,0.032930469,,Q7KWX2,1.41E-18,Probable CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase 1) (PGP synthase 1),cardiolipin biosynthetic process [GO:0032049]; phospholipid biosynthetic process [GO:0008654],GO:0005524; GO:0005739; GO:0008444; GO:0008654; GO:0032049
3310,Pocillopora_acuta_HIv2___RNAseq.g6374.t1,33.89355032,0.070905255,1.02025103,0.007552313,0.033002012,,NA,NA,NA,NA,NA
3311,Pocillopora_acuta_HIv2___RNAseq.g16697.t1,51.69049424,-0.38044005,1.100683256,0.007556007,0.03300818,,P20735,1.91E-149,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; zymogen activation [GO:0031638],GO:0002682; GO:0002951; GO:0005886; GO:0006536; GO:0006750; GO:0006751; GO:0031179; GO:0031638; GO:0036374; GO:0050727; GO:0103068
3312,Pocillopora_acuta_HIv2___RNAseq.g10899.t1,537.6114597,-1.420656233,1.673883008,0.007564492,0.033035268,,O35972,2.96E-31,"Large ribosomal subunit protein uL23m (39S ribosomal protein L23, mitochondrial) (L23mt) (MRP-L23) (L23 mitochondrial-related protein)",mitochondrial translation [GO:0032543]; translation [GO:0006412],GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543
3313,Pocillopora_acuta_HIv2___RNAseq.g15458.t1,16.30616753,-0.418585242,1.141705547,0.007587632,0.033126323,,Q09575,2.12E-19,Uncharacterized protein K02A2.6,DNA integration [GO:0015074],GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575
3314,Pocillopora_acuta_HIv2___RNAseq.g11140.t1,80.93153464,-0.415450361,1.120018352,0.007600279,0.033171526,,NA,NA,NA,NA,NA
3315,Pocillopora_acuta_HIv2___RNAseq.g22366.t1,2478.84738,-1.694522021,1.485546973,0.007636206,0.033316219,,O43602,8.56E-46,Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X),axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; retina development in camera-type eye [GO:0060041],GO:0001764; GO:0005829; GO:0005856; GO:0005874; GO:0005875; GO:0007399; GO:0007417; GO:0008017; GO:0019901; GO:0035082; GO:0035556; GO:0043005; GO:0060041
3316,Pocillopora_acuta_HIv2___RNAseq.g14033.t1,24.71063587,-0.943570206,1.642392551,0.007638038,0.033316219,,NA,NA,NA,NA,NA
3317,Pocillopora_acuta_HIv2___TS.g6579.t1,663.5969427,-1.39421501,0.645004887,0.007679125,0.033485336,,Q969N2,0,GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein),attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182],GO:0005789; GO:0016020; GO:0016255; GO:0030182; GO:0031410; GO:0042765; GO:0051402
3318,Pocillopora_acuta_HIv2___RNAseq.g9675.t1,152.4950271,-0.063365118,1.020690296,0.007685988,0.033505165,,Q91YT7,2.29E-10,YTH domain-containing family protein 2,embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; gamete generation [GO:0007276]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; organelle assembly [GO:0070925]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of cell adhesion [GO:0030155]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]; regulation of rRNA processing [GO:2000232]; spermatogonial cell division [GO:0007284]; stress granule assembly [GO:0034063],GO:0000932; GO:0001556; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0007276; GO:0007284; GO:0010494; GO:0030155; GO:0034063; GO:0034451; GO:0043488; GO:0045087; GO:0045746; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0062153; GO:0070925; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247; GO:2000232; GO:2000737
3319,Pocillopora_acuta_HIv2___TS.g26021.t1,2935.179113,-1.909220734,1.908388936,0.007688942,0.033507943,,Q795M8,9.50E-11,Putative potassium channel protein YugO,,GO:0005267; GO:0005886
3320,Pocillopora_acuta_HIv2___RNAseq.g26319.t1,4443.852525,1.372857168,0.626969633,0.007694307,0.033521223,,Q9UJA9,4.20E-89,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-),cell communication [GO:0007154],GO:0000210; GO:0005576; GO:0005886; GO:0007154; GO:0008270
3321,Pocillopora_acuta_HIv2___RNAseq.g13683.t1,3735.239222,1.398739004,0.648530775,0.007717468,0.033611999,,Q9BXW4,4.18E-61,Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C) (MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma),aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; protein exit from endoplasmic reticulum [GO:0032527],GO:0000045; GO:0000421; GO:0000422; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008429; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0032527; GO:0035973; GO:0036464; GO:0097352
3322,Pocillopora_acuta_HIv2___RNAseq.g7991.t1,180.6593687,0.629445883,1.20856941,0.00778818,0.033909763,,Q2YDM5,2.46E-25,"Sperm microtubule inner protein 8 (Testis, prostate and placenta-expressed protein)",,GO:0005737; GO:0005856; GO:0031514
3323,Pocillopora_acuta_HIv2___RNAseq.g15320.t1,128.8273344,-0.69836249,1.252925275,0.007797889,0.03394182,,NA,NA,NA,NA,NA
3324,Pocillopora_acuta_HIv2___RNAseq.g13676.t1,611.0646081,-0.724870663,1.271907726,0.007846047,0.034136255,,NA,NA,NA,NA,NA
3325,Pocillopora_acuta_HIv2___RNAseq.g10408.t1,1143.398657,-1.60936169,1.013210226,0.007847279,0.034136255,,P23511,7.20E-32,Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA),positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; transcription by RNA polymerase II [GO:0006366],GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0016602; GO:0032993; GO:0045893; GO:0045944; GO:0048511; GO:0090575
3326,Pocillopora_acuta_HIv2___RNAseq.g11253.t1,562.242763,-0.286715269,1.036303341,0.007860443,0.034183236,,NA,NA,NA,NA,NA
3327,Pocillopora_acuta_HIv2___RNAseq.g8093.t1,2555.995305,-1.436201207,0.687633563,0.00786945,0.034212121,,Q06A37,0,Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7),adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chordate embryonic development [GO:0043009]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]; ventricular trabecula myocardium morphogenesis [GO:0003222],GO:0000785; GO:0000978; GO:0001501; GO:0001974; GO:0003007; GO:0003222; GO:0003226; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006364; GO:0006366; GO:0007417; GO:0007512; GO:0007605; GO:0007628; GO:0008015; GO:0009617; GO:0010468; GO:0010880; GO:0016887; GO:0021545; GO:0021553; GO:0021772; GO:0030217; GO:0030540; GO:0035116; GO:0035909; GO:0036302; GO:0040018; GO:0042048; GO:0042393; GO:0042472; GO:0043009; GO:0043584; GO:0045944; GO:0048752; GO:0050767; GO:0050890; GO:0060041; GO:0060123; GO:0060324; GO:0060384; GO:0060411; GO:0060429; GO:0062009; GO:0140658; GO:1990841
3328,Pocillopora_acuta_HIv2___RNAseq.g22701.t1,172.9761247,0.193060741,1.038499974,0.007881181,0.034252825,,Q86V85,9.99E-85,Integral membrane protein GPR180 (Intimal thickness-related receptor),G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236],GO:0007186; GO:0016020; GO:0019236
3329,Pocillopora_acuta_HIv2___TS.g22400.t1,407.8765465,0.369875002,1.098779895,0.007885399,0.034260861,,Q8K0U4,1.99E-129,Heat shock 70 kDa protein 12A,,GO:0005524; GO:0005634; GO:0005737
3330,Pocillopora_acuta_HIv2___RNAseq.g16055.t1,521.2871487,-1.019947756,1.484667613,0.007898868,0.034309075,,NA,NA,NA,NA,NA
3331,Pocillopora_acuta_HIv2___RNAseq.g17534.t1,547.2114644,-1.609250197,1.62921973,0.007905195,0.034326249,,Q8JFV8,7.59E-39,Synaptic vesicle membrane protein VAT-1 homolog (EC 1.-.-.-),negative regulation of mitochondrial fusion [GO:0010637],GO:0005741; GO:0008270; GO:0010637; GO:0016491
3332,Pocillopora_acuta_HIv2___RNAseq.g8813.t1,290.2611181,-0.665106368,1.263288103,0.007933538,0.034438985,,Q11127,1.31E-40,"Alpha-(1,3)-fucosyltransferase 4 (4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase) (EC 2.4.1.152) (Fucosyltransferase 4) (Fucosyltransferase IV) (Fuc-TIV) (FucT-IV) (Galactoside 3-L-fucosyltransferase)",fucosylation [GO:0036065]; glycosphingolipid biosynthetic process [GO:0006688]; inflammatory response [GO:0006954]; Lewis x epitope biosynthetic process [GO:0106402]; lymphocyte migration into lymph node [GO:0097022]; oligosaccharide metabolic process [GO:0009311]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neutrophil migration [GO:1902624]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; regulation of leukocyte cell-cell adhesion [GO:1903037],GO:0005802; GO:0006487; GO:0006493; GO:0006688; GO:0006954; GO:0009311; GO:0009986; GO:0017083; GO:0032580; GO:0036065; GO:0046920; GO:0071944; GO:0097022; GO:0106402; GO:1902624; GO:1903037; GO:1903238
3333,Pocillopora_acuta_HIv2___RNAseq.g8531.t1,150.7649386,-0.678742499,1.279558238,0.007944682,0.034471884,,Q4R6V2,0,T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon),,GO:0005524; GO:0005813; GO:0005832; GO:0016887; GO:0031681; GO:0051082; GO:0140662
3334,Pocillopora_acuta_HIv2___TS.g25541.t1,181.5471659,-0.833764737,1.350294684,0.007945884,0.034471884,,Q7TPQ9,3.77E-35,Arrestin domain-containing protein 3,fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of hippo signaling [GO:0035332]; protein transport [GO:0015031]; skin development [GO:0043588]; temperature homeostasis [GO:0001659],GO:0001659; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0031649; GO:0031651; GO:0031699; GO:0035332; GO:0043588; GO:0060613; GO:0071878; GO:0090327; GO:0120163
3335,Pocillopora_acuta_HIv2___RNAseq.g26778.t1,1470.527445,0.906553258,1.405704882,0.007949471,0.034477107,,O57460,2.97E-34,Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein),blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; protein processing [GO:0016485]; proteolysis [GO:0006508],GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264
3336,Pocillopora_acuta_HIv2___RNAseq.g11090.t1,41.21559427,-0.351408974,1.085530688,0.007958209,0.034504659,,NA,NA,NA,NA,NA
3337,Pocillopora_acuta_HIv2___RNAseq.g26762.t1,633.1053682,-0.256675775,1.036634367,0.007969889,0.034544942,,NA,NA,NA,NA,NA
3338,Pocillopora_acuta_HIv2___TS.g11975.t2,378.1264302,-0.762353062,1.294502081,0.007997602,0.034654676,,P23921,0,Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit),2'-deoxyribonucleotide biosynthetic process [GO:0009265]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; male gonad development [GO:0008584]; mitochondrial DNA replication [GO:0006264]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]; ribonucleoside diphosphate metabolic process [GO:0009185],GO:0000731; GO:0004748; GO:0005524; GO:0005635; GO:0005739; GO:0005829; GO:0005971; GO:0006206; GO:0006264; GO:0006281; GO:0008584; GO:0009185; GO:0009263; GO:0009265; GO:0010212; GO:0010971; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0060041; GO:0061731; GO:0070318; GO:0097718; GO:1900087
3339,Pocillopora_acuta_HIv2___RNAseq.g20661.t1,417.2296741,0.763975604,1.32233233,0.008012591,0.03470923,,P46436,1.35E-23,Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma),cellular oxidant detoxification [GO:0098869]; glutathione metabolic process [GO:0006749],GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0006749; GO:0098869
3340,Pocillopora_acuta_HIv2___RNAseq.g13122.t1,124.927915,-0.338950939,1.079429047,0.008033599,0.034789811,,Q8N567,1.04E-42,Zinc finger CCHC domain-containing protein 9,,GO:0003723; GO:0005654; GO:0005730; GO:0008270
3341,Pocillopora_acuta_HIv2___RNAseq.g8207.t1,637.8197685,0.601274755,1.256038101,0.008036451,0.034791749,,P24507,1.85E-34,Synaptotagmin-C (Synaptic vesicle protein O-p65-C),calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059],GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0017156; GO:0017158; GO:0030276; GO:0030672; GO:0071277
3342,Pocillopora_acuta_HIv2___RNAseq.g2716.t1,3466.382893,1.734019991,1.068314935,0.008073617,0.034942189,,O88818,0,Plastin-3 (T-plastin),actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639],GO:0005509; GO:0005737; GO:0005884; GO:0032432; GO:0051015; GO:0051017; GO:0051639
3343,Pocillopora_acuta_HIv2___RNAseq.g4679.t1,670.3949432,1.462797488,0.710243178,0.008079217,0.034955966,,P57729,1.11E-23,Ras-related protein Rab-38 (Melanoma antigen NY-MEL-1),endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of protein localization to cell periphery [GO:1904377]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192],GO:0003924; GO:0005525; GO:0005739; GO:0005764; GO:0005769; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0007005; GO:0007264; GO:0012505; GO:0015031; GO:0016020; GO:0016192; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0044297; GO:0045335; GO:0048023; GO:0048471; GO:0060155; GO:0072657; GO:0090383; GO:1903232; GO:1904377; GO:2001247
3344,Pocillopora_acuta_HIv2___RNAseq.g16101.t1,346.3235676,-1.097687667,1.497718656,0.008088229,0.034984491,,Q8CG45,1.38E-112,Aflatoxin B1 aldehyde reductase member 2 (rAFAR2) (EC 1.1.1.n11) (Succinic semialdehyde reductase) (SSA reductase),daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629],GO:0004032; GO:0004033; GO:0005635; GO:0005737; GO:0005739; GO:0005795; GO:0006629; GO:0019119; GO:0044597; GO:0044598
3345,Pocillopora_acuta_HIv2___RNAseq.g7454.t2,22.4460646,-1.201902688,1.745291409,0.008103657,0.035040746,,P0CI65,3.24E-37,Nephrocystin-3,cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055],GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546
3346,Pocillopora_acuta_HIv2___TS.g13643.t1,327.793406,0.664145865,1.215403664,0.00812407,0.035118516,,A2ASS6,8.24E-23,Titin (EC 2.7.11.1) (Connectin),adult heart development [GO:0007512]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of relaxation of cardiac muscle [GO:1901897]; sarcomere organization [GO:0045214]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591],GO:0001701; GO:0001756; GO:0003007; GO:0004674; GO:0004713; GO:0005200; GO:0005516; GO:0005524; GO:0005634; GO:0005859; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0021591; GO:0030017; GO:0030018; GO:0030506; GO:0031430; GO:0031672; GO:0031674; GO:0035995; GO:0043056; GO:0045214; GO:0046872; GO:0048738; GO:0055002; GO:0055003; GO:0055008; GO:0060419; GO:0106310; GO:1901897
3347,Pocillopora_acuta_HIv2___RNAseq.g17672.t1,143.6293806,-0.747447862,1.329441796,0.008143425,0.035191663,,Q60739,6.60E-35,BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1),apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of protein phosphorylation [GO:0001933]; neuron differentiation [GO:0030182]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; protein localization to mitochondrion [GO:0070585]; protein stabilization [GO:0050821],GO:0000774; GO:0001933; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0014040; GO:0016020; GO:0030182; GO:0034393; GO:0043066; GO:0048471; GO:0050821; GO:0051087; GO:0070585; GO:2000672
3348,Pocillopora_acuta_HIv2___RNAseq.g14056.t1,783.754468,-0.721146928,1.283254686,0.008151257,0.035214988,,O96005,0,Putative lipid scramblase CLPTM1 (Cleft lip and palate transmembrane protein 1),cell differentiation [GO:0030154]; regulation of T cell differentiation in thymus [GO:0033081],GO:0005886; GO:0009897; GO:0012505; GO:0016020; GO:0030154; GO:0033081; GO:0050811
3349,Pocillopora_acuta_HIv2___RNAseq.g28106.t1b,525.3494587,-0.151822535,1.028360084,0.00815785,0.035232949,,Q91WA3,2.07E-152,Histone deacetylase 11 (HD11) (EC 3.5.1.98),chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; oligodendrocyte development [GO:0014003],GO:0000118; GO:0004407; GO:0005634; GO:0005737; GO:0005886; GO:0006325; GO:0014003; GO:0040029; GO:0140297
3350,Pocillopora_acuta_HIv2___RNAseq.g28751.t1,574.5448254,-0.455799478,1.085939609,0.008161004,0.035236049,,Q9NZI7,1.09E-112,Upstream-binding protein 1 (Transcription factor LBP-1),angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0032897; GO:0045944; GO:1990837
3351,Pocillopora_acuta_HIv2___TS.g29833.t1,33.50231289,-0.269147896,1.048749086,0.008165855,0.03524647,,NA,NA,NA,NA,NA
3352,Pocillopora_acuta_HIv2___RNAseq.g28065.t1,882.755549,0.81005106,1.360380589,0.008187348,0.0353287,,Q6Q7I7,2.65E-07,Platelet-derived growth factor subunit B (PDGF subunit B) (PDGF-2) (Platelet-derived growth factor B chain) (Platelet-derived growth factor beta polypeptide),cell chemotaxis [GO:0060326]; cellular response to mycophenolic acid [GO:0071506]; embryonic placenta development [GO:0001892]; heart development [GO:0007507]; metanephric glomerular mesangial cell development [GO:0072255]; monocyte chemotaxis [GO:0002548]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphatidylinositol biosynthetic process [GO:0010512]; negative regulation of platelet activation [GO:0010544]; paracrine signaling [GO:0038001]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric mesenchymal cell migration [GO:2000591]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; response to wounding [GO:0009611],GO:0001892; GO:0001938; GO:0002548; GO:0003104; GO:0005161; GO:0005615; GO:0005737; GO:0006468; GO:0007507; GO:0008083; GO:0008284; GO:0009611; GO:0009986; GO:0010512; GO:0010544; GO:0010629; GO:0014911; GO:0016176; GO:0016323; GO:0018108; GO:0030335; GO:0031954; GO:0035793; GO:0038001; GO:0042803; GO:0043406; GO:0043410; GO:0043536; GO:0045840; GO:0045893; GO:0048008; GO:0048146; GO:0048661; GO:0050921; GO:0051781; GO:0051897; GO:0060326; GO:0070374; GO:0071506; GO:0072126; GO:0072255; GO:0072593; GO:0090280; GO:1900127; GO:1904707; GO:2000379; GO:2000573; GO:2000591
3353,Pocillopora_acuta_HIv2___TS.g22622.t1,5425.140613,-1.333726606,0.611353459,0.008228689,0.035486441,Myosin-9,P14105,6.83E-36,"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)",actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myosin filament assembly [GO:0031034]; platelet formation [GO:0030220]; protein transport [GO:0015031]; regulation of cell shape [GO:0008360],GO:0000146; GO:0001525; GO:0001725; GO:0001726; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005826; GO:0005829; GO:0005886; GO:0005938; GO:0006509; GO:0008360; GO:0015031; GO:0015629; GO:0016460; GO:0030036; GO:0030048; GO:0030220; GO:0030224; GO:0031034; GO:0031252; GO:0032154; GO:0032506; GO:0032982; GO:0032991; GO:0042803; GO:0043495; GO:0043534; GO:0051015; GO:0060471; GO:0060473
3354,Pocillopora_acuta_HIv2___RNAseq.g1903.t1,68.06267004,-0.267591226,1.056250192,0.008228811,0.035486441,,Q5F3A6,1.31E-79,Ubiquitin thioesterase OTU1 (EC 3.4.19.12),endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536],GO:0004843; GO:0005737; GO:0016236; GO:0016579; GO:0030968; GO:0035523; GO:0035871; GO:0036503; GO:0046872; GO:0070536; GO:0071108; GO:1990167; GO:1990168
3355,Pocillopora_acuta_HIv2___RNAseq.g42.t1,240.0938493,-0.624338942,1.212483424,0.008239869,0.0355213,,Q8BLN6,0,Protein unc-80 homolog (mUNC-80),monoatomic cation homeostasis [GO:0055080],GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080
3356,Pocillopora_acuta_HIv2___RNAseq.g26590.t1,238.7718995,1.678819096,1.121419748,0.008241806,0.0355213,,Q3YBN2,8.89E-07,Tear acid lipase-like protein (TALLP),sterol metabolic process [GO:0016125],GO:0004771; GO:0005615; GO:0008289; GO:0016125; GO:0043231
3357,Pocillopora_acuta_HIv2___RNAseq.g4464.t1,345.9009988,-0.54393673,1.133533354,0.008249246,0.035542776,,Q61029,1.37E-12,"Lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma (Thymopoietin isoforms beta/delta/epsilon/gamma) (TP beta/delta/epsilon/gamma)",regulation of DNA-templated transcription [GO:0006355],GO:0000785; GO:0003677; GO:0005634; GO:0005635; GO:0005637; GO:0006355
3358,Pocillopora_acuta_HIv2___RNAseq.g23422.t1,62.07274216,-0.459023411,1.127730229,0.008258006,0.035569923,,NA,NA,NA,NA,NA
3359,Pocillopora_acuta_HIv2___RNAseq.g24323.t1,507.4724562,-0.933426649,1.436144644,0.008274253,0.035629295,,NA,NA,NA,NA,NA
3360,Pocillopora_acuta_HIv2___RNAseq.g21021.t1,4513.055432,-1.579647001,0.923159081,0.008297824,0.035720158,,Q66KI8,2.81E-79,Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein homolog) (Protein primglo) (xPgo),negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],GO:0005886; GO:0016055; GO:0017147; GO:0030178
3361,Pocillopora_acuta_HIv2___RNAseq.g26052.t1,970.4615698,1.767253236,1.129602859,0.008307317,0.035744042,,NA,NA,NA,NA,NA
3362,Pocillopora_acuta_HIv2___RNAseq.g7660.t2,598.4106083,-1.737553524,1.197516975,0.008308315,0.035744042,,Q91WC9,6.84E-117,Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.116) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta),arachidonic acid metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; icosanoid metabolic process [GO:0006690]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727],GO:0001516; GO:0004806; GO:0005654; GO:0005886; GO:0006640; GO:0006690; GO:0007405; GO:0010898; GO:0016298; GO:0019369; GO:0022008; GO:0046340; GO:0046872; GO:0047372; GO:0050727; GO:1901696
3363,Pocillopora_acuta_HIv2___RNAseq.g14274.t1,39.12787521,-0.095301264,1.020745453,0.008311868,0.035748694,,NA,NA,NA,NA,NA
3364,Pocillopora_acuta_HIv2___RNAseq.g14581.t1,79.58387131,-1.138039002,1.584812725,0.008346095,0.035885232,,NA,NA,NA,NA,NA
3365,Pocillopora_acuta_HIv2___RNAseq.g19633.t1,35.16923961,-0.469309973,1.165446714,0.008359469,0.035932053,,NA,NA,NA,NA,NA
3366,Pocillopora_acuta_HIv2___RNAseq.g19467.t1,173.3892064,-0.310914067,1.067994063,0.008368975,0.035956935,,Q5QD12,4.60E-17,Trace amine-associated receptor 7a (TaR-7a) (Trace amine receptor 7a) (mTaar7a),,GO:0001594; GO:0005886
3367,Pocillopora_acuta_HIv2___RNAseq.g15837.t1,4778.990361,1.674148427,1.01970915,0.00837023,0.035956935,,Q9U5M4,4.16E-14,Tropomyosin-2,actin filament organization [GO:0007015]; muscle contraction [GO:0006936],GO:0005884; GO:0006936; GO:0007015; GO:0051015
3368,Pocillopora_acuta_HIv2___RNAseq.g20140.t1,267.3290661,-0.608336267,1.251039873,0.00838029,0.035989466,,Q8VE09,3.91E-147,Tetratricopeptide repeat protein 39C (TPR repeat protein 39C),cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474],GO:0032474; GO:0060271
3369,Pocillopora_acuta_HIv2___RNAseq.g16133.t1a,81.34025431,-0.175484905,1.023073421,0.008383364,0.035991977,,Q9WTN5,7.89E-125,Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1),endocytosis involved in viral entry into host cell [GO:0075509]; positive regulation of autophagy [GO:0010508]; sodium ion transmembrane transport [GO:0035725],GO:0005248; GO:0005765; GO:0010008; GO:0010508; GO:0015280; GO:0016020; GO:0019905; GO:0022832; GO:0031901; GO:0034702; GO:0035725; GO:0036019; GO:0042802; GO:0042803; GO:0055038; GO:0072345; GO:0075509; GO:0080025; GO:0097682
3370,Pocillopora_acuta_HIv2___RNAseq.g20401.t1,89.23461027,-0.146049771,1.027420052,0.00839805,0.03604433,,A4IF62,0,DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A),defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383],GO:0003677; GO:0003899; GO:0005634; GO:0005666; GO:0005829; GO:0006383; GO:0031981; GO:0032728; GO:0045087; GO:0046872; GO:0051607
3371,Pocillopora_acuta_HIv2___RNAseq.g30977.t1,79.13515956,-0.322843956,1.069036193,0.008410325,0.036086308,,NA,NA,NA,NA,NA
3372,Pocillopora_acuta_HIv2___RNAseq.g19470.t1,4616.902312,1.417531867,0.679814041,0.008416888,0.036103758,,A0A481NSZ4,3.75E-90,Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP),defense response to bacterium [GO:0042742]; innate immune response [GO:0045087],GO:0005615; GO:0008289; GO:0042742; GO:0045087
3373,Pocillopora_acuta_HIv2___RNAseq.g23244.t1,10.35844537,0.563059504,1.219375129,0.008419648,0.03610489,,Q09575,5.59E-26,Uncharacterized protein K02A2.6,DNA integration [GO:0015074],GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575
3374,Pocillopora_acuta_HIv2___RNAseq.g30803.t1,643.5862467,-0.686658412,1.24990332,0.008425481,0.036119195,,Q9Y2G8,6.35E-109,DnaJ homolog subfamily C member 16 (Endoplasmic reticulum DNA J domain-containing protein 8) (ER-resident protein ERdj8) (ERdj8),regulation of autophagosome size [GO:0016243],GO:0005789; GO:0016243
3375,Pocillopora_acuta_HIv2___TS.g17199.t1,3983.641332,1.593465297,0.885390282,0.008431161,0.036132835,,P19137,9.77E-10,Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha),animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888],GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0009887; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043010; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0048514; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046
3376,Pocillopora_acuta_HIv2___RNAseq.g25626.t1b,225.6220248,-0.452223387,1.086312361,0.008454722,0.036223073,,Q99MX7,4.35E-06,Transmembrane protein 121B (Cat eye syndrome critical region protein 6 homolog),,
3377,Pocillopora_acuta_HIv2___TS.g19755.t2,98.28494344,-0.09662071,1.016502185,0.00845796,0.036226214,,Q8T773,4.69E-118,Putative malate dehydrogenase 1B (EC 1.1.1.-),malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],GO:0006099; GO:0006108; GO:0016615; GO:0016616
3378,Pocillopora_acuta_HIv2___RNAseq.g12816.t1,60.65888687,-0.368027302,1.092345832,0.008460834,0.036227798,,Q9CYC6,5.05E-93,m7GpppN-mRNA hydrolase (EC 3.6.1.62) (mRNA-decapping enzyme 2),"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]",GO:0000184; GO:0000290; GO:0000932; GO:0003723; GO:0004534; GO:0005654; GO:0005737; GO:0006402; GO:0016442; GO:0030054; GO:0030145; GO:0032211; GO:0043488; GO:0071044; GO:0140933; GO:1904872
3379,Pocillopora_acuta_HIv2___RNAseq.g10025.t1,32.57078446,-0.464219494,1.112788187,0.008468748,0.036250952,,NA,NA,NA,NA,NA
3380,Pocillopora_acuta_HIv2___RNAseq.g22909.t1,33.69163984,2.226070637,1.29987704,0.008483181,0.03629681,,NA,NA,NA,NA,NA
3381,Pocillopora_acuta_HIv2___RNAseq.g804.t1,106.5858604,0.999502008,1.624142022,0.00848448,0.03629681,,A2ASS6,2.09E-09,Titin (EC 2.7.11.1) (Connectin),adult heart development [GO:0007512]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of relaxation of cardiac muscle [GO:1901897]; sarcomere organization [GO:0045214]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591],GO:0001701; GO:0001756; GO:0003007; GO:0004674; GO:0004713; GO:0005200; GO:0005516; GO:0005524; GO:0005634; GO:0005859; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0021591; GO:0030017; GO:0030018; GO:0030506; GO:0031430; GO:0031672; GO:0031674; GO:0035995; GO:0043056; GO:0045214; GO:0046872; GO:0048738; GO:0055002; GO:0055003; GO:0055008; GO:0060419; GO:0106310; GO:1901897
3382,Pocillopora_acuta_HIv2___RNAseq.g10178.t1,597.0149219,-0.799680612,1.346270382,0.008498391,0.036345572,BTB/POZ domain-containing protein 16,Q95J53,6.11E-89,BTB/POZ domain-containing protein 16,,
3383,Pocillopora_acuta_HIv2___RNAseq.g16928.t3,5447.65606,1.826269886,1.269018807,0.008516505,0.036412275,,O70521,4.34E-40,Regulator of G-protein signaling 19 (RGS19) (G-alpha-interacting protein) (GAIP),negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to ethanol [GO:0045471],GO:0000139; GO:0001965; GO:0005096; GO:0005903; GO:0008277; GO:0009968; GO:0030136; GO:0045471
3384,Pocillopora_acuta_HIv2___RNAseq.g26337.t1,47.98183862,-0.291638543,1.062688284,0.008576548,0.036658152,,F1NV61,3.83E-29,Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508],GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0042742; GO:0043525; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686
3385,Pocillopora_acuta_HIv2___RNAseq.g5307.t1,787.0241,0.354245076,1.105113519,0.008580115,0.036662565,,NA,NA,NA,NA,NA
3386,Pocillopora_acuta_HIv2___RNAseq.g11595.t1,593.7769162,-0.781005133,1.291939287,0.008586454,0.036677422,,P82933,1.38E-55,"Small ribosomal subunit protein uS9m (28S ribosomal protein S9, mitochondrial) (MRP-S9) (S9mt)",mitochondrial translation [GO:0032543],GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0032543
3387,Pocillopora_acuta_HIv2___RNAseq.g3131.t1,63.22330548,-0.120709291,1.018855001,0.008588664,0.036677422,,Q8CEE0,3.35E-80,Centrosomal protein of 57 kDa (Cep57) (Testis-specific protein 57) (Translokin),fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286],GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034451; GO:0042803; GO:0043015; GO:0051260
3388,Pocillopora_acuta_HIv2___RNAseq.g12257.t1,95.10117774,0.916900627,1.606600387,0.00861009,0.03675807,,F1NWE3,7.09E-13,Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha),negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; peptidyl-tyrosine dephosphorylation [GO:0035335]; synaptic membrane adhesion [GO:0099560],GO:0004725; GO:0005886; GO:0008201; GO:0030424; GO:0030426; GO:0030517; GO:0030672; GO:0035335; GO:0042803; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0098839; GO:0099560
3389,Pocillopora_acuta_HIv2___RNAseq.g3094.t1,661.5787531,1.718273274,1.299516714,0.008648893,0.036908587,,P49288,2.49E-29,Melatonin receptor type 1C (Mel-1C-R) (Mel1c receptor) (CKB),G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820],GO:0004930; GO:0005654; GO:0005886; GO:0007186; GO:0008502; GO:0045820; GO:0046325; GO:1904408
3390,Pocillopora_acuta_HIv2___RNAseq.g3482.t1,140.2256611,-1.608342124,0.926670153,0.00865045,0.036908587,,Q8JIR0,1.62E-57,Polycomb complex protein BMI-1-A (Polycomb group RING finger protein 4-A),"cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; hematopoietic stem cell migration [GO:0035701]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; primitive hemopoiesis [GO:0060215]",GO:0000122; GO:0006338; GO:0021549; GO:0031519; GO:0035102; GO:0035701; GO:0045814; GO:0046872; GO:0060215; GO:1990841
3391,Pocillopora_acuta_HIv2___RNAseq.g29988.t1,81.53589654,-0.352374231,1.085407536,0.008659624,0.036936835,,O18404,1.89E-90,"3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51, EC 1.1.1.62) (3-hydroxyacyl-CoA dehydrogenase type II) (Hydroxysteroid dehydrogenase) (EC 1.1.1.-, EC 1.1.1.53) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Scully protein) (Type II HADH)",acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; steroid metabolic process [GO:0008202],GO:0003857; GO:0004303; GO:0005739; GO:0006631; GO:0006637; GO:0008202; GO:0008205; GO:0008209; GO:0008210; GO:0016229; GO:0018454; GO:0030678; GO:0035410; GO:0047015; GO:0047022; GO:0047035; GO:0090646; GO:0106282; GO:0106283
3392,Pocillopora_acuta_HIv2___RNAseq.g22053.t2,357.6060357,-0.665980971,1.201297484,0.008668221,0.036952522,,NA,NA,NA,NA,NA
3393,Pocillopora_acuta_HIv2___TS.g14275.t1b,724.0521661,-0.734399965,1.251673357,0.008668412,0.036952522,,P34473,1.30E-19,Uncharacterized protein F58A4.6,,
3394,Pocillopora_acuta_HIv2___RNAseq.g8644.t1,1640.572074,-1.608007667,0.95587031,0.008676419,0.036975758,,Q95NR9,4.08E-102,Calmodulin (CaM),,GO:0005509; GO:0030234
3395,Pocillopora_acuta_HIv2___TS.g11523.t1b,1097.739657,-1.264796361,1.742384356,0.008705415,0.037082503,,A0A1B0GVH7,1.51E-21,IQ domain-containing protein M,,
3396,Pocillopora_acuta_HIv2___RNAseq.g20864.t1,382.6366226,-0.756493437,1.275464196,0.008706594,0.037082503,,Q6NRT5,0,COP9 signalosome complex subunit 1 (Signalosome subunit 1),,GO:0005737; GO:0008180
3397,Pocillopora_acuta_HIv2___RNAseq.g15953.t1,211.5070917,1.633001354,0.999629977,0.008725959,0.037154039,,Q923Y9,2.14E-06,Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1),G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950],GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0008227; GO:0043950
3398,Pocillopora_acuta_HIv2___RNAseq.g29446.t1,1041.780864,1.666064148,1.252133292,0.008734292,0.037178575,,Q13613,1.47E-67,"Phosphatidylinositol-3-phosphate phosphatase MTMR1 (EC 3.1.3.-) (Myotubularin-related protein 1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95)",phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],GO:0004438; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0016020; GO:0042803; GO:0046856; GO:0052629; GO:0060304
3399,Pocillopora_acuta_HIv2___RNAseq.g4172.t1,13.48723832,-0.547095754,1.213288394,0.00877013,0.037320142,,NA,NA,NA,NA,NA
3400,Pocillopora_acuta_HIv2___RNAseq.g22356.t1,667.6809503,-0.988434848,1.463246681,0.008794332,0.037406527,,Q8BXX9,2.11E-32,Coiled-coil domain-containing protein 169,,
3401,Pocillopora_acuta_HIv2___TS.g13944.t1,252.4266847,0.6402817,1.27591237,0.008795603,0.037406527,,Q8C5H1,0,Anoctamin-4 (Transmembrane protein 16D),calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; establishment of localization in cell [GO:0051649],GO:0005254; GO:0005886; GO:0017128; GO:0046983; GO:0051649; GO:0061589; GO:0061590; GO:0061591; GO:1902476
3402,Pocillopora_acuta_HIv2___TS.g10282.t1,19189.45527,1.347320972,0.632891557,0.008849013,0.037622612,,Q9I954,3.83E-08,Thymosin beta-b,actin filament organization [GO:0007015]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989],GO:0003785; GO:0005737; GO:0005856; GO:0007015; GO:0030334; GO:0042989
3403,Pocillopora_acuta_HIv2___RNAseq.g23533.t1,38.79251201,0.647097461,1.25828297,0.00885554,0.037639297,,NA,NA,NA,NA,NA
3404,Pocillopora_acuta_HIv2___RNAseq.g506.t1,149.7276353,-0.08115989,1.021518769,0.008865903,0.037672273,,A1L0Y2,6.62E-60,Neuralized-like protein 4,,GO:0005737; GO:0005814
3405,Pocillopora_acuta_HIv2___RNAseq.g4805.t1,63.07006563,-0.796404364,1.380947077,0.008870708,0.037681622,,NA,NA,NA,NA,NA
3406,Pocillopora_acuta_HIv2___RNAseq.g420.t1,20.59109328,-0.875739977,1.454539989,0.008884075,0.037718432,,Q09575,5.50E-91,Uncharacterized protein K02A2.6,DNA integration [GO:0015074],GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575
3407,Pocillopora_acuta_HIv2___RNAseq.g19328.t1,392.0763464,-0.184160941,1.025935429,0.008884589,0.037718432,,Q6P756,3.93E-97,Adaptin ear-binding coat-associated protein 2 (NECAP-2),endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],GO:0005886; GO:0005905; GO:0006897; GO:0015031; GO:0016192; GO:0030125
3408,Pocillopora_acuta_HIv2___RNAseq.g5348.t1a,913.4121656,1.649225526,1.511846397,0.008896675,0.037758659,,Q5XJN2,3.63E-60,Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30),cell redox homeostasis [GO:0045454]; hematopoietic stem cell proliferation [GO:0071425]; immune system process [GO:0002376],GO:0002376; GO:0005576; GO:0005764; GO:0016667; GO:0016671; GO:0045454; GO:0047134; GO:0071425
3409,Pocillopora_acuta_HIv2___RNAseq.g18163.t1,738.9168634,-0.634984821,1.192515894,0.008924541,0.037865814,,Q924H2,2.71E-54,Mediator of RNA polymerase II transcription subunit 15 (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (mPcqap),positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019],GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0032968; GO:0035019; GO:0051123; GO:0060261; GO:0070847
3410,Pocillopora_acuta_HIv2___RNAseq.g16305.t1,86.26277885,-0.472323815,1.117483804,0.008938796,0.037915174,,NA,NA,NA,NA,NA
3411,Pocillopora_acuta_HIv2___TS.g7298.t1,19.50306451,1.837620774,1.53317305,0.008942866,0.037921319,,NA,NA,NA,NA,NA
3412,Pocillopora_acuta_HIv2___RNAseq.g2472.t1,60.52846526,-0.505189776,1.116468524,0.008953275,0.037954329,,P35601,1.65E-46,Replication factor C subunit 1 (A1-P145) (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (Differentiation-specific element-binding protein) (ISRE-binding protein) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit),DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893],GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0019904; GO:0031391; GO:0032991; GO:0043565; GO:0045892; GO:0045893; GO:0061860; GO:0140297
3413,Pocillopora_acuta_HIv2___RNAseq.g26573.t1,132.7446472,-0.441447971,1.097340004,0.008956158,0.037955426,,P97603,2.58E-09,Neogenin,"axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; protein secretion [GO:0009306]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550]",GO:0001764; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009306; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0044295; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550
3414,Pocillopora_acuta_HIv2___RNAseq.g20144.t1,1237.888977,1.718810634,1.838780606,0.008978152,0.038027245,Growth/differentiation factor 6,Q6HA10,1.11E-57,Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16),activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; epithelial cell migration [GO:0010631]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of SMAD protein signal transduction [GO:0060391]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395],GO:0001656; GO:0005125; GO:0005615; GO:0006915; GO:0008083; GO:0010631; GO:0030509; GO:0032332; GO:0032924; GO:0035788; GO:0042802; GO:0045444; GO:0045666; GO:0045893; GO:0060391; GO:0060395; GO:1900745; GO:1990009
3415,Pocillopora_acuta_HIv2___TS.g28567.t1,31.08593146,-0.333628873,1.078791435,0.008978398,0.038027245,,NA,NA,NA,NA,NA
3416,Pocillopora_acuta_HIv2___TS.g201.t2,806.7224903,-1.44723147,0.730793968,0.008980992,0.038027245,,Q8TE73,0,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729
3417,Pocillopora_acuta_HIv2___RNAseq.g26540.t1,3285.506035,-1.640066037,0.995386587,0.008987251,0.038042609,,Q9U6Y6,5.86E-13,GFP-like fluorescent chromoprotein amFP486,bioluminescence [GO:0008218]; generation of precursor metabolites and energy [GO:0006091],GO:0006091; GO:0008218
3418,Pocillopora_acuta_HIv2___RNAseq.g9027.t1,2280.979393,-1.550972838,1.882000888,0.00899333,0.038055858,,P22004,2.50E-42,Bone morphogenetic protein 6 (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1),BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cartilage development [GO:0051216]; cellular response to BMP stimulus [GO:0071773]; cellular response to iron ion [GO:0071281]; cellular response to mechanical stimulus [GO:0071260]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intracellular iron ion homeostasis [GO:0006879]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular permeability [GO:0043117]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to retinoic acid [GO:0032526]; skeletal system development [GO:0001501]; type B pancreatic cell development [GO:0003323],GO:0000122; GO:0001501; GO:0001649; GO:0001654; GO:0001822; GO:0001938; GO:0001958; GO:0003323; GO:0005125; GO:0005615; GO:0006879; GO:0006954; GO:0006955; GO:0008083; GO:0008284; GO:0010628; GO:0014823; GO:0030182; GO:0030501; GO:0030509; GO:0030539; GO:0031666; GO:0031982; GO:0032026; GO:0032332; GO:0032349; GO:0032526; GO:0043117; GO:0045603; GO:0045666; GO:0045669; GO:0045944; GO:0046982; GO:0050679; GO:0050714; GO:0050731; GO:0051216; GO:0051384; GO:0060348; GO:0060391; GO:0060586; GO:0070700; GO:0071260; GO:0071281; GO:0071773; GO:1903392; GO:2000048; GO:2000860
3419,Pocillopora_acuta_HIv2___RNAseq.g23178.t1,407.628302,1.647227851,1.180979525,0.008995643,0.038055858,,A2AJ76,1.99E-12,Hemicentin-2,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808],GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023
3420,Pocillopora_acuta_HIv2___TS.g7543.t1,290.8252955,1.62181125,0.998781717,0.00904073,0.038231612,,A1ZAY1,1.88E-42,SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains),establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251],GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219
3421,Pocillopora_acuta_HIv2___RNAseq.g13579.t1,643.5881392,-0.736790305,1.303427769,0.009045063,0.038231612,,Q2KI83,2.96E-85,DnaJ homolog subfamily C member 17,spliceosomal complex disassembly [GO:0000390],GO:0000390; GO:0003723; GO:0005681; GO:0005737
3422,Pocillopora_acuta_HIv2___RNAseq.g10887.t1,273.2122581,-0.075223164,1.01176553,0.009045117,0.038231612,,NA,NA,NA,NA,NA
3423,Pocillopora_acuta_HIv2___TS.g25027.t2,697.5292977,-0.883863453,1.42476693,0.00906435,0.03830171,,NA,NA,NA,NA,NA
3424,Pocillopora_acuta_HIv2___RNAseq.g28823.t1,36.82690935,-0.422941531,1.126822364,0.009093716,0.038414574,,Q9D110,2.21E-42,"5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase)",folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],GO:0005524; GO:0005542; GO:0005739; GO:0009396; GO:0030272; GO:0035999; GO:0046653; GO:0046872
3425,Pocillopora_acuta_HIv2___TS.g1110.t1,348.8857018,-1.238289272,1.712744292,0.009124898,0.03852762,,Q5U5A6,5.57E-24,Notch-regulated ankyrin repeat-containing protein,Notch signaling pathway [GO:0007219],GO:0004857; GO:0005737; GO:0007219; GO:0019208
3426,Pocillopora_acuta_HIv2___RNAseq.g11922.t1,219.4694991,-1.01291032,1.57351348,0.009125804,0.03852762,,Q5EBP3,8.97E-37,Armadillo repeat-containing protein 5,"adrenal cortex development [GO:0035801]; anatomical structure morphogenesis [GO:0009653]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; gastrulation [GO:0007369]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; regulation of steroid biosynthetic process [GO:0050810]; T cell proliferation [GO:0042098]",GO:0001701; GO:0001707; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0007369; GO:0009653; GO:0016020; GO:0030097; GO:0035801; GO:0042098; GO:0043367; GO:0050810; GO:0051607
3427,Pocillopora_acuta_HIv2___TS.g27264.t1,47.83831136,-0.170501502,1.023688108,0.009131025,0.038533511,,Q9NPF2,1.22E-44,Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1),apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659
3428,Pocillopora_acuta_HIv2___RNAseq.g19906.t1,359.7046469,-1.683541817,1.492520609,0.009132527,0.038533511,,NA,NA,NA,NA,NA
3429,Pocillopora_acuta_HIv2___RNAseq.g16640.t1,27.18170368,-0.470556944,1.112569451,0.009140038,0.038553955,,NA,NA,NA,NA,NA
3430,Pocillopora_acuta_HIv2___RNAseq.g24163.t1,129.9857876,-0.589707773,1.217494271,0.00915956,0.038625037,,A0A2B4SJA1,7.19E-45,Stimulator of interferon genes protein 2 (Sp-STING2),activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; innate immune response [GO:0045087]; positive regulation of macroautophagy [GO:0016239]; positive regulation of type I interferon production [GO:0032481]; reticulophagy [GO:0061709],GO:0000045; GO:0002218; GO:0005776; GO:0005789; GO:0016239; GO:0032481; GO:0035438; GO:0045087; GO:0061507; GO:0061709
3431,Pocillopora_acuta_HIv2___RNAseq.g3743.t1,1180.333072,-1.69864978,1.711977864,0.009170577,0.038660223,,Q08E39,9.08E-18,Protein sprouty homolog 2 (Spry-2),animal organ development [GO:0048513]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],GO:0005829; GO:0005874; GO:0010719; GO:0030512; GO:0031397; GO:0032587; GO:0040037; GO:0046580; GO:0048513; GO:0070373; GO:1902747
3432,Pocillopora_acuta_HIv2___RNAseq.g16303.t1,204.6674652,-1.802792161,1.469933649,0.009182531,0.038699338,,P54797,1.60E-64,Transport and Golgi organization 2 homolog (Ser/Thr-rich protein T10 in DGCR region),Golgi organization [GO:0007030]; protein secretion [GO:0009306],GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0007030; GO:0009306
3433,Pocillopora_acuta_HIv2___RNAseq.g11125.t1,617.4440437,-0.562240667,1.162186726,0.009193599,0.038733916,,NA,NA,NA,NA,NA
3434,Pocillopora_acuta_HIv2___RNAseq.g6186.t1,122.1510796,-0.3219635,1.072627961,0.009196092,0.038733916,,Q6AY78,2.83E-46,Solute carrier family 22 member 18 (Organic cation transporter-like protein 2) (ORCTL-2),monoatomic ion transport [GO:0006811]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908],GO:0005635; GO:0005737; GO:0006811; GO:0015293; GO:0016324; GO:0031625; GO:0042908; GO:1990961
3435,Pocillopora_acuta_HIv2___RNAseq.g25724.t1,651.359024,1.592621196,0.968423052,0.009238441,0.038900963,,NA,NA,NA,NA,NA
3436,Pocillopora_acuta_HIv2___RNAseq.g3893.t1,153.0668073,0.065615153,1.01981254,0.009246219,0.038922383,,Q54KG1,4.55E-91,Probable ATP-dependent RNA helicase ddx41 (EC 3.6.4.13) (DEAD box protein 41),"mRNA splicing, via spliceosome [GO:0000398]",GO:0000398; GO:0003724; GO:0003729; GO:0005524; GO:0005681; GO:0016887; GO:0046872
3437,Pocillopora_acuta_HIv2___RNAseq.g5227.t1,241.1096726,-0.438782507,1.103358403,0.009253144,0.038940202,,Q8VD66,2.50E-125,(Lyso)-N-acylphosphatidylethanolamine lipase (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 4) (Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4),lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidic acid biosynthetic process [GO:0006654],GO:0004622; GO:0005739; GO:0005811; GO:0006654; GO:0016042; GO:0042171; GO:0055088; GO:0070291; GO:0070292
3438,Pocillopora_acuta_HIv2___RNAseq.g5105.t1,38.26201146,-0.973296943,1.531992939,0.009265189,0.038979549,,NA,NA,NA,NA,NA
3439,Pocillopora_acuta_HIv2___TS.g6241.t1e,2993.397705,-1.425473773,0.719421528,0.009323502,0.039213471,,P94598,0,Glutamate dehydrogenase (GDH) (EC 1.4.1.3) (NAD(P)H-utilizing glutamate dehydrogenase),glutamate biosynthetic process [GO:0006537],GO:0004352; GO:0004354; GO:0005829; GO:0006537
3440,Pocillopora_acuta_HIv2___RNAseq.g5138.t1,10953.83448,1.415740672,0.705028151,0.009374014,0.03941446,,Q90XW6,8.82E-46,Iroquois-class homeodomain protein irx-4-A (Iroquois homeobox protein 4-A),brain development [GO:0007420]; cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; heart development [GO:0007507]; proximal/distal pattern formation [GO:0009954],GO:0000981; GO:0003677; GO:0005634; GO:0007420; GO:0007507; GO:0009953; GO:0009954; GO:0030154
3441,Pocillopora_acuta_HIv2___RNAseq.g12742.t2,260.9572929,-0.324811995,1.062482824,0.009425698,0.039616873,,O70237,2.45E-64,Zinc finger protein Gfi-1b (Growth factor independent protein 1B),positive regulation of granulocyte differentiation [GO:0030854]; regulation of erythrocyte differentiation [GO:0045646]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0030854; GO:0045646; GO:0046872; GO:1903706
3442,Pocillopora_acuta_HIv2___RNAseq.g24386.t1,41.31007396,-0.241028094,1.04925171,0.009427633,0.039616873,,P39428,3.07E-49,TNF receptor-associated factor 1,apoptotic process [GO:0006915]; protein K63-linked ubiquitination [GO:0070534]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0005164; GO:0005737; GO:0006915; GO:0008270; GO:0009898; GO:0031625; GO:0031996; GO:0033209; GO:0042802; GO:0043122; GO:0070534; GO:2001236
3443,Pocillopora_acuta_HIv2___RNAseq.g14512.t1,197.094253,-0.608033486,1.231894416,0.009438519,0.039640516,,Q969Q5,2.91E-58,Ras-related protein Rab-24,autophagy [GO:0006914]; intracellular protein transport [GO:0006886],GO:0003924; GO:0005525; GO:0005776; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0012505; GO:0030667
3444,Pocillopora_acuta_HIv2___RNAseq.g1221.t1,1344.585613,1.982192423,1.689208601,0.00943874,0.039640516,,NA,NA,NA,NA,NA
3445,Pocillopora_acuta_HIv2___RNAseq.g18123.t1,2002.506618,-1.607506944,0.950459832,0.009443769,0.039650125,,Q9R0R1,1.38E-24,Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228),iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756],GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025
3446,Pocillopora_acuta_HIv2___TS.g7849.t1,377.8303579,0.126680359,1.015330624,0.009510492,0.039918677,,F1NY98,6.56E-31,Cell adhesion molecule DSCAM (Down syndrome cell adhesion molecule homolog),axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],GO:0005886; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:1990782; GO:1990890
3447,Pocillopora_acuta_HIv2___RNAseq.g18564.t2,747.4161375,-0.726760497,1.268828682,0.009527526,0.03997857,,Q96C24,6.34E-67,Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin),exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684],GO:0001778; GO:0005543; GO:0005768; GO:0005886; GO:0006886; GO:0006887; GO:0030073; GO:0030658; GO:0031092; GO:0031267; GO:0032418; GO:0042043; GO:0045921; GO:0046676; GO:0046872; GO:0050714; GO:0070382; GO:0071985; GO:1905684
3448,Pocillopora_acuta_HIv2___RNAseq.g26105.t1,186.8114366,-0.118531941,1.008698623,0.009533526,0.039992145,,Q13075,5.33E-18,Baculoviral IAP repeat-containing protein 1 (Neuronal apoptosis inhibitory protein),apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nervous system development [GO:0007399]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JNK cascade [GO:0046330]; pyroptotic inflammatory response [GO:0070269]; regulation of apoptotic process [GO:0042981],GO:0002221; GO:0004869; GO:0005524; GO:0005737; GO:0006915; GO:0006954; GO:0007399; GO:0010804; GO:0016045; GO:0016323; GO:0016887; GO:0032731; GO:0042742; GO:0042981; GO:0043027; GO:0043066; GO:0043154; GO:0043524; GO:0045087; GO:0046330; GO:0046456; GO:0046872; GO:0050729; GO:0061702; GO:0070269; GO:0072557; GO:0120283
3449,Pocillopora_acuta_HIv2___RNAseq.g25968.t1,976.0448047,1.60635867,1.050878155,0.009584582,0.040194662,,NA,NA,NA,NA,NA
3450,Pocillopora_acuta_HIv2___RNAseq.g20940.t1,95.52375776,-0.343769765,1.048501859,0.009589019,0.040201617,,Q5M7N9,1.29E-31,Extended synaptotagmin-3 (E-Syt3),endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],GO:0005789; GO:0005886; GO:0006869; GO:0008289; GO:0046872; GO:0061817; GO:0140268
3451,Pocillopora_acuta_HIv2___RNAseq.g26887.t1,51.76490261,1.651261765,0.956799833,0.009626186,0.040345741,,NA,NA,NA,NA,NA
3452,Pocillopora_acuta_HIv2___TS.g6462.t1,107.3648229,-0.270002176,1.04616137,0.009641373,0.040397686,,Q9MYM7,1.77E-12,"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)",lipid glycosylation [GO:0030259]; protein glycosylation [GO:0006486],GO:0000139; GO:0006486; GO:0008499; GO:0030259; GO:0047275
3453,Pocillopora_acuta_HIv2___RNAseq.g27358.t1,84.73551635,-0.729206474,1.26345641,0.00965368,0.040437539,,NA,NA,NA,NA,NA
3454,Pocillopora_acuta_HIv2___TS.g2574.t2,153.2078099,-1.463304018,1.533401026,0.009678564,0.040530039,,Q0VAA2,2.05E-22,Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74),,
3455,Pocillopora_acuta_HIv2___RNAseq.g25714.t1,1268.450835,0.406834207,1.090048492,0.00968638,0.040550967,,NA,NA,NA,NA,NA
3456,Pocillopora_acuta_HIv2___RNAseq.g10454.t1,348.6061334,0.145827908,1.022766892,0.009689169,0.040550967,,E9Q9M8,8.24E-20,PWWP domain-containing protein 2B,chromatin remodeling [GO:0006338]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of cold-induced thermogenesis [GO:0120161],GO:0005634; GO:0005654; GO:0006338; GO:0032968; GO:0120161; GO:0120325
3457,Pocillopora_acuta_HIv2___TS.g1932.t1,64.18140727,-0.366918191,1.092269896,0.009725624,0.040691763,,O70244,1.15E-11,Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584],GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062
3458,Pocillopora_acuta_HIv2___RNAseq.g24154.t1,43.20797999,-0.206666132,1.034375636,0.009753371,0.040796055,,P58545,3.03E-58,BTB/POZ domain-containing protein 3,cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008],GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0042802; GO:0048813
3459,Pocillopora_acuta_HIv2___TS.g4335.t1,111.4769704,0.178605165,1.034948027,0.009759747,0.040810924,,Q26627,3.72E-16,Sperm receptor for egg jelly (suREJ),detection of mechanical stimulus [GO:0050982],GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0030246; GO:0050982
3460,Pocillopora_acuta_HIv2___RNAseq.g18121.t1,6819.874183,-1.783223288,1.954109183,0.009781871,0.040888955,Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2,Q6K3R5,3.79E-66,Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2),calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814],GO:0005509; GO:0005774; GO:0005886; GO:0006814; GO:0006874; GO:0015369; GO:0070588
3461,Pocillopora_acuta_HIv2___RNAseq.g20930.t1,68.17663182,1.680568098,1.173767476,0.009784062,0.040888955,,NA,NA,NA,NA,NA
3462,Pocillopora_acuta_HIv2___TS.g20330.t1,468.7308912,-0.507910214,1.124931638,0.009789594,0.040900257,,A7E3W5,1.11E-41,Synaptogyrin-2 (Cellugyrin),regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499],GO:0030672; GO:0031594; GO:0045055; GO:0048499
3463,Pocillopora_acuta_HIv2___RNAseq.g4350.t1,208.1878449,0.1602336,1.028628211,0.009814454,0.040992278,,A7YWP4,0,Histidine ammonia-lyase (Histidase) (EC 4.3.1.3),L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557],GO:0004397; GO:0005737; GO:0006548; GO:0019556; GO:0019557
3464,Pocillopora_acuta_HIv2___RNAseq.g25124.t1,265.8318325,-0.269746963,1.057239271,0.009845421,0.041109751,,NA,NA,NA,NA,NA
3465,Pocillopora_acuta_HIv2___RNAseq.g3138.t1,36.01730674,-0.544936882,1.156367851,0.009852041,0.041125519,,NA,NA,NA,NA,NA
3466,Pocillopora_acuta_HIv2___RNAseq.g26996.t1,113.0930928,-0.229103941,1.049188653,0.009861591,0.041153504,,P0DXC0,4.14E-180,Cyclic GMP-AMP synthase-like receptor 3 (Sp-cGLR3) (Cyclic-di-AMP synthase cGLR3) (EC 2.7.7.85),innate immune response [GO:0045087],GO:0003690; GO:0005524; GO:0005525; GO:0016779; GO:0045087; GO:0046872
3467,Pocillopora_acuta_HIv2___TS.g20846.t1,2193.743304,1.610374821,1.131360677,0.009873145,0.041189838,,NA,NA,NA,NA,NA
3468,Pocillopora_acuta_HIv2___RNAseq.g17210.t1,100.021397,-0.286955538,1.061560031,0.0099306,0.041417589,,Q6DGR4,2.21E-94,Protein HGH1 homolog,,
3469,Pocillopora_acuta_HIv2___TS.g17408.t1,67.2630005,-0.256683097,1.0548635,0.009950894,0.041490264,,A0JM23,5.84E-39,Nephrocystin-3,"cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]",GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095
3470,Pocillopora_acuta_HIv2___RNAseq.g13980.t1c,84.87039422,-0.214633122,1.027340619,0.010014475,0.041743335,,Q80WA4,4.76E-57,RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1),"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA processing [GO:0050684]; regulation of RNA metabolic process [GO:0051252]; spinal cord development [GO:0021510]",GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0021510; GO:0050684; GO:0051252; GO:0120163; GO:1990825
3471,Pocillopora_acuta_HIv2___TS.g15866.t1,49.17667418,-0.953116057,1.452925403,0.010026594,0.041781807,,NA,NA,NA,NA,NA
3472,Pocillopora_acuta_HIv2___TS.g7062.t1,144.7311617,1.862711946,1.435770774,0.010045517,0.041848603,,P97821,9.42E-34,Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)],negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913],GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005813; GO:0006508; GO:0008234; GO:0008239; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0051087; GO:0051603; GO:0062023; GO:1903052; GO:1903980; GO:2001235
3473,Pocillopora_acuta_HIv2___RNAseq.g28251.t1,2338.024874,-1.500633984,0.859573235,0.010048899,0.041850641,Sodium- and chloride-dependent GABA transporter 1 (GAT-1),P23978,1.73E-167,Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1),"amino acid transport [GO:0006865]; associative learning [GO:0008306]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; inorganic anion import across plasma membrane [GO:0098658]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]",GO:0005283; GO:0005332; GO:0005886; GO:0006865; GO:0007612; GO:0007613; GO:0008306; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014070; GO:0014074; GO:0015185; GO:0015378; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051939; GO:0098658; GO:0098719; GO:0098793; GO:0098810; GO:0098982; GO:1902476
3474,Pocillopora_acuta_HIv2___RNAseq.g15958.t1,42.74324068,-0.217254384,1.032799109,0.010062232,0.041894106,,B3EWZ8,8.99E-24,Ectin,,GO:0005576
3475,Pocillopora_acuta_HIv2___RNAseq.g18045.t1,1760.605807,1.423457861,1.832303648,0.010074532,0.041933245,,Q6GL62,5.25E-12,DNA-binding protein inhibitor ID-4 (Inhibitor of DNA binding 4) (Inhibitor of differentiation 4),negative regulation of transcription by RNA polymerase II [GO:0000122],GO:0000122; GO:0005634; GO:0005737; GO:0043425; GO:0046983
3476,Pocillopora_acuta_HIv2___TS.g12273.t1,61.70175649,-0.085868554,1.01362291,0.010081975,0.041952153,,NA,NA,NA,NA,NA
3477,Pocillopora_acuta_HIv2___RNAseq.g7848.t1,120.2220932,-0.449293011,1.140074741,0.010087003,0.041961006,,Q8TCF1,5.44E-82,AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1),cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617],GO:0005737; GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843
3478,Pocillopora_acuta_HIv2___RNAseq.g10314.t1,517.6028137,-0.513580603,1.107457798,0.01009681,0.041978469,,O43663,2.82E-105,Protein regulator of cytokinesis 1,cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465],GO:0000022; GO:0000226; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0008017; GO:0008284; GO:0015630; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0045171; GO:0051256; GO:0051301; GO:0070938; GO:1990023
3479,Pocillopora_acuta_HIv2___RNAseq.g30657.t1,881.3703429,1.336683115,0.651731942,0.010097006,0.041978469,,Q5ZK62,0,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)",cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456],GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090
3480,Pocillopora_acuta_HIv2___RNAseq.g18145.t1,258.6701047,-0.239655108,1.050771266,0.010118841,0.042047523,,NA,NA,NA,NA,NA
3481,Pocillopora_acuta_HIv2___RNAseq.g8902.t1,4224.056603,-1.530582319,0.87561124,0.01011943,0.042047523,,NA,NA,NA,NA,NA
3482,Pocillopora_acuta_HIv2___RNAseq.g16474.t1,150.7683596,-1.56084865,1.833641736,0.010126488,0.042064767,Solute carrier family 12 member 2,P55013,0,Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter),cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; inorganic cation import across plasma membrane [GO:0098659]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078],GO:0006884; GO:0008511; GO:0008519; GO:0016323; GO:0016324; GO:0046873; GO:0055064; GO:0055075; GO:0055078; GO:0071944; GO:0098659; GO:1990573
3483,Pocillopora_acuta_HIv2___RNAseq.g2501.t1,11.91901156,-1.386668413,2.037069046,0.010143317,0.042122579,,Q8N8K9,8.71E-07,Uncharacterized protein KIAA1958,,
3484,Pocillopora_acuta_HIv2___RNAseq.g29688.t1,417.2924478,0.867459259,1.531223049,0.010159867,0.042179197,,NA,NA,NA,NA,NA
3485,Pocillopora_acuta_HIv2___RNAseq.g30525.t1,23.24992788,-1.721308894,2.008156777,0.010168879,0.042204494,,Q09575,1.09E-26,Uncharacterized protein K02A2.6,DNA integration [GO:0015074],GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575
3486,Pocillopora_acuta_HIv2___RNAseq.g25785.t1a,203.1539267,-0.799010175,1.316577009,0.01017919,0.042235169,,NA,NA,NA,NA,NA
3487,Pocillopora_acuta_HIv2___RNAseq.g22611.t1,213.4798397,-0.777960172,1.303099648,0.010191812,0.042275413,,P39689,6.28E-08,Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein) (p21),"cellular response to amino acid starvation [GO:0034198]; cellular response to gamma radiation [GO:0071480]; cellular response to UV-B [GO:0071493]; cellular senescence [GO:0090398]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; epidermis development [GO:0008544]; fibroblast proliferation [GO:0048144]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; oncogene-induced cell senescence [GO:0090402]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into nucleus [GO:0006606]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of DNA biosynthetic process [GO:2000278]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic cell cycle [GO:0007346]; response to UV [GO:0009411]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]",GO:0000307; GO:0001701; GO:0001933; GO:0001934; GO:0004860; GO:0004861; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006606; GO:0006974; GO:0006977; GO:0006978; GO:0007095; GO:0007265; GO:0007346; GO:0007507; GO:0008285; GO:0008544; GO:0009411; GO:0010629; GO:0016604; GO:0019901; GO:0019912; GO:0030216; GO:0030308; GO:0030332; GO:0030890; GO:0031625; GO:0032991; GO:0034198; GO:0042060; GO:0042246; GO:0042771; GO:0043066; GO:0043068; GO:0043616; GO:0044877; GO:0046872; GO:0048144; GO:0048146; GO:0048471; GO:0051726; GO:0070557; GO:0071480; GO:0071493; GO:0090398; GO:0090402; GO:0140311; GO:1902806; GO:1904706; GO:1905179; GO:2000045; GO:2000134; GO:2000278; GO:2000279; GO:2000379
3488,Pocillopora_acuta_HIv2___RNAseq.g12417.t1,170.5693446,-1.029179943,1.488020169,0.010198321,0.042290285,,Q60HG7,0,Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2),cysteine biosynthetic process [GO:0019344]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; transsulfuration [GO:0019346],GO:0004123; GO:0005516; GO:0005737; GO:0006629; GO:0018272; GO:0019344; GO:0019346; GO:0030170; GO:0043066; GO:0043123; GO:0044524; GO:0044540; GO:0047982; GO:0051092; GO:0070814; GO:0080146; GO:0098606
3489,Pocillopora_acuta_HIv2___RNAseq.14358_t,528.1519995,0.361902317,1.073537555,0.010213228,0.042339962,,Q96PQ7,1.80E-168,Kelch-like protein 5,,GO:0003779; GO:0005737; GO:0005829; GO:0005856
3490,Pocillopora_acuta_HIv2___RNAseq.g26013.t1,218.4121168,-1.088458774,1.524394771,0.010232049,0.042405834,,NA,NA,NA,NA,NA
3491,Pocillopora_acuta_HIv2___TS.g11002.t4,167.397861,1.685870512,1.378354003,0.010249423,0.042465671,,P07207,6.79E-80,Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein],"actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]",GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048
3492,Pocillopora_acuta_HIv2___RNAseq.g16241.t1,204.584886,-0.319034037,1.071312707,0.010258207,0.042489892,,P70500,1.22E-83,CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase),CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661],GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341
3493,Pocillopora_acuta_HIv2___RNAseq.g30139.t1,821.7959062,-1.471651006,1.32836699,0.010272945,0.042538757,,Q921G7,0,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)",electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979],GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031966; GO:0033539; GO:0046872; GO:0048039; GO:0051536; GO:0051539
3494,Pocillopora_acuta_HIv2___TS.g23223.t2,146.0321922,-0.167210079,1.014064461,0.0102897,0.042595941,,P48763,1.06E-159,Sodium/hydrogen exchanger 2 (H7) (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2),epithelial cell differentiation [GO:0030855]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814],GO:0005886; GO:0006814; GO:0006885; GO:0008104; GO:0015385; GO:0015386; GO:0016324; GO:0030855; GO:0035725; GO:0051453; GO:0071805; GO:0098719
3495,Pocillopora_acuta_HIv2___RNAseq.g21339.t1,328.8837905,0.506553191,1.162466931,0.010326808,0.042737326,,P47799,2.74E-111,Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor),adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of protein kinase A signaling [GO:0010738],GO:0004963; GO:0005886; GO:0007186; GO:0007189; GO:0008528; GO:0008584; GO:0009755; GO:0010738; GO:0016020; GO:0042699; GO:0043235; GO:0051897; GO:0070374; GO:0071372
3496,Pocillopora_acuta_HIv2___TS.g2709.t1,2877.740114,-1.584653422,0.939997161,0.010353853,0.042836992,ZP domain-containing protein,G8HTB6,1.65E-39,ZP domain-containing protein,,GO:0016020
3497,Pocillopora_acuta_HIv2___RNAseq.g19685.t1,27.80111317,1.652625084,1.644606497,0.010403702,0.043030926,,NA,NA,NA,NA,NA
3498,Pocillopora_acuta_HIv2___RNAseq.g1658.t1,228.5676773,-0.165250958,1.032365819,0.010418427,0.043079512,,B5FXA0,8.37E-36,Electron transfer flavoprotein regulatory factor 1 (LYR motif-containing protein 5),respiratory electron transport chain [GO:0022904],GO:0005739; GO:0022904
3499,Pocillopora_acuta_HIv2___RNAseq.g29836.t1,906.6614444,-1.546921946,1.111755978,0.010432152,0.043123936,,Q8QGQ6,3.28E-60,Circadian locomoter output cycles protein kaput,circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; protein acetylation [GO:0006473]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775],GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005829; GO:0006357; GO:0006473; GO:0006974; GO:0032922; GO:0046983; GO:0051775; GO:0070888; GO:1990513
3500,Pocillopora_acuta_HIv2___RNAseq.g866.t1,88.67056913,-1.70110729,1.60224267,0.010446391,0.043170459,,NA,NA,NA,NA,NA
3501,Pocillopora_acuta_HIv2___RNAseq.g20738.t1,22.32893462,-0.383668727,1.073057426,0.010463235,0.043227715,,NA,NA,NA,NA,NA
3502,Pocillopora_acuta_HIv2___RNAseq.g17163.t1,149.1370795,-0.244407395,1.051065522,0.010468274,0.043236183,,Q76KP1,6.61E-83,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)",,GO:0008376; GO:0032580; GO:0033842
3503,Pocillopora_acuta_HIv2___RNAseq.g4382.t1,111.890237,-0.174786839,1.035378066,0.010499837,0.043354168,,NA,NA,NA,NA,NA
3504,Pocillopora_acuta_HIv2___RNAseq.25025_t,118.5853645,-0.20015324,1.024620686,0.010509632,0.043382225,Frizzled-4 ,Q9IA05,1.74E-06,Frizzled-4 (Fz-4) (cFz-4),"angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; cell population proliferation [GO:0008283]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum vasculature morphogenesis [GO:0061301]; endothelial cell differentiation [GO:0045446]; establishment of blood-brain barrier [GO:0060856]; extracellular matrix-cell signaling [GO:0035426]; locomotion involved in locomotory behavior [GO:0031987]; luteinization [GO:0001553]; negative regulation of cell-substrate adhesion [GO:0010812]; non-canonical Wnt signaling pathway [GO:0035567]; Norrin signaling pathway [GO:0110135]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; progesterone secretion [GO:0042701]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to hypoxia [GO:0001666]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]",GO:0001525; GO:0001540; GO:0001553; GO:0001568; GO:0001570; GO:0001666; GO:0004896; GO:0004930; GO:0005886; GO:0005911; GO:0007223; GO:0007605; GO:0008283; GO:0009986; GO:0010812; GO:0016055; GO:0017147; GO:0019955; GO:0030165; GO:0030335; GO:0030425; GO:0030947; GO:0031625; GO:0031987; GO:0034446; GO:0035426; GO:0035567; GO:0042701; GO:0042803; GO:0042813; GO:0043507; GO:0044877; GO:0045446; GO:0045893; GO:0046982; GO:0051091; GO:0060070; GO:0060856; GO:0061299; GO:0061301; GO:0061304; GO:0070062; GO:0098978; GO:0110135; GO:0150012; GO:1990830
3505,Pocillopora_acuta_HIv2___RNAseq.g5981.t1,152.7840851,-0.482239765,1.097201486,0.010515382,0.043393575,,A0A2J6RX17,1.84E-07,Nucleotide-binding leucine-rich repeat (NLR)-like protein (EC 3.5.99.-),nucleoside metabolic process [GO:0009116],GO:0009116; GO:0016787; GO:0043531
3506,Pocillopora_acuta_HIv2___RNAseq.g20576.t1,429.9997347,1.316161592,1.615828867,0.010548259,0.043516833,,A1KZ92,9.84E-23,Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2),hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],GO:0004519; GO:0004601; GO:0005615; GO:0005783; GO:0005886; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0140825
3507,Pocillopora_acuta_HIv2___RNAseq.g13766.t1,762.8855621,-0.810125689,1.336282555,0.010608749,0.043753905,,O60306,0,RNA helicase aquarius (EC 3.6.4.13) (Intron-binding protein of 160 kDa) (IBP160),"mRNA splicing, via spliceosome [GO:0000398]",GO:0000398; GO:0003723; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0016020; GO:0016887; GO:0034458; GO:0071007; GO:0071013
3508,Pocillopora_acuta_HIv2___RNAseq.g15819.t1,118.9816506,-0.805677112,1.330091654,0.010630408,0.043830736,,Q7TNH6,8.91E-06,Nephrocystin-3,"atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]",GO:0001822; GO:0001947; GO:0003283; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095
3509,Pocillopora_acuta_HIv2___RNAseq.g13261.t1,324.726134,-0.271778565,1.052360262,0.010643072,0.043870444,,Q5XGI5,4.48E-135,WD repeat domain-containing protein 83 (Mitogen-activated protein kinase organizer 1) (MAPK organizer 1),,GO:0005737
3510,Pocillopora_acuta_HIv2___RNAseq.g13247.t1,97.403952,-0.846360373,1.351166054,0.010647473,0.043876082,,NA,NA,NA,NA,NA
3511,Pocillopora_acuta_HIv2___RNAseq.g10409.t1,447.0132057,-0.777643495,1.276447609,0.010669452,0.043954129,,Q8K194,2.28E-19,U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein (U4/U6.U5 snRNP 27 kDa protein) (U4/U6.U5-27K) (U4/U6.U5 tri-snRNP-associated protein 3),mRNA processing [GO:0006397]; RNA splicing [GO:0008380],GO:0005634; GO:0006397; GO:0008380
3512,Pocillopora_acuta_HIv2___RNAseq.g8580.t1,677.0473222,-0.946730602,1.338277988,0.010695424,0.044048579,,O95185,7.66E-07,Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C),anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; ectopic germ cell programmed cell death [GO:0035234]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental process [GO:0051094]; positive regulation of reproductive process [GO:2000243]; regulation of neuron migration [GO:2001222],GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0019901; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0033564; GO:0035234; GO:0043025; GO:0043065; GO:0045202; GO:0051094; GO:0061643; GO:1990791; GO:2000243; GO:2001222
3513,Pocillopora_acuta_HIv2___TS.g13106.t1,45.52915615,-0.180692298,1.02023019,0.010713823,0.044111796,,A2ALV5,7.69E-36,Protein shortage in chiasmata 1 ortholog (EC 3.6.-.-) (Protein ZIP2 homolog) (MZip2),reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130],GO:0000712; GO:0000794; GO:0003697; GO:0005694; GO:0007130; GO:0007131; GO:0016887
3514,Pocillopora_acuta_HIv2___TS.g8264.t1,1804.337266,1.57688197,1.220633213,0.01071953,0.044122732,,NA,NA,NA,NA,NA
3515,Pocillopora_acuta_HIv2___RNAseq.g29194.t1,52.60334231,-0.272446681,1.039766775,0.010740008,0.044194447,,NA,NA,NA,NA,NA
3516,Pocillopora_acuta_HIv2___RNAseq.g22992.t1,214.8727797,-0.522496896,1.154312452,0.010751582,0.044223501,,Q6PGT0,1.02E-122,Transcriptional adapter 3-A (ADA3 homolog A) (Transcriptional adapter 3-like A) (ADA3-like protein A),regulation of transcription by RNA polymerase II [GO:0006357],GO:0000124; GO:0003713; GO:0005634; GO:0006357
3517,Pocillopora_acuta_HIv2___RNAseq.g28196.t1,129.2329339,1.607287467,1.457101475,0.010753184,0.044223501,,P16112,8.16E-20,Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2],cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; proteolysis [GO:0006508]; skeletal system development [GO:0001501],GO:0001501; GO:0002052; GO:0005201; GO:0005540; GO:0005576; GO:0005615; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0043202; GO:0045202; GO:0046872; GO:0062023; GO:0072534
3518,Pocillopora_acuta_HIv2___RNAseq.g30596.t1,3380.504331,1.423164864,0.76213323,0.010781169,0.044325988,,Q6AZG8,1.31E-48,Prostamide/prostaglandin F synthase (Prostamide/PG F synthase) (Prostamide/PGF synthase) (EC 1.11.1.20) (Peroxiredoxin-like 2B),prostaglandin biosynthetic process [GO:0001516],GO:0001516; GO:0005829; GO:0016616
3519,Pocillopora_acuta_HIv2___TS.g28867.t2,1865.249767,-1.461636521,0.792008371,0.010806502,0.04441752,,Q8VHT6,2.29E-104,Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase),arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404],GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0032259; GO:0046685
3520,Pocillopora_acuta_HIv2___RNAseq.g14240.t1,913.1079224,1.07938935,1.493488106,0.010813492,0.04443362,,Q58CQ9,5.33E-148,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1),pantothenate metabolic process [GO:0015939],GO:0005886; GO:0015939; GO:0017159; GO:0098552
3521,Pocillopora_acuta_HIv2___TS.g10157.t2,113.486793,-0.309718314,1.070288452,0.010834446,0.044494588,,Q9WVM6,4.32E-36,Tolloid-like protein 2 (EC 3.4.24.-),cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of skeletal muscle tissue growth [GO:0048632]; protein processing [GO:0016485],GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0048632
3522,Pocillopora_acuta_HIv2___RNAseq.g25583.t1,856.6580091,-0.473182589,1.143961914,0.010834481,0.044494588,Chloroquine resistance transporter paralog 2,Q550A6,1.91E-08,Crt homolog 2 (Chloroquine resistance transporter paralog 2) (DdCRTp2),amino acid transport [GO:0006865],GO:0005774; GO:0006865; GO:0042910
3523,Pocillopora_acuta_HIv2___RNAseq.g14613.t1,5362.453589,-1.260705778,0.595029428,0.010842622,0.044515382,,NA,NA,NA,NA,NA
3524,Pocillopora_acuta_HIv2___RNAseq.g26272.t1,715.2314395,-1.140437282,1.515554376,0.010848764,0.044527959,,Q5TJF5,7.19E-91,(3R)-3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (Estradiol 17-beta-dehydrogenase 8) (EC 1.1.1.62) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239),estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290],GO:0004303; GO:0005759; GO:0006633; GO:0006703; GO:0047035; GO:0051290; GO:0070404; GO:0106386
3525,Pocillopora_acuta_HIv2___TS.g26966.t1,214.6490588,-0.449770924,1.080220925,0.010886067,0.044668388,,NA,NA,NA,NA,NA
3526,Pocillopora_acuta_HIv2___RNAseq.g11880.t1,343.8419124,-0.606449684,1.15426038,0.010892923,0.044683847,,Q5DTY9,7.53E-56,BTB/POZ domain-containing protein KCTD16,protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],GO:0008277; GO:0042734; GO:0042995; GO:0043235; GO:0045211; GO:0051260
3527,Pocillopora_acuta_HIv2___TS.g25068.t1,467.0827182,1.74446147,1.608540741,0.010910851,0.044744697,,Q9H3S4,1.68E-78,Thiamine pyrophosphokinase 1 (hTPK1) (Placental protein 20) (PP20) (Thiamin pyrophosphokinase 1),regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772],GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0010510; GO:0016301; GO:0030975; GO:0042802; GO:0141200
3528,Pocillopora_acuta_HIv2___RNAseq.g16934.t1,360.232186,-1.192243127,1.488412929,0.0109246,0.044788384,,Q8IV20,1.43E-77,Purine nucleoside phosphorylase LACC1 (EC 2.4.2.1) (Adenosine deaminase LACC1) (EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1) (EC 2.4.2.28),inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of cellular pH [GO:0030641]; regulation of inflammatory response [GO:0050727]; regulation of purine nucleotide metabolic process [GO:1900542],GO:0002221; GO:0002720; GO:0004000; GO:0004731; GO:0005507; GO:0005634; GO:0005777; GO:0005783; GO:0006954; GO:0017061; GO:0030641; GO:0045087; GO:0046936; GO:0047975; GO:0050727; GO:0070431; GO:1900542
3529,Pocillopora_acuta_HIv2___RNAseq.g20447.t1,118.0815082,-0.13460082,1.016889219,0.010936108,0.04482286,,NA,NA,NA,NA,NA
3530,Pocillopora_acuta_HIv2___RNAseq.g23055.t1b,86.64197666,-0.854249709,1.314970166,0.010941197,0.044831013,,Q09575,2.84E-16,Uncharacterized protein K02A2.6,DNA integration [GO:0015074],GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575
3531,Pocillopora_acuta_HIv2___RNAseq.g28298.t1,133.1888515,-0.828780788,1.472285683,0.010962415,0.044896592,,Q9DB41,1.49E-101,Mitochondrial glutamate carrier 2 (GC-2) (Glutamate/H(+) symporter 2) (Solute carrier family 25 member 18),aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490],GO:0005280; GO:0005313; GO:0005743; GO:0015183; GO:0015810; GO:0015813; GO:0043490
3532,Pocillopora_acuta_HIv2___RNAseq.g5400.t1,480.6096243,-1.224310771,1.603288798,0.01096341,0.044896592,,NA,NA,NA,NA,NA
3533,Pocillopora_acuta_HIv2___RNAseq.g9120.t1,1361.31624,-0.548268192,1.152906023,0.010968898,0.04490635,,Q17GZ9,1.59E-171,Actin-related protein 5,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of DNA-templated transcription [GO:0006355],GO:0005737; GO:0006281; GO:0006310; GO:0006338; GO:0006355; GO:0031011
3534,Pocillopora_acuta_HIv2___TS.g10074.t1,24.78737487,-0.819672525,1.369156322,0.01098877,0.044961471,,Q09575,1.05E-22,Uncharacterized protein K02A2.6,DNA integration [GO:0015074],GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575
3535,Pocillopora_acuta_HIv2___RNAseq.g16476.t1,701.6752673,-0.628866909,1.207460665,0.010989668,0.044961471,,NA,NA,NA,NA,NA
3536,Pocillopora_acuta_HIv2___RNAseq.g8544.t1,45.6376298,-0.226264547,1.047902411,0.010991687,0.044961471,,NA,NA,NA,NA,NA
3537,Pocillopora_acuta_HIv2___RNAseq.g15648.t1,427.2391547,-0.917436846,1.402781912,0.011025451,0.045086833,,Q8IV61,1.89E-135,Ras guanyl-releasing protein 3 (Calcium and DAG-regulated guanine nucleotide exchange factor III) (Guanine nucleotide exchange factor for Rap1),MAPK cascade [GO:0000165]; Ras protein signal transduction [GO:0007265]; small GTPase-mediated signal transduction [GO:0007264],GO:0000165; GO:0005085; GO:0005096; GO:0005509; GO:0005886; GO:0007264; GO:0007265; GO:0019900; GO:0019992; GO:0031267; GO:0032045; GO:0048471
3538,Pocillopora_acuta_HIv2___RNAseq.g35.t1,780.66677,-0.580331692,1.166171678,0.011083162,0.045310022,ZP domain-containing protein,G8HTB6,1.44E-55,ZP domain-containing protein,,GO:0016020
3539,Pocillopora_acuta_HIv2___RNAseq.g28737.t1,196.7189593,-0.098311462,1.020736787,0.011103046,0.045378486,,Q7Z494,4.59E-32,Nephrocystin-3,"atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]",GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095
3540,Pocillopora_acuta_HIv2___TS.g8276.t1,18.56828207,-0.501786917,1.135292497,0.011171218,0.045634832,,Q92626,3.34E-31,Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment],angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825
3541,Pocillopora_acuta_HIv2___TS.g12601.t1,76.95796252,-0.802092294,1.53986129,0.011178743,0.045634832,,Q8BMJ7,2.45E-15,Cell growth regulator with RING finger domain protein 1 (Cell growth regulatory gene 19 protein),negative regulation of cell growth [GO:0030308]; regulation of cell cycle [GO:0051726],GO:0005654; GO:0005783; GO:0030308; GO:0046872; GO:0051726
3542,Pocillopora_acuta_HIv2___RNAseq.g8501.t1,149.6991045,-0.175511169,1.035497468,0.011179184,0.045634832,,Q5RBA8,5.33E-157,Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2),5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; purine nucleotide biosynthetic process [GO:0006164],GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164
3543,Pocillopora_acuta_HIv2___TS.g19140.t1b,516.1239737,-0.611472627,1.202155959,0.011181097,0.045634832,,O14041,1.30E-11,Uncharacterized nucleolar protein C2C4.08,,GO:0003676; GO:0005634; GO:0005730
3544,Pocillopora_acuta_HIv2___TS.g16617.t2,105.2631871,-0.386375254,1.065775506,0.011181544,0.045634832,,NA,NA,NA,NA,NA
3545,Pocillopora_acuta_HIv2___RNAseq.g3624.t1,4031.253279,-1.499696204,0.87838073,0.011234048,0.045836184,,Q1LW01,3.56E-39,Hatching enzyme 1.2 (EC 3.4.24.67) (Choriolysin H homolog 1) (High choriolytic enzyme 1 homolog) (zHCE-1),hatching [GO:0035188]; proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0008270; GO:0035188
3546,Pocillopora_acuta_HIv2___RNAseq.g11262.t1,102.8875522,0.854055978,1.375872668,0.011268919,0.045965495,,NA,NA,NA,NA,NA
3547,Pocillopora_acuta_HIv2___RNAseq.g3166.t1,575.394708,-1.535050119,1.640959673,0.011273719,0.045972109,Rhodopsin,P09241,1.16E-26,Rhodopsin,cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; visual perception [GO:0007601],GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0016020; GO:0016918; GO:0033583; GO:0071482
3548,Pocillopora_acuta_HIv2___RNAseq.g17964.t1,407.2387682,-0.454284177,1.082069582,0.011284004,0.045988688,,Q5ZJ97,2.30E-17,Uncharacterized protein KIAA1143 homolog,,
3549,Pocillopora_acuta_HIv2___RNAseq.g12586.t1,38.60898323,-0.598318529,1.181132607,0.011284144,0.045988688,,P30974,2.57E-11,Tachykinin-like peptides receptor 86C (NKD),G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217],GO:0002121; GO:0004995; GO:0005886; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016020
3550,Pocillopora_acuta_HIv2___RNAseq.g17728.t1,107.9247406,-1.089311135,1.424786135,0.011291091,0.046004041,,Q7RTR2,3.38E-73,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)",canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110],GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223
3551,Pocillopora_acuta_HIv2___RNAseq.g13648.t2,235.425285,-0.574611904,1.21980358,0.01130432,0.04604497,,Q14746,0,Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein),"glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",GO:0000139; GO:0000301; GO:0005795; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0044877; GO:0070085
3552,Pocillopora_acuta_HIv2___TS.g9512.t1a,874.8784367,-0.546824249,1.128082411,0.01132588,0.046119801,,NA,NA,NA,NA,NA
3553,Pocillopora_acuta_HIv2___RNAseq.g21354.t2,255.746503,-0.603436218,1.173864187,0.011346525,0.046190862,,Q8K4Q7,5.19E-91,Ceramide kinase (mCERK) (EC 2.7.1.138) (Acylsphingosine kinase),ceramide metabolic process [GO:0006672],GO:0000287; GO:0001729; GO:0005524; GO:0005739; GO:0005886; GO:0006672; GO:0016020; GO:0102773
3554,Pocillopora_acuta_HIv2___TS.g20153.t1a,2002.140506,-1.573192823,0.978522142,0.011369262,0.0462704,,P14733,3.96E-89,Lamin-B1,cellular response to L-glutamate [GO:1905232]; heterochromatin formation [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of JNK cascade [GO:0046330]; protein localization to nuclear envelope [GO:0090435],GO:0003690; GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0007097; GO:0008432; GO:0010971; GO:0016363; GO:0031507; GO:0031965; GO:0034399; GO:0043274; GO:0046330; GO:0051664; GO:0090435; GO:0160123; GO:1905232; GO:1990837
3555,Pocillopora_acuta_HIv2___RNAseq.g5145.t1,726.7913474,1.055333264,1.594324188,0.011440141,0.046545767,,Q0V7M1,8.77E-150,Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1),determination of left/right symmetry [GO:0007368]; heart development [GO:0007507],GO:0004674; GO:0005524; GO:0005789; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0016607; GO:0106310
3556,Pocillopora_acuta_HIv2___RNAseq.g26359.t1,695.2047916,-0.550542466,1.12931658,0.011445958,0.046556336,,Q90341,2.27E-41,Transcriptional regulator Myc-1 (c-Myc-1) (c-Myc I),,GO:0000981; GO:0003677; GO:0005634; GO:0046983
3557,Pocillopora_acuta_HIv2___RNAseq.g26503.t1,559.8714194,-1.062010845,1.55406246,0.011476374,0.046666931,,Q99L13,1.87E-139,"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)",valine catabolic process [GO:0006574],GO:0005739; GO:0006574; GO:0008442; GO:0050661; GO:0051287
3558,Pocillopora_acuta_HIv2___RNAseq.g2915.t1,1410.827702,-1.4706009,0.845290197,0.01151741,0.046820637,,Q9NYQ6,5.70E-42,Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2),"apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609
3559,Pocillopora_acuta_HIv2___RNAseq.g19522.t1,67.08665133,-0.811219114,1.38124397,0.011539299,0.046896437,,P42527,2.44E-11,Myosin heavy chain kinase A (MHCK-A) (EC 2.7.11.7),actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; chemotaxis [GO:0006935]; mitotic cytokinesis [GO:0000281]; myosin II filament disassembly [GO:0031037]; protein autophosphorylation [GO:0046777],GO:0000281; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005826; GO:0005938; GO:0006935; GO:0016208; GO:0016905; GO:0030552; GO:0031037; GO:0042802; GO:0043262; GO:0043531; GO:0045159; GO:0046777; GO:0051015; GO:0051017; GO:0051764
3560,Pocillopora_acuta_HIv2___RNAseq.g20652.t1,137.9640991,0.428122898,1.118215147,0.011547605,0.046917011,,P30937,5.29E-26,Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R),cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072
3561,Pocillopora_acuta_HIv2___RNAseq.17885_t,1565.483166,-1.522516074,0.923219581,0.01155491,0.046933507,,NA,NA,NA,NA,NA
3562,Pocillopora_acuta_HIv2___RNAseq.g15510.t1,230.2156744,1.685729421,1.958725192,0.011567825,0.046972772,Forkhead box protein A2,O42097,9.12E-81,Hepatocyte nuclear factor 3-beta (HNF-3-beta) (HNF-3B) (Forkhead box protein A2) (Me-HNF3B),anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0019904; GO:0030154
3563,Pocillopora_acuta_HIv2___RNAseq.g24790.t1,397.6804685,-1.295532044,1.595357935,0.011582907,0.047020817,,A0A1X7TVA9,6.63E-12,Death domain-containing ATP nucleosidase (DDAN) (EC 3.5.99.-),nucleoside metabolic process [GO:0009116],GO:0009116; GO:0016787
3564,Pocillopora_acuta_HIv2___TS.g21614.t2,404.348896,-0.663862454,1.209828644,0.011618739,0.047153042,,P04352,1.93E-63,Calmodulin (CaM),,GO:0005509; GO:0005737; GO:0005856; GO:0031514
3565,Pocillopora_acuta_HIv2___RNAseq.g24051.t1,302.817258,-1.410430349,1.570460957,0.01164461,0.047244779,,A4IF63,1.60E-06,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630
3566,Pocillopora_acuta_HIv2___RNAseq.g19209.t1,114.2613464,-0.725182739,1.372223605,0.011668084,0.047326742,,NA,NA,NA,NA,NA
3567,Pocillopora_acuta_HIv2___RNAseq.g30473.t1,13.324303,-1.344152598,1.901719081,0.011677768,0.04734923,,Q8N8K9,7.80E-06,Uncharacterized protein KIAA1958,,
3568,Pocillopora_acuta_HIv2___RNAseq.g16268.t1,578.6054294,-0.581812564,1.170783444,0.011680175,0.04734923,,NA,NA,NA,NA,NA
3569,Pocillopora_acuta_HIv2___TS.g8359.t1,114.4162622,-0.532552919,1.167531027,0.01169316,0.047388586,,Q5R6J1,1.85E-107,Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1),sodium ion transmembrane transport [GO:0035725],GO:0015175; GO:0015293; GO:0016324; GO:0035725
3570,Pocillopora_acuta_HIv2___RNAseq.g30208.t1,125.3516473,-0.334351404,1.086458248,0.011702982,0.04739908,,P13914,3.60E-30,"Arylamine N-acetyltransferase, pineal gland isozyme NAT-3 (Arylamine acetylase) (EC 2.3.1.5) (N-hydroxyarylamine O-acetyltransferase) (EC 2.3.1.118)",,GO:0004060; GO:0046990
3571,Pocillopora_acuta_HIv2___RNAseq.g1075.t1,2897.252499,1.460154733,0.842013769,0.011705727,0.04739908,,Q9H3U7,4.25E-21,SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2),extracellular matrix organization [GO:0030198]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; positive regulation of vascular wound healing [GO:0035470],GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010595; GO:0030198; GO:0035470; GO:0045743; GO:0045766; GO:0045931; GO:0050840; GO:0071944; GO:1900748; GO:2000573; GO:2001028
3572,Pocillopora_acuta_HIv2___RNAseq.g11721.t1,127.6898496,0.149321761,1.026042581,0.011707821,0.04739908,,P14318,8.03E-35,Muscle-specific protein 20,actin filament organization [GO:0007015]; myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739],GO:0005737; GO:0007015; GO:0007520; GO:0015629; GO:0051015; GO:1901739
3573,Pocillopora_acuta_HIv2___TS.g2955.t1,61.30272482,-0.428110708,1.141627502,0.011709708,0.04739908,,P21328,5.60E-06,RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase),,GO:0003964
3574,Pocillopora_acuta_HIv2___RNAseq.g25890.t1,3245.872679,1.472071581,0.830248405,0.011712134,0.04739908,,B3EWZ5,2.83E-80,MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1),,GO:0005576; GO:0016020
3575,Pocillopora_acuta_HIv2___TS.g18294.t2,481.5629966,-1.500178772,0.906959438,0.011716192,0.047401134,,A8JF70,3.39E-82,Outer dynein arm protein 1 (Docking complex component 2),cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158],GO:0036157; GO:0036158; GO:0060294
3576,Pocillopora_acuta_HIv2___RNAseq.g26135.t1,108.1829519,-1.140248919,1.553650289,0.011722045,0.047401134,,NA,NA,NA,NA,NA
3577,Pocillopora_acuta_HIv2___RNAseq.g17945.t2,1248.080523,-1.061959141,1.411097367,0.011722473,0.047401134,,NA,NA,NA,NA,NA
3578,Pocillopora_acuta_HIv2___RNAseq.g880.t1,346.339787,-0.290861776,1.059060362,0.011785235,0.047641599,,NA,NA,NA,NA,NA
3579,Pocillopora_acuta_HIv2___RNAseq.g3587.t1,550.6751231,-0.680287991,1.221695403,0.011794006,0.047646744,,Q3KQ77,5.78E-65,Calaxin (EF-hand calcium-binding domain-containing protein 1),cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; regulation of cilium movement [GO:0003352]; regulation of flagellated sperm motility [GO:1901317],GO:0003341; GO:0003352; GO:0005509; GO:0005737; GO:0005856; GO:0005929; GO:0036158; GO:1901317
3580,Pocillopora_acuta_HIv2___RNAseq.g10110.t1,98.54015842,-0.35495694,1.056689665,0.011795204,0.047646744,,NA,NA,NA,NA,NA
3581,Pocillopora_acuta_HIv2___RNAseq.g21706.t1,18.48870268,-1.909852746,4.220196945,0.01179639,0.047646744,,NA,NA,NA,NA,NA
3582,Pocillopora_acuta_HIv2___TS.g11671.t1,525.2690754,-1.350852257,0.685954719,0.011834476,0.047787229,,NA,NA,NA,NA,NA
3583,Pocillopora_acuta_HIv2___RNAseq.g28353.t1,47.09748671,1.639123736,1.236379952,0.01187408,0.047933769,,NA,NA,NA,NA,NA
3584,Pocillopora_acuta_HIv2___RNAseq.g9149.t1,7807.417419,1.685861281,1.360288974,0.011903709,0.04803997,,NA,NA,NA,NA,NA
3585,Pocillopora_acuta_HIv2___RNAseq.g12144.t2,268.2934922,-0.780904195,1.274504104,0.011930484,0.048134595,,P70587,7.58E-151,Leucine-rich repeat-containing protein 7 (Densin-180) (Densin) (Protein LAP1),"cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; response to organic cyclic compound [GO:0014070]",GO:0005829; GO:0005912; GO:0010976; GO:0014069; GO:0014070; GO:0015629; GO:0016323; GO:0019901; GO:0030175; GO:0043113; GO:0043194; GO:0043197; GO:0045197; GO:0098609; GO:0098839; GO:0098887; GO:0098968; GO:0098978
3586,Pocillopora_acuta_HIv2___RNAseq.g445.t1,444.4022568,0.123883423,1.021004825,0.011951785,0.048207089,,NA,NA,NA,NA,NA
3587,Pocillopora_acuta_HIv2___RNAseq.g9330.t1,101.0739975,-1.440858944,1.583088895,0.011983151,0.048320127,,NA,NA,NA,NA,NA
3588,Pocillopora_acuta_HIv2___TS.g30330.t1,702.8067609,-1.56254166,1.213392553,0.012038642,0.048530356,,P42638,1.54E-13,Tropomyosin-2 (Tropomyosin II) (SmTMII) (TMII),actin filament organization [GO:0007015]; muscle contraction [GO:0006936],GO:0005884; GO:0006936; GO:0007015; GO:0051015
3589,Pocillopora_acuta_HIv2___RNAseq.g13304.t1,665.776148,-0.347919442,1.078545233,0.012075501,0.048656753,,Q6GLN7,4.31E-28,Transmembrane protein 163,,GO:0008270; GO:0030672; GO:0031901
3590,Pocillopora_acuta_HIv2___RNAseq.g7903.t1,83.30795959,-0.286754554,1.063175737,0.012076724,0.048656753,,Q5PQN9,1.90E-62,"Large ribosomal subunit protein mL38 (39S ribosomal protein L38, mitochondrial) (L38mt) (MRP-L38)",,GO:0005739; GO:0005762
3591,Pocillopora_acuta_HIv2___TS.g15134.t1,4469.942083,-1.403032306,0.755191343,0.012125612,0.048840117,Mechanosensory protein 2,Q27433,1.32E-128,Mechanosensory protein 2,detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612],GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792
3592,Pocillopora_acuta_HIv2___RNAseq.g12235.t1,327.1418587,-0.491299926,1.106347662,0.012150884,0.048928282,,Q96LX7,2.44E-34,Coiled-coil domain-containing protein 17,,
3593,Pocillopora_acuta_HIv2___RNAseq.g15493.t1,99.06249307,0.951540859,1.415957041,0.01219386,0.049087667,,NA,NA,NA,NA,NA
3594,Pocillopora_acuta_HIv2___RNAseq.g8018.t1,64.74827906,-0.384504972,1.101937898,0.012204712,0.049113549,,P0CG11,1.47E-32,Chromosome transmission fidelity protein 8 homolog,DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],GO:0003677; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264
3595,Pocillopora_acuta_HIv2___RNAseq.g21053.t1,766.0144719,-0.452140613,1.131053788,0.01220708,0.049113549,,NA,NA,NA,NA,NA
3596,Pocillopora_acuta_HIv2___RNAseq.g1398.t1,277.0492131,-0.395112051,1.066318689,0.012245869,0.04925591,,Q498T4,3.31E-58,"Large ribosomal subunit protein uL2m (39S ribosomal protein L2, mitochondrial) (L2mt) (MRP-L2)",mitochondrial translation [GO:0032543],GO:0003723; GO:0003735; GO:0005654; GO:0005762; GO:0032543
3597,Pocillopora_acuta_HIv2___RNAseq.g20784.t1,34.39506124,-0.346085918,1.093809897,0.012267363,0.049328645,,NA,NA,NA,NA,NA
3598,Pocillopora_acuta_HIv2___RNAseq.g9672.t1,475.8128449,-0.658566918,1.230441064,0.012290036,0.049406081,,Q5RA07,1.15E-111,Guanine nucleotide-binding protein-like 1,DNA damage response [GO:0006974],GO:0003924; GO:0005525; GO:0006974
3599,Pocillopora_acuta_HIv2___RNAseq.g7580.t1,102.3375406,-0.05997834,1.020337882,0.012299382,0.049429915,,Q08CH7,1.37E-07,Radial spoke head 10 homolog B,,GO:0005737; GO:0005856; GO:0097729
3600,Pocillopora_acuta_HIv2___RNAseq.g15255.t1,414.8962038,-0.91769585,1.395279314,0.012304479,0.049436661,,Q9CXT6,2.73E-16,Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.73) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8) (Lysine-specific demethylase 8),circadian regulation of gene expression [GO:0032922]; fibroblast proliferation [GO:0048144]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; regulation of signal transduction by p53 class mediator [GO:1901796],GO:0000086; GO:0001701; GO:0002039; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006508; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0048144; GO:0051864; GO:0106157; GO:1901796
3601,Pocillopora_acuta_HIv2___RNAseq.g12166.t1,309.814925,-1.37517944,1.515121601,0.012318312,0.049478495,,Q9D119,1.81E-12,Protein phosphatase 1 regulatory subunit 27 (Dysferlin-interacting protein 1),,GO:0004864; GO:0019902
3602,Pocillopora_acuta_HIv2___RNAseq.g26096.t1,212.3265191,-0.154790587,1.028527314,0.01236456,0.049650472,,Q3BJS1,6.72E-49,Forkhead box protein N4,amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; heart looping [GO:0001947]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of heart contraction [GO:0008016]; retina layer formation [GO:0010842]; ventral spinal cord interneuron fate commitment [GO:0060579],GO:0000981; GO:0000987; GO:0001947; GO:0003682; GO:0005634; GO:0006355; GO:0008016; GO:0010842; GO:0035881; GO:0036302; GO:0043565; GO:0045944; GO:0060579
3603,Pocillopora_acuta_HIv2___RNAseq.g2710.t1,313.6171524,-0.347320548,1.086861086,0.012368767,0.049653578,,Q571C7,3.51E-32,Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150) (TFIIIB150) (Transcription factor-like nuclear regulator),regulation of DNA-templated transcription [GO:0006355]; RNA polymerase III preinitiation complex assembly [GO:0070898],GO:0000126; GO:0001156; GO:0005634; GO:0005654; GO:0006355; GO:0070898
3604,Pocillopora_acuta_HIv2___TS.g22632.t2,147.631473,-0.280303972,1.034937003,0.012403854,0.049780617,,Q32TF8,0,EF-hand domain-containing family member C2,multi-ciliated epithelial cell differentiation [GO:1903251]; regulation of neuron projection development [GO:0010975]; specification of pronephric distal tubule identity [GO:0039010],GO:0005879; GO:0010975; GO:0039010; GO:1903251
3605,Pocillopora_acuta_HIv2___TS.g9942.t1,786.290413,-0.736043298,1.210586945,0.012419038,0.049827729,,NA,NA,NA,NA,NA
3606,Pocillopora_acuta_HIv2___RNAseq.g14039.t2,3338.807728,1.428448208,0.784660675,0.012462303,0.049987451,,Q7M329,8.80E-35,Ribonuclease T2 (EC 4.6.1.19),innate immune response [GO:0045087]; RNA catabolic process [GO:0006401],GO:0003723; GO:0004521; GO:0004540; GO:0005576; GO:0005615; GO:0005758; GO:0005764; GO:0005788; GO:0006401; GO:0033897; GO:0043202; GO:0045087